Citrus Sinensis ID: 027927

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------
Protein Sequence
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFILFQS
Secondary Structure (PSIPRED)
cccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHccccHHHHcccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHHcccccccccHHHHcccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEHEccHHccccccccHHHccHHHcccEcccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHcccccHHHHHHHHcccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHHHHccccccccccc
Coil and Loop (DISEMBL)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKyihsanvihrdlkpsnlllnancdlkicdfglarptsenefMTEYVVTRwyrapelllnssdytaAIDVWSVGCIFMElmnrrplfpgndhVHQMRLLIELlgtptdadlgfvrnEDAKRYIrqlpqhprqslaqvfphvhPLAIDLVDrmltfdpmkritgeffvpykpfqcccgciefilfqs
Flexible Loop (DISEMBL)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFILFQS
Low Complexity Region (SEG)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFILFQS
Disordered region (IsUnstruct)
*****YQIIR***SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFILF**
Disordered Region (DISOPRED)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP*******AQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFILF**
Disordered Region (DISEMBL)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFILFQS
Disordered Region (DISPRO)
*DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIE******
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFILFQS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	217	2.2.26 [Sep-21-2011]
Q39023	370	Mitogen-activated protein	yes	no	0.898	0.527	0.892	1e-101
Q84UI5	398	Mitogen-activated protein	yes	no	0.894	0.487	0.841	1e-95
Q06060	394	Mitogen-activated protein	N/A	no	0.894	0.492	0.841	3e-95
Q07176	387	Mitogen-activated protein	N/A	no	0.894	0.501	0.841	8e-95
Q10N20	369	Mitogen-activated protein	no	no	0.898	0.528	0.789	2e-93
A2XFC8	369	Mitogen-activated protein	N/A	no	0.898	0.528	0.789	2e-93
Q40532	393	Mitogen-activated protein	N/A	no	0.894	0.493	0.820	1e-92
Q39026	395	Mitogen-activated protein	no	no	0.884	0.486	0.823	2e-89
Q40531	371	Mitogen-activated protein	N/A	no	0.898	0.525	0.723	2e-84
Q40353	371	Mitogen-activated protein	N/A	no	0.884	0.517	0.723	4e-84

>sp|Q39023|MPK3_ARATH Mitogen-activated protein kinase 3 OS=Arabidopsis thaliana GN=MPK3 PE=1 SV=2

 Score =  369 bits (946), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 174/195 (89%), Positives = 185/195 (94%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN+IHRDLKPSNLLLNANCDLKIC
Sbjct: 122 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKIC 181

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSEN+FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct: 182 DFGLARPTSENDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 241

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGF  NEDAKRYIRQLP  PRQ LA++F HV+P+AIDLV
Sbjct: 242 KDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNPMAIDLV 301

Query: 181 DRMLTFDPMKRITGE 195
           DRMLTFDP +RIT E
Sbjct: 302 DRMLTFDPNRRITVE 316

Involved in oxidative stress-mediated signaling cascade to oxidative (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Mediates the phosphorylation of VIP1 and subsequent stress genes transcription in response to Agrobacterium.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q84UI5|MPK1_ORYSJ Mitogen-activated protein kinase 1 OS=Oryza sativa subsp. japonica GN=MPK1 PE=1 SV=1

 Score =  348 bits (894), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 164/195 (84%), Positives = 183/195 (93%), Gaps = 1/195 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 151 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 210

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLNSS+YTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 211 DFGLARTTSETDFMTEYVVTRWYRAPELLLNSSEYTAAIDVWSVGCIFMELMDRKPLFPG 270

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP +ADL FV NE+A+RYIRQLP+H RQS  + FPHVHPLAIDLV
Sbjct: 271 RDHVHQLRLLMELIGTPNEADLDFV-NENARRYIRQLPRHARQSFPEKFPHVHPLAIDLV 329

Query: 181 DRMLTFDPMKRITGE 195
           ++MLTFDP +RIT E
Sbjct: 330 EKMLTFDPRQRITVE 344

Involved in sphingolipid elicitor (SE)-dependent defense signaling pathway. Acts downstream of heterotrimeric G protein alpha subunit and small GTPase RAC1. May regulate the expression of various genes involved in biotic and abiotic stress response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q06060|MAPK_PEA Mitogen-activated protein kinase homolog D5 OS=Pisum sativum PE=2 SV=1

 Score =  347 bits (891), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 164/195 (84%), Positives = 183/195 (93%), Gaps = 1/195 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 146 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 205

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 206 DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 265

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP++ADLGF+ NE+AKRYIRQLP + RQS  + FPHVHP AIDLV
Sbjct: 266 RDHVHQLRLLMELIGTPSEADLGFL-NENAKRYIRQLPLYRRQSFQEKFPHVHPEAIDLV 324

Query: 181 DRMLTFDPMKRITGE 195
           ++MLTFDP +RIT E
Sbjct: 325 EKMLTFDPRQRITVE 339

Pisum sativum (taxid: 3888)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q07176|MMK1_MEDSA Mitogen-activated protein kinase homolog MMK1 OS=Medicago sativa GN=MMK1 PE=1 SV=1

 Score =  346 bits (887), Expect = 8e-95,   Method: Compositional matrix adjust.
 Identities = 164/195 (84%), Positives = 182/195 (93%), Gaps = 1/195 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 139 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 198

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 199 DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 258

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP++ DLGF+ NE+AKRYIRQLP + RQS  + FPHVHP AIDLV
Sbjct: 259 RDHVHQLRLLMELIGTPSEDDLGFL-NENAKRYIRQLPPYRRQSFQEKFPHVHPEAIDLV 317

Query: 181 DRMLTFDPMKRITGE 195
           ++MLTFDP KRIT E
Sbjct: 318 EKMLTFDPRKRITVE 332

May play a role in the mitogenic induction of symbiotic root nodules on Alfalfa by Rhizobium signal molecules.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q10N20|MPK5_ORYSJ Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. japonica GN=MPK5 PE=1 SV=1

 Score =  342 bits (876), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 154/195 (78%), Positives = 182/195 (93%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+ IIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 120 MDTDLHHIIRSNQELSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 179

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARP+SE++ MTEYVVTRWYRAPELLLNS+DY+AAIDVWSVGCIFMEL+NR+PLFPG
Sbjct: 180 DFGLARPSSESDMMTEYVVTRWYRAPELLLNSTDYSAAIDVWSVGCIFMELINRQPLFPG 239

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+HQMRL+ E++GTPTD +LGF+RNEDA++Y+R LPQ+PR++ A +FP V P A+DL+
Sbjct: 240 RDHMHQMRLITEVIGTPTDDELGFIRNEDARKYMRHLPQYPRRTFASMFPRVQPAALDLI 299

Query: 181 DRMLTFDPMKRITGE 195
           +RMLTF+P++RIT E
Sbjct: 300 ERMLTFNPLQRITVE 314

Involved in disease resistance and abiotic stress tolerance signaling pathways. Acts as a positive regulator of drought, salt and cold tolerance. Negatively modulates pathogenesis-related (PR) gene expression and broad-spectrum disease resistance.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|A2XFC8|MPK5_ORYSI Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. indica GN=MPK5 PE=1 SV=2

 Score =  342 bits (876), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 154/195 (78%), Positives = 182/195 (93%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+ IIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 120 MDTDLHHIIRSNQELSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 179

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARP+SE++ MTEYVVTRWYRAPELLLNS+DY+AAIDVWSVGCIFMEL+NR+PLFPG
Sbjct: 180 DFGLARPSSESDMMTEYVVTRWYRAPELLLNSTDYSAAIDVWSVGCIFMELINRQPLFPG 239

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+HQMRL+ E++GTPTD +LGF+RNEDA++Y+R LPQ+PR++ A +FP V P A+DL+
Sbjct: 240 RDHMHQMRLITEVIGTPTDDELGFIRNEDARKYMRHLPQYPRRTFASMFPRVQPAALDLI 299

Query: 181 DRMLTFDPMKRITGE 195
           +RMLTF+P++RIT E
Sbjct: 300 ERMLTFNPLQRITVE 314

Involved in disease resistance and abiotic stress tolerance signaling pathways.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1

 Score =  339 bits (869), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 160/195 (82%), Positives = 181/195 (92%), Gaps = 1/195 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 144 MDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 203

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 204 DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 263

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP++A++ F+ NE+AKRYIRQLP + RQS  + FPHV+P AIDLV
Sbjct: 264 RDHVHQLRLLMELIGTPSEAEMEFL-NENAKRYIRQLPLYRRQSFVEKFPHVNPAAIDLV 322

Query: 181 DRMLTFDPMKRITGE 195
           ++MLTFDP +RIT E
Sbjct: 323 EKMLTFDPRRRITVE 337

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39026|MPK6_ARATH Mitogen-activated protein kinase 6 OS=Arabidopsis thaliana GN=MPK6 PE=1 SV=1

 Score =  328 bits (841), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 159/193 (82%), Positives = 180/193 (93%), Gaps = 1/193 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 147 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 206

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE++FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 207 DFGLARVTSESDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 266

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP++ +L    NE+AKRYIRQLP +PRQS+   FP VHPLAIDL+
Sbjct: 267 RDHVHQLRLLMELIGTPSEEEL-EFLNENAKRYIRQLPPYPRQSITDKFPTVHPLAIDLI 325

Query: 181 DRMLTFDPMKRIT 193
           ++MLTFDP +RIT
Sbjct: 326 EKMLTFDPRRRIT 338

Involved in oxidative stress-mediated signaling cascade (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Phosphorylates 1-aminocyclopropane-1-carboxylic acid synthases (ACS2 and ACS6) and may be involved in the regulation of bacterial elicitor flagellin-induced ethylene production. Regulates locally gene-mediated and basal resitance response to certain pathogens. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1

 Score =  311 bits (797), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 141/195 (72%), Positives = 171/195 (87%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRS+Q+L+++HCQYFLYQLLRGLKY+HSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 122 MDTDLHQIIRSSQALTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIC 181

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI MEL+ R PLFPG
Sbjct: 182 DFGLARTTSEADFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELIKREPLFPG 241

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D+  Q+ L+I LLG+P D+DLGF+R+++A++Y++ LP+ PR   +Q FP V PLA+DL 
Sbjct: 242 RDYAQQLGLIIALLGSPEDSDLGFLRSDNARKYVKHLPRVPRHPFSQKFPDVSPLALDLA 301

Query: 181 DRMLTFDPMKRITGE 195
           +RML FDP KRIT E
Sbjct: 302 ERMLVFDPAKRITVE 316

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1

 Score =  310 bits (794), Expect = 4e-84,   Method: Compositional matrix adjust.
 Identities = 139/192 (72%), Positives = 173/192 (90%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ ++++HC+YF+YQLLRGLKY+HSANV+HRDLKPSNLLLNANCDLKI 
Sbjct: 121 MDTDLHQIIRSNQPMTDDHCRYFVYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 180

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLN SDYTAAID+WSVGCI  E++ R+PLFPG
Sbjct: 181 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSDYTAAIDIWSVGCILGEIVTRQPLFPG 240

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D+VHQ+RL+ EL+G+P DA LGF+R+E+A+RY+RQLPQ+P+Q+ +  FP++ P A+DL+
Sbjct: 241 RDYVHQLRLVTELIGSPDDASLGFLRSENARRYVRQLPQYPKQNFSARFPNMSPGAVDLL 300

Query: 181 DRMLTFDPMKRI 192
           ++ML FDP KRI
Sbjct: 301 EKMLIFDPSKRI 312

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	217
381355659	375	mitogen-activated protein kinase 1 [Citr	0.889	0.514	1.0	1e-110
122894104	375	mitogen-activated protein kinase [Citrus	0.889	0.514	0.989	1e-109
297746188	329	unnamed protein product [Vitis vinifera]	0.898	0.592	0.902	1e-102
225435179	375	PREDICTED: mitogen-activated protein kin	0.898	0.52	0.902	1e-102
255582993	280	big map kinase/bmk, putative [Ricinus co	0.898	0.696	0.897	1e-101
297815708	370	mitogen-activated protein kinase 3 [Arab	0.898	0.527	0.902	1e-100
55978182	369	mitogen-activated protein kinase 3 [Chor	0.898	0.528	0.902	1e-100
224106027	371	predicted protein [Populus trichocarpa]	0.898	0.525	0.887	1e-100
334702083	370	mitogen-activated protein [Cucumis melo]	0.894	0.524	0.902	1e-100
297748119	376	mitogen-activated protein kinase 3 [Goss	0.898	0.518	0.887	1e-100

>gi|381355659|gb|AFG26277.1| mitogen-activated protein kinase 1 [Citrus sinensis]

 Score =  404 bits (1038), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 193/193 (100%), Positives = 193/193 (100%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 127 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 186

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG
Sbjct: 187 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 246

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV
Sbjct: 247 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 306

Query: 181 DRMLTFDPMKRIT 193
           DRMLTFDPMKRIT
Sbjct: 307 DRMLTFDPMKRIT 319

Source: Citrus sinensis

Species: Citrus sinensis

Genus: Citrus

Family: Rutaceae

Order: Sapindales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|122894104|gb|ABM67698.1| mitogen-activated protein kinase [Citrus sinensis]

 Score =  400 bits (1027), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 191/193 (98%), Positives = 192/193 (99%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 127 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 186

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG
Sbjct: 187 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 246

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV
Sbjct: 247 KDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 306

Query: 181 DRMLTFDPMKRIT 193
           DRMLTFDPMKRIT
Sbjct: 307 DRMLTFDPMKRIT 319

Source: Citrus sinensis

Species: Citrus sinensis

Genus: Citrus

Family: Rutaceae

Order: Sapindales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297746188|emb|CBI16244.3| unnamed protein product [Vitis vinifera]

 Score =  375 bits (963), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 176/195 (90%), Positives = 185/195 (94%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 81  MDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 140

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPT+ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF G
Sbjct: 141 DFGLARPTAENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFAG 200

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGFVRN+DA+RYI QLPQHPRQ L  VFPH+HPLAIDL+
Sbjct: 201 KDHVHQMRLLTELLGTPTESDLGFVRNDDARRYIMQLPQHPRQPLVNVFPHIHPLAIDLI 260

Query: 181 DRMLTFDPMKRITGE 195
           DRMLTFDP KRIT E
Sbjct: 261 DRMLTFDPTKRITVE 275

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225435179|ref|XP_002284807.1| PREDICTED: mitogen-activated protein kinase 3 [Vitis vinifera]

 Score =  375 bits (962), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 176/195 (90%), Positives = 185/195 (94%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 127 MDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 186

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPT+ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF G
Sbjct: 187 DFGLARPTAENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFAG 246

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGFVRN+DA+RYI QLPQHPRQ L  VFPH+HPLAIDL+
Sbjct: 247 KDHVHQMRLLTELLGTPTESDLGFVRNDDARRYIMQLPQHPRQPLVNVFPHIHPLAIDLI 306

Query: 181 DRMLTFDPMKRITGE 195
           DRMLTFDP KRIT E
Sbjct: 307 DRMLTFDPTKRITVE 321

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255582993|ref|XP_002532266.1| big map kinase/bmk, putative [Ricinus communis] gi|223528054|gb|EEF30132.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  373 bits (957), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 175/195 (89%), Positives = 187/195 (95%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 32  MDTDLHQIIRSNQSLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 91

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENEFMTEYVVTRWYRAPELLLNSS+YTAAIDVWSVGCI+MELMNR+PLFPG
Sbjct: 92  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSEYTAAIDVWSVGCIYMELMNRKPLFPG 151

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGF++NEDAKRYIRQL  +PRQ L +VFPHVHPLAIDL+
Sbjct: 152 KDHVHQMRLLTELLGTPTESDLGFIKNEDAKRYIRQLTPYPRQPLDKVFPHVHPLAIDLI 211

Query: 181 DRMLTFDPMKRITGE 195
           DRMLTFDP KRIT E
Sbjct: 212 DRMLTFDPTKRITVE 226

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297815708|ref|XP_002875737.1| mitogen-activated protein kinase 3 [Arabidopsis lyrata subsp. lyrata] gi|297321575|gb|EFH51996.1| mitogen-activated protein kinase 3 [Arabidopsis lyrata subsp. lyrata]

 Score =  370 bits (951), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 176/195 (90%), Positives = 185/195 (94%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN+IHRDLKPSNLLLNANCDLKIC
Sbjct: 122 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKIC 181

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSEN+FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct: 182 DFGLARPTSENDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 241

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT+ADLGF  NEDAKRYIRQLP  PRQ LA++F HV+PLAIDLV
Sbjct: 242 KDHVHQMRLLTELLGTPTEADLGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNPLAIDLV 301

Query: 181 DRMLTFDPMKRITGE 195
           DRMLTFDP +RIT E
Sbjct: 302 DRMLTFDPNRRITVE 316

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|55978182|gb|AAV68711.1| mitogen-activated protein kinase 3 [Chorispora bungeana]

 Score =  370 bits (949), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 176/195 (90%), Positives = 185/195 (94%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 121 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 180

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENEFMTEYVVTRWYRAPELLLNSS+YTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct: 181 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSEYTAAIDVWSVGCIFMELMNRKPLFPG 240

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGF  NEDAKRYIRQLP  PRQ LA++F HV+PLAIDLV
Sbjct: 241 KDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYIRQLPSFPRQPLAKLFSHVNPLAIDLV 300

Query: 181 DRMLTFDPMKRITGE 195
           DRMLTFDP +RIT E
Sbjct: 301 DRMLTFDPNRRITVE 315

Source: Chorispora bungeana

Species: Chorispora bungeana

Genus: Chorispora

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106027|ref|XP_002314017.1| predicted protein [Populus trichocarpa] gi|222850425|gb|EEE87972.1| predicted protein [Populus trichocarpa]

 Score =  369 bits (948), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 173/195 (88%), Positives = 186/195 (95%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ LSEEHCQYFLYQ+LRGLKYIHSAN+IHRDLKPSNLLLNANCDLKIC
Sbjct: 122 MDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANIIHRDLKPSNLLLNANCDLKIC 181

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct: 182 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 241

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLG PT++DLGFVRNEDA+RYI+QL  HPR+SLA++FP VHPLAIDL+
Sbjct: 242 KDHVHQMRLLTELLGKPTESDLGFVRNEDARRYIQQLDSHPRRSLAELFPLVHPLAIDLI 301

Query: 181 DRMLTFDPMKRITGE 195
           D+MLTFDP KRIT E
Sbjct: 302 DKMLTFDPTKRITVE 316

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334702083|gb|AEG89601.1| mitogen-activated protein [Cucumis melo]

 Score =  369 bits (947), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 176/195 (90%), Positives = 186/195 (95%), Gaps = 1/195 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 123 MDTDLHQIIRSNQSLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 182

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENE MTEYVVTRWYRAPELLLNS DYTAAID+WSVGCIF+ELMNRRPLFPG
Sbjct: 183 DFGLARPTSENECMTEYVVTRWYRAPELLLNS-DYTAAIDIWSVGCIFLELMNRRPLFPG 241

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGF+RNED+KRY+RQLP HPRQ LA VFPHVHPLAIDLV
Sbjct: 242 RDHVHQMRLLTELLGTPTESDLGFIRNEDSKRYLRQLPPHPRQPLATVFPHVHPLAIDLV 301

Query: 181 DRMLTFDPMKRITGE 195
           D+MLTFDP KRIT E
Sbjct: 302 DKMLTFDPTKRITVE 316

Source: Cucumis melo

Species: Cucumis melo

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297748119|gb|ADI52626.1| mitogen-activated protein kinase 3 [Gossypium hirsutum]

 Score =  369 bits (946), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 173/195 (88%), Positives = 187/195 (95%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 127 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 186

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARP SENEFMTEYVVTRWYRAPE+LLNSSDYTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct: 187 DFGLARPASENEFMTEYVVTRWYRAPEILLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 246

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           NDHVHQMRLL ELLGTPT++DLGF++NEDA+RYIRQLP +PRQ LA VFPHV+ +A+DL+
Sbjct: 247 NDHVHQMRLLTELLGTPTESDLGFLQNEDARRYIRQLPAYPRQQLANVFPHVNRMALDLI 306

Query: 181 DRMLTFDPMKRITGE 195
           DRMLTFDP +RIT E
Sbjct: 307 DRMLTFDPTRRITVE 321

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	217
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.898	0.527	0.892	6.1e-94
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.884	0.486	0.829	3.7e-87
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.930	0.537	0.694	3.4e-77
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.889	0.513	0.709	2.4e-76
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.889	0.531	0.689	8.1e-76
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.889	0.523	0.699	4e-74
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.884	0.488	0.715	8.4e-74
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.889	0.518	0.637	8e-69
TAIR|locus:2012808	370	MPK1 "mitogen-activated protei	0.889	0.521	0.639	2.4e-67
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.921	0.543	0.605	1.3e-66

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
 Identities = 174/195 (89%), Positives = 185/195 (94%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN+IHRDLKPSNLLLNANCDLKIC
Sbjct:   122 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKIC 181

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLARPTSEN+FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct:   182 DFGLARPTSENDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 241

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              DHVHQMRLL ELLGTPT++DLGF  NEDAKRYIRQLP  PRQ LA++F HV+P+AIDLV
Sbjct:   242 KDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNPMAIDLV 301

Query:   181 DRMLTFDPMKRITGE 195
             DRMLTFDP +RIT E
Sbjct:   302 DRMLTFDPNRRITVE 316

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 871 (311.7 bits), Expect = 3.7e-87, P = 3.7e-87
 Identities = 160/193 (82%), Positives = 182/193 (94%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct:   147 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 206

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR TSE++FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct:   207 DFGLARVTSESDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 266

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              DHVHQ+RLL+EL+GTP++ +L F+ NE+AKRYIRQLP +PRQS+   FP VHPLAIDL+
Sbjct:   267 RDHVHQLRLLMELIGTPSEEELEFL-NENAKRYIRQLPPYPRQSITDKFPTVHPLAIDLI 325

Query:   181 DRMLTFDPMKRIT 193
             ++MLTFDP +RIT
Sbjct:   326 EKMLTFDPRRRIT 338

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
 Identities = 141/203 (69%), Positives = 177/203 (87%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRSNQSL+++HCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN+NCDLKI 
Sbjct:   127 MDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLKIT 186

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR TSE E+MTEYVVTRWYRAPELLLNSS+YT+AIDVWSVGCIF E+M R PLFPG
Sbjct:   187 DFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLFPG 246

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+VHQ++L+ EL+G+P  A L F+R+ +A++Y+++LP+ PRQ+ +  FP ++  AIDL+
Sbjct:   247 KDYVHQLKLITELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNSTAIDLL 306

Query:   181 DRMLTFDPMKRITGEFFVPYKPF 203
             ++ML FDP+KRIT E  + Y P+
Sbjct:   307 EKMLVFDPVKRITVEEALCY-PY 328

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
 Identities = 137/193 (70%), Positives = 170/193 (88%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRSNQ L+++HC++FLYQLLRGLKY+HSANV+HRDLKPSNLLLNANCDLK+ 
Sbjct:   127 MDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLG 186

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR  SE +FMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E M R PLFPG
Sbjct:   187 DFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTREPLFPG 246

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+VHQ+RL+ EL+G+P D+ LGF+R+++A+RY+RQLPQ+PRQ+ A  FP++   A+DL+
Sbjct:   247 KDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLL 306

Query:   181 DRMLTFDPMKRIT 193
             ++ML FDP +RIT
Sbjct:   307 EKMLVFDPSRRIT 319

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 764 (274.0 bits), Expect = 8.1e-76, P = 8.1e-76
 Identities = 133/193 (68%), Positives = 169/193 (87%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRS Q+L+++HCQYFLYQ+LRGLKYIHSANV+HRDLKPSNL+LN NCDLKIC
Sbjct:   117 MDTDLHQIIRSTQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKIC 176

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR ++E E MTEYVVTRWYRAPELLLNSS+YT AID+WSVGCIFME++ R  LFPG
Sbjct:   177 DFGLARTSNETEIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPG 236

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+V Q++L+ ELLG+P D+DL F+R+++A++Y++QLP   +QS  + FP++ P+A+DL 
Sbjct:   237 KDYVQQLKLITELLGSPDDSDLDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLA 296

Query:   181 DRMLTFDPMKRIT 193
             ++ML FDP KRIT
Sbjct:   297 EKMLVFDPSKRIT 309

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 748 (268.4 bits), Expect = 4.0e-74, P = 4.0e-74
 Identities = 135/193 (69%), Positives = 167/193 (86%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+ IIRSNQ L+++H ++FLYQLLRGLKY+HSANV+HRDLKPSNLLLNANCDLKI 
Sbjct:   124 MDTDLHHIIRSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 183

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR  SE +FMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E+M R PLFPG
Sbjct:   184 DFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPG 243

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+V Q+RL+ EL+G+P D+ LGF+R+++A+RY+RQLPQ+PRQ+ A  FP++   A+DL+
Sbjct:   244 RDYVQQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLL 303

Query:   181 DRMLTFDPMKRIT 193
              +ML FDP +RIT
Sbjct:   304 QKMLVFDPNRRIT 316

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 745 (267.3 bits), Expect = 8.4e-74, P = 8.4e-74
 Identities = 138/193 (71%), Positives = 167/193 (86%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             M+ DLY+ ++S+Q L+++H  YF+YQ+LRGLKYIHSANV+HRDLKPSNLLL+  CDLKIC
Sbjct:   144 MEFDLYRTLKSDQELTKDHGMYFMYQILRGLKYIHSANVLHRDLKPSNLLLSTQCDLKIC 203

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR T E+  MTEYVVTRWYRAPELLL SSDYTAAIDVWSVGCIFME+MNR PLFPG
Sbjct:   204 DFGLARATPESNLMTEYVVTRWYRAPELLLGSSDYTAAIDVWSVGCIFMEIMNREPLFPG 263

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D V+Q+RLL+EL+GTP++ +LG + +E AKRYIRQLP  PRQS  + FP+V PLAIDLV
Sbjct:   264 KDQVNQLRLLLELIGTPSEEELGSL-SEYAKRYIRQLPTLPRQSFTEKFPNVPPLAIDLV 322

Query:   181 DRMLTFDPMKRIT 193
             ++MLTFDP +RI+
Sbjct:   323 EKMLTFDPKQRIS 335

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 698 (250.8 bits), Expect = 8.0e-69, P = 8.0e-69
 Identities = 123/193 (63%), Positives = 165/193 (85%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL +I+RSNQ+L+ + C++ +YQLLRGLKY+HSAN++HRDL+PSN+LLN+  +LKI 
Sbjct:   125 MDTDLQRILRSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSKNELKIG 184

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR TS+ +FMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E+M  +PLFPG
Sbjct:   185 DFGLARTTSDTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTGQPLFPG 244

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+VHQ+RL+ EL+G+P ++ LGF+R+++A+RY+RQLP++P+Q  A  FP +   AIDL+
Sbjct:   245 KDYVHQLRLITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARFPKMPTTAIDLL 304

Query:   181 DRMLTFDPMKRIT 193
             +RML FDP +RI+
Sbjct:   305 ERMLVFDPNRRIS 317

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

TAIR|locus:2012808 MPK1 "mitogen-activated protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 684 (245.8 bits), Expect = 2.4e-67, P = 2.4e-67
 Identities = 124/194 (63%), Positives = 159/194 (81%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QII+S+Q LS +HCQYFL+QLLRGLKYIHSAN++HRDLKP NLL+NANCDLKIC
Sbjct:   116 MDTDLHQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKIC 175

Query:    61 DFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
             DFGLAR ++ + +FMTEYVVTRWYRAPELLL   +Y  +IDVWSVGCIF EL+ R+P+F 
Sbjct:   176 DFGLARASNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFQ 235

Query:   120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             G + ++Q++L++ +LG+  + DL F+ N  AKRYIR LP  P  SL++++P  H LAIDL
Sbjct:   236 GTECLNQLKLIVNILGSQREEDLEFIDNPKAKRYIRSLPYSPGMSLSRLYPGAHVLAIDL 295

Query:   180 VDRMLTFDPMKRIT 193
             + +ML FDP KRI+
Sbjct:   296 LQKMLVFDPSKRIS 309

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006635 "fatty acid beta-oxidation" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0008219 "cell death" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009755 "hormone-mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0016558 "protein import into peroxisome matrix" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0009734 "auxin mediated signaling pathway" evidence=TAS

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 677 (243.4 bits), Expect = 1.3e-66, P = 1.3e-66
 Identities = 123/203 (60%), Positives = 162/203 (79%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QII+S+QSLS++HC+YFL+QLLRGLKY+HSAN++HRDLKP NLL+NANCDLKIC
Sbjct:   116 MDTDLHQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC 175

Query:    61 DFGLARPTSENE-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
             DFGLAR +  NE FMTEYVVTRWYRAPELLL   +Y  +IDVWSVGCIF E++ R+P+FP
Sbjct:   176 DFGLARTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFP 235

Query:   120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             G + ++Q++L+I ++G+  ++D+ F+ N  A+R+I+ LP      L+ ++P  +PLAIDL
Sbjct:   236 GTECLNQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDL 295

Query:   180 VDRMLTFDPMKRI--TGEFFVPY 200
             + RML FDP KRI  T     PY
Sbjct:   296 LQRMLVFDPTKRISVTDALLHPY 318

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q84UI5	MPK1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8410	0.8940	0.4874	yes	no
Q39023	MPK3_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8923	0.8986	0.5270	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.914
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00024457001	SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (375 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00016645001	SubName- Full=Putative uncharacterized protein (Chromosome chr11 scaffold_13, whole genome shot [...] (354 aa)			•			•		•	0.810
	GSVIVG00025258001	SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (355 aa)			•			•		•	0.810
	GSVIVG00016514001	SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (354 aa)			•			•		•	0.809
	GSVIVG00026902001	SubName- Full=Chromosome chr15 scaffold_40, whole genome shotgun sequence; (195 aa)						•			0.800
	GSVIVG00002536001	SubName- Full=Chromosome chr2 scaffold_132, whole genome shotgun sequence; (121 aa)						•			0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	217
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-143
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-130
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-114
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-99
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-98
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-95
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-87
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-86
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-81
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-80
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-79
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-74
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-73
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-73
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-72
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-72
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-70
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-68
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-67
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-64
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-64
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-64
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-62
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-61
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-61
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-61
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-58
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-58
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-57
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-56
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-54
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-53
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-53
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-53
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-53
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-53
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-52
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-52
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-52
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-51
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-50
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-49
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-48
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-47
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-47
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-47
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-47
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-45
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-44
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-43
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-42
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-41
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-41
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-40
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-38
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-37
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-34
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-31
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-31
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-28
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-21
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-20
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-17
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-17
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-16
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-15
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-13
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-13
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-13
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	6e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	9e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	1e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	6e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.004

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  403 bits (1038), Expect = e-143
 Identities = 151/194 (77%), Positives = 176/194 (90%), Gaps = 1/194 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRS+Q+LS++HCQYFLYQLLRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 91  MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 150

Query: 61  DFGLARPTSEN-EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLAR TSE  +FMTEYVVTRWYRAPELLLN S+YT AIDVWSVGCIF EL+ R+PLFP
Sbjct: 151 DFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G D+VHQ++L+ ELLG+P++ DLGF+RNE A+RYIR LP  PRQS A++FPH +PLAIDL
Sbjct: 211 GKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDL 270

Query: 180 VDRMLTFDPMKRIT 193
           +++ML FDP KRIT
Sbjct: 271 LEKMLVFDPSKRIT 284

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  369 bits (950), Expect = e-130
 Identities = 124/199 (62%), Positives = 165/199 (82%), Gaps = 4/199 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDL+++I+S Q L+++H QYFLYQ+LRGLKY+HSANVIHRDLKPSN+L+N+NCDLKIC
Sbjct: 86  METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKIC 145

Query: 61  DFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR       E  F+TEYVVTRWYRAPELLL+SS YT AID+WSVGCIF EL+ R+P
Sbjct: 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           LFPG D++ Q+ L++E+LGTP++ DL F+ +E A+ Y++ LP+ P++ L+++FP   P A
Sbjct: 206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEA 265

Query: 177 IDLVDRMLTFDPMKRITGE 195
           IDL+++ML FDP KRIT +
Sbjct: 266 IDLLEKMLVFDPKKRITAD 284

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  328 bits (844), Expect = e-114
 Identities = 120/199 (60%), Positives = 154/199 (77%), Gaps = 5/199 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY++I++ Q LS +H QYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN NCDLKIC
Sbjct: 90  METDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKIC 148

Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR          F+TEYV TRWYRAPE++LNS  YT AID+WSVGCI  E+++ RP
Sbjct: 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           LFPG D++HQ+ L++ +LGTP+  DL  + +  A+ YI+ LP  P+    ++FP+  P A
Sbjct: 209 LFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKA 268

Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRIT E
Sbjct: 269 LDLLDKMLTFNPHKRITVE 287

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  289 bits (743), Expect = 8e-99
 Identities = 113/198 (57%), Positives = 153/198 (77%), Gaps = 5/198 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M++DL+ II S+Q L+EEH +YFLYQLLRGLKYIHSANVIHRDLKPSNLL+N +C+L+I 
Sbjct: 90  MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIG 149

Query: 61  DFGLAR-----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           DFG+AR     PT    FMTEYV TRWYRAPELLL+  +YT AID+WSVGCIF E++ RR
Sbjct: 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
            LFPG ++VHQ++L++ +LG+P++  L  + ++  ++YI+ LP+      +++FP   P 
Sbjct: 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE 269

Query: 176 AIDLVDRMLTFDPMKRIT 193
           A+DL+ +ML FDP +RIT
Sbjct: 270 ALDLLSQMLQFDPEERIT 287

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  288 bits (740), Expect = 2e-98
 Identities = 114/200 (57%), Positives = 151/200 (75%), Gaps = 5/200 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+ DL+QIIRS Q L++ H Q F+YQ+L GLKYIHSANV+HRDLKP NLL+NA+C+LKIC
Sbjct: 88  MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKIC 147

Query: 61  DFGLARPTSEN-----EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           DFGLAR  SEN      FMTEYV TRWYRAPE++L+   YT AIDVWSVGCI  EL+ R+
Sbjct: 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
           P+F G D+V Q+  ++++LGTP +  L  + +  A+ YIR LP  P++    +FP+ +PL
Sbjct: 208 PVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPL 267

Query: 176 AIDLVDRMLTFDPMKRITGE 195
           A+DL++++L FDP KRI+ E
Sbjct: 268 ALDLLEKLLAFDPTKRISVE 287

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  282 bits (723), Expect = 1e-95
 Identities = 102/195 (52%), Positives = 140/195 (71%), Gaps = 3/195 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q LS++H Q+ +YQ+LRGLKYIHSA +IHRDLKPSN+ +N +C+LKI 
Sbjct: 102 MGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 160

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q++ ++ L+GTP +  L  + +E A+ YI+ LPQ P++   +VF   +PLAIDL+
Sbjct: 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLL 278

Query: 181 DRMLTFDPMKRITGE 195
           ++ML  DP KRIT  
Sbjct: 279 EKMLVLDPDKRITAA 293

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  260 bits (668), Expect = 2e-87
 Identities = 97/201 (48%), Positives = 140/201 (69%), Gaps = 7/201 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDL+ +IR+N  L + H +Y +YQLL+ LKYIHS NVIHRDLKPSN+LLN++C +K+ 
Sbjct: 91  METDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLA 149

Query: 61  DFGLARPTSE------NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           DFGLAR  SE      N  +T+YV TRWYRAPE+LL S+ YT  +D+WSVGCI  E++  
Sbjct: 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP 174
           +PLFPG   ++Q+  +IE++G P+  D+  +++  A   +  LP  PR+ L ++ P    
Sbjct: 210 KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASD 269

Query: 175 LAIDLVDRMLTFDPMKRITGE 195
            A+DL+ ++L F+P KR+T E
Sbjct: 270 DALDLLKKLLVFNPNKRLTAE 290

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  258 bits (660), Expect = 3e-86
 Identities = 110/201 (54%), Positives = 144/201 (71%), Gaps = 7/201 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M++DL+Q+I++N  L+ EH Q+FLYQLLR LKYIH+ANV HRDLKP N+L NA+C LKIC
Sbjct: 86  MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKIC 145

Query: 61  DFGLARP----TSENEFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMNRR 115
           DFGLAR     T    F T+YV TRWYRAPEL  +  S YT AID+WS+GCIF E++  +
Sbjct: 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL-PQHPRQSLAQVFPHVHP 174
           PLFPG + VHQ+ L+ +LLGTP+   +  VRNE A+RY+  +  + P    +Q FP+  P
Sbjct: 206 PLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP-FSQKFPNADP 264

Query: 175 LAIDLVDRMLTFDPMKRITGE 195
           LA+ L++R+L FDP  R T E
Sbjct: 265 LALRLLERLLAFDPKDRPTAE 285

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  245 bits (626), Expect = 3e-81
 Identities = 98/195 (50%), Positives = 140/195 (71%), Gaps = 3/195 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           + TDL++++ S + L ++  QYFLYQ+LRGLKY+HSA V+HRDLKPSN+L+N NCDLKIC
Sbjct: 92  LGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKIC 150

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   ++  MT YV TR+YRAPE++L    Y   +D+WS GCIF E++  +PLFPG
Sbjct: 151 DFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHV+Q  ++ +LLGTP D  +  + +E+  R+++ LP+      ++ F +  P AIDL+
Sbjct: 209 KDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLL 268

Query: 181 DRMLTFDPMKRITGE 195
           ++ML FDP KRI+  
Sbjct: 269 EKMLVFDPQKRISAA 283

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  241 bits (616), Expect = 3e-80
 Identities = 95/197 (48%), Positives = 124/197 (62%), Gaps = 3/197 (1%)

Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           MDTDLY++I+  Q  L E   + +LYQLL+GL + HS  ++HRDLKP NLL+N    LK+
Sbjct: 80  MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKL 139

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR   S     T YVVTRWYRAPELLL    Y+  +D+WSVGCIF EL++RRPLF
Sbjct: 140 ADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG   + Q+  +   LGTP         +  A+ Y    P+     L ++FP+  P A+D
Sbjct: 200 PGKSEIDQLFKIFRTLGTPDPEVWPKFTS-LARNYKFSFPKKAGMPLPKLFPNASPQALD 258

Query: 179 LVDRMLTFDPMKRITGE 195
           L+ +ML +DP KRIT E
Sbjct: 259 LLSQMLHYDPHKRITAE 275

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  237 bits (608), Expect = 4e-79
 Identities = 84/196 (42%), Positives = 118/196 (60%), Gaps = 6/196 (3%)

Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            D DL + +      LS    +  +YQLLRGL Y HS  ++HRDLKP N+L+N +  LK+
Sbjct: 80  CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKL 139

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  VVT WYRAPE+LL S  Y+ A+D+WSVGCIF E++  +PLF
Sbjct: 140 ADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199

Query: 119 PGNDHVHQMRLLIELLGTPTDAD-LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+  + Q+  + ++LGTPT+    G  +      Y    P+ P + L +V P + P  I
Sbjct: 200 PGDSEIDQLFKIFQILGTPTEESWPGVTKL---PDYKPTFPKFPPKDLEKVLPRLDPEGI 256

Query: 178 DLVDRMLTFDPMKRIT 193
           DL+ +ML ++P KRI+
Sbjct: 257 DLLSKMLQYNPAKRIS 272

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  226 bits (578), Expect = 6e-74
 Identities = 102/206 (49%), Positives = 143/206 (69%), Gaps = 9/206 (4%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q LS+EH Q+ +YQLLRGLKYIHSA +IHRDLKPSN+ +N +C+L+I 
Sbjct: 102 MGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 161 DFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           ND++ Q++ ++E++GTP+   L  + +E A++YI+ LP  P+Q L ++F   +PLAIDL+
Sbjct: 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLL 278

Query: 181 DRMLTFDPMKRITGE------FFVPY 200
           ++ML  D  KRI+        +F  Y
Sbjct: 279 EKMLVLDSDKRISASEALAHPYFSQY 304

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  225 bits (576), Expect = 4e-73
 Identities = 98/199 (49%), Positives = 134/199 (67%), Gaps = 5/199 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M +DL++II S Q LS +H + FLYQ+LRGLKY+HSA ++HRD+KP NLL+N+NC LKIC
Sbjct: 86  MQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKIC 145

Query: 61  DFGLAR--PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFGLAR     E++ MT+ VVT++YRAPE+L+ S  YT+A+D+WSVGCIF EL+ RR LF
Sbjct: 146 DFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP--RQSLAQVFPHVHPLA 176
                + Q+ L+ +LLGTP+   +     E A+ +I + P  P     L  +       A
Sbjct: 206 QAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILRGPHKPPSLPVLYTLSSQATHEA 264

Query: 177 IDLVDRMLTFDPMKRITGE 195
           + L+ RML FDP KRI+  
Sbjct: 265 VHLLCRMLVFDPDKRISAA 283

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  224 bits (573), Expect = 4e-73
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 104 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 162

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 163 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 280

Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 281 EKMLVLDSDKRITA 294

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  221 bits (565), Expect = 2e-72
 Identities = 78/198 (39%), Positives = 121/198 (61%), Gaps = 7/198 (3%)

Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           MD DL  ++ S +   +E   + ++ QLL GL+Y+HS  ++HRD+K SN+L+N +  LK+
Sbjct: 82  MDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKL 141

Query: 60  CDFGLARPTS--ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            DFGLARP +   +   T  V+T WYR PELLL ++ Y   +D+WSVGCI  EL   +P+
Sbjct: 142 ADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPHVH-PL 175
           F G+  + Q+  + EL G+PTD +   V      +    +  +  ++ L + F H+  P 
Sbjct: 202 FQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL--KPKKPYKRRLREFFKHLIDPS 259

Query: 176 AIDLVDRMLTFDPMKRIT 193
           A+DL+D++LT DP KRI+
Sbjct: 260 ALDLLDKLLTLDPKKRIS 277

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  221 bits (565), Expect = 7e-72
 Identities = 91/193 (47%), Positives = 141/193 (73%), Gaps = 3/193 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL ++++ ++ LSE+  Q+ +YQ+L+GLKYIH+A +IHRDLKP NL +N +C+LKI 
Sbjct: 102 MGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKIL 160

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T     MT YVVTRWYRAPE++LN   YT  +D+WSVGCI  E++  +PLF G
Sbjct: 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q+  ++++ GTP+   +  +++EDAK Y+++LP+  ++    + P+ +PLA++++
Sbjct: 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVL 278

Query: 181 DRMLTFDPMKRIT 193
           ++ML  D   RIT
Sbjct: 279 EKMLVLDAESRIT 291

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  214 bits (548), Expect = 8e-70
 Identities = 85/198 (42%), Positives = 119/198 (60%), Gaps = 11/198 (5%)

Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+TDL ++I+     L+    + ++   LRGL+Y+HS  ++HRDLKP+NLL+ ++  LK+
Sbjct: 84  METDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKL 143

Query: 60  CDFGLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR   S N  MT  VVTRWYRAPELL  +  Y   +D+WSVGCIF EL+ R P  
Sbjct: 144 ADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR---YIRQLPQHPRQSLAQVFPHVHPL 175
           PG+  + Q+  + E LGTPT+ +              Y+ +    P   L Q+FP     
Sbjct: 204 PGDSDIDQLGKIFEALGTPTEEN-----WPGVTSLPDYV-EFKPFPPTPLKQIFPAASDD 257

Query: 176 AIDLVDRMLTFDPMKRIT 193
           A+DL+ R+LT +P KRIT
Sbjct: 258 ALDLLQRLLTLNPNKRIT 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  212 bits (540), Expect = 4e-68
 Identities = 92/193 (47%), Positives = 131/193 (67%), Gaps = 4/193 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL +I+     LSE+  QY +YQ+L GLKYIHSA +IHRDLKP NL +N +C+LKI 
Sbjct: 102 MQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKIL 159

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTRWYRAPE++LN   Y   +D+WSVGCI  E++  + LF G
Sbjct: 160 DFGLAR--HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D++ Q+  ++++ G P    +  + ++ AK YI+ LP++PR+  + +FP   P A+DL+
Sbjct: 218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLL 277

Query: 181 DRMLTFDPMKRIT 193
           ++ML  D  KR+T
Sbjct: 278 EKMLELDVDKRLT 290

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  207 bits (528), Expect = 5e-67
 Identities = 86/205 (41%), Positives = 119/205 (58%), Gaps = 23/205 (11%)

Query: 1   MDTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           M+ +LYQ+++  +    SE   +  +YQ+L+GL +IH     HRDLKP NLL++    +K
Sbjct: 80  MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVK 139

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           I DFGLAR        T+YV TRWYRAPE+LL S+ Y++ +D+W++GCI  EL   RPLF
Sbjct: 140 IADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199

Query: 119 PGNDHVHQMRLLIELLGTPTDAD----------LGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           PG+  + Q+  +  +LGTPT  D          LGF           + PQ    SL Q+
Sbjct: 200 PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF-----------RFPQFAPTSLHQL 248

Query: 169 FPHVHPLAIDLVDRMLTFDPMKRIT 193
            P+  P AIDL+  ML +DP KR T
Sbjct: 249 IPNASPEAIDLIKDMLRWDPKKRPT 273

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  202 bits (515), Expect = 3e-64
 Identities = 91/200 (45%), Positives = 134/200 (67%), Gaps = 7/200 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKI 59
           M+TDL  ++     LSEEH + F+YQLLRGLKYIHSANV+HRDLKP+N+ +N  +  LKI
Sbjct: 98  METDLANVLEQGP-LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156

Query: 60  CDFGLARPT----SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR      S   +++E +VT+WYR+P LLL+ ++YT AID+W+ GCIF E++  +
Sbjct: 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
           PLF G   + QM+L++E +    + D   + N     ++R     PR+ L  + P V+P 
Sbjct: 217 PLFAGAHELEQMQLILESVPVVREEDRNELLNVIPS-FVRNDGGEPRRPLRDLLPGVNPE 275

Query: 176 AIDLVDRMLTFDPMKRITGE 195
           A+D ++++LTF+PM R+T E
Sbjct: 276 ALDFLEQILTFNPMDRLTAE 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  199 bits (509), Expect = 4e-64
 Identities = 80/199 (40%), Positives = 122/199 (61%), Gaps = 6/199 (3%)

Query: 1   MDTDLYQIIR-SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M +DL +++R   + L E   + ++  LL+G+ Y+H+  ++HRDLKP+NLL++A+  LKI
Sbjct: 81  MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140

Query: 60  CDFGLARPTSENE--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            DFGLAR  SE E    +  V TRWYRAPELL  +  Y   +D+W+VGCIF EL+N  PL
Sbjct: 141 ADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPL 200

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           FPG + + Q+ ++   LGTP +     + +  D  + I   P+     L ++FP   P A
Sbjct: 201 FPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK-ITF-PESKPIPLEEIFPDASPEA 258

Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+  +L +DP KR++  
Sbjct: 259 LDLLKGLLVYDPSKRLSAA 277

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  198 bits (505), Expect = 7e-64
 Identities = 64/190 (33%), Positives = 101/190 (53%), Gaps = 28/190 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+ +++    LSE+  +++L Q+L  L+Y+HS  ++HRDLKP N+LL+ +  +K+ DFG
Sbjct: 83  DLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFG 142

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           LAR     E +T +V T  Y APE+LL    Y  A+D+WS+G I  EL+  +P FPG+D 
Sbjct: 143 LARQLDPGEKLTTFVGTPEYMAPEVLLGKG-YGKAVDIWSLGVILYELLTGKPPFPGDDQ 201

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + ++    + +G P                                  + P A DL+ ++
Sbjct: 202 LLEL---FKKIGKPKPPFPPP------------------------EWDISPEAKDLIRKL 234

Query: 184 LTFDPMKRIT 193
           L  DP KR+T
Sbjct: 235 LVKDPEKRLT 244

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  198 bits (505), Expect = 1e-62
 Identities = 89/208 (42%), Positives = 122/208 (58%), Gaps = 21/208 (10%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I     L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 103 MDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 160

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPG 219

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVR--NEDAKRYIRQLPQHPRQSLAQVFP-------- 170
            DH+ Q   +IE LGTP+D    F+       + Y+   P++   S  ++FP        
Sbjct: 220 TDHIDQWNKIIEQLGTPSDE---FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDS 276

Query: 171 --HVH---PLAIDLVDRMLTFDPMKRIT 193
             H       A DL+ +ML  DP KRI+
Sbjct: 277 ESHNKLKASQARDLLSKMLVIDPEKRIS 304

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  192 bits (491), Expect = 3e-61
 Identities = 86/186 (46%), Positives = 116/186 (62%), Gaps = 8/186 (4%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-E 72
             SE  C   + QLL G+ ++H   ++HRDLK SNLLLN    LKICDFGLAR      +
Sbjct: 104 LQSEVKC--LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161

Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIE 132
             T+ VVT WYRAPELLL + +Y+ AID+WSVGCIF EL+ ++PLFPG   + Q+  + +
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221

Query: 133 LLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP--LAIDLVDRMLTFDPM 189
           LLGTPT+    GF     AK+      ++P   L + FP +       DL++R+LT+DP 
Sbjct: 222 LLGTPTEKIWPGFSELPGAKKKTF--TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279

Query: 190 KRITGE 195
           KRI+ E
Sbjct: 280 KRISAE 285

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  191 bits (488), Expect = 3e-61
 Identities = 68/191 (35%), Positives = 99/191 (51%), Gaps = 25/191 (13%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +     LSE+  +    Q+LRGL+Y+HS  +IHRDLKP N+LL+ N  +KI DFG
Sbjct: 84  DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFG 143

Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA+     +  +T +V T WY APE+LL  + Y   +DVWS+G I  EL+  +P F G +
Sbjct: 144 LAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGEN 203

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
            + Q++L+  +LG P + D     +                            A DL+ +
Sbjct: 204 ILDQLQLIRRILGPPLEFDEPKWSS------------------------GSEEAKDLIKK 239

Query: 183 MLTFDPMKRIT 193
            L  DP KR T
Sbjct: 240 CLNKDPSKRPT 250

Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  191 bits (488), Expect = 6e-61
 Identities = 87/202 (43%), Positives = 120/202 (59%), Gaps = 12/202 (5%)

Query: 1   MDTDL--YQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL 57
           MD DL  Y      + +L     + F YQLL+G+ + H   V+HRDLKP NLL+N   +L
Sbjct: 80  MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL 139

Query: 58  KICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           K+ DFGLAR    P   N F  E VVT WYRAP++LL S  Y+ +ID+WSVGCI  E++ 
Sbjct: 140 KLADFGLARAFGIPV--NTFSNE-VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
            RPLFPG ++  Q+  +  ++GTPT++    +       Y    P++P Q L Q+FPH  
Sbjct: 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LPEYKPTFPRYPPQDLQQLFPHAD 254

Query: 174 PLAIDLVDRMLTFDPMKRITGE 195
           PL IDL+ R+L  +P  RI+  
Sbjct: 255 PLGIDLLHRLLQLNPELRISAH 276

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  185 bits (472), Expect = 3e-58
 Identities = 76/207 (36%), Positives = 114/207 (55%), Gaps = 16/207 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQY--FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           MD DL  ++  N S+     Q   ++ QLL G+ Y+H  +++HRD+K +N+L++    LK
Sbjct: 97  MDHDLSGLL-ENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILK 155

Query: 59  ICDFGLARPTSENEFM------------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
           I DFGLARP                   T  VVTRWYR PELLL    YT A+D+W +GC
Sbjct: 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC 215

Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
           +F E+  RRP+  G   + Q+ L+ +L GTPT+      R+      +     +PR +L 
Sbjct: 216 VFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR-TLE 274

Query: 167 QVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           + F  + P  +DL+ ++L+ DP KR+T
Sbjct: 275 ERFGKLGPEGLDLLSKLLSLDPYKRLT 301

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  184 bits (468), Expect = 5e-58
 Identities = 86/202 (42%), Positives = 120/202 (59%), Gaps = 13/202 (6%)

Query: 1   MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           +D DL + + S     L     + +LYQLL+G+ Y HS  V+HRDLKP NLL++    LK
Sbjct: 80  LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALK 139

Query: 59  ICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           + DFGLAR    P       T  VVT WYRAPE+LL S  Y+  +D+WS+GCIF E++NR
Sbjct: 140 LADFGLARAFGVPVRT---YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
           RPLFPG+  + Q+  +   LGTP +    G     D   Y    P+  RQ L++V P++ 
Sbjct: 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD---YKPTFPKWARQDLSKVVPNLD 253

Query: 174 PLAIDLVDRMLTFDPMKRITGE 195
              +DL+ +ML +DP KRI+ +
Sbjct: 254 EDGLDLLSKMLVYDPAKRISAK 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  182 bits (465), Expect = 4e-57
 Identities = 86/197 (43%), Positives = 118/197 (59%), Gaps = 5/197 (2%)

Query: 2   DTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           + DL  ++ +  +  SE   +  + QLLRGL+Y+H   +IHRDLK SNLLL     LKI 
Sbjct: 91  EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIA 150

Query: 61  DFGLARPTSE-NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLAR      + MT  VVT WYRAPELLL  + YT AID+W+VGCI  EL+  +PL P
Sbjct: 151 DFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210

Query: 120 GNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           G   + Q+ L+I+LLGTP ++   GF       ++   LP+ P  +L   FP +    + 
Sbjct: 211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT--LPKQPYNNLKHKFPWLSEAGLR 268

Query: 179 LVDRMLTFDPMKRITGE 195
           L++ +L +DP KR T E
Sbjct: 269 LLNFLLMYDPKKRATAE 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  179 bits (457), Expect = 3e-56
 Identities = 79/195 (40%), Positives = 114/195 (58%), Gaps = 7/195 (3%)

Query: 1   MDTDLYQIIR--SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           +D DL   +       L  E  +  + QLLRG+ ++HS  ++HRDLKP N+L+ ++  +K
Sbjct: 88  VDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVK 147

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           I DFGLAR  S    +T  VVT WYRAPE+LL SS Y   +D+WSVGCIF EL  RRPLF
Sbjct: 148 IADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLF 206

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G     Q+  + +++G P++ +  + RN    R     P +  +S     P +    +D
Sbjct: 207 RGTSEADQLDKIFDVIGLPSEEE--WPRNVSLPR--SSFPSYTPRSFKSFVPEICEEGLD 262

Query: 179 LVDRMLTFDPMKRIT 193
           L+ +MLTF+P KRI+
Sbjct: 263 LLKKMLTFNPHKRIS 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  174 bits (444), Expect = 9e-54
 Identities = 79/219 (36%), Positives = 120/219 (54%), Gaps = 18/219 (8%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M +DL +++     L+E   +  L Q+L GL  +H    +HRDL P+N+ +N+    KI 
Sbjct: 102 MASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA 161

Query: 61  DFGLAR---------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 105
           DFGLAR                    E MT  VVT WYRAPELL+ +  Y  A+D+WSVG
Sbjct: 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221

Query: 106 CIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
           CIF EL+  +PLFPG + + Q+  + ELLGTP + +    +      Y    P+ P + L
Sbjct: 222 CIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKK--LPLYTEFTPRKP-KDL 278

Query: 166 AQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ 204
             +FP+    AIDL+  +L  +P++RI+ +  + ++ F+
Sbjct: 279 KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317

Length = 335

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  172 bits (439), Expect = 1e-53
 Identities = 84/202 (41%), Positives = 117/202 (57%), Gaps = 10/202 (4%)

Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +DTDL Q +      LS  + + FL+QLLRGL Y H   V+HRDLKP NLL++   +LK+
Sbjct: 85  LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKL 144

Query: 60  CDFGLARPTS--ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            DFGLAR  S     +  E VVT WYR P++LL S++Y+ ++D+W VGCIF E+   RPL
Sbjct: 145 ADFGLARAKSVPSKTYSNE-VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203

Query: 118 FPG-NDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHV--H 173
           FPG  D   Q+  +  +LGTPT+    G   N + K Y    P +P + L    P +   
Sbjct: 204 FPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRI 261

Query: 174 PLAIDLVDRMLTFDPMKRITGE 195
           P   +L  + L ++P KRI+  
Sbjct: 262 PHGEELALKFLQYEPKKRISAA 283

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  172 bits (437), Expect = 3e-53
 Identities = 69/194 (35%), Positives = 114/194 (58%), Gaps = 4/194 (2%)

Query: 1   MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           MD +LY++I+   + L E+  + ++YQLL+ L ++H   + HRD+KP N+L+  +  LK+
Sbjct: 82  MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI-LKL 140

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG  R        TEY+ TRWYRAPE LL    Y   +D+W+VGC+F E+++  PLFP
Sbjct: 141 ADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G + + Q+  + ++LGTP DA++     +          +     L ++ P+     +DL
Sbjct: 201 GTNELDQIAKIHDVLGTP-DAEVLKKFRKSRHMNYNFPSKKG-TGLRKLLPNASAEGLDL 258

Query: 180 VDRMLTFDPMKRIT 193
           + ++L +DP +RIT
Sbjct: 259 LKKLLAYDPDERIT 272

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  172 bits (437), Expect = 3e-53
 Identities = 71/197 (36%), Positives = 112/197 (56%), Gaps = 9/197 (4%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  +  S   L  +  + +++QLL+ + Y HS N+IHRD+KP N+L++ +  LK+CDFG 
Sbjct: 87  LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGF 146

Query: 65  ARPTSEN--EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           AR         +T+YV TRWYRAPELL+  ++Y   +DVW++GCI  EL++  PLFPG+ 
Sbjct: 147 ARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206

Query: 123 HVHQMRLLIELLGTPTDADLG-FVRNEDAKRY--IRQLPQHPRQSLAQVFP-HVHPLAID 178
            + Q+ L+ + LG    +    F  N    R+  +        +SL + +P  V   A+D
Sbjct: 207 DIDQLYLIQKCLGPLPPSHQELFSSN---PRFAGVAFPEPSQPESLERRYPGKVSSPALD 263

Query: 179 LVDRMLTFDPMKRITGE 195
            +   L  DP +R+T +
Sbjct: 264 FLKACLRMDPKERLTCD 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  171 bits (436), Expect = 4e-53
 Identities = 81/200 (40%), Positives = 121/200 (60%), Gaps = 10/200 (5%)

Query: 1   MDTDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC 55
           +D+DL + + SN     + L  +  + F+YQLL+G+ + H   V+HRDLKP NLL++   
Sbjct: 88  LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK 147

Query: 56  D-LKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             LKI D GL R  +   +  T  +VT WYRAPE+LL S+ Y+  +D+WSVGCIF E+  
Sbjct: 148 GLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
           ++PLFPG+  + Q+  + +LLGTPT+     V      R   + PQ   Q L++  P + 
Sbjct: 208 KQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK---LRDWHEFPQWKPQDLSRAVPDLS 264

Query: 174 PLAIDLVDRMLTFDPMKRIT 193
           P  +DL+ +ML +DP KRI+
Sbjct: 265 PEGLDLLQKMLRYDPAKRIS 284

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  171 bits (434), Expect = 8e-53
 Identities = 84/200 (42%), Positives = 121/200 (60%), Gaps = 12/200 (6%)

Query: 1   MDTDLYQIIRSNQSLSEEH--CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-L 57
           +D DL + + S+   ++     + +LYQ+LRG+ Y HS  V+HRDLKP NLL++   + L
Sbjct: 83  LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142

Query: 58  KICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           K+ DFGLAR    P       T  VVT WYRAPE+LL S  Y+  +D+WSVGCIF E++N
Sbjct: 143 KLADFGLARAFGIPVRT---FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
           ++PLFPG+  + ++  +  +LGTP +     V +     Y    P+ P + LA V P + 
Sbjct: 200 QKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LPDYKSAFPKWPPKDLATVVPTLE 257

Query: 174 PLAIDLVDRMLTFDPMKRIT 193
           P  +DL+ +ML  DP KRIT
Sbjct: 258 PAGVDLLSKMLRLDPSKRIT 277

Length = 294

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  170 bits (433), Expect = 1e-52
 Identities = 76/175 (43%), Positives = 104/175 (59%), Gaps = 9/175 (5%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR----PTSENEFMTEYV 78
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR    P       T  V
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEV 161

Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 221

Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +     V       Y    P+  RQ  ++V P +     DL+ +ML +DP KRI+
Sbjct: 222 EVVWPGV--TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS 274

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  169 bits (431), Expect = 3e-52
 Identities = 84/198 (42%), Positives = 112/198 (56%), Gaps = 4/198 (2%)

Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           MD DL  ++ S     SE+H + F+ QLL GL Y H  N +HRD+K SN+LLN    +K+
Sbjct: 98  MDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157

Query: 60  CDFGLAR--PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            DFGLAR   + E+   T  V+T WYR PELLL    Y  AIDVWS GCI  EL  ++P+
Sbjct: 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F  N  + Q+ L+  L G+P  A    V        ++   Q+ R+ L + F  +   A+
Sbjct: 218 FQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQY-RRRLREEFSFIPTPAL 276

Query: 178 DLVDRMLTFDPMKRITGE 195
           DL+D MLT DP KR T E
Sbjct: 277 DLLDHMLTLDPSKRCTAE 294

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  169 bits (429), Expect = 4e-52
 Identities = 86/199 (43%), Positives = 117/199 (58%), Gaps = 9/199 (4%)

Query: 2   DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           D DL +   S N  +  E  + F++QLL+GL + HS NV+HRDLKP NLL+N N +LK+ 
Sbjct: 82  DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLA 141

Query: 61  DFGLARP--TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPL 117
           DFGLAR        +  E VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPL
Sbjct: 142 DFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Query: 118 FPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           FPGND   Q++ +  LLGTPT+    G  +  D K Y          SL  V P ++   
Sbjct: 201 FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP---MYPATTSLVNVVPKLNSTG 257

Query: 177 IDLVDRMLTFDPMKRITGE 195
            DL+  +L  +P++RI+ E
Sbjct: 258 RDLLQNLLVCNPVQRISAE 276

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  168 bits (426), Expect = 7e-51
 Identities = 90/207 (43%), Positives = 124/207 (59%), Gaps = 16/207 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I  +  L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 108 MDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 165

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    N  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  EL+    +F G
Sbjct: 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQG 224

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHP----- 174
            DH+ Q   +IE LGTP+ A+         + Y+   PQ+P  S  ++FP  + P     
Sbjct: 225 TDHIDQWNKVIEQLGTPS-AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESER 283

Query: 175 ------LAIDLVDRMLTFDPMKRITGE 195
                  A DL+ +ML  DP KRI+ +
Sbjct: 284 DKLKTSQARDLLSKMLVIDPDKRISVD 310

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  163 bits (415), Expect = 5e-50
 Identities = 73/198 (36%), Positives = 112/198 (56%), Gaps = 14/198 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +D+     +   Q +  E  + +LYQ+L+G+ + HS  V+HRDLKP NLL++    +K+ 
Sbjct: 89  LDS-----LPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLA 143

Query: 61  DFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    P       T  VVT WYRAPE+LL S  Y+  +D+WS+G IF E+  ++P
Sbjct: 144 DFGLARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           LF G+  + Q+  +  +LGTPT+     V       Y    P+  + SL     ++    
Sbjct: 201 LFHGDSEIDQLFRIFRILGTPTEDVWPGV--TSLPDYKNTFPKWKKGSLRSAVKNLDEDG 258

Query: 177 IDLVDRMLTFDPMKRITG 194
           +DL+++ML +DP KRI+ 
Sbjct: 259 LDLLEKMLIYDPAKRISA 276

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  162 bits (411), Expect = 5e-49
 Identities = 80/225 (35%), Positives = 114/225 (50%), Gaps = 38/225 (16%)

Query: 4   DLYQIIR-----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-- 56
           DL+QII+        S+     +  L+Q+L G+ Y+HS  V+HRDLKP+N+L+       
Sbjct: 89  DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER 148

Query: 57  --LKICDFGLAR--------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
             +KI D GLAR            +      VVT WYRAPELLL +  YT AID+W++GC
Sbjct: 149 GVVKIGDLGLARLFNAPLKPLADLDPV----VVTIWYRAPELLLGARHYTKAIDIWAIGC 204

Query: 107 IFMELMNRRPLFPGND---------HVHQMRLLIELLGTPTDADLGFVRN---EDAKRYI 154
           IF EL+   P+F G +            Q+  + E+LGTPT+ D   ++     D     
Sbjct: 205 IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKD 264

Query: 155 RQLPQHPRQSLAQVFPHVH----PLAIDLVDRMLTFDPMKRITGE 195
            +   +P  SLA+     H        DL+ ++L +DP KRIT E
Sbjct: 265 FKTKTYPSNSLAKWM-EKHKKPDSQGFDLLRKLLEYDPTKRITAE 308

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  160 bits (405), Expect = 2e-48
 Identities = 85/208 (40%), Positives = 120/208 (57%), Gaps = 5/208 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEH-CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL Q +    +    H  + FL+QLLRGL Y H   V+HRDLKP NLL+N   +LK+
Sbjct: 86  LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKL 145

Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S   +  +  VVT WYR P++LL S+DY+  ID+W VGCIF E+   RPLF
Sbjct: 146 ADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    Q+  +  +LGTPT+    G + NE+ K Y    P++    L    P +     
Sbjct: 206 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGA 263

Query: 178 DLVDRMLTFDPMKRITGEFFVPYKPFQC 205
           +L+ ++L F+  KRI+ E  + +  F C
Sbjct: 264 ELLSKLLQFEGRKRISAEEAMKHPYFHC 291

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  158 bits (401), Expect = 1e-47
 Identities = 84/198 (42%), Positives = 119/198 (60%), Gaps = 5/198 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEH-CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL Q +    ++   H  + FLYQ+LRGL Y H   V+HRDLKP NLL+N   +LK+
Sbjct: 86  LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKL 145

Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S   +  +  VVT WYR P++LL SS+Y+  ID+W VGCIF E+ + RPLF
Sbjct: 146 ADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    ++ L+  LLGTPT+    G   N++ K Y    P++  Q L    P +    I
Sbjct: 206 PGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGI 263

Query: 178 DLVDRMLTFDPMKRITGE 195
           +L+ + L ++  KRI+ E
Sbjct: 264 ELLTKFLQYESKKRISAE 281

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  157 bits (397), Expect = 3e-47
 Identities = 81/198 (40%), Positives = 119/198 (60%), Gaps = 5/198 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEH-CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D+DL Q + +  +L   H  + F++QLLRGL Y H   ++HRDLKP NLL+N   +LK+
Sbjct: 85  LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKL 144

Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S   +  +  VVT WYR P++LL S++Y+  ID+W VGCI  E+   RP+F
Sbjct: 145 ADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    ++ L+  LLGTPT+    G   NE+ + Y+   PQ+  Q L    P +    I
Sbjct: 205 PGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGI 262

Query: 178 DLVDRMLTFDPMKRITGE 195
           DL+  +L ++   RI+ E
Sbjct: 263 DLLSSLLLYETKSRISAE 280

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  158 bits (401), Expect = 3e-47
 Identities = 86/205 (41%), Positives = 121/205 (59%), Gaps = 16/205 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286

Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  157 bits (399), Expect = 6e-47
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 104 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 220

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279

Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRIS 304

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  150 bits (382), Expect = 8e-45
 Identities = 72/191 (37%), Positives = 104/191 (54%), Gaps = 8/191 (4%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           N   +    +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S +
Sbjct: 113 NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Query: 72  E-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
           +       T  VVT WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVH-PLAIDLVDRML 184
           + L+ +L G+ T      V   +  + +  LPQ   R+   ++ P+V  P A+DL+D++L
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLL 291

Query: 185 TFDPMKRITGE 195
             DP KRI  +
Sbjct: 292 VLDPAKRIDAD 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  149 bits (377), Expect = 2e-44
 Identities = 71/183 (38%), Positives = 112/183 (61%), Gaps = 7/183 (3%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEF 73
           L E   + +L+Q+LRG+++ HS N+IHRD+KP N+L++ +  +K+CDFG AR   +  E 
Sbjct: 97  LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156

Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
            T+YV TRWYRAPELL+  + Y  A+D+W+VGC+  E++   PLFPG+  + Q+  +I+ 
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC 216

Query: 134 LGT--PTDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
           LG   P   ++ F +N        +LP+    + L + FP +  L +DL  + L  DP  
Sbjct: 217 LGNLIPRHQEI-FQKNPLFA--GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDD 273

Query: 191 RIT 193
           R +
Sbjct: 274 RPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  146 bits (370), Expect = 3e-43
 Identities = 68/197 (34%), Positives = 111/197 (56%), Gaps = 7/197 (3%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T L ++ ++ + + E   +  ++Q L+ + + H  N IHRD+KP N+L+     +K+CDF
Sbjct: 85  TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDF 144

Query: 63  GLARPTSENEFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G AR  +      T+YV TRWYRAPELL+  + Y   +DVW++GC+F EL+  +PL+PG 
Sbjct: 145 GFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204

Query: 122 DHVHQMRLLIELLG--TPTDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLAID 178
             V Q+ L+ + LG   P    + F  N+  K     +P+   R+ L   FP++   A+ 
Sbjct: 205 SDVDQLYLIRKTLGDLIPRHQQI-FSTNQFFKGL--SIPEPETREPLESKFPNISSPALS 261

Query: 179 LVDRMLTFDPMKRITGE 195
            +   L  DP +R++ E
Sbjct: 262 FLKGCLQMDPTERLSCE 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  145 bits (366), Expect = 1e-42
 Identities = 71/174 (40%), Positives = 105/174 (60%), Gaps = 13/174 (7%)

Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWY 83
           ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  VVT WY
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 175

Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD-- 141
           RAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G+  V Q+  +++++G P + D  
Sbjct: 176 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234

Query: 142 --LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
             +   R     +          Q + +    +  L  DL+ + LTF+P KRI+
Sbjct: 235 RDVALPRQAFHSK--------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  144 bits (364), Expect = 4e-41
 Identities = 73/186 (39%), Positives = 111/186 (59%), Gaps = 5/186 (2%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPT 68
           R+N +L     + + YQL R L YIHS  + HRDLKP NLL++ N   LK+CDFG A+  
Sbjct: 162 RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              +    Y+ +R+YRAPEL+L +++YT  ID+WS+GCI  E++   P+F G   V Q+ 
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281

Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP-LAIDLVDRMLTFD 187
            +I++LGTPT+  L  +    A     + P    + L +VFP   P  AI+ + + L ++
Sbjct: 282 RIIQVLGTPTEDQLKEMNPNYAD---IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338

Query: 188 PMKRIT 193
           P+KR+ 
Sbjct: 339 PLKRLN 344

Length = 440

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  140 bits (355), Expect = 5e-41
 Identities = 80/208 (38%), Positives = 120/208 (57%), Gaps = 22/208 (10%)

Query: 1   MDTDLYQ-IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M TDL Q +I+    L   + + F++QLLRGL YIH  +++HRDLKP NLL++   +LK+
Sbjct: 85  MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKL 144

Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S  ++  +  VVT WYR P++LL ++DY++A+D+W  GCIF+E++  +P F
Sbjct: 145 ADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Query: 119 PG-NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH--------PRQSLAQVF 169
           PG +D   Q+  +  +LG PT         ED    + +LP +          Q L  V+
Sbjct: 205 PGVSDVFEQLEKIWTVLGVPT---------EDTWPGVSKLPNYKPEWFLPCKPQQLRVVW 255

Query: 170 PHVH--PLAIDLVDRMLTFDPMKRITGE 195
             +   P A DL  +ML   P  RI+ +
Sbjct: 256 KRLSRPPKAEDLASQMLMMFPKDRISAQ 283

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  138 bits (349), Expect = 3e-40
 Identities = 74/179 (41%), Positives = 106/179 (59%), Gaps = 5/179 (2%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL 164

Query: 75  TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELL 134
           T  VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L+
Sbjct: 165 TPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223

Query: 135 GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+
Sbjct: 224 GLPPEDD--WPRDVTLPRGAFS-PRGPR-PVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  131 bits (332), Expect = 2e-38
 Identities = 46/111 (41%), Positives = 69/111 (62%), Gaps = 3/111 (2%)

Query: 4   DLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICD 61
            L  +++ N+  LSE+     L Q+L GL+Y+HS  +IHRDLKP N+LL+++   +K+ D
Sbjct: 77  SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLAD 136

Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           FGL++  TS+   +   V T  Y APE+LL    Y+   D+WS+G I  EL
Sbjct: 137 FGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  129 bits (326), Expect = 9e-37
 Identities = 68/182 (37%), Positives = 104/182 (57%), Gaps = 6/182 (3%)

Query: 18  EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE--NEFMT 75
           E  + ++YQL++ + + H  +++HRD+KP NLL++ N  LK+CDFG AR  SE  N   T
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159

Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLG 135
           EYV TRWYR+PELLL +  Y  A+D+WSVGCI  EL + +PLFPG   + Q+  + ++LG
Sbjct: 160 EYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG 218

Query: 136 TPTDADLGFVRNEDAKRYIRQLP--QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                 +    +      +R  P   HP+    +    +  + +DL+  +L  +P  R  
Sbjct: 219 PLPAEQMKLFYSNPRFHGLR-FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL 277

Query: 194 GE 195
            E
Sbjct: 278 TE 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  124 bits (313), Expect = 1e-34
 Identities = 77/214 (35%), Positives = 118/214 (55%), Gaps = 22/214 (10%)

Query: 3   TDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           TDL Q +  +   L  E+ + FL+QLLRGL YIH   ++HRDLKP NLL++   +LK+ D
Sbjct: 87  TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLAD 146

Query: 62  FGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           FGLAR  S  +   +  VVT WYR P++LL S++Y+  +D+W VGCIF+E++     FPG
Sbjct: 147 FGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206

Query: 121 -NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ--------HPRQSLAQVFPH 171
             D   Q+  +  +LGTP         NED    +  LP         +  ++L Q +  
Sbjct: 207 MKDIQDQLERIFLVLGTP---------NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNK 257

Query: 172 VHPL--AIDLVDRMLTFDPMKRITGEFFVPYKPF 203
           +  +  A DL  ++L   P  R++ +  + ++ F
Sbjct: 258 LSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  117 bits (296), Expect = 2e-32
 Identities = 48/192 (25%), Positives = 89/192 (46%), Gaps = 32/192 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  +++    L E   + +  Q+L GL Y+HS  ++HRD+K +N+L++++  +K+ DFG 
Sbjct: 88  LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147

Query: 65  AR--PTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           A+     E    T  V  T ++ APE ++   +Y  A D+WS+GC  +E+   +P +   
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
            +       +  +G+  +                ++P+           H+   A D + 
Sbjct: 207 GNPMA---ALYKIGSSGEPP--------------EIPE-----------HLSEEAKDFLR 238

Query: 182 RMLTFDPMKRIT 193
           + L  DP KR T
Sbjct: 239 KCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (295), Expect = 1e-31
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 28/201 (13%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICD 61
            DL + I     LSE    + L Q+L  L+Y+HS  +IHRD+KP N+LL+ +   +K+ D
Sbjct: 86  EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLID 145

Query: 62  FGLARPTSE-------NEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELM 112
           FGLA+   +           +  V T  Y APE+LL  S    +++ D+WS+G    EL+
Sbjct: 146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL 205

Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV 172
              P F G  +       ++++                       P             +
Sbjct: 206 TGLPPFEGEKNSSATSQTLKII------------------LELPTPSLASPLSPSNPELI 247

Query: 173 HPLAIDLVDRMLTFDPMKRIT 193
              A DL+ ++L  DP  R++
Sbjct: 248 SKAASDLLKKLLAKDPKNRLS 268

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  114 bits (289), Expect = 2e-31
 Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 36/195 (18%)

Query: 4   DLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL Q I+      +   EE    +  QL   LKY+HS  ++HRD+KP N+ L +N  +K+
Sbjct: 85  DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKL 144

Query: 60  CDFGLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG+++  S    + + VV T +Y +PEL  N   Y    D+WS+GC+  EL   +  F
Sbjct: 145 GDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPF 203

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G +       L+EL           +           +P      L            +
Sbjct: 204 EGEN-------LLELALK--------ILKGQ----YPPIPSQYSSEL-----------RN 233

Query: 179 LVDRMLTFDPMKRIT 193
           LV  +L  DP +R +
Sbjct: 234 LVSSLLQKDPEERPS 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  115 bits (289), Expect = 4e-31
 Identities = 80/234 (34%), Positives = 116/234 (49%), Gaps = 51/234 (21%)

Query: 4   DLYQIIRSNQS---------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           DL+ II+ +++         L     +  LYQ+L G+ Y+H+  V+HRDLKP+N+L+   
Sbjct: 85  DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 144

Query: 55  CD----LKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
                 +KI D G AR    P      +   VVT WYRAPELLL +  YT AID+W++GC
Sbjct: 145 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204

Query: 107 IFMELMNRRPLFPGND---------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
           IF EL+   P+F             H  Q+  +  ++G P D D      ED    IR++
Sbjct: 205 IFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDW-----ED----IRKM 255

Query: 158 PQHP-------RQSLAQV----FPHVHPLAID-----LVDRMLTFDPMKRITGE 195
           P++P       R + A      +   H +  D     L+ ++LT DP KRIT E
Sbjct: 256 PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSE 309

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 5e-31
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 39/195 (20%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +      SEE  +++  +++  L+Y+HS  +I+RDLKP N+LL+A+  +K+ DFG
Sbjct: 79  ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFG 138

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA+  +SE      +  T  Y APE+LL    Y  A+D WS+G +  E++  +P F   D
Sbjct: 139 LAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197

Query: 123 H--VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDL 179
              +++  L   L                                   FP  + P A DL
Sbjct: 198 RKEIYEKILKDPL----------------------------------RFPEFLSPEARDL 223

Query: 180 VDRMLTFDPMKRITG 194
           +  +L  DP KR+  
Sbjct: 224 ISGLLQKDPTKRLGS 238

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  113 bits (283), Expect = 3e-30
 Identities = 81/236 (34%), Positives = 118/236 (50%), Gaps = 55/236 (23%)

Query: 4   DLYQIIRSNQS---------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           DL+ II+ +++         L     +  LYQ+L G+ Y+H+  V+HRDLKP+N+L+   
Sbjct: 85  DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 144

Query: 55  CD----LKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
                 +KI D G AR    P      +   VVT WYRAPELLL +  YT AID+W++GC
Sbjct: 145 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204

Query: 107 IFMELMNRRPLF--------PGNDHVH-QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
           IF EL+   P+F          N + H Q+  +  ++G P D D      ED    I+++
Sbjct: 205 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW-----ED----IKKM 255

Query: 158 PQHPRQSLAQVFPH----------------VHP--LAIDLVDRMLTFDPMKRITGE 195
           P+H   +L + F                  V P   A  L+ ++LT DP+KRIT E
Sbjct: 256 PEH--STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (266), Expect = 4e-28
 Identities = 53/196 (27%), Positives = 86/196 (43%), Gaps = 34/196 (17%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L +++   + L E   + +  QLL GL Y+HS  ++HRD+KP+N+ L+ N  +K+ DFG 
Sbjct: 86  LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGC 145

Query: 65  A-----RPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPL 117
           A       T+  E +     T  Y APE++       +  A D+WS+GC+ +E+   +  
Sbjct: 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +   D+  Q+   +     P                   +P   + S         P   
Sbjct: 206 WSELDNEFQIMFHVGAGHKP------------------PIPDSLQLS---------PEGK 238

Query: 178 DLVDRMLTFDPMKRIT 193
           D +DR L  DP KR T
Sbjct: 239 DFLDRCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  105 bits (265), Expect = 6e-28
 Identities = 42/113 (37%), Positives = 71/113 (62%), Gaps = 2/113 (1%)

Query: 5   LYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           L  +++S NQ+L+E    Y   +LL+GL+Y+HS  +IHRD+K +N+LL ++ ++K+ DFG
Sbjct: 84  LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFG 143

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           L+   S+ +     V T ++ APE ++N   Y    D+WS+G   +EL   +P
Sbjct: 144 LSAQLSDTKARNTMVGTPYWMAPE-VINGKPYDYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  104 bits (261), Expect = 3e-27
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 39/197 (19%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL  ++ +  SL E+  + ++ +++  L+Y+HS  +IHRDLKP N+L+++N  LK+ DFG
Sbjct: 79  DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFG 138

Query: 64  LARPTSENEFMT---------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           L++       +            V T  Y APE++L    ++  +D WS+GCI  E +  
Sbjct: 139 LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVG 197

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP 174
            P F G               TP +     + N   +                    V  
Sbjct: 198 IPPFHGE--------------TP-EEIFQNILNGKIEWP--------------EDVEVSD 228

Query: 175 LAIDLVDRMLTFDPMKR 191
            AIDL+ ++L  DP KR
Sbjct: 229 EAIDLISKLLVPDPEKR 245

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  101 bits (253), Expect = 4e-26
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 35/192 (18%)

Query: 4   DL-YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL Y + +     SEE  ++++ +++  L+Y+HS  +IHRD+KP N+LL+    + I DF
Sbjct: 86  DLRYHLSQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDF 144

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME-LMNRRPLFPGN 121
            +A   + +   T    T  Y APE +L    Y+ A+D WS+G    E L  +RP + G+
Sbjct: 145 NIATKVTPDTLTTSTSGTPGYMAPE-VLCRQGYSVAVDWWSLGVTAYECLRGKRP-YRGH 202

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL-AIDLV 180
                                         R IR   +  +++   ++P      AID +
Sbjct: 203 S-----------------------------RTIRDQIRAKQETADVLYPATWSTEAIDAI 233

Query: 181 DRMLTFDPMKRI 192
           +++L  DP KR+
Sbjct: 234 NKLLERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 99.6 bits (249), Expect = 2e-25
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 50/207 (24%)

Query: 1   MD----TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD 56
           MD    TD+  I ++   ++E    Y   ++L+GL+Y+HS NVIHRD+K  N+LL+ +  
Sbjct: 97  MDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS 154

Query: 57  LKICDFGL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL---- 111
           +K+ DFG  A+ T E       V T ++ APE++    DY   +D+WS+G + +E+    
Sbjct: 155 VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGE 213

Query: 112 ---MNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
              +   PL        +   LI   G P                     ++P    +  
Sbjct: 214 PPYLREPPL--------RALFLITTKGIPP-------------------LKNPE-KWSPE 245

Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITGE 195
           F        D +++ L  DP KR + E
Sbjct: 246 F-------KDFLNKCLVKDPEKRPSAE 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 99.2 bits (248), Expect = 3e-25
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 55/215 (25%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L Q IR   SL E+  +++  ++L  L+Y+HS  +IHRDLKP N+LL+ +  +KI DFG
Sbjct: 88  ELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFG 147

Query: 64  LARPTSENEFMTE---------------------YVVTRWYRAPELLLNSSDYTAAIDVW 102
            A+    N                          +V T  Y +PELL        + D+W
Sbjct: 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLW 206

Query: 103 SVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR 162
           ++GCI  +++  +P F G++     + +++                       +      
Sbjct: 207 ALGCIIYQMLTGKPPFRGSNEYLTFQKILK----------------------LEYS---- 240

Query: 163 QSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITGEF 196
                 FP    P A DL++++L  DP  R+    
Sbjct: 241 ------FPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.7 bits (241), Expect = 2e-24
 Identities = 36/112 (32%), Positives = 66/112 (58%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++++   S  E   + +  Q+L GL+Y+H  N +HRD+K +N+L++ N  +K+ DFG+
Sbjct: 89  LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGM 148

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           A+   E  F   +  + ++ APE++     Y  A D+WS+GC  +E+   +P
Sbjct: 149 AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.5 bits (241), Expect = 3e-24
 Identities = 48/130 (36%), Positives = 69/130 (53%), Gaps = 11/130 (8%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIH-----SANVIHRDLKPSNLLLNAN 54
           DL Q+I    +  + + EE     L QLL  L   H        V+HRDLKP+N+ L+AN
Sbjct: 87  DLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN 146

Query: 55  CDLKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLA+    ++ F   YV T +Y +PE L + S Y    D+WS+GC+  EL  
Sbjct: 147 NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCA 205

Query: 114 RRPLFPGNDH 123
             P F   + 
Sbjct: 206 LSPPFTARNQ 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 94.1 bits (234), Expect = 2e-23
 Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 31/189 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D   +I++   L E+  + ++ +++ G++ +H   +IHRD+KP NLL++    LK+ DFG
Sbjct: 83  DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFG 142

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+R   EN+   ++V T  Y APE +L   D     D WS+GC+  E +   P F     
Sbjct: 143 LSRNGLENK---KFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAE-- 196

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                       TP         +      + +    P     +V     P A+DL++R+
Sbjct: 197 ------------TP---------DAVFDNILSRRINWP----EEVKEFCSPEAVDLINRL 231

Query: 184 LTFDPMKRI 192
           L  DP KR+
Sbjct: 232 LCMDPAKRL 240

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 3e-23
 Identities = 50/141 (35%), Positives = 76/141 (53%), Gaps = 9/141 (6%)

Query: 3   TDLYQ-IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           TDL + + +  + L EE   Y L + LRGL Y+H   VIHRD+K  N+LL  N ++K+ D
Sbjct: 97  TDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156

Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMNRRP 116
           FG++    S       ++ T ++ APE++         Y A  DVWS+G   +EL + +P
Sbjct: 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Query: 117 LFPGNDHVHQMRLLIELLGTP 137
             P  D +H MR L ++   P
Sbjct: 217 --PLCD-MHPMRALFKIPRNP 234

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 93.5 bits (233), Expect = 3e-23
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 30/190 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+ I+R      E   ++++  ++   +Y+H+  +I+RDLKP NLLL++N  +K+ DFG
Sbjct: 79  ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG 138

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            A+     +    +  T  Y APE++LN   Y  ++D WS+G +  EL+  RP F G D 
Sbjct: 139 FAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPF-GEDD 196

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVDR 182
              M +  ++L                 +   +L           FP ++   A DL+ +
Sbjct: 197 EDPMEIYNDIL-----------------KGNGKL----------EFPNYIDKAAKDLIKQ 229

Query: 183 MLTFDPMKRI 192
           +L  +P +R+
Sbjct: 230 LLRRNPEERL 239

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 4e-23
 Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 2/113 (1%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L QII+      E     ++YQ+L+GL Y+H   VIHRD+K +N+L   +  +K+ DFG+
Sbjct: 86  LRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGV 145

Query: 65  ARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           A   ++       VV T ++ APE ++  S  + A D+WS+GC  +EL+   P
Sbjct: 146 ATKLNDVSKDDASVVGTPYWMAPE-VIEMSGASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 91.9 bits (229), Expect = 1e-22
 Identities = 42/136 (30%), Positives = 71/136 (52%), Gaps = 5/136 (3%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFG 63
           L  +++    + E    Y   Q+L+GL Y+H+  ++IHRD+KPSNLL+N+  ++KI DFG
Sbjct: 86  LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFG 145

Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGN 121
           +++           +V T  Y +PE +   S Y+ A D+WS+G   +E  + + P F   
Sbjct: 146 ISKVLENTLDQCNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFP-FLPP 203

Query: 122 DHVHQMRLLIELLGTP 137
                  L+  +   P
Sbjct: 204 GQPSFFELMQAICDGP 219

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.2 bits (227), Expect = 2e-22
 Identities = 55/190 (28%), Positives = 86/190 (45%), Gaps = 34/190 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+ +I   N++L+EE     LYQ L+GL+Y+HS   IHRD+K  N+LLN     K+ DFG
Sbjct: 87  DIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG 144

Query: 64  LA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           ++ + T         + T ++ APE++     Y    D+WS+G   +E+   +P  P   
Sbjct: 145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKP--P-YS 200

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLAIDLVD 181
            +H MR +                          +P  P  +L+   P    P   D V 
Sbjct: 201 DIHPMRAIFM------------------------IPNKPPPTLSD--PEKWSPEFNDFVK 234

Query: 182 RMLTFDPMKR 191
           + L  DP +R
Sbjct: 235 KCLVKDPEER 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 3e-21
 Identities = 51/167 (30%), Positives = 87/167 (52%), Gaps = 23/167 (13%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEF 73
           L+E   +Y   Q+L  L ++HS  VIHRDLK  N+LL  + D+K+ DFG+ A+  S  + 
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159

Query: 74  MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL 129
              ++ T ++ APE++      D  Y    D+WS+G   +EL    P  P ++ ++ MR+
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRV 216

Query: 130 LIELLGT--PT-DADLGF------------VRNEDAKRYIRQLPQHP 161
           L+++L +  PT D    +            V++ D +    +L +HP
Sbjct: 217 LLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.4 bits (220), Expect = 3e-21
 Identities = 40/120 (33%), Positives = 66/120 (55%), Gaps = 5/120 (4%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF- 73
           L E +  + L ++L GL+Y+H    IHRD+K +N+LL+   D+K+ DFG++   +     
Sbjct: 95  LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154

Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
              +V T ++ APE++  S  Y    D+WS+G   +EL    P  P    +H MR+L  +
Sbjct: 155 RNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEP--P-LSDLHPMRVLFLI 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 86.8 bits (216), Expect = 8e-21
 Identities = 42/118 (35%), Positives = 58/118 (49%), Gaps = 12/118 (10%)

Query: 4   DLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   +R N+  LS      F  Q+ RG++Y+ S N IHRDL   N L+  N  +KI DF
Sbjct: 87  DLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDF 146

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           GL+R   +++    Y         RW  APE L     +T+  DVWS G +  E+   
Sbjct: 147 GLSRDLYDDD---YYRKRGGKLPIRWM-APESLKEGK-FTSKSDVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 87.1 bits (216), Expect = 1e-20
 Identities = 41/107 (38%), Positives = 58/107 (54%), Gaps = 4/107 (3%)

Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPE 87
           L+GL Y+HS  +IHRD+KPSN+LL     +K+CDFG++     +   T +  T +Y APE
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE 173

Query: 88  LLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELL 134
            +     Y+   DVWS+G   +E+   R  FP           IELL
Sbjct: 174 RIQGKP-YSITSDVWSLGLTLLEVAQNR--FPFPPEGEPPLGPIELL 217

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 86.1 bits (214), Expect = 2e-20
 Identities = 39/111 (35%), Positives = 54/111 (48%), Gaps = 11/111 (9%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
              + LS      F  Q+ RG++Y+ S N IHRDL   N L+  N  +KI DFGL+R   
Sbjct: 95  NRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154

Query: 70  ENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           +++    Y V       RW  APE L     +T+  DVWS G +  E+   
Sbjct: 155 DDD---YYKVKGGKLPIRWM-APESLKEGK-FTSKSDVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 2e-20
 Identities = 53/193 (27%), Positives = 94/193 (48%), Gaps = 31/193 (16%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP 67
            +R+     E+  ++F  Q+L GL Y+HS  ++HRDLK  NLL++A+   KI DFG+++ 
Sbjct: 98  CLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157

Query: 68  TSE---NEFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELM-NRRPLFPGND 122
           + +   N+       + ++ APE++ + S  Y+A +D+WS+GC+ +E+   RRP    ++
Sbjct: 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--SDE 215

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                   +  LG                   R  P  P      V  ++ P+A+D ++ 
Sbjct: 216 EAIAA---MFKLGN-----------------KRSAPPIP----PDVSMNLSPVALDFLNA 251

Query: 183 MLTFDPMKRITGE 195
             T +P  R T  
Sbjct: 252 CFTINPDNRPTAR 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.8 bits (210), Expect = 4e-20
 Identities = 41/125 (32%), Positives = 64/125 (51%), Gaps = 6/125 (4%)

Query: 2   DTDLYQIIRSNQS----LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL 57
             DL + I   +     + E+       QLLRGL+ +H   ++HRDLK +N+LL AN  +
Sbjct: 83  FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLV 142

Query: 58  KICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           KI D G+++   +N   T+ + T  Y APE +     Y+   D+WS+GC+  E+    P 
Sbjct: 143 KIGDLGISKVLKKNMAKTQ-IGTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Query: 118 FPGND 122
           F    
Sbjct: 201 FEARS 205

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (213), Expect = 5e-20
 Identities = 38/123 (30%), Positives = 72/123 (58%), Gaps = 13/123 (10%)

Query: 2   DTDLYQI------------IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNL 49
           D+DLY +            ++     SE+  ++++ +L+  L+++H  ++++RDLKP N+
Sbjct: 68  DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENI 127

Query: 50  LLNANCDLKICDFGLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 108
           LL+A   + +CDFGL++   ++N+    +  T  Y APE+LL+   YT  +D WS+G + 
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187

Query: 109 MEL 111
            E+
Sbjct: 188 FEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.8 bits (210), Expect = 5e-20
 Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 4/121 (3%)

Query: 5   LYQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           LY  I  +  Q   EE   ++L+Q++  + YIH A ++HRD+K  N+ L     +K+ DF
Sbjct: 86  LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDF 145

Query: 63  GLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G+++       M E VV T +Y +PE L     Y    D+W++GC+  EL+  +  F   
Sbjct: 146 GISKILGSEYSMAETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204

Query: 122 D 122
           +
Sbjct: 205 N 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 84.3 bits (209), Expect = 8e-20
 Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 31/170 (18%)

Query: 25  YQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWY 83
             +L+GL Y+H    +IHRD+KPSN+L+N+   +K+CDFG++     +   T +V T  Y
Sbjct: 107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSY 165

Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGNDHVHQMRLLIELLGTPTDAD- 141
            APE  +  +DY+   D+WS+G   +EL   R P  P ND                  + 
Sbjct: 166 MAPE-RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND------------PPDGIFEL 212

Query: 142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
           L ++ NE   R    LP          F    P   D V+  L  DP +R
Sbjct: 213 LQYIVNEPPPR----LPSGK-------FS---PDFQDFVNLCLIKDPRER 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.5 bits (210), Expect = 9e-20
 Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 36/189 (19%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +R +    E   +++  Q++  L+Y+HS ++++RDLKP NLLL+++  +KI DFG
Sbjct: 87  ELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFG 146

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            A+      +      T  Y APE++L S  Y  A+D W++G +  E++   P F  ++ 
Sbjct: 147 FAKRVKGRTYTL--CGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVDR 182
           +     ++E          G VR                      FP    P A DL+  
Sbjct: 204 IQIYEKILE----------GKVR----------------------FPSFFSPDAKDLIRN 231

Query: 183 MLTFDPMKR 191
           +L  D  KR
Sbjct: 232 LLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 1e-19
 Identities = 37/120 (30%), Positives = 65/120 (54%), Gaps = 1/120 (0%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
             ++E++    + ++L  LKYIH   VIHRD+K +N+L+    ++K+CDFG+A   ++N 
Sbjct: 96  GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155

Query: 73  FM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
              + +V T ++ APE++     Y    D+WS+G    E+    P +   D    M L+ 
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.6 bits (204), Expect = 4e-19
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 2/107 (1%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           Q  +EE       Q++  L+Y+H    ++HRDL P+N++L  +  + I DFGLA+     
Sbjct: 108 QRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE 167

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
             +T  V T  Y  PE++ N   Y    DVW+ GCI  ++   +P F
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.7 bits (199), Expect = 2e-18
 Identities = 43/109 (39%), Positives = 62/109 (56%), Gaps = 9/109 (8%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLA-----RPTSENEFMTE 76
           +  QLLRGL Y+H   +IHRD+K +NLL+++    L+I DFG A     + T   EF  +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 77  YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
            + T  + APE+L     Y  + DVWSVGC+ +E+   +P  P N   H
Sbjct: 168 LLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKP--PWNAEKH 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.9 bits (197), Expect = 4e-18
 Identities = 41/152 (26%), Positives = 84/152 (55%), Gaps = 8/152 (5%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP- 67
           +++  +L+E   + +  Q+L G++Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 95  LKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154

Query: 68  ---TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
               S    M     T ++ +PE +++   Y    DVWSVGC  +E++  +P  P  +  
Sbjct: 155 QTICSSGTGMKSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKP--PWAEF- 210

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ 156
             M  + ++   PT+  L    + DA+ ++R+
Sbjct: 211 EAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 6e-18
 Identities = 45/131 (34%), Positives = 70/131 (53%), Gaps = 8/131 (6%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            D+YQ+ R    LSE    Y   + L+GL Y+H    IHRD+K +N+LL  + D+K+ DF
Sbjct: 88  QDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADF 145

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFP 119
           G+ A+ T+       ++ T ++ APE+        Y    D+W++G   +EL   +P  P
Sbjct: 146 GVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP--P 203

Query: 120 GNDHVHQMRLL 130
             D +H MR L
Sbjct: 204 MFD-LHPMRAL 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.9 bits (194), Expect = 1e-17
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 6/126 (4%)

Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE-YVVTRW 82
           L ++L+GL Y+HS   IHRD+K +N+LL+   D+K+ DFG+A   ++ +     +V T +
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADL 142
           + APE++  S+ Y +  D+WS+G   +EL    P  P +D +H MR+L  +         
Sbjct: 167 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLT 222

Query: 143 G-FVRN 147
           G F + 
Sbjct: 223 GEFSKP 228

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 78.3 bits (193), Expect = 1e-17
 Identities = 41/131 (31%), Positives = 70/131 (53%), Gaps = 4/131 (3%)

Query: 4   DLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL+++++    + L E+    F  Q+L GL ++HS  ++HRD+K  NL L+A  ++KI D
Sbjct: 85  DLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGD 144

Query: 62  FGLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
            G+A+  S+N      +V T +Y +PE L     Y    DVW++G +  E    +  F  
Sbjct: 145 LGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203

Query: 121 NDHVHQMRLLI 131
           N+    +  +I
Sbjct: 204 NNQGALILKII 214

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 1e-17
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 28/209 (13%)

Query: 1   MDTD-LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLK 58
           MD   L +I +    +  E        ++ GL Y+++ + ++HRD+KPSN+L+N+   +K
Sbjct: 85  MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIK 144

Query: 59  ICDFGLARPTSE--NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +CDFG+   + E  N     +V T  Y +PE  +    YT   DVWS+G   +EL   + 
Sbjct: 145 LCDFGV---SGELINSIADTFVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGK- 199

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL-AQVFPHVHPL 175
            FP                     D G          ++Q+ Q P   L +  FP     
Sbjct: 200 -FPFAF--------------SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP---ED 241

Query: 176 AIDLVDRMLTFDPMKRITGEFFVPYKPFQ 204
             D VD  L  DP +R T +      PF 
Sbjct: 242 LRDFVDACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.0 bits (192), Expect = 3e-17
 Identities = 42/115 (36%), Positives = 61/115 (53%), Gaps = 2/115 (1%)

Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAP 86
           +++GL Y+ S  ++HRD+KPSN+L+N    +K+CDFG++     N     YV T  Y AP
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-NSIAKTYVGTNAYMAP 162

Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           E +     Y    DVWS+G  FMEL   R  +P         + ++LL    D D
Sbjct: 163 ERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 77.2 bits (190), Expect = 4e-17
 Identities = 43/173 (24%), Positives = 90/173 (52%), Gaps = 25/173 (14%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           +  E   + F+ Q+L+GL Y+H+  +IHRD+K +N+L++    +KI DFG+++    N  
Sbjct: 102 AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161

Query: 74  MTEYVVTR-------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+    R       ++ APE++  +S YT   D+WS+GC+ +E++  +  FP      Q
Sbjct: 162 STKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCT---Q 217

Query: 127 MRLLIELLGT-----PTDADLGFVRNEDAKRYIRQ---LPQHPRQSLAQVFPH 171
           ++ + ++        P++       + +A  ++ +   +  + R + A++  H
Sbjct: 218 LQAIFKIGENASPEIPSNI------SSEAIDFLEKTFEIDHNKRPTAAELLKH 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 76.8 bits (190), Expect = 5e-17
 Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 13/117 (11%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   +R + + L+ +       Q+ +G++Y+ S N +HRDL   N L+  N  +KI DF
Sbjct: 87  DLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDF 146

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GL+R   E++    Y          +W  APE L +   +T+  DVWS G +  E+ 
Sbjct: 147 GLSRDIYEDD---YYRKRGGGKLPIKWM-APESLKDGK-FTSKSDVWSFGVLLWEIF 198

Length = 258

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 76.6 bits (188), Expect = 7e-17
 Identities = 43/117 (36%), Positives = 70/117 (59%), Gaps = 5/117 (4%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E +    L ++L+GL Y+HS   IHRD+K +N+LL+   D+K+ DFG+A   ++ +  
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y    D+WS+G   +EL    P  P +D +H MR+L
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVL 210

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 76.8 bits (189), Expect = 1e-16
 Identities = 41/121 (33%), Positives = 69/121 (57%), Gaps = 2/121 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  SE+  +++  +++  L Y+HS +V++RDLK  NL+L+ +  +KI DFG
Sbjct: 81  ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG 140

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 141 LCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Query: 123 H 123
           H
Sbjct: 200 H 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 76.6 bits (188), Expect = 1e-16
 Identities = 39/118 (33%), Positives = 67/118 (56%), Gaps = 2/118 (1%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-F 73
            +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +    +   
Sbjct: 92  FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151

Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
           M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   DH     L++
Sbjct: 152 MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.0 bits (187), Expect = 2e-16
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 9/156 (5%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 143

Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++ + ++E     +  T  Y APE ++N   +T + D WS G +  E++     F G D
Sbjct: 144 LSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202

Query: 123 HVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQL 157
               M ++++  LG P      F+  E A+  +R L
Sbjct: 203 RKETMTMILKAKLGMPQ-----FLSPE-AQSLLRAL 232

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 75.0 bits (184), Expect = 2e-16
 Identities = 43/123 (34%), Positives = 62/123 (50%), Gaps = 4/123 (3%)

Query: 2   DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
             DL Q I+  +     E+    +  Q+  G+++IH   V+HRD+K  N+ L  N  +K+
Sbjct: 82  GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKL 141

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG AR  TS   +   YV T +Y  PE+  N   Y    D+WS+GCI  EL   +  F
Sbjct: 142 GDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPF 200

Query: 119 PGN 121
             N
Sbjct: 201 QAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 2e-16
 Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 1/101 (0%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           N    EE   ++  ++  GL+ +H   +++RDLKP N+LL+    ++I D GLA    E 
Sbjct: 96  NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           E +   V T  Y APE ++ +  YT + D W +GC+  E++
Sbjct: 156 ETIRGRVGTVGYMAPE-VVKNERYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.4 bits (185), Expect = 3e-16
 Identities = 40/109 (36%), Positives = 61/109 (55%), Gaps = 1/109 (0%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           N    EE   ++  ++L GL+ +H  N ++RDLKP N+LL+    ++I D GLA    E 
Sbjct: 96  NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           E +   V T  Y APE +LN+  YT + D W +GC+  E++  +  F G
Sbjct: 156 ESIRGRVGTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (185), Expect = 3e-16
 Identities = 52/166 (31%), Positives = 88/166 (53%), Gaps = 12/166 (7%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++          +++  +LL  L+ +H  NVI+RDLKP N+LL+    + +CDFG
Sbjct: 79  ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   +++  T  +  T  Y APELLL    YT A+D W++G +  E++   P F  ++
Sbjct: 139 LCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFY-DE 196

Query: 123 HVHQM--RLLIELLGTPTDADLGFVRNEDAKRYIRQ-LPQHPRQSL 165
           +V++M  ++L E L  P   D       DAK  +   L + P + L
Sbjct: 197 NVNEMYRKILQEPLRFPDGFD------RDAKDLLIGLLSRDPTRRL 236

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.5 bits (183), Expect = 4e-16
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 31/189 (16%)

Query: 6   YQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           Y I    +    E    ++  Q++ GL+++H   +++RDLKP N+LL+ + +++I D GL
Sbjct: 82  YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL 141

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           A      + +     T  Y APE+L     Y  ++D +++GC   E++  R         
Sbjct: 142 AVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGR--------- 191

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLAIDLVDRM 183
                      +P       V  E+ KR   ++           +P    P A DL + +
Sbjct: 192 -----------SPFRQRKEKVEKEELKRRTLEMAVE--------YPDKFSPEAKDLCEAL 232

Query: 184 LTFDPMKRI 192
           L  DP KR+
Sbjct: 233 LQKDPEKRL 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 74.7 bits (183), Expect = 5e-16
 Identities = 40/129 (31%), Positives = 71/129 (55%), Gaps = 2/129 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  SE+  +++  +++  L Y+HS  +++RDLK  NL+L+ +  +KI DFG
Sbjct: 81  ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFG 140

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   ++   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 141 LCKEGITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 200 HEKLFELIL 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.3 bits (182), Expect = 6e-16
 Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 24/196 (12%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSE 70
           ++ L+E   Q    Q+L  L+Y+HS  +IHRDLK  N+LL  + D+K+ DFG+ A+    
Sbjct: 104 DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163

Query: 71  NEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            +    ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P +  ++ 
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 220

Query: 127 MRLLIEL-------LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           MR+L+++       L  P+   + F   +  K  + + P+  R S AQ+  H        
Sbjct: 221 MRVLLKIAKSEPPTLSQPSKWSMEF--RDFLKTALDKHPE-TRPSAAQLLEH------PF 271

Query: 180 VDRMLTFDPMKRITGE 195
           V  + +  P++ +  E
Sbjct: 272 VSSVTSNRPLRELVAE 287

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.3 bits (183), Expect = 6e-16
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 12/125 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+ +    E   +++  +++ GL+++H   +I+RDLK  N+LL++   +KI DFG
Sbjct: 82  DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG 141

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +   V T        Y APE+L     Y  A+D W++G +  E++  +  
Sbjct: 142 MCK-----EGILGGVTTSTFCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSP 195

Query: 118 FPGND 122
           F G+D
Sbjct: 196 FEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 74.3 bits (182), Expect = 7e-16
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 31/201 (15%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           I S   L+EE        +L+ L Y+HS  VIHRD+K  ++LL  +  +K+ DFG     
Sbjct: 108 IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167

Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           S++    + +V T ++ APE +++ + Y   +D+WS+G + +E+++  P +  +  V  M
Sbjct: 168 SKDVPKRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226

Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           + L               R+    +              +    + P+  D ++RMLT +
Sbjct: 227 KRL---------------RDSPPPK-------------LKNAHKISPVLRDFLERMLTRE 258

Query: 188 PMKRITGEFFVPYKPFQCCCG 208
           P +R T +  + + PF    G
Sbjct: 259 PQERATAQELLDH-PFLLQTG 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 73.6 bits (181), Expect = 9e-16
 Identities = 34/102 (33%), Positives = 59/102 (57%), Gaps = 3/102 (2%)

Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVV 79
           +YF  QL   L+++HS  ++HRD+KP+N+ + A   +K+ D GL R  +S+       V 
Sbjct: 110 KYF-VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           T +Y +PE  ++ + Y    D+WS+GC+  E+   +  F G+
Sbjct: 169 TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 1e-15
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 9/174 (5%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D   ++ +   LSE+H ++++ ++   +  +H    IHRDLKP N L++A+  +K+ DFG
Sbjct: 87  DFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFG 146

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG--- 120
           L++      +    V +  Y APE +L    Y   +D WS+GC+  E +   P F G   
Sbjct: 147 LSKGIV--TYANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL---PQHPRQSLAQVFPH 171
           N+    ++   E L  P   D  F  +++A   I +L   P     SL  +  H
Sbjct: 204 NETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.1 bits (179), Expect = 1e-15
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 23/169 (13%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSEN 71
           + L+E   +    Q L  L Y+H   +IHRDLK  N+L   + D+K+ DFG+ A+ T   
Sbjct: 98  RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157

Query: 72  EFMTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           +    ++ T ++ APE+++   S D  Y    DVWS+G   +E+     + P +  ++ M
Sbjct: 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ---IEPPHHELNPM 214

Query: 128 RLLIEL-------LGTPTDADLGF--------VRNEDAKRYIRQLPQHP 161
           R+L+++       L  P+     F         +N DA+    QL QHP
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 73.2 bits (179), Expect = 1e-15
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 98  LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157

Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGE---PPHSELHPMKVL 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.8 bits (179), Expect = 2e-15
 Identities = 41/119 (34%), Positives = 65/119 (54%), Gaps = 8/119 (6%)

Query: 1   MDTDLY----QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANC 55
           MDT L     ++     ++ E+        +++ L+Y+HS  +VIHRD+KPSN+L+N N 
Sbjct: 82  MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG 141

Query: 56  DLKICDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMEL 111
            +K+CDFG++    ++   T     + Y APE +   LN   Y    DVWS+G   +EL
Sbjct: 142 QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 73.1 bits (179), Expect = 2e-15
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 81  ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 140

Query: 63  GLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 141 GLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199

Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 200 DHEKLFELIL 209

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 72.2 bits (178), Expect = 2e-15
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 12/107 (11%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
            +LS +    F  Q+ +G++Y+ S   +HRDL   N L+  +  +KI DFGL+R   +++
Sbjct: 100 STLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159

Query: 73  FMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +   Y          RW  APE  L    +T+  DVWS G +  E+ 
Sbjct: 160 Y---YRKKTGGKLPIRWM-APE-SLKDGIFTSKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.3 bits (177), Expect = 2e-15
 Identities = 46/132 (34%), Positives = 74/132 (56%), Gaps = 6/132 (4%)

Query: 4   DLYQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL-KIC 60
           DL + I   + +  SE+    +  Q+  GLK+IH   ++HRD+K  N+ L+ N  + K+ 
Sbjct: 85  DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLG 144

Query: 61  DFGLARPTSEN-EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFG+AR  +++ E     V T +Y +PE+  N   Y    D+WS+GC+  EL   +  F 
Sbjct: 145 DFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFE 203

Query: 120 GNDHVHQMRLLI 131
           GN+ +HQ+ L I
Sbjct: 204 GNN-LHQLVLKI 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 72.3 bits (177), Expect = 3e-15
 Identities = 45/194 (23%), Positives = 89/194 (45%), Gaps = 34/194 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +   E+  Q +  +++  L+++H   +I+RD+K  N+LL++N  + + DFG
Sbjct: 91  ELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 150

Query: 64  LARP--TSENEFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMNRRPLFP- 119
           L++     E E    +  T  Y AP+++      +  A+D WS+G +  EL+     F  
Sbjct: 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210

Query: 120 -GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G  +                        E ++R ++  P +P++        +  LA D
Sbjct: 211 DGEKNSQA---------------------EISRRILKSEPPYPQE--------MSALAKD 241

Query: 179 LVDRMLTFDPMKRI 192
           ++ R+L  DP KR+
Sbjct: 242 IIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 72.7 bits (178), Expect = 3e-15
 Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 39/197 (19%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M T LYQ      + SE+  +++  +++  L+++H   +++RD+K  N+LL++   + + 
Sbjct: 92  MFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLT 147

Query: 61  DFGLARP--TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFGL++   + E E    +  T  Y APE++     +  A+D WS+G             
Sbjct: 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI------------ 195

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRN---EDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
                     L+ ELL   +   L   RN   E ++R ++  P  P          + P 
Sbjct: 196 ----------LIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--------SFIGPE 237

Query: 176 AIDLVDRMLTFDPMKRI 192
           A DL+ ++L  DP KR+
Sbjct: 238 AQDLLHKLLRKDPKKRL 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.8 bits (178), Expect = 3e-15
 Identities = 40/117 (34%), Positives = 70/117 (59%), Gaps = 4/117 (3%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++  + + EE        +LRGL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 90  LDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG 149

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +EL + R P+ P
Sbjct: 150 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.5 bits (178), Expect = 3e-15
 Identities = 41/100 (41%), Positives = 56/100 (56%), Gaps = 8/100 (8%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVTRWYR 84
             L+GL Y+HS   IHRD+K  N+LL     +K+ DFG A   S  N F    V T ++ 
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF----VGTPYWM 178

Query: 85  APELLL--NSSDYTAAIDVWSVGCIFMELMNRR-PLFPGN 121
           APE++L  +   Y   +DVWS+G   +EL  R+ PLF  N
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 71.4 bits (175), Expect = 4e-15
 Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 2/112 (1%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R N  L E+   +F  Q+L  L ++H+  ++HRDLK  N+LL+ +   +KI DFG+++  
Sbjct: 93  RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           S        V T  Y +PE L     Y    D+W++GC+  EL + +  F  
Sbjct: 153 SSKSKAYTVVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 71.2 bits (175), Expect = 5e-15
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 33/207 (15%)

Query: 5   LYQIIRS--NQSLSEEHC-QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           L  I++S   +   +E      L ++L+GL+Y+HS   IHRD+K  N+LL  +  +KI D
Sbjct: 86  LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIAD 145

Query: 62  FGLARPTSENEFMTE-----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           FG++   ++    T      +V T  + APE++     Y    D+WS G   +EL     
Sbjct: 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
             P + +     L++ L   P   +       D K+Y            ++ F       
Sbjct: 206 --PYSKYPPMKVLMLTLQNDPPSLE----TGADYKKY------------SKSFR------ 241

Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPF 203
             ++   L  DP KR T E  + +K F
Sbjct: 242 -KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.0 bits (174), Expect = 6e-15
 Identities = 37/105 (35%), Positives = 59/105 (56%), Gaps = 3/105 (2%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEFMT 75
           E+   ++  Q+L GLKY+H   ++HRD+K  N+L+N     +KI DFG ++  +     T
Sbjct: 107 EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166

Query: 76  E-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           E +  T  Y APE++      Y A  D+WS+GC  +E+   +P F
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 9e-15
 Identities = 42/126 (33%), Positives = 70/126 (55%), Gaps = 9/126 (7%)

Query: 1   MDT-DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYI---HSANVIHRDLKPSNLLLNANCD 56
           MD   L Q+++    + E         +LRGL Y+   H   ++HRD+KPSN+L+N+  +
Sbjct: 81  MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGE 138

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRR 115
           +K+CDFG++     +     +V TR Y +PE  L  + YT   D+WS+G   +E+ + R 
Sbjct: 139 IKLCDFGVSGQLI-DSMANSFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRY 196

Query: 116 PLFPGN 121
           P+ P +
Sbjct: 197 PIPPPD 202

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 71.3 bits (175), Expect = 9e-15
 Identities = 43/130 (33%), Positives = 66/130 (50%), Gaps = 23/130 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I ++   SE    ++   ++ GL+Y+H   +++RDLK  NLLL+    +KI DFG
Sbjct: 88  DLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFG 146

Query: 64  LARP-------TS----ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           L +        TS      EF+          APE+L  +S YT A+D W +G +  E++
Sbjct: 147 LCKEGMGFGDRTSTFCGTPEFL----------APEVLTETS-YTRAVDWWGLGVLIYEML 195

Query: 113 NRRPLFPGND 122
                FPG+D
Sbjct: 196 VGESPFPGDD 205

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 71.2 bits (174), Expect = 9e-15
 Identities = 40/97 (41%), Positives = 58/97 (59%), Gaps = 6/97 (6%)

Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPE 87
           L+GL Y+HS N+IHRD+K  N+LL     +K+ DFG A  +S       +V T ++ APE
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPE 187

Query: 88  LLL--NSSDYTAAIDVWSVGCIFMELMNRRP-LFPGN 121
           ++L  +   Y   +DVWS+G   +EL  R+P LF  N
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.2 bits (174), Expect = 1e-14
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 18/207 (8%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 90  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 149

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGND 122
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P + 
Sbjct: 150 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD- 206

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAI-DLV 180
                + L  + G P + D        A+      P+ P + L+   P    P+AI +L+
Sbjct: 207 ----AKELELMFGCPVEGD-------PAESETSPRPRPPGRPLSSYGPDSRPPMAIFELL 255

Query: 181 DRMLTFDPMKRITGEFFVPYKPFQCCC 207
           D ++   P K  +G F   ++ F   C
Sbjct: 256 DYIVNEPPPKLPSGVFGAEFQDFVNKC 282

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.9 bits (173), Expect = 1e-14
 Identities = 41/116 (35%), Positives = 63/116 (54%), Gaps = 7/116 (6%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +DL ++    + L E       +  L+GL Y+HS N+IHRD+K  N+LL     +K+ DF
Sbjct: 112 SDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 169

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRP 116
           G A   S       +V T ++ APE++L  +   Y   +DVWS+G   +EL  R+P
Sbjct: 170 GSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 70.1 bits (171), Expect = 2e-14
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 3/113 (2%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP
Sbjct: 184 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.6 bits (170), Expect = 2e-14
 Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 9/115 (7%)

Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-------PTSENE 72
           C+Y   Q+L G+ Y+H+  V+HRD+K +N++L  N  +K+ DFG AR         + + 
Sbjct: 105 CKY-TKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163

Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
            +     T ++ APE ++N S Y    D+WS+GC   E+   +P     D +  M
Sbjct: 164 MLKSMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM 217

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.7 bits (170), Expect = 2e-14
 Identities = 45/130 (34%), Positives = 71/130 (54%), Gaps = 9/130 (6%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+Y +      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N D+K+ DFG
Sbjct: 95  DIYHV---TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFG 151

Query: 64  L-ARPTSENEFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           + A+ T+       ++ T ++ APE+  +  +  Y    D+W+VG   +EL   +P  P 
Sbjct: 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP--PM 209

Query: 121 NDHVHQMRLL 130
            D +H MR L
Sbjct: 210 FD-LHPMRAL 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 69.5 bits (170), Expect = 3e-14
 Identities = 35/115 (30%), Positives = 64/115 (55%), Gaps = 2/115 (1%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H   +I+RDLKP N+LL+ + +++I D GL
Sbjct: 84  IYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGL 143

Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           A    + +  T+ Y  T  + APELL    +Y  ++D +++G    E++  R  F
Sbjct: 144 AVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 69.6 bits (170), Expect = 3e-14
 Identities = 40/114 (35%), Positives = 61/114 (53%), Gaps = 5/114 (4%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-AR 66
           ++   Q L E    Y LY  L GL+++H+  +IHRD+K +N+LL     +K+ DFG+ A+
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177

Query: 67  PTSENEFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRP 116
            TS        V T ++ APE++         Y A  DVWS+G   +EL +  P
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 3e-14
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 6/104 (5%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           ++L+++    F YQ+ RG++++ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 73  FMTEYVVTR----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +  +    R    W  APE L +   YT   DVWS G +  E+ 
Sbjct: 187 YYRKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 4e-14
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 16/166 (9%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L ++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP---TDAD 141
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYL-NENPLRALYLIATNGTPELQNPER 240

Query: 142 LGFVRNE----------DAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           L  V  +          D +   ++L QHP   LA+    + PL I
Sbjct: 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLII 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.9 bits (168), Expect = 4e-14
 Identities = 41/172 (23%), Positives = 87/172 (50%), Gaps = 8/172 (4%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           +++  +L+E   + +  Q+L G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Query: 69  S----ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
                    +     T ++ +PE +++   Y    DVWS+GC  +E++  +P  P  ++ 
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKP--PWAEY- 212

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
             M  + ++   PT+  L    +E A+ ++  +    R   +      HP A
Sbjct: 213 EAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLRHPFA 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 68.8 bits (168), Expect = 4e-14
 Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 3/112 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +D  L ++  + ++LSE     +  QLL G+ Y+H   ++HRDLK  N+ L  N  LKI 
Sbjct: 89  LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIG 147

Query: 61  DFGLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           DFG++R      +  T +  T +Y +PE  L    Y +  D+WS+GCI  E+
Sbjct: 148 DFGVSRLLMGSCDLATTFTGTPYYMSPE-ALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.6 bits (167), Expect = 5e-14
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 23/178 (12%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDL +  + N +L EE   Y   ++LRGL ++H   VIHRD+K  N+LL  N ++K+ DF
Sbjct: 97  TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 155

Query: 63  GLARPTSEN-EFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMNRRPL 117
           G++            ++ T ++ APE++    +    Y    D+WS+G   +E+    P 
Sbjct: 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 214

Query: 118 FPGNDHVHQMRLLIELLGTPTD--------------ADLGFVRNEDAKRYIRQLPQHP 161
            P  D +H MR L  +   P                 +   V+N   +    QL +HP
Sbjct: 215 -PLCD-MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.1 bits (169), Expect = 6e-14
 Identities = 37/120 (30%), Positives = 64/120 (53%), Gaps = 2/120 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S+    E   +++  +++ GL+++H   +I+RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     E     +  T  Y APE+L     Y  ++D WS G +  E++  +  F G D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGED 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 7e-14
 Identities = 48/185 (25%), Positives = 76/185 (41%), Gaps = 47/185 (25%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL---------- 64
            +EE  ++++ + +  +  IH    IHRD+KP NLLL+A   +K+ DFGL          
Sbjct: 98  FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157

Query: 65  ------------------ARPTSENEFMTEY-----------VVTRWYRAPELLLNSSDY 95
                             ++P S       +           V T  Y APE+ L +  Y
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-Y 216

Query: 96  TAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI---ELLGTPTDADLGFVRNEDAKR 152
               D WS+G I  E++   P F  ++     R +I   E L  P +  L    + +AK 
Sbjct: 217 NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPL----SPEAKD 272

Query: 153 YIRQL 157
            I++L
Sbjct: 273 LIKRL 277

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 68.5 bits (167), Expect = 8e-14
 Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 7/116 (6%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +DL ++    + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DF
Sbjct: 102 SDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRP 116
           G A   +       +V T ++ APE++L  +   Y   +DVWS+G   +EL  R+P
Sbjct: 160 GSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 8e-14
 Identities = 34/107 (31%), Positives = 61/107 (57%), Gaps = 2/107 (1%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMT 75
           E+   ++L ++   L+++H   +I+RDLKP N+LL+A   +K+ DFGL + +  E     
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F   +
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.1 bits (166), Expect = 1e-13
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 1/107 (0%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           N    E+   ++  +L  GL+ +    +++RDLKP N+LL+    ++I D GLA    E 
Sbjct: 96  NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           E +   V T  Y APE++ N   YT + D W +GC+  E++  +  F
Sbjct: 156 ETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 29/97 (29%), Positives = 57/97 (58%), Gaps = 1/97 (1%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           ++  Q+  G+ ++HS ++++RD+KP N+LL+   + ++ D GLA    + + +T+   T 
Sbjct: 99  HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            Y APE+L     Y+  +D +++GC   E++  R  F
Sbjct: 159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 49/142 (34%), Positives = 78/142 (54%), Gaps = 11/142 (7%)

Query: 3   TDLYQ-IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           TDL +  ++  + + E    Y L++ L GL+++H    IHRD+K +N+LL     +K+ D
Sbjct: 108 TDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167

Query: 62  FGL-ARPTSENEFMTEYVVTRWYRAPELL-----LNSSDYTAAIDVWSVGCIFMELMNRR 115
           FG+ A+ TS        V T ++ APE++     L+S+ Y A  DVWS+G   +EL +  
Sbjct: 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGD 226

Query: 116 PLFPGNDHVHQMRLLIELLGTP 137
           P  P  D +H MR L ++   P
Sbjct: 227 P--PLAD-LHPMRALFKIPRNP 245

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 67.4 bits (164), Expect = 1e-13
 Identities = 42/113 (37%), Positives = 62/113 (54%), Gaps = 8/113 (7%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR   +NE+         
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPGNDHVHQMRLL 130
            +W  APE  +N   +T   DVWS G + ME++   R P +PG  +   +R L
Sbjct: 167 IKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.8 bits (166), Expect = 1e-13
 Identities = 40/127 (31%), Positives = 62/127 (48%), Gaps = 10/127 (7%)

Query: 1   MDTDL---YQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNAN 54
           MD  L   Y+ +       + EE         ++ L Y+     +IHRD+KPSN+LL+ N
Sbjct: 85  MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN 144

Query: 55  CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELM 112
            ++K+CDFG++    ++   T     R Y APE +  S+   Y    DVWS+G    E+ 
Sbjct: 145 GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA 204

Query: 113 NRRPLFP 119
             +  FP
Sbjct: 205 TGK--FP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 28/222 (12%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDLY  + + ++++          +LR ++Y+H   +IHRD+K  N+ +N   D+ + DF
Sbjct: 167 TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226

Query: 63  GLARPTSENEFMTEYVVTRWY--------RAPELLLNSSDYTAAIDVWSVGCIFME---- 110
           G A       F  +    ++Y         APELL     Y  A+D+WS G +  E    
Sbjct: 227 GAAC------FPVDINANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATC 279

Query: 111 ---LMNRRPLFPGNDHVHQMRLLIELLGT-PTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
              L  +  L    D   Q++L+I   GT P +  +    N D + YI    +  R+  +
Sbjct: 280 HDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD-EIYIGLAKKSSRKPGS 338

Query: 167 Q-VFPHVHPLAID---LVDRMLTFDPMKRITGEFFVPYKPFQ 204
           + ++ +++ L ID   L+ +ML FD   R + E  + +  FQ
Sbjct: 339 RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380

Length = 391

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.7 bits (165), Expect = 2e-13
 Identities = 36/125 (28%), Positives = 69/125 (55%), Gaps = 3/125 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +S  E   +++  ++   L Y+HS N+++RDLKP N+LL++   + + DFG
Sbjct: 82  ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFG 141

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   ++++  T +  T  Y APE ++    Y   +D W +G +  E++   P F   D
Sbjct: 142 LCKEGIAQSDTTTTFCGTPEYLAPE-VIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200

Query: 123 HVHQM 127
            V +M
Sbjct: 201 -VAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 30/186 (16%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           I ++  ++EE        +L+ L ++H+  VIHRD+K  ++LL ++  +K+ DFG     
Sbjct: 106 IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165

Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           S+     + +V T ++ APE +++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 166 SKEVPRRKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224

Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           + +               R+    +      ++  +        V P     +DRML  D
Sbjct: 225 KRI---------------RDNLPPKL-----KNLHK--------VSPRLRSFLDRMLVRD 256

Query: 188 PMKRIT 193
           P +R T
Sbjct: 257 PAQRAT 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 44/117 (37%), Positives = 60/117 (51%), Gaps = 14/117 (11%)

Query: 4   DLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL   +R  +   L+ E    F YQ+ +G+ ++ S N IHRDL   N+LL     +KICD
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184

Query: 62  FGLARPTSENEFMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           FGLAR    +   + YVV        +W  APE + N   YT   DVWS G +  E+
Sbjct: 185 FGLARDIMND---SNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.3 bits (164), Expect = 2e-13
 Identities = 35/109 (32%), Positives = 68/109 (62%), Gaps = 1/109 (0%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE+  +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 83  DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L   + Y ++ D +S+GC+  +L+
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 45/193 (23%), Positives = 86/193 (44%), Gaps = 34/193 (17%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T LYQ     +  +E   + ++ +++  L ++H   +I+RD+K  N+LL++   + + DF
Sbjct: 94  THLYQ----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDF 149

Query: 63  GLARP--TSENEFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNRRPLFP 119
           GL++     E E    +  T  Y APE++   S  +  A+D WS+G +  EL+     F 
Sbjct: 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            +   +                    ++E ++R ++  P  P          +   A D 
Sbjct: 210 VDGEQNS-------------------QSEISRRILKSKPPFP--------KTMSAEARDF 242

Query: 180 VDRMLTFDPMKRI 192
           + ++L  DP KR+
Sbjct: 243 IQKLLEKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 2e-13
 Identities = 33/115 (28%), Positives = 64/115 (55%), Gaps = 3/115 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +R++   S     ++  +++  L+Y+HS  +++RDLKP N+LL+    +K+ DFG
Sbjct: 87  ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFG 146

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+   +  +      T  Y APE ++ S  +  A+D W++G +  E++   P F
Sbjct: 147 FAKKLRDRTWTL--CGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.9 bits (163), Expect = 2e-13
 Identities = 47/191 (24%), Positives = 81/191 (42%), Gaps = 34/191 (17%)

Query: 4   DLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DLY  ++  +   L E     +  Q+   L+Y+H  +++HRDLK  N+ L     +K+ D
Sbjct: 86  DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGD 145

Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
            G+AR   ++ +  +  + T +Y +PEL  N   Y    DVW++GC   E+   +  F  
Sbjct: 146 LGIARVLENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNA 204

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D    +  +IE                       +LP  P+    ++         +L+
Sbjct: 205 KDMNSLVYRIIE----------------------GKLPPMPKDYSPEL--------GELI 234

Query: 181 DRMLTFDPMKR 191
             ML+  P KR
Sbjct: 235 ATMLSKRPEKR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 66.8 bits (163), Expect = 2e-13
 Identities = 35/118 (29%), Positives = 62/118 (52%), Gaps = 4/118 (3%)

Query: 4   DLYQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DLY+ I + + +   E+    +  Q+   LK++H   ++HRD+K  N+ L  +  +K+ D
Sbjct: 85  DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGD 144

Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG+AR   S  E     + T +Y +PE+  N   Y    D+W++GC+  E+   +  F
Sbjct: 145 FGIARVLNSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.1 bits (164), Expect = 2e-13
 Identities = 38/125 (30%), Positives = 63/125 (50%), Gaps = 12/125 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++HS  +I+RDLK  N++L+A   +KI DFG
Sbjct: 87  DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFG 146

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +     TR       Y APE++     Y  ++D W+ G +  E++  +P 
Sbjct: 147 MCK-----ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPP 200

Query: 118 FPGND 122
           F G D
Sbjct: 201 FDGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.4 bits (164), Expect = 2e-13
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 20/211 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP--- 119
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F    
Sbjct: 142 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200

Query: 120 --------GNDHVHQMRLLIEL-----LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
                     D++ Q+ L  ++     L     + L    N+D K  +   PQ     + 
Sbjct: 201 SSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADI- 259

Query: 167 QVFPHVHPLAIDLVDRMLTFDPMK-RITGEF 196
           Q  P    +  DL+++     P K  I+GEF
Sbjct: 260 QGHPFFRNVDWDLMEQKQVVPPFKPNISGEF 290

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.0 bits (163), Expect = 2e-13
 Identities = 44/140 (31%), Positives = 73/140 (52%), Gaps = 9/140 (6%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDL +  + N +L E+   Y   ++LRGL ++H+  VIHRD+K  N+LL  N ++K+ DF
Sbjct: 107 TDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165

Query: 63  GLARPTSEN-EFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPL 117
           G++            ++ T ++ APE++       + Y    D+WS+G   +E+    P 
Sbjct: 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP- 224

Query: 118 FPGNDHVHQMRLLIELLGTP 137
            P  D +H MR L  +   P
Sbjct: 225 -PLCD-MHPMRALFLIPRNP 242

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 67.3 bits (164), Expect = 2e-13
 Identities = 39/125 (31%), Positives = 66/125 (52%), Gaps = 3/125 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +   E   +++  ++   + Y+HS N+I+RDLKP N+LL++   + + DFG
Sbjct: 82  ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFG 141

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   E E  T  +  T  Y APE +L    Y   +D W +G +  E++   P F   D
Sbjct: 142 LCKEGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Query: 123 HVHQM 127
            V QM
Sbjct: 201 -VSQM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 67.6 bits (165), Expect = 3e-13
 Identities = 41/105 (39%), Positives = 54/105 (51%), Gaps = 12/105 (11%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           +L  E    F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +  
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND-- 267

Query: 74  MTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + YVV        +W  APE + N   YT   DVWS G +  E+
Sbjct: 268 -SNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.6 bits (162), Expect = 3e-13
 Identities = 32/112 (28%), Positives = 64/112 (57%), Gaps = 5/112 (4%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           ++S  +L+E   + +  Q+L G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156

Query: 69  S----ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
                    M     T ++ +PE +++   Y    D+WSVGC  +E++  +P
Sbjct: 157 QTICLSGTGMKSVTGTPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.7 bits (163), Expect = 3e-13
 Identities = 37/121 (30%), Positives = 64/121 (52%), Gaps = 2/121 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +S  E   +++  ++   L Y+HS N+I+RDLKP N+LL++   + + DFG
Sbjct: 82  ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFG 141

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   E+   T  +  T  Y APE+L     Y   +D W +G +  E++   P F   D
Sbjct: 142 LCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Query: 123 H 123
            
Sbjct: 201 T 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 3e-13
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 14/171 (8%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +LR L Y+H+  VIHRD+K  ++LL ++  +K+ DFG  A+ 
Sbjct: 109 IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168

Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE +++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 169 SKEVPKRKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227

Query: 128 RLLIELLGTPTDA------------DLGFVRNEDAKRYIRQLPQHPRQSLA 166
           R + + L                  DL  VR    +   ++L QHP   LA
Sbjct: 228 RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.8 bits (163), Expect = 4e-13
 Identities = 35/115 (30%), Positives = 62/115 (53%), Gaps = 3/115 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +R       +  +++  +L+   +Y+HS ++I+RDLKP NLLL+    +K+ DFG
Sbjct: 104 ELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG 163

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+   +  F      T  Y APE ++ S  +  A+D W++G +  E +   P F
Sbjct: 164 FAKKVPDRTFT--LCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.5 bits (162), Expect = 4e-13
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 16/166 (9%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP------- 137
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYL-NENPLRALYLIATNGTPELQNPEK 240

Query: 138 -TDADLGFVR-----NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
            +     F+      + + +   ++L QHP   +A+    + PL  
Sbjct: 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIA 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 5e-13
 Identities = 38/100 (38%), Positives = 52/100 (52%), Gaps = 8/100 (8%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VVTRW 82
           Q+  G+ Y+ S N IHRDL   N+L+  N   KI DFGLAR   ++E+          +W
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             APE   N   +T   DVWS G +  E++   R P +PG
Sbjct: 171 -TAPE-AANYGRFTIKSDVWSFGILLTEIVTYGRVP-YPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.8 bits (160), Expect = 6e-13
 Identities = 44/176 (25%), Positives = 82/176 (46%), Gaps = 28/176 (15%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE 76
           E    ++  ++  GL+ +H   +++RDLKP N+LL+ +  ++I D GLA    E + +  
Sbjct: 101 EGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160

Query: 77  YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGT 136
            V T  Y APE++ N   YT + D W++GC+  E++       G     Q +  I     
Sbjct: 161 RVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIA------GQSPFQQRKKKI----- 208

Query: 137 PTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI 192
                    + E+ +R ++++ +   +  +       P A  L   +L  DP +R+
Sbjct: 209 ---------KREEVERLVKEVQEEYSEKFS-------PDARSLCKMLLCKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 66.5 bits (162), Expect = 6e-13
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 31/207 (14%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNAN----------------CDL 57
            S  H    ++Q    L Y H+  +++H DLKP N+L+  +                C +
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 58  KICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           +ICD G      E    T  V TR YR+PE++L    +  + D+WS+GCI  EL   + L
Sbjct: 288 RICDLGGC--CDERHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLL 344

Query: 118 FPGNDHVHQMRLLIELLGT-PTD--ADLGFVRNEDAKRYIRQL-----PQH-PRQSLAQV 168
           +  +D++  + L+ + LG  P++     G            QL     P+H  R + A+ 
Sbjct: 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARP 404

Query: 169 FPHV--HPLAIDLVDRMLTFDPMKRIT 193
              V    L  DL+  +L +D  KR+ 
Sbjct: 405 VREVIRDDLLCDLIYGLLHYDRQKRLN 431

Length = 467

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.7 bits (160), Expect = 7e-13
 Identities = 38/120 (31%), Positives = 69/120 (57%), Gaps = 3/120 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 83  DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+  R   P   H
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL--RGHSPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 66.2 bits (161), Expect = 7e-13
 Identities = 35/95 (36%), Positives = 58/95 (61%), Gaps = 6/95 (6%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTE---YV 78
           F YQ+ RG++++ S N +HRDL   N+LL     +KICDFGLAR    ++ ++++   ++
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             +W  APE + ++  YT   DVWS G +  E+ +
Sbjct: 302 PVKWM-APESIFDNL-YTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.5 bits (159), Expect = 7e-13
 Identities = 44/130 (33%), Positives = 69/130 (53%), Gaps = 9/130 (6%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+Y +      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N  +K+ DFG
Sbjct: 95  DIYHV---TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFG 151

Query: 64  L-ARPTSENEFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           + A+ T+       ++ T ++ APE+  +     Y    D+W+VG   +EL   +P  P 
Sbjct: 152 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP--PM 209

Query: 121 NDHVHQMRLL 130
            D +H MR L
Sbjct: 210 FD-LHPMRAL 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.0 bits (161), Expect = 9e-13
 Identities = 38/100 (38%), Positives = 58/100 (58%), Gaps = 10/100 (10%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEYVVTRW 82
           Q+L G+ Y+H  +++HRD+KPSNLL+N+  ++KI DFG++R     + M      V T  
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIA 233

Query: 83  YRAPELL---LNSSDYTA-AIDVWSVGCIFMEL-MNRRPL 117
           Y +PE +   LN   Y   A D+WS+G   +E  + R P 
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.5 bits (159), Expect = 1e-12
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 16/166 (9%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++H+  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP---TDAD 141
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYL-NENPLRALYLIATNGTPELQNPEK 240

Query: 142 LGFVRNEDAKRYI----------RQLPQHPRQSLAQVFPHVHPLAI 177
           L  +  +   R +          ++L QHP   LA+    + PL +
Sbjct: 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLIL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 64.8 bits (158), Expect = 1e-12
 Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 6/115 (5%)

Query: 4   DLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
            L   +RS   Q L          Q+  G+ Y+   N IHRDL   N+L+  +   K+ D
Sbjct: 88  SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVAD 147

Query: 62  FGLARPTSENEFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           FGLAR   E+ +++    +  +W  APE   +   ++   DVWS G +  E+   
Sbjct: 148 FGLARLIKEDVYLSSDKKIPYKW-TAPE-AASHGTFSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 65.0 bits (158), Expect = 1e-12
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 31/196 (15%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 107 IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166

Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 167 SKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225

Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           +++ +                        LP  P+         V P     +DR+L  D
Sbjct: 226 KMIRD-----------------------NLP--PKLKNLH---KVSPSLKGFLDRLLVRD 257

Query: 188 PMKRITGEFFVPYKPF 203
           P +R T    + + PF
Sbjct: 258 PAQRATAAELLKH-PF 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.7 bits (157), Expect = 1e-12
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 8/153 (5%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           +++  +L+E   + +  Q+L+G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156

Query: 69  S----ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
                    +     T ++ +PE +++   Y    DVWSV C  +E++  +P  P  ++ 
Sbjct: 157 QTICMSGTGIKSVTGTPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKP--PWAEY- 212

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
             M  + ++   PT   L    ++  + +++Q+
Sbjct: 213 EAMAAIFKIATQPTKPMLPDGVSDACRDFLKQI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.3 bits (159), Expect = 1e-12
 Identities = 36/115 (31%), Positives = 62/115 (53%), Gaps = 3/115 (2%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           ++QI RS +   E   +++  ++   L ++H   VI+RDLK  N+LL+A    K+ DFG+
Sbjct: 84  MFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGM 142

Query: 65  ARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +         T +  T  Y APE +L   +Y  ++D W++G +  E+M  +P F
Sbjct: 143 CKEGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.1 bits (158), Expect = 1e-12
 Identities = 34/116 (29%), Positives = 65/116 (56%), Gaps = 2/116 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L ++H   +I+RDLK  N+LL+A+  +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYG 141

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + +      +  + +  T  Y APE +L   +Y  ++D W++G +  E+M  R  F
Sbjct: 142 MCKEGLGPGDTTSTFCGTPNYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.0 bits (158), Expect = 2e-12
 Identities = 34/116 (29%), Positives = 63/116 (54%), Gaps = 2/116 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +   E   +++  ++   L Y+HS N+++RDLKP N+LL++   + + DFG
Sbjct: 82  ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 141

Query: 64  LARPTSE-NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           L +   E N   + +  T  Y APE +L+   Y   +D W +G +  E++   P F
Sbjct: 142 LCKENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 64.3 bits (156), Expect = 2e-12
 Identities = 38/99 (38%), Positives = 52/99 (52%), Gaps = 6/99 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VVTRW 82
           Q+  G+ YI   N IHRDL+ +N+L+      KI DFGLAR   +NE+          +W
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL+ + R  +PG
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.9 bits (155), Expect = 3e-12
 Identities = 39/99 (39%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VVTRW 82
           Q+  G+ YI   N IHRDL+ +N+L+  N   KI DFGLAR   +NE+          +W
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL+ + R  +PG
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 3e-12
 Identities = 40/117 (34%), Positives = 63/117 (53%), Gaps = 17/117 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DLY+     + L+ E    + +Q+ +G++++ S   IHRDL   N+LL+ N  +KICDFG
Sbjct: 170 DLYK-----KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224

Query: 64  LARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           LAR   ++    +YV         +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 225 LARDIYKD---PDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.1 bits (156), Expect = 3e-12
 Identities = 36/102 (35%), Positives = 59/102 (57%), Gaps = 8/102 (7%)

Query: 25  YQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWY 83
           Y +++GLK++    N+IHRD+KP+N+L+N N  +K+CDFG++     +   T  +  + Y
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSY 167

Query: 84  RAPELL--LNSSD---YTAAIDVWSVGCIFMEL-MNRRPLFP 119
            APE +     +    YT   DVWS+G   +E+ + R P  P
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 3e-12
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 20/206 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +  L  E       +LL  L Y+H   +IHRD+K  N+ L+   +  + DFG
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230

Query: 64  LARPTSENEFMTE---YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFME-LMNRRPLF 118
            A     +    +   +  T    +PELL L+   Y A  D+WS G +  E  +    LF
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 119 --PGNDHVHQMRLLIELLGTPTDADLGFVRNEDA------KRYIRQLPQHPRQSLAQVFP 170
                    Q+R +I  +       L F +N         K+Y   L + P      +  
Sbjct: 289 GKQVKSSSSQLRSIIRCMQV---HPLEFPQNGSTNLCKHFKQYAIVL-RPPYTIPPVIRK 344

Query: 171 HVHPLAID-LVDRMLTFDPMKRITGE 195
           +   + ++ L+ +MLTFD   R + +
Sbjct: 345 YGMHMDVEYLIAKMLTFDQEFRPSAQ 370

Length = 392

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.1 bits (156), Expect = 3e-12
 Identities = 40/117 (34%), Positives = 62/117 (52%), Gaps = 17/117 (14%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
             +LY+     + L+ E    + +Q+ RG++++ S   IHRDL   N+LL+ N  +KICD
Sbjct: 162 GDELYK-----EPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD 216

Query: 62  FGLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           FGLAR   ++    +YV         +W  APE + +   YT   DVWS G +  E+
Sbjct: 217 FGLARDIYKD---PDYVRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.5 bits (154), Expect = 3e-12
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 6/123 (4%)

Query: 4   DLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL ++I+      + + E+    +  QL   L+++HS  V+HRD+KP+N+ + A   +K+
Sbjct: 88  DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL 147

Query: 60  CDFGLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            D GL R  S        +V T +Y +PE  ++ + Y    D+WS+GC+  E+   +  F
Sbjct: 148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Query: 119 PGN 121
            G+
Sbjct: 207 YGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 3e-12
 Identities = 56/199 (28%), Positives = 83/199 (41%), Gaps = 30/199 (15%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-PTSENEFMTEYVVTRWYR 84
           Q+L GL+Y+H+  +IHRD+K  N+ +N    + I D G A+ P     F+     T    
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETN 223

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELM------NRRPLFPGNDHV----HQMRLLIELL 134
           APE+L     Y +  D+WS G +  E++         P     ++V      +  +I  L
Sbjct: 224 APEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282

Query: 135 GT-----PTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP--LAID---LVDRML 184
                  P D     VR      +I       RQ   + +P      L ID   LV +ML
Sbjct: 283 KVHPEEFPRDPGSRLVRG-----FIEYASLE-RQPYTR-YPCFQRVNLPIDGEFLVHKML 335

Query: 185 TFDPMKRITGEFFVPYKPF 203
           TFD   R + E  + Y  F
Sbjct: 336 TFDAAMRPSAEEILNYPMF 354

Length = 357

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 63.5 bits (154), Expect = 3e-12
 Identities = 43/127 (33%), Positives = 69/127 (54%), Gaps = 18/127 (14%)

Query: 12  NQSLSEEHCQYFLYQL---LRG----LKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           ++ L +   ++  YQL   LRG    +KY+   N +HRDL   N+L+N+N + K+ DFGL
Sbjct: 94  DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGL 153

Query: 65  ARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           +R   E++    Y  +      RW  APE  +    +T+A DVWS G +  E+M+   RP
Sbjct: 154 SR-VLEDDPEGTYTTSGGKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Query: 117 LFPGNDH 123
            +  ++H
Sbjct: 211 YWDMSNH 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.5 bits (154), Expect = 4e-12
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 6/102 (5%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VV 79
              Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+         
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
            +W  APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 167 IKW-TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 63.3 bits (155), Expect = 4e-12
 Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 36/195 (18%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKIC 60
           D DL+ +++    LSE   +  + QL+  L  +H  N+IH D+K  N+L +   D + +C
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 61  DFGLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           D+GL +   +     + Y  T  Y +PE  +   +Y  + D W+VG +  EL+       
Sbjct: 153 DYGLCKIIGTP----SCYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTG----- 202

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAID 178
                            P      F  +ED +  +  L    RQ     F  +V   A D
Sbjct: 203 ---------------KHP------FKEDEDEELDLESL--LKRQQKKLPFIKNVSKNAND 239

Query: 179 LVDRMLTFDPMKRIT 193
            V  ML ++   R+T
Sbjct: 240 FVQSMLKYNINYRLT 254

Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.5 bits (155), Expect = 4e-12
 Identities = 45/164 (27%), Positives = 68/164 (41%), Gaps = 32/164 (19%)

Query: 31  LKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELL- 89
           LK  H   VIHRD+KPSN+LL+A+ ++K+CDFG++    +++  T       Y APE + 
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERID 187

Query: 90  --LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN 147
               +  Y    DVWS+G   +EL   +  +       ++              L  +  
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV--------------LTKILQ 233

Query: 148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
           E+           P     + F    P     VD  LT D  KR
Sbjct: 234 EEP----------PSLPPNEGFS---PDFCSFVDLCLTKDHRKR 264

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 63.1 bits (153), Expect = 4e-12
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 6/102 (5%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           F  Q+  G+ YI   N IHRDL+ +N+L++ +   KI DFGLAR   +NE+         
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPG 120
            +W  APE  +N   +T   DVWS G +  E++    + +PG
Sbjct: 168 IKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.1 bits (153), Expect = 5e-12
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 6/123 (4%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL Q+I    +  + + E     +  QL   ++++HS  V+HRD+KP+N+ + A   +K+
Sbjct: 88  DLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKL 147

Query: 60  CDFGLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            D GL R  +S+       V T +Y +PE  ++ + Y    D+WS+GC+  E+   +  F
Sbjct: 148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Query: 119 PGN 121
            G+
Sbjct: 207 YGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 63.7 bits (155), Expect = 5e-12
 Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 2/116 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L ++H   +I+RDLK  N+LL+A   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F
Sbjct: 142 MCKEGIRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.5 bits (154), Expect = 5e-12
 Identities = 37/119 (31%), Positives = 63/119 (52%), Gaps = 3/119 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           + +  +R N+    +   ++  Q++   +Y+ S N+++RDLKP NLLL+ +  +K+ DFG
Sbjct: 117 EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            A+      +      T  Y APE+LLN     AA D W++G    E++   P F  N+
Sbjct: 177 FAKVVDTRTYT--LCGTPEYIAPEILLNVGHGKAA-DWWTLGIFIYEILVGCPPFYANE 232

Length = 340

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.1 bits (153), Expect = 6e-12
 Identities = 37/120 (30%), Positives = 65/120 (54%), Gaps = 2/120 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFG 141

Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     +  T  +  T  Y APE+LL    Y  ++D WS G +  E++  +  F G+D
Sbjct: 142 MCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.7 bits (152), Expect = 8e-12
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQ+ RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203

Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 204 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.8 bits (153), Expect = 8e-12
 Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 13/100 (13%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+ +G+ Y+ S   IHRDL   N+L+ +   +KI DFGLA+   E++   +Y   + 
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKE 170

Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
                  WY APE  L +S +++A DVWS G    EL   
Sbjct: 171 PGESPIFWY-APE-CLRTSKFSSASDVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.9 bits (153), Expect = 8e-12
 Identities = 40/107 (37%), Positives = 57/107 (53%), Gaps = 15/107 (14%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F  Q+ +G+ ++ S N IHRD+   N+LL      KICDFGLAR    N+  + YVV   
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MND--SNYVVKGN 273

Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MNRRPLFPG 120
                +W  APE + +   YT   DVWS G +  E+  + + P +PG
Sbjct: 274 ARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.6 bits (152), Expect = 8e-12
 Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 8/100 (8%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVVTRW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 170 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 63.1 bits (153), Expect = 8e-12
 Identities = 38/113 (33%), Positives = 63/113 (55%), Gaps = 6/113 (5%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T    +I  + +LS      F YQ+  G++++ S N +HRDL   N+L+     +KICDF
Sbjct: 224 TRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDF 283

Query: 63  GLARP-TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           GLAR    ++ ++++   ++  +W  APE + N+  YT   DVWS G +  E+
Sbjct: 284 GLARDIMRDSNYISKGSTFLPLKWM-APESIFNNL-YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 9e-12
 Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 10/109 (9%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW--- 82
           Q+  G+ Y+ + N IHRDL   N+L+  N   K+ DFGLAR   E+ +       ++   
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIK 169

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG--NDHVHQM 127
           + APE     + ++   DVWS G +  E++   R P +PG  N  V Q 
Sbjct: 170 WTAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMP-YPGMTNAEVLQQ 216

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.3 bits (151), Expect = 9e-12
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 28/176 (15%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR---- 81
           Q+ +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +    ++   EY   +    
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK---EYYTVKDDLD 173

Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
               WY APE L+ S  Y A+ DVWS G    EL+        +     M L ++++G P
Sbjct: 174 SPVFWY-APECLIQSKFYIAS-DVWSFGVTLYELLTY-----CDSESSPMTLFLKMIG-P 225

Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           T   +   R        ++LP+ P     +V+         L+ +   F P KR T
Sbjct: 226 THGQMTVTRLVRVLEEGKRLPR-PPNCPEEVY--------QLMRKCWEFQPSKRTT 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 34/111 (30%), Positives = 59/111 (53%), Gaps = 7/111 (6%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ ++E++    ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141

Query: 65  ARPTSENEFMTEYVVT-----RWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++    +E   +         +WY APE  +N   +++  DVWS G +  E
Sbjct: 142 SKALGADENYYKAKTHGKWPVKWY-APE-CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 35/105 (33%), Positives = 62/105 (59%), Gaps = 8/105 (7%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY 77
           ++  +++ GL+++HS  +I+RDLK  N++L+ +  +KI DFG+ +   EN F     + +
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTF 156

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
             T  Y APE+L     YT ++D WS G +  E++  +  F G+D
Sbjct: 157 CGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 12/98 (12%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           + +Q+ RG++++ S   IHRDL   N+LL+ N  +KICDFGLAR   ++    +YV    
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGS 235

Query: 81  -----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 236 ARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.8 bits (150), Expect = 2e-11
 Identities = 38/100 (38%), Positives = 50/100 (50%), Gaps = 13/100 (13%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+HS + IHRDL   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 168

Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
                  WY A E L  +    A+ DVWS G    EL+  
Sbjct: 169 DGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)

Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV 79
           C Y + Q+  G++Y+ S   IHRDL   N+LL ++  +KI DFGL R   +NE   ++ V
Sbjct: 100 CDYAV-QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHYV 155

Query: 80  TRWYR-------APELLLNSSDYTAAIDVWSVGCIFMEL 111
              +        APE  L +  ++ A DVW  G    E+
Sbjct: 156 MEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 35/120 (29%), Positives = 63/120 (52%), Gaps = 2/120 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++HS  +I+RDLK  N++L++   +KI DFG
Sbjct: 87  DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 146

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +    +   T+ +  T  Y APE ++    Y  ++D W+ G +  E++  +  F G D
Sbjct: 147 MCKENMWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 61.0 bits (148), Expect = 3e-11
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 11/96 (11%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY-------VVTRW 82
           G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   ++     Y       +  RW
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
             APE  +    +T+A DVWS G +  E+M+   RP
Sbjct: 178 -TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 61.3 bits (149), Expect = 3e-11
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 5/107 (4%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG       
Sbjct: 135 SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194

Query: 71  NEFM--TEYVVTRWYRAPELLLN---SSDYTAAIDVWSVGCIFMELM 112
           N  +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 37/125 (29%), Positives = 63/125 (50%), Gaps = 12/125 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E    ++  ++  GL ++H   +I+RDLK  N++L++   +KI DFG
Sbjct: 87  DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFG 146

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E M + V TR       Y APE++     Y  ++D W+ G +  E++  +P 
Sbjct: 147 MCK-----EHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPP 200

Query: 118 FPGND 122
           F G D
Sbjct: 201 FDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 4e-11
 Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTE--YVV 79
           L  +  G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R    SE  + T+   + 
Sbjct: 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 172 IRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 60.2 bits (146), Expect = 4e-11
 Identities = 28/90 (31%), Positives = 50/90 (55%), Gaps = 7/90 (7%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTR 81
            +   ++Y+ S   IHRDL   N L+  +  +K+ DFGLAR   ++++     T++ V +
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV-K 166

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           W  AP  + + S +++  DVWS G +  E+
Sbjct: 167 W--APPEVFDYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.5 bits (147), Expect = 4e-11
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 27/139 (19%)

Query: 18  EHCQYFLY--QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT 75
           +H +  LY  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGL +   +++   
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK--- 162

Query: 76  EYVVTR--------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP--LF-- 118
           EY   R        WY APE  L  S ++ A DVWS G +  EL      +  P   F  
Sbjct: 163 EYYKVREPGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR 220

Query: 119 -PGNDHVHQMRL--LIELL 134
             GND   QM +  LIELL
Sbjct: 221 MMGNDKQGQMIVYHLIELL 239

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.8 bits (147), Expect = 4e-11
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 5/100 (5%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     ++  +    R   
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200

Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPG 120
            + APE L +   YT   DVWS G +  E+       +PG
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 5e-11
 Identities = 40/127 (31%), Positives = 70/127 (55%), Gaps = 10/127 (7%)

Query: 4   DLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL Q I+S    N++  E        Q+L  + ++HS ++IHRD+K +N+LL +N  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 60  CDFGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RR 115
            DFG ++    T  ++    +  T +Y APE +     Y+   D++S+G +  EL+  +R
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKR 243

Query: 116 PLFPGND 122
           P F G +
Sbjct: 244 P-FDGEN 249

Length = 496

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 60.2 bits (146), Expect = 5e-11
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 6/85 (7%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTRWYRA 85
           G++Y+ S N IHRDL   N L+  N  LKI DFG++R      +      + +  +W  A
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TA 163

Query: 86  PELLLNSSDYTAAIDVWSVGCIFME 110
           PE  LN   YT+  DVWS G +  E
Sbjct: 164 PE-ALNYGRYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 6e-11
 Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 66/218 (30%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA--- 65
           IR +    EE  ++++ +L+  L  +H    IHRD+KP N+L++A+  +K+ DFGL    
Sbjct: 93  IRKDV-FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151

Query: 66  ---------RPTSENEFMTEYVVTRW------------------YRAPELLLNSSDYTAA 98
                       S N    + V+ R                   Y APE+L   + Y   
Sbjct: 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLE 210

Query: 99  IDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP 158
            D WS+G I  E++   P F  +                          E   + I    
Sbjct: 211 CDWWSLGVILYEMLYGFPPFYSDT-----------------------LQETYNKII---- 243

Query: 159 QHPRQSLAQVFPHVHPL---AIDLVDRMLTFDPMKRIT 193
            + ++SL   FP   P+   AIDL+ R+L  DP  R+ 
Sbjct: 244 -NWKESL--RFPPDPPVSPEAIDLICRLLC-DPEDRLG 277

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.4 bits (146), Expect = 6e-11
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR   + ++  +    R   
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV 200

Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 8e-11
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 6/108 (5%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
             + Q+LS +   +   Q+  G+ Y+H   VIH+D+   N +++    +KI D  L+R  
Sbjct: 108 ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 69  SENEFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
              ++      E    +W  A E L+N  +Y++A DVWS G +  ELM
Sbjct: 168 FPMDYHCLGDNENRPVKWM-ALESLVN-KEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 59.6 bits (144), Expect = 9e-11
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     ++  +    R   
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206

Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 207 KWMAPEALFDRI-YTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.8 bits (145), Expect = 9e-11
 Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 46/187 (24%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--------------- 66
           YF   +L  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFGL++               
Sbjct: 106 YFAETVL-ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 67  PTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
                EF+ + V  T  Y APE++L    Y   +D W++G I  E +     F G+    
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPE- 222

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                 EL G     D+ +   ++A      LP                 A DL+ R+L 
Sbjct: 223 ------ELFGQVISDDIEWPEGDEA------LP---------------ADAQDLISRLLR 255

Query: 186 FDPMKRI 192
            +P++R+
Sbjct: 256 QNPLERL 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 59.7 bits (144), Expect = 1e-10
 Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 37/151 (24%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+  ++    +LSEE  Q+++ + +  +  IH    IHRD+KP NLLL+A   +K+ DFG
Sbjct: 87  DMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG 146

Query: 64  LA-----------------RPTSENEFMT-------------------EYVVTRWYRAPE 87
           L                   P S+  F                       V T  Y APE
Sbjct: 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206

Query: 88  LLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + + +  Y    D WS+G I  E++   P F
Sbjct: 207 VFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 35/123 (28%), Positives = 62/123 (50%), Gaps = 4/123 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           ++  + Q ++ +    E       YQ++  L  +HS  ++HRDLK +N+ L     +K+ 
Sbjct: 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211

Query: 61  DFGLARPTSEN---EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           DFG ++  S++   +  + +  T +Y APE L     Y+   D+WS+G I  EL+     
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRP 270

Query: 118 FPG 120
           F G
Sbjct: 271 FKG 273

Length = 478

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 51/170 (30%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS----- 69
           LSEE  +++  ++L  L+Y+H   +++RDLKP N+LL+ +  + + DF L++ +      
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Query: 70  -----------------ENEFMTE--------YVVTRWYRAPELLLNSSDYTAAIDVWSV 104
                             +E  +E        +V T  Y APE +++   + +A+D W++
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTL 218

Query: 105 GCIFMELM---------NRR----------PLFPGNDHV-HQMRLLIELL 134
           G +  E++         NR             FPG+  V    R LI  L
Sbjct: 219 GILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKL 268

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.8 bits (144), Expect = 2e-10
 Identities = 40/127 (31%), Positives = 57/127 (44%), Gaps = 25/127 (19%)

Query: 26  QLLRGLKYIHS-------ANVIHRDLKPSNLLL-----------------NANCDLKICD 61
           QLL  L Y H+         V+HRDLKP N+ L                 N     KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPG 120
           FGL++           V T +Y +PELLL+ +  Y    D+W++GCI  EL + +  F  
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 121 NDHVHQM 127
            ++  Q+
Sbjct: 246 ANNFSQL 252

Length = 1021

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.4 bits (141), Expect = 2e-10
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 11/95 (11%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT------RWY 83
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+R   E++    Y         RW 
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRW- 175

Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
            APE  +    +T+A DVWS G +  E+M+   RP
Sbjct: 176 TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 8/123 (6%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R      E+  Q++L +L+  +  +H    +HRD+KP N+L++    +K+ DFG A   +
Sbjct: 94  RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153

Query: 70  ENE--FMTEYVVTRWYRAPELL--LNSSD---YTAAIDVWSVGCIFMELM-NRRPLFPGN 121
            N+       V T  Y APE+L  +N      Y    D WS+G I  E++  R P   G 
Sbjct: 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213

Query: 122 DHV 124
              
Sbjct: 214 SAK 216

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.8 bits (142), Expect = 3e-10
 Identities = 56/192 (29%), Positives = 81/192 (42%), Gaps = 39/192 (20%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG---LARPTSENEFMTEYVVTRW 82
           QLL  + YIH   +IHRD+K  N+L+N   D+ + DFG    AR +    F      T  
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 83  YRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLF--PGNDHVHQMRLLIELLGTPTD 139
             APE+L     YT ++D+WS G  IF   ++   LF     D              P D
Sbjct: 328 TNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR-----------PYD 375

Query: 140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVF----------PHVHP-------LAID---L 179
           A +  +  + A+ ++ + PQH    L   +           +  P       L +D   L
Sbjct: 376 AQILRIIRQ-AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYL 434

Query: 180 VDRMLTFDPMKR 191
           V R LTFD  +R
Sbjct: 435 VCRALTFDGARR 446

Length = 461

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.9 bits (140), Expect = 3e-10
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 13/120 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   IRS   + + +    F  Q+ +G++Y+ S   +HRDL   N +L+ +  +K+ DF
Sbjct: 83  DLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADF 142

Query: 63  GLARPTSENEFMTEYVVTRWYRAPEL--------LLNSSDYTAAIDVWSVGCIFMELMNR 114
           GLAR   + E+   Y V   +   +L         L +  +T   DVWS G +  ELM R
Sbjct: 143 GLARDIYDKEY---YSVHN-HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.1 bits (140), Expect = 3e-10
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YV 78
           F +Q+ RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E +   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
             +W  A E L +   YT   DVWS G +  E++
Sbjct: 192 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 57.7 bits (140), Expect = 4e-10
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 11/108 (10%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++  + +     +   +Q+  G+ Y+ S + +HRDL   N+LL      KI DFG+
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141

Query: 65  ARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 105
           +R          Y  T       +WY APE  +N   +++  DVWS G
Sbjct: 142 SRALGAGS--DYYRATTAGRWPLKWY-APE-CINYGKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.6 bits (139), Expect = 4e-10
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 14/96 (14%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY-------- 77
           Q+  G+KY+ S N +HRDL   N L+  N  +KI DFG++R    N +  +Y        
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSGDYYRIQGRAV 193

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +  RW     +LL    +T A DVW+ G    E++ 
Sbjct: 194 LPIRWMSWESILLGK--FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 57.8 bits (140), Expect = 4e-10
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTE--YVVTR 81
           Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  E   V  +
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           W  A E +L+   YT   DVWS G    ELM    +P
Sbjct: 177 WM-ALESILH-RIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.4 bits (139), Expect = 4e-10
 Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 5/105 (4%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
            SL       + YQL   L Y+ S   +HRD+   N+L+++   +K+ DFGL+R   +  
Sbjct: 102 YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161

Query: 73  FMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           +          +W  APE  +N   +T+A DVW  G    E++  
Sbjct: 162 YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 5/109 (4%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           + SN  + E+  +++  +++  L  IHS  +IHRD+KP N+LL+ +  LK+ DFG     
Sbjct: 133 LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192

Query: 69  SENEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
            E   +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.2 bits (140), Expect = 5e-10
 Identities = 36/114 (31%), Positives = 58/114 (50%), Gaps = 6/114 (5%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY--VVTRWY 83
           QLL  ++YIH   +IHRD+K  N+ LN +  + + DFG A P  +     +Y  V T   
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334

Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMNRR--PLFPGNDHVH-QMRLLIELL 134
            +PE+L     Y    D+WS G I +++++    P+  G      Q+  +I+ L
Sbjct: 335 NSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.9 bits (140), Expect = 6e-10
 Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 20/131 (15%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICD 61
           L +++ ++ +L        + Q+L  L   H+  ++HRDLKP N++++        K+ D
Sbjct: 66  LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLD 125

Query: 62  FGL------------ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           FG+            A  T      TE + T  Y APE L      T   D+++ G IF+
Sbjct: 126 FGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRGEP-VTPNSDLYAWGLIFL 180

Query: 110 ELMNRRPLFPG 120
           E +  + +  G
Sbjct: 181 ECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.9 bits (137), Expect = 7e-10
 Identities = 32/84 (38%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT---EYVVTRWYRAP 86
           G+ Y+ S N IHRDL   N L+  N  LKI DFG++R   +  + +   + +  +W  AP
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAP 163

Query: 87  ELLLNSSDYTAAIDVWSVGCIFME 110
           E  LN   Y++  DVWS G +  E
Sbjct: 164 E-ALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 56.5 bits (136), Expect = 8e-10
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 7/86 (8%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTRWYRA 85
           G+ Y+ S+NVIHRDL   N L+  N  +K+ DFG+ R   ++++     T++ V +W  +
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-KW-SS 169

Query: 86  PELLLNSSDYTAAIDVWSVGCIFMEL 111
           PE + + S Y++  DVWS G +  E+
Sbjct: 170 PE-VFSFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 3/89 (3%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F   +  G++Y+   N +HRDL   N+L++ +   K+ DFGLA+  S+ +   +  V +W
Sbjct: 107 FALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-KW 165

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             APE L     ++   DVWS G +  E+
Sbjct: 166 -TAPEALREKK-FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.1 bits (135), Expect = 1e-09
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F+  +  G++Y+ S N IHRDL   N +LN N  + + DFGL++     ++  +   +  
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 81  --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 178 PVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 5/85 (5%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VVTRWYRAP 86
           G++Y+   + IHRDL   N L+++   +K+ DFG+ R   ++E+ +        +W   P
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPP 170

Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
           E + N S Y++  DVWS G +  E+
Sbjct: 171 E-VFNFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 5/106 (4%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--P 67
            +  +LS +   +F   + RG+ Y+     IHRDL   N+L+  N   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               + M    V RW       LN S YT   DVWS G +  E+++
Sbjct: 176 VYVKKTMGRLPV-RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.1 bits (135), Expect = 2e-09
 Identities = 31/110 (28%), Positives = 57/110 (51%), Gaps = 2/110 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+ ++   E   +++  ++   L ++H   +I+RDLK  N+LL+     K+ DFG
Sbjct: 82  DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 141

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           + +    N   T  +  T  Y APE +L    Y  ++D W++G +  E++
Sbjct: 142 MCKEGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.8 bits (134), Expect = 3e-09
 Identities = 39/151 (25%), Positives = 62/151 (41%), Gaps = 37/151 (24%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+  ++    +L+EE  Q+++ + +  +  IH    IHRD+KP NLLL++   +K+ DFG
Sbjct: 87  DMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 146

Query: 64  LA---RPTSENEFMTEY---------------------------------VVTRWYRAPE 87
           L    +     EF                                     V T  Y APE
Sbjct: 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206

Query: 88  LLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + + +  Y    D WS+G I  E++   P F
Sbjct: 207 VFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 55.0 bits (133), Expect = 4e-09
 Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 14/94 (14%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY-------- 77
           ++  G+ Y+ +   +HRDL   N ++  +  +KI DFG+ R   E    T+Y        
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----TDYYRKGGKGL 182

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  RW  APE  L    +T   DVWS G +  E+
Sbjct: 183 LPVRWM-APE-SLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.4 bits (133), Expect = 4e-09
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 5/109 (4%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           + SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG     
Sbjct: 133 LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192

Query: 69  SENEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
           ++   +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 54.7 bits (131), Expect = 4e-09
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 5/102 (4%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F+  +  G++Y+ S + IHRDL   N +LN N ++ + DFGL++     ++  +  + + 
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 83  ---YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
              + A E L +   YT   DVWS G    E+  R +  +PG
Sbjct: 177 PVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 14/106 (13%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           S+S  +  Y   Q+  G+KY+ S N +HRDL   N L+  +  +KI DFG++R    N +
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR----NLY 180

Query: 74  MTEY--------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             +Y        +  RW     +LL    +T A DVW+ G    E+
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 54.5 bits (131), Expect = 5e-09
 Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 7/91 (7%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVT 80
             +  G+ Y+ S   IHRDL   N L++    +K+ DFGL+R   ++E+     +++ V 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV- 165

Query: 81  RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           RW   PE+LL S  +++  DVW+ G +  E+
Sbjct: 166 RW-SPPEVLLYSK-FSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.0 bits (132), Expect = 5e-09
 Identities = 36/113 (31%), Positives = 58/113 (51%), Gaps = 7/113 (6%)

Query: 5   LYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           L   +R ++ ++  ++   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG
Sbjct: 95  LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFG 154

Query: 64  LAR--PTSENEFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA+     E E+  E   V  +W  A E +L+   YT   DVWS G    ELM
Sbjct: 155 LAKLLGADEKEYHAEGGKVPIKWM-ALESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 54.7 bits (131), Expect = 6e-09
 Identities = 31/111 (27%), Positives = 57/111 (51%), Gaps = 7/111 (6%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E+  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG      E+  +
Sbjct: 99  LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158

Query: 75  TEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLF 118
              V   T  Y +PE+L    D    Y    D WS+G C++  L    P +
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.0 bits (130), Expect = 7e-09
 Identities = 31/122 (25%), Positives = 56/122 (45%), Gaps = 14/122 (11%)

Query: 4   DLYQIIRSNQS---------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           DL Q +R+ +S         LS +       Q+  G+ ++ +A  +HRDL   N L+++ 
Sbjct: 94  DLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ 153

Query: 55  CDLKICDFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            ++K+    L++    +E        +  RW  APE +    D++   DVWS G +  E+
Sbjct: 154 REVKVSLLSLSKDVYNSEYYKLRNALIPLRWL-APEAVQE-DDFSTKSDVWSFGVLMWEV 211

Query: 112 MN 113
             
Sbjct: 212 FT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 7/111 (6%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E+  ++++ +++  +  IH  + +HRD+KP N+LL+ N  +++ DFG     +++  +
Sbjct: 99  LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158

Query: 75  TEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLF 118
              V   T  Y +PE+L    D    Y    D WS+G C++  L    P +
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY------VV 79
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR    +E  TEY      V 
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE--TEYHADGGKVP 174

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            +W  A E +L+   +T   DVWS G    ELM
Sbjct: 175 IKWM-ALESILHRR-FTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 6/85 (7%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----EYVVTRWYRA 85
           G++Y+ S + IHRDL   N L+     LKI DFG++R   +  + +    + +  +W  A
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TA 164

Query: 86  PELLLNSSDYTAAIDVWSVGCIFME 110
           PE  LN   Y++  DVWS G +  E
Sbjct: 165 PE-ALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 53.0 bits (127), Expect = 1e-08
 Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 12/100 (12%)

Query: 26  QLLR-------GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV 78
           QLL+       G++Y+ S  ++HRDL   N+L++ +   K+ DFGLAR  S     ++  
Sbjct: 101 QLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160

Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           V +W  APE L +   +++  DVWS G +  E+ +  R P
Sbjct: 161 V-KW-TAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 7/103 (6%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           +L+ +    F   +  G++Y+     IHRDL   N+L+  N   KI DFGL+R   E  +
Sbjct: 115 TLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVY 172

Query: 74  MTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           + +    +  RW       LN S YT   DVWS G +  E+++
Sbjct: 173 VKKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 52.8 bits (126), Expect = 2e-08
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 7/103 (6%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           +LS +   +F   + RG+ Y+     IHRDL   N+L+  N   KI DFGL+R   +  +
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVY 165

Query: 74  MTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           + +    +  RW       LN S YT   DVWS G +  E+++
Sbjct: 166 VKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.6 bits (126), Expect = 2e-08
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 11/101 (10%)

Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-PTSENEFMTE--- 76
           Q    ++  GL ++H  N IH DL   N LL A+  +KI D+GL+     E+ ++T    
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162

Query: 77  YVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIFMEL 111
           +V  RW  APEL+      L   D T   +VWS+G    EL
Sbjct: 163 WVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 52.2 bits (125), Expect = 3e-08
 Identities = 31/99 (31%), Positives = 46/99 (46%), Gaps = 17/99 (17%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R       MT    T 
Sbjct: 108 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR------LMTGDTYTA 161

Query: 81  --------RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
                   +W  APE L  +  ++   DVW+ G +  E+
Sbjct: 162 HAGAKFPIKW-TAPESLAYNK-FSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.1 bits (122), Expect = 6e-08
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVTR 81
            ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL++   +++ +       +
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159

Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFME 110
           W   + APE  +N   +++  DVWS G    E
Sbjct: 160 WPLKWYAPE-CINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.4 bits (123), Expect = 6e-08
 Identities = 41/123 (33%), Positives = 61/123 (49%), Gaps = 16/123 (13%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQ-----LLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           DL   +RSN+ +  +  Q  + Q     +  GL ++H A+ IH DL   N  L A+  +K
Sbjct: 81  DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVK 140

Query: 59  ICDFGLARPT-SENEFMTE---YVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIF 108
           I D+GLA     E+ ++T+    V  RW  APEL+      L   D T   ++WS+G   
Sbjct: 141 IGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIRGQDLLPKDQTKKSNIWSLGVTM 199

Query: 109 MEL 111
            EL
Sbjct: 200 WEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.2 bits (122), Expect = 7e-08
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 8/118 (6%)

Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR 66
           Q  ++   L      +   Q+  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 67  PTSENEFMT----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
                ++        +  RW   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.3 bits (123), Expect = 9e-08
 Identities = 39/146 (26%), Positives = 63/146 (43%), Gaps = 45/146 (30%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA---RPTSEN-- 71
           E+  ++++ +L   ++ +H    IHRD+KP N+L++ +  +K+ DFGL    R T ++  
Sbjct: 100 EDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 72  ------------EFMTEY---------------------------VVTRWYRAPELLLNS 92
                       E   E+                           V T  Y APE+LL +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219

Query: 93  SDYTAAIDVWSVGCIFMELMNRRPLF 118
             YT   D WSVG I  E++  +P F
Sbjct: 220 G-YTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.0 bits (122), Expect = 9e-08
 Identities = 47/215 (21%), Positives = 81/215 (37%), Gaps = 56/215 (26%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL  ++    + SE+  ++++ + +  ++ +H    IHRD+KP N+L++    +K+ DFG
Sbjct: 87  DLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFG 146

Query: 64  LA-----------------------RPTSENEFMTEYV---------VTRW--------- 82
           L+                       R  + N    + +         +  W         
Sbjct: 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAY 206

Query: 83  -------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI---E 132
                  Y APE+ L    Y    D WS+G I  E +   P F   +     R +I   E
Sbjct: 207 STVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE 265

Query: 133 LLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
            L  P D  L      +A+  IR+L  +    L +
Sbjct: 266 TLYFPDDIHLSV----EAEDLIRRLITNAENRLGR 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.6 bits (121), Expect = 1e-07
 Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 14/94 (14%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--------PTSENEFMTEY 77
           Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R          SEN+ +   
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIP-- 195

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
              RW     +  N   YT   DVW+ G +  E+
Sbjct: 196 --IRWMPPESIFYNR--YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.3 bits (120), Expect = 1e-07
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 14/95 (14%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY-------- 77
           Q+  G+KY+ S N +HRDL   N L+  N  +KI DFG++R    N +  +Y        
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR----NLYAGDYYRIQGRAV 201

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +  RW     +L+    +T A DVW+ G    E++
Sbjct: 202 LPIRWMAWECILMGK--FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 15/125 (12%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV----- 79
            Q+  G++Y+ S + +HRDL   N L+     +KI DFGL+R     ++   Y V     
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY---YRVQSKSL 187

Query: 80  --TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR--RPLFP-GNDHVHQMRLLIELL 134
              RW   PE +L    +T   D+WS G +  E+ +   +P +   N  V +M    +LL
Sbjct: 188 LPVRWM-PPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL 245

Query: 135 GTPTD 139
             P D
Sbjct: 246 PCPED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 49.2 bits (117), Expect = 3e-07
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 3/89 (3%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F   +   ++Y+ + N +HRDL   N+L++ +   K+ DFGL +  S  +   +  V +W
Sbjct: 107 FSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW 165

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             APE  L    ++   DVWS G +  E+
Sbjct: 166 -TAPE-ALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 49.3 bits (118), Expect = 4e-07
 Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 12/106 (11%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           SLS     Y   Q+  G++Y+ S N +HRDL   N L+  N  +KI DFG++R    +++
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 74  MTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
              Y V        RW     +LL    +T   DVW+ G    E++
Sbjct: 186 ---YRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 50/163 (30%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA---RPTSEN-- 71
           E+  ++++ +L   ++ +H    IHRD+KP N+L++ +  +K+ DFGL    R T ++  
Sbjct: 100 EDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 72  ------------EFMTEY-------------------------------VVTRWYRAPEL 88
                       +F  E+                               V T  Y APE+
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219

Query: 89  LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH-QMRLL 130
           LL +  YT   D WSVG I  E++  +P F     +  QM+++
Sbjct: 220 LLRTG-YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 48.9 bits (116), Expect = 4e-07
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 6/102 (5%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L++    +   Q+  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R     ++ 
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 75  T----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                  +  RW   PE ++    +T   DVWS+G +  E+ 
Sbjct: 177 RVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 48.6 bits (116), Expect = 5e-07
 Identities = 38/159 (23%), Positives = 66/159 (41%), Gaps = 27/159 (16%)

Query: 4   DLYQIIRSN--------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNL 49
           DL + +RS+                L+         Q+  G+ Y+ S + +HRDL   N 
Sbjct: 94  DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153

Query: 50  LLNANCDLKICDFGLARPTSENEFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 105
           L+  +  +KI DFG++R     ++        +  RW   PE ++    +T   DVWS G
Sbjct: 154 LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFG 211

Query: 106 CIFMELMN--RRPLFPGND-----HVHQMRLLIELLGTP 137
            +  E+    ++P +  ++      + Q RLL      P
Sbjct: 212 VVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCP 250

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 6e-07
 Identities = 19/42 (45%), Positives = 29/42 (69%)

Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA 65
           + Q+L GL+ +H   ++HRD+KP NLL+  +  +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 7e-07
 Identities = 21/56 (37%), Positives = 34/56 (60%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           EE    ++ ++   L Y+H   +IHRDLKP N+L++    +K+ DFGL++ T   E
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 48.3 bits (115), Expect = 7e-07
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 8/97 (8%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F+  +  G++Y+ + N IHRDL   N +L  +  + + DFGL++     ++   Y   R 
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY---YRQGRI 174

Query: 83  YRAPE--LLLNS-SD--YTAAIDVWSVGCIFMELMNR 114
            + P   + + S +D  YT+  DVW+ G    E+  R
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.9 bits (114), Expect = 8e-07
 Identities = 31/116 (26%), Positives = 55/116 (47%), Gaps = 9/116 (7%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+  I    ++ EE  + +  +++  L  +H   ++ RDL P+N+LL+    +++  F  
Sbjct: 72  LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR 131

Query: 65  AR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
                 + + E      V   Y APE +   S+ T A D WS+G I  EL+  + L
Sbjct: 132 WSEVEDSCDGE-----AVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 45/206 (21%), Positives = 73/206 (35%), Gaps = 63/206 (30%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+  ++   +   E   ++++ +L   ++ +H    IHRD+KP N+L++ +  +K+ DFG
Sbjct: 87  DMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146

Query: 64  L------------------------------------------------ARPTSENEFMT 75
           L                                                A    +     
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206

Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLG 135
             V T  Y APE+LL    YT   D WSVG I  E++  +P F              L  
Sbjct: 207 SLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQPPF--------------LAP 251

Query: 136 TPTDADLGFVRNEDAKRYIRQLPQHP 161
           TPT+  L  +  E+      Q+   P
Sbjct: 252 TPTETQLKVINWENTLHIPPQVKLSP 277

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 33/122 (27%), Positives = 62/122 (50%), Gaps = 11/122 (9%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTR 81
           ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++  +     +  R
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MNRRPLFPGNDHVHQMRLLIE--LLGTP 137
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   +R ++E  LL  P
Sbjct: 187 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVLRFVMEGGLLDKP 243

Query: 138 TD 139
            +
Sbjct: 244 DN 245

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 33/113 (29%), Positives = 58/113 (51%), Gaps = 5/113 (4%)

Query: 5   LYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           L   +R ++ SL  +    +  Q+ +G+ Y+    ++HR+L   N+LL ++  ++I DFG
Sbjct: 95  LLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFG 154

Query: 64  LAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +A    P  +  F +E+     + A E +L    YT   DVWS G    E+M+
Sbjct: 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 26/86 (30%), Positives = 46/86 (53%), Gaps = 6/86 (6%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTRWYRA 85
           G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++  +     +  RW  A
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-A 189

Query: 86  PELLLNSSDYTAAIDVWSVGCIFMEL 111
           PE L +   +T + D+WS G +  E+
Sbjct: 190 PESLKDGV-FTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 2e-06
 Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 22/167 (13%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG-LARPTSENEF 73
           L E+  +++L +++  +  +H    +HRD+KP N+LL+ N  +++ DFG   R  ++   
Sbjct: 99  LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158

Query: 74  MTEYVV-TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLFP-------G 120
            +   V T  Y +PE+L    D    Y    D WS+G C++  L    P +        G
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
               H+          P   D+    +E+AK  IR+L   P   L +
Sbjct: 219 KIMNHKEHFQF----PPDVTDV----SEEAKDLIRRLICSPETRLGR 257

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTE--YVVTR 81
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     E E+  +   +  +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           W       ++   +T   DVWS G    ELM
Sbjct: 177 WMALE--CIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.6 bits (108), Expect = 5e-06
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 11/93 (11%)

Query: 29  RGLKYIHSANVIHRDLKPSNLLLNA---NCD--LKICDFGLARPTSENEFMTE----YVV 79
           +G  Y+   + IHRDL   N L++    + D  +KI DFGLAR   ++++  +     + 
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            RW  APE LL+   +T   DVWS G +  E++
Sbjct: 177 VRWM-APESLLDGK-FTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.4 bits (108), Expect = 8e-06
 Identities = 28/102 (27%), Positives = 44/102 (43%), Gaps = 11/102 (10%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV--- 78
           + L  +L  L YIHS   IHR +K S++LL+ +  + +     +    ++      V   
Sbjct: 105 FILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164

Query: 79  ------VTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMN 113
                    W  +PE+L  N   Y    D++SVG    EL N
Sbjct: 165 PKSSVKNLPWL-SPEVLQQNLQGYNEKSDIYSVGITACELAN 205

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 31/121 (25%), Positives = 57/121 (47%), Gaps = 9/121 (7%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTR 81
           Q+  G++Y+ S   +H+DL   N+L+     +KI D GL+R     ++        +  R
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP-GNDHVHQMRLLIELLGTPT 138
           W   PE ++    +++  D+WS G +  E+ +   +P +   N  V +M    +LL    
Sbjct: 192 WM-PPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSE 249

Query: 139 D 139
           D
Sbjct: 250 D 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.8 bits (103), Expect = 2e-05
 Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 6/90 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTR 81
           Q+  G+ Y+ S + +HRDL   N L+     +KI DFG++R     ++        +  R
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           W   PE +L    +T   D+WS G +  E+
Sbjct: 190 WM-PPESILYRK-FTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.9 bits (101), Expect = 4e-05
 Identities = 25/92 (27%), Positives = 47/92 (51%), Gaps = 11/92 (11%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----EYVVTRWYRA 85
           G+ ++H  N +H DL   N  L ++  +K+ D+G+     + +++     + V  RW  A
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-A 169

Query: 86  PELL------LNSSDYTAAIDVWSVGCIFMEL 111
           PEL+      L +++ T   +VW++G    EL
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 43.2 bits (102), Expect = 5e-05
 Identities = 32/109 (29%), Positives = 50/109 (45%), Gaps = 22/109 (20%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----------------RPTSENEF 73
            ++Y+HS  V+HRDLKP N+LL    ++ I D+G A                        
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 74  MT---EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           MT   + V T  Y APE LL     + + D++++G I  +++     FP
Sbjct: 185 MTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLS--FP 230

Length = 932

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 42.2 bits (99), Expect = 7e-05
 Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 7/92 (7%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG-LARPTSENEF--MTEYVVTRWYRAP 86
           G+KY+     +H+ L    +L+N++   KI  F  L    SE  +  M+      W  AP
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW-AAP 177

Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           E  +    +++A DVWS G +  E+M+   RP
Sbjct: 178 E-AIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 41.4 bits (98), Expect = 9e-05
 Identities = 14/39 (35%), Positives = 24/39 (61%), Gaps = 1/39 (2%)

Query: 34  IHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           +H A ++H DL  SN+++  +  L + DFGL + + E E
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDEIE 143

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 41.4 bits (98), Expect = 1e-04
 Identities = 16/40 (40%), Positives = 24/40 (60%), Gaps = 1/40 (2%)

Query: 35  HSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           HSA +IH DL  SN++L+    + + DFGLA  + + E  
Sbjct: 112 HSAGIIHGDLTTSNMILSGG-KIYLIDFGLAEFSKDLEDR 150

Length = 211

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 34/110 (30%), Positives = 51/110 (46%), Gaps = 13/110 (11%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL---------- 64
           +SE    Y L  +L+ L YIH    +HR +K S++L++   D K+   GL          
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMINHG 155

Query: 65  ARPTSENEFMTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMN 113
            R    ++F    V    + +PE+L  N   Y A  D++SVG    EL N
Sbjct: 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 205

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 24/92 (26%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTR 81
           Q+  G++++ S +V+H+DL   N+L+    ++KI D GL R     ++        +  R
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W  +PE ++    ++   D+WS G +  E+ +
Sbjct: 192 WM-SPEAIMYGK-FSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.9 bits (93), Expect = 5e-04
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 13/135 (9%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD----FGLARPT 68
           + +SE      L+  LRGL Y+H    IHR++K S++L++ +  + +      + L R  
Sbjct: 96  EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155

Query: 69  SENEFMTEY-----VVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            + + + ++      V  W  +PELL      Y    D++SVG    EL   R   P  D
Sbjct: 156 QKAKVVYDFPQFSTSVLPWL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQD 212

Query: 123 HVHQMRLLIELLGTP 137
            +    LL +L G P
Sbjct: 213 MLRTQMLLQKLKGPP 227

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.9 bits (94), Expect = 6e-04
 Identities = 13/39 (33%), Positives = 22/39 (56%), Gaps = 1/39 (2%)

Query: 34  IHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           +H A ++H DL  SN ++  +  L + DFGL + +   E
Sbjct: 444 LHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDLIE 481

Length = 535

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 38.6 bits (90), Expect = 0.001
 Identities = 30/98 (30%), Positives = 40/98 (40%), Gaps = 25/98 (25%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEFMTEYVVTRWYR-- 84
           G KY+   + IHRD+   N LL         KI DFG+AR      +   Y     YR  
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI----YRASY-----YRKG 178

Query: 85  ----------APELLLNSSDYTAAIDVWSVGCIFMELM 112
                      PE  L+   +T+  DVWS G +  E+ 
Sbjct: 179 GRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIF 215

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 37.8 bits (88), Expect = 0.001
 Identities = 32/140 (22%), Positives = 50/140 (35%), Gaps = 21/140 (15%)

Query: 5   LYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           L  I+    + L+EE       Q L  L+ +H        L   + LL           G
Sbjct: 3   LADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL--------DG 54

Query: 64  -LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +A  T E      Y +     APE++     YT   D++S+G    E ++        +
Sbjct: 55  SVAFKTPEQSRPDPYFM-----APEVIQGQ-SYTEKADIYSLGITLYEALDYE---LPYN 105

Query: 123 HVHQMR--LLIELLGTPTDA 140
              ++   L I L G P D 
Sbjct: 106 EERELSAILEILLNGMPADD 125

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 37.3 bits (87), Expect = 0.003
 Identities = 14/41 (34%), Positives = 22/41 (53%), Gaps = 1/41 (2%)

Query: 34  IHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           +H A ++H DL  SN++L+    +   DFGL   + E E  
Sbjct: 108 LHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDK 147

Length = 204

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 37.5 bits (87), Expect = 0.004
 Identities = 17/46 (36%), Positives = 26/46 (56%), Gaps = 1/46 (2%)

Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLA 65
           Q  + Q+L  L  +HS  ++HRD+KP N++ +      KI D G A
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	217
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.98
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.98
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.98
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.98
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.98
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.98
KOG0610	459	consensus Putative serine/threonine protein kinase	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.98
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.98
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.98
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.98
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
PHA02988	283	hypothetical protein; Provisional	99.98
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.98
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.96
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.96
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.96
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.96
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.96
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.96
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.96
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.95
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.94
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.94
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.93
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.91
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.91
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.91
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.91
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.91
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG3653	534	consensus Transforming growth factor beta/activin	99.91
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.9
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.9
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.89
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.89
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.88
KOG1152	772	consensus Signal transduction serine/threonine kin	99.86
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.85
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.84
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.73
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.71
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.68
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.52
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.49
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.47
PRK12274	218	serine/threonine protein kinase; Provisional	99.41
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.36
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.31
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.28
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.27
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.27
PRK09188	365	serine/threonine protein kinase; Provisional	99.26
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.23
smart00090	237	RIO RIO-like kinase.	99.15
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.15
COG4248	637	Uncharacterized protein with protein kinase and he	99.14
PRK10345	210	hypothetical protein; Provisional	99.07
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.04
PRK14879	211	serine/threonine protein kinase; Provisional	98.95
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.92
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.92
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.82
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.78
KOG1243	690	consensus Protein kinase [General function predict	98.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.65
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.64
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.59
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.57
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.42
PRK09902	216	hypothetical protein; Provisional	98.41
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.36
KOG3087	229	consensus Serine/threonine protein kinase [General	98.32
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.26
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.25
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.01
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.81
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.68
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.5
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.16
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	96.98
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.51
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.84
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.81
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.59
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.57
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.44
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.39
PRK05231	319	homoserine kinase; Provisional	95.33
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.21
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.2
COG0661	517	AarF Predicted unusual protein kinase [General fun	95.14
PRK10271	188	thiK thiamine kinase; Provisional	95.03
PF01636	239	APH: Phosphotransferase enzyme family This family	94.9
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.86
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	94.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	94.54
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.5
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.4
KOG0576	829	consensus Mitogen-activated protein kinase kinase	94.39
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	94.36
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.35
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	94.32
COG2334	331	Putative homoserine kinase type II (protein kinase	93.54
PLN02236	344	choline kinase	93.17
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	93.17
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	92.73
PRK11768	325	serine/threonine protein kinase; Provisional	92.65
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.56
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	92.56
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	92.41
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	92.22
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	91.95
KOG1235	538	consensus Predicted unusual protein kinase [Genera	91.88
PRK06148	1013	hypothetical protein; Provisional	90.86
PRK06149	972	hypothetical protein; Provisional	90.78
PHA03111	444	Ser/Thr kinase; Provisional	88.26
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	88.06
PRK09550	401	mtnK methylthioribose kinase; Reviewed	86.56
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	86.49
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	85.97
PRK12396	409	5-methylribose kinase; Reviewed	85.42
PTZ00296	442	choline kinase; Provisional	81.82
PLN02876	822	acyl-CoA dehydrogenase	81.03

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-46  Score=280.92  Aligned_cols=207  Identities=64%  Similarity=1.110  Sum_probs=195.7

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC---CCccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE---NEFMTEY   77 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~~~   77 (217)
                      |+.+|..+++.++.|+.+.++.++.||++||.|+|+.+++|||+||.|++++.+..+|++|||+|+....   .......
T Consensus       108 MetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeY  187 (359)
T KOG0660|consen  108 METDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEY  187 (359)
T ss_pred             HhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcc
Confidence            5789999999999999999999999999999999999999999999999999999999999999987753   4445667


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ..|.+|+|||.+.....++.+.||||.||++.|+++|++.|.+.+...++..|++..|.|+++.+.......++.++...
T Consensus       188 VaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~sl  267 (359)
T KOG0660|consen  188 VATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSL  267 (359)
T ss_pred             eeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhC
Confidence            77999999999988888999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ++.+..+++..+++.++.+++|+++||.+||.+|+|++|+|+|||+..+.
T Consensus       268 p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  268 PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            99999999999999999999999999999999999999999999999663

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=275.12  Aligned_cols=205  Identities=40%  Similarity=0.690  Sum_probs=182.6

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |+.+|+++++.. +.+++..++.|+.||+.||+++|++|+.|||+||+|||+.....+||+|||+|+.............
T Consensus        92 Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVS  171 (538)
T KOG0661|consen   92 MDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVS  171 (538)
T ss_pred             hhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhh
Confidence            578999999876 6799999999999999999999999999999999999999988999999999999888887788888


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      |.+|+|||++.....++.+.|+||+||+++|+.+-++.|++.++.+++.+|.+.+|.|....|..- ..-....--..++
T Consensus       172 TRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-~~La~~mnf~~P~  250 (538)
T KOG0661|consen  172 TRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-YNLASAMNFRFPQ  250 (538)
T ss_pred             cccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-HHHHHHhccCCCc
Confidence            999999999999998999999999999999999999999999999999999999999998876543 1111222224455


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ...-.+..+.++.++++.++|.+||++||.+||||.++|+||||+..
T Consensus       251 ~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  251 VKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             CCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence            55566778888899999999999999999999999999999999954

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.7e-42  Score=249.61  Aligned_cols=206  Identities=41%  Similarity=0.683  Sum_probs=182.6

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-cccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-TEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~   78 (217)
                      |+.+|..++++. ..+++..++.++.+++.|++|||+++|.|||+||.|++++.+|.+|++|||+++.++..... ....
T Consensus        83 m~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V  162 (318)
T KOG0659|consen   83 MPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQV  162 (318)
T ss_pred             ccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccce
Confidence            467889999886 67999999999999999999999999999999999999999999999999999887754433 2236


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      -+.+|+|||.+.+.+.++...|+||.||++.|++.|.+.|.+.++-+++..|+..+|.|.+..|..+........+..  
T Consensus       163 ~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~--  240 (318)
T KOG0659|consen  163 VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ--  240 (318)
T ss_pred             eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc--
Confidence            688999999999999999999999999999999999999999999999999999999999999998887666555553  


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                       .+......+++..+.+++||+++||.+||.+|+|++|+|.|+||++...+
T Consensus       241 -~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  241 -FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             -CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence             33444455888899999999999999999999999999999999976443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-43  Score=270.72  Aligned_cols=178  Identities=31%  Similarity=0.532  Sum_probs=151.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC---CCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      ||+|+|.+-.++.+.+...+.+++|++.|+.|||++||.||||||+|||+..+   -.+|++|||+++..++...+.+.+
T Consensus       260 GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlC  339 (475)
T KOG0615|consen  260 GGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLC  339 (475)
T ss_pred             CccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhc
Confidence            79999999999999999999999999999999999999999999999999876   558999999999999989999999


Q ss_pred             ccccccCcccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           79 VTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH-QMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~--~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ||+.|.|||++...+  ....+.|+||+||++|-+++|.+||.+..... ...+|.+-  .                   
T Consensus       340 GTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G--~-------------------  398 (475)
T KOG0615|consen  340 GTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG--R-------------------  398 (475)
T ss_pred             CCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC--c-------------------
Confidence            999999999997543  22347899999999999999999998755333 33333321  1                   


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                            -...+..+..++.+.++||.+||..||++|||++|+|+||||+..
T Consensus       399 ------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  399 ------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             ------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence                  111123344688999999999999999999999999999999965

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-42  Score=262.74  Aligned_cols=206  Identities=37%  Similarity=0.701  Sum_probs=180.7

Q ss_pred             CCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-CCEEEecccccccCCCCCccc
Q 027927            1 MDTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMT   75 (217)
Q Consensus         1 l~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~   75 (217)
                      |+.||.++++.    +..++.-.++-+++||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+....++...
T Consensus       104 mP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epni  183 (364)
T KOG0658|consen  104 MPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNI  183 (364)
T ss_pred             chHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCce
Confidence            46788888885    6889999999999999999999999999999999999999987 899999999999988888778


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ....+..|+|||.+.+...++.+.||||.||++.||+.|++.|.+.+...++..|++.+|.|+.++...+......... 
T Consensus       184 SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~-  262 (364)
T KOG0658|consen  184 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKF-  262 (364)
T ss_pred             eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccC-
Confidence            8888999999999999999999999999999999999999999999999999999999999999887666554432222 


Q ss_pred             hCCCCCccchhh-hCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          156 QLPQHPRQSLAQ-VFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       156 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                        ++.....+.+ .....++++.+|+.++|.++|.+|.++.|++.||||......
T Consensus       263 --p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  263 --PQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             --cccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence              2222333434 456788999999999999999999999999999999987655

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-42  Score=259.13  Aligned_cols=177  Identities=28%  Similarity=0.459  Sum_probs=150.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      ||+|.++++..+++++....+++.++++||.|||+ ++|+||||||.|+|++..|.+||||||.+....++ .+.+..||
T Consensus       162 gGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT  240 (364)
T KOG0581|consen  162 GGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGT  240 (364)
T ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hccccccc
Confidence            68999999999999999999999999999999996 99999999999999999999999999999888777 67888999


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN--DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ..|+|||.+.+.. ++.++||||||+.++|+.+|..|+...  .....+..+......+++.                  
T Consensus       241 ~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~------------------  301 (364)
T KOG0581|consen  241 SAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR------------------  301 (364)
T ss_pred             ccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC------------------
Confidence            9999999997665 899999999999999999999999764  1222233222222222221                  


Q ss_pred             CCCccchhhhCC-CCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFP-HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                               .+. .+|++|.+||..||+.||.+|||+.|+++|||++...
T Consensus       302 ---------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  302 ---------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             ---------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence                     122 3889999999999999999999999999999999653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.8e-42  Score=253.58  Aligned_cols=205  Identities=32%  Similarity=0.664  Sum_probs=171.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~   79 (217)
                      +.++.+-|... .-++.+.++++++|++.|++|+|+++++||||||+||+++.+|.+||||||+|+-.. .+........
T Consensus        84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVA  163 (396)
T KOG0593|consen   84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVA  163 (396)
T ss_pred             chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhh
Confidence            34555556555 569999999999999999999999999999999999999999999999999998776 5566666788


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      |.+|+|||.+.++..++...||||+||++.||++|++.|++.++.+++..|....|...+.-...+.....-.-+..-..
T Consensus       164 TRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~  243 (396)
T KOG0593|consen  164 TRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEP  243 (396)
T ss_pred             hhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCC
Confidence            99999999999988899999999999999999999999999999999999999999877665433332222222222222


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ....++....+.++.-+++|+++||..||.+|++-++++.|+||.++
T Consensus       244 ~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  244 EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            33445677778899999999999999999999999999999999743

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.5e-41  Score=254.45  Aligned_cols=205  Identities=40%  Similarity=0.725  Sum_probs=178.7

Q ss_pred             CccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccc
Q 027927            2 DTDLYQIIRSNQ----SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~   76 (217)
                      +.+|.+++....    .++...++.+++||+.||+|||+++|+|||+||.||+++.+|.+||+|||++..... ......
T Consensus       100 d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~  179 (323)
T KOG0594|consen  100 DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTP  179 (323)
T ss_pred             cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccc
Confidence            467888888865    588899999999999999999999999999999999999999999999999986663 334567


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ...|.+|+|||++.+...++...||||+||++.||++++..|.+..+..++.+|++..|.|.+..|..+......+.  .
T Consensus       180 evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~--~  257 (323)
T KOG0594|consen  180 EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA--P  257 (323)
T ss_pred             cEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc--c
Confidence            78899999999999998899999999999999999999999999999999999999999999999987775544333  2


Q ss_pred             CCCCC-ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          157 LPQHP-RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       157 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ..... ...+....+..+++..+++.+||+++|.+|.|++.+|.||||.....
T Consensus       258 f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  258 FPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            22222 45566777777899999999999999999999999999999997743

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-40  Score=250.11  Aligned_cols=213  Identities=38%  Similarity=0.593  Sum_probs=182.9

Q ss_pred             CCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccc
Q 027927            1 MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~   78 (217)
                      ++.+|..++.+.+ ++...+++.++.|++.|+.|||+++|+|||+|++|+|++..|.+|++|||+|+.++.... .....
T Consensus       159 ~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lV  238 (419)
T KOG0663|consen  159 VEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLV  238 (419)
T ss_pred             HHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceE
Confidence            3568899998875 899999999999999999999999999999999999999999999999999998876532 34556


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      -|.+|+|||.+.+.+.++.+.|+||+||++.+++.+.+.|.+..+..++.+|+..+|.|++..|...........+....
T Consensus       239 VTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~  318 (419)
T KOG0663|consen  239 VTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSE  318 (419)
T ss_pred             EEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCC
Confidence            68999999999999999999999999999999999999999999999999999999999999999888777665443333


Q ss_pred             CCCccchhhhCCC--CChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc--ccCceeecc
Q 027927          159 QHPRQSLAQVFPH--VHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC--CCGCIEFIL  214 (217)
Q Consensus       159 ~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~--~~~~~~~~~  214 (217)
                      +.. ..+...+..  ++....+|+.++|.+||.+|.||++.|+|+||.+  ..-+++++.
T Consensus       319 ~py-n~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~P  377 (419)
T KOG0663|consen  319 HPY-NNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFP  377 (419)
T ss_pred             CCc-hhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcC
Confidence            222 222333332  5689999999999999999999999999999998  456665554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-40  Score=265.67  Aligned_cols=170  Identities=33%  Similarity=0.523  Sum_probs=153.0

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Cccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~   81 (217)
                      ++|-.+++..+++++.+++.+++||+.||.|||+++|+|||+|..|++++.+..+|++|||+|..+... +...+.+|||
T Consensus       103 ~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTP  182 (592)
T KOG0575|consen  103 GSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTP  182 (592)
T ss_pred             ccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCC
Confidence            688899998899999999999999999999999999999999999999999999999999999887744 6778899999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|.|||++...+ .+..+||||+||++|.+++|++||....-.+.+.+|...-                           
T Consensus       183 NYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~---------------------------  234 (592)
T KOG0575|consen  183 NYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE---------------------------  234 (592)
T ss_pred             cccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC---------------------------
Confidence            999999997555 7899999999999999999999999887777777776521                           


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                          ..++..+|.++++||.+||..||.+|||++++|.|+||+
T Consensus       235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence                122336889999999999999999999999999999995

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-40  Score=244.52  Aligned_cols=178  Identities=31%  Similarity=0.526  Sum_probs=155.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      .|+|+|+|...-.++++..+++|+|+++|+.|||.++|+|+|+||+||+++.+..++++|||++.....++.....+|||
T Consensus       107 rGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTP  186 (411)
T KOG0599|consen  107 RGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTP  186 (411)
T ss_pred             cchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCC
Confidence            37899999999999999999999999999999999999999999999999999999999999999999998889999999


Q ss_pred             cccCcccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           82 WYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        82 ~~~~Pe~~~~-----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .|+|||.+.+     .+.++...|+|++||++|.++.|.+||......-.+..|++-.-....+.               
T Consensus       187 gYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe---------------  251 (411)
T KOG0599|consen  187 GYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE---------------  251 (411)
T ss_pred             cccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc---------------
Confidence            9999999864     34577899999999999999999999987665555555554222222222               


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                  +.++|...++||.+||+.||++|.|++|+|+||||.+.
T Consensus       252 ------------Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  252 ------------WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             ------------hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence                        34688899999999999999999999999999999643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=257.85  Aligned_cols=174  Identities=30%  Similarity=0.506  Sum_probs=154.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--------   73 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------   73 (217)
                      +|+|.++|++.+.+++..++.++.+|+.||+|||++||+||||||+|||++.++.++|+|||.++.+.....        
T Consensus       158 nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~  237 (604)
T KOG0592|consen  158 NGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDP  237 (604)
T ss_pred             CCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCc
Confidence            689999999999999999999999999999999999999999999999999999999999999875433211        


Q ss_pred             ------cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           74 ------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        74 ------~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                            .....||-.|.+||++... ..++.+|+|+|||++|+|+.|++||.+..+.-.+++|+...-            
T Consensus       238 ~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y------------  304 (604)
T KOG0592|consen  238 NQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY------------  304 (604)
T ss_pred             ccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc------------
Confidence                  1346788999999998544 489999999999999999999999999999999999987432            


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                         .+++++++.+.+||+++|..||++|+|+.+|-+||||.+..
T Consensus       305 -------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  305 -------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             -------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence                               23446789999999999999999999999999999999653

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-40  Score=256.89  Aligned_cols=202  Identities=38%  Similarity=0.639  Sum_probs=172.9

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEY   77 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~   77 (217)
                      |+.+|..++.+. -.+++.+++.+|+|++.||+|+|++|+.|||||..|||+|.+|.+||+|||+|..+....  .....
T Consensus       200 MdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~r  279 (560)
T KOG0600|consen  200 MDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSR  279 (560)
T ss_pred             ccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccc
Confidence            567888888884 569999999999999999999999999999999999999999999999999998655443  34455


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .-|++|+|||.+.+...++.+.|+||.||++.||+.|.+.|.+..+.+++..|++.+|.|.+..|. .........+...
T Consensus       280 VvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~  358 (560)
T KOG0600|consen  280 VVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQ  358 (560)
T ss_pred             eEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCC
Confidence            668999999999999999999999999999999999999999999999999999999999999887 2222111111111


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                       +.-...+.+.+..+++..++|+.+||..||.+|.||.++|+|+||.
T Consensus       359 -~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  359 -QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             -CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence             1223446666888999999999999999999999999999999994

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=257.67  Aligned_cols=173  Identities=32%  Similarity=0.494  Sum_probs=153.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-CCEEEecccccccC-CCCCccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPT-SENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~-~~~~~~~~~~~   79 (217)
                      ||+|++++.+.+++.+..+++++.|++.|++|||++||+||||||+|++++.+ +.+||+|||++... .......+.+|
T Consensus       104 gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cG  183 (370)
T KOG0583|consen  104 GGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCG  183 (370)
T ss_pred             CccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCC
Confidence            67999999999999999999999999999999999999999999999999999 99999999999887 56778889999


Q ss_pred             cccccCcccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~-~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++.|+|||++.+.. .-+.++|+||+||++|.|++|..||........+..+...  .                      
T Consensus       184 sp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~----------------------  239 (370)
T KOG0583|consen  184 SPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--E----------------------  239 (370)
T ss_pred             CcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--C----------------------
Confidence            99999999998766 4578999999999999999999999987766666654331  0                      


Q ss_pred             CCCccchhhhCCCC-ChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          159 QHPRQSLAQVFPHV-HPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       159 ~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                             ..++..+ |+++.+++++||..||.+|+|+.+++.||||+.
T Consensus       240 -------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  240 -------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                   1122234 899999999999999999999999999999996

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9e-39  Score=253.18  Aligned_cols=208  Identities=52%  Similarity=0.944  Sum_probs=170.9

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC----cccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTE   76 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~   76 (217)
                      ++++|.+++..+..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......    ....
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  165 (338)
T cd07859          86 MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD  165 (338)
T ss_pred             CCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccC
Confidence            467899999998899999999999999999999999999999999999999999999999999986543221    1123


Q ss_pred             ccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|+|||.+.+. ..++.++|+||+||++|++++|..||.+.........+....+.+..................
T Consensus       166 ~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  245 (338)
T cd07859         166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLS  245 (338)
T ss_pred             CCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHH
Confidence            4678899999987542 347889999999999999999999999888888888888877877666555444444444554


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ..............+.+++.+.++|.+||+.||++|||++++++||||++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         246 SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            44444444555666778899999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.4e-39  Score=257.89  Aligned_cols=203  Identities=35%  Similarity=0.644  Sum_probs=161.3

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC--CEEEecccccccCCCCCcccc
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC--DLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      |+.+|+++|+.+  ..++...++.++.||+.||.+||+.||+|+||||+|||+...+  .+|++|||.+........  +
T Consensus       270 L~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy--t  347 (586)
T KOG0667|consen  270 LSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY--T  347 (586)
T ss_pred             hhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce--e
Confidence            567999999998  5689999999999999999999999999999999999996543  589999999866554433  7


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCch--------
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE--------  148 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  148 (217)
                      ...+..|+|||++.+.+ ++.+.|||||||++.||++|.+.|.+.++.++++.|++.+|.|+...+......        
T Consensus       348 YiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~  426 (586)
T KOG0667|consen  348 YIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLK  426 (586)
T ss_pred             eeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccC
Confidence            78899999999999887 899999999999999999999999999999999999999998886643321111        


Q ss_pred             ------------------HHHHHHHh-CCC---C-CccchhhhCC-CCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          149 ------------------DAKRYIRQ-LPQ---H-PRQSLAQVFP-HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       149 ------------------~~~~~~~~-~~~---~-~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                                        ..+..... ...   . ....+..... .....|++||++||.+||.+|+|+.++|+||||.
T Consensus       427 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  427 GFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLT  506 (586)
T ss_pred             CceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccc
Confidence                              00010000 000   0 1112222222 2346689999999999999999999999999999


Q ss_pred             cc
Q 027927          205 CC  206 (217)
Q Consensus       205 ~~  206 (217)
                      ..
T Consensus       507 ~~  508 (586)
T KOG0667|consen  507 GT  508 (586)
T ss_pred             cc
Confidence            43

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-39  Score=258.39  Aligned_cols=175  Identities=29%  Similarity=0.462  Sum_probs=155.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      ||+|++++...+++++.++.++++||+.|+.|+|..+|+|+|+||+|++++..+.+|++|||+|.....+....+.+|++
T Consensus        96 gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSP  175 (786)
T KOG0588|consen   96 GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSP  175 (786)
T ss_pred             CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCc
Confidence            78999999999999999999999999999999999999999999999999999999999999998888888889999999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|.+||++.+.+..+.++||||.||+||.+++|..||.+.+-..++-+...                             
T Consensus       176 HYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~-----------------------------  226 (786)
T KOG0588|consen  176 HYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR-----------------------------  226 (786)
T ss_pred             ccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-----------------------------
Confidence            999999999998889999999999999999999999986542222222211                             


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                        ..-+++.++++++++||++||.+||++|+|.+|++.|||+.+..
T Consensus       227 --G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  227 --GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             --CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence              11234567999999999999999999999999999999999653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=246.77  Aligned_cols=177  Identities=28%  Similarity=0.467  Sum_probs=144.4

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccCCC----CCccc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSE----NEFMT   75 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~----~~~~~   75 (217)
                      ||+|.+++.+.+ .+++..++++.+||++||+|||++|++|+||||+|||++. ++.+||+|||.+.....    .....
T Consensus       100 ~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~  179 (313)
T KOG0198|consen  100 GGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSEL  179 (313)
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccc
Confidence            689999999986 8999999999999999999999999999999999999999 79999999998876553    22234


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN-DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ...|++.|+|||++.+......++||||+||++.+|++|..||... .......++..   ..                 
T Consensus       180 ~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---~~-----------------  239 (313)
T KOG0198|consen  180 SVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---ED-----------------  239 (313)
T ss_pred             cccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---cC-----------------
Confidence            5788999999999975322345999999999999999999999763 22222222211   00                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                               ..+.++..+++++.+|+.+||..||++||||+++|+|||.++..
T Consensus       240 ---------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  240 ---------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                     11244556889999999999999999999999999999998643

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.1e-38  Score=243.06  Aligned_cols=202  Identities=39%  Similarity=0.710  Sum_probs=161.8

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      ++++|.+++... ..++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....... ......
T Consensus        85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~  164 (288)
T cd07871          85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV  164 (288)
T ss_pred             CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCce
Confidence            356889888765 458999999999999999999999999999999999999999999999999986543222 223456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+...++.++|+||+||++|++++|..||.+....+....+....+.+....+............. .+
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  243 (288)
T cd07871         165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL-FP  243 (288)
T ss_pred             ecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc-cC
Confidence            78899999998765567899999999999999999999999988888888888888888777665543322111100 11


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ...........+.++++++++|++||++||.+|||++|+++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            112223334455688999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.3e-38  Score=242.45  Aligned_cols=197  Identities=38%  Similarity=0.679  Sum_probs=161.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++...  ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.............+
T Consensus        92 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  171 (290)
T cd07862          92 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV  171 (290)
T ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccc
Confidence            56788888764  4589999999999999999999999999999999999999999999999999876655444455677


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+.. ++.++|+||+||++|++++|..||.+..+.+.+..+....+.+.+..+........    .....
T Consensus       172 ~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~  246 (290)
T cd07862         172 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR----QAFHS  246 (290)
T ss_pred             cccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc----hhccC
Confidence            89999999986544 78899999999999999999999999998899999988877766655432211100    01112


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      .+........+.+++.+.+++.+||+.||++|||+.++|+||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         247 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             CCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            23334555666788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=228.92  Aligned_cols=177  Identities=31%  Similarity=0.453  Sum_probs=151.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---CCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|+.-|-+.-.+++..+-.++.||++||+|+|.+||+|||+||+|+++..   ..-+||+|||++...+.........
T Consensus        94 G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~  173 (355)
T KOG0033|consen   94 GGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFA  173 (355)
T ss_pred             chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccccccc
Confidence            5666655555567889999999999999999999999999999999999843   4568999999998888666666788


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      |+|.|++||++...+ ++..+|||+.||++|-++.|.+||.+.+...++..|+...-..+..                  
T Consensus       174 GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~------------------  234 (355)
T KOG0033|consen  174 GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP------------------  234 (355)
T ss_pred             CCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc------------------
Confidence            999999999997665 8999999999999999999999999988888888887643333332                  


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                               .+++++++.++|+++||..||++|+|+.|+|+|||+.+-
T Consensus       235 ---------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  235 ---------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             ---------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence                     244789999999999999999999999999999999854

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=232.84  Aligned_cols=172  Identities=29%  Similarity=0.470  Sum_probs=154.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      ||+|+.++++-+++++..++.++.||+.||+|||+++|++||+||+||++|.+|-+|++|||+++.....  ..+.+|||
T Consensus       128 GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTP  205 (355)
T KOG0616|consen  128 GGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTP  205 (355)
T ss_pred             CccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCc
Confidence            8999999999999999999999999999999999999999999999999999999999999999887655  56789999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||++... +++.++|.|||||++|||+.|.+||........+.+|.+..                           
T Consensus       206 eYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~---------------------------  257 (355)
T KOG0616|consen  206 EYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK---------------------------  257 (355)
T ss_pred             cccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc---------------------------
Confidence            99999999654 48999999999999999999999999999888888887621                           


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCC-----CCHhhhccCCCCcccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKR-----ITGEFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R-----~t~~~ll~~~~f~~~~  207 (217)
                          -..+..+++++++|++++|+.|-++|     .-..++..||||+...
T Consensus       258 ----v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  258 ----VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             ----ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence                12234578999999999999999999     3567899999999553

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-37  Score=246.05  Aligned_cols=205  Identities=49%  Similarity=0.915  Sum_probs=170.2

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +|++|.++++. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......  .....++
T Consensus       102 ~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t  178 (343)
T cd07878         102 MGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVAT  178 (343)
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC--cCCcccc
Confidence            36778877764 57999999999999999999999999999999999999999999999999998765432  2344678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+...++.++|+||+||++|++++|..||.+......+..+.+..+.+...............+.......
T Consensus       179 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (343)
T cd07878         179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHM  258 (343)
T ss_pred             ccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccc
Confidence            89999999876556788999999999999999999999988888888888887777766555555555555555555555


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      +...+.......++.+.++|.+||+.||.+|||+.++++||||.....
T Consensus       259 ~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         259 PQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             cchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence            555556666677889999999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=238.01  Aligned_cols=175  Identities=28%  Similarity=0.496  Sum_probs=153.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc-CCCCCccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVV   79 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~-~~~~~~~~~~~~   79 (217)
                      .||+|+-.|.+++.++++.++.++..|+.||.|||+.||+|||+||+|||++..|.++|+|||+++. ...+....+.+|
T Consensus       108 ~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcG  187 (357)
T KOG0598|consen  108 NGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCG  187 (357)
T ss_pred             CCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccC
Confidence            3789999999999999999999999999999999999999999999999999999999999999974 444455667799


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      |+.|+|||++...+ ++.++|.||||+++|+|++|.+||.+.+....+.+|.+.-                         
T Consensus       188 T~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-------------------------  241 (357)
T KOG0598|consen  188 TPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-------------------------  241 (357)
T ss_pred             CccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------------------------
Confidence            99999999998775 8999999999999999999999999988777777776521                         


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCC----CHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI----TGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~----t~~~ll~~~~f~~~  206 (217)
                           ....+..++++.+++++++|..||++|.    .+.++-+||||...
T Consensus       242 -----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             -----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence                 1112223779999999999999999995    78899999999854

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=248.98  Aligned_cols=176  Identities=23%  Similarity=0.441  Sum_probs=149.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      ||+|.|++.+ ..+++.++..+.++++.||+|||.+||+|+|||.+||+++.+|.+||+|||++..+.... ...+..||
T Consensus       354 ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGT  432 (550)
T KOG0578|consen  354 GGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGT  432 (550)
T ss_pred             CCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCC
Confidence            6788898888 459999999999999999999999999999999999999999999999999987766544 45678999


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++. .+.++++.||||||++++||+-|++||-...+..-+.+|...+....                      
T Consensus       433 PYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l----------------------  489 (550)
T KOG0578|consen  433 PYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL----------------------  489 (550)
T ss_pred             CCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc----------------------
Confidence            9999999985 44589999999999999999999999987665555555544322211                      


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                            ...+.+|+.+++|+.+||+.|+.+|++|.|||+||||+.++
T Consensus       490 ------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  490 ------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             ------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence                  12346899999999999999999999999999999997553

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.1e-37  Score=252.92  Aligned_cols=203  Identities=34%  Similarity=0.606  Sum_probs=158.2

Q ss_pred             CccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-CEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      +++|.+++.    .+..+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||++...........
T Consensus       150 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  229 (440)
T PTZ00036        150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS  229 (440)
T ss_pred             CccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCccc
Confidence            466766664    457899999999999999999999999999999999999998665 699999999976655444445


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.+...++.++|+||+||++|++++|.+||.+......+..+.+..+.+....+........ .  ..
T Consensus       230 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~-~--~~  306 (440)
T PTZ00036        230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA-D--IK  306 (440)
T ss_pred             CCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh-c--cc
Confidence            67788999999987666688999999999999999999999999888888888888887765543321110000 0  00


Q ss_pred             CCCCCccchh-hhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          157 LPQHPRQSLA-QVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ........+. .++...++++++||.+||..||.+|||+.++++||||+...
T Consensus       307 ~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        307 FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             CCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            0111111222 22335778999999999999999999999999999998654

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.7e-37  Score=253.04  Aligned_cols=203  Identities=27%  Similarity=0.431  Sum_probs=155.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCC----------------CEEEeccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANC----------------DLKICDFG   63 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~----------------~~~l~d~~   63 (217)
                      +|++|.+++.+++.+++..+..++.||+.||+|||+ .||+||||||+||+++.++                .+||+|||
T Consensus       214 ~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG  293 (467)
T PTZ00284        214 YGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG  293 (467)
T ss_pred             cCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCC
Confidence            478899999998999999999999999999999998 5999999999999998765                48999999


Q ss_pred             ccccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccc
Q 027927           64 LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  143 (217)
                      .+.....  ......+++.|+|||++.+.. ++.++|||||||++|++++|+.||.+......+..+.+..+.++.....
T Consensus       294 ~~~~~~~--~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~  370 (467)
T PTZ00284        294 GCCDERH--SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAG  370 (467)
T ss_pred             ccccCcc--ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Confidence            8743322  233457889999999997654 8899999999999999999999999988888888888888876654333


Q ss_pred             ccCchHHHHHHHhCCCC----CccchhhhC-------CCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          144 FVRNEDAKRYIRQLPQH----PRQSLAQVF-------PHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~----~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .........+.......    ....+....       ...++.+.+||++||++||++|||++|+|+||||.+.
T Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        371 RCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             hccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence            22222222222111110    000000000       0124678999999999999999999999999999975

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.6e-36  Score=235.30  Aligned_cols=197  Identities=37%  Similarity=0.646  Sum_probs=158.6

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  169 (288)
T cd07863          90 DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV  169 (288)
T ss_pred             ccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccc
Confidence            46788888764  4589999999999999999999999999999999999999999999999999876554444444567


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|+|||.+.+.. ++.++|+||+||++|++++|..||...........+....+.+....+.......    ......
T Consensus       170 ~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  244 (288)
T cd07863         170 TLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP----RGAFSP  244 (288)
T ss_pred             cccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc----ccccCC
Confidence            88899999986554 7889999999999999999999999888888888888877766554443221110    001122


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ..........+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         245 RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            22334455666788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=230.26  Aligned_cols=178  Identities=30%  Similarity=0.450  Sum_probs=147.9

Q ss_pred             CccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---CCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      ||+|+..+..++.  ++++++..+++||..|+.|||+.+|.|||+||+|+|...   +..+||+|||+++.-.......+
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~T  222 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMT  222 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccC
Confidence            7899999988755  999999999999999999999999999999999999964   45689999999988777777778


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH----VHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      .+.|+.|.|||++- ...++.+.|+||+||++|-+++|.+||..+..    .....+|..                    
T Consensus       223 Pc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~--------------------  281 (400)
T KOG0604|consen  223 PCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT--------------------  281 (400)
T ss_pred             CcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc--------------------
Confidence            88999999999884 44488999999999999999999999976542    122222221                    


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                         ..-..+...|+    .+|.+.+++|+++|..+|++|.|+.++++|||+.+..
T Consensus       282 ---gqy~FP~pEWs----~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  282 ---GQYEFPEPEWS----CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             ---cCccCCChhHh----HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence               22223333333    3789999999999999999999999999999998653

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-36  Score=242.87  Aligned_cols=204  Identities=47%  Similarity=0.782  Sum_probs=162.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~   79 (217)
                      +++|.+++..+..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......  ......+
T Consensus        87 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  166 (372)
T cd07853          87 QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV  166 (372)
T ss_pred             ccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCc
Confidence            56788889888899999999999999999999999999999999999999999999999999986543221  2233456


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+...++.++|+||+||++|++++|..||.+.........+....+.+....+...... ....+.....
T Consensus       167 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~~~~~~~~~~  245 (372)
T cd07853         167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG-ARAHILRGPH  245 (372)
T ss_pred             CCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH-HHHHHHhCCC
Confidence            788999999877666788999999999999999999999999988999999888887766544333221 1222222221


Q ss_pred             CCcc--chhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQ--SLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .+..  .........++++.++|.+||+.||++|||++++++||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         246 KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            1111  1112334568899999999999999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.5e-36  Score=235.92  Aligned_cols=207  Identities=35%  Similarity=0.605  Sum_probs=152.6

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~   78 (217)
                      ++++|.+++..+ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...... .......
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  164 (303)
T cd07869          85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV  164 (303)
T ss_pred             CCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCc
Confidence            357888888765 67999999999999999999999999999999999999999999999999988654322 2223456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+...++.++|+||+||++|++++|..||.+..+ ......+....+.+....+.......... ....
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  243 (303)
T cd07869         165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK-PERF  243 (303)
T ss_pred             ccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc-cccc
Confidence            788999999987666678899999999999999999999987543 45556666666665544433221100000 0000


Q ss_pred             CCCCccchhhhC--CCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          158 PQHPRQSLAQVF--PHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       158 ~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      .......+...+  ...++.+.+++++||+.||++|||++++++||||++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            000111111111  124578999999999999999999999999999997644

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.1e-36  Score=234.39  Aligned_cols=205  Identities=40%  Similarity=0.714  Sum_probs=162.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++... ..++...+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||.+....... ......+
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  166 (309)
T cd07872          87 DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV  166 (309)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccc
Confidence            56788888765 558999999999999999999999999999999999999999999999999986543322 2233456


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+...++.++|+||+|+++|++++|..||...+.......+....+.+....|............ ....
T Consensus       167 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  245 (309)
T cd07872         167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY-NFPK  245 (309)
T ss_pred             cccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh-hcCc
Confidence            788999999876666788999999999999999999999988888888888888887777655443322211111 1112


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ..........+.+++++.++|.+||+.||.+|||++|+++||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         246 YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             cCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            222233344556889999999999999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.3e-36  Score=239.86  Aligned_cols=202  Identities=42%  Similarity=0.712  Sum_probs=154.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      +++|.+.+..  .++...+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.............+++
T Consensus       109 ~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~  186 (359)
T cd07876         109 DANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR  186 (359)
T ss_pred             CcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccC
Confidence            4566666643  58899999999999999999999999999999999999999999999999987654444444557788


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.. ++.++|+||||+++|++++|..||.+.+....+..+.+..+.+.......... ....+.......+
T Consensus       187 ~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  264 (359)
T cd07876         187 YYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP-TVRNYVENRPQYP  264 (359)
T ss_pred             CCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH-HHHHHHhhCCCCC
Confidence            999999986554 78899999999999999999999998888778877777777665433222111 1122222222221


Q ss_pred             ccchhh------------hCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          162 RQSLAQ------------VFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      .....+            .....++++.++|.+||+.||++|||+.|+|+||||..+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         265 GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             CcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence            111111            1123467899999999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.4e-36  Score=236.94  Aligned_cols=206  Identities=74%  Similarity=1.242  Sum_probs=175.7

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Cccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~   79 (217)
                      ++++|.+++.+++++++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus        91 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  170 (337)
T cd07858          91 MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV  170 (337)
T ss_pred             CCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccccccccc
Confidence            36789999998899999999999999999999999999999999999999999999999999998765433 22233456


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|+|||.+.+...++.++|+||||+++|++++|..||.+.+.......+....+.+.+..+.........++......
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (337)
T cd07858         171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPY  250 (337)
T ss_pred             ccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCc
Confidence            78899999886555578899999999999999999999998887788888888888887777766666666666666665


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ..........+.+++++.++|++||+.+|++|||++++++||||+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         251 TPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             ccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            55555566667899999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.9e-36  Score=238.75  Aligned_cols=201  Identities=41%  Similarity=0.702  Sum_probs=155.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      +++|.+.+..  .++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.............++.
T Consensus       112 ~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~  189 (364)
T cd07875         112 DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR  189 (364)
T ss_pred             CCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccC
Confidence            4567777754  58899999999999999999999999999999999999999999999999997665544445567789


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.. ++.++|+|||||++|++++|..||.+.+....+..+.+..+.+.+....... .....+........
T Consensus       190 ~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  267 (364)
T cd07875         190 YYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYA  267 (364)
T ss_pred             CcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh-HHHHHHHhhCCCcC
Confidence            999999986554 7889999999999999999999999998888888888877766543322221 11122222211111


Q ss_pred             ccch------------hhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          162 RQSL------------AQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ....            .......+.+++++|.+||+.||.+|||+.++|+||||..+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         268 GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             CCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            1111            11112245789999999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.9e-36  Score=232.45  Aligned_cols=199  Identities=34%  Similarity=0.640  Sum_probs=147.7

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccccccc
Q 027927            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVVTR   81 (217)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~   81 (217)
                      .+..+.+....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......  ......+++
T Consensus        86 ~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  165 (287)
T cd07848          86 MLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR  165 (287)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccccccccc
Confidence            333344445679999999999999999999999999999999999999999999999999987654322  222346788


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHH-HHHHHhCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA-KRYIRQLPQH  160 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  160 (217)
                      .|+|||.+.+.. ++.++|+||+||++|++++|+.||...........+.+..+..+...+........ ..........
T Consensus       166 ~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (287)
T cd07848         166 WYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNH  244 (287)
T ss_pred             ccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccC
Confidence            999999986554 78899999999999999999999998877777766666655544332221111000 0000000111


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ...........+++++.++|++||+.||++|||++++++||||
T Consensus       245 ~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         245 PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1111223334578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.9e-36  Score=235.14  Aligned_cols=208  Identities=59%  Similarity=1.077  Sum_probs=179.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC----ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~   77 (217)
                      +++|.+++.++.++++..+..++.||+.||++||++|++|+||+|.||+++.++.++|+|||.+.......    .....
T Consensus        87 ~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~  166 (330)
T cd07834          87 ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY  166 (330)
T ss_pred             hhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccccccccc
Confidence            45788999888899999999999999999999999999999999999999999999999999987655442    23344


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|++||.+.+....+.++|+||+|++++++++|..||........+..+....+.+.+..+..........+....
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (330)
T cd07834         167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSL  246 (330)
T ss_pred             ccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhc
Confidence            56788999999876646789999999999999999999999999988888888888888887776666666666666666


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                      .......+....+.+++++.++|.+||+.+|.+|||++++++||||++....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         247 PKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             ccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            6666667777778899999999999999999999999999999999966443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-35  Score=233.88  Aligned_cols=202  Identities=36%  Similarity=0.626  Sum_probs=147.3

Q ss_pred             CccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE----ecCCCEEEecccccccC
Q 027927            2 DTDLYQIIRSN---------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARPT   68 (217)
Q Consensus         2 ~~~L~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~   68 (217)
                      +++|.+++...         ..+++..++.++.||+.||+|||++|++|+||||+||++    +.++.++|+|||.+...
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            56777777532         358999999999999999999999999999999999999    45678999999998654


Q ss_pred             CCCC----ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---------HHHHHHHHHHhC
Q 027927           69 SENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---------VHQMRLLIELLG  135 (217)
Q Consensus        69 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---------~~~~~~~~~~~~  135 (217)
                      ....    ......+++.|+|||.+.+...++.++|+||+||++|++++|..||.....         ...+..+....+
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG  242 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence            4321    123456788899999987766678899999999999999999999965432         355667777777


Q ss_pred             CCCCccccccCchH-----HHHHHHhCCC--CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          136 TPTDADLGFVRNED-----AKRYIRQLPQ--HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       136 ~~~~~~~~~~~~~~-----~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      .+.+..+.......     ..........  .............+..+.++|++||++||.+|||++|+|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            76665544322111     0011000000  00001111122345779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-35  Score=230.89  Aligned_cols=207  Identities=39%  Similarity=0.705  Sum_probs=160.7

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      ++++|.+++.+. ..++...+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  165 (301)
T cd07873          86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV  165 (301)
T ss_pred             cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccc
Confidence            356888888764 678999999999999999999999999999999999999999999999999886543322 222345


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|++||.+.+...++.++|+||||+++|++++|..||...+.......+....+.+.+..|.......... .....
T Consensus       166 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  244 (301)
T cd07873         166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK-SYNYP  244 (301)
T ss_pred             eeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc-ccccC
Confidence            67889999998766567889999999999999999999999888888888888877776665544322111000 00111


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      .............+++++.++|.+||+.||.+|||++|+++||||++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            11112223344568899999999999999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-35  Score=238.27  Aligned_cols=203  Identities=25%  Similarity=0.369  Sum_probs=151.2

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC--Ccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--EFMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~   78 (217)
                      ++++|.+++.....++...+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+......  .......
T Consensus       165 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  244 (391)
T PHA03212        165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA  244 (391)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccccc
Confidence            35789999988889999999999999999999999999999999999999999999999999998543221  1223456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-------ChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN-------DHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                      +++.|+|||.+.+. .++.++|+||+||++|++++|..||...       .....+..+....+..+..... .......
T Consensus       245 gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~-~~~~~~~  322 (391)
T PHA03212        245 GTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI-DAQANLD  322 (391)
T ss_pred             CccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc-chhHHHH
Confidence            89999999998654 4789999999999999999999887543       2345566666666655433221 1111111


Q ss_pred             HHH----HhCCCCC--ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          152 RYI----RQLPQHP--RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       152 ~~~----~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ...    ......+  ...+.. ...++.++.++|++||+.||++|||++|+|+||||+..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTN-LYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHH-HhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            111    1111111  111111 12356789999999999999999999999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=232.87  Aligned_cols=202  Identities=30%  Similarity=0.528  Sum_probs=157.3

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec--------------------CCCEE
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--------------------NCDLK   58 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~--------------------~~~~~   58 (217)
                      ||.|++|+++++  .+++...++.+..|+++++++||+.+++|.|+||+||++..                    +..++
T Consensus       173 lG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~  252 (415)
T KOG0671|consen  173 LGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIK  252 (415)
T ss_pred             cChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceE
Confidence            578999999997  67999999999999999999999999999999999999832                    23488


Q ss_pred             EecccccccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Q 027927           59 ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT  138 (217)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~  138 (217)
                      ++|||.+....+..  .....|..|+|||++.+.+ |+..+|+||+||+|+|+.+|...|...++.+.++-|...+|+.+
T Consensus       253 vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P  329 (415)
T KOG0671|consen  253 VIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIP  329 (415)
T ss_pred             EEecCCcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCc
Confidence            99999987654433  5667889999999999887 99999999999999999999999999999999977777888766


Q ss_pred             CccccccCchHHHHH-------------HHhCCCCCccchhhhCCC---CChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          139 DADLGFVRNEDAKRY-------------IRQLPQHPRQSLAQVFPH---VHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       139 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                      ..............-             .+.+. .+..++......   .-.++.|||++||.+||++|+|+.|+|.|||
T Consensus       330 ~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~-~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpF  408 (415)
T KOG0671|consen  330 SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVF-EPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPF  408 (415)
T ss_pred             HHHhhhhhhHhhhhcccccCccccccccchhhh-cCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHH
Confidence            554443311111000             00011 111222222111   2256899999999999999999999999999


Q ss_pred             Cccc
Q 027927          203 FQCC  206 (217)
Q Consensus       203 f~~~  206 (217)
                      |...
T Consensus       409 F~~~  412 (415)
T KOG0671|consen  409 FARL  412 (415)
T ss_pred             hhcC
Confidence            9854

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.2e-36  Score=236.67  Aligned_cols=173  Identities=28%  Similarity=0.491  Sum_probs=144.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.+++.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ........++
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            678999999999999999999999999999999999999999999999999999999999999865322 2223445689


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+||++|++++|..||...+.......+...  .                        
T Consensus       159 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~------------------------  211 (323)
T cd05571         159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--E------------------------  211 (323)
T ss_pred             ccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--C------------------------
Confidence            9999999986544 789999999999999999999999876644433332210  0                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                           ...+..+++++.++|++||+.||++||     ++.++++||||.+.
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                 012235789999999999999999999     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.6e-35  Score=232.97  Aligned_cols=207  Identities=55%  Similarity=0.964  Sum_probs=168.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-----cc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~   75 (217)
                      ++++|.+++..+..+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+........     ..
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  167 (332)
T cd07857          88 MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT  167 (332)
T ss_pred             ccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccccccc
Confidence            3678999998889999999999999999999999999999999999999999999999999999875433211     12


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...++..|+|||.+.+...++.++|+||+|++++++++|..||...+.......++...+.+....+.............
T Consensus       168 ~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
T cd07857         168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR  247 (332)
T ss_pred             CcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHH
Confidence            34567889999987665557889999999999999999999999888888888888888877655444443333333334


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      .....+........+..+..+.+++.+||+.||++|||+.+++.|||++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         248 SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence            4434444445555667789999999999999999999999999999998553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-35  Score=234.27  Aligned_cols=205  Identities=54%  Similarity=0.966  Sum_probs=171.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-----ccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~~   76 (217)
                      +++|.+++..+..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+........     ...
T Consensus        91 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  170 (334)
T cd07855          91 ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE  170 (334)
T ss_pred             hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccc
Confidence            568889998888899999999999999999999999999999999999999999999999998865433221     123


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..++..|++||.+.+....+.++|+||+|+++|++++|..||.+.+....+..+....+.++...+..............
T Consensus       171 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~  250 (334)
T cd07855         171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN  250 (334)
T ss_pred             ccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhh
Confidence            46678899999986655578899999999999999999999999888888888888888887766655555555555554


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ........+....+..++++.++|++||+.+|.+|||++++++||||++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         251 LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence            45455555666677789999999999999999999999999999999855

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-35  Score=233.03  Aligned_cols=205  Identities=50%  Similarity=0.923  Sum_probs=172.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +|++|.+++.. .++++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......  .....++
T Consensus       102 ~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~  178 (343)
T cd07851         102 MGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVAT  178 (343)
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCccc
Confidence            36788888876 57999999999999999999999999999999999999999999999999998765433  2334567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+....+.++|+||+|+++|++++|..||........+..+....+.+.+..+..........++......
T Consensus       179 ~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (343)
T cd07851         179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQM  258 (343)
T ss_pred             ccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhcccc
Confidence            78999998865545788999999999999999999999988888888888888777776666555556666666666666


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ............++.+.++|++||+.+|.+|||+.++++||||+++..
T Consensus       259 ~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         259 PKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             CCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence            555666666677999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=232.37  Aligned_cols=206  Identities=57%  Similarity=1.024  Sum_probs=167.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----cccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~   77 (217)
                      +++|.+++.. ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++........    ....
T Consensus        91 ~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  169 (336)
T cd07849          91 ETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY  169 (336)
T ss_pred             ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCc
Confidence            5577777754 5799999999999999999999999999999999999999999999999998865433221    1234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|+|||.+.+...++.++|+||+|++++++++|..||.+.+.......+....+.+....+..........+....
T Consensus       170 ~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (336)
T cd07849         170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSL  249 (336)
T ss_pred             CcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhc
Confidence            56788999998766555788999999999999999999999988888888888888777766665544444444455444


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      .......+....+.+++++.++|.+||+.+|++|||+.++++||||+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         250 PFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             CcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            444445555566678899999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-35  Score=234.64  Aligned_cols=201  Identities=40%  Similarity=0.697  Sum_probs=154.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      +++|.+.+..  .++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.............+++
T Consensus       105 ~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~  182 (355)
T cd07874         105 DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR  182 (355)
T ss_pred             cccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccC
Confidence            4566666654  58899999999999999999999999999999999999999999999999997665554445567889


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.. ++.++|+|||||++|++++|..||.+.+....+..+.+..+.+....+..... ....+........
T Consensus       183 ~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  260 (355)
T cd07874         183 YYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYA  260 (355)
T ss_pred             CccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH-HHHHHHhcCCccc
Confidence            999999986554 78899999999999999999999999888888888877776665443322211 1122222111110


Q ss_pred             c------------cchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          162 R------------QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .            ..........+.++.++|.+||..||++|||++|+++||||+.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         261 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             cccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            0            00111122345778999999999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.1e-35  Score=220.09  Aligned_cols=204  Identities=39%  Similarity=0.672  Sum_probs=164.2

Q ss_pred             ccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC----CCEEEecccccccCCCCCc
Q 027927            3 TDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN----CDLKICDFGLARPTSENEF   73 (217)
Q Consensus         3 ~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~   73 (217)
                      .+|..+|+-+     +.++...++.++.||+.|++|||++.+.|||+||.||++..+    |++|++|+|+++.+.+.-.
T Consensus       112 hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plk  191 (438)
T KOG0666|consen  112 HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLK  191 (438)
T ss_pred             hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccc
Confidence            4677777654     569999999999999999999999999999999999999887    9999999999976554321


Q ss_pred             ----cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------hHHHHHHHHHHhCCCCCc
Q 027927           74 ----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---------HVHQMRLLIELLGTPTDA  140 (217)
Q Consensus        74 ----~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~---------~~~~~~~~~~~~~~~~~~  140 (217)
                          .....-|.+|+|||.+.+.+.++.+.|+|+.||++.|+++-++.|.+..         ...++.+|++.+|.|.+.
T Consensus       192 pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~  271 (438)
T KOG0666|consen  192 PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDK  271 (438)
T ss_pred             ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccc
Confidence                2334557889999999999999999999999999999999999997642         467899999999999999


Q ss_pred             cccccCchHHHH-HHHhCCC--CC---ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          141 DLGFVRNEDAKR-YIRQLPQ--HP---RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       141 ~~~~~~~~~~~~-~~~~~~~--~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .|.......... .+.....  ..   -..+-.....-++...+|+.+||.+||.+|+|++++++|+||..-
T Consensus       272 ~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  272 DWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             cchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence            998776554442 2222111  11   111222233356779999999999999999999999999999954

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=229.29  Aligned_cols=171  Identities=23%  Similarity=0.443  Sum_probs=144.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++++.+.+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||.+......  .....+++
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~  162 (291)
T cd05612          85 GGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTP  162 (291)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccccCCh
Confidence            6799999999999999999999999999999999999999999999999999999999999998765432  22346788


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.. .+.++|+|||||++|++++|..||........+..+....                           
T Consensus       163 ~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------------------------  214 (291)
T cd05612         163 EYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---------------------------  214 (291)
T ss_pred             hhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------------------
Confidence            999999886554 7889999999999999999999998876655554443210                           


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                          ...+..+++.+.++|++||+.||.+|++     ++++++||||+..
T Consensus       215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence                0112245788999999999999999995     9999999999854

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.4e-35  Score=225.84  Aligned_cols=200  Identities=40%  Similarity=0.662  Sum_probs=151.2

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++.+ +..+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  161 (284)
T cd07839          82 DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV  161 (284)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCcc
Confidence            5678888765 5779999999999999999999999999999999999999999999999999887544322 1223456


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|+|||.+.+...++.++|+||+|+++|++++|..|+ .+.+....+..+.+..+.+....+........  ......
T Consensus       162 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  239 (284)
T cd07839         162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD--YKPYPM  239 (284)
T ss_pred             ccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc--ccccCC
Confidence            788999999876665788999999999999999988775 55555666677766666554433221110000  000001


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ......+.+..+.+++++.++|++||+.||.+|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111122344556788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-35  Score=212.97  Aligned_cols=205  Identities=33%  Similarity=0.569  Sum_probs=173.2

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc----
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----   75 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~----   75 (217)
                      |+.+|..++.+. .+++..++++++++++.||.|+|.+.|.|||+|+.|++++.+|.++|+|||+++.+...+...    
T Consensus       106 cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpry  185 (376)
T KOG0669|consen  106 CEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRY  185 (376)
T ss_pred             hhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCc
Confidence            356788888886 789999999999999999999999999999999999999999999999999997665443322    


Q ss_pred             -cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           76 -EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        76 -~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                       ...-+.+|++||.+.+.+.++++.|+|.-||++.+++++.+.+.++.+.+++..|...+|....+-|..+....+...+
T Consensus       186 tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~si  265 (376)
T KOG0669|consen  186 TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSI  265 (376)
T ss_pred             ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhc
Confidence             2234788999999999999999999999999999999999999999999999999999999999999988888776665


Q ss_pred             H--hCCCCCccchhhhC--CCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          155 R--QLPQHPRQSLAQVF--PHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       155 ~--~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      .  .+.+..........  ..-.++..++++++|..||.+|++++++++|.||..
T Consensus       266 e~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  266 ELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            2  22322222222211  123478999999999999999999999999999984

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-34  Score=223.34  Aligned_cols=200  Identities=38%  Similarity=0.663  Sum_probs=156.9

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-cccc
Q 027927            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~   77 (217)
                      +++|.+++...   ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (285)
T cd07861          82 SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE  161 (285)
T ss_pred             CCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCC
Confidence            45788887653   5699999999999999999999999999999999999999999999999998865433211 1233


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||.+.+...++.++|+||||++++++++|..||.+.........+.+..+.+.+..|......  ..+....
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  239 (285)
T cd07861         162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL--PDYKNTF  239 (285)
T ss_pred             cccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh--HHHHhhc
Confidence            55788999998876655788999999999999999999999988877777777777776665554433222  2222222


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ..............+++++.++|++||+.||.+|||+++++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            2222233344455688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4e-35  Score=227.32  Aligned_cols=177  Identities=24%  Similarity=0.357  Sum_probs=142.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |++|.+++...  ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.............+
T Consensus        84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g  163 (285)
T cd05631          84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVG  163 (285)
T ss_pred             CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCC
Confidence            57888887653  4699999999999999999999999999999999999999999999999999876554444445578


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|+|||.+.+. .++.++|+||+||++|++++|..||...........+......                       
T Consensus       164 ~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------------------  219 (285)
T cd05631         164 TVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-----------------------  219 (285)
T ss_pred             CCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-----------------------
Confidence            8999999998654 4789999999999999999999999865432222111111000                       


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                          ........+++++.+|+++||+.||.+||+     ++++++||||++.
T Consensus       220 ----~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         220 ----DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             ----ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence                001223457899999999999999999997     8999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-35  Score=226.01  Aligned_cols=187  Identities=24%  Similarity=0.370  Sum_probs=149.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cc----
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FM----   74 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~----   74 (217)
                      +|++.++++..  .-+++..+..++++++.||.|||.+|.+|||||+.|||++.+|.++|+|||.+..+..+. ..    
T Consensus       108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf  187 (516)
T KOG0582|consen  108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRF  187 (516)
T ss_pred             CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEee
Confidence            58999999886  459999999999999999999999999999999999999999999999999875543332 11    


Q ss_pred             ccccccccccCccccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHH
Q 027927           75 TEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~-~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (217)
                      .+..++++|+|||++. +...|+.++||||||++..|+.+|..||....++..+-  +.+.+.++...........    
T Consensus       188 ~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLqn~pp~~~t~~~~~d~----  261 (516)
T KOG0582|consen  188 NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQNDPPTLLTSGLDKDE----  261 (516)
T ss_pred             ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhcCCCCCcccccCChHH----
Confidence            4568899999999954 44458899999999999999999999998877665543  3334444433322222111    


Q ss_pred             HHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                                     ...++..+..+|..||..||.+|||++++|.|+||++.-.+
T Consensus       262 ---------------~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  262 ---------------DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             ---------------hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence                           11355789999999999999999999999999999976443

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.7e-35  Score=227.56  Aligned_cols=204  Identities=42%  Similarity=0.695  Sum_probs=159.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++... ..+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus        91 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  170 (309)
T cd07845          91 EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV  170 (309)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccc
Confidence            45778888764 679999999999999999999999999999999999999999999999999987654331 2222344


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|+|||.+.+...++.++|+||+|+++|++++|..||...+....+..+....+.+....+............. ...
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  249 (309)
T cd07845         171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT-LPK  249 (309)
T ss_pred             cccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccccc-ccC
Confidence            6779999998765667889999999999999999999999999888888888888777665543322211111110 111


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .+...+......+++++.++|++||+.||++|||++++++||||++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         250 QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             CCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            11112233344568999999999999999999999999999999955

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4e-35  Score=230.86  Aligned_cols=173  Identities=21%  Similarity=0.388  Sum_probs=144.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.+...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... ........++
T Consensus        80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            579999999989999999999999999999999999999999999999999999999999998765322 2233445688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||+||++|++++|..||...........+...  .                        
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~------------------------  212 (320)
T cd05590         160 PDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--E------------------------  212 (320)
T ss_pred             ccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--C------------------------
Confidence            999999988654 4788999999999999999999999887765554444320  0                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH------hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG------EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~------~~ll~~~~f~~~  206 (217)
                           ...+..+++++.++|++||+.||.+|+++      +++++||||++.
T Consensus       213 -----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         213 -----VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence                 01122467899999999999999999998      899999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=230.43  Aligned_cols=173  Identities=28%  Similarity=0.484  Sum_probs=143.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++..++.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........++
T Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          77 GGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence            679999999988999999999999999999999999999999999999999999999999999865322 2223345688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+||++|++++|..||.+.........+...   +                       
T Consensus       157 ~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---~-----------------------  209 (312)
T cd05585         157 PEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---P-----------------------  209 (312)
T ss_pred             cccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---C-----------------------
Confidence            9999999986554 788999999999999999999999876654444333210   0                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC---CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---t~~~ll~~~~f~~~  206 (217)
                           ...+..+++++.++|.+||+.||.+||   ++.++++||||.+.
T Consensus       210 -----~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         210 -----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence                 012235778999999999999999997   57899999999964

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-34  Score=229.30  Aligned_cols=203  Identities=23%  Similarity=0.330  Sum_probs=144.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      .++|.+++.+. .++++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+.............++
T Consensus       140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt  219 (357)
T PHA03209        140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT  219 (357)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccccc
Confidence            56788888764 77999999999999999999999999999999999999999999999999998654443334455688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCC---------hHHHHHHHHHHhCCCCCccccccCchHH
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PGND---------HVHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf-~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                      ..|+|||.+.+.. ++.++|+|||||++|+++++..++ ....         ....+..+....+..+............
T Consensus       220 ~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  298 (357)
T PHA03209        220 VETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV  298 (357)
T ss_pred             ccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHH
Confidence            9999999986554 789999999999999999865444 3321         1223333334333332221111111222


Q ss_pred             HHHHHhCC--CCCccch-hhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          151 KRYIRQLP--QHPRQSL-AQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       151 ~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      ..+.....  ..+.... ......++.++.++|++||+.||++|||+.|+|+||||++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        299 RGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            22222111  1111110 1112256788899999999999999999999999999986

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-34  Score=223.10  Aligned_cols=202  Identities=39%  Similarity=0.750  Sum_probs=160.3

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--cccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~   78 (217)
                      |++|.+++.. ..++++..+..++.||+.||++||+.|++|+||+|+||+++.++.++++|||.+.......  ......
T Consensus        82 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  161 (286)
T cd07832          82 PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV  161 (286)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccccc
Confidence            6889999876 4679999999999999999999999999999999999999999999999999886654332  123446


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++..|+|||.+.+....+.++|+||+|++++++++|.++|....+...+..+....+.+....+........... ....
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  240 (286)
T cd07832         162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK-ITFP  240 (286)
T ss_pred             CcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc-ccCC
Confidence            788899999987666578899999999999999999999988888888888887777665544433222111111 1111


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                      ......+....++.+..+.++|++||..+|++|||++++++||||.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            2222334556667889999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4e-35  Score=232.46  Aligned_cols=171  Identities=25%  Similarity=0.397  Sum_probs=145.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++..+..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+......  .....+++
T Consensus       115 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~  192 (340)
T PTZ00426        115 GGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTP  192 (340)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--cceecCCh
Confidence            6899999999999999999999999999999999999999999999999999999999999998765432  23456889


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.. ++.++|+||+||++|++++|..||...+....+..+....                           
T Consensus       193 ~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------------------------  244 (340)
T PTZ00426        193 EYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------------------------  244 (340)
T ss_pred             hhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------------------------
Confidence            999999986554 7889999999999999999999998876554444443210                           


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                          ...+..+++.+.++|++||+.||++|+     |++++++||||++.
T Consensus       245 ----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        245 ----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                012234678899999999999999995     89999999999965

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-35  Score=231.45  Aligned_cols=174  Identities=29%  Similarity=0.475  Sum_probs=156.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE-ecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-NANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      ||+|+|||.++ .-+.++.+++++.||+.|+.|+|...+||+|+||+|+++ ..-|-+||.|||++.++..+....+.+|
T Consensus       101 ~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCG  180 (864)
T KOG4717|consen  101 GGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCG  180 (864)
T ss_pred             CchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccc
Confidence            57999999988 669999999999999999999999999999999999876 5568899999999999988888899999


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|.|||++.+.....++.|||||||++|.+++|+.||....+.+.+..|+...-                        
T Consensus       181 SLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------------------------  236 (864)
T KOG4717|consen  181 SLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------------------------  236 (864)
T ss_pred             hhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc------------------------
Confidence            99999999999988778899999999999999999999998887777776665321                        


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             .++..++.++++||..||..||++|.|++++..++|++..
T Consensus       237 -------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  237 -------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             -------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence                   2344688999999999999999999999999999999965

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-35  Score=231.72  Aligned_cols=171  Identities=25%  Similarity=0.407  Sum_probs=143.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++++.+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......  ....+++
T Consensus       102 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~  179 (329)
T PTZ00263        102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTP  179 (329)
T ss_pred             CChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ceecCCh
Confidence            67999999999999999999999999999999999999999999999999999999999999987654332  2456888


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.. .+.++|+|||||++|++++|..||.+......+..+...  ..                        
T Consensus       180 ~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~------------------------  232 (329)
T PTZ00263        180 EYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RL------------------------  232 (329)
T ss_pred             hhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--Cc------------------------
Confidence            999999986554 688999999999999999999999876654444333220  00                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                           ..+..++..+.++|++||+.||++|++     ++++++||||++.
T Consensus       233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence                 112236788999999999999999997     7999999999863

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-34  Score=224.50  Aligned_cols=206  Identities=41%  Similarity=0.708  Sum_probs=161.0

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++.... .+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  164 (298)
T cd07841          85 ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV  164 (298)
T ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccccccc
Confidence            678999998876 89999999999999999999999999999999999999999999999999987654432 2223345


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|.|||.+.+...++.++|+||+|++++++++|..+|.+..+...+..+....+.+....+.......  .+ .....
T Consensus       165 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~  241 (298)
T cd07841         165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP--DY-VEFKP  241 (298)
T ss_pred             ceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc--cc-ccccc
Confidence            6789999988665567889999999999999999988898887777777777666655544432211111  11 11112


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCce
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCI  210 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~  210 (217)
                      .+...........+.++.++|.+||+.+|++|||+.++++|+||++.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         242 FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            222333445566789999999999999999999999999999999875443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-34  Score=226.68  Aligned_cols=202  Identities=36%  Similarity=0.623  Sum_probs=145.7

Q ss_pred             CccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE----ecCCCEEEecccccccC
Q 027927            2 DTDLYQIIRSN---------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARPT   68 (217)
Q Consensus         2 ~~~L~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~   68 (217)
                      +++|.+++..+         ..+++..+..++.||+.||.|||+.+++|+||||+||++    +.++.++|+|||++...
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence            56777777532         358899999999999999999999999999999999999    45678999999998765


Q ss_pred             CCCC----ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------hHHHHHHHHHHhC
Q 027927           69 SENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---------HVHQMRLLIELLG  135 (217)
Q Consensus        69 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~---------~~~~~~~~~~~~~  135 (217)
                      ....    ......+++.|+|||.+.+...++.++|+||+||++|++++|..||....         .......+....+
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG  242 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence            4322    12334668889999998766667889999999999999999999997543         2345666677777


Q ss_pred             CCCCccccccCchH----HHHHHHhCCCCC---ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          136 TPTDADLGFVRNED----AKRYIRQLPQHP---RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       136 ~~~~~~~~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      .+....|.......    ............   ...........+..+.+++.+||+.||.+|||++|+|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            66655543321110    000000000000   000111122345779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.3e-35  Score=229.03  Aligned_cols=173  Identities=28%  Similarity=0.490  Sum_probs=143.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.++..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..... ........++
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            678999999989999999999999999999999999999999999999999999999999998765322 2223345688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+|||||++|++++|..||...+.......+....                          
T Consensus       159 ~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--------------------------  211 (323)
T cd05595         159 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------------------------  211 (323)
T ss_pred             cCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------------------
Confidence            999999998654 47899999999999999999999998766544443332100                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                           ...+..+++++.++|++||+.||.+|+     ++.++++|+||.+.
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence                 012235779999999999999999998     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.7e-35  Score=230.29  Aligned_cols=173  Identities=27%  Similarity=0.458  Sum_probs=142.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++...+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..... ........++
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            578999999989999999999999999999999999999999999999999999999999999865322 2223345688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+|||||++|++++|..||...+.......+...                           
T Consensus       159 ~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------------------  210 (328)
T cd05593         159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------------------------  210 (328)
T ss_pred             cCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC---------------------------
Confidence            9999999986544 788999999999999999999999776544333322110                           


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                          ....+..+++++.++|++||+.||++|+     ++.++++|+||...
T Consensus       211 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         211 ----DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             ----CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                0012235778999999999999999997     89999999999854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-35  Score=225.13  Aligned_cols=173  Identities=29%  Similarity=0.460  Sum_probs=155.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      ||+|+||+...++|++.+++.+++||..|+.|+|.++++|+|+|.+|||+|.++.+|++|||++..+.......+.+|++
T Consensus       137 ~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSP  216 (668)
T KOG0611|consen  137 GGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSP  216 (668)
T ss_pred             CccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCc
Confidence            68999999999999999999999999999999999999999999999999999999999999998888888889999999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|.+||++.+.+.-++..|.||||+++|.++.|.-||.+.+....+.+|..-  ..                        
T Consensus       217 LYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G--aY------------------------  270 (668)
T KOG0611|consen  217 LYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG--AY------------------------  270 (668)
T ss_pred             ccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--cc------------------------
Confidence            9999999988887799999999999999999999999999876666666441  11                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                            ..+.-+.++.-||+.||.++|.+|.|+.++-.|.|.+.-
T Consensus       271 ------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  271 ------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             ------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence                  112344678899999999999999999999999998854

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-34  Score=224.05  Aligned_cols=201  Identities=41%  Similarity=0.729  Sum_probs=155.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Cccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~   79 (217)
                      +++|.+++... ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus        89 ~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  168 (293)
T cd07843          89 EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV  168 (293)
T ss_pred             CcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccc
Confidence            46788888765 45999999999999999999999999999999999999999999999999988765543 22233456


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|++||.+.+....+.++|+||+|++++++++|..||..........++....+.+.+..|........... .....
T Consensus       169 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  247 (293)
T cd07843         169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK-KTFTK  247 (293)
T ss_pred             cccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc-ccccc
Confidence            78899999887665568899999999999999999999999888888888888777666554432211110000 00000


Q ss_pred             CCccchhhhCCC--CChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          160 HPRQSLAQVFPH--VHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       160 ~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      .....+...++.  +++.+.++|++||+.+|++|||+.|++.||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         248 YPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            111111222222  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.8e-35  Score=231.02  Aligned_cols=178  Identities=22%  Similarity=0.378  Sum_probs=141.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~   79 (217)
                      |++|.+++..+..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......  ......+
T Consensus        89 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~g  168 (332)
T cd05614          89 GGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG  168 (332)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccC
Confidence            67999999998999999999999999999999999999999999999999999999999999986543322  2234568


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+....+.++|+|||||++|++++|..||...........+..                   ......  
T Consensus       169 t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-------------------~~~~~~--  227 (332)
T cd05614         169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR-------------------RILKCD--  227 (332)
T ss_pred             CccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH-------------------HHhcCC--
Confidence            89999999987655578899999999999999999999964321111111100                   000000  


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                            ......+++.+.+++.+||+.||++||     +++++++||||+..
T Consensus       228 ------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         228 ------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                  012234778999999999999999999     88899999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-34  Score=222.64  Aligned_cols=199  Identities=35%  Similarity=0.710  Sum_probs=153.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +++|.+.+.+. ..+++..+..++.|++.||++||+.|++|+||+|+||+++. +.++|+|||.+.............++
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~  161 (282)
T cd07831          83 DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYIST  161 (282)
T ss_pred             CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCC
Confidence            56888888774 57999999999999999999999999999999999999999 99999999998765544433445567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|+|||.+......+.++|+||+||++|++++|..||.+.+..+.+..+....+.+.+.............  ......
T Consensus       162 ~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  239 (282)
T cd07831         162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN--YNFPSK  239 (282)
T ss_pred             cccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc--ccCccc
Confidence            889999987655556889999999999999999999999888877777777766655443211100000000  000111


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ...........++..+.++|.+||+.+|++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1112233344678999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=233.44  Aligned_cols=175  Identities=25%  Similarity=0.435  Sum_probs=143.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.+++.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..... ........++
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            578999999999999999999999999999999999999999999999999999999999999865322 2223445688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+...++.++|+||+||++|++++|..||......+.+..+...  ..                     ..
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~---------------------~~  216 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KV---------------------RF  216 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CC---------------------CC
Confidence            99999999876655788999999999999999999999876654443333210  00                     00


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC----CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI----TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~----t~~~ll~~~~f~~~  206 (217)
                             ....+++++.++|++||+.||.+||    ++.++++||||.+.
T Consensus       217 -------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         217 -------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             -------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence                   0113678899999999999999998    79999999999854

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-34  Score=227.12  Aligned_cols=173  Identities=24%  Similarity=0.409  Sum_probs=142.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++..+..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+..... ........++
T Consensus        80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            578999999988999999999999999999999999999999999999999999999999998764322 2223445678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+||++|++++|..||...+.......+...  .                        
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~------------------------  212 (316)
T cd05620         160 PDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T------------------------  212 (316)
T ss_pred             cCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C------------------------
Confidence            9999999986554 788999999999999999999999876654443333210  0                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH-hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG-EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-~~ll~~~~f~~~  206 (217)
                           ......++.++.++|++||+.||++|+++ +++++||||+..
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         213 -----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence                 01112367889999999999999999998 588899999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-34  Score=230.40  Aligned_cols=203  Identities=24%  Similarity=0.302  Sum_probs=151.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~   78 (217)
                      +++|.+++.....+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++........   .....
T Consensus       169 ~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~  248 (392)
T PHA03207        169 KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS  248 (392)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccc
Confidence            568899998888999999999999999999999999999999999999999999999999999865543321   22356


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      +++.|+|||.+.... ++.++|+||+||++|++++|..||.+..   ....+..+.+..+..+.......... ....+.
T Consensus       249 gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~-~~~~~~  326 (392)
T PHA03207        249 GTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN-LCKHFK  326 (392)
T ss_pred             cccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh-HHHHHH
Confidence            789999999886554 7889999999999999999999997643   34556666665554433222111111 111111


Q ss_pred             hCCCCCcc--chhhh--CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          156 QLPQHPRQ--SLAQV--FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       156 ~~~~~~~~--~~~~~--~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ........  .....  ...++.++.++|++||..||.+|||+.++|+||||+..
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        327 QYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             hhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            11111111  11111  12456789999999999999999999999999999864

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.6e-34  Score=229.08  Aligned_cols=202  Identities=42%  Similarity=0.733  Sum_probs=155.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      +++|.+.+...  ++...+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.............++.
T Consensus       104 ~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~  181 (353)
T cd07850         104 DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR  181 (353)
T ss_pred             CCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccc
Confidence            56778877654  8999999999999999999999999999999999999999999999999987665544434456678


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+. .++.++|+||+|++++++++|..||...+....+..+....+.+......... .....+........
T Consensus       182 ~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  259 (353)
T cd07850         182 YYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ-PTVRNYVENRPKYA  259 (353)
T ss_pred             cccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh-hhhhHHhhcCCCCC
Confidence            89999998654 47899999999999999999999999888888888888777776553322211 11122222111111


Q ss_pred             ccchhhh-------------CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          162 RQSLAQV-------------FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      .......             ....++.+.++|.+||+.||++|||+.++|+||||+.+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~  318 (353)
T cd07850         260 GYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY  318 (353)
T ss_pred             CcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence            1111111             123456789999999999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=228.37  Aligned_cols=176  Identities=31%  Similarity=0.473  Sum_probs=152.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC----CCEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN----CDLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      ||+|+|.+.+. .+++..+..++.||+.|++|||+.|++|+|+||+|+++...    +.++++|||++............
T Consensus       120 GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~  198 (382)
T KOG0032|consen  120 GGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTI  198 (382)
T ss_pred             CchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeee
Confidence            78999999887 59999999999999999999999999999999999999543    57999999999888877778889


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +|++.|+|||++... .++..+|+||+|+++|.|++|..||.+.........+...--..                    
T Consensus       199 ~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f--------------------  257 (382)
T KOG0032|consen  199 VGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF--------------------  257 (382)
T ss_pred             cCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC--------------------
Confidence            999999999999644 48999999999999999999999999988766666444321111                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ....++.++..+.++|++||..||.+|+|+.++|+|||+++.
T Consensus       258 -------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  258 -------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             -------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence                   123455788999999999999999999999999999999975

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-34  Score=227.21  Aligned_cols=173  Identities=25%  Similarity=0.420  Sum_probs=143.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++..... ........++
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            679999999988999999999999999999999999999999999999999999999999998864322 2222344678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+||++|++++|..||...+.......+....                          
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--------------------------  212 (318)
T cd05570         160 PDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--------------------------  212 (318)
T ss_pred             ccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            8999999986554 7889999999999999999999998776554443332100                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH-----hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG-----EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~~ll~~~~f~~~  206 (217)
                           ...+..+++++.++|++||+.||++|||+     .++++||||++.
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         213 -----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             -----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                 01122467899999999999999999999     999999999875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-33  Score=218.90  Aligned_cols=200  Identities=39%  Similarity=0.694  Sum_probs=157.1

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      +++|.+++..  +..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        82 ~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  161 (284)
T cd07860          82 HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV  161 (284)
T ss_pred             ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccccc
Confidence            4577788765  3568999999999999999999999999999999999999999999999999886543322 122334


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++..|++||.+.+....+.++|+||||+++|++++|..||...+......++.+..+.+....+.....  .........
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  239 (284)
T cd07860         162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--LPDYKPSFP  239 (284)
T ss_pred             ccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH--HHHHHhhcc
Confidence            567899999887666568899999999999999999999998888778888887777765544332211  122222233


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ...........+.+++++.++|.+||+.||.+|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            333334444556688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-34  Score=219.28  Aligned_cols=200  Identities=43%  Similarity=0.757  Sum_probs=158.2

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      +++|.+++....  .+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  160 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV  160 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence            568899988776  79999999999999999999999999999999999999999999999999986543221 112234


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++..|+|||.+.+...++.++|+||+|+++|++++|..||...........+.+..+.+.+..+......  ........
T Consensus       161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  238 (283)
T cd07835         161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL--PDYKPTFP  238 (283)
T ss_pred             cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc--hhhhhhcc
Confidence            5778999998866555688999999999999999999999988877777777777666665544322111  12222222


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ...........+.+++++.++|.+||+.||.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            223333444566788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.7e-34  Score=226.24  Aligned_cols=211  Identities=45%  Similarity=0.821  Sum_probs=168.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC------ccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE------FMT   75 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~------~~~   75 (217)
                      +++|.+++.++ .+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......      ...
T Consensus        92 ~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~  170 (337)
T cd07852          92 ETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT  170 (337)
T ss_pred             ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchh
Confidence            46788888776 88999999999999999999999999999999999999999999999999886543322      222


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...++..|++||.+.+....+.++|+||+|+++|++++|+.||.+........++....+.+....+.............
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (337)
T cd07852         171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLD  250 (337)
T ss_pred             cccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhh
Confidence            34567889999988766557889999999999999999999999888888888888877766655444333333333333


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCceeec
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFI  213 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~~~  213 (217)
                      ..............+.++.++.++|.+||+.||.+|||+.++++||||++...+.+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~  308 (337)
T cd07852         251 SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP  308 (337)
T ss_pred             hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC
Confidence            3333334444555666889999999999999999999999999999999775554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.6e-34  Score=220.63  Aligned_cols=201  Identities=32%  Similarity=0.637  Sum_probs=149.0

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~   81 (217)
                      ++|..+++....+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus        85 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  164 (286)
T cd07847          85 TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR  164 (286)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCccccc
Confidence            4566666666789999999999999999999999999999999999999999999999999987654433 222345677


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|++||.+.+...++.++|+||+|++++++++|..||.+....+....+....+..........................
T Consensus       165 ~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (286)
T cd07847         165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPET  244 (286)
T ss_pred             ccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCccc
Confidence            89999998665557889999999999999999999998877766666655544433221110000000000000000111


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ........+.++..+.+++.+||+.+|++|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         245 REPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            122334455678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.3e-34  Score=226.92  Aligned_cols=173  Identities=25%  Similarity=0.432  Sum_probs=144.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~   80 (217)
                      |++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... .........++
T Consensus        85 ~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  164 (324)
T cd05587          85 GGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT  164 (324)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCC
Confidence            67999999998999999999999999999999999999999999999999999999999999876432 22233445688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+||++|++++|..||.+.+.......+....                          
T Consensus       165 ~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--------------------------  217 (324)
T cd05587         165 PDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--------------------------  217 (324)
T ss_pred             ccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            9999999986554 7889999999999999999999998877655554443210                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH-----hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG-----EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~~ll~~~~f~~~  206 (217)
                           ...+..+++++.+++++||..||.+|++.     +++++||||+..
T Consensus       218 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         218 -----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                 01123467899999999999999999987     899999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=232.19  Aligned_cols=180  Identities=26%  Similarity=0.434  Sum_probs=152.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      ||++.+.++....+.+..+..++++++.|+.|||+++.+|+|||+.||++..+|.++|+|||.+........ ..+..||
T Consensus        95 gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGT  174 (467)
T KOG0201|consen   95 GGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGT  174 (467)
T ss_pred             CcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccccccc
Confidence            789999999998889999999999999999999999999999999999999999999999999877665433 3778999


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+.. ++.++||||||++.++|++|.+|+....++..+..|                           +..
T Consensus       175 PfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------------------------pk~  226 (467)
T KOG0201|consen  175 PFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------------------------PKS  226 (467)
T ss_pred             ccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---------------------------cCC
Confidence            9999999998554 899999999999999999999999877653322222                           111


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCceee
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEF  212 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~~  212 (217)
                      ..+.   +...+++.+++||..||..||+.||||.+||.|+|++..+.+...
T Consensus       227 ~PP~---L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L  275 (467)
T KOG0201|consen  227 APPR---LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSEL  275 (467)
T ss_pred             CCCc---cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHH
Confidence            1111   222688999999999999999999999999999999987766543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=230.92  Aligned_cols=176  Identities=30%  Similarity=0.473  Sum_probs=144.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---------   72 (217)
                      |++|.+++.+.+.+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||.+.......         
T Consensus        85 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~  164 (350)
T cd05573          85 GGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS  164 (350)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccc
Confidence            67999999998899999999999999999999999999999999999999999999999999987654332         


Q ss_pred             ---------------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 027927           73 ---------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI  131 (217)
Q Consensus        73 ---------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~  131 (217)
                                           ......+++.|+|||.+.+. .++.++|+|||||++|++++|..||...........+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  243 (350)
T cd05573         165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKII  243 (350)
T ss_pred             ccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHh
Confidence                                 22345678899999998665 47899999999999999999999998877555444443


Q ss_pred             HHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-HhhhccCCCCccc
Q 027927          132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-GEFFVPYKPFQCC  206 (217)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-~~~ll~~~~f~~~  206 (217)
                      .......                     .      .....+++++.++|.+||. ||.+|++ ++++++||||+..
T Consensus       244 ~~~~~~~---------------------~------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         244 NWKESLR---------------------F------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             ccCCccc---------------------C------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            3110000                     0      0011267999999999998 9999999 9999999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-34  Score=228.44  Aligned_cols=173  Identities=26%  Similarity=0.472  Sum_probs=143.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.+++.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........++
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            678999999999999999999999999999999999999999999999999999999999998864322 2223345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+|||||++|++++|..||...+.......+...   +                       
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-----------------------  212 (323)
T cd05575         160 PEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P-----------------------  212 (323)
T ss_pred             hhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-----------------------
Confidence            999999998654 4788999999999999999999999877654444433220   0                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH----hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG----EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~~ll~~~~f~~~  206 (217)
                           ....+.+++.+.++|++||+.||.+||++    .++++||||.+.
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         213 -----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence                 01223567899999999999999999998    599999999854

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-34  Score=227.03  Aligned_cols=173  Identities=25%  Similarity=0.474  Sum_probs=143.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.+++.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..... ........++
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  163 (323)
T cd05584          84 GGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGT  163 (323)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCC
Confidence            579999999999999999999999999999999999999999999999999999999999998864322 2223345688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. .+.++|+||||+++|++++|..||...........+...  .                        
T Consensus       164 ~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~------------------------  216 (323)
T cd05584         164 IEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--K------------------------  216 (323)
T ss_pred             ccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C------------------------
Confidence            9999999986554 688999999999999999999999876654444333220  0                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                           ...++.+++++.++|++||+.||++||     ++.++++||||+..
T Consensus       217 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         217 -----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence                 012334678999999999999999999     89999999999854

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.2e-34  Score=227.52  Aligned_cols=178  Identities=28%  Similarity=0.457  Sum_probs=149.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-----------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-----------   70 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-----------   70 (217)
                      ||++-.+|.+.+.|++++++.++.+++.|++.+|+.|++|+||||+|+|+|..|.+||+|||++.....           
T Consensus       225 GGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~  304 (550)
T KOG0605|consen  225 GGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDE  304 (550)
T ss_pred             CccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchh
Confidence            789999999999999999999999999999999999999999999999999999999999998742110           


Q ss_pred             -----------C--C------------------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc
Q 027927           71 -----------N--E------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN  113 (217)
Q Consensus        71 -----------~--~------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~  113 (217)
                                 .  .                        ......|||.|+|||++.+.+ ++..+|.|||||++||++.
T Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLv  383 (550)
T KOG0605|consen  305 QMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLV  383 (550)
T ss_pred             hhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHh
Confidence                       0  0                        011357899999999998776 8999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC
Q 027927          114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT  193 (217)
Q Consensus       114 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  193 (217)
                      |.+||...++.+.+++|+.-......+                     .      ....++++.|||.+||. ||.+|.-
T Consensus       384 GyPPF~s~tp~~T~rkI~nwr~~l~fP---------------------~------~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  384 GYPPFCSETPQETYRKIVNWRETLKFP---------------------E------EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhhhccCC---------------------C------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999988887622111000                     0      01356899999999999 9999986


Q ss_pred             ---HhhhccCCCCccccC
Q 027927          194 ---GEFFVPYKPFQCCCG  208 (217)
Q Consensus       194 ---~~~ll~~~~f~~~~~  208 (217)
                         ++||-+||||+...+
T Consensus       436 ~~G~~EIK~HPfF~~v~W  453 (550)
T KOG0605|consen  436 SKGAEEIKKHPFFKGVDW  453 (550)
T ss_pred             cccHHHHhcCCccccCCc
Confidence               889999999996643

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-34  Score=227.41  Aligned_cols=173  Identities=24%  Similarity=0.397  Sum_probs=144.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+..... ........++
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            578999999989999999999999999999999999999999999999999999999999998865322 2223345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||+|+++|++++|..||...........+....                          
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--------------------------  212 (321)
T cd05591         160 PDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--------------------------  212 (321)
T ss_pred             ccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            899999988654 47889999999999999999999998877665555443210                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC-------CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-------TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-------t~~~ll~~~~f~~~  206 (217)
                           ...+..+++++.++|++||+.||++|+       +++++++||||...
T Consensus       213 -----~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         213 -----VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence                 011123678999999999999999999       99999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-34  Score=226.05  Aligned_cols=202  Identities=45%  Similarity=0.838  Sum_probs=158.7

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccc
Q 027927            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWY   83 (217)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~   83 (217)
                      +|.+++  +..+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||.+......  .....++..|
T Consensus       105 ~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y  180 (342)
T cd07879         105 DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWY  180 (342)
T ss_pred             CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecc
Confidence            344443  246899999999999999999999999999999999999999999999999998654322  2234567789


Q ss_pred             cCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCcc
Q 027927           84 RAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQ  163 (217)
Q Consensus        84 ~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (217)
                      +|||.+.+...++.++|+||||++++++++|+.||.+.+....+..+....+.+.+.....................+..
T Consensus       181 ~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (342)
T cd07879         181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRK  260 (342)
T ss_pred             cChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccc
Confidence            99998866445788999999999999999999999988877777777776665544433333333333344444444455


Q ss_pred             chhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          164 SLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                      .+....+..++.+.++|++||+.||.+|||+++++.||||+.....
T Consensus       261 ~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         261 DFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             hHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            5566666788999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=221.86  Aligned_cols=175  Identities=29%  Similarity=0.449  Sum_probs=149.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC------CCEEEecccccccCCCCCccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN------CDLKICDFGLARPTSENEFMT   75 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~------~~~~l~d~~~~~~~~~~~~~~   75 (217)
                      ||+|.+|+++.+.+++..++.++.||+.|+++||+++|+||||||+|||++..      ..+|++|||+++.+.......
T Consensus        93 gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~  172 (429)
T KOG0595|consen   93 GGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAE  172 (429)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHH
Confidence            69999999999999999999999999999999999999999999999999775      458999999999999988889


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      +.+|++.|+|||++... .|+.++|+||+|+++|++++|..||......+....+.+.....                  
T Consensus       173 tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~------------------  233 (429)
T KOG0595|consen  173 TLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV------------------  233 (429)
T ss_pred             HhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc------------------
Confidence            99999999999999654 48999999999999999999999999888777766443311111                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                                .......++...+++...|..+|..|.+..+-+.|++...
T Consensus       234 ----------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  234 ----------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             ----------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                      1111235566778888888899999999888888888773

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.6e-34  Score=229.05  Aligned_cols=176  Identities=26%  Similarity=0.379  Sum_probs=140.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---------   72 (217)
                      |++|.+++.+++.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......         
T Consensus        85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  164 (363)
T cd05628          85 GGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLN  164 (363)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccc
Confidence            67999999999999999999999999999999999999999999999999999999999999886432210         


Q ss_pred             ---------------------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 027927           73 ---------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH  125 (217)
Q Consensus        73 ---------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~  125 (217)
                                                 ......|++.|+|||.+.+.. ++.++|+|||||++|++++|..||.+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~  243 (363)
T cd05628         165 HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQE  243 (363)
T ss_pred             ccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence                                       012346889999999986554 7889999999999999999999998877655


Q ss_pred             HHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCC---CCCCHhhhccCCC
Q 027927          126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPM---KRITGEFFVPYKP  202 (217)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~---~R~t~~~ll~~~~  202 (217)
                      .+..+.........                     +      ....+++++.++|.+|+. +|.   .||+++++++|||
T Consensus       244 ~~~~i~~~~~~~~~---------------------p------~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~  295 (363)
T cd05628         244 TYKKVMNWKETLIF---------------------P------PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPF  295 (363)
T ss_pred             HHHHHHcCcCcccC---------------------C------CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCC
Confidence            55554431111000                     0      011367899999999876 444   4689999999999


Q ss_pred             Cccc
Q 027927          203 FQCC  206 (217)
Q Consensus       203 f~~~  206 (217)
                      |++.
T Consensus       296 f~~~  299 (363)
T cd05628         296 FEGV  299 (363)
T ss_pred             CCCC
Confidence            9854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-33  Score=224.48  Aligned_cols=204  Identities=50%  Similarity=0.921  Sum_probs=165.5

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +|++|.++++. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......  .....++
T Consensus       104 ~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~  180 (345)
T cd07877         104 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVAT  180 (345)
T ss_pred             cccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc--ccccccC
Confidence            36778877765 46999999999999999999999999999999999999999999999999988654322  2334567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|+|||.+.+....+.++|+||+|++++++++|..||...........+....+.+.+.............+.......
T Consensus       181 ~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (345)
T cd07877         181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM  260 (345)
T ss_pred             CCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhccc
Confidence            88999998866555788999999999999999999999888777777777777776666655555544444555544444


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      +...........++++.++|.+||+.||.+|||+.++++||||++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         261 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             CCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence            44444454556789999999999999999999999999999999653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.9e-34  Score=225.58  Aligned_cols=173  Identities=25%  Similarity=0.442  Sum_probs=143.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... .......++
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            6899999999889999999999999999999999999999999999999999999999999998654322 233445688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+||++|++++|..||.+.+.......+...  .                        
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~------------------------  212 (316)
T cd05592         160 PDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--R------------------------  212 (316)
T ss_pred             ccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C------------------------
Confidence            9999999986554 788999999999999999999999887655544433210  0                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHh-hhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE-FFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~-~ll~~~~f~~~  206 (217)
                           ...+..++.++.++|++||+.||++||++. ++++||||+..
T Consensus       213 -----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         213 -----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence                 011224678899999999999999999875 88899999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-33  Score=223.71  Aligned_cols=203  Identities=23%  Similarity=0.378  Sum_probs=145.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |++|.+++.+...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+...... ......++
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~  165 (331)
T cd06649          87 GGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGT  165 (331)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCC
Confidence            579999999988999999999999999999999986 6999999999999999999999999998655432 22345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc---------------
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV---------------  145 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------  145 (217)
                      +.|+|||.+.+.. ++.++|+|||||++|++++|..||...+.......+...............               
T Consensus       166 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (331)
T cd06649         166 RSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHG  244 (331)
T ss_pred             cCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccc
Confidence            8999999986554 789999999999999999999999776654433222110000000000000               


Q ss_pred             ----CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          146 ----RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       146 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                          ....................  ....+++++.+||.+||+.||++|||++++++||||+....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         245 MDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             cccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                00000111111111100000  01246789999999999999999999999999999996543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=227.40  Aligned_cols=179  Identities=25%  Similarity=0.403  Sum_probs=146.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.+.+.+++..+..++.||+.||++||++|++||||+|+||+++.++.++|+|||++.....  ......+++
T Consensus        85 g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~  162 (333)
T cd05600          85 GGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSP  162 (333)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCc
Confidence            689999999989999999999999999999999999999999999999999999999999999865543  234457889


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+. .++.++|+|||||++|++++|..||...........+..........                     
T Consensus       163 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------  220 (333)
T cd05600         163 DYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP---------------------  220 (333)
T ss_pred             cccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCC---------------------
Confidence            99999998665 47899999999999999999999998776555544443211100000                     


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                        ........+++++.++|.+||..+|.+|||++++++||||...
T Consensus       221 --~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         221 --VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             --CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence              0000012467899999999999999999999999999999964

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.4e-35  Score=229.80  Aligned_cols=174  Identities=29%  Similarity=0.505  Sum_probs=143.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~   79 (217)
                      |++|.+++..++.+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||++.... .........+
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            57899999988999999999999999999999997 799999999999999999999999999886432 2223334568


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+. .++.++|+|||||++|++++|..||...........+...  .                       
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~-----------------------  212 (325)
T cd05594         159 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--E-----------------------  212 (325)
T ss_pred             CcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--C-----------------------
Confidence            8999999998654 4789999999999999999999999876644433332210  0                       


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCcccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCCC  207 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~~  207 (217)
                            ...+..+++++.++|++||+.||++|+     ++.++++||||.+..
T Consensus       213 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         213 ------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence                  011234678999999999999999997     999999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.8e-33  Score=218.82  Aligned_cols=200  Identities=41%  Similarity=0.739  Sum_probs=154.8

Q ss_pred             CccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccCCCCC-cc
Q 027927            2 DTDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE-FM   74 (217)
Q Consensus         2 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~   74 (217)
                      +++|.+++...     ..+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||.+....... ..
T Consensus        89 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~  168 (295)
T cd07837          89 DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY  168 (295)
T ss_pred             CcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCcccc
Confidence            46788887653     45899999999999999999999999999999999999998 8899999999886543221 11


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+++.|.|||.+.+....+.++|+||+|+++|++++|..||.+..+......+....+.+....+........  ..
T Consensus       169 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  246 (295)
T cd07837         169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRD--WH  246 (295)
T ss_pred             CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccc--hh
Confidence            2234577899999886655578899999999999999999999998888888877777766665544332211111  11


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                       ..............+.+++++.++|.+||..||.+|||+++++.||||+
T Consensus       247 -~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         247 -EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             -hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence             1112222233444456889999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.2e-34  Score=226.54  Aligned_cols=182  Identities=23%  Similarity=0.381  Sum_probs=140.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccC-CCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~   80 (217)
                      |++|.+++.+++.+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++... ..........++
T Consensus        80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            6799999998899999999999999999999999999999999999999999999999999988642 222333455788


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+||++|++++|..||.......             ...  ...............  
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-------------~~~--~~~~~~~~~~~~~~~--  221 (329)
T cd05588         160 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSD-------------NPD--QNTEDYLFQVILEKQ--  221 (329)
T ss_pred             ccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccc-------------ccc--ccchHHHHHHHHcCC--
Confidence            9999999986544 7889999999999999999999996321000             000  000000000000000  


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCC------HhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT------GEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t------~~~ll~~~~f~~~  206 (217)
                           ...+..+++++.++|++||+.||.+|+|      ++++++||||.+.
T Consensus       222 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         222 -----IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence                 1123357789999999999999999997      7899999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=198.79  Aligned_cols=204  Identities=41%  Similarity=0.671  Sum_probs=176.6

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|..+... ++.++.+.++.++.|+++||.++|++++.|+|+||.|.+++.+|.+|++|||+++.++..- +.+...-
T Consensus        84 dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevv  163 (292)
T KOG0662|consen   84 DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV  163 (292)
T ss_pred             hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceee
Confidence            4567777655 5889999999999999999999999999999999999999999999999999998877654 3455677


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +.+|++|.++.+.+.++.+.|+||-||++.|+.. |.+.|++.+-.+++.+|+...|.+.+..|..+.......  .--.
T Consensus       164 tlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk--~yp~  241 (292)
T KOG0662|consen  164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK--PYPI  241 (292)
T ss_pred             eeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc--ccCC
Confidence            8999999999999999999999999999999976 788899999999999999999999999988766543211  1122


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ..+...|+++.++++....++++++|.-+|.+|++++.+++||||...+
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            3344578899999999999999999999999999999999999998643

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.3e-34  Score=225.92  Aligned_cols=173  Identities=24%  Similarity=0.398  Sum_probs=145.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........++
T Consensus        85 ~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  164 (323)
T cd05616          85 GGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGT  164 (323)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCC
Confidence            579999999989999999999999999999999999999999999999999999999999999865332 2223345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+||++|++++|..||.+.........+....                          
T Consensus       165 ~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------------------------  217 (323)
T cd05616         165 PDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------------------------  217 (323)
T ss_pred             hhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            9999999986544 7899999999999999999999998877665555444310                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH-----hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG-----EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~~ll~~~~f~~~  206 (217)
                           ...+..+++++.+++.+||+.||.+|++.     .++++||||+..
T Consensus       218 -----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         218 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence                 01123467899999999999999999984     799999999854

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=217.69  Aligned_cols=201  Identities=45%  Similarity=0.807  Sum_probs=160.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++... ..+++..+..++.|++.||++||+++++|+||+|+||+++.++.++++|||.+....... ......+
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV  160 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence            46788888774 689999999999999999999999999999999999999999999999999886654433 2223456


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|.+||.+.+...++.++|+||+|+++|++++|+.||...+....+..+.+..+.+....+........... .....
T Consensus       161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  239 (283)
T cd05118         161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK-FSFPK  239 (283)
T ss_pred             cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh-hhhcc
Confidence            77899999987664678999999999999999999999999888888888887777776655554433211111 11222


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ..........+.++.++.++|.+||+.||.+||++++++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            22223344556688999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2e-33  Score=222.44  Aligned_cols=209  Identities=37%  Similarity=0.656  Sum_probs=164.1

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---------
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---------   71 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---------   71 (217)
                      ++++|.+++.....+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......         
T Consensus       102 ~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  181 (335)
T PTZ00024        102 MASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD  181 (335)
T ss_pred             cccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccc
Confidence            35789999998889999999999999999999999999999999999999999999999999988655411         


Q ss_pred             ------CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           72 ------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        72 ------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                            .......++..|++||.+.+....+.++|+||+|++++++++|..||....+...+..+.+..+.+....|...
T Consensus       182 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (335)
T PTZ00024        182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQA  261 (335)
T ss_pred             ccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcch
Confidence                  11112344677999999876555688999999999999999999999988888888888888777766544322


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCceee
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEF  212 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~~  212 (217)
                      ....  .. ..................+.++.++|.+||+.+|.+|||+++++.||||+....+.+.
T Consensus       262 ~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~~~  325 (335)
T PTZ00024        262 KKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDP  325 (335)
T ss_pred             hhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCCCc
Confidence            1100  00 0111111223344455678999999999999999999999999999999977665543

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=217.61  Aligned_cols=200  Identities=43%  Similarity=0.770  Sum_probs=158.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++.+. ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV  160 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence            56899999887 689999999999999999999999999999999999999999999999999886554332 2223344


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|+|||.+.+...++.++|+||+|++++++++|..||........+..+....+.+.+..+.......  .+......
T Consensus       161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  238 (282)
T cd07829         161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP--DYKPTFPK  238 (282)
T ss_pred             CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc--cccccccc
Confidence            6779999998766467889999999999999999999999888888888888877777665443222211  11111122


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ..........+.++..+.++|++||..+|++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            22223344455678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.6e-34  Score=223.20  Aligned_cols=173  Identities=24%  Similarity=0.418  Sum_probs=142.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.+++++...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...... .......++
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            6799999998889999999999999999999999999999999999999999999999999988653222 223345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|+|||.+.+.. ++.++|+||+||++|++++|..||...........+.. . .+                       
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-~-~~-----------------------  213 (316)
T cd05619         160 PDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-D-NP-----------------------  213 (316)
T ss_pred             ccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-C-CC-----------------------
Confidence            8999999986554 78999999999999999999999987665444433321 0 00                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHh-hhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE-FFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~-~ll~~~~f~~~  206 (217)
                            ..+..++.++.++|.+||+.||.+|+++. ++++||||+..
T Consensus       214 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         214 ------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             ------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence                  01123668899999999999999999997 89999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-33  Score=218.06  Aligned_cols=200  Identities=41%  Similarity=0.765  Sum_probs=157.4

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccc
Q 027927            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~   77 (217)
                      +++|.+++...   ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+....... .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (284)
T cd07836          81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE  160 (284)
T ss_pred             CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccc
Confidence            46788888764   368999999999999999999999999999999999999999999999999886543321 12233


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|++||.+.+...++.++|+|++|++++++++|..||.+.+..+....+.+....+.+..+......  ..+....
T Consensus       161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  238 (284)
T cd07836         161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL--PEYKPTF  238 (284)
T ss_pred             cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC--chhcccc
Confidence            45778999998866655788999999999999999999999988888888888887777766554332211  1111222


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ............+..++.+.+++.+||+.||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            2222233344455678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.2e-33  Score=218.71  Aligned_cols=201  Identities=35%  Similarity=0.606  Sum_probs=150.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~   75 (217)
                      +++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+........     ..
T Consensus       102 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  181 (310)
T cd07865         102 EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT  181 (310)
T ss_pred             CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCcc
Confidence            56777877765 3789999999999999999999999999999999999999999999999998865433221     12


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...++..|+|||.+.+....+.++|+||+|+++|++++|..||...+.......+....+..+...+.............
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (310)
T cd07865         182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKME  261 (310)
T ss_pred             CcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhcc
Confidence            33456789999988666556889999999999999999999999888777777777777766555443332222111111


Q ss_pred             hCCCCCccc-hhhh-CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          156 QLPQHPRQS-LAQV-FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       156 ~~~~~~~~~-~~~~-~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                       ........ .... ....++.+.++|.+||+.||.+|||++++++||||
T Consensus       262 -~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         262 -LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             -CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence             01110000 0111 11235778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=216.63  Aligned_cols=201  Identities=39%  Similarity=0.715  Sum_probs=157.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--cccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~   78 (217)
                      +++|.+++.+. ..+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++++|||.+.......  ......
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (287)
T cd07840          83 DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV  162 (287)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccc
Confidence            45788888775 689999999999999999999999999999999999999999999999999987654432  122345


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++..|++||.+.+...++.++|+||||++++++++|..||...........+....+.+....+............... 
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  241 (287)
T cd07840         163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPK-  241 (287)
T ss_pred             cccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcccc-
Confidence            5778999998766555788999999999999999999999988888888888887777766655443332111111111 


Q ss_pred             CCCccchhhhCCC-CChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ............. +++.+.+++++||+.+|.+|||+++++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         242 KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            1111122233333 38999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-34  Score=228.24  Aligned_cols=176  Identities=28%  Similarity=0.466  Sum_probs=141.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---------   72 (217)
                      |++|.+++.+++.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        85 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  164 (364)
T cd05599          85 GGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS  164 (364)
T ss_pred             CcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccc
Confidence            68999999998999999999999999999999999999999999999999999999999999876432211         


Q ss_pred             ------------------------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 027927           73 ------------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND  122 (217)
Q Consensus        73 ------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~  122 (217)
                                                    ......|++.|+|||.+.... ++.++|+|||||++|++++|..||....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~Pf~~~~  243 (364)
T cd05599         165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPPFCSDN  243 (364)
T ss_pred             ccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCCCCCCC
Confidence                                          011235789999999886544 7899999999999999999999998776


Q ss_pred             hHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC---Hhhhcc
Q 027927          123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT---GEFFVP  199 (217)
Q Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~~ll~  199 (217)
                      .......+.......                     ..+      ....+++++.++|++||. +|.+|++   ++++++
T Consensus       244 ~~~~~~~i~~~~~~~---------------------~~~------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         244 PQETYRKIINWKETL---------------------QFP------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHHHHHHcCCCcc---------------------CCC------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            555444443210000                     000      011367899999999997 9999998   999999


Q ss_pred             CCCCccc
Q 027927          200 YKPFQCC  206 (217)
Q Consensus       200 ~~~f~~~  206 (217)
                      ||||+..
T Consensus       296 h~~~~~~  302 (364)
T cd05599         296 HPFFKGV  302 (364)
T ss_pred             CCCcCCC
Confidence            9999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=212.99  Aligned_cols=202  Identities=45%  Similarity=0.760  Sum_probs=163.8

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |..+|..++.  -.++-+.+.+++.|++.|+.+||+.||+|||+||+||++..+..+|+.|||++..-...-.......+
T Consensus       103 m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvt  180 (369)
T KOG0665|consen  103 MDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVT  180 (369)
T ss_pred             hhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhhe
Confidence            4556777776  46788899999999999999999999999999999999999999999999999766555455667778


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|.|||++++.+ +.+.+||||+||++.+|++|...|.+.+.-.++.++.+.+|.+.+.-...+ ....+.++...++.
T Consensus       181 Ryyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL-~~~~r~yv~~~~~y  258 (369)
T KOG0665|consen  181 RYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL-QPTVRNYVENRPQY  258 (369)
T ss_pred             eeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh-hHHHHHHhhcChHh
Confidence            8999999999887 899999999999999999999999999999999999999999876643322 22233333333332


Q ss_pred             CccchhhhCC------------CCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          161 PRQSLAQVFP------------HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ......+.++            .-...+.+++.+||..+|++|.+++++|+|||++-|
T Consensus       259 ~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  259 QAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             hccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence            2222333322            223568999999999999999999999999999833

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.8e-34  Score=226.96  Aligned_cols=177  Identities=25%  Similarity=0.400  Sum_probs=143.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--cccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~   78 (217)
                      |++|.+++++. ..+++..+..++.||+.||++||+.+++||||+|+||+++.++.++|+|||.+.........  ....
T Consensus        85 ~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  164 (330)
T cd05601          85 GGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV  164 (330)
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeeccc
Confidence            67999999887 78999999999999999999999999999999999999999999999999998765443222  2346


Q ss_pred             ccccccCcccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHH
Q 027927           79 VTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (217)
Q Consensus        79 ~~~~~~~Pe~~~~-----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (217)
                      +++.|+|||.+..     ...++.++|+||+||++|++++|..||........+..+.......                
T Consensus       165 gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------  228 (330)
T cd05601         165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL----------------  228 (330)
T ss_pred             CCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc----------------
Confidence            7889999998853     2346789999999999999999999998776655554443311000                


Q ss_pred             HHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                           ..      .....+++++.++|++||. +|.+|||++++++||||...
T Consensus       229 -----~~------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         229 -----KF------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             -----CC------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence                 00      0112467899999999998 99999999999999999854

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-33  Score=222.00  Aligned_cols=203  Identities=44%  Similarity=0.859  Sum_probs=160.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.. .++++..+..++.||+.||++||++|++|+||+|+||+++.++.++++|||.+.......  ....+++
T Consensus       103 ~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~  179 (343)
T cd07880         103 GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM--TGYVVTR  179 (343)
T ss_pred             CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc--cccccCC
Confidence            5678777764 679999999999999999999999999999999999999999999999999986554322  2335577


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|++||.+.+....+.++|+||+|++++++++|..||...........+....+.................+........
T Consensus       180 ~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (343)
T cd07880         180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFR  259 (343)
T ss_pred             cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccC
Confidence            89999988654457889999999999999999999999887777777776655544433222222333334444444444


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ........+.+++++.++|.+||+.||++|||+.+++.||||+...
T Consensus       260 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         260 KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             cchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            4455556677899999999999999999999999999999999763

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=221.33  Aligned_cols=169  Identities=29%  Similarity=0.396  Sum_probs=142.4

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcC-cEecCcCCCCEEEecCC-CEEEecccccccCCCC-Ccccc
Q 027927            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANC-DLKICDFGLARPTSEN-EFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~-i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~-~~~~~   76 (217)
                      +|+|.+++.+  ++.++...+..++.+|++|++|||+++ |+|+|+|++|+|++.++ .+||+|||++...... .....
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~  203 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTS  203 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccC
Confidence            6899999988  689999999999999999999999999 99999999999999997 9999999999776654 33444


Q ss_pred             ccccccccCcccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~-~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..||+.|+|||++.+ ...++.++||||+|+++|++++|..||.+....+....+......+.                 
T Consensus       204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-----------------  266 (362)
T KOG0192|consen  204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-----------------  266 (362)
T ss_pred             CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence            788999999999974 34589999999999999999999999998887444444443222221                 


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  ++...++.+..+|.+||+.||++||++.+++.
T Consensus       267 ------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 ------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                        12236789999999999999999999999854

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-34  Score=226.92  Aligned_cols=173  Identities=26%  Similarity=0.447  Sum_probs=144.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.+++.++..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~  161 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT  161 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence            5799999998889999999999999999999999999999999999999999999999999998654433 223345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||||+++|++++|..||...+.......+....                          
T Consensus       162 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------------------  214 (318)
T cd05582         162 VEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------------------  214 (318)
T ss_pred             hhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            8999999886544 6889999999999999999999998776555444332210                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                           ...+..+++.+.++|++||+.||.+|||     ++++++||||+..
T Consensus       215 -----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         215 -----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence                 0122346789999999999999999999     6779999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=216.00  Aligned_cols=197  Identities=39%  Similarity=0.693  Sum_probs=154.2

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++...  ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        89 ~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  168 (287)
T cd07838          89 DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV  168 (287)
T ss_pred             ccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccc
Confidence            45788888775  3599999999999999999999999999999999999999999999999999877655444444456


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|++||.+.+.. ++.++|+||+|+++|++++|..||.+........++....+.+....+.........    ....
T Consensus       169 ~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  243 (287)
T cd07838         169 TLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS----SFPS  243 (287)
T ss_pred             cccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh----hccc
Confidence            78899999986554 788999999999999999999999988888888887776555433322211110000    0111


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ..........+.+++.+.++|++||+.||.+||+++++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            22222344445677899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.9e-34  Score=227.22  Aligned_cols=177  Identities=25%  Similarity=0.337  Sum_probs=142.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~   79 (217)
                      |++|.+++.+ ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.......  ......+
T Consensus       127 gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~g  205 (370)
T cd05596         127 GGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG  205 (370)
T ss_pred             CCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCC
Confidence            6799998876 468999999999999999999999999999999999999999999999999987654322  1234568


Q ss_pred             cccccCcccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           80 TRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~---~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ++.|+|||.+.+..   .++.++|+|||||++|++++|..||.+......+..+.........                 
T Consensus       206 t~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----------------  268 (370)
T cd05596         206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF-----------------  268 (370)
T ss_pred             CcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC-----------------
Confidence            89999999986432   3678999999999999999999999887665555444321110000                 


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCC--CCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~~ll~~~~f~~~  206 (217)
                                .....++.++.++|++||..+|.+  |+|++++++||||++.
T Consensus       269 ----------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         269 ----------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             ----------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence                      001246799999999999999988  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-33  Score=215.25  Aligned_cols=201  Identities=41%  Similarity=0.722  Sum_probs=158.4

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++..+.  .++...+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  160 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS  160 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCC
Confidence            678999998865  789999999999999999999999999999999999999999999999999876655444444566


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|+|||.+......+.++|+||+|++++++++|..||...........+....+.+....+....... .........
T Consensus       161 ~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  239 (283)
T cd07830         161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA-SKLGFRFPQ  239 (283)
T ss_pred             cccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh-ccccccccc
Confidence            7889999988666557889999999999999999999999888888888887777766554332111000 000011111


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ..........+..++.+.++|++||+.+|.+|||++|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            12222344444557899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-33  Score=226.72  Aligned_cols=202  Identities=26%  Similarity=0.333  Sum_probs=143.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~   77 (217)
                      +++|.+++... ..++...+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......   .....
T Consensus       243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  322 (461)
T PHA03211        243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI  322 (461)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence            46788888765 579999999999999999999999999999999999999999999999999986543221   12234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-C------ChHHHHHHHHHHhCCCCCccccccCchHH
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG-N------DHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~-~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                      .++..|++||.+.+.. ++.++|||||||++|++++|..++.. .      .....+.++++..+...............
T Consensus       323 ~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~  401 (461)
T PHA03211        323 AGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV  401 (461)
T ss_pred             CCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence            6889999999986554 78999999999999999987755432 1      12334444444433322211111111111


Q ss_pred             HHHHHh-----CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          151 KRYIRQ-----LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       151 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      ..+...     ........+... ..+++++.+||++||+.||++|||+.|+|+||||++
T Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        402 SQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            111111     111111122222 246788999999999999999999999999999985

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.7e-34  Score=227.27  Aligned_cols=172  Identities=32%  Similarity=0.567  Sum_probs=148.9

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-ccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-TEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~   81 (217)
                      |+|+.+|...+.++++.++.++.+++.||.|||+++|.|+|+||.||+++..|.+|++|||+++..+.+... ...-|+|
T Consensus        85 g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtP  164 (808)
T KOG0597|consen   85 GDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTP  164 (808)
T ss_pred             hhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcc
Confidence            599999999999999999999999999999999999999999999999999999999999999888776554 4567899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+. +++..+|+|||||++||++.|++||....-.+.+..|..   .+.                       
T Consensus       165 lYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~---d~v-----------------------  217 (808)
T KOG0597|consen  165 LYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK---DPV-----------------------  217 (808)
T ss_pred             cccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---CCC-----------------------
Confidence            99999998654 589999999999999999999999977654444444432   111                       


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                           ..+.+.+..+.+|++++|..||.+|.|-.+++.|||++..
T Consensus       218 -----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  218 -----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             -----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                 1122578999999999999999999999999999999854

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-34  Score=208.88  Aligned_cols=162  Identities=30%  Similarity=0.495  Sum_probs=136.1

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--cC--cEecCcCCCCEEEecCCCEEEecccccccCCCCCc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHS--AN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~--~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (217)
                      +|+|..+++.    ++.+++..+++++.|++.||..+|+  .+  ++||||||.||+++.+|.+||+|||+++.+.....
T Consensus       104 ~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t  183 (375)
T KOG0591|consen  104 AGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT  183 (375)
T ss_pred             ccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH
Confidence            4788888855    4779999999999999999999999  44  99999999999999999999999999988776544


Q ss_pred             -cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           74 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        74 -~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                       .....|||.|++||.+.+.+ ++.++||||+||++|||..-++||.+..-.++-.+|.+ +..+               
T Consensus       184 fA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q-gd~~---------------  246 (375)
T KOG0591|consen  184 FAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ-GDYP---------------  246 (375)
T ss_pred             HHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc-CCCC---------------
Confidence             46689999999999998776 89999999999999999999999999854444444433 2111               


Q ss_pred             HHHhCCCCCccchhhhC-CCCChhHHHHHHHhcccCCCCCCCH
Q 027927          153 YIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFDPMKRITG  194 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~t~  194 (217)
                                    .++ ..+|.++..+|.-|+.+||..||+.
T Consensus       247 --------------~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  247 --------------PLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             --------------CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence                          111 2477899999999999999999996

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-33  Score=222.98  Aligned_cols=182  Identities=23%  Similarity=0.380  Sum_probs=139.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~   80 (217)
                      |++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... .........++
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            57899999988999999999999999999999999999999999999999999999999999886432 22223345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||||+++|++++|..||......             ...  ...............   
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------------~~~--~~~~~~~~~~~i~~~---  220 (329)
T cd05618         160 PNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSS-------------DNP--DQNTEDYLFQVILEK---  220 (329)
T ss_pred             ccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCc-------------CCc--ccccHHHHHHHHhcC---
Confidence            999999998654 4788999999999999999999999532100             000  000000000000000   


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCC------HhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT------GEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t------~~~ll~~~~f~~~  206 (217)
                          ...++..++..+.++|++||+.||.+|+|      +.++++||||++.
T Consensus       221 ----~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         221 ----QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence                01123457789999999999999999998      4799999999865

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.6e-34  Score=224.78  Aligned_cols=173  Identities=24%  Similarity=0.460  Sum_probs=143.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~   80 (217)
                      |++|.+++.+...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... .........++
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            67899999999999999999999999999999999999999999999999999999999999886432 22233445688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+||++|++++|..||...+.......+...   .                       
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~---~-----------------------  212 (325)
T cd05604         160 PEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK---P-----------------------  212 (325)
T ss_pred             hhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---C-----------------------
Confidence            9999999986544 788999999999999999999999877655444333220   0                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHh----hhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE----FFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~----~ll~~~~f~~~  206 (217)
                           ....+..+..+.++|++||+.+|.+||++.    +++.||||+..
T Consensus       213 -----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         213 -----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             -----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence                 011234678899999999999999999874    89999999854

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-33  Score=221.37  Aligned_cols=172  Identities=27%  Similarity=0.463  Sum_probs=141.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|..++.. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..... ........++
T Consensus        86 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~  164 (324)
T cd05589          86 GGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGT  164 (324)
T ss_pred             CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccC
Confidence            5688877765 5799999999999999999999999999999999999999999999999998764322 2223445688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+|||||++|++++|..||.+.+.......+....                          
T Consensus       165 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--------------------------  217 (324)
T cd05589         165 PEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--------------------------  217 (324)
T ss_pred             ccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998654 47889999999999999999999998776555444333210                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                           ...+..+++.+.++|++||+.||.+||     ++.++++||||++.
T Consensus       218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence                 011234678999999999999999999     79999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-33  Score=221.51  Aligned_cols=180  Identities=24%  Similarity=0.408  Sum_probs=139.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~   80 (217)
                      |++|.+++...+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.... .........++
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            67999999988899999999999999999999999999999999999999999999999999886532 22333456788


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||||+++|++++|..||.........                 ..............  
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-----------------~~~~~~~~~~~~~~--  219 (327)
T cd05617         160 PNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-----------------NTEDYLFQVILEKP--  219 (327)
T ss_pred             cccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCccc-----------------ccHHHHHHHHHhCC--
Confidence            999999998654 4788999999999999999999999642210000                 00000000000000  


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCC------HhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT------GEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t------~~~ll~~~~f~~~  206 (217)
                           ...+..++..+.+++++||+.||.+|++      ++++++||||+..
T Consensus       220 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         220 -----IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence                 0123347788999999999999999998      5699999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-33  Score=213.11  Aligned_cols=172  Identities=23%  Similarity=0.409  Sum_probs=139.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----ccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~   77 (217)
                      |++|.+++.+...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.........    ...
T Consensus        88 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  167 (263)
T cd06625          88 GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV  167 (263)
T ss_pred             CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCC
Confidence            5789999999889999999999999999999999999999999999999999999999999988654322111    234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|+|||.+.+.. .+.++|+||+|+++|++++|+.||................                       
T Consensus       168 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------------------  223 (263)
T cd06625         168 TGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-----------------------  223 (263)
T ss_pred             CcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-----------------------
Confidence            5677899999987654 7889999999999999999999997654433322221100                       


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                            ........++..+.++|++||..+|.+|||+.++++|+||
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 ------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                  0011233577899999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-33  Score=215.71  Aligned_cols=201  Identities=40%  Similarity=0.705  Sum_probs=148.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-cccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~   79 (217)
                      +++|.+++... ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+........ .....+
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  165 (291)
T cd07844          86 DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV  165 (291)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccccccc
Confidence            56888888764 5789999999999999999999999999999999999999999999999998865432211 122345


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|+|||.+.+...++.++|+||+|+++|++++|..||.... .......+....+.+.+..+............ ...
T Consensus       166 ~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  244 (291)
T cd07844         166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY-SFP  244 (291)
T ss_pred             ccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc-ccc
Confidence            6789999988765557889999999999999999999997665 45556666666666554443322211000000 000


Q ss_pred             CCCccchhhhCCCCC--hhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVH--PLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~--~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      .............++  .++.+++.+||+.+|.+|||++++++||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            111122223333444  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.5e-33  Score=214.75  Aligned_cols=202  Identities=34%  Similarity=0.669  Sum_probs=150.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      +++|.++......++...+..++.||+.||+|||+.|++|+|++|+||+++.++.++|+|||++....... ......++
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  163 (286)
T cd07846          84 HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVAT  163 (286)
T ss_pred             ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccce
Confidence            34566666666779999999999999999999999999999999999999999999999999886544332 22234567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+....+.++|+||+|++++++++|..||...........+....+.........................
T Consensus       164 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd07846         164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK  243 (286)
T ss_pred             eeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccccccc
Confidence            88999999876555678999999999999999999999877776666666665544322211111100000000000111


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      .........+.++..+.+++++||+.+|.+|||+.++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             CcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            1122333456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1e-32  Score=214.58  Aligned_cols=204  Identities=41%  Similarity=0.744  Sum_probs=158.3

Q ss_pred             CccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccCCCCC-ccccc
Q 027927            2 DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE-FMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~~~~   77 (217)
                      +++|.+++.....  +++..+..++.||+.||++||+++++|+||+|+||+++. ++.++++|||.+....... .....
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (294)
T PLN00009         84 DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE  163 (294)
T ss_pred             cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccC
Confidence            5678888766533  578899999999999999999999999999999999985 5578999999986543321 12233


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|++||.+.+...++.++|+||+|+++|++++|..||...........+....+.+....|........  +....
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  241 (294)
T PLN00009        164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD--YKSAF  241 (294)
T ss_pred             ceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh--hhhhc
Confidence            5578899999886655578899999999999999999999998888777887777777776665543332211  12222


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ............+.+++++.+++.+||..+|++||++.++++||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            22223334444567889999999999999999999999999999999764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=230.66  Aligned_cols=165  Identities=28%  Similarity=0.488  Sum_probs=146.0

Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCccccccccccccCcccc
Q 027927           11 SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVTRWYRAPELL   89 (217)
Q Consensus        11 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~~Pe~~   89 (217)
                      +.+.+++..++.++..|+.||.|||++||+|||+|.+|||+|.+|.+||+|||+++..- ......+.+|||.|+|||++
T Consensus       461 ~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil  540 (694)
T KOG0694|consen  461 HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVL  540 (694)
T ss_pred             ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhh
Confidence            34789999999999999999999999999999999999999999999999999997644 55667889999999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhC
Q 027927           90 LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (217)
Q Consensus        90 ~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (217)
                      .+.. |+.+.|.|+|||++|+|+.|+.||.+.++.++...|+..-                               ..++
T Consensus       541 ~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~-------------------------------~~yP  588 (694)
T KOG0694|consen  541 TEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE-------------------------------VRYP  588 (694)
T ss_pred             ccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------------------CCCC
Confidence            7665 8999999999999999999999999999999988887511                               1123


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCH-----hhhccCCCCcccc
Q 027927          170 PHVHPLAIDLVDRMLTFDPMKRITG-----EFFVPYKPFQCCC  207 (217)
Q Consensus       170 ~~~~~~~~~li~~~l~~dp~~R~t~-----~~ll~~~~f~~~~  207 (217)
                      -.+|.++.++++++|..+|++|.-.     +++.+||||++..
T Consensus       589 ~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  589 RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            3578999999999999999999876     6888899999663

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7e-33  Score=219.97  Aligned_cols=203  Identities=44%  Similarity=0.823  Sum_probs=150.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccCCCCC----cccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE----FMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~----~~~~   76 (217)
                      +++|.+++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++++|||.+.......    ....
T Consensus        99 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  177 (342)
T cd07854          99 ETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE  177 (342)
T ss_pred             cccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccc
Confidence            4577777764 57999999999999999999999999999999999999975 4568999999886543211    1122


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..++..|+|||.+.+...++.++|+|||||++|++++|..||....+......+........+........ ........
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  256 (342)
T cd07854         178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN-VIPSFVRN  256 (342)
T ss_pred             ccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh-hhhhhhhh
Confidence            34577899999876555578899999999999999999999988877666655554332222211111111 11111121


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .......+.....+.++.++.++|++||+.||.+|||++++++||||+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         257 DGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             cccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            22233344455566788999999999999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.6e-33  Score=220.03  Aligned_cols=173  Identities=23%  Similarity=0.397  Sum_probs=144.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.+++.....+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...... .......++
T Consensus        85 ~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt  164 (323)
T cd05615          85 GGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGT  164 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCC
Confidence            6799999999899999999999999999999999999999999999999999999999999988653322 223345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||+||++|++++|..||.+.........+.....                         
T Consensus       165 ~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-------------------------  218 (323)
T cd05615         165 PDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-------------------------  218 (323)
T ss_pred             ccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------------
Confidence            999999988654 478899999999999999999999988766555544443100                         


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                            ..+..+++++.+++.+||+.+|.+|++     .+++++||||+..
T Consensus       219 ------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         219 ------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             ------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence                  112246788999999999999999998     4789999999964

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.8e-33  Score=216.48  Aligned_cols=177  Identities=25%  Similarity=0.402  Sum_probs=138.6

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~   76 (217)
                      |++|.+++..    +..+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus        77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            5788877743    46799999999999999999999999999999999999999999999999999866543322 233


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.+. .++.++|+||+|+++|++++|..||...............                       
T Consensus       157 ~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-----------------------  212 (280)
T cd05608         157 YAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR-----------------------  212 (280)
T ss_pred             cCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh-----------------------
Confidence            4678899999998655 4788999999999999999999999765422111111110                       


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                      ....    .......+++.+.+++.+||+.||++||     |++++++||||++.
T Consensus       213 ~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         213 ILND----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             hccc----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            0000    0012235788999999999999999999     88999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-33  Score=225.77  Aligned_cols=177  Identities=25%  Similarity=0.399  Sum_probs=138.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---------   72 (217)
                      |++|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......         
T Consensus        85 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~  164 (381)
T cd05626          85 GGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGS  164 (381)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccc
Confidence            67999999999999999999999999999999999999999999999999999999999999864321000         


Q ss_pred             ---------------------------------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc
Q 027927           73 ---------------------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN  113 (217)
Q Consensus        73 ---------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~  113 (217)
                                                             ......|++.|+|||.+.+.. ++.++|+|||||++|++++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~ellt  243 (381)
T cd05626         165 HIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLV  243 (381)
T ss_pred             cccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHHHHHHh
Confidence                                                   012346889999999986554 7889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhccc--CCCCC
Q 027927          114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF--DPMKR  191 (217)
Q Consensus       114 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--dp~~R  191 (217)
                      |..||...........+.........                           .....+++++.++|.+|+..  ++..|
T Consensus       244 G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~s~~~~dli~~ll~~~~~~~~R  296 (381)
T cd05626         244 GQPPFLAPTPTETQLKVINWENTLHI---------------------------PPQVKLSPEAVDLITKLCCSAEERLGR  296 (381)
T ss_pred             CCCCCcCCCHHHHHHHHHccccccCC---------------------------CCCCCCCHHHHHHHHHHccCcccccCC
Confidence            99999876654444333321110000                           01124679999999997654  44459


Q ss_pred             CCHhhhccCCCCccc
Q 027927          192 ITGEFFVPYKPFQCC  206 (217)
Q Consensus       192 ~t~~~ll~~~~f~~~  206 (217)
                      ++++++++||||++.
T Consensus       297 ~~~~~~l~hp~f~~~  311 (381)
T cd05626         297 NGADDIKAHPFFSEV  311 (381)
T ss_pred             CCHHHHhcCcccCCC
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-32  Score=217.02  Aligned_cols=206  Identities=48%  Similarity=0.896  Sum_probs=162.7

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      ++++|.+++++ .++++..+..++.|++.||++||+.+++|+||+|.||+++.++.++|+|||.+......  .....++
T Consensus        92 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~  168 (328)
T cd07856          92 LGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVST  168 (328)
T ss_pred             hccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--cCCCccc
Confidence            36678887765 56889999999999999999999999999999999999999999999999988654322  2234567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+...++.++|+||+|++++++++|..||...........+.+..+.+++.....................
T Consensus       169 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (328)
T cd07856         169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKR  248 (328)
T ss_pred             ccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcccc
Confidence            78999998765455788999999999999999999999988877777777777777765544333333223333333333


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                      ...+.....+.+++.+.++|++||+.+|++|||+++++.||||+..+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         249 EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             CCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence            3344455556788999999999999999999999999999999866443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=222.18  Aligned_cols=163  Identities=29%  Similarity=0.405  Sum_probs=138.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccC------CCCCccccccccccccCccc
Q 027927           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT------SENEFMTEYVVTRWYRAPEL   88 (217)
Q Consensus        15 l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~------~~~~~~~~~~~~~~~~~Pe~   88 (217)
                      +++.++++++++++.||+|||.+||+||||||.|+|++.+|.+||+|||.+...      +.........|||.|+|||.
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~  286 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL  286 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence            899999999999999999999999999999999999999999999999998755      22233455789999999998


Q ss_pred             ccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccch
Q 027927           89 LLNS---SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL  165 (217)
Q Consensus        89 ~~~~---~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (217)
                      +...   ...+.+.||||+||+||.++.|+.||.+....+.+.+|+..--..++                          
T Consensus       287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~--------------------------  340 (576)
T KOG0585|consen  287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPE--------------------------  340 (576)
T ss_pred             hcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCC--------------------------
Confidence            8762   23467899999999999999999999999888888888762111111                          


Q ss_pred             hhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          166 AQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       166 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                         .+.+..+++++|.+||..||++|+++.++..|||....
T Consensus       341 ---~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  341 ---NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ---cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence               11356889999999999999999999999999998744

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-33  Score=222.03  Aligned_cols=173  Identities=25%  Similarity=0.470  Sum_probs=143.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.+...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........++
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            578999999988999999999999999999999999999999999999999999999999999865322 2223445688


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||+||++|++++|..||........+..+...   +                       
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-----------------------  212 (325)
T cd05602         160 PEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P-----------------------  212 (325)
T ss_pred             ccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-----------------------
Confidence            999999988654 4788999999999999999999999877655544443320   0                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHh----hhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE----FFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~----~ll~~~~f~~~  206 (217)
                           ....+.+++.+.++|++||+.||.+|+++.    ++++|+||...
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         213 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             -----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence                 012235778999999999999999999987    89999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.2e-33  Score=216.52  Aligned_cols=201  Identities=36%  Similarity=0.690  Sum_probs=152.9

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-------
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-------   73 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------   73 (217)
                      +++|.+.+.. ...+++..+..++.|++.||++||++|++|+|++|+||+++.++.++|+|||.+........       
T Consensus        98 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  177 (311)
T cd07866          98 DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG  177 (311)
T ss_pred             CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCc
Confidence            4566666665 35799999999999999999999999999999999999999999999999998865432211       


Q ss_pred             -----cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCch
Q 027927           74 -----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE  148 (217)
Q Consensus        74 -----~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (217)
                           .....+++.|+|||.+.+...++.++|+||+|+++|++++|..||.+.........+....+.+.+..+......
T Consensus       178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (311)
T cd07866         178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSL  257 (311)
T ss_pred             ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhc
Confidence                 112244677999998866655788999999999999999999999988888888888887776665543321110


Q ss_pred             HHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ..... ..................++.+.++|++||+.||.+|||+.+++.||||
T Consensus       258 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         258 PGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             ccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            00000 0001111122333445667889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2e-33  Score=221.23  Aligned_cols=173  Identities=25%  Similarity=0.436  Sum_probs=141.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+.+.+...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........++
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            578999999888999999999999999999999999999999999999999999999999998864322 2223345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+|||||++|++++|..||...+.......+..   .+                       
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~-----------------------  212 (321)
T cd05603         160 PEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH---KP-----------------------  212 (321)
T ss_pred             cccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc---CC-----------------------
Confidence            8999999986544 78899999999999999999999987764444333321   00                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHh----hhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE----FFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~----~ll~~~~f~~~  206 (217)
                           ...++..+..+.++|.+||+.||.+|+++.    ++++|+||...
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence                 112234678899999999999999999764    99999999854

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-33  Score=214.26  Aligned_cols=200  Identities=34%  Similarity=0.631  Sum_probs=148.2

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccccccc
Q 027927            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVVTR   81 (217)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~   81 (217)
                      .+..+.++...+++..+..++.||+.|+++||+++++|+|++|+||+++.++.++|+|||.+.......  ......++.
T Consensus        86 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~  165 (288)
T cd07833          86 LLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR  165 (288)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCccccc
Confidence            444555566779999999999999999999999999999999999999999999999999987654433  223345678


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.....++.++|+||+|+++|++++|..||...........+....+..........................
T Consensus       166 ~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (288)
T cd07833         166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQ  245 (288)
T ss_pred             CCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCC
Confidence            89999998766457889999999999999999999998877777666666665554443222111100000000000001


Q ss_pred             ccchhhh-CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          162 RQSLAQV-FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       162 ~~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ....... ...+++++.++|++||..+|++|||++++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         246 PESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            1111222 23358999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-33  Score=215.52  Aligned_cols=178  Identities=32%  Similarity=0.522  Sum_probs=140.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccC-CCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~   80 (217)
                      +++|.+++.+++.++...+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+... ..........++
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  161 (260)
T PF00069_consen   82 GGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGT  161 (260)
T ss_dssp             TEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3489999998899999999999999999999999999999999999999999999999999998753 333344556778


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|.|||.+......+.++|+||+|++++++++|..||...........+.+.........               ..  
T Consensus       162 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~--  224 (260)
T PF00069_consen  162 PEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---------------SQ--  224 (260)
T ss_dssp             GGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------------TT--
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------------cc--
Confidence            8999999986345578999999999999999999999987643333333322111110000               00  


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                             .....+..+.++|++||+.||++|||++++++||||
T Consensus       225 -------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                   000112789999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-33  Score=214.95  Aligned_cols=177  Identities=26%  Similarity=0.384  Sum_probs=141.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.............+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  163 (285)
T cd05605          84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVG  163 (285)
T ss_pred             CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccC
Confidence            57888888654  5699999999999999999999999999999999999999999999999999876544433344567


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|++||.+.+. .++.++|+||+|+++|++++|..||.+.........+.......                      
T Consensus       164 ~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------  220 (285)
T cd05605         164 TVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----------------------  220 (285)
T ss_pred             CCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------------------
Confidence            8899999998654 47889999999999999999999998765433222222110000                      


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                           ....+..+++.+.++|.+||+.||.+||     +++++++||||...
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         221 -----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             -----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence                 0112234778899999999999999999     99999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-33  Score=226.03  Aligned_cols=176  Identities=25%  Similarity=0.410  Sum_probs=139.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC----------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----------   71 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~----------   71 (217)
                      |++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......          
T Consensus        85 gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~  164 (382)
T cd05625          85 GGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGD  164 (382)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccc
Confidence            6799999998889999999999999999999999999999999999999999999999999986422100          


Q ss_pred             --------------------------------------CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc
Q 027927           72 --------------------------------------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN  113 (217)
Q Consensus        72 --------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~  113 (217)
                                                            .......|++.|+|||.+.+.. ++.++|+||+||++|++++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~ellt  243 (382)
T cd05625         165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLV  243 (382)
T ss_pred             ccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHHHHHh
Confidence                                                  0011235788999999986554 7899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC
Q 027927          114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT  193 (217)
Q Consensus       114 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  193 (217)
                      |..||...........+.........                           .....+++++.++|.+|+ .+|.+|++
T Consensus       244 G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------p~~~~~s~~~~~li~~l~-~~p~~R~~  295 (382)
T cd05625         244 GQPPFLAQTPLETQMKVINWQTSLHI---------------------------PPQAKLSPEASDLIIKLC-RGPEDRLG  295 (382)
T ss_pred             CCCCCCCCCHHHHHHHHHccCCCcCC---------------------------CCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence            99999877654444333321100000                           011247799999999986 59999998


Q ss_pred             ---HhhhccCCCCccc
Q 027927          194 ---GEFFVPYKPFQCC  206 (217)
Q Consensus       194 ---~~~ll~~~~f~~~  206 (217)
                         ++++++||||+..
T Consensus       296 ~~~~~ei~~hp~f~~~  311 (382)
T cd05625         296 KNGADEIKAHPFFKTI  311 (382)
T ss_pred             CCCHHHHhcCCCcCCc
Confidence               9999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3e-33  Score=224.09  Aligned_cols=177  Identities=25%  Similarity=0.348  Sum_probs=141.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~   79 (217)
                      |++|.+++.+. .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++........  .....+
T Consensus       127 gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~g  205 (370)
T cd05621         127 GGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG  205 (370)
T ss_pred             CCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCC
Confidence            68999999764 689999999999999999999999999999999999999999999999999876543322  234568


Q ss_pred             cccccCcccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           80 TRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~---~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ++.|+|||.+.+.+   .++.++|+||+||++|++++|..||...+....+..+..........                
T Consensus       206 t~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p----------------  269 (370)
T cd05621         206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP----------------  269 (370)
T ss_pred             CcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC----------------
Confidence            99999999986432   36789999999999999999999998877655555544311111000                


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCC--CCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~~ll~~~~f~~~  206 (217)
                                 ....+++.+.+++.+||..++.+  |+|+.++++||||++.
T Consensus       270 -----------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         270 -----------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             -----------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence                       01136788999999999866654  8999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-33  Score=226.47  Aligned_cols=176  Identities=25%  Similarity=0.391  Sum_probs=139.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC----------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----------   71 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~----------   71 (217)
                      |++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......          
T Consensus        85 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~  164 (376)
T cd05598          85 GGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD  164 (376)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccc
Confidence            6899999999999999999999999999999999999999999999999999999999999986422100          


Q ss_pred             ----------------------------------CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 027927           72 ----------------------------------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL  117 (217)
Q Consensus        72 ----------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~p  117 (217)
                                                        .......|++.|+|||.+.+.. ++.++|+||+||++|++++|..|
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell~G~~P  243 (376)
T cd05598         165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPP  243 (376)
T ss_pred             ccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeehhhCCCC
Confidence                                              0001236788999999986554 78899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCC---CH
Q 027927          118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TG  194 (217)
Q Consensus       118 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---t~  194 (217)
                      |.+.........+........                           ......+++++.++|.+|+ .+|.+|+   |+
T Consensus       244 f~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         244 FLADTPAETQLKVINWETTLH---------------------------IPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             CCCCCHHHHHHHHhccCcccc---------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            987765444333221000000                           0011247789999999977 5999999   99


Q ss_pred             hhhccCCCCccc
Q 027927          195 EFFVPYKPFQCC  206 (217)
Q Consensus       195 ~~ll~~~~f~~~  206 (217)
                      .++++||||+..
T Consensus       296 ~ell~h~~~~~~  307 (376)
T cd05598         296 DEIKAHPFFKGI  307 (376)
T ss_pred             HHHhCCCCcCCC
Confidence            999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-32  Score=211.14  Aligned_cols=172  Identities=26%  Similarity=0.425  Sum_probs=138.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-CEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |++|.++++++..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++ .++++|||.+.......   ...++
T Consensus        93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~  169 (267)
T PHA03390         93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYDGT  169 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc---cCCCC
Confidence            679999999988999999999999999999999999999999999999999998 99999999886554332   23567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ-MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ..|+|||.+.+.. ++.++|+||+|++++++++|..||........ ...+...                       . .
T Consensus       170 ~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------~-~  224 (267)
T PHA03390        170 LDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-----------------------Q-Q  224 (267)
T ss_pred             CcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-----------------------h-c
Confidence            8899999986544 78899999999999999999999975432211 1111100                       0 0


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-HhhhccCCCCcc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-GEFFVPYKPFQC  205 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-~~~ll~~~~f~~  205 (217)
                          .........++.+.++|.+||+.+|.+|++ ++++++||||++
T Consensus       225 ----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        225 ----KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ----ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                000122357899999999999999999996 599999999985

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.2e-33  Score=211.70  Aligned_cols=176  Identities=28%  Similarity=0.474  Sum_probs=143.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.+...++...+..++.||+.||++||+++++|+||+|+||+++.++.++|+|||.+.............++.
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          77 GGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCc
Confidence            67999999998889999999999999999999999999999999999999999999999999987665543333446778


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND--HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      .|++||.+.... ++.++|+|++|+++|++++|..||....  .......+.....                        
T Consensus       157 ~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------  211 (262)
T cd05572         157 EYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG------------------------  211 (262)
T ss_pred             CccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC------------------------
Confidence            899999876544 7889999999999999999999997655  2222222211000                        


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCcccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCCC  207 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~~  207 (217)
                           ....+...++++.++|.+||+.+|.+|||     +.|+++||||++..
T Consensus       212 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         212 -----KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             -----CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence                 00112234688999999999999999999     99999999999653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8e-33  Score=218.87  Aligned_cols=202  Identities=22%  Similarity=0.382  Sum_probs=142.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |++|.+++++.+.+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...... ......++
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~  165 (333)
T cd06650          87 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGT  165 (333)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCC
Confidence            679999999988999999999999999999999975 7999999999999999999999999988654322 22334678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH-HhCCCCCccccccCch-----------
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIE-LLGTPTDADLGFVRNE-----------  148 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----------  148 (217)
                      ..|+|||.+.+. .++.++|+||+||++|++++|..||...........+.. ..+.+...........           
T Consensus       166 ~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (333)
T cd06650         166 RSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPD  244 (333)
T ss_pred             ccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhccc
Confidence            899999988654 478899999999999999999999976554322211110 0111111000000000           


Q ss_pred             -----HHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          149 -----DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       149 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                           ...+..............  ...++.++.+||.+||+.||++|||+++++.|+||+..+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         245 SRPPMAIFELLDYIVNEPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             ccccccHHHHHHHHhcCCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                 000000000000000000  113568899999999999999999999999999999664

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.1e-33  Score=214.12  Aligned_cols=177  Identities=25%  Similarity=0.380  Sum_probs=141.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++..++.+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++++|||.+....... .....++.
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  159 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence            67899999998999999999999999999999999999999999999999999999999999886543322 22346788


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV--HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      .|+|||.+.....++.++|+||+|++++++++|..||......  ........                       .   
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----------------------~---  213 (279)
T cd05633         160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----------------------T---  213 (279)
T ss_pred             CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-----------------------c---
Confidence            9999998864444788999999999999999999999754321  11110000                       0   


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccccCc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~~~~  209 (217)
                          .....+..+++++.++|++||+.||++|+     |+.++++||||++....
T Consensus       214 ----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         214 ----VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             ----CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence                00112335778999999999999999999     69999999999976433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=224.88  Aligned_cols=176  Identities=26%  Similarity=0.416  Sum_probs=139.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---------   72 (217)
                      |++|.+++.+.+.+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......         
T Consensus        85 gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  164 (377)
T cd05629          85 GGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL  164 (377)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccc
Confidence            68999999999999999999999999999999999999999999999999999999999999885321100         


Q ss_pred             ---------------------------------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc
Q 027927           73 ---------------------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN  113 (217)
Q Consensus        73 ---------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~  113 (217)
                                                             ......|++.|+|||.+.+. .++.++|+||+||++|++++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt  243 (377)
T cd05629         165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMFECLI  243 (377)
T ss_pred             cccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchhhhhhhc
Confidence                                                   00123578899999998654 47899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCC--
Q 027927          114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR--  191 (217)
Q Consensus       114 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R--  191 (217)
                      |..||........+..+........                     .+      ....+++++.++|++||. +|.+|  
T Consensus       244 G~~Pf~~~~~~~~~~~i~~~~~~~~---------------------~p------~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         244 GWPPFCSENSHETYRKIINWRETLY---------------------FP------DDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             CCCCCCCCCHHHHHHHHHccCCccC---------------------CC------CCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            9999987766555544432100000                     00      011367899999999998 66665  


Q ss_pred             -CCHhhhccCCCCccc
Q 027927          192 -ITGEFFVPYKPFQCC  206 (217)
Q Consensus       192 -~t~~~ll~~~~f~~~  206 (217)
                       +|++++++||||+..
T Consensus       296 r~~~~~~l~hp~~~~~  311 (377)
T cd05629         296 RGGAHEIKSHPFFRGV  311 (377)
T ss_pred             CCCHHHHhcCCCcCCC
Confidence             699999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.9e-33  Score=215.63  Aligned_cols=177  Identities=25%  Similarity=0.403  Sum_probs=140.1

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |++|.+++...  ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g  163 (285)
T cd05630          84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG  163 (285)
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCC
Confidence            67899888654  4699999999999999999999999999999999999999999999999998866544433344567


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|+|||.+.+.. ++.++|+||+|+++|++++|..||..............                    ...... 
T Consensus       164 ~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~--------------------~~~~~~-  221 (285)
T cd05630         164 TVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER--------------------LVKEVQ-  221 (285)
T ss_pred             CccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh--------------------hhhhhh-
Confidence            88999999986544 78899999999999999999999976432111111110                    000000 


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                            ......+++++.+++++||+.||.+|||     ++|+++||||+..
T Consensus       222 ------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         222 ------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             ------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence                  0122356788999999999999999999     8999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.2e-33  Score=229.03  Aligned_cols=174  Identities=25%  Similarity=0.433  Sum_probs=142.2

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---Ccc
Q 027927            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFM   74 (217)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~   74 (217)
                      +++|.++++..    ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++......   ...
T Consensus       123 ~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~  202 (496)
T PTZ00283        123 AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG  202 (496)
T ss_pred             CCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeecccccccccc
Confidence            57899888653    57999999999999999999999999999999999999999999999999998654322   223


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+++.|+|||.+.+. .++.++|+||||+++|++++|..||........+..+....                    
T Consensus       203 ~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~--------------------  261 (496)
T PTZ00283        203 RTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR--------------------  261 (496)
T ss_pred             ccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--------------------
Confidence            345688999999998654 47899999999999999999999998765444333322100                    


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                ....++.+++++.+++.+||+.||.+|||+.++++|||++..
T Consensus       262 ----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        262 ----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                      011234577999999999999999999999999999998753

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.4e-32  Score=207.59  Aligned_cols=171  Identities=26%  Similarity=0.442  Sum_probs=138.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      +++|.++++..  .++++..+..++.+++.|+++||++|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        84 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  163 (257)
T cd08223          84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI  163 (257)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcccccc
Confidence            57899999773  569999999999999999999999999999999999999999999999999886554322 223345


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+. .++.++|+||+|++++++++|..||...+.......+...  ..                     
T Consensus       164 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~--~~---------------------  219 (257)
T cd08223         164 GTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KL---------------------  219 (257)
T ss_pred             CCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CC---------------------
Confidence            67889999988654 4788999999999999999999999766543333322210  00                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                             ......+++++.+++.+||+.+|.+|||+.++++||||
T Consensus       220 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 -------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                   01123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-33  Score=224.23  Aligned_cols=176  Identities=30%  Similarity=0.436  Sum_probs=140.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---------   72 (217)
                      |++|.+++.+++.+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~  164 (360)
T cd05627          85 GGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT  164 (360)
T ss_pred             CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccc
Confidence            67999999999999999999999999999999999999999999999999999999999999876432110         


Q ss_pred             ---------------------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 027927           73 ---------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH  125 (217)
Q Consensus        73 ---------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~  125 (217)
                                                 ......|++.|+|||++.+.. ++.++|+|||||++|++++|..||.......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~  243 (360)
T cd05627         165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQE  243 (360)
T ss_pred             cCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCCCCHHH
Confidence                                       011346788999999986554 7889999999999999999999998776555


Q ss_pred             HHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCC---CHhhhccCCC
Q 027927          126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TGEFFVPYKP  202 (217)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---t~~~ll~~~~  202 (217)
                      ....+.......                     ..+      ....+++++.++|.+|+. ||.+|+   +++++++|||
T Consensus       244 ~~~~i~~~~~~~---------------------~~p------~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         244 TYRKVMNWKETL---------------------VFP------PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             HHHHHHcCCCce---------------------ecC------CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence            444443210000                     000      011367899999999874 999998   4799999999


Q ss_pred             Cccc
Q 027927          203 FQCC  206 (217)
Q Consensus       203 f~~~  206 (217)
                      |++.
T Consensus       296 f~~~  299 (360)
T cd05627         296 FEGV  299 (360)
T ss_pred             CCCC
Confidence            9864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-32  Score=211.93  Aligned_cols=178  Identities=22%  Similarity=0.332  Sum_probs=138.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |++|.+++...  ..++...+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence            67888888654  4589999999999999999999999999999999999999999999999999876655444444567


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|+|||.+.+.. ++.++|+||+||++|++++|..||...........+...                   ....   
T Consensus       157 ~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~---  213 (277)
T cd05607         157 TNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR-------------------TLED---  213 (277)
T ss_pred             CCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH-------------------hhcc---
Confidence            88999999986655 889999999999999999999999654321111111000                   0000   


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCH----hhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG----EFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~~ll~~~~f~~~  206 (217)
                          ........+++++.++|++||+.||.+||++    ++++.|+||+..
T Consensus       214 ----~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         214 ----EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             ----ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence                0000112477899999999999999999999    667899999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-33  Score=223.20  Aligned_cols=167  Identities=28%  Similarity=0.445  Sum_probs=136.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE-ecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-NANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |+.+.+.+...+... ..+..|+.+|+.|+.|||++|++|||+||+|||+ +..+.++|+|||.+......  +.+.+-+
T Consensus       400 g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t  476 (612)
T KOG0603|consen  400 GGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALT  476 (612)
T ss_pred             ccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchh
Confidence            456777777766665 8888899999999999999999999999999999 58899999999998665544  4455678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|.|||++... .++.++|+||||++||+|++|+.||......   ..+....+.+..                     
T Consensus       477 ~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~---------------------  531 (612)
T KOG0603|consen  477 LQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF---------------------  531 (612)
T ss_pred             hcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc---------------------
Confidence            889999999744 4899999999999999999999999776543   111111111111                     


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                              ...+|..+++||++||++||.+|+++.++..||||-
T Consensus       532 --------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  532 --------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             --------ccccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence                    135889999999999999999999999999999993

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=215.54  Aligned_cols=202  Identities=39%  Similarity=0.674  Sum_probs=145.3

Q ss_pred             CccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec----CCCEEEecccccccCCCCC
Q 027927            2 DTDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA----NCDLKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~----~~~~~l~d~~~~~~~~~~~   72 (217)
                      +++|.+++...     ..+++..+..++.||+.||+|||+.+++|+||+|+||+++.    ++.++++|||.+.......
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~  166 (316)
T cd07842          87 EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL  166 (316)
T ss_pred             CcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCc
Confidence            45677766542     36899999999999999999999999999999999999999    8999999999887543322


Q ss_pred             c----cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---------HHHHHHHHHhCCCCC
Q 027927           73 F----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV---------HQMRLLIELLGTPTD  139 (217)
Q Consensus        73 ~----~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~---------~~~~~~~~~~~~~~~  139 (217)
                      .    .....++..|+|||.+.+...++.++|+||||++++++++|..||.+....         ..+..+++.++.+..
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  246 (316)
T cd07842         167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTE  246 (316)
T ss_pred             ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCch
Confidence            1    223455778999998876666788999999999999999999999765432         344555555555544


Q ss_pred             ccccccCchHHHHH-HHhCC--CCCccch---hhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          140 ADLGFVRNEDAKRY-IRQLP--QHPRQSL---AQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       140 ~~~~~~~~~~~~~~-~~~~~--~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                      ..+........... .....  ..+....   .......+..+.+++.+||+.||++|||+.++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            33321111111000 00000  0110111   11112577889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.2e-32  Score=211.84  Aligned_cols=201  Identities=41%  Similarity=0.649  Sum_probs=152.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      +++|.+++.+. ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+........  .....
T Consensus        99 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  178 (302)
T cd07864          99 DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV  178 (302)
T ss_pred             CccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccce
Confidence            45677777764 5799999999999999999999999999999999999999999999999998865543321  12224


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      .+..|++||.+.+....+.++|+||+|++++++++|..||...........+.+..+.+.+..+............+...
T Consensus       179 ~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (302)
T cd07864         179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKK  258 (302)
T ss_pred             eccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccccccccc
Confidence            46679999988655556889999999999999999999999888877787887777766554443222111100000000


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                       .........+..+++.+.+++.+||+.+|.+|||+++++.||||
T Consensus       259 -~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         259 -QYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             -ccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence             01112223344578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-32  Score=209.46  Aligned_cols=171  Identities=25%  Similarity=0.504  Sum_probs=138.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-------cc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-------FM   74 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-------~~   74 (217)
                      +++|.+++...+.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......       ..
T Consensus        90 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (267)
T cd06628          90 GGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR  169 (267)
T ss_pred             CCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccc
Confidence            56899999998999999999999999999999999999999999999999999999999999886554211       11


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....++..|++||.+.+.. ++.++|+||+|+++|++++|..||...........+...   .                 
T Consensus       170 ~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~-----------------  228 (267)
T cd06628         170 PSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN---A-----------------  228 (267)
T ss_pred             cccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---C-----------------
Confidence            1234677899999886544 678999999999999999999999876543332222110   0                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                                .......++..+.++|++||+.||.+||++.++++||||
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 ----------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ----------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                      011223467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-32  Score=220.29  Aligned_cols=177  Identities=25%  Similarity=0.322  Sum_probs=140.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~   79 (217)
                      |++|.+++++. .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......  ......+
T Consensus       127 gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~g  205 (371)
T cd05622         127 GGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG  205 (371)
T ss_pred             CCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCccc
Confidence            67899998764 58999999999999999999999999999999999999999999999999987654332  2234568


Q ss_pred             cccccCcccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           80 TRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~---~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ++.|+|||.+.+..   .++.++|+|||||++|++++|..||...+....+..+.........                 
T Consensus       206 t~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----------------  268 (371)
T cd05622         206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF-----------------  268 (371)
T ss_pred             CccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC-----------------
Confidence            99999999986432   3678999999999999999999999887765555444431111000                 


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCC--CCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~~ll~~~~f~~~  206 (217)
                                .....++..+.++|.+||..++.+  |++++++++|+||++.
T Consensus       269 ----------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         269 ----------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             ----------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence                      011247899999999999844443  7899999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-32  Score=226.04  Aligned_cols=173  Identities=26%  Similarity=0.412  Sum_probs=141.4

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---cc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FM   74 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~   74 (217)
                      |++|.+++..    ..++++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++.......   ..
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~  228 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA  228 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccc
Confidence            6788887754    4579999999999999999999999999999999999999999999999999987654332   12


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....|++.|+|||.+.+. .++.++|+|||||++|++++|..||........+..+...  ..                 
T Consensus       229 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~--~~-----------------  288 (478)
T PTZ00267        229 SSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG--KY-----------------  288 (478)
T ss_pred             cccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-----------------
Confidence            345688999999988654 4789999999999999999999999876655444433321  00                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                                 ...+..+++++.++|.+||..||++|||+++++.|+|++.
T Consensus       289 -----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        289 -----------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             -----------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence                       0012246788999999999999999999999999999874

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-32  Score=200.96  Aligned_cols=168  Identities=25%  Similarity=0.367  Sum_probs=142.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCccccc
Q 027927           12 NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLL   90 (217)
Q Consensus        12 ~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~   90 (217)
                      .+++|+..+-++...++.||.||.+ ++++|||+||+|||+|..|.+||||||.+.++..+.......|.+.|++||.+-
T Consensus       185 k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERid  264 (391)
T KOG0983|consen  185 KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERID  264 (391)
T ss_pred             cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccC
Confidence            4689999999999999999999995 689999999999999999999999999999988888888889999999999984


Q ss_pred             C--CCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhh
Q 027927           91 N--SSDYTAAIDVWSVGCIFMELMNRRPLFPGN-DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ  167 (217)
Q Consensus        91 ~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (217)
                      .  .+.+...+|+||||+.++++.+|+.||.+. .+.+.+.++...  .|+.                         +..
T Consensus       265 p~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~-------------------------L~~  317 (391)
T KOG0983|consen  265 PPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL-------------------------LPG  317 (391)
T ss_pred             CCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC-------------------------CCc
Confidence            2  234678999999999999999999999875 456666555541  1110                         000


Q ss_pred             hCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          168 VFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       168 ~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                       -..+|++|.+|+..||..|+.+||.-.++|+|||+...+
T Consensus       318 -~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  318 -HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             -ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence             113889999999999999999999999999999998543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-33  Score=217.70  Aligned_cols=176  Identities=27%  Similarity=0.496  Sum_probs=160.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |||+|..++++.+++....++.++..+++|++|||++||++||+||+|++++.+|-+||.|||++++.+.+....+.+||
T Consensus       503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGT  582 (732)
T KOG0614|consen  503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGT  582 (732)
T ss_pred             cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCC
Confidence            79999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|.|||++.+.+ -..++|.||||+++||+++|.+||.+.+++..+..|.+-...                        
T Consensus       583 pEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~------------------------  637 (732)
T KOG0614|consen  583 PEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK------------------------  637 (732)
T ss_pred             cccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh------------------------
Confidence            9999999998776 678999999999999999999999999999999988762211                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                           -.++..++....++|+++...+|.+|.-     +.++-.|.||.+.
T Consensus       638 -----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  638 -----IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             -----hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence                 1223346788999999999999999987     8899999999954

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.2e-32  Score=208.08  Aligned_cols=173  Identities=27%  Similarity=0.420  Sum_probs=139.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-------Ccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-------EFM   74 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-------~~~   74 (217)
                      |++|.+++.++.++++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+......       ...
T Consensus        86 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  165 (265)
T cd06631          86 GGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML  165 (265)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccc
Confidence            5799999998889999999999999999999999999999999999999999999999999988654221       112


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....++..|++||.+.+.. .+.++|+||+|++++++++|..||...+.......+....+.                  
T Consensus       166 ~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  226 (265)
T cd06631         166 KSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL------------------  226 (265)
T ss_pred             cccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC------------------
Confidence            2345678899999886544 688999999999999999999999765533322222111000                  


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                                .......++.++.++|++||..+|.+|||+.++++||||
T Consensus       227 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ----------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                      111223577889999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4e-32  Score=208.91  Aligned_cols=173  Identities=24%  Similarity=0.397  Sum_probs=135.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~   78 (217)
                      +++|.+++...  ..+++..+..++.|++.|++|||+++++|+|++|+||+++.++.++|+|||++...... .......
T Consensus        93 ~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  172 (272)
T cd06637          93 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI  172 (272)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCccc
Confidence            46899998874  46899999999999999999999999999999999999999999999999998654332 2223456


Q ss_pred             ccccccCcccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           79 VTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~----~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ++..|+|||.+.+.    ..++.++|+||+||++|++++|..||..............   ..                 
T Consensus       173 g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~-----------------  232 (272)
T cd06637         173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP-----------------  232 (272)
T ss_pred             ccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CC-----------------
Confidence            78889999988532    2367799999999999999999999965543222211110   00                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                             .  .......++..+.+++.+||+.+|.+|||+++++.||||
T Consensus       233 -------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 -------A--PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -------C--CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                   0  001112466889999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-32  Score=217.04  Aligned_cols=179  Identities=22%  Similarity=0.366  Sum_probs=142.1

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      |++|.+++++ ...+++..++.++.||+.||++||++|++||||||+||+++.++.++|+|||.+........  .....
T Consensus        85 ~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~  164 (332)
T cd05623          85 GGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV  164 (332)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccc
Confidence            6899999987 47899999999999999999999999999999999999999999999999998865433222  22346


Q ss_pred             ccccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           79 VTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        79 ~~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      +++.|+|||.+..    ...++.++|+||+||++|++++|..||...+....+..+......                  
T Consensus       165 gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------------  226 (332)
T cd05623         165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER------------------  226 (332)
T ss_pred             cCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc------------------
Confidence            8899999998852    334678999999999999999999999877665555544321000                  


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCC--CCCHhhhccCCCCccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITGEFFVPYKPFQCC  206 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~~ll~~~~f~~~  206 (217)
                              .........+++++.+++++||..++.+  |++++++++||||.+.
T Consensus       227 --------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         227 --------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             --------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence                    0011122357899999999999776554  7899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.5e-32  Score=210.14  Aligned_cols=180  Identities=24%  Similarity=0.357  Sum_probs=142.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.+++.+++..++.++.|++.|++|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence            68899999988899999999999999999999999999999999999999999999999999886543322 23346788


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|++||.+.+...++.++|+||+|+++|++++|..||.................                          
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------  213 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------------------------  213 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--------------------------
Confidence            999999986554578899999999999999999999976532111000000000                          


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccccCce
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCCCGCI  210 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~~~~~  210 (217)
                        .....+..+++++.+++++||..+|.+|+     ++.++++||||+......
T Consensus       214 --~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         214 --MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             --cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence              00112234678999999999999999999     999999999999765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-33  Score=218.11  Aligned_cols=172  Identities=27%  Similarity=0.468  Sum_probs=155.2

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      ||+|.+.|..++  -++++.+..|+.|++.|+.|||+++|.|||||+.||+++.++.++|+|||+++...... ...+..
T Consensus        88 Gg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvv  167 (426)
T KOG0589|consen   88 GGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVV  167 (426)
T ss_pred             CCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheec
Confidence            789999997764  68999999999999999999999999999999999999999999999999999888776 778899


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      |++.|++||.+.+.+ ++.++|||||||++|++.+-+++|...+-.....++......|.+.                  
T Consensus       168 GTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~------------------  228 (426)
T KOG0589|consen  168 GTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS------------------  228 (426)
T ss_pred             CCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc------------------
Confidence            999999999886554 8999999999999999999999999998888888887755444333                  


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                                  .++.++..+|+.||..+|..||++.++|.+|...
T Consensus       229 ------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  229 ------------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             ------------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence                        4679999999999999999999999999998776

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.2e-32  Score=209.90  Aligned_cols=177  Identities=28%  Similarity=0.394  Sum_probs=141.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g  163 (285)
T cd05632          84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVG  163 (285)
T ss_pred             CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCC
Confidence            46788887653  4699999999999999999999999999999999999999999999999998865544333344577


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|+|||.+.+. .++.++|+||+|+++|++++|..||...........+........                     
T Consensus       164 ~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------------------  221 (285)
T cd05632         164 TVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------------------  221 (285)
T ss_pred             CcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------------------
Confidence            8999999998654 478899999999999999999999987654333332222111100                     


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                            ......+++.+.+++.+||+.||.+|||     ++++++|+||++.
T Consensus       222 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         222 ------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             ------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence                  0122346788999999999999999999     8899999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.9e-32  Score=207.90  Aligned_cols=178  Identities=21%  Similarity=0.340  Sum_probs=139.5

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++.+ ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++....... ......+
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  165 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG  165 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccc
Confidence            4678777765 4679999999999999999999999999999999999999999999999999886543321 2233457


Q ss_pred             cccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        80 ~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      +..|+|||.+..    ...++.++|+||+||++|++++|..||...........+....  ..                 
T Consensus       166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~-----------------  226 (282)
T cd06643         166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP-----------------  226 (282)
T ss_pred             cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC--CC-----------------
Confidence            788999998742    2335678999999999999999999997765444433332210  00                 


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                               .......++.++.++|++||+.+|.+|||+.++++||||+...
T Consensus       227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         227 ---------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             ---------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence                     0011224668899999999999999999999999999999654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-32  Score=207.44  Aligned_cols=175  Identities=29%  Similarity=0.474  Sum_probs=141.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++...+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.....   .....++.
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~  157 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP  157 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence            678999999888999999999999999999999999999999999999999999999999998765433   22335677


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|++||.+.+.. ++.++|+||+|+++|++++|..||...........+.......                        
T Consensus       158 ~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------  212 (260)
T cd05611         158 DYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW------------------------  212 (260)
T ss_pred             CccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC------------------------
Confidence            899999986654 7889999999999999999999998766544443332210000                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCH---hhhccCCCCcccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG---EFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~---~~ll~~~~f~~~~  207 (217)
                         .......+++.+.++|++||+.+|.+|||+   +|++.||||++..
T Consensus       213 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         213 ---PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             ---CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence               001122467899999999999999999955   7999999998653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.8e-32  Score=214.52  Aligned_cols=203  Identities=21%  Similarity=0.262  Sum_probs=138.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-------
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-------   72 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-------   72 (217)
                      +++|.+++..+  ..+++..++.++.|++.||+|||+++++|+||||+||+++.++.++++||+.........       
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  162 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH  162 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccc
Confidence            47899999764  569999999999999999999999999999999999999999999999997643321111       


Q ss_pred             -ccccccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCc-cccccCchH
Q 027927           73 -FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA-DLGFVRNED  149 (217)
Q Consensus        73 -~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  149 (217)
                       ......++..|+|||.+.+. ..++.++|+||+||+++++++|..||..............  +..+.. .........
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  240 (327)
T cd08227         163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchhhhh
Confidence             11123445679999998653 3478899999999999999999999976554333222211  111000 000000000


Q ss_pred             HH-------------HHHH---hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          150 AK-------------RYIR---QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       150 ~~-------------~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ..             ....   ................+++.+.+++++||+.||++|||++++++||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence            00             0000   000000001111223467899999999999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-32  Score=208.73  Aligned_cols=174  Identities=25%  Similarity=0.414  Sum_probs=140.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      +++|.+++..+ ++++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++++|||.+...... .......++
T Consensus        83 ~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  161 (274)
T cd06609          83 GGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGT  161 (274)
T ss_pred             CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCC
Confidence            56899999875 8999999999999999999999999999999999999999999999999998766543 222344567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+.. ++.++|+||+|+++|++++|..||...........+.... .                        
T Consensus       162 ~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~------------------------  215 (274)
T cd06609         162 PFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-P------------------------  215 (274)
T ss_pred             ccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-C------------------------
Confidence            7899999986655 8899999999999999999999997655333222221100 0                        


Q ss_pred             CccchhhhCCC-CChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                           ...... +++++.+++.+||..+|.+|||++++++||||++..
T Consensus       216 -----~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         216 -----PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             -----CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                 001112 678899999999999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-32  Score=214.44  Aligned_cols=179  Identities=22%  Similarity=0.362  Sum_probs=140.6

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--cccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~   78 (217)
                      |++|.+++.+ ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.........  ....
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  164 (331)
T cd05597          85 GGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV  164 (331)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccccee
Confidence            6899999977 467999999999999999999999999999999999999999999999999998655433221  2245


Q ss_pred             ccccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           79 VTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        79 ~~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      +++.|+|||.+..    ...++.++|+||+||++|++++|..||........+..+.......                 
T Consensus       165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------  227 (331)
T cd05597         165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF-----------------  227 (331)
T ss_pred             ccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc-----------------
Confidence            7899999999863    2346778999999999999999999998766555544443211000                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCC--CCCHhhhccCCCCccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITGEFFVPYKPFQCC  206 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~~ll~~~~f~~~  206 (217)
                               ........+++++.++|++||..++++  |++++++++||||...
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         228 ---------QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             ---------cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence                     011112247789999999999765554  8899999999999854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.1e-32  Score=208.80  Aligned_cols=177  Identities=25%  Similarity=0.450  Sum_probs=141.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      |++|.+++.. .+++...+..++.|++.|+++||++|++||||+|+||+++.++.++|+|||.+....... ......++
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  178 (285)
T cd06648         100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT  178 (285)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCC
Confidence            6789999988 679999999999999999999999999999999999999999999999999875443321 12234577


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+.. ++.++|+||+|++++++++|..||...+.......+... ..+                       
T Consensus       179 ~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~-----------------------  233 (285)
T cd06648         179 PYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPP-----------------------  233 (285)
T ss_pred             ccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCC-----------------------
Confidence            8899999886544 788999999999999999999999766544333332211 000                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                          .......++..+.+++++||+.+|++|||+.++++||||++...
T Consensus       234 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         234 ----KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             ----CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                00011236688999999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.7e-32  Score=208.04  Aligned_cols=172  Identities=23%  Similarity=0.439  Sum_probs=135.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC----Cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----EFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~----~~~~~~   77 (217)
                      +++|.+++.+...++...+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++......    ......
T Consensus        90 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (266)
T cd06651          90 GGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV  169 (266)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccC
Confidence            5689999999888999999999999999999999999999999999999999999999999988654321    111223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|+|||.+.+. .++.++|+||+|+++|++++|..||...........+..   ....                  
T Consensus       170 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~------------------  227 (266)
T cd06651         170 TGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN------------------  227 (266)
T ss_pred             CccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC------------------
Confidence            467789999988654 478899999999999999999999976543333222211   0000                  


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                              ......+++.+.+++ +|+..+|++|||++++++||||+
T Consensus       228 --------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         228 --------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             --------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                    111223567888898 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.9e-32  Score=205.21  Aligned_cols=173  Identities=27%  Similarity=0.479  Sum_probs=141.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.+...+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.............++.
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  165 (258)
T cd06632          86 GGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSP  165 (258)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCc
Confidence            56899999998889999999999999999999999999999999999999999999999999887654443334456778


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|++||.+.....++.++|+||+|+++|++++|..||...........+...                            
T Consensus       166 ~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------------------------  217 (258)
T cd06632         166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS----------------------------  217 (258)
T ss_pred             ceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc----------------------------
Confidence            8999998854434788999999999999999999999765432222221110                            


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                       ......+..+++.+.+++++||+.+|.+|||+++++.|||+
T Consensus       218 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         218 -KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence             00112233567899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.8e-32  Score=208.94  Aligned_cols=177  Identities=28%  Similarity=0.452  Sum_probs=138.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++... ..+++..+..++.|++.|+++||+ .|++|+||+|+||+++.++.++|+|||.+......... ...+
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~  161 (265)
T cd06605          83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVG  161 (265)
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cccC
Confidence            47899999887 889999999999999999999999 99999999999999999999999999987654332221 2566


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH--VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +..|++||.+.+. .++.++|+||+|++++++++|..||.....  ......+.....                      
T Consensus       162 ~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------  218 (265)
T cd06605         162 TSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN----------------------  218 (265)
T ss_pred             ChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc----------------------
Confidence            7889999988655 478999999999999999999999965421  111111111000                      


Q ss_pred             CCCCccchhhhCCC-CChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          158 PQHPRQSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       158 ~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                        ....   ..... +++++.++|.+||..+|.+|||+.+++.||||++.+
T Consensus       219 --~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         219 --EPPP---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             --CCCC---CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence              0000   01111 678899999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-31  Score=210.38  Aligned_cols=201  Identities=23%  Similarity=0.360  Sum_probs=142.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |++|.+++++.+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||.+...... ......++
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~  161 (308)
T cd06615          83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGT  161 (308)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCCCC
Confidence            57999999998999999999999999999999997 58999999999999999999999999987544322 22344677


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccc-------ccc--CchHHH
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADL-------GFV--RNEDAK  151 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~--~~~~~~  151 (217)
                      ..|++||.+.+. .++.++|+||+|++++++++|..||...+.......+............       ...  ......
T Consensus       162 ~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (308)
T cd06615         162 RSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF  240 (308)
T ss_pred             cCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHH
Confidence            889999987544 3788999999999999999999999765533322211111000000000       000  000000


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      +............  .....+++++.+++.+||..+|++|||+.++++||||.++
T Consensus       241 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         241 ELLDYIVNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             HHHHHHhcCCCcc--CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            1111111110000  0111367889999999999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.8e-32  Score=222.77  Aligned_cols=202  Identities=24%  Similarity=0.320  Sum_probs=139.9

Q ss_pred             CccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--c
Q 027927            2 DTDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--M   74 (217)
Q Consensus         2 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~   74 (217)
                      +++|.+++...     .......+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........  .
T Consensus       246 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  325 (501)
T PHA03210        246 DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD  325 (501)
T ss_pred             ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCccccccc
Confidence            45677776543     2344677889999999999999999999999999999999999999999999876543322  2


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCC--ChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGN--DHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~p-f~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                      ....++..|+|||.+.+.. ++.++|||||||++|++++|..+ +...  .....+..+....+........  ......
T Consensus       326 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~  402 (501)
T PHA03210        326 YGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD--PPCKLF  402 (501)
T ss_pred             ccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCC--cHHHHH
Confidence            2356889999999986654 78999999999999999998754 4322  3344444444443322221110  011111


Q ss_pred             HHHHhCC-CCCccchhhh--CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          152 RYIRQLP-QHPRQSLAQV--FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       152 ~~~~~~~-~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .++.... ..........  ...++.++.++|.+||++||++|||+.|+|+||||.+.
T Consensus       403 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        403 DYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            2221111 0000111111  12366889999999999999999999999999999854

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.2e-32  Score=209.80  Aligned_cols=176  Identities=25%  Similarity=0.448  Sum_probs=139.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      |++|.+++.. +.+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus       103 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  181 (292)
T cd06658         103 GGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGT  181 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecC
Confidence            5678888755 568999999999999999999999999999999999999999999999999886543222 12334567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|+|||.+.+. .++.++|+||+|++++++++|..||...+.......+.......                       
T Consensus       182 ~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------  237 (292)
T cd06658         182 PYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-----------------------  237 (292)
T ss_pred             ccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-----------------------
Confidence            889999988544 47889999999999999999999998766544333222110000                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                           ......++..+.+++.+||..||++|||++++++||||+...
T Consensus       238 -----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         238 -----VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             -----cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence                 001123568899999999999999999999999999999553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.2e-32  Score=209.53  Aligned_cols=172  Identities=28%  Similarity=0.483  Sum_probs=143.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.....+++..+..++.||+.||++||+.|++|+||+|.||+++.++.++|+|||++......  .....+++
T Consensus        85 ~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~  162 (290)
T cd05580          85 GGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTP  162 (290)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCc
Confidence            6899999999999999999999999999999999999999999999999999999999999998765544  33446788


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|++||.+.+. ..+.++|+||||+++|++++|..||...........+..  +.                         
T Consensus       163 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~-------------------------  214 (290)
T cd05580         163 EYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GK-------------------------  214 (290)
T ss_pred             cccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CC-------------------------
Confidence            89999988654 478899999999999999999999977664333333221  00                         


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCcccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~~  207 (217)
                          ...+..+++.+.++|++||..||.+|+     +++++++||||+...
T Consensus       215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence                011234578899999999999999999     999999999998654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-31  Score=204.30  Aligned_cols=171  Identities=28%  Similarity=0.435  Sum_probs=139.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~   78 (217)
                      |++|.++++..  ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  162 (256)
T cd08529          83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV  162 (256)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccc
Confidence            67999999875  6799999999999999999999999999999999999999999999999998876544322 23345


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+.. ++.++|+||||++++++++|..||...........+....                        
T Consensus       163 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------  217 (256)
T cd08529         163 GTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV------------------------  217 (256)
T ss_pred             cCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence            678899999886544 7889999999999999999999998766444333332200                        


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                            .......+++++.+++++||+.+|++||++.++++|||+
T Consensus       218 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 ------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                  001111466889999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-31  Score=207.15  Aligned_cols=200  Identities=38%  Similarity=0.651  Sum_probs=143.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++..+ ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  165 (291)
T cd07870          86 HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV  165 (291)
T ss_pred             cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccc
Confidence            46777776553 568899999999999999999999999999999999999999999999999886533221 1223345


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++.|+|||.+.+...++.++|+||+|++++++++|..||..... ...+..+....+.+.+..+.......  .+.....
T Consensus       166 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  243 (291)
T cd07870         166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP--NYKPEWF  243 (291)
T ss_pred             cccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc--cccchhc
Confidence            78899999886555567899999999999999999999976543 34444454545544443322111100  0000000


Q ss_pred             -CCCccchhhhCC--CCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 -QHPRQSLAQVFP--HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 -~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                       ............  ..++.+.+++.+||..||++|||+++++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             001111112221  135789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.8e-32  Score=205.39  Aligned_cols=173  Identities=27%  Similarity=0.461  Sum_probs=137.0

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++.. ...+++..+..++.|++.|+.+||+.+++|+||+|.||+++.++.++|+|||.+....... ......+
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  161 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIG  161 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccC
Confidence            5689999976 4678999999999999999999999999999999999999999999999999987655433 2233456


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|++||.+.+. ..+.++|+||+|++++++++|..||...........+..   ..                      
T Consensus       162 ~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~----------------------  215 (256)
T cd06612         162 TPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KP----------------------  215 (256)
T ss_pred             CccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CC----------------------
Confidence            7789999988655 478899999999999999999999976543221111100   00                      


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                         .........++..+.++|.+||+.+|++|||++++++||||
T Consensus       216 ---~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 ---PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ---CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence               00001122466889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=8.4e-32  Score=211.52  Aligned_cols=175  Identities=25%  Similarity=0.466  Sum_probs=139.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc------
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF------   73 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------   73 (217)
                      |++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........      
T Consensus        85 ~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (316)
T cd05574          85 GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL  164 (316)
T ss_pred             CCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccc
Confidence            67999999864  5799999999999999999999999999999999999999999999999998764322110      


Q ss_pred             ------------------------cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 027927           74 ------------------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL  129 (217)
Q Consensus        74 ------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~  129 (217)
                                              .....++..|+|||.+.+.. .+.++|+||||+++|++++|..||.+.+....+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  243 (316)
T cd05574         165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSN  243 (316)
T ss_pred             ccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHH
Confidence                                    11234577899999986554 78899999999999999999999987665443333


Q ss_pred             HHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC----HhhhccCCCCcc
Q 027927          130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT----GEFFVPYKPFQC  205 (217)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t----~~~ll~~~~f~~  205 (217)
                      +...   .                    ...      .....+++++.++|++||+.||++|||    ++++++||||++
T Consensus       244 ~~~~---~--------------------~~~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         244 ILKK---E--------------------VTF------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HhcC---C--------------------ccC------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            2210   0                    000      001125789999999999999999999    999999999997


Q ss_pred             c
Q 027927          206 C  206 (217)
Q Consensus       206 ~  206 (217)
                      .
T Consensus       295 ~  295 (316)
T cd05574         295 V  295 (316)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2.4e-32  Score=196.70  Aligned_cols=171  Identities=26%  Similarity=0.403  Sum_probs=151.2

Q ss_pred             CccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIR--SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~--~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +|+|+..|+  ...++++.....++.|++.|+.|+|..+++||||||+|+|++..+.++++|||-+..-. .....+.+|
T Consensus       106 ~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcg  184 (281)
T KOG0580|consen  106 RGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCG  184 (281)
T ss_pred             CchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeec
Confidence            578999999  56889999999999999999999999999999999999999999999999999875544 444567899


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      |..|.+||...+.. .+...|+|++|++.|+.+.|.+||......+.+++|.+.--.                       
T Consensus       185 t~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-----------------------  240 (281)
T KOG0580|consen  185 TLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-----------------------  240 (281)
T ss_pred             ccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-----------------------
Confidence            99999999996554 788999999999999999999999988888888888763222                       


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                              .+..++.++.|+|.+||..+|.+|.+..|++.|||+..
T Consensus       241 --------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  241 --------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             --------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                    22468899999999999999999999999999999874

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.98  E-value=7.8e-32  Score=208.44  Aligned_cols=173  Identities=23%  Similarity=0.416  Sum_probs=135.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~   78 (217)
                      +++|.+++...  ..+++..+..++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus       103 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  182 (282)
T cd06636         103 AGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI  182 (282)
T ss_pred             CCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCccc
Confidence            46899998764  45889999999999999999999999999999999999999999999999987654322 1223345


Q ss_pred             ccccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           79 VTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        79 ~~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      +++.|+|||.+..    ...++.++|+||||+++|++++|..||...........+..   ..                 
T Consensus       183 ~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~-----------------  242 (282)
T cd06636         183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP-----------------  242 (282)
T ss_pred             ccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---CC-----------------
Confidence            7888999998753    23467789999999999999999999976543222211110   00                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                               ........++.++.++|++||+.||.+|||+.++++||||
T Consensus       243 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 ---------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ---------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                     0001112467899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.98  E-value=8e-32  Score=206.46  Aligned_cols=177  Identities=27%  Similarity=0.422  Sum_probs=139.7

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-----
Q 027927            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----   73 (217)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----   73 (217)
                      |++|.+++++.   ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........     
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~  162 (267)
T cd06610          83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV  162 (267)
T ss_pred             CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccc
Confidence            57899999875   4589999999999999999999999999999999999999999999999998865543321     


Q ss_pred             cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHH
Q 027927           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (217)
                      .....++..|++||.+......+.++|+||+|++++++++|..||........+......   .... .           
T Consensus       163 ~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-~-----------  227 (267)
T cd06610         163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS-L-----------  227 (267)
T ss_pred             cccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC-c-----------
Confidence            123456788999999876645788999999999999999999999766544333332221   0000 0           


Q ss_pred             HHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                                ........+++.+.+++.+||..||.+|||+.++++||||
T Consensus       228 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         228 ----------ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ----------CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                      0000123567899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.98  E-value=1.2e-31  Score=208.93  Aligned_cols=175  Identities=24%  Similarity=0.459  Sum_probs=139.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      |++|.+++.+ ..+++..+..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus       100 ~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  178 (296)
T cd06655         100 GGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  178 (296)
T ss_pred             CCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCC
Confidence            5788888876 4689999999999999999999999999999999999999999999999998765443322 2234567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+. .++.++|+||+||++|++++|..||...+.......+... ..+                       
T Consensus       179 ~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~-----------------------  233 (296)
T cd06655         179 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP-----------------------  233 (296)
T ss_pred             ccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCc-----------------------
Confidence            789999988654 4788999999999999999999999876643333222110 000                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                          .......+++.+.++|++||..||.+|||+.+++.||||+..
T Consensus       234 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         234 ----ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             ----ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence                001123467889999999999999999999999999999954

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.98  E-value=1e-31  Score=214.20  Aligned_cols=168  Identities=24%  Similarity=0.302  Sum_probs=128.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccccccccCcccccC
Q 027927           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVTRWYRAPELLLN   91 (217)
Q Consensus        13 ~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~   91 (217)
                      ...++..+..++.||+.||+|||++|++|+|||++||+++.++.++|+|||++....... ......++..|++||.+..
T Consensus       163 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  242 (353)
T PLN00034        163 HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT  242 (353)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCcccccc
Confidence            346788889999999999999999999999999999999999999999999987654321 2234567889999998743


Q ss_pred             C----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhh
Q 027927           92 S----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ  167 (217)
Q Consensus        92 ~----~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (217)
                      .    ...+.++|||||||++|++++|..||...........+.......                           ...
T Consensus       243 ~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~  295 (353)
T PLN00034        243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ---------------------------PPE  295 (353)
T ss_pred             ccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC---------------------------CCC
Confidence            2    223568999999999999999999997432211111111100000                           011


Q ss_pred             hCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          168 VFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       168 ~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ....+++++.++|.+||+.||++|||+.|+++||||....
T Consensus       296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        296 APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            2235678999999999999999999999999999999663

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.4e-31  Score=205.97  Aligned_cols=177  Identities=24%  Similarity=0.415  Sum_probs=146.1

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-------
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-------   71 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-------   71 (217)
                      .||+|..+++++  +.+++..++.++.+++.||+|||..||++||+||+|||+-.+|.+-|+||.++....-.       
T Consensus       160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~  239 (459)
T KOG0610|consen  160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS  239 (459)
T ss_pred             CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence            389999999887  67999999999999999999999999999999999999999999999999876432100       


Q ss_pred             ---------------------------C-----------------------ccccccccccccCcccccCCCCCCchhhH
Q 027927           72 ---------------------------E-----------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDV  101 (217)
Q Consensus        72 ---------------------------~-----------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di  101 (217)
                                                 .                       ......||..|+|||++.+.+ -+.++|.
T Consensus       240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDW  318 (459)
T KOG0610|consen  240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDW  318 (459)
T ss_pred             CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCchhhH
Confidence                                       0                       001234566799999998877 6889999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHH
Q 027927          102 WSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD  181 (217)
Q Consensus       102 wslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  181 (217)
                      |+||+++|||+.|.-||.+....+.+..++..--..++                             .+.++..++|||+
T Consensus       319 WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~-----------------------------~~~vs~~akDLIr  369 (459)
T KOG0610|consen  319 WTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE-----------------------------EPEVSSAAKDLIR  369 (459)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC-----------------------------CCcchhHHHHHHH
Confidence            99999999999999999999887777766542111110                             1146788999999


Q ss_pred             HhcccCCCCCCC----HhhhccCCCCcccc
Q 027927          182 RMLTFDPMKRIT----GEFFVPYKPFQCCC  207 (217)
Q Consensus       182 ~~l~~dp~~R~t----~~~ll~~~~f~~~~  207 (217)
                      ++|..||++|.-    |.||-+||||+...
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             HHhccChhhhhccccchHHhhcCccccCCC
Confidence            999999999999    99999999999553

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.9e-33  Score=203.51  Aligned_cols=204  Identities=44%  Similarity=0.783  Sum_probs=169.1

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC--Ccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--EFMTEYVVT   80 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~   80 (217)
                      .+|..+|-.-..++.+.++.+++||++||.|||+.||.||||||.|.+++.+-.+|+||||+++.....  ..+....-+
T Consensus       141 SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVT  220 (449)
T KOG0664|consen  141 SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVT  220 (449)
T ss_pred             hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHH
Confidence            466777777788999999999999999999999999999999999999999999999999999765543  334556668


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+.+.++.+.||||.||++.|++.++..|....+.+++..|.+.+|.|+-+....-.+..-...++.....
T Consensus       221 QYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~  300 (449)
T KOG0664|consen  221 QYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRA  300 (449)
T ss_pred             HHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCC
Confidence            88999999999999999999999999999999999999999999999999999999988776666555544444443333


Q ss_pred             Cccc-hhhhC--CCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          161 PRQS-LAQVF--PHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~-~~~~~--~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      +... +..+.  .+-..+..+++.++|.+||.+|++..+++.|++..+.
T Consensus       301 Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  301 PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            2221 11111  1234568899999999999999999999999998854

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.98  E-value=1.9e-31  Score=204.71  Aligned_cols=175  Identities=26%  Similarity=0.357  Sum_probs=136.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      +++|.+++...+.+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (267)
T cd06645          90 GGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGT  169 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCc
Confidence            46899999998999999999999999999999999999999999999999999999999999886544322 12334678


Q ss_pred             ccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        81 ~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ..|+|||.+..  ...++.++|+||+||++|++++|..||...............  .....                  
T Consensus       170 ~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~~------------------  229 (267)
T cd06645         170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQPP------------------  229 (267)
T ss_pred             ccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCCCC------------------
Confidence            88999998742  234678999999999999999999998655432222211110  00000                  


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                            .......++..+.++|.+||+.+|++|||++++++|||
T Consensus       230 ------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 ------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                  00011135678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.98  E-value=1.4e-31  Score=208.64  Aligned_cols=178  Identities=24%  Similarity=0.436  Sum_probs=139.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      |++|.+++.+ ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  179 (296)
T cd06654         101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  179 (296)
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCC
Confidence            5789998865 5689999999999999999999999999999999999999999999999998765433221 2234677


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||+||++|++++|..||...........+.. .+.+                       
T Consensus       180 ~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~-----------------------  234 (296)
T cd06654         180 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP-----------------------  234 (296)
T ss_pred             ccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCC-----------------------
Confidence            889999988654 478899999999999999999999976553222211110 0000                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                          .......+++.+.+++.+||..+|.+|||+.++++||||......
T Consensus       235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  279 (296)
T cd06654         235 ----ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL  279 (296)
T ss_pred             ----CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCc
Confidence                001122466889999999999999999999999999999866443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.98  E-value=1.8e-31  Score=207.34  Aligned_cols=175  Identities=24%  Similarity=0.367  Sum_probs=136.6

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~   76 (217)
                      |++|.++++.    +..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus       108 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  187 (291)
T cd06639         108 GGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT  187 (291)
T ss_pred             CCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccC
Confidence            5688888763    46799999999999999999999999999999999999999999999999998865443221 223


Q ss_pred             ccccccccCcccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           77 YVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~----~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      ..++..|++||.+....    ..+.++|+||+||++|++++|..||...........+.+   .....            
T Consensus       188 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~------------  252 (291)
T cd06639         188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPT------------  252 (291)
T ss_pred             ccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCC------------
Confidence            45678899999875432    257899999999999999999999977654333332221   00000            


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                                   .......+..+.++|.+||+.+|.+||++.++++||||+
T Consensus       253 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 -------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                         001123557899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.98  E-value=1.7e-31  Score=204.87  Aligned_cols=176  Identities=28%  Similarity=0.521  Sum_probs=138.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-CEEEecccccccCCCCC-----ccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE-----FMT   75 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~-----~~~   75 (217)
                      |++|.+++++.+++++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+.......     ...
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  166 (268)
T cd06630          87 GGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG  166 (268)
T ss_pred             CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccc
Confidence            578999999989999999999999999999999999999999999999998776 58999999986654321     112


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...++..|++||.+.+. .++.++|+|++|++++++++|..||...........+.......                  
T Consensus       167 ~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------  227 (268)
T cd06630         167 QLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT------------------  227 (268)
T ss_pred             ccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC------------------
Confidence            33567789999988654 47889999999999999999999996544322222221110000                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                              ........+++++.+++.+||..+|.+|||+.++++||||+
T Consensus       228 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 --------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             --------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                    00112234678999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.98  E-value=2.5e-31  Score=202.65  Aligned_cols=171  Identities=27%  Similarity=0.398  Sum_probs=138.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-CEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++...  ..+++..+..++.+++.|+++||++|++|+||+|+||+++.++ .++++|||.+.............
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  162 (256)
T cd08220          83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV  162 (256)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccc
Confidence            56899999874  4589999999999999999999999999999999999998654 57999999987765544444456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++..|+|||.+... ..+.++|+||+|++++++++|..||...+.......+....                        
T Consensus       163 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~------------------------  217 (256)
T cd08220         163 GTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT------------------------  217 (256)
T ss_pred             cCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC------------------------
Confidence            78889999988654 47889999999999999999999997765443333222100                        


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                            .......+++++.+++.+||+.+|.+|||++++++||||
T Consensus       218 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         218 ------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                  001122467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=9.6e-32  Score=211.00  Aligned_cols=207  Identities=20%  Similarity=0.238  Sum_probs=142.1

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-------
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-------   72 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-------   72 (217)
                      +++|.+++.+.  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++++||+.+.......       
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            46889999864  568999999999999999999999999999999999999999999999999875443211       


Q ss_pred             -ccccccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHH
Q 027927           73 -FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        73 -~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                       ......++..|++||.+... ..++.++|+||+|++++++++|..||............  ..+.... .+........
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~  239 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPC-LLDKSTYPLY  239 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCcc-ccccCchhhh
Confidence             11233456679999988653 34678999999999999999999999876543322211  1111110 0000000000


Q ss_pred             HHHHHh------CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCcee
Q 027927          151 KRYIRQ------LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIE  211 (217)
Q Consensus       151 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~  211 (217)
                      ......      ...............++.++.+++++||..||++|||++++++||||++......
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~  306 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNT  306 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccch
Confidence            000000      0000000001111234578999999999999999999999999999997765443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=1.6e-31  Score=207.23  Aligned_cols=173  Identities=24%  Similarity=0.338  Sum_probs=133.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCccccc
Q 027927           12 NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLL   90 (217)
Q Consensus        12 ~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~   90 (217)
                      +..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.............++..|++||.+.
T Consensus       101 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (288)
T cd06616         101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID  180 (288)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhc
Confidence            46799999999999999999999974 99999999999999999999999999987654443334446778899999986


Q ss_pred             CC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhh
Q 027927           91 NS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV  168 (217)
Q Consensus        91 ~~--~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (217)
                      +.  ..++.++|+||+|+++|++++|..||.....  ....+.+.......                       ......
T Consensus       181 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~-----------------------~~~~~~  235 (288)
T cd06616         181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPP-----------------------ILSNSE  235 (288)
T ss_pred             cccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCC-----------------------cCCCcC
Confidence            55  3578899999999999999999999965431  11111111110000                       000111


Q ss_pred             CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          169 FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       169 ~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                      ...+++++.+||++||+.+|++|||++++++||||+.....
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence            13477899999999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=1.3e-31  Score=206.83  Aligned_cols=177  Identities=25%  Similarity=0.382  Sum_probs=140.4

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |++|.+++.+..  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence            478999998765  799999999999999999999999999999999999999999999999998866544333344556


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|++||.+.+.. ++.++|+||+|++++++++|..||...........+.+.                       .. 
T Consensus       157 ~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------~~-  211 (277)
T cd05577         157 TPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-----------------------TL-  211 (277)
T ss_pred             CCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-----------------------cc-
Confidence            77899999986554 788999999999999999999999765431111111110                       00 


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                         .........+++.+.++|++||+.+|.+||     ++.++++||||.+.
T Consensus       212 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         212 ---EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             ---cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence               001112334679999999999999999999     88889999999854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=2e-31  Score=203.89  Aligned_cols=175  Identities=31%  Similarity=0.518  Sum_probs=141.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---------   72 (217)
                      |++|.+++.+.+.+++..+..++.||+.||++||+.+++|+||+|+||+++.++.++|+|||++.......         
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          77 GGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            56999999988899999999999999999999999999999999999999999999999999876543321         


Q ss_pred             ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        73 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      ......++..|++||...... .+.++|+||||++++++++|..||...........+..  +...              
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--------------  219 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIE--------------  219 (265)
T ss_pred             cccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcC--------------
Confidence            122345677899999886554 78899999999999999999999987665444333322  0000              


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCH---hhhccCCCCccc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG---EFFVPYKPFQCC  206 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~---~~ll~~~~f~~~  206 (217)
                             .     .. ...+++.+.+++++||+.+|.+|||+   .++++||||++.
T Consensus       220 -------~-----~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         220 -------W-----PE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             -------C-----Cc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence                   0     00 01147889999999999999999999   999999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA02988 hypothetical protein; Provisional

Probab=99.98  E-value=1.8e-31  Score=206.64  Aligned_cols=167  Identities=19%  Similarity=0.194  Sum_probs=136.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      ||+|.+++++++.++......++.+++.|+.+||+ .+++|+||+|+||+++.++.++++|||++.......  ....++
T Consensus       106 ~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~  183 (283)
T PHA02988        106 RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNVNF  183 (283)
T ss_pred             CCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccccCc
Confidence            57899999999999999999999999999999998 489999999999999999999999999986544322  234567


Q ss_pred             ccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           81 RWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        81 ~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ..|+|||.+.+. ..++.++|+|||||++|++++|..||......+....+......+                      
T Consensus       184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------  241 (283)
T PHA02988        184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL----------------------  241 (283)
T ss_pred             ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC----------------------
Confidence            889999998642 357899999999999999999999998776554444333211111                      


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                             ..+...++.+.+++.+||+.||++|||++++++
T Consensus       242 -------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 -------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                   011246788999999999999999999999975

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.98  E-value=3.3e-31  Score=207.24  Aligned_cols=176  Identities=24%  Similarity=0.361  Sum_probs=139.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---------   72 (217)
                      |++|.+++++.+.+++..+..++.|++.|++|||+++++|+||+|.||+++.++.++++|||.+.......         
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (305)
T cd05609          85 GGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI  164 (305)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccccccc
Confidence            57999999998999999999999999999999999999999999999999999999999999875311000         


Q ss_pred             -------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           73 -------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        73 -------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                             ......++..|++||.+.+.. .+.++|+||||+++|++++|..||.+....+....+.......+       
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  236 (305)
T cd05609         165 EKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-------  236 (305)
T ss_pred             ccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-------
Confidence                   001134567799999886544 78999999999999999999999987665444433322100000       


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC---HhhhccCCCCccc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT---GEFFVPYKPFQCC  206 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~~ll~~~~f~~~  206 (217)
                                           .....+++++.++|++||+.+|.+||+   +.++++||||.+.
T Consensus       237 ---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         237 ---------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             ---------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence                                 011136788999999999999999998   7899999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-31  Score=205.76  Aligned_cols=180  Identities=24%  Similarity=0.387  Sum_probs=140.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Cccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~   79 (217)
                      +++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++|||.+...... .......+
T Consensus        86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  165 (280)
T cd06611          86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIG  165 (280)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeec
Confidence            56888888774 67999999999999999999999999999999999999999999999999987554332 12233456


Q ss_pred             cccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        80 ~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      +..|++||.+..    ...++.++|+||+|+++|++++|..||...........+..  +..+                 
T Consensus       166 ~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~-----------------  226 (280)
T cd06611         166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--SEPP-----------------  226 (280)
T ss_pred             chhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--CCCC-----------------
Confidence            788999998742    23357789999999999999999999977654333322211  0000                 


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                               .......++.++.++|.+||..+|.+|||+.++++||||.+....
T Consensus       227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (280)
T cd06611         227 ---------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN  271 (280)
T ss_pred             ---------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence                     001122467889999999999999999999999999999987544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=3.7e-31  Score=203.58  Aligned_cols=177  Identities=27%  Similarity=0.496  Sum_probs=138.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~   78 (217)
                      |++|.+++++...++...+..++.||+.||.+||+++++|+||+|+||+++.++.++++|||.+.......   ......
T Consensus        92 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  171 (272)
T cd06629          92 GGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ  171 (272)
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccccccccccccc
Confidence            67899999998899999999999999999999999999999999999999999999999999886543211   122345


Q ss_pred             ccccccCcccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~-~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ++..|++||.+.... .++.++|+||+|++++++++|..||...........+......+                    
T Consensus       172 ~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------  231 (272)
T cd06629         172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP--------------------  231 (272)
T ss_pred             CCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC--------------------
Confidence            677899999886543 36789999999999999999999996544332222111100000                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                           .........++.++.++|.+||..+|.+|||++++++||||
T Consensus       232 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         232 -----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                 00011223467899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=5.3e-31  Score=204.83  Aligned_cols=177  Identities=22%  Similarity=0.369  Sum_probs=137.3

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      |++|.+++.+ ...+++..+..++.|++.|+++||+++++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  172 (292)
T cd06644          93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIG  172 (292)
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecC
Confidence            5677777755 4679999999999999999999999999999999999999999999999999876533221 1233456


Q ss_pred             cccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        80 ~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ++.|++||.+..    ...++.++|+||+||++|++++|..||...........+..   ...+                
T Consensus       173 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~----------------  233 (292)
T cd06644         173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPP----------------  233 (292)
T ss_pred             CccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCc----------------
Confidence            788999998852    23357789999999999999999999976554333222211   0000                


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                               .......++.++.++|++||+.+|++||+++++++||||...
T Consensus       234 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         234 ---------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             ---------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                     001122467889999999999999999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=3.2e-31  Score=210.12  Aligned_cols=156  Identities=28%  Similarity=0.419  Sum_probs=120.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccccccccccCccccc
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELLL   90 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~Pe~~~   90 (217)
                      +++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........   .....++..|+|||.+.
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  249 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF  249 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhh
Confidence            478889999999999999999999999999999999999999999999999865433221   11223456799999886


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhC
Q 027927           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (217)
Q Consensus        91 ~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (217)
                      +.. ++.++|+||||+++|++++ |..||.+......+.........                             ....
T Consensus       250 ~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----------------------------~~~~  299 (338)
T cd05102         250 DKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-----------------------------MRAP  299 (338)
T ss_pred             cCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-----------------------------CCCC
Confidence            544 7889999999999999996 99999765432222111110000                             0112


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          170 PHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       170 ~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ...++.+.+++.+||+.||.+|||+.++++
T Consensus       300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         300 ENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            346788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=2.4e-31  Score=203.48  Aligned_cols=175  Identities=27%  Similarity=0.446  Sum_probs=141.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-TEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~   79 (217)
                      |++|.+++.....+++..+..++.|++.|+++||+ .+++|+||+|+||+++.++.++|+|||.+......... ....+
T Consensus        83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  162 (264)
T cd06623          83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVG  162 (264)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceee
Confidence            47999999988999999999999999999999999 99999999999999999999999999988765543332 24456


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      +..|.+||.+... .++.++|+|+||+++|++++|..||.....   .+....+..   ..                   
T Consensus       163 ~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~-------------------  219 (264)
T cd06623         163 TVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP-------------------  219 (264)
T ss_pred             cccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC-------------------
Confidence            7889999988554 578899999999999999999999976642   221111110   00                   


Q ss_pred             CCCCCccchhhhCCC-CChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          157 LPQHPRQSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                              ....... ++..+.++|++||+.+|++|||+.++++|||+++..
T Consensus       220 --------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         220 --------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             --------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                    0011223 678899999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=2.8e-31  Score=203.55  Aligned_cols=172  Identities=23%  Similarity=0.461  Sum_probs=136.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC----Cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----EFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~----~~~~~~   77 (217)
                      |++|.+++.+...+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+......    ......
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  169 (265)
T cd06652          90 GGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV  169 (265)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccC
Confidence            5789999998888999999999999999999999999999999999999999999999999988654321    112234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|+|||.+.+.. .+.++|+||||+++|++++|..||...........+.   ..+..                  
T Consensus       170 ~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~------------------  227 (265)
T cd06652         170 TGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN------------------  227 (265)
T ss_pred             CCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC------------------
Confidence            5677899999886544 7889999999999999999999997654333322211   11100                  


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                              ...+..++..+.+++++|+. +|++|||++++++|||+.
T Consensus       228 --------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         228 --------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             --------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                    01123456789999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=4e-31  Score=202.19  Aligned_cols=171  Identities=32%  Similarity=0.501  Sum_probs=139.2

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIH-----SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh-----~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (217)
                      +++|.+++..    ..++++..+..++.||+.||++||     +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  164 (265)
T cd08217          85 GGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS  164 (265)
T ss_pred             CCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc
Confidence            5688888866    467999999999999999999999     8999999999999999999999999999987665443


Q ss_pred             c-cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           73 F-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        73 ~-~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                      . .....++..|++||.+.+.. .+.++|+||||++++++++|..||...+.......+...                  
T Consensus       165 ~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------  225 (265)
T cd08217         165 SFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG------------------  225 (265)
T ss_pred             ccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC------------------
Confidence            3 33456788899999986544 788999999999999999999999876533332222110                  


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                                  .........+..+.+++.+||+.+|++|||+.++++|||+
T Consensus       226 ------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                        0011223467889999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=2.3e-31  Score=203.24  Aligned_cols=173  Identities=27%  Similarity=0.443  Sum_probs=140.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++....++++..+..++.||++||.+||+++++|+||+|+||+++.++.++|+|||.+.............++.
T Consensus        84 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  163 (258)
T cd05578          84 GGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTP  163 (258)
T ss_pred             CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCCh
Confidence            67999999888899999999999999999999999999999999999999999999999999987665543444556778


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|.+||.+.+.. .+.++|+||+|+++|++++|..||...... ....+......                         
T Consensus       164 ~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-------------------------  216 (258)
T cd05578         164 GYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET-------------------------  216 (258)
T ss_pred             hhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc-------------------------
Confidence            899999886554 788999999999999999999999765531 01111110000                         


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCH--hhhccCCCC
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG--EFFVPYKPF  203 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~--~~ll~~~~f  203 (217)
                        .....+...+.++.++|++||..||.+||++  +++++||||
T Consensus       217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence              0011223466899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=212.41  Aligned_cols=165  Identities=29%  Similarity=0.411  Sum_probs=139.0

Q ss_pred             ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc-
Q 027927            3 TDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV-   79 (217)
Q Consensus         3 ~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~-   79 (217)
                      |+|.++|+.  +..++......++.||++|++||++++++||||.+.||||+.+..+|++|||+++............+ 
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k  365 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK  365 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence            789999998  57799999999999999999999999999999999999999999999999999996555443322222 


Q ss_pred             -cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           80 -TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        80 -~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                       +..|.|||++...+ ++.++|||||||+|+|+++ |+.|+.+....+.+..+.+-..-+                    
T Consensus       366 fPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp--------------------  424 (468)
T KOG0197|consen  366 FPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP--------------------  424 (468)
T ss_pred             CCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC--------------------
Confidence             45699999996555 9999999999999999998 899999988777776665422222                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV  198 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll  198 (217)
                                .++.+++++-++|..|++.+|++|||++.+.
T Consensus       425 ----------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  425 ----------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             ----------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                      2335889999999999999999999999664

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=7.5e-32  Score=216.70  Aligned_cols=175  Identities=23%  Similarity=0.387  Sum_probs=145.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEecC-CCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      .|+|+.|++++++++.++++.|++||+.||.|||++.  |+|||||=+||+++++ |.|||+|+|+|.....+.. ....
T Consensus       127 SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-ksvI  205 (632)
T KOG0584|consen  127 SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-KSVI  205 (632)
T ss_pred             CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-ceec
Confidence            5899999999999999999999999999999999987  9999999999999865 8999999999987665543 3479


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      |||.|+|||.+.  ..|....||||||++++||+|+.-||....+..++.+.+-.+..|..                   
T Consensus       206 GTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s-------------------  264 (632)
T KOG0584|consen  206 GTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA-------------------  264 (632)
T ss_pred             cCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH-------------------
Confidence            999999999884  34889999999999999999999999876655554444332222211                   


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                            +..+   -.|++++||.+||.. .+.|+|+.|+|.||||..-.|
T Consensus       265 ------l~kV---~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  265 ------LSKV---KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             ------hhcc---CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence                  1111   238899999999999 999999999999999997544

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-32  Score=221.16  Aligned_cols=176  Identities=27%  Similarity=0.456  Sum_probs=145.8

Q ss_pred             CccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccCC-CCCcccc
Q 027927            2 DTDLYQIIRSN-QSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTS-ENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l--~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~-~~~~~~~   76 (217)
                      ||+|.++++.. +++  ++..+..+.+||++||.|||++.|||||||.+|++++. .|.+|++|||-+++.. .+++..+
T Consensus       656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence            89999999986 888  89999999999999999999999999999999999964 7899999999987754 4566677


Q ss_pred             ccccccccCcccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~-~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..|+..|+|||++-+ .+.++.++|||||||++.||.+|++||.....++-  .+++.+                     
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkVG---------------------  792 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKVG---------------------  792 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhhc---------------------
Confidence            889999999999853 34578999999999999999999999965443221  122111                     


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                           .-+..+.++..++.+++.||.+|+.+||..||+|.++|++||++-
T Consensus       793 -----myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~  837 (1226)
T KOG4279|consen  793 -----MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH  837 (1226)
T ss_pred             -----ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence                 111223344467899999999999999999999999999999983

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=3.7e-31  Score=204.62  Aligned_cols=177  Identities=27%  Similarity=0.400  Sum_probs=136.6

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      +++|.++++.    +..+++..+..++.||+.||+|||++ +++|+||+|+||+++.++.++|+|||.+...........
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (283)
T cd06617          83 DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI  162 (283)
T ss_pred             cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            5677777754    35789999999999999999999997 999999999999999999999999999876544333333


Q ss_pred             ccccccccCcccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           77 YVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~---~~~~~~~Diwslg~~l~~l~~~~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      ..++..|++||.+.+.   ..++.++|+||+|+++|++++|..||.... ..+.+.....  +...              
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--------------  226 (283)
T cd06617         163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSP--------------  226 (283)
T ss_pred             ccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCCC--------------
Confidence            4567889999987542   235788999999999999999999996432 2222221111  0000              


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                 .  .....++.++.++|.+||..+|.+|||++++++||||++..
T Consensus       227 -----------~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         227 -----------Q--LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -----------C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                       0  00113678899999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=9.6e-31  Score=202.72  Aligned_cols=178  Identities=25%  Similarity=0.397  Sum_probs=138.8

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      |++|.+++...   ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~  161 (286)
T cd06622          83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTN  161 (286)
T ss_pred             CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccccC
Confidence            56888888774   479999999999999999999997 59999999999999999999999999988655332 22334


Q ss_pred             cccccccCcccccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           78 VVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~-----~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      .++..|++||.+.+..     .++.++|+||+||++|++++|..||...........+.......               
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------  226 (286)
T cd06622         162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD---------------  226 (286)
T ss_pred             CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC---------------
Confidence            5677899999875432     24778999999999999999999997654333222222111100               


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                  ....++.+++++.++|.+||+.+|.+||+++++++||||....
T Consensus       227 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         227 ------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             ------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence                        0112334778999999999999999999999999999998664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=1.6e-31  Score=211.30  Aligned_cols=179  Identities=23%  Similarity=0.387  Sum_probs=141.4

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--cccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~   78 (217)
                      |++|.+++.+ +..+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||++.........  ....
T Consensus        85 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  164 (331)
T cd05624          85 GGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV  164 (331)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeecccc
Confidence            6899999987 478999999999999999999999999999999999999999999999999998665433222  2346


Q ss_pred             ccccccCcccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           79 VTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~----~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      +++.|+|||.+.+.    ..++.++|+||+|+++|++++|..||...+....+..+.....                   
T Consensus       165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------  225 (331)
T cd05624         165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-------------------  225 (331)
T ss_pred             CCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-------------------
Confidence            88999999988542    3467899999999999999999999987665444443332100                   


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCC--CCCHhhhccCCCCccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITGEFFVPYKPFQCC  206 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~~ll~~~~f~~~  206 (217)
                             ..........++.++.++|.+||..++.+  |++++++++|+||+..
T Consensus       226 -------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         226 -------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             -------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence                   00111122346789999999999976654  5799999999999854

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=2.3e-31  Score=207.48  Aligned_cols=175  Identities=23%  Similarity=0.442  Sum_probs=137.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      |++|.+++.+ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+........ .....++
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  178 (297)
T cd06656         100 GGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  178 (297)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCC
Confidence            5788998866 5689999999999999999999999999999999999999999999999998865443322 2234567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|++||.+.+. .++.++|+||+|+++|++++|..||...+.......+.. .+.+                       
T Consensus       179 ~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-----------------------  233 (297)
T cd06656         179 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-----------------------  233 (297)
T ss_pred             ccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC-----------------------
Confidence            889999988654 478899999999999999999999976543221111100 0000                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                          ....+..+++.+.+++.+||..+|.+|||++++++||||+..
T Consensus       234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         234 ----ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence                001122466889999999999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4e-31  Score=203.32  Aligned_cols=174  Identities=25%  Similarity=0.414  Sum_probs=135.1

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~   76 (217)
                      +++|.+++..    +.++++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  172 (275)
T cd06608          93 GGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT  172 (275)
T ss_pred             CCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcC
Confidence            4678888765    3689999999999999999999999999999999999999999999999999886543322 2233


Q ss_pred             ccccccccCcccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           77 YVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~----~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      ..++..|+|||.+...    ..++.++|+||+|++++++++|..||...........+..   .....            
T Consensus       173 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~------------  237 (275)
T cd06608         173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPT------------  237 (275)
T ss_pred             ccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCC------------
Confidence            4567889999987532    3356789999999999999999999976543333322211   00000            


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                                   .......+..+.++|++||..||++|||+.++++|||+
T Consensus       238 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 -------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                         00112356889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.5e-31  Score=204.23  Aligned_cols=177  Identities=25%  Similarity=0.465  Sum_probs=140.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      |++|.++++.+ .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+........ .....++
T Consensus        86 ~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06917          86 GGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGT  164 (277)
T ss_pred             CCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCC
Confidence            57899998774 799999999999999999999999999999999999999999999999998876544332 2334567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+...++.++|+||+|+++|++++|..||...........+..                           .
T Consensus       165 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---------------------------~  217 (277)
T cd06917         165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---------------------------S  217 (277)
T ss_pred             cceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---------------------------C
Confidence            7899999886555568899999999999999999999976543221111000                           0


Q ss_pred             CccchhhhCC-CCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          161 PRQSLAQVFP-HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       161 ~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                      ..   ..... ..+.++.+++.+||..||.+|||+.+++.|+||++....
T Consensus       218 ~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         218 KP---PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             CC---CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence            00   00111 256889999999999999999999999999999876543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.9e-31  Score=200.83  Aligned_cols=175  Identities=26%  Similarity=0.413  Sum_probs=137.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      |++|.+++... ..+++..+..++.|++.||++||+++++|+||+|+||+++.++.++++|||.+....... ......+
T Consensus        84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  163 (262)
T cd06613          84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIG  163 (262)
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccC
Confidence            46889988876 789999999999999999999999999999999999999999999999999886654332 2233456


Q ss_pred             cccccCcccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           80 TRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        80 ~~~~~~Pe~~~~~--~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +..|++||.+.+.  ..++.++|+||+|++++++++|..||...........+....-.+..                  
T Consensus       164 ~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------------  225 (262)
T cd06613         164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK------------------  225 (262)
T ss_pred             CccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc------------------
Confidence            7789999988654  24678999999999999999999999876644333322211000000                  


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                              ......++.++.+++++||..+|.+|||+.+++.|+|
T Consensus       226 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         226 --------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             --------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                    0011134578999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=4e-31  Score=204.93  Aligned_cols=182  Identities=30%  Similarity=0.516  Sum_probs=144.1

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      |++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  178 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG  178 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccC
Confidence            479999999986 89999999999999999999999999999999999999999999999999875443221 1123345


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +..|++||.+.+. .++.++|+||+|+++|++++|..||...........+... ..+ .                    
T Consensus       179 ~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-~--------------------  235 (286)
T cd06614         179 TPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIP-P--------------------  235 (286)
T ss_pred             CcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCC-C--------------------
Confidence            6789999988654 4788999999999999999999999766544333322210 000 0                    


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCceee
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEF  212 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~~  212 (217)
                            ......++..+.++|++||+.+|.+|||++++++|+||++.|....+
T Consensus       236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~  282 (286)
T cd06614         236 ------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEF  282 (286)
T ss_pred             ------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCchHhh
Confidence                  00112356889999999999999999999999999999987765543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=1.1e-30  Score=199.96  Aligned_cols=175  Identities=29%  Similarity=0.472  Sum_probs=137.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-----cc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~~   76 (217)
                      +++|.+++.++..+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.........     ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~  162 (264)
T cd06626          83 GGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS  162 (264)
T ss_pred             CCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccC
Confidence            5789999999888999999999999999999999999999999999999999999999999988665433221     12


Q ss_pred             ccccccccCcccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~--~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ..++..|++||.+....  ..+.++|+|++|++++++++|..||............... +....               
T Consensus       163 ~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~---------------  226 (264)
T cd06626         163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP---------------  226 (264)
T ss_pred             CcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC---------------
Confidence            45677899999986443  2678999999999999999999999765322222111111 10000               


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                                . .....+++.+.++|.+||+.+|.+|||+++++.|||+
T Consensus       227 ----------~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         227 ----------I-PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ----------C-CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                      0 0012357889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.9e-31  Score=209.97  Aligned_cols=176  Identities=27%  Similarity=0.419  Sum_probs=132.8

Q ss_pred             ccHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---ccccc
Q 027927            3 TDLYQIIRSNQSL-SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYV   78 (217)
Q Consensus         3 ~~L~~~l~~~~~l-~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~   78 (217)
                      .+|..+|++.... +.-.++.+..|++.|+.+.|.+||||.|+||.|+++-. |.+||+|||.+..+.....   ....+
T Consensus       444 ~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQv  522 (677)
T KOG0596|consen  444 IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQV  522 (677)
T ss_pred             ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeecccc
Confidence            5788999887554 44689999999999999999999999999999998754 6899999999977665433   34578


Q ss_pred             ccccccCcccccCCC----------CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCch
Q 027927           79 VTRWYRAPELLLNSS----------DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE  148 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~----------~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (217)
                      ||+.|++||++....          ..+.++|||||||++|+|+.|+.||..-.  ..++++.....+..+-.       
T Consensus       523 GT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~Ie-------  593 (677)
T KOG0596|consen  523 GTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNHEIE-------  593 (677)
T ss_pred             CcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCcccc-------
Confidence            999999999986321          25678999999999999999999995422  12222222111101001       


Q ss_pred             HHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                      ...+..  ..++.++++.||..||++|||+.++|+|||.+-.
T Consensus       594 ----------------fp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  594 ----------------FPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             ----------------ccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence                            111111  1339999999999999999999999999999853

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=7.9e-31  Score=199.71  Aligned_cols=171  Identities=29%  Similarity=0.470  Sum_probs=139.2

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccc
Q 027927            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~   76 (217)
                      |++|.+++++.    ..++...+..++.+++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  162 (258)
T cd08215          83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT  162 (258)
T ss_pred             CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecc
Confidence            46899998874    789999999999999999999999999999999999999999999999999987654433 2334


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|++||...... .+.++|+|++|++++++++|..||................                      
T Consensus       163 ~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------  219 (258)
T cd08215         163 VVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------------------  219 (258)
T ss_pred             eeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC----------------------
Confidence            56788899999875544 7889999999999999999999997665333332221100                      


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                              .......++.++.+++++||..+|.+|||+.++++||||
T Consensus       220 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 --------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                    011122467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=6.6e-31  Score=204.86  Aligned_cols=175  Identities=27%  Similarity=0.492  Sum_probs=139.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      +++|.+++.. ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus       102 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  180 (297)
T cd06659         102 GGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  180 (297)
T ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence            4678887755 678999999999999999999999999999999999999999999999999886543322 12334577


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|+|||.+.+.. ++.++|+||+|++++++++|..||...........+..   ....                     
T Consensus       181 ~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------------------  235 (297)
T cd06659         181 PYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPPP---------------------  235 (297)
T ss_pred             ccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCCC---------------------
Confidence            8899999886544 78899999999999999999999976654443332211   0000                     


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                          .......++..+.++|++||+.+|.+|||++++++||||.+.
T Consensus       236 ----~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         236 ----KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             ----CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence                011123467889999999999999999999999999999966

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=3.3e-31  Score=200.19  Aligned_cols=164  Identities=24%  Similarity=0.364  Sum_probs=132.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.+...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+......  .....++.
T Consensus        69 ~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~  146 (237)
T cd05576          69 GGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVEN  146 (237)
T ss_pred             CCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCc
Confidence            5799999998888999999999999999999999999999999999999999999999999977554432  12234466


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|++||.+... ..+.++|+||+|+++|++++|..|+......                 ..            ...   
T Consensus       147 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~------------~~~---  193 (237)
T cd05576         147 MYCAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----------------IN------------THT---  193 (237)
T ss_pred             cccCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cc------------ccc---
Confidence            79999987544 3688999999999999999999877432100                 00            000   


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCH-----hhhccCCCC
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG-----EFFVPYKPF  203 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~~ll~~~~f  203 (217)
                         ....+..+++.+.++|++||+.||++|+|+     +++++||||
T Consensus       194 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         194 ---TLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ---ccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence               001223467889999999999999999996     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=7.2e-31  Score=200.23  Aligned_cols=171  Identities=24%  Similarity=0.437  Sum_probs=138.1

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~   78 (217)
                      +++|.+++...  ..+++..+..++.|++.|+++||+++++|+||+|+||+++.++.++++|||.+........ .....
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  162 (256)
T cd08218          83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI  162 (256)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhcc
Confidence            57899988764  3689999999999999999999999999999999999999999999999998866544322 12334


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+.. .+.++|+||+|++++++++|..||...........+..  +..                     
T Consensus       163 ~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~---------------------  218 (256)
T cd08218         163 GTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSY---------------------  218 (256)
T ss_pred             CCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCC---------------------
Confidence            677899999886544 78899999999999999999999976655444333321  100                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                             ......++.++.++|++||+.+|.+||+++++++||||
T Consensus       219 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 -------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                   01123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-30  Score=197.49  Aligned_cols=170  Identities=31%  Similarity=0.556  Sum_probs=140.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      +++|.+++.....+++..+..++.|++.|+.+||+.+++|+||+|.||+++.++.++++|||.+...... .......++
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          77 GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            6799999999888999999999999999999999999999999999999999999999999988665443 223345667


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+.. .+.++|+|+||+++|++++|..||...+.......+..  ..                        
T Consensus       157 ~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~------------------------  209 (250)
T cd05123         157 PEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DP------------------------  209 (250)
T ss_pred             ccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CC------------------------
Confidence            7899999886554 78899999999999999999999977665333333322  00                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH---hhhccCCCC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG---EFFVPYKPF  203 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~---~~ll~~~~f  203 (217)
                           .......+..+.+++++||..||.+|||+   +++++||||
T Consensus       210 -----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 -----LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                 01122346889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=1.3e-30  Score=198.81  Aligned_cols=171  Identities=27%  Similarity=0.507  Sum_probs=140.1

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      |++|.+++...  ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+....... ......
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (256)
T cd08221          83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV  162 (256)
T ss_pred             CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccC
Confidence            57899999875  568999999999999999999999999999999999999999999999999886654433 233456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|.+||.+.+.. ++.++|+||+|++++++++|..||...........+..  +..                     
T Consensus       163 ~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~---------------------  218 (256)
T cd08221         163 GTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNY---------------------  218 (256)
T ss_pred             CCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCC---------------------
Confidence            788999999886554 77899999999999999999999977665444443321  100                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                             ......++.++.+++.+||+.+|.+|||+.++++|+|+
T Consensus       219 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         219 -------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                   01113467889999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-31  Score=213.11  Aligned_cols=170  Identities=24%  Similarity=0.415  Sum_probs=141.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCccccccccccccCccccc
Q 027927           12 NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVTRWYRAPELLL   90 (217)
Q Consensus        12 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~   90 (217)
                      ++.|++.++..+.+|++.||.|||+++|+|+|+|..|||++.+|.++|+|||.+-+... ........|+|.|+|||++.
T Consensus       124 ~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvm  203 (1187)
T KOG0579|consen  124 GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVM  203 (1187)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchhee
Confidence            57899999999999999999999999999999999999999999999999998744332 23345679999999999986


Q ss_pred             C----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchh
Q 027927           91 N----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA  166 (217)
Q Consensus        91 ~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (217)
                      +    ..+|.+++||||||++|.+|..+.+|.....++..+-++.+   ..++..                         
T Consensus       204 CET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTL-------------------------  255 (1187)
T KOG0579|consen  204 CETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTL-------------------------  255 (1187)
T ss_pred             eccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcc-------------------------
Confidence            4    34688999999999999999999999988777666555543   111111                         


Q ss_pred             hhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          167 QVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       167 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                      ..+...+..|.||+.+||..||..||++.++|+|||+++..+-
T Consensus       256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            1123456889999999999999999999999999999987654

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=5.1e-31  Score=202.30  Aligned_cols=175  Identities=27%  Similarity=0.377  Sum_probs=135.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      +++|.++++.+..+++..+..++.|++.|+.+||+.|++|+|++|+||+++.++.++++|||.+....... ......++
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (267)
T cd06646          90 GGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGT  169 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccC
Confidence            46899999888899999999999999999999999999999999999999999999999999987654322 12334567


Q ss_pred             ccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        81 ~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ..|+|||.+..  ...++.++|+||+|+++|++++|..||...........+...                         
T Consensus       170 ~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------------------  224 (267)
T cd06646         170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------------------  224 (267)
T ss_pred             ccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------------------
Confidence            88999998742  233577899999999999999999998654322111111000                         


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                       ............++..+.++|++||..+|++|||++++++|+|
T Consensus       225 -~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 -NFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -CCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence             0000000011246788999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=1.2e-30  Score=198.62  Aligned_cols=173  Identities=26%  Similarity=0.453  Sum_probs=141.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~   78 (217)
                      +++|.+++.+...+++..+..++.|++.||++||+.+++|+|++|+||+++.++.++|+|||.+........   .....
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  164 (260)
T cd06606          85 GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR  164 (260)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCC
Confidence            678999999988999999999999999999999999999999999999999999999999999877665543   34456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++..|.+||.+.... .+.++|+|+||++++++++|..||........  .......                       
T Consensus       165 ~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~-----------------------  218 (260)
T cd06606         165 GTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS-----------------------  218 (260)
T ss_pred             CCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc-----------------------
Confidence            778899999885544 78899999999999999999999976552111  1111000                       


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                         .......+...+..+.++|.+||..+|.+||++.++++||||
T Consensus       219 ---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 ---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ---cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence               001112233457899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=1.1e-30  Score=202.11  Aligned_cols=168  Identities=21%  Similarity=0.340  Sum_probs=133.3

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.+++...                ..++...+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~  171 (283)
T cd05048          92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS  171 (283)
T ss_pred             CCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcce
Confidence            57899999765                45788999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      ........   .....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+...  .     
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~--~-----  243 (283)
T cd05048         172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR--Q-----  243 (283)
T ss_pred             eeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence            65433221   22334567899999886544 7899999999999999997 99999876644433322210  0     


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                             .......+++++.+++.+||+.||.+|||+.+++++
T Consensus       244 -----------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         244 -----------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             -----------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                   001223578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=1.6e-30  Score=198.62  Aligned_cols=167  Identities=23%  Similarity=0.319  Sum_probs=133.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----ccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~   77 (217)
                      +++|.+++.....+++..+..++.|++.||++||++|++|+||+|.||+++.++.++|+|||.+.........    ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            4689999998889999999999999999999999999999999999999999999999999998765443221    112


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+... ..+.++|+||||+++|++++ |..||...........+.+ ...                    
T Consensus       159 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~--------------------  216 (257)
T cd05116         159 KWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GER--------------------  216 (257)
T ss_pred             CCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCC--------------------
Confidence            224689999988544 47889999999999999997 9999977654433333221 000                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ...+..+++++.++|++||+.||.+||+++++..
T Consensus       217 ---------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 ---------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                     0122347789999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=6.8e-31  Score=226.21  Aligned_cols=175  Identities=28%  Similarity=0.425  Sum_probs=138.5

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-------CcEecCcCCCCEEEec-----------------
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSA-------NVIHRDLKPSNLLLNA-----------------   53 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~-------~i~H~di~~~nil~~~-----------------   53 (217)
                      +++|.++|..    ...+++..++.++.||+.||+|||+.       +|+|+||||+||+++.                 
T Consensus        98 gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng  177 (1021)
T PTZ00266         98 AGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG  177 (1021)
T ss_pred             CCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence            5789998876    36799999999999999999999984       4999999999999964                 


Q ss_pred             CCCEEEecccccccCCCCCccccccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 027927           54 NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIE  132 (217)
Q Consensus        54 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~  132 (217)
                      .+.++|+|||++.............+++.|+|||.+... ..++.++|||||||++|++++|..||........+.....
T Consensus       178 ~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk  257 (1021)
T PTZ00266        178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK  257 (1021)
T ss_pred             CCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHh
Confidence            344899999998766544444455789999999998643 3468899999999999999999999976554333222221


Q ss_pred             HhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          133 LLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ..  + .                           ......++++.+||.+||..+|.+|||+.++|.|+|+++.
T Consensus       258 ~~--p-~---------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        258 RG--P-D---------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             cC--C-C---------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            10  0 0                           0012357889999999999999999999999999999855

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=1.7e-30  Score=197.16  Aligned_cols=172  Identities=28%  Similarity=0.486  Sum_probs=137.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |++|.+++... ..++...+..++.|++.|+++||+.|++||||+|+||+++.++.++|+|||.+.............++
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  160 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGT  160 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecC
Confidence            47899999887 68999999999999999999999999999999999999999999999999988766544323445677


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.... .+.++|+||+|++++++++|..||...+.......... ...+ ..                    
T Consensus       161 ~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~-~~--------------------  217 (253)
T cd05122         161 PYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPP-GL--------------------  217 (253)
T ss_pred             CcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCC-Cc--------------------
Confidence            8899999886554 78899999999999999999999976643333222211 0000 00                    


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                            .....++..+.++|++||..||++|||+.++++|||
T Consensus       218 ------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         218 ------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                  000113688999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.6e-30  Score=200.57  Aligned_cols=170  Identities=32%  Similarity=0.600  Sum_probs=140.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--------   73 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------   73 (217)
                      +++|.+++++.+.++...+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+........        
T Consensus        86 ~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  165 (280)
T cd05581          86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA  165 (280)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCC
Confidence            689999999988999999999999999999999999999999999999999999999999998865443221        


Q ss_pred             -------------cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCc
Q 027927           74 -------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA  140 (217)
Q Consensus        74 -------------~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~  140 (217)
                                   .....++..|++||...... .+.++|+|+||++++++++|..||........+..+....      
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------  238 (280)
T cd05581         166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE------  238 (280)
T ss_pred             ccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC------
Confidence                         12234567899999876543 7889999999999999999999998776544443333110      


Q ss_pred             cccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCH----hhhccCCCC
Q 027927          141 DLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG----EFFVPYKPF  203 (217)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~~ll~~~~f  203 (217)
                                               ...+..+++.+.++|++||..+|.+|||+    +++++||||
T Consensus       239 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         239 -------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence                                     01122457889999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=2.3e-30  Score=198.81  Aligned_cols=174  Identities=26%  Similarity=0.463  Sum_probs=133.4

Q ss_pred             CccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccCCCCC-cccc
Q 027927            2 DTDLYQIIRSN-QSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE-FMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l--~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~~~   76 (217)
                      |++|.++++++ .++  +...+..++.||+.||++||+.|++|+||+|.||+++. ++.++|+|||.+....... ....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~  168 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET  168 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence            57899999875 556  88899999999999999999999999999999999976 6789999999886543322 1223


Q ss_pred             ccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|++||.+... ..++.++|+||+|++++++++|..||................                     
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  227 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF---------------------  227 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---------------------
Confidence            4567889999987543 236789999999999999999999996543211100000000                     


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                             .....++..+++++.+++++||+.+|.+|||+.+++.||||
T Consensus       228 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 -------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                   00111233467889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=7.9e-31  Score=202.42  Aligned_cols=177  Identities=25%  Similarity=0.418  Sum_probs=140.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      |++|.++++. .++++..+..++.|++.|+++||+.+++|+||+|+||+++.++.++++|||.+........ .....++
T Consensus        86 ~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06640          86 GGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT  164 (277)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCc
Confidence            5789999876 5689999999999999999999999999999999999999999999999999866544322 2233567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|+|||.+.+.. .+.++|+||||+++|++++|..||...........+..  +.                        
T Consensus       165 ~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~------------------------  217 (277)
T cd06640         165 PFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NN------------------------  217 (277)
T ss_pred             ccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CC------------------------
Confidence            7899999886544 78899999999999999999999976543322211100  00                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCce
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCI  210 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~  210 (217)
                          .......++..+.+++.+||+.+|.+||++.++++|+||.+...+.
T Consensus       218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06640         218 ----PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKT  263 (277)
T ss_pred             ----CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhh
Confidence                0111223568899999999999999999999999999999775543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-31  Score=196.82  Aligned_cols=193  Identities=24%  Similarity=0.393  Sum_probs=143.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC---EEEecccccccCCCC-------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSEN-------   71 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~-------   71 (217)
                      ||+|...|.+++.+++.++.+++++|+.||.+||++||.|||+||+||+......   +||+||.+.......       
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            7899999999999999999999999999999999999999999999999866544   799999876432221       


Q ss_pred             -CccccccccccccCccccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccC
Q 027927           72 -EFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR  146 (217)
Q Consensus        72 -~~~~~~~~~~~~~~Pe~~~----~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (217)
                       +...+..|+-.|+|||++.    +...+..+.|.|||||++|-|++|.+||.+.-            |..=-++-+...
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C------------g~dCGWdrGe~C  307 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC------------GADCGWDRGEVC  307 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc------------CCcCCccCCCcc
Confidence             2223456677799999863    22346778999999999999999999997653            111111112222


Q ss_pred             chHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ...-+..+..+.+..-.--..-+..+|.+.+++|+.+|..|+.+|.++.++++|||++..
T Consensus       308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence            222223333333222111122344689999999999999999999999999999999943

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=6.4e-31  Score=203.13  Aligned_cols=172  Identities=24%  Similarity=0.389  Sum_probs=129.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCcccccCC
Q 027927           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNS   92 (217)
Q Consensus        13 ~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~   92 (217)
                      ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+.
T Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  168 (279)
T cd06619          90 RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGE  168 (279)
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCC
Confidence            35789999999999999999999999999999999999999999999999998655432 22345678899999988655


Q ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCC
Q 027927           93 SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV  172 (217)
Q Consensus        93 ~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (217)
                      . ++.++|+||+|+++|++++|..||............                .............      .......
T Consensus       169 ~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~----------------~~~~~~~~~~~~~------~~~~~~~  225 (279)
T cd06619         169 Q-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP----------------LQLLQCIVDEDPP------VLPVGQF  225 (279)
T ss_pred             C-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccch----------------HHHHHHHhccCCC------CCCCCcC
Confidence            4 788999999999999999999999652211000000                0000000000000      0011236


Q ss_pred             ChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          173 HPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       173 ~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ++++.+++.+||+.+|.+||+++++++||||++...
T Consensus       226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            788999999999999999999999999999997743

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.4e-31  Score=190.16  Aligned_cols=194  Identities=28%  Similarity=0.551  Sum_probs=150.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-CCEEEecccccccCCCCCccccccccccccCcccccC
Q 027927           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLN   91 (217)
Q Consensus        13 ~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~   91 (217)
                      +.++.-.++.++.+++.||.|+|++||+|||+||.|++++.. .+++|+|+|++...-.....+-...+..|.-||.+..
T Consensus       127 ~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd  206 (338)
T KOG0668|consen  127 PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD  206 (338)
T ss_pred             hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheee
Confidence            457788999999999999999999999999999999999976 4589999999987766655555666788999999998


Q ss_pred             CCCCCchhhHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCCcccc-ccCchHHHHHHHhCCCCCccchhhhC
Q 027927           92 SSDYTAAIDVWSVGCIFMELMNRRPLF-PGNDHVHQMRLLIELLGTPTDADLG-FVRNEDAKRYIRQLPQHPRQSLAQVF  169 (217)
Q Consensus        92 ~~~~~~~~Diwslg~~l~~l~~~~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (217)
                      .+.+..+.|+|||||++..++..+.|| .+.++.+++-+|.+.+|...-.... ...-.-..++-.-+.+..+..|+.+.
T Consensus       207 y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi  286 (338)
T KOG0668|consen  207 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFI  286 (338)
T ss_pred             chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhC
Confidence            888999999999999999999988776 5778899999999888764211100 00000001111122233444555544


Q ss_pred             C-----CCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          170 P-----HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       170 ~-----~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      +     -++++++||+.++|.+|..+|+|+.|++.||||...
T Consensus       287 ~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  287 NSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             CccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            3     267999999999999999999999999999999854

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=1.7e-30  Score=201.31  Aligned_cols=174  Identities=25%  Similarity=0.350  Sum_probs=134.4

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~   76 (217)
                      |++|.+++++    ...+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus       104 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  183 (286)
T cd06638         104 GGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT  183 (286)
T ss_pred             CCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCcccc
Confidence            5788888753    3568999999999999999999999999999999999999999999999999987654322 2233


Q ss_pred             ccccccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           77 YVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      ..++..|+|||.+..    ...++.++|+||+||++|++++|..||..............   ..               
T Consensus       184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~---------------  245 (286)
T cd06638         184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NP---------------  245 (286)
T ss_pred             ccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cC---------------
Confidence            457888999998743    23367899999999999999999999976543222211100   00               


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                               ... ......++..+.++|.+||+.||.+|||+.++++|+||
T Consensus       246 ---------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 ---------PPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ---------CCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                     000 00112346789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-32  Score=231.20  Aligned_cols=174  Identities=26%  Similarity=0.394  Sum_probs=146.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-----cccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-----FMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~   76 (217)
                      ||+|.+.++.++..++.....+..|++.|++|||++|||||||||.||+++.+|.+|++|||.+.....+.     ....
T Consensus      1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred             cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence            78999999999999999999999999999999999999999999999999999999999999997765542     2345


Q ss_pred             ccccccccCcccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHHHHH
Q 027927           77 YVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~--~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (217)
                      ..||+.|+|||++.+..  .-.-++|||||||++.||++|..||...+. ++++..... +.                  
T Consensus      1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-gh------------------ 1458 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-GH------------------ 1458 (1509)
T ss_pred             hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-cC------------------
Confidence            78899999999997654  235689999999999999999999976553 333332221 11                  


Q ss_pred             HHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                                 .++++..+|++..+||+.||..||++|++++|++.|-|-+.
T Consensus      1459 -----------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1459 -----------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             -----------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence                       12333458899999999999999999999999999998773

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=3.1e-30  Score=200.91  Aligned_cols=178  Identities=25%  Similarity=0.367  Sum_probs=135.9

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++.. +..+++..+..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        97 ~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  176 (296)
T cd06618          97 STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAG  176 (296)
T ss_pred             CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCC
Confidence            4456666655 4679999999999999999999997 5999999999999999999999999999876544333334456


Q ss_pred             cccccCcccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           80 TRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        80 ~~~~~~Pe~~~~~---~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      +..|++||.+...   ...+.++|+||+|+++|++++|..||..... .+....+..   ....                
T Consensus       177 ~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~----------------  237 (296)
T cd06618         177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEPP----------------  237 (296)
T ss_pred             CccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCCC----------------
Confidence            7789999988543   2357789999999999999999999965322 222222111   0000                


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                              .. .....++.++.+++.+||+.||.+|||++++++|+||+...
T Consensus       238 --------~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         238 --------SL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             --------CC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence                    00 00113568899999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=2.4e-30  Score=197.51  Aligned_cols=168  Identities=26%  Similarity=0.367  Sum_probs=137.1

Q ss_pred             CccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC
Q 027927            2 DTDLYQIIRSN---------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (217)
                      |++|.+++...         ..+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            68999999886         789999999999999999999999999999999999999999999999999987655432


Q ss_pred             ---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCch
Q 027927           73 ---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE  148 (217)
Q Consensus        73 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (217)
                         ......++..|+|||.+... .++.++|+||+|++++++++ |..||...........+...  .            
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~------------  224 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--Y------------  224 (262)
T ss_pred             ccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C------------
Confidence               12334557789999988655 47889999999999999998 69999877654444333320  0            


Q ss_pred             HHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                      .......+++++.+++.+||..+|.+|||+.+++++
T Consensus       225 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 ----------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ----------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                            001123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=1.4e-30  Score=205.65  Aligned_cols=203  Identities=20%  Similarity=0.257  Sum_probs=137.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-----
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-----   74 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----   74 (217)
                      +++|.+++++.  ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++||+.+.........     
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            46888988875  45899999999999999999999999999999999999999999999999754322111100     


Q ss_pred             ---ccccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHH
Q 027927           75 ---TEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        75 ---~~~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                         ....++..|++||.+.+. ..++.++|+||+|++++++++|..||..............   .+....+........
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  239 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK---GPPYSPLDITTFPCE  239 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc---CCCCCCccccccchh
Confidence               011234569999998654 3367899999999999999999999987654433322221   111111100000000


Q ss_pred             HHHHH------------hC-------CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          151 KRYIR------------QL-------PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       151 ~~~~~------------~~-------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      .....            ..       ..............+++.+.+|+++||+.||++|||++++++||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence            00000            00       00000000111234668899999999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=7.1e-31  Score=202.61  Aligned_cols=177  Identities=25%  Similarity=0.402  Sum_probs=139.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      +++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++++|||.+........ .....++
T Consensus        86 ~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06642          86 GGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT  164 (277)
T ss_pred             CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCc
Confidence            4688888865 5789999999999999999999999999999999999999999999999998866543322 1223567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+. .++.++|+||+|++++++++|..||...........+..                           .
T Consensus       165 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---------------------------~  216 (277)
T cd06642         165 PFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK---------------------------N  216 (277)
T ss_pred             ccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc---------------------------C
Confidence            789999988654 478899999999999999999999865443222111100                           0


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCce
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCI  210 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~  210 (217)
                      .   ........+.++.+++.+||+.+|.+|||+.++++||||+......
T Consensus       217 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06642         217 S---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKT  263 (277)
T ss_pred             C---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhH
Confidence            0   0111224668899999999999999999999999999998765444

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.1e-30  Score=196.95  Aligned_cols=167  Identities=19%  Similarity=0.230  Sum_probs=133.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc----cc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----EY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~----~~   77 (217)
                      +++|.+++.++..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+..........    ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~  158 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG  158 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence            57899999998899999999999999999999999999999999999999999999999999987654332211    11


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+... .++.++|+||||+++|++++ |..||...........+....  .                   
T Consensus       159 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~-------------------  216 (257)
T cd05060         159 RWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--R-------------------  216 (257)
T ss_pred             cccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--c-------------------
Confidence            123569999988544 47889999999999999997 999997766544333322100  0                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......+++.+.++|.+||..+|++|||+.++++
T Consensus       217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                     0122346788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=221.55  Aligned_cols=179  Identities=24%  Similarity=0.356  Sum_probs=154.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~   79 (217)
                      ||+|-.++.+..++|++.++.++..|+.||..||+.|+|||||||+|||++..|.++|+|||.+-++...+.  .....|
T Consensus       159 GGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVG  238 (1317)
T KOG0612|consen  159 GGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVG  238 (1317)
T ss_pred             CchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccC
Confidence            899999999999999999999999999999999999999999999999999999999999999887765443  356789


Q ss_pred             cccccCcccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           80 TRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        80 ~~~~~~Pe~~~~~----~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ||.|+|||++...    +.++...|.||+||++|+|+.|.-||....-.+.+.+|+........+.              
T Consensus       239 TPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~--------------  304 (1317)
T KOG0612|consen  239 TPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD--------------  304 (1317)
T ss_pred             CCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc--------------
Confidence            9999999999632    4578899999999999999999999999888888998887522221110              


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC---HhhhccCCCCccccC
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT---GEFFVPYKPFQCCCG  208 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~~ll~~~~f~~~~~  208 (217)
                                   ...+|.++++||++++. +|..|..   ++++-+||||.+..+
T Consensus       305 -------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  305 -------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             -------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence                         12488999999999887 6777888   999999999997654

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4e-30  Score=195.61  Aligned_cols=171  Identities=27%  Similarity=0.455  Sum_probs=139.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      +++|.+++.+...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus        83 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  162 (254)
T cd06627          83 NGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGT  162 (254)
T ss_pred             CCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccc
Confidence            468999999889999999999999999999999999999999999999999999999999999876554332 2334567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.... .+.++|+|++|++++++++|..||...........+..   .                        
T Consensus       163 ~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~------------------------  214 (254)
T cd06627         163 PYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---D------------------------  214 (254)
T ss_pred             hhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---c------------------------
Confidence            7899999886554 78899999999999999999999976543222222111   0                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                         ........++..+.+++.+||..+|++|||+.+++.||||
T Consensus       215 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 ---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence               0011233567899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=3.7e-30  Score=200.60  Aligned_cols=168  Identities=23%  Similarity=0.288  Sum_probs=129.3

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.++++++.                .++...+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  166 (297)
T cd05089          87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS  166 (297)
T ss_pred             CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCC
Confidence            468999987643                5889999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      ..............+..|++||...... ++.++|+||||+++|++++ |..||...........+....          
T Consensus       167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~----------  235 (297)
T cd05089         167 RGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----------  235 (297)
T ss_pred             ccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC----------
Confidence            5332211111122245699999885544 7889999999999999997 999997765444333221100          


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                          ....+..+++.+.+++.+||+.+|.+|||++++++.
T Consensus       236 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 --------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                001123467899999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=5.7e-30  Score=200.43  Aligned_cols=174  Identities=26%  Similarity=0.379  Sum_probs=136.6

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......   ....++
T Consensus        98 ~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~  174 (307)
T cd06607          98 LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGT  174 (307)
T ss_pred             CCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CCccCC
Confidence            4567777754 467999999999999999999999999999999999999999999999999987654332   233567


Q ss_pred             ccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        81 ~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ..|++||.+.+  ...++.++|+||+|+++|++++|..||...........+..  ...+.                   
T Consensus       175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~-------------------  233 (307)
T cd06607         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NDSPT-------------------  233 (307)
T ss_pred             ccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--CCCCC-------------------
Confidence            78999998742  34477899999999999999999999977654433222211  00000                   


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                              ......+..+.++|.+||+.+|.+|||+.+++.||||....
T Consensus       234 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         234 --------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             --------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                    00112567899999999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=4.3e-30  Score=199.64  Aligned_cols=167  Identities=22%  Similarity=0.347  Sum_probs=131.2

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.+++..+.                .++...+..++.||+.|+++||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a  170 (291)
T cd05094          91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS  170 (291)
T ss_pred             CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcc
Confidence            578999997653                3889999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      ........   .....++..|++||.+.+.. ++.++|+||+|+++|++++ |..||...........+..  +..    
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~----  243 (291)
T cd05094         171 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ--GRV----  243 (291)
T ss_pred             cccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC--CCC----
Confidence            65443221   12234567899999886544 7889999999999999998 9999977665443332211  000    


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                              .......+..+.+++.+||+.+|++|||++++++
T Consensus       244 ------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         244 ------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence                                    0111235688999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=4.7e-30  Score=199.19  Aligned_cols=167  Identities=21%  Similarity=0.332  Sum_probs=131.2

Q ss_pred             CccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccC
Q 027927            2 DTDLYQIIRSNQ-------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (217)
Q Consensus         2 ~~~L~~~l~~~~-------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   68 (217)
                      +++|.++++.++             .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  170 (288)
T cd05093          91 HGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV  170 (288)
T ss_pred             CCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccc
Confidence            578999997654             4899999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           69 SENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        69 ~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      .....   .....++..|+|||.+.+. .++.++|+||||++++++++ |..||...........+...  ..       
T Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~--~~-------  240 (288)
T cd05093         171 YSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG--RV-------  240 (288)
T ss_pred             cCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--Cc-------
Confidence            33221   1223345679999988654 47889999999999999998 89999776544433333220  00       


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                           .......++++.+++.+||+.||.+|||+.+++.
T Consensus       241 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         241 ---------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                 0011246688999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.3e-31  Score=213.46  Aligned_cols=176  Identities=22%  Similarity=0.355  Sum_probs=154.7

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +|+++++++.+++++.+..++.++.|++.|++|||+++|+|||+|++|++++.+..++|+|||++..+.......+.+|+
T Consensus       138 ~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgs  217 (596)
T KOG0586|consen  138 SGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGS  217 (596)
T ss_pred             cCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCCC
Confidence            47899999999999999999999999999999999999999999999999999999999999999999888888899999


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|.|||.+.+....++.+|+|++|+++|-+++|..||.+.+-.....+.                              
T Consensus       218 ppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------------------------------  267 (596)
T KOG0586|consen  218 PPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------------------------------  267 (596)
T ss_pred             CCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh------------------------------
Confidence            99999999988887799999999999999999999999886522211111                              


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                       ....-.++..++.++.++|+++|..+|.+|++.+++..|.|.....
T Consensus       268 -l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  268 -LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             -eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence             1112233345788999999999999999999999999999998553

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=5.7e-30  Score=197.78  Aligned_cols=167  Identities=25%  Similarity=0.285  Sum_probs=131.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc---ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~   77 (217)
                      +++|.++++.+ +.+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||++.........   ...
T Consensus        92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~  171 (279)
T cd05109          92 YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG  171 (279)
T ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCC
Confidence            57899999874 67999999999999999999999999999999999999999999999999998765433221   112


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|++||...+.. ++.++|+||||+++|++++ |..||...........+.. ...+                   
T Consensus       172 ~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~-------------------  230 (279)
T cd05109         172 KVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL-------------------  230 (279)
T ss_pred             ccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC-------------------
Confidence            3356799999886554 7889999999999999998 8899876544333222211 1100                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ......+.++.+++.+||+.||++|||+.+++.
T Consensus       231 ----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 ----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      011246688999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=1.1e-29  Score=199.36  Aligned_cols=173  Identities=26%  Similarity=0.387  Sum_probs=137.3

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      .++|.+++.. ..++++..+..++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||.+.....   .....++
T Consensus       104 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~  180 (313)
T cd06633         104 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGT  180 (313)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCcccc
Confidence            4677777765 46799999999999999999999999999999999999999999999999998754322   2244667


Q ss_pred             ccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        81 ~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ..|++||.+..  ...++.++|+||+|++++++++|..||...........+.... .+                     
T Consensus       181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------  238 (313)
T cd06633         181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP---------------------  238 (313)
T ss_pred             ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC---------------------
Confidence            88999998742  2346789999999999999999999997765544443332110 00                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ......++..+.+++.+||+.+|.+||++.++++||||+..
T Consensus       239 -------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         239 -------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             -------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                   00112356779999999999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=6.5e-30  Score=198.82  Aligned_cols=176  Identities=26%  Similarity=0.477  Sum_probs=138.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      +++|.+++.. +.+++..+..++.|++.|+++||+.|++|+||+|.||+++.++.++++|||.+....... ......++
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            4678887754 568999999999999999999999999999999999999999999999999876543322 12234567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+. .++.++|+||+|+++|++++|..||...........+....  +                       
T Consensus       180 ~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~-----------------------  233 (292)
T cd06657         180 PYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--P-----------------------  233 (292)
T ss_pred             ccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--C-----------------------
Confidence            889999987544 47889999999999999999999998765443333222100  0                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                        ... .....+++.+.+++.+||..+|.+||++.++++||||....
T Consensus       234 --~~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         234 --PKL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             --ccc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence              000 01124678899999999999999999999999999999664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-31  Score=204.32  Aligned_cols=177  Identities=27%  Similarity=0.395  Sum_probs=146.4

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      ||+|.=.|-+.+  -+++..+..++.+|+.||++||+.+||+||+||+|||+|..|.++|+|+|+|..+..........|
T Consensus       269 GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvG  348 (591)
T KOG0986|consen  269 GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVG  348 (591)
T ss_pred             CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccC
Confidence            566666666654  799999999999999999999999999999999999999999999999999999888888888899


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      |..|+|||++.+.. ++.+.|.|+|||++|+|+.|+.||........                    .++..+.....  
T Consensus       349 T~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--------------------~eEvdrr~~~~--  405 (591)
T KOG0986|consen  349 TVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--------------------REEVDRRTLED--  405 (591)
T ss_pred             cccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------------------HHHHHHHHhcc--
Confidence            99999999997766 99999999999999999999999976432111                    11111111111  


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                           -.++...+|++++++++.+|..||++|.     .+.++-+||+|+..
T Consensus       406 -----~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  406 -----PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             -----hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence                 1233457899999999999999999996     46699999999965

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=1.2e-29  Score=193.34  Aligned_cols=170  Identities=26%  Similarity=0.407  Sum_probs=137.4

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      +++|.+++.+    ...+++..+..++.|++.||++||+.|++|+||+|.||+++.++.++|+|||.+...... .....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~  161 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQ  161 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccccc
Confidence            5688888866    467899999999999999999999999999999999999999999999999998765544 33345


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|.+||.+.+. .++.++|+||+|++++++++|..||...+.......+...                        
T Consensus       162 ~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------------------  216 (256)
T cd08530         162 IGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG------------------------  216 (256)
T ss_pred             cCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------------
Confidence            577889999998654 4788999999999999999999999876644332222110                        


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                            .........+.++.+++.+||+.+|.+|||+.++++||+.
T Consensus       217 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 ------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                  0011122466889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=8.3e-30  Score=196.81  Aligned_cols=167  Identities=23%  Similarity=0.375  Sum_probs=131.8

Q ss_pred             CccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc
Q 027927            2 DTDLYQIIRSNQ--------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (217)
Q Consensus         2 ~~~L~~~l~~~~--------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   67 (217)
                      |++|.++++.++              .+++..+..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        92 ~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~  171 (280)
T cd05049          92 HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD  171 (280)
T ss_pred             CCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCccccee
Confidence            578999987653              478999999999999999999999999999999999999999999999998865


Q ss_pred             CCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcccc
Q 027927           68 TSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        68 ~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  143 (217)
                      ......   .....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+..  +.       
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~--~~-------  241 (280)
T cd05049         172 VYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ--GR-------  241 (280)
T ss_pred             cccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC-------
Confidence            432221   12233457799999886544 7889999999999999998 9999977665444333321  00       


Q ss_pred             ccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                           .......++..+.+++++||..||.+|||+.|+++
T Consensus       242 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         242 ---------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             ---------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                 01112246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=1.1e-29  Score=194.53  Aligned_cols=167  Identities=23%  Similarity=0.365  Sum_probs=131.6

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc--cc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~   77 (217)
                      +++|.+++...  ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..........  ..
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~  165 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  165 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence            57899999764  468999999999999999999999999999999999999999999999999987654432211  12


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+..|++||.+.+. ..+.++|+||||+++|++++ |..||.+.........+.....                     
T Consensus       166 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------------  223 (263)
T cd05052         166 KFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---------------------  223 (263)
T ss_pred             CCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---------------------
Confidence            234579999988554 47889999999999999998 8999977654433333221000                     


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......+++++.+++.+||..+|++|||+.++++
T Consensus       224 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         224 ---------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                     0112346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=7.6e-30  Score=198.12  Aligned_cols=179  Identities=23%  Similarity=0.387  Sum_probs=138.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~   79 (217)
                      |++|.+++....++++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........  .....+
T Consensus        89 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  168 (290)
T cd05613          89 GGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG  168 (290)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccC
Confidence            578999999988999999999999999999999999999999999999999999999999998865433221  123456


Q ss_pred             cccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|++||.+... ...+.++|+||+|+++|++++|..||...........+.......                    .
T Consensus       169 ~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------------------~  228 (290)
T cd05613         169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--------------------E  228 (290)
T ss_pred             CcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--------------------C
Confidence            7889999988643 235678999999999999999999996432211111111110000                    0


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~~  207 (217)
                             ......+++.+.+++++||+.||.+||     ++++++.||||+..-
T Consensus       229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence                   011224678899999999999999997     899999999999663

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=7.6e-30  Score=202.15  Aligned_cols=157  Identities=27%  Similarity=0.399  Sum_probs=122.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccccccccccCccccc
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELLL   90 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~Pe~~~   90 (217)
                      +++...+..++.||+.||+|||++|++||||||.||+++.++.++|+|||++........   .....++..|+|||.+.
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  248 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF  248 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence            689999999999999999999999999999999999999999999999999876533221   11223456799999886


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhC
Q 027927           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (217)
Q Consensus        91 ~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (217)
                      +.. ++.++|+||+||+++++++ |..||.+....+...........+                             ...
T Consensus       249 ~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~  298 (337)
T cd05054         249 DKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-----------------------------RAP  298 (337)
T ss_pred             CCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-----------------------------CCC
Confidence            554 8899999999999999997 999997644322222221110000                             011


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          170 PHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       170 ~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                      ...++++.+++.+||+.+|++||++.+++++
T Consensus       299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3.8e-30  Score=185.83  Aligned_cols=167  Identities=21%  Similarity=0.293  Sum_probs=126.5

Q ss_pred             ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            3 TDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |||.+++++ +.++++..+..++.||+.||+|||+++      ||+||+++.++.+++  ||.+.......    ..+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            689999987 467999999999999999999999998      999999999999999  99876544322    25789


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      .|+|||.+.+.. ++.++||||+||++|++++|..||...... .....+...........                   
T Consensus        69 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  128 (176)
T smart00750       69 YFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-------------------  128 (176)
T ss_pred             cccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-------------------
Confidence            999999996554 788999999999999999999999654332 11222211110000000                   


Q ss_pred             CccchhhhCCCCC--hhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVH--PLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~--~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                       ..    ....++  .++.++|.+||..+|.+|||+.++++|+|+...
T Consensus       129 -~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      129 -RS----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             -cc----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence             00    000122  369999999999999999999999999987643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=8.4e-30  Score=194.31  Aligned_cols=171  Identities=27%  Similarity=0.443  Sum_probs=135.6

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC-EEEecccccccCCCCCc-cccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEF-MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~-~~l~d~~~~~~~~~~~~-~~~~   77 (217)
                      +++|.+++....  .+++..+..++.|++.||++||+.+++|+||+|+||+++.++. ++++|||.+........ ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  162 (257)
T cd08225          83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC  162 (257)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccccc
Confidence            578999887653  5899999999999999999999999999999999999998865 69999998866544322 2233


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|.|||.+.+.. ++.++|+||+|++++++++|..||...........+...   .                    
T Consensus       163 ~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~--------------------  218 (257)
T cd08225         163 VGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG---Y--------------------  218 (257)
T ss_pred             CCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---c--------------------
Confidence            5677899999875543 788999999999999999999999766543333222110   0                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                             .....+..+.++.++|.+||..+|++|||+.++++||||
T Consensus       219 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 -------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                   011123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.3e-29  Score=196.69  Aligned_cols=184  Identities=27%  Similarity=0.422  Sum_probs=134.6

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      |++|.+++..    ...++...+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~  163 (287)
T cd06621          85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-AGTF  163 (287)
T ss_pred             CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-cccc
Confidence            5678777643    3568999999999999999999999999999999999999999999999999876543322 1233


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH--VHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      .++..|++||.+.+. .++.++|+|++|+++|++++|..||.....  ..... .                    .....
T Consensus       164 ~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~--------------------~~~~~  221 (287)
T cd06621         164 TGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE-L--------------------LSYIV  221 (287)
T ss_pred             cCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH-H--------------------HHHHh
Confidence            567789999988544 478899999999999999999999975521  00000 0                    00110


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      .................++.+.++|.+||..+|++|||+.|++.||||++...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            00000000000000123577999999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=8.8e-30  Score=197.57  Aligned_cols=181  Identities=22%  Similarity=0.339  Sum_probs=138.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~   79 (217)
                      |++|.+++..+..+++..+..++.|++.||++||+.+++|+||+|.||+++.++.++++|||.+........  .....+
T Consensus        89 ~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  168 (288)
T cd05583          89 GGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG  168 (288)
T ss_pred             CCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccC
Confidence            568999998888899999999999999999999999999999999999999999999999998765433221  122356


Q ss_pred             cccccCcccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~-~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|++||.+.+.. ..+.++|+||+|++++++++|..||...........+.+.                   ..... 
T Consensus       169 ~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-------------------~~~~~-  228 (288)
T cd05583         169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR-------------------ILKSK-  228 (288)
T ss_pred             CccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH-------------------HHccC-
Confidence            78899999875433 2577999999999999999999999643221111111110                   00000 


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC---HhhhccCCCCccccCc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT---GEFFVPYKPFQCCCGC  209 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~~ll~~~~f~~~~~~  209 (217)
                             ......+++.+.+++.+||+.||++|||   +.++++||||++...+
T Consensus       229 -------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         229 -------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             -------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                   0112346788999999999999999998   5677999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=1.4e-29  Score=193.38  Aligned_cols=168  Identities=19%  Similarity=0.300  Sum_probs=132.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc--ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~   78 (217)
                      +++|.+++... ..+++..+..++.||+.||++||+.|++|+||+|.||+++.++.++++|||.+..........  ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK  162 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence            57899999875 478999999999999999999999999999999999999999999999999876544332211  123


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ++..|++||.+.+.. ++.++|+||||+++|++++ |..||...........+......                     
T Consensus       163 ~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  220 (256)
T cd05113         163 FPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------------------  220 (256)
T ss_pred             cChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---------------------
Confidence            346799999886544 7889999999999999998 99999766544443333221100                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                               ......+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       221 ---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ---------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                     0111356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=1.1e-29  Score=195.99  Aligned_cols=168  Identities=23%  Similarity=0.360  Sum_probs=130.7

Q ss_pred             CccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC---CEEEecccccccCCCC
Q 027927            2 DTDLYQIIRSNQ-------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSEN   71 (217)
Q Consensus         2 ~~~L~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~   71 (217)
                      |++|.+++...+       .+++..+..++.||+.||+|||+++++|+||+|+||+++.++   .++|+|||.+......
T Consensus        93 g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~  172 (277)
T cd05036          93 GGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA  172 (277)
T ss_pred             CCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCc
Confidence            679999997753       489999999999999999999999999999999999998765   5899999998765322


Q ss_pred             Ccc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           72 EFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        72 ~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      ...   .....+..|++||.+.+.. ++.++|+|||||++|++++ |..||...........+.... .           
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~-----------  239 (277)
T cd05036         173 SYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R-----------  239 (277)
T ss_pred             cceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c-----------
Confidence            211   1222345799999986554 8899999999999999996 999998765544332221100 0           


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                        ...+..++..+.+++++||+.+|.+|||+.++++|
T Consensus       240 ------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 ------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                              01123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=211.14  Aligned_cols=172  Identities=20%  Similarity=0.344  Sum_probs=143.6

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW   82 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~   82 (217)
                      |-|+.+|+..+.+++.....|.++|+.|++|||.+.|+|||+|.-|||+..+..+||+|||-++........-...||..
T Consensus       197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVa  276 (904)
T KOG4721|consen  197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVA  276 (904)
T ss_pred             ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHh
Confidence            57999999999999999999999999999999999999999999999999999999999999877766666667899999


Q ss_pred             ccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCc
Q 027927           83 YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR  162 (217)
Q Consensus        83 ~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (217)
                      |+|||++.+.+ ++.+.|||||||+||+|++|..||.+-+...++      +|.-...                      
T Consensus       277 WMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAII------wGVGsNs----------------------  327 (904)
T KOG4721|consen  277 WMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII------WGVGSNS----------------------  327 (904)
T ss_pred             hhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeE------EeccCCc----------------------
Confidence            99999997665 899999999999999999999999775432221      1111000                      


Q ss_pred             cchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          163 QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                       ..-..+...+..|+=||++||+-.|..||++++++.|--+.
T Consensus       328 -L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  328 -LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             -ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence             00112335678899999999999999999999999986544

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=8.8e-30  Score=200.16  Aligned_cols=168  Identities=23%  Similarity=0.263  Sum_probs=131.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccc---c
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---Y   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~---~   77 (217)
                      +++|.++++++ ..++...+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+...........   .
T Consensus        92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  171 (316)
T cd05108          92 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG  171 (316)
T ss_pred             CCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCC
Confidence            57899999885 5689999999999999999999999999999999999999999999999999976554332211   2


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+..|++||.+.+. .++.++|+||||+++|++++ |..||.+....... .+.+.....                   
T Consensus       172 ~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~-------------------  230 (316)
T cd05108         172 KVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL-------------------  230 (316)
T ss_pred             ccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCC-------------------
Confidence            235579999988654 47889999999999999987 89999765543322 222211000                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                ...+..+.++.+++.+||..+|.+|||+.+++.+
T Consensus       231 ----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         231 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      0112356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.1e-29  Score=196.70  Aligned_cols=186  Identities=26%  Similarity=0.392  Sum_probs=138.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +++|.+++.+.++++...+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...... ......++
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~  165 (284)
T cd06620          87 CGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFVGT  165 (284)
T ss_pred             CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCccccC
Confidence            57899999988899999999999999999999997 68999999999999999999999999987544322 12234678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+. .++.++|+||+||+++++++|..||..........                ................
T Consensus       166 ~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~  228 (284)
T cd06620         166 STYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ----------------DDPMGILDLLQQIVQE  228 (284)
T ss_pred             cccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh----------------hhhhHHHHHHHHHhhc
Confidence            889999988654 47889999999999999999999997644321000                0000000000000000


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      .....  ....++.++.+++.+||+.||.+|||++|+++|+||.+.+
T Consensus       229 ~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         229 PPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             cCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            00000  0012567899999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=4.3e-30  Score=199.89  Aligned_cols=176  Identities=24%  Similarity=0.446  Sum_probs=136.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      |++|.+++.+ ..++...+..++.|++.|+++||++|++|+|++|+||+++.++.++|+|||.+....... ......++
T Consensus       100 ~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  178 (293)
T cd06647         100 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  178 (293)
T ss_pred             CCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCC
Confidence            5789998876 458899999999999999999999999999999999999999999999999875443322 22234567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|++||.+... .++.++|+||+|+++|++++|..||...........+.. .+.+                       
T Consensus       179 ~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~-----------------------  233 (293)
T cd06647         179 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-----------------------  233 (293)
T ss_pred             hhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC-----------------------
Confidence            789999988654 478899999999999999999999976543222111100 0000                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                         . ......++..+.++|++||..+|.+||++++++.|+||++..
T Consensus       234 ---~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         234 ---E-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ---C-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence               0 001223567899999999999999999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=9.7e-30  Score=204.15  Aligned_cols=156  Identities=25%  Similarity=0.374  Sum_probs=120.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc---ccccccccccCccccc
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEYVVTRWYRAPELLL   90 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~Pe~~~   90 (217)
                      +++...+.+++.||+.||+|||++|++||||||+||+++.++.++|+|||++.........   ....++..|+|||.+.
T Consensus       208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  287 (374)
T cd05106         208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF  287 (374)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhc
Confidence            5788999999999999999999999999999999999999999999999998654432211   1122345799999886


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhC
Q 027927           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (217)
Q Consensus        91 ~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (217)
                      +. .++.++|+||+|+++|++++ |..||..................+                             ...
T Consensus       288 ~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-----------------------------~~~  337 (374)
T cd05106         288 DC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-----------------------------SRP  337 (374)
T ss_pred             CC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-----------------------------cCC
Confidence            54 47899999999999999996 999997654322222222110000                             011


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          170 PHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       170 ~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ...++++.+++.+||+.||.+|||+.++++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            235689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-29  Score=193.92  Aligned_cols=170  Identities=22%  Similarity=0.451  Sum_probs=136.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC----Cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----EFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~----~~~~~~   77 (217)
                      +++|.+++.+...+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......    ......
T Consensus        90 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (264)
T cd06653          90 GGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV  169 (264)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCcccccc
Confidence            5789999998888999999999999999999999999999999999999999999999999998654321    111234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|++||.+.+.. .+.++|+||||++++++++|..||...........+   ...+..                  
T Consensus       170 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~------------------  227 (264)
T cd06653         170 TGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTK------------------  227 (264)
T ss_pred             CCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCCC------------------
Confidence            5678899999886544 788999999999999999999999765433322221   111111                  


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                              ...+..+++.+.+++++||. +|.+|||+.+++.|||
T Consensus       228 --------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~  263 (264)
T cd06653         228 --------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF  263 (264)
T ss_pred             --------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence                    12334577899999999999 5799999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.1e-29  Score=192.72  Aligned_cols=167  Identities=25%  Similarity=0.339  Sum_probs=132.4

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc--cc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~   77 (217)
                      |++|.++++...  .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+..........  ..
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA  164 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence            689999998754  79999999999999999999999999999999999999999999999999987665332211  11


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+..|++||.+... .++.++|+||||++++++++ |..||.+.........+......                    
T Consensus       165 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------  223 (261)
T cd05068         165 KFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM--------------------  223 (261)
T ss_pred             cCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            223469999988544 47889999999999999998 99999776654444333221100                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ......+..+.+++.+||+.+|.+||+++++++
T Consensus       224 ----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 ----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                      011245688999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=199.25  Aligned_cols=179  Identities=25%  Similarity=0.407  Sum_probs=146.8

Q ss_pred             ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            3 TDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         3 ~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      |++.|+++.. ++|+++++..+++..+.||.|||...-+|||||..||+++.+|..||+|||.+..+...- ..++..|+
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGT  192 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGT  192 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccC
Confidence            6889999875 889999999999999999999999999999999999999999999999999997665432 23567899


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++..-+ +...+||||||++..++..|.+|+.+-.++.   .|+..-..|                       
T Consensus       193 PFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~P-----------------------  245 (502)
T KOG0574|consen  193 PFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKP-----------------------  245 (502)
T ss_pred             cccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCC-----------------------
Confidence            9999999997655 7899999999999999999999997654321   111110111                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCce
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCI  210 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~  210 (217)
                        ++--..+...|.+|.||+++||...|++|.|+-++++|+|++++.||.
T Consensus       246 --PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  246 --PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             --CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence              111111223568899999999999999999999999999999998885

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.5e-29  Score=198.20  Aligned_cols=173  Identities=28%  Similarity=0.405  Sum_probs=135.7

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +++|.+++.. ..++++..+..++.|++.|+.+||+.+++|+||+|.||+++.++.++++|||.+......   ....++
T Consensus        98 ~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~  174 (308)
T cd06634          98 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGT  174 (308)
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---ccccCC
Confidence            4577777754 467999999999999999999999999999999999999999999999999987654432   233567


Q ss_pred             ccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        81 ~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ..|+|||.+..  ....+.++|+||||++++++++|..||...........+.... .+                     
T Consensus       175 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------  232 (308)
T cd06634         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP---------------------  232 (308)
T ss_pred             ccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CC---------------------
Confidence            78999998742  2346779999999999999999999987654333322222100 00                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ......++..+.++|++||+.+|.+||++.++++|+|+...
T Consensus       233 -------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         233 -------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             -------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                   00112466889999999999999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.6e-29  Score=211.25  Aligned_cols=176  Identities=21%  Similarity=0.324  Sum_probs=119.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccCCCC--CccccccccccccCcccccCCC
Q 027927           17 EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSEN--EFMTEYVVTRWYRAPELLLNSS   93 (217)
Q Consensus        17 ~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~   93 (217)
                      ...+..++.||+.||+|||+++|+||||||+||+++. ++.++|+|||++......  .......+++.|+|||.+....
T Consensus       254 ~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~  333 (566)
T PLN03225        254 NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST  333 (566)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccC
Confidence            3457789999999999999999999999999999986 578999999998654322  2223456788999999764221


Q ss_pred             ---------------------CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           94 ---------------------DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        94 ---------------------~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                                           .+..++||||+||++|+++++..++  ......+.......+...            ..
T Consensus       334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~------------~~  399 (566)
T PLN03225        334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDL------------VA  399 (566)
T ss_pred             CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcH------------HH
Confidence                                 1223569999999999999865543  333333333333222211            01


Q ss_pred             HHHhCCCCCccch---hhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          153 YIRQLPQHPRQSL---AQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       153 ~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      +............   ............+||++||+.||++|||++++|+||||++.
T Consensus       400 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~  456 (566)
T PLN03225        400 WRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDRE  456 (566)
T ss_pred             HHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCC
Confidence            1111111111111   11122234557799999999999999999999999999865

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.9e-30  Score=224.52  Aligned_cols=173  Identities=19%  Similarity=0.215  Sum_probs=125.1

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC-------------------EEEe
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-------------------LKIC   60 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~-------------------~~l~   60 (217)
                      ++++|.++|.+. ..++...++.++.||+.||+|||++||+||||||+||+++..+.                   ++++
T Consensus        62 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~  141 (793)
T PLN00181         62 EDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSR  141 (793)
T ss_pred             CCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccc
Confidence            467999999764 56999999999999999999999999999999999999965444                   5555


Q ss_pred             cccccccCCCCC-----------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 027927           61 DFGLARPTSENE-----------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH  123 (217)
Q Consensus        61 d~~~~~~~~~~~-----------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~  123 (217)
                      |||++.......                 ......+++.|+|||.+.+.. ++.++|||||||++|||+++..|+.... 
T Consensus       142 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~-  219 (793)
T PLN00181        142 EIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS-  219 (793)
T ss_pred             ccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH-
Confidence            666553211000                 001134677899999986655 7899999999999999999887764321 


Q ss_pred             HHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                       .....+.... .+                        ..     .....+...+++.+||+.+|.+|||+.|+++||||
T Consensus       220 -~~~~~~~~~~-~~------------------------~~-----~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~  268 (793)
T PLN00181        220 -RTMSSLRHRV-LP------------------------PQ-----ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI  268 (793)
T ss_pred             -HHHHHHHHhh-cC------------------------hh-----hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence             1111111100 00                        00     00112556789999999999999999999999999


Q ss_pred             ccc
Q 027927          204 QCC  206 (217)
Q Consensus       204 ~~~  206 (217)
                      .+.
T Consensus       269 ~~~  271 (793)
T PLN00181        269 NEP  271 (793)
T ss_pred             hhh
Confidence            864

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=1.2e-29  Score=195.13  Aligned_cols=167  Identities=26%  Similarity=0.321  Sum_probs=127.9

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.+++++++                .++...+..++.|++.|++|||+.|++|+||+|+||+++.++.++++|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            578999997643                4789999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      ..............+..|+|||.+... .++.++|+||||++++++++ |..||...+.......+...           
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----------  227 (270)
T cd05047         160 RGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-----------  227 (270)
T ss_pred             cccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----------
Confidence            532211111112224569999988544 47889999999999999996 99999765543333222110           


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                   .   .   .......+.++.+++.+|++.+|.+|||+.++++
T Consensus       228 -------------~---~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 -------------Y---R---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------C---C---CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                         0   0   0111235688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=1.1e-29  Score=196.06  Aligned_cols=177  Identities=24%  Similarity=0.409  Sum_probs=139.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      +++|.+++.+ ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+........ .....++
T Consensus        86 ~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06641          86 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT  164 (277)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCC
Confidence            4688888876 5689999999999999999999999999999999999999999999999998865443221 2233567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|++||.+.+. ..+.++|+||+|++++++++|..||...........+..  +.                        
T Consensus       165 ~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~------------------------  217 (277)
T cd06641         165 PFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK--NN------------------------  217 (277)
T ss_pred             ccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc--CC------------------------
Confidence            789999988644 478899999999999999999999976543332222111  00                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCce
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCI  210 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~  210 (217)
                          .......++.++.+++.+||+.+|.+||++.++++||||.+.+...
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~  263 (277)
T cd06641         218 ----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKT  263 (277)
T ss_pred             ----CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhcc
Confidence                0011234678899999999999999999999999999999775433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=2e-29  Score=194.92  Aligned_cols=167  Identities=20%  Similarity=0.338  Sum_probs=130.7

Q ss_pred             CccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927            2 DTDLYQIIRSNQ---------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus         2 ~~~L~~~l~~~~---------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      +++|.++++.++               .++...+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~  170 (280)
T cd05092          91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR  170 (280)
T ss_pred             CCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCcee
Confidence            578999988753               48899999999999999999999999999999999999999999999999886


Q ss_pred             cCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccc
Q 027927           67 PTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADL  142 (217)
Q Consensus        67 ~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~  142 (217)
                      .......   .....+++.|++||.+.+.. ++.++|+||||+++|++++ |..||...........+...  ..     
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~-----  242 (280)
T cd05092         171 DIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG--RE-----  242 (280)
T ss_pred             EcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC--cc-----
Confidence            5433221   11223356799999886554 7889999999999999998 89999766544433322210  00     


Q ss_pred             cccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          143 GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                             ......+++.+.+++.+||+.||.+||++.++++
T Consensus       243 -----------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         243 -----------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                   0112246788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.8e-29  Score=192.73  Aligned_cols=168  Identities=18%  Similarity=0.263  Sum_probs=131.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc--ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~   78 (217)
                      |++|.++++.+ ..+++..+..++.|++.|+++||++|++|+||+|+||+++.++.++++|||.+..........  ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  162 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK  162 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence            57899999764 578999999999999999999999999999999999999999999999999886554322111  112


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+..|+|||.+.+.. ++.++|+||+|+++|++++ |..||....+......+.....                      
T Consensus       163 ~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------  219 (256)
T cd05059         163 FPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----------------------  219 (256)
T ss_pred             CCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc----------------------
Confidence            235699999886544 7889999999999999998 7999976654433332221000                      


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                              .......+..+.+++.+||+.+|++|||+.++++.
T Consensus       220 --------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 --------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             --------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                    01112367889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=1.8e-29  Score=194.74  Aligned_cols=168  Identities=21%  Similarity=0.348  Sum_probs=129.7

Q ss_pred             CccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC
Q 027927            2 DTDLYQIIRSNQ----------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (217)
Q Consensus         2 ~~~L~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~   71 (217)
                      +++|.+++++..          .++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  172 (277)
T cd05062          93 RGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  172 (277)
T ss_pred             CCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCc
Confidence            578999997632          3577889999999999999999999999999999999999999999999988654332


Q ss_pred             Ccc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           72 EFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        72 ~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      ...   ....++..|+|||.+.+. .++.++|+||||+++|++++ |..||.+.........+.....            
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~------------  239 (277)
T cd05062         173 DYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL------------  239 (277)
T ss_pred             ceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc------------
Confidence            221   112335679999988654 47899999999999999998 7889876654433332221100            


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                        .......+..+.+++.+||+.+|++|||+.+++++
T Consensus       240 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 ------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              01112456789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=3.8e-30  Score=196.87  Aligned_cols=167  Identities=29%  Similarity=0.442  Sum_probs=131.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~   76 (217)
                      +++|.+++...  ..++...+..++.||+.||+|||+++++|++|+++||+++.++.+||+|||+.........   ...
T Consensus        85 ~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~  164 (259)
T PF07714_consen   85 GGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSS  164 (259)
T ss_dssp             TEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            47999999997  7899999999999999999999999999999999999999999999999999876633222   123


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ......|.|||.+.... ++.++||||||+++|++++ |+.||...........+.+...                    
T Consensus       165 ~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------------------  223 (259)
T PF07714_consen  165 QQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------------------  223 (259)
T ss_dssp             SESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------------------
T ss_pred             ccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------------------
Confidence            34567799999986554 7899999999999999999 6899987765555444422110                    


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ......++..+.++|.+||+.+|.+|||+.++++
T Consensus       224 ----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 ----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                      1122346788999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=195.68  Aligned_cols=175  Identities=29%  Similarity=0.473  Sum_probs=152.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc-CCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~-~~~~~~~~~~~~~   80 (217)
                      ||+|+=.|...+.+++...+.+...|+.||.|||+++|++||+|.+|.+++.+|.+|++|||+++. +.......+.+|+
T Consensus       252 GGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGT  331 (516)
T KOG0690|consen  252 GGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGT  331 (516)
T ss_pred             CceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCC
Confidence            788888888889999999999999999999999999999999999999999999999999999864 4455667889999


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      |.|+|||++. ...++.+.|.|.+||++|+|++|..||...+...++..|...-                          
T Consensus       332 PEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed--------------------------  384 (516)
T KOG0690|consen  332 PEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED--------------------------  384 (516)
T ss_pred             hhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh--------------------------
Confidence            9999999995 4458999999999999999999999999888776666665411                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~~~  208 (217)
                           -.++..++++++.|+.++|..||++|.     .+.|+.+|+||....+
T Consensus       385 -----~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W  432 (516)
T KOG0690|consen  385 -----LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW  432 (516)
T ss_pred             -----ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence                 122336889999999999999999997     4789999999996544

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=2.4e-29  Score=193.43  Aligned_cols=167  Identities=24%  Similarity=0.352  Sum_probs=129.4

Q ss_pred             CccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-
Q 027927            2 DTDLYQIIRS------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-   74 (217)
Q Consensus         2 ~~~L~~~l~~------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-   74 (217)
                      +++|.+++..      ...++...+..++.|++.||+|||+++++|+||||+||+++.++.++++|||.+......... 
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  169 (272)
T cd05075          90 HGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR  169 (272)
T ss_pred             CCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCccccee
Confidence            4688887742      245899999999999999999999999999999999999999999999999998765433211 


Q ss_pred             --ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           75 --TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        75 --~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                        .....++.|.+||...+. .++.++|+||||+++|++++ |..||...........+... ..               
T Consensus       170 ~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~---------------  232 (272)
T cd05075         170 QGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NR---------------  232 (272)
T ss_pred             cCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CC---------------
Confidence              122345679999988654 47889999999999999998 78999776544333322210 00               


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                    ......++..+.++|.+||+.||.+|||++++++
T Consensus       233 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  266 (272)
T cd05075         233 --------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC  266 (272)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                          0112246688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=3.2e-29  Score=191.24  Aligned_cols=167  Identities=20%  Similarity=0.309  Sum_probs=132.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc--ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~   78 (217)
                      |++|.+++... ..++...+..++.|++.||+|||++|++|+||+|+||+++.++.++++|||.+..........  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK  162 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence            57899999764 568999999999999999999999999999999999999999999999999886544332221  223


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ++..|+|||.+.+. .++.++|+||+|+++|++++ |..||...+.......+......                     
T Consensus       163 ~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------------------  220 (256)
T cd05114         163 FPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------------------  220 (256)
T ss_pred             CchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---------------------
Confidence            34579999988644 47889999999999999999 89999876655444443321000                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ..+...+..+.+++.+||+.+|.+|||++++++
T Consensus       221 ---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 ---------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                     001124578999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=2.1e-29  Score=194.96  Aligned_cols=156  Identities=18%  Similarity=0.314  Sum_probs=123.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccccccccccCcccc
Q 027927           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELL   89 (217)
Q Consensus        13 ~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~Pe~~   89 (217)
                      ..++...+..++.|++.||++||++|++||||||+||+++.++.++|+|||++........   .....+++.|+|||.+
T Consensus       119 ~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (283)
T cd05091         119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI  198 (283)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHH
Confidence            3588899999999999999999999999999999999999999999999998765433221   1223345689999988


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhh
Q 027927           90 LNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV  168 (217)
Q Consensus        90 ~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (217)
                      .... ++.++|+||||+++|++++ |..||.+.........+.....                              ...
T Consensus       199 ~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------------------------------~~~  247 (283)
T cd05091         199 MYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV------------------------------LPC  247 (283)
T ss_pred             hcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc------------------------------CCC
Confidence            6544 7889999999999999998 8888877655444433332100                              011


Q ss_pred             CCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          169 FPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       169 ~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ....+..+.+++.+||+.+|.+||++.++++
T Consensus       248 ~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         248 PDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            2346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=3.7e-29  Score=193.35  Aligned_cols=167  Identities=22%  Similarity=0.258  Sum_probs=130.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~   77 (217)
                      +++|.+++... +.+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||.+........   ....
T Consensus        92 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  171 (279)
T cd05111          92 LGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH  171 (279)
T ss_pred             CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCC
Confidence            57999999764 6799999999999999999999999999999999999999999999999999865432221   1223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|++||.+.+.. ++.++|+||||+++|++++ |..||.+....... .+.+....+.                  
T Consensus       172 ~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~------------------  231 (279)
T cd05111         172 KTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLA------------------  231 (279)
T ss_pred             CCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCC------------------
Confidence            4556799999886544 7899999999999999998 99999776543322 2222111110                  


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 .....+.++.+++.+|+..+|++|||+.++++
T Consensus       232 -----------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 -----------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             -----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                       01124567899999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=8.2e-30  Score=199.22  Aligned_cols=168  Identities=26%  Similarity=0.322  Sum_probs=128.3

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.++++...                .++...+..++.|++.|+++||++|++||||+|+||+++.++.++|+|||++
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~  171 (303)
T cd05088          92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  171 (303)
T ss_pred             CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccC
Confidence            578999997643                5789999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      ..............+..|++||.+.+. .++.++|+||||++++++++ |..||...........+..   ..       
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~~-------  240 (303)
T cd05088         172 RGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GY-------  240 (303)
T ss_pred             cccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc---CC-------
Confidence            532211111112234569999987544 47889999999999999997 9999976554333222110   00       


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                       .   ......+++++.+++.+||+.+|.+|||+++++++
T Consensus       241 -----------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 -----------------R---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -----------------c---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             0   00112367889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=2.5e-29  Score=191.86  Aligned_cols=165  Identities=21%  Similarity=0.330  Sum_probs=130.1

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++++..  .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......  .....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~  161 (256)
T cd05082          84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKL  161 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--CCCcc
Confidence            468999998753  48999999999999999999999999999999999999999999999999886543322  12233


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|+|||.+... .++.++|+||+|+++|++++ |..||...........+...   .                     
T Consensus       162 ~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---~---------------------  216 (256)
T cd05082         162 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---Y---------------------  216 (256)
T ss_pred             ceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---C---------------------
Confidence            5679999988544 47889999999999999997 89998765543333222110   0                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                            ........++.+.+++.+||+.+|++|||+.++++
T Consensus       217 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 ------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                  00122346789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.97  E-value=2.4e-29  Score=193.10  Aligned_cols=167  Identities=18%  Similarity=0.225  Sum_probs=130.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc--ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~   78 (217)
                      +++|.+++... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++++|||............  ...
T Consensus        90 ~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  169 (266)
T cd05064          90 NGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGK  169 (266)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCC
Confidence            56899999875 579999999999999999999999999999999999999999999999999765433222111  123


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ++..|+|||.+.+. .++.++|+||+|+++|++++ |..||...........+.....                      
T Consensus       170 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----------------------  226 (266)
T cd05064         170 SPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR----------------------  226 (266)
T ss_pred             CceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----------------------
Confidence            35679999988654 47899999999999999775 9999987665443333221000                      


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                              ...+..++..+.+++.+||+.+|.+|||++++++
T Consensus       227 --------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 --------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                    0112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=3.2e-29  Score=195.14  Aligned_cols=173  Identities=16%  Similarity=0.228  Sum_probs=129.9

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--------cc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--------FM   74 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--------~~   74 (217)
                      .++.+.+......++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.......        ..
T Consensus       111 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~  190 (294)
T PHA02882        111 ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK  190 (294)
T ss_pred             cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccc
Confidence            4566777766668899999999999999999999999999999999999999999999999986543211        11


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+++.|+|||...+.. ++.++|+||+||+++++++|..||.+............                  .++.
T Consensus       191 ~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~------------------~~~~  251 (294)
T PHA02882        191 DLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK------------------CDFI  251 (294)
T ss_pred             cccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH------------------HHHH
Confidence            2245789999999886554 78999999999999999999999976532221111111                  0000


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      .......     ...+..++.+.++++.|+..+|.+||+..++++
T Consensus       252 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        252 KRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1111000     012245688999999999999999999999875

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=4.3e-29  Score=193.77  Aligned_cols=174  Identities=22%  Similarity=0.368  Sum_probs=134.1

Q ss_pred             CccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC
Q 027927            2 DTDLYQIIRSN----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (217)
Q Consensus         2 ~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~   71 (217)
                      +++|.+++++.          ...+...+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+......
T Consensus        93 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~  172 (288)
T cd05061          93 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET  172 (288)
T ss_pred             CCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcccccccc
Confidence            57999999763          23466788999999999999999999999999999999999999999999988654332


Q ss_pred             Ccc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           72 EFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        72 ~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      ...   ....++..|++||.+.+.. ++.++|+||+|+++|++++ |..||.+.........+... +.           
T Consensus       173 ~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~-----------  239 (288)
T cd05061         173 DYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GY-----------  239 (288)
T ss_pred             ccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC-----------
Confidence            211   1123356799999886543 7889999999999999998 78888776544433322210 00           


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc------CCCCccc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP------YKPFQCC  206 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~------~~~f~~~  206 (217)
                                        .......++.+.+++++||+.||.+|||+.++++      ||||...
T Consensus       240 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         240 ------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence                              0011235688999999999999999999999987      9999854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=3.6e-29  Score=191.24  Aligned_cols=167  Identities=19%  Similarity=0.261  Sum_probs=131.0

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----cc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   76 (217)
                      +++|.+++.. ...+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.........    ..
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            5789999976 467999999999999999999999999999999999999999999999999988654433221    11


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..++..|+|||.+.... ++.++|+||||+++|++++ |..||...........+... ..                   
T Consensus       158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~-------------------  216 (257)
T cd05115         158 GKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-KR-------------------  216 (257)
T ss_pred             CCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CC-------------------
Confidence            12246799999886544 7889999999999999996 99999876554433222110 00                   


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ...+...++++.++|.+||+.+|++||++.++.+
T Consensus       217 ----------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ----------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      0112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=3.7e-29  Score=191.23  Aligned_cols=170  Identities=28%  Similarity=0.484  Sum_probs=133.3

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~   76 (217)
                      +++|.+++..    ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++. +.++++|||.+...... .....
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~  164 (260)
T cd08222          86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATT  164 (260)
T ss_pred             CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcccccC
Confidence            4678777753    467999999999999999999999999999999999999975 57999999988654332 22233


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|++||.+.+. ..+.++|+||+|++++++++|..||...........+..  +..                   
T Consensus       165 ~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~-------------------  222 (260)
T cd08222         165 FTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPT-------------------  222 (260)
T ss_pred             CCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCC-------------------
Confidence            4567789999987543 467899999999999999999999976554333322211  000                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                               ......++.++.++|.+||..+|.+||++.++++||||
T Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 ---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                     01122467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=3.6e-29  Score=200.96  Aligned_cols=156  Identities=30%  Similarity=0.425  Sum_probs=119.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc---ccccccccccCccccc
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEYVVTRWYRAPELLL   90 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~Pe~~~   90 (217)
                      .++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.........   ....++..|+|||.+.
T Consensus       210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  289 (375)
T cd05104         210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF  289 (375)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhc
Confidence            5788999999999999999999999999999999999999999999999998755433211   1122345699999886


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhC
Q 027927           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (217)
Q Consensus        91 ~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (217)
                      +.. ++.++|+||||+++|++++ |..||..................+                             ..+
T Consensus       290 ~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~  339 (375)
T cd05104         290 NCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-----------------------------LSP  339 (375)
T ss_pred             CCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-----------------------------CCC
Confidence            544 7889999999999999997 888987654332222221110000                             011


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          170 PHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       170 ~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ...+.++.+++.+||+.||++|||+.++++
T Consensus       340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            234678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=4.7e-29  Score=190.80  Aligned_cols=167  Identities=28%  Similarity=0.379  Sum_probs=131.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      +++|.+++++.  ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........  ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence            46899999764  45899999999999999999999999999999999999999999999999998655433221  122


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|++||...+. ..+.++|+||||+++|++++ |..||.+.........+.... .+                   
T Consensus       164 ~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~-------------------  222 (260)
T cd05069         164 KFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RM-------------------  222 (260)
T ss_pred             ccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC-------------------
Confidence            345679999987544 47889999999999999998 899998765544333322100 00                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ......+..+.+++++||+.||.+||+++++++
T Consensus       223 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 ----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                      112246688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.96  E-value=3.8e-29  Score=190.37  Aligned_cols=167  Identities=22%  Similarity=0.337  Sum_probs=127.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc---cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT---EY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~   77 (217)
                      |++|.+++++. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+..........   ..
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            57899999764 568999999999999999999999999999999999999999999999999886543221111   11


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+..|+|||.+.+.. .+.++|+||||+++|++++ |..||...........+..                        
T Consensus       157 ~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~------------------------  211 (252)
T cd05084         157 QIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ------------------------  211 (252)
T ss_pred             CCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc------------------------
Confidence            1234699999885544 7889999999999999997 8888865543322221111                        


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ....      ......+..+.+++++||+.+|++|||++++++
T Consensus       212 ~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         212 GVRL------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CCCC------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0000      112245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=5.1e-29  Score=194.67  Aligned_cols=168  Identities=31%  Similarity=0.434  Sum_probs=130.6

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---ccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~   76 (217)
                      +++|.++++...  .++...+..++.|++.||+|||+++++|+||+|+||+++.++.++++|||.+........   ...
T Consensus       123 ~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  202 (302)
T cd05055         123 YGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN  202 (302)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCC
Confidence            579999997653  389999999999999999999999999999999999999999999999999865543321   112


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..++..|+|||.+.+.. ++.++|+||+|+++|++++ |..||.................                    
T Consensus       203 ~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------------  261 (302)
T cd05055         203 ARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY--------------------  261 (302)
T ss_pred             CCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC--------------------
Confidence            23456799999886554 7889999999999999998 9999976543332222221000                    


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                         ..      ......++++.+++.+||+.+|++|||+.++++
T Consensus       262 ---~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         262 ---RM------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---cC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence               00      011235688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=1.9e-29  Score=192.39  Aligned_cols=168  Identities=28%  Similarity=0.473  Sum_probs=133.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      +++|.+++...  ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++++|||.+....... ......
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  161 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV  161 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccccc
Confidence            46888888753  568999999999999999999999999999999999999999999999999986554322 223345


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+.. .+.++|+||+|+++|++++|..||...+.......+..  +..                     
T Consensus       162 ~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--~~~---------------------  217 (255)
T cd08219         162 GTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--GSY---------------------  217 (255)
T ss_pred             CCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc--CCC---------------------
Confidence            778899999885544 78899999999999999999999976654333322221  000                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                             ...+..++..+.++|.+||+.||.+|||+.++++-
T Consensus       218 -------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 -------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                   01122466889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=4e-29  Score=191.16  Aligned_cols=167  Identities=25%  Similarity=0.381  Sum_probs=131.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      +++|.++++..  ..++...+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+.........  ...
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA  164 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence            57999999764  56899999999999999999999999999999999999999999999999998765433211  122


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+... .++.++|+||||+++|++++ |..||...........+.....                     
T Consensus       165 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---------------------  222 (261)
T cd05072         165 KFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---------------------  222 (261)
T ss_pred             ccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            345679999988544 47889999999999999998 9999977654443333221100                     


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......++.++.+++.+||+.+|++|||++++++
T Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 ---------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                     0111246788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.96  E-value=3.9e-29  Score=194.56  Aligned_cols=174  Identities=24%  Similarity=0.311  Sum_probs=132.5

Q ss_pred             CccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC
Q 027927            2 DTDLYQIIRSNQ-----------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE   70 (217)
Q Consensus         2 ~~~L~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~   70 (217)
                      +++|.+++.+..           .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05051         103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             CCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeeccc
Confidence            578999998765           799999999999999999999999999999999999999999999999998865433


Q ss_pred             CCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           71 NEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        71 ~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~--~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                      ...   .....++..|+|||.+.+.. ++.++|+||||+++|++++  +..||........+............      
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------  255 (296)
T cd05051         183 SDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGR------  255 (296)
T ss_pred             CcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccc------
Confidence            321   12233456799999886544 7899999999999999987  67788765544444333321111000      


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                       .........++.++.+++.+||+.||.+|||++++++
T Consensus       256 -----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         256 -----------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             -----------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence                             0000112346688999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=4.6e-29  Score=195.02  Aligned_cols=174  Identities=24%  Similarity=0.303  Sum_probs=129.0

Q ss_pred             CccHHHHHHhC-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecc
Q 027927            2 DTDLYQIIRSN-------------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF   62 (217)
Q Consensus         2 ~~~L~~~l~~~-------------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~   62 (217)
                      +++|.+++...                   ..++...+..++.||+.||+|||+.|++|+||||+||+++.++.++|+||
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Df  182 (304)
T cd05096         103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF  182 (304)
T ss_pred             CCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCC
Confidence            57888888653                   23677889999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHHHHHHhCCC
Q 027927           63 GLARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPGNDHVHQMRLLIELLGTP  137 (217)
Q Consensus        63 ~~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~--~~~pf~~~~~~~~~~~~~~~~~~~  137 (217)
                      |++........   .....++..|+|||.+.... ++.++|+||||+++|++++  +..||...................
T Consensus       183 G~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~  261 (304)
T cd05096         183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQ  261 (304)
T ss_pred             ccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhc
Confidence            99875543321   11223366799999886544 7899999999999999986  567777655444433322211100


Q ss_pred             CCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ..                       .......+.+++.+.+++.+||+.||++|||+.++.+
T Consensus       262 ~~-----------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         262 GR-----------------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             cc-----------------------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            00                       0001112346788999999999999999999999853

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=6.7e-29  Score=195.26  Aligned_cols=174  Identities=26%  Similarity=0.372  Sum_probs=137.5

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +++|.+++.. ..++++..+..++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||.+.....   .....++
T Consensus       108 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~  184 (317)
T cd06635         108 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGT  184 (317)
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cccccCC
Confidence            4677777755 46799999999999999999999999999999999999999999999999998754332   2234567


Q ss_pred             ccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        81 ~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ..|++||.+..  ....+.++|+||+|++++++++|..||...........+.......                     
T Consensus       185 ~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------  243 (317)
T cd06635         185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------------------  243 (317)
T ss_pred             ccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------------------
Confidence            78999998742  3346789999999999999999999997765444443333211100                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                              .....+++.+.+++.+||+.+|.+|||+.++++|+|+....
T Consensus       244 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         244 --------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             --------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                    00113567899999999999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=6e-29  Score=189.73  Aligned_cols=168  Identities=23%  Similarity=0.298  Sum_probs=133.2

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----cc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MT   75 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~   75 (217)
                      +++|.+++.++.  .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........    ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            579999998864  689999999999999999999999999999999999999999999999999876544221    11


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ...++..|++||.+.... ++.++|+||||++++++++ |..||......+....+.......                 
T Consensus       159 ~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  220 (257)
T cd05040         159 HLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-----------------  220 (257)
T ss_pred             CCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC-----------------
Confidence            233456799999875444 7889999999999999998 999997766554443332200000                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  ......+..+.+++.+||+.+|++|||+.++++
T Consensus       221 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         221 ------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                        011235688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=6.1e-29  Score=190.43  Aligned_cols=167  Identities=26%  Similarity=0.394  Sum_probs=131.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      +++|.+++.+.  ..++...+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+.........  ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~  163 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  163 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence            56899999864  45899999999999999999999999999999999999999999999999998765443321  123


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|++||..... .++.++|+||||+++|++++ |..||...........+......                    
T Consensus       164 ~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------------------  222 (262)
T cd05071         164 KFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------------  222 (262)
T ss_pred             cccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC--------------------
Confidence            345679999987544 47889999999999999999 88888776544433322210000                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                .....++..+.+++.+|++.+|.+|||+.++++
T Consensus       223 ----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                      011246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=4.9e-29  Score=190.64  Aligned_cols=167  Identities=27%  Similarity=0.392  Sum_probs=130.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc--cc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~   77 (217)
                      +++|.+++++.  ..++...+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+..........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence            57899999764  468999999999999999999999999999999999999999999999999987654332211  12


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||..... .++.++|+||||+++|++++ |..||.+.........+.....                     
T Consensus       164 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  221 (260)
T cd05070         164 KFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR---------------------  221 (260)
T ss_pred             CCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            334579999987544 47889999999999999998 8899977654443333221000                     


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               .......+..+.+++.+||..+|.+|||++++..
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         222 ---------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                     0112246688999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=1.8e-29  Score=196.26  Aligned_cols=168  Identities=28%  Similarity=0.428  Sum_probs=130.6

Q ss_pred             CccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRS----------------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~----------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.++++.                ...++...+..++.|++.||+|||+++++|+||+|.||+++.++.++|+|||.+
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~  179 (293)
T cd05053         100 HGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA  179 (293)
T ss_pred             CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccc
Confidence            5688888864                246899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      .........   ....++..|+|||.+.+. .++.++|+||+|+++|++++ |..||...........+....       
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------  251 (293)
T cd05053         180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY-------  251 (293)
T ss_pred             cccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            765433211   112234569999987544 47889999999999999997 899997765444333222100       


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                             ........+..+.+++.+||..+|++|||+.+++++
T Consensus       252 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         252 -----------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             -----------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                                   001122456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=4.5e-29  Score=191.43  Aligned_cols=168  Identities=25%  Similarity=0.336  Sum_probs=131.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-c--cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-T--EY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~--~~   77 (217)
                      +++|.+++..+ ..++...+..++.|++.|+++||+++++|+||+|+||+++.++.++++|||++......... .  ..
T Consensus        89 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  168 (266)
T cd05033          89 NGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG  168 (266)
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCC
Confidence            56899999775 57999999999999999999999999999999999999999999999999998766422111 1  12


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|++||.+.+. .++.++|+||||+++|++++ |..||...........+......+                   
T Consensus       169 ~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------  228 (266)
T cd05033         169 KIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP-------------------  228 (266)
T ss_pred             CCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence            234679999988644 47889999999999999987 999997655444333332110000                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                 .....++.+.+++.+||+.+|++||++++++++
T Consensus       229 -----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 -----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                       112466889999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.96  E-value=5.5e-29  Score=195.47  Aligned_cols=167  Identities=28%  Similarity=0.412  Sum_probs=130.4

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.+++...                ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus       102 ~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~  181 (314)
T cd05099         102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA  181 (314)
T ss_pred             CCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccccc
Confidence            57899999764                34888999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      .........   ....++..|++||.+.+. .++.++|+||||+++|++++ |..||...........+...  ..    
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~----  254 (314)
T cd05099         182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG--HR----  254 (314)
T ss_pred             ccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CC----
Confidence            655432211   112234579999988654 47889999999999999998 88899776544444333210  00    


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                              ......++.++.+++.+||+.+|++|||+.++++
T Consensus       255 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         255 ------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                    0112346688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=5.3e-29  Score=190.82  Aligned_cols=164  Identities=20%  Similarity=0.239  Sum_probs=125.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC-------EEEecccccccCCCCCc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-------LKICDFGLARPTSENEF   73 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~-------~~l~d~~~~~~~~~~~~   73 (217)
                      +++|..++..+ ..+++..+..++.||+.||+|||+++++|+||+|+||+++.++.       ++++|||.+......  
T Consensus        88 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--  165 (262)
T cd05077          88 FGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--  165 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc--
Confidence            46788888754 67999999999999999999999999999999999999987664       899999987544322  


Q ss_pred             cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~-~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                       ....++..|+|||.+.....++.++|+||||+++|+++ .|..||......+... ...   .                
T Consensus       166 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~---~----------------  224 (262)
T cd05077         166 -QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYE---G----------------  224 (262)
T ss_pred             -ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHh---c----------------
Confidence             22345678999998865556788999999999999997 5788876543222111 000   0                


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                          ..        ......+.++.++|.+||+.||.+||++.+++++
T Consensus       225 ----~~--------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 ----QC--------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ----Cc--------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                00        0011234678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=4e-29  Score=192.16  Aligned_cols=167  Identities=22%  Similarity=0.317  Sum_probs=129.8

Q ss_pred             CccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-
Q 027927            2 DTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-   74 (217)
Q Consensus         2 ~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-   74 (217)
                      +++|.+++...      ..++...+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        91 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  170 (273)
T cd05035          91 HGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR  170 (273)
T ss_pred             CCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeecccccccc
Confidence            46788787442      36899999999999999999999999999999999999999999999999998765433221 


Q ss_pred             --ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           75 --TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        75 --~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                        .....+..|++||.+... .++.++|+||+|+++|++++ |..||.+.........+...  ..              
T Consensus       171 ~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~--------------  233 (273)
T cd05035         171 QGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--NR--------------  233 (273)
T ss_pred             ccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CC--------------
Confidence              112235679999988544 47889999999999999998 88999776554433322210  00              


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                    ...+..+++.+.+++.+||+.||++|||+.++++
T Consensus       234 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         234 --------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             --------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          0112346789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=6.8e-29  Score=189.83  Aligned_cols=167  Identities=22%  Similarity=0.359  Sum_probs=132.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-cccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-TEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~   78 (217)
                      +++|.+++++.  ..++...+..++.||+.||++||++|++|+||+|+||+++.++.++++|||.+......... ....
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~  165 (261)
T cd05148          86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK  165 (261)
T ss_pred             cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCC
Confidence            56999999864  56899999999999999999999999999999999999999999999999988655432211 1223


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ++..|++||.+... .++.++|+||||++++++++ |..||......+....+......                     
T Consensus       166 ~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  223 (261)
T cd05148         166 IPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------------------  223 (261)
T ss_pred             CceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---------------------
Confidence            45679999988554 47889999999999999998 89999776654444433321000                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......++.+.+++.+||+.||.+|||++++++
T Consensus       224 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ---------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                     012246788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=9.3e-29  Score=188.63  Aligned_cols=165  Identities=23%  Similarity=0.343  Sum_probs=130.6

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.++++...  .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........  ....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~  161 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGKL  161 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--cCCC
Confidence            468999998765  799999999999999999999999999999999999999999999999999876643222  2234


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|.+||.+... .++.++|+||+|++++++++ |..||...........+...                        .
T Consensus       162 ~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------------------~  216 (256)
T cd05039         162 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG------------------------Y  216 (256)
T ss_pred             cccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC------------------------C
Confidence            5679999988544 47889999999999999997 99998765433322211110                        0


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                            .......+++.+.++|++||..+|.+|||+++++.
T Consensus       217 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 ------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                  00112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=7.7e-29  Score=189.21  Aligned_cols=163  Identities=20%  Similarity=0.239  Sum_probs=126.7

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-------CEEEecccccccCCCCCc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-------DLKICDFGLARPTSENEF   73 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~   73 (217)
                      +++|.+++...+ .++...+..++.||+.||+|||++|++|+||+|+||+++.++       .++++|||.+......  
T Consensus        84 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~--  161 (259)
T cd05037          84 FGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR--  161 (259)
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccccc--
Confidence            578999998876 799999999999999999999999999999999999999887       7999999998765442  


Q ss_pred             cccccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           74 MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                       ....+...|++||.+... ..++.++|+||+|++++++++ |..||..............                   
T Consensus       162 -~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-------------------  221 (259)
T cd05037         162 -EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-------------------  221 (259)
T ss_pred             -cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-------------------
Confidence             223455679999998655 357889999999999999998 5777755432211111100                   


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                           ...        ........+.+++.+||..+|.+|||+.++++
T Consensus       222 -----~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 -----QHR--------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -----CCC--------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                 000        00111267999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=5.3e-29  Score=191.99  Aligned_cols=167  Identities=22%  Similarity=0.386  Sum_probs=130.8

Q ss_pred             CccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC
Q 027927            2 DTDLYQIIRSN----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (217)
Q Consensus         2 ~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~   71 (217)
                      +++|.+++...          ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~  172 (277)
T cd05032          93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET  172 (277)
T ss_pred             CCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccC
Confidence            47899998753          23678899999999999999999999999999999999999999999999988655433


Q ss_pred             Cc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           72 EF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        72 ~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      ..   .....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||...+.......+.. ...           
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~-----------  239 (277)
T cd05032         173 DYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGH-----------  239 (277)
T ss_pred             cccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCC-----------
Confidence            22   12233467799999886544 7889999999999999998 8999977664443332221 000           


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                        ...+...+.++.+++++||+.+|++|||+.++++
T Consensus       240 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 ------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                              0112235688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=9.3e-30  Score=201.14  Aligned_cols=202  Identities=34%  Similarity=0.581  Sum_probs=153.9

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-CCEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      .-+|.++|++-+   -|...++..++.|+..||..|-..|++|.||||+||||+.. ..+||||||.|...+.+... ..
T Consensus       517 slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit-PY  595 (752)
T KOG0670|consen  517 SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT-PY  595 (752)
T ss_pred             hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccccc-HH
Confidence            457888888853   48899999999999999999999999999999999999876 45799999999877766543 33


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccC--chHHHH---
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR--NEDAKR---  152 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---  152 (217)
                      .-+..|.|||++.+-+ +....|+||.||+||++++|+..|++..+-+.+...+++.|..+...+..-.  .+....   
T Consensus       596 LVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~n  674 (752)
T KOG0670|consen  596 LVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLN  674 (752)
T ss_pred             HHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccc
Confidence            4467899999998876 8899999999999999999999999999999999999998887765432111  000000   


Q ss_pred             ----HHHhCC----------CCCccchhhhC----------CCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          153 ----YIRQLP----------QHPRQSLAQVF----------PHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       153 ----~~~~~~----------~~~~~~~~~~~----------~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                          ..+.+.          -.|-..+.+..          +.+-.++.+|+.+||..||++|.|..++|.||||..
T Consensus       675 f~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  675 FLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             eEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                000000          00111111111          112256899999999999999999999999999974

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=5.6e-29  Score=194.81  Aligned_cols=167  Identities=28%  Similarity=0.418  Sum_probs=129.3

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.+++..++                .++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus       108 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a  187 (307)
T cd05098         108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA  187 (307)
T ss_pred             CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCccc
Confidence            568999997642                4888999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCccc---cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEFMT---EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~~~---~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      ..........   ...++..|+|||.+.+. .++.++|+||+|+++|++++ |..||...........+..  +.     
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~-----  259 (307)
T cd05098         188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE--GH-----  259 (307)
T ss_pred             ccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc--CC-----
Confidence            6554322111   11234579999988654 37889999999999999998 8888866543332222211  00     


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                             ....+...+.++.+++.+||+.+|++|||+.++++
T Consensus       260 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         260 -----------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             -----------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence                                   00112346789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.1e-28  Score=185.85  Aligned_cols=173  Identities=38%  Similarity=0.665  Sum_probs=138.8

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW   82 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~   82 (217)
                      ++|.+++.....++...+..++.+++.++++||+.+++|+||+|.||+++.++.++++|||.+.............++..
T Consensus        72 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  151 (244)
T smart00220       72 GDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE  151 (244)
T ss_pred             CCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence            48999998877799999999999999999999999999999999999999999999999999877665544455567788


Q ss_pred             ccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCc
Q 027927           83 YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR  162 (217)
Q Consensus        83 ~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (217)
                      |++||.+.... .+.++|+|++|++++++++|..||....................                        
T Consensus       152 ~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------------  206 (244)
T smart00220      152 YMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF------------------------  206 (244)
T ss_pred             CCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC------------------------
Confidence            99999886443 67899999999999999999999976433322222221100000                        


Q ss_pred             cchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          163 QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                         ......++.++.+++.+||..+|++||++.++++||||
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence               00001166889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=8.2e-29  Score=188.78  Aligned_cols=167  Identities=29%  Similarity=0.440  Sum_probs=132.8

Q ss_pred             CccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccc--c
Q 027927            2 DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE--Y   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~   77 (217)
                      |++|.+++.....  +++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+...........  .
T Consensus        85 ~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (258)
T smart00219       85 GGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGG  164 (258)
T ss_pred             CCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccC
Confidence            5789999987655  99999999999999999999999999999999999999999999999999876554422221  2


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|++||.+. ...++.++|+|++|++++++++ |..||...........+.....                     
T Consensus       165 ~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  222 (258)
T smart00219      165 KLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------------------  222 (258)
T ss_pred             CCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------------
Confidence            2457899999884 4447899999999999999998 7888877554444433322100                     


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               .......+.++.+++.+||..+|++|||+.++++
T Consensus       223 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 ---------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                     0111236788999999999999999999999975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.96  E-value=1.1e-28  Score=193.00  Aligned_cols=168  Identities=27%  Similarity=0.396  Sum_probs=130.7

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.+++.+.                ..++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~  184 (304)
T cd05101         105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA  184 (304)
T ss_pred             CCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccc
Confidence            56899998764                24778889999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      .........   ....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+....  .    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~----  257 (304)
T cd05101         185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH--R----  257 (304)
T ss_pred             eecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--c----
Confidence            765433221   1223356799999886544 7889999999999999998 788887665444333222100  0    


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                              .......+..+.+++.+||+.+|.+|||+.++++.
T Consensus       258 ------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         258 ------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence                                    01122467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=8.8e-29  Score=189.23  Aligned_cols=167  Identities=25%  Similarity=0.368  Sum_probs=132.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      +++|.+++...  ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+.........  ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA  163 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence            57899998764  46899999999999999999999999999999999999999999999999988655422211  122


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+... .++.++|+||+|++++++++ |..||.+.........+......                    
T Consensus       164 ~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  222 (260)
T cd05067         164 KFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------------------  222 (260)
T ss_pred             cccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------------------
Confidence            345679999988544 37889999999999999998 99999877655444433211100                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ......+.++.+++.+||+.+|++|||+++++.
T Consensus       223 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ----------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                      112245688999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=1.1e-28  Score=188.64  Aligned_cols=164  Identities=17%  Similarity=0.235  Sum_probs=126.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC--------EEEecccccccCCCCC
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--------LKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--------~~l~d~~~~~~~~~~~   72 (217)
                      +++|.++++.+ ..++...+..++.||+.||+|||+.|++|+||||+||+++.++.        ++++|||.+...... 
T Consensus        83 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-  161 (258)
T cd05078          83 FGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-  161 (258)
T ss_pred             CCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc-
Confidence            57899999875 45899999999999999999999999999999999999987765        589999987544332 


Q ss_pred             ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        73 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                        ....++..|++||.+.+....+.++|+||+|+++|++++|. .|+............ .                   
T Consensus       162 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~-------------------  219 (258)
T cd05078         162 --EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-E-------------------  219 (258)
T ss_pred             --hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-H-------------------
Confidence              22356778999999876555788999999999999999984 565544332221111 0                   


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                          ..        ...+...+.++.+++.+||+.||.+|||++++++.
T Consensus       220 ----~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         220 ----DR--------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----cc--------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                00        01122345789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=1.2e-28  Score=188.55  Aligned_cols=167  Identities=28%  Similarity=0.375  Sum_probs=126.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~   75 (217)
                      +++|.+++.+. ..++...+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+........     ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  160 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT  160 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence            57899999775 4567888899999999999999999999999999999999999999999998865432211     11


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ...++..|+|||.+... .++.++|+||||+++|++++| .+||...........+.. ...+                 
T Consensus       161 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~-~~~~-----------------  221 (262)
T cd05058         161 GAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRL-----------------  221 (262)
T ss_pred             cCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCC-----------------
Confidence            22345679999988654 478899999999999999995 566655443332221111 0000                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  ......++.+.+++.+||..+|++||++.+++.
T Consensus       222 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         222 ------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             ------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                        001135678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=1e-28  Score=189.50  Aligned_cols=169  Identities=27%  Similarity=0.430  Sum_probs=129.7

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~   76 (217)
                      +++|.+++..    ...+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++++|||.+........ ...
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  165 (267)
T cd08228          86 AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  165 (267)
T ss_pred             CCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhc
Confidence            4688888753    35689999999999999999999999999999999999999999999999998876543322 223


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|++||.+.+.. .+.++|+||+|+++|++++|..||..... ...........+.++                 
T Consensus       166 ~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------  227 (267)
T cd08228         166 LVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP-----------------  227 (267)
T ss_pred             CCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC-----------------
Confidence            45677899999886544 78899999999999999999999865431 111111111111110                 


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 .....++..+.+++.+||..+|++|||+.++++
T Consensus       228 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 -----------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             -----------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                       001135678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=1e-30  Score=207.13  Aligned_cols=176  Identities=31%  Similarity=0.499  Sum_probs=144.7

Q ss_pred             CCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC---CCEEEecccccccCCCCCccc
Q 027927            1 MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFMT   75 (217)
Q Consensus         1 l~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~   75 (217)
                      |.|++.++|-.  .++|++...+.++.||+.||.|||-+||+|+|+||+||++...   ..+||||||+++.+++.....
T Consensus       645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr  724 (888)
T KOG4236|consen  645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR  724 (888)
T ss_pred             hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence            34566666644  4899999999999999999999999999999999999999654   458999999999999998888


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...|++.|+|||++.+.+ +..+-|+||.||++|-.++|..||....+  +-.+|...                      
T Consensus       725 sVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNA----------------------  779 (888)
T KOG4236|consen  725 SVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNA----------------------  779 (888)
T ss_pred             hhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccc--hhHHhhcc----------------------
Confidence            999999999999997655 88999999999999999999999976442  11111110                      


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                       .-..+..+    +.++++.++|||..+|+..-.+|.|+++.|.|||+++.
T Consensus       780 -aFMyPp~P----W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  780 -AFMYPPNP----WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             -ccccCCCc----hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence             00111222    23588999999999999999999999999999999964

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.1e-28  Score=188.67  Aligned_cols=167  Identities=28%  Similarity=0.411  Sum_probs=132.2

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      +++|.+++.+.  ..++...+..++.+++.|+++||++|++|+||+|+||+++.++.++++|||.+.........  ...
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  164 (261)
T cd05034          85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA  164 (261)
T ss_pred             CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence            57899999875  47899999999999999999999999999999999999999999999999988765432211  112


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+..|++||.+.+. ..+.++|+||+|++++++++ |..||.+.........+......+                   
T Consensus       165 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------------  224 (261)
T cd05034         165 KFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-------------------  224 (261)
T ss_pred             CCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence            234579999988654 47889999999999999998 999998766554444433211100                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 .....+.++.+++.+||..+|.+|||++++++
T Consensus       225 -----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         225 -----------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                       11234678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.96  E-value=1.4e-28  Score=188.67  Aligned_cols=169  Identities=28%  Similarity=0.433  Sum_probs=129.1

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~   76 (217)
                      |++|.++++.    ...+++..+..++.||+.||++||++|++|+||+|+||+++.++.++++|||.+........ ...
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd08229          86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  165 (267)
T ss_pred             CCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCccccc
Confidence            5688888864    35689999999999999999999999999999999999999999999999998765543322 223


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..++..|++||.+.+.. .+.++|+||+|+++|++++|..||.+.... ............+                  
T Consensus       166 ~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------  226 (267)
T cd08229         166 LVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------------------  226 (267)
T ss_pred             ccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC------------------
Confidence            45678899999885544 788999999999999999999999654321 1110000000000                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ......+++.+.+++.+||..+|.+|||+.++++
T Consensus       227 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         227 ----------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ----------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                      0011236788999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-29  Score=181.43  Aligned_cols=172  Identities=27%  Similarity=0.343  Sum_probs=127.8

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-   74 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-   74 (217)
                      .|||.|.++.    +..+++..+..++.+|++||.+||+..  .+|+||||.||++..++.+.++|||.+......... 
T Consensus       107 ~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~  186 (302)
T KOG2345|consen  107 RGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGS  186 (302)
T ss_pred             cccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeech
Confidence            3678887755    357999999999999999999999998  999999999999999999999999988654322111 


Q ss_pred             ---------ccccccccccCcccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccc
Q 027927           75 ---------TEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        75 ---------~~~~~~~~~~~Pe~~~~~~--~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  143 (217)
                               .....+..|+|||.+....  ..+.++|||||||++|.++.|..||....         +.++..      
T Consensus       187 ~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~GgSl------  251 (302)
T KOG2345|consen  187 RQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGGSL------  251 (302)
T ss_pred             HHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCCeE------
Confidence                     1234477899999985332  24789999999999999999999995321         101100      


Q ss_pred             ccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                 ......+...+..- ..+|..+.++|+.||++||.+||++.+++.+
T Consensus       252 -----------aLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  252 -----------ALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             -----------EEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence                       00011111111111 1277899999999999999999999999763

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=1.4e-28  Score=189.02  Aligned_cols=167  Identities=24%  Similarity=0.348  Sum_probs=131.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc--ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~   78 (217)
                      +++|.+++.+. ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+..........  ...
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  169 (270)
T cd05056          90 LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK  169 (270)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCC
Confidence            57899999875 468999999999999999999999999999999999999999999999999886554332211  122


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ++..|+|||.+... .++.++|+||||++++++++ |..||...........+.... .                     
T Consensus       170 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~---------------------  226 (270)
T cd05056         170 LPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-R---------------------  226 (270)
T ss_pred             ccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-c---------------------
Confidence            34579999987544 47889999999999999885 999998776544433322100 0                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                              ...+...++.+.++|.+|+..+|.+|||+.+++.
T Consensus       227 --------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         227 --------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                    0112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.96  E-value=1.2e-28  Score=190.47  Aligned_cols=167  Identities=23%  Similarity=0.290  Sum_probs=130.2

Q ss_pred             CccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc
Q 027927            2 DTDLYQIIRSN--------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (217)
Q Consensus         2 ~~~L~~~l~~~--------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (217)
                      +++|.+++...        ..++...+..++.|++.||+|||+++++|+||+|+||+++.++.++++|||+++.......
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~  172 (280)
T cd05043          93 WGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY  172 (280)
T ss_pred             CCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCce
Confidence            46888888664        4589999999999999999999999999999999999999999999999999875433221


Q ss_pred             c---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchH
Q 027927           74 M---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNED  149 (217)
Q Consensus        74 ~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (217)
                      .   ....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+.. ...+            
T Consensus       173 ~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~------------  238 (280)
T cd05043         173 HCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYRL------------  238 (280)
T ss_pred             EEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCCC------------
Confidence            1   1233456799999886554 7889999999999999998 9999977654333222211 0000            


Q ss_pred             HHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          150 AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                       .....+++++.+++.+|++.||++|||+.++++
T Consensus       239 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 -----------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                             011235688999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.96  E-value=1.2e-28  Score=191.36  Aligned_cols=156  Identities=26%  Similarity=0.370  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccccccccccCcccc
Q 027927           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELL   89 (217)
Q Consensus        13 ~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~Pe~~   89 (217)
                      .+++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........   .....++..|++||.+
T Consensus       122 ~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~  201 (290)
T cd05045         122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL  201 (290)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence            3578999999999999999999999999999999999999999999999999865432221   1122335679999987


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhh
Q 027927           90 LNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV  168 (217)
Q Consensus        90 ~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (217)
                      .+. .++.++|+||||++++++++ |..||.+...........+..                        ..      ..
T Consensus       202 ~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------------------~~------~~  250 (290)
T cd05045         202 FDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY------------------------RM------ER  250 (290)
T ss_pred             ccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC------------------------CC------CC
Confidence            544 47889999999999999998 999997765443333221100                        00      01


Q ss_pred             CCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          169 FPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       169 ~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ...++.++.+++.+||+.+|++||++.++++
T Consensus       251 ~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         251 PENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            2246788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.5e-28  Score=186.98  Aligned_cols=167  Identities=24%  Similarity=0.333  Sum_probs=129.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc---ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~   77 (217)
                      |++|.+++++. ..++...+..++.+++.||++||+++++|+||+|+||+++.++.++|+|||.+.........   ...
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            67899999764 57899999999999999999999999999999999999999999999999988654422111   111


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+..|+|||.+.+. .++.++|+||||+++|++++ |..||...........+.... ..                   
T Consensus       156 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~-------------------  214 (251)
T cd05041         156 QIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RM-------------------  214 (251)
T ss_pred             cceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CC-------------------
Confidence            224569999988654 47889999999999999998 788886655332222221100 00                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ......+.++.+++.+||+.+|.+|||++++++
T Consensus       215 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         215 ----------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                      011245688999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=1.8e-28  Score=189.81  Aligned_cols=168  Identities=18%  Similarity=0.335  Sum_probs=129.3

Q ss_pred             CccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccc
Q 027927            2 DTDLYQIIRSN-----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL   64 (217)
Q Consensus         2 ~~~L~~~l~~~-----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~   64 (217)
                      +++|.+++..+                 ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~  170 (283)
T cd05090          91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL  170 (283)
T ss_pred             CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccc
Confidence            46888888532                 2478899999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCc
Q 027927           65 ARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDA  140 (217)
Q Consensus        65 ~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~  140 (217)
                      +........   .....++..|++||.+.+.. ++.++|+||||+++|++++ |..||.+.........+... ..    
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~----  244 (283)
T cd05090         171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QL----  244 (283)
T ss_pred             cccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc----
Confidence            876533221   12233456799999886544 7889999999999999998 88899765543332222110 00    


Q ss_pred             cccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          141 DLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                               ......+++.+.+++.+||+.||++||++.+++++
T Consensus       245 -------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         245 -------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                                     01122467889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=1.9e-28  Score=189.66  Aligned_cols=181  Identities=23%  Similarity=0.277  Sum_probs=130.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----cccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~   77 (217)
                      +++|.+++..+ .+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+........    ....
T Consensus        92 ~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  170 (283)
T cd05080          92 LGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG  170 (283)
T ss_pred             CCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCC
Confidence            56889998774 599999999999999999999999999999999999999999999999999876543221    1122


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|++||.+.+. ..+.++|+||||++++++++|..|+......  +..+..   ...    ...............
T Consensus       171 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~---~~~----~~~~~~~~~~~~~~~  240 (283)
T cd05080         171 DSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIG---PKQ----GQMTVVRLIELLERG  240 (283)
T ss_pred             CCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhc---ccc----cccchhhhhhhhhcC
Confidence            345569999988544 4788999999999999999999998654311  001100   000    000000011111111


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ..      .......+.++.+++.+||+.+|++|||++++++
T Consensus       241 ~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         241 MR------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CC------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11      0123456789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=2e-28  Score=186.60  Aligned_cols=165  Identities=24%  Similarity=0.351  Sum_probs=129.5

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |++|.+++....  .++...+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+.......  .....
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  159 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--DNSKL  159 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC--CCCCC
Confidence            579999998753  58999999999999999999999999999999999999999999999999886543221  12233


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|++||.+.+. .++.++|+||||+++|++++ |..||...........+..  +.                      
T Consensus       160 ~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~----------------------  214 (254)
T cd05083         160 PVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK--GY----------------------  214 (254)
T ss_pred             CceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC--CC----------------------
Confidence            5679999988544 47889999999999999997 8999977654333222211  00                      


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                         .   ......+++.+.+++++||+.+|.+||++++++.
T Consensus       215 ---~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         215 ---R---MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ---C---CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               0   0012246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.4e-28  Score=188.71  Aligned_cols=167  Identities=25%  Similarity=0.286  Sum_probs=130.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccc---c
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---Y   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~---~   77 (217)
                      +++|.+++..+ ..+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||.+...........   .
T Consensus        92 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  171 (279)
T cd05057          92 LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG  171 (279)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCC
Confidence            57899999875 5799999999999999999999999999999999999999999999999999876543322111   1


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+..|++||.+... .++.++|+||+|++++++++ |..||...........+.. ....                   
T Consensus       172 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~-------------------  230 (279)
T cd05057         172 KVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERL-------------------  230 (279)
T ss_pred             cccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCC-------------------
Confidence            224569999988544 47889999999999999998 9999977654433332221 0000                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ..+...+..+.+++.+||..+|++|||+.++++
T Consensus       231 ----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         231 ----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                      011235578999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.96  E-value=3.4e-28  Score=184.87  Aligned_cols=167  Identities=23%  Similarity=0.350  Sum_probs=130.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc--ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~   78 (217)
                      +++|.+++... ..+++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||.+..........  ...
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            57899988764 568999999999999999999999999999999999999999999999999886543322111  122


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+..|++||.+... .++.++|+||+|+++|++++ |..||...........+...   .                    
T Consensus       156 ~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~---~--------------------  211 (250)
T cd05085         156 IPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---Y--------------------  211 (250)
T ss_pred             CcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---C--------------------
Confidence            34569999988544 47889999999999999998 89999766543332222110   0                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                             .......++..+.+++.+|++.+|++|||+.++++
T Consensus       212 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 -------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                   00112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=2.6e-28  Score=186.08  Aligned_cols=167  Identities=22%  Similarity=0.346  Sum_probs=130.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--cccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~   78 (217)
                      +++|.++++.. ..++++.+..++.|++.|+++||+.+++|+||+|.||+++.++.++|+|||.+.........  ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK  162 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence            57899999875 56899999999999999999999999999999999999999999999999988655433211  1223


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+..|++||.+.+. .++.++|+||+|+++|++++ |..||...........+.+....                     
T Consensus       163 ~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  220 (256)
T cd05112         163 FPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---------------------  220 (256)
T ss_pred             cchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC---------------------
Confidence            35679999988654 47889999999999999998 89999766544333332110000                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......+..+.+++.+||+.+|++|||+.++++
T Consensus       221 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~  253 (256)
T cd05112         221 ---------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLH  253 (256)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                     001124688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=3.3e-28  Score=186.77  Aligned_cols=167  Identities=25%  Similarity=0.339  Sum_probs=130.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc----c
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----E   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~----~   76 (217)
                      +++|.+++.++ ..++...+..++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+..........    .
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  169 (268)
T cd05063          90 NGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG  169 (268)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccC
Confidence            46899999764 678999999999999999999999999999999999999999999999999886554322111    1


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...+..|++||.+... .++.++|+||+|+++|++++ |..||...........+......+                  
T Consensus       170 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~------------------  230 (268)
T cd05063         170 GKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP------------------  230 (268)
T ss_pred             CCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC------------------
Confidence            1123469999988654 47889999999999999987 999997765544443332211000                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  .....+..+.+++.+|+..+|++||++.++++
T Consensus       231 ------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 ------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                        01235688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=2.4e-28  Score=193.43  Aligned_cols=168  Identities=27%  Similarity=0.396  Sum_probs=130.1

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|.+++...                ..++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus       102 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~  181 (334)
T cd05100         102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA  181 (334)
T ss_pred             CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccc
Confidence            56899998763                24778899999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      .........   ....++..|++||.+.+.. ++.++|+||||+++|++++ |..||...........+....       
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------  253 (334)
T cd05100         182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH-------  253 (334)
T ss_pred             eecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Confidence            665433211   1122345699999886544 7889999999999999998 888887765444333222100       


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                             ........+.++.+++.+||+.+|++|||+.+++++
T Consensus       254 -----------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         254 -----------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                                   001122456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=3.3e-28  Score=187.45  Aligned_cols=169  Identities=21%  Similarity=0.317  Sum_probs=131.6

Q ss_pred             CccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC
Q 027927            2 DTDLYQIIRSNQ---------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (217)
                      +++|.+++....         .++...+..++.|++.||+|||+.+++|+||+|+||+++.++.++++|||++.......
T Consensus        92 ~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~  171 (275)
T cd05046          92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE  171 (275)
T ss_pred             CCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCccc
Confidence            579999998766         79999999999999999999999999999999999999999999999999875433221


Q ss_pred             c--cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchH
Q 027927           73 F--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNED  149 (217)
Q Consensus        73 ~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (217)
                      .  .....++..|++||.+.+.. .+.++|+||||++++++++ |..||...........+...  ..            
T Consensus       172 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~------------  236 (275)
T cd05046         172 YYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KL------------  236 (275)
T ss_pred             ccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--Cc------------
Confidence            1  12234466799999885443 6789999999999999998 78888765543333322110  00            


Q ss_pred             HHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          150 AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                    . ......++..+.+++.+||+.+|.+|||+.++++.
T Consensus       237 --------------~-~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         237 --------------E-LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --------------C-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                          0 00122467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=4.3e-28  Score=186.97  Aligned_cols=164  Identities=20%  Similarity=0.255  Sum_probs=125.7

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-------CEEEecccccccCCCCCc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-------DLKICDFGLARPTSENEF   73 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~   73 (217)
                      +++|.++++. .+.++...+..++.||+.||+|||+++++|+||+|+||+++..+       .++++|||.+......  
T Consensus       100 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--  177 (274)
T cd05076         100 HGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--  177 (274)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--
Confidence            5688888876 46799999999999999999999999999999999999997643       3799999987543222  


Q ss_pred             cccccccccccCcccccCCCCCCchhhHHHHHHHHHHH-HcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l-~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                       ....++..|++||.+.+...++.++|+||||+++|++ ++|..||............ .                    
T Consensus       178 -~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~--------------------  235 (274)
T cd05076         178 -EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-E--------------------  235 (274)
T ss_pred             -cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH-H--------------------
Confidence             1234567799999886655578999999999999998 4689999765432221111 0                    


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                         ...        ..+...++.+.++|.+||+.+|++|||+.+++++
T Consensus       236 ---~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         236 ---KKH--------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ---hcc--------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence               000        0111234679999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=3.2e-28  Score=186.94  Aligned_cols=168  Identities=27%  Similarity=0.433  Sum_probs=132.8

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      |++|.+++..    ...+++..++.++.|++.||.+||+ .+++|+||+|.||+++.++.++|+|||.+...........
T Consensus        93 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  172 (269)
T cd08528          93 GAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS  172 (269)
T ss_pred             CCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccccccc
Confidence            4678877743    4679999999999999999999996 7899999999999999999999999999876555444445


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..++..|++||.+.+.. ++.++|+||||+++|++++|..||...........+......+                   
T Consensus       173 ~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------  232 (269)
T cd08528         173 VVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-------------------  232 (269)
T ss_pred             ccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-------------------
Confidence            56788899999986544 7899999999999999999999997665443333222211000                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                .....+++.+.++|++||+.||++||++.|+..
T Consensus       233 ----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~  265 (269)
T cd08528         233 ----------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA  265 (269)
T ss_pred             ----------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence                      001135688999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-28  Score=190.22  Aligned_cols=174  Identities=24%  Similarity=0.398  Sum_probs=151.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc-CCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~-~~~~~~~~~~~~~   80 (217)
                      ||+|-=.++.-+.+.+..+..++..|+-||-+||++||++||+|.+||+++.+|.+|++|||+++. ........+.+|+
T Consensus       434 GGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGT  513 (683)
T KOG0696|consen  434 GGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGT  513 (683)
T ss_pred             CchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCC
Confidence            567777777778999999999999999999999999999999999999999999999999999864 3344556788999


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      |.|+|||++.-++ ++.++|.||+||+|||++.|++||.+.++.++++.|++.-                          
T Consensus       514 PdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn--------------------------  566 (683)
T KOG0696|consen  514 PDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN--------------------------  566 (683)
T ss_pred             CcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--------------------------
Confidence            9999999986554 8999999999999999999999999999999999988732                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH-----hhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG-----EFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~~ll~~~~f~~~~  207 (217)
                           ...+..+|.++.++++..|...|.+|.-.     +++-.||||++..
T Consensus       567 -----vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  567 -----VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             -----CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence                 12334578999999999999999999753     4778899999653

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=5.2e-28  Score=188.33  Aligned_cols=174  Identities=25%  Similarity=0.353  Sum_probs=130.2

Q ss_pred             CccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC
Q 027927            2 DTDLYQIIRSNQ------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (217)
Q Consensus         2 ~~~L~~~l~~~~------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   69 (217)
                      +++|.+++....            .++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus       101 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             CCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccc
Confidence            578888886532            47888999999999999999999999999999999999999999999999886543


Q ss_pred             CCCcc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           70 ENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        70 ~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~--~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      .....   ....++..|+|||.+.+.. ++.++|+||||++++++++  +..||...........+.+......      
T Consensus       181 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------  253 (295)
T cd05097         181 SGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQG------  253 (295)
T ss_pred             cCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcc------
Confidence            32211   1223356799999886544 7899999999999999987  6678876655444443332111000      


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                       ........+..++.+.+++.+|++.+|.+|||++++++
T Consensus       254 -----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         254 -----------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             -----------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                             00001112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=2.3e-28  Score=208.65  Aligned_cols=172  Identities=33%  Similarity=0.528  Sum_probs=129.0

Q ss_pred             cHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-------------
Q 027927            4 DLYQIIRSNQSL-SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-------------   69 (217)
Q Consensus         4 ~L~~~l~~~~~l-~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-------------   69 (217)
                      +|.++++.+... ....+++++++|++||+|+|++||+||||||.||+++.++.|||+|||++....             
T Consensus       682 ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~  761 (1351)
T KOG1035|consen  682 LLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFS  761 (1351)
T ss_pred             HHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCcc
Confidence            466777776655 688999999999999999999999999999999999999999999999986511             


Q ss_pred             ------CCCccccccccccccCcccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           70 ------ENEFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        70 ------~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                            .........||-.|.|||.+.+..  .++.++|+||||++++||+.   ||.  ..++....+..+.....+..
T Consensus       762 ~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~LR~g~iP~~  836 (1351)
T KOG1035|consen  762 TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG--TSMERASILTNLRKGSIPEP  836 (1351)
T ss_pred             ccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhcccCCCCCC
Confidence                  111234567788899999997666  58899999999999999985   353  22333332222211111100


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                                              +.++.+.-+.-..+|+.||+.||++||||.|+|++.||-
T Consensus       837 ------------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  837 ------------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             ------------------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence                                    111112225567899999999999999999999999997

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.96  E-value=4.1e-28  Score=185.59  Aligned_cols=167  Identities=28%  Similarity=0.397  Sum_probs=130.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      +++|.+++.+.  ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.........  ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (260)
T cd05073          84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  163 (260)
T ss_pred             CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence            57899999874  46788899999999999999999999999999999999999999999999988655432211  122


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|++||.+... .++.++|+||||+++|++++ |..||...+.......+...   ..                  
T Consensus       164 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~------------------  221 (260)
T cd05073         164 KFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YR------------------  221 (260)
T ss_pred             cccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---CC------------------
Confidence            334669999988544 47889999999999999998 89999876544443332210   00                  


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               .......+.++.+++.+||+.+|++||++++++.
T Consensus       222 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 ---------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ---------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                     0111346688999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.96  E-value=4.3e-28  Score=186.32  Aligned_cols=167  Identities=23%  Similarity=0.290  Sum_probs=129.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccc---c
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---Y   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~---~   77 (217)
                      +++|.++++.. +.++...+..++.|++.||++||++|++|+||+|+||+++.++.++++|||.+...........   .
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  168 (269)
T cd05065          89 NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS  168 (269)
T ss_pred             CCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccc
Confidence            56899999864 6689999999999999999999999999999999999999999999999998765433221111   1


Q ss_pred             c---ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHH
Q 027927           78 V---VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (217)
Q Consensus        78 ~---~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (217)
                      .   .+..|++||.+... .++.++|+||+|+++|++++ |..||...........+......                 
T Consensus       169 ~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~-----------------  230 (269)
T cd05065         169 LGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL-----------------  230 (269)
T ss_pred             cCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC-----------------
Confidence            1   13469999988644 47889999999999999886 99999776544333332210000                 


Q ss_pred             HHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                   .....++..+.+++.+||..+|.+||++++++.
T Consensus       231 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 -------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         011245688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=4.4e-28  Score=186.24  Aligned_cols=172  Identities=24%  Similarity=0.324  Sum_probs=127.8

Q ss_pred             CccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---
Q 027927            2 DTDLYQIIRSNQ-----SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---   73 (217)
Q Consensus         2 ~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---   73 (217)
                      +++|.+++....     ..+...+..++.||+.||+|||++|++|+||||+||+++.++.++++|||.+........   
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            579999998753     246788899999999999999999999999999999999999999999998754322211   


Q ss_pred             cccccccccccCcccccC------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccC
Q 027927           74 MTEYVVTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR  146 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~------~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (217)
                      .....++..|+|||.+..      ....+.++|+||+|+++|++++ |..||....+..............         
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------  229 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK---------  229 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc---------
Confidence            122234567999998743      2235779999999999999998 788887765544443333211110         


Q ss_pred             chHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                      .........+++.+.+++..|+ .||.+|||++++++
T Consensus       230 ----------------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         230 ----------------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ----------------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                            0011123356788899999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=4.9e-28  Score=185.86  Aligned_cols=167  Identities=25%  Similarity=0.388  Sum_probs=129.2

Q ss_pred             CccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-----CEEEecccccccCC
Q 027927            2 DTDLYQIIRSN-------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-----DLKICDFGLARPTS   69 (217)
Q Consensus         2 ~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-----~~~l~d~~~~~~~~   69 (217)
                      |++|.+++.+.       ..++...+..++.|++.||+|||+.+++|+||+|+||+++.++     .++++|||++....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~  162 (269)
T cd05044          83 GGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY  162 (269)
T ss_pred             CCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccc
Confidence            57899998753       3478899999999999999999999999999999999999887     89999999886543


Q ss_pred             CCCcc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           70 ENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        70 ~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                      .....   .....+..|++||.+.+. ..+.++|+||||+++|++++ |..||...........+... ..         
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~---------  231 (269)
T cd05044         163 KSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR---------  231 (269)
T ss_pred             cccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc---------
Confidence            32211   122335679999988654 47899999999999999997 99999766554433322110 00         


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                          ......++..+.++|.+||+.+|.+||+++++++
T Consensus       232 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 --------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                0112246688999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=5.2e-28  Score=189.06  Aligned_cols=167  Identities=22%  Similarity=0.254  Sum_probs=128.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~   77 (217)
                      +++|.+++..+ ..++...+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+........   ....
T Consensus        92 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  171 (303)
T cd05110          92 HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG  171 (303)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCC
Confidence            47899998775 4689999999999999999999999999999999999999999999999999875443221   1122


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|++||.+.+.. ++.++|+||||+++|++++ |..||.+....... .+......+                   
T Consensus       172 ~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~-------------------  230 (303)
T cd05110         172 KMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERL-------------------  230 (303)
T ss_pred             ccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC-------------------
Confidence            3356799999885444 7889999999999999987 88998765432222 121110000                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ......+..+.+++.+|+..+|++||+++++++
T Consensus       231 ----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~  263 (303)
T cd05110         231 ----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAA  263 (303)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      011235578999999999999999999999866

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.96  E-value=5.6e-28  Score=185.52  Aligned_cols=167  Identities=23%  Similarity=0.295  Sum_probs=131.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc----c
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----E   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~----~   76 (217)
                      |++|.+++... ..++...+..++.|++.|+++||+.+++|+||+|+||+++.++.++++|||.+..........    .
T Consensus        89 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  168 (267)
T cd05066          89 NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG  168 (267)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCC
Confidence            57899999875 568999999999999999999999999999999999999999999999999887654432211    1


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...+..|++||.+.+.. ++.++|+||+|+++|++++ |..||...........+.+....                   
T Consensus       169 ~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  228 (267)
T cd05066         169 GKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-------------------  228 (267)
T ss_pred             CccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-------------------
Confidence            11245799999886544 7889999999999999886 99999776544433333211000                   


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 .....+++.+.+++.+|++.+|.+|||+.++++
T Consensus       229 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 -----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                       011235688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=7.9e-28  Score=184.39  Aligned_cols=169  Identities=27%  Similarity=0.460  Sum_probs=128.8

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~   76 (217)
                      |++|.+++.+    ...++...+..++.+++.||++||+.|++|+||+|+||+++.++.++++|||.+........ ...
T Consensus        86 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  165 (267)
T cd08224          86 AGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  165 (267)
T ss_pred             CCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccce
Confidence            5689988865    35589999999999999999999999999999999999999999999999998865443321 233


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..++..|.+||.+.+.. ++.++|+||+|+++|++++|..||......  .....+..                      
T Consensus       166 ~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~----------------------  220 (267)
T cd08224         166 LVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKI----------------------  220 (267)
T ss_pred             ecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhh----------------------
Confidence            45677899999886544 788999999999999999999999654310  00011000                      


Q ss_pred             CCCCCccchhhh-CCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQV-FPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                       ....   .... ...++..+.++|.+||..+|++|||+.++++
T Consensus       221 -~~~~---~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         221 -EKCD---YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -hcCC---CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             0000   0001 1145678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=5.6e-28  Score=187.46  Aligned_cols=167  Identities=22%  Similarity=0.332  Sum_probs=128.1

Q ss_pred             CccHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEE
Q 027927            2 DTDLYQIIRSN----------------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI   59 (217)
Q Consensus         2 ~~~L~~~l~~~----------------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l   59 (217)
                      +++|.++++..                      ..++...+..++.|++.||++||+++++|+||+|.||+++.++.+++
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l  171 (288)
T cd05050          92 YGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI  171 (288)
T ss_pred             CCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEE
Confidence            46888888753                      24788899999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCCCcc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhC
Q 027927           60 CDFGLARPTSENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLG  135 (217)
Q Consensus        60 ~d~~~~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~  135 (217)
                      +|||.+.........   .....+..|+|||.+.+. .++.++|+||||+++|++++ |..||.+....+....+..  +
T Consensus       172 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~--~  248 (288)
T cd05050         172 ADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD--G  248 (288)
T ss_pred             CccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--C
Confidence            999988654332211   122335569999988554 47889999999999999997 8888876654443332211  0


Q ss_pred             CCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          136 TPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ..                            ......++.++.+++.+||+.+|.+|||+.|+++
T Consensus       249 ~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         249 NV----------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CC----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            00                            0012246688999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.96  E-value=9.4e-28  Score=186.97  Aligned_cols=174  Identities=21%  Similarity=0.311  Sum_probs=128.8

Q ss_pred             CccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC
Q 027927            2 DTDLYQIIRSNQ-----------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE   70 (217)
Q Consensus         2 ~~~L~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~   70 (217)
                      +++|.+++.+..           .++...+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05095         103 NGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             CCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccC
Confidence            578999987753           367789999999999999999999999999999999999999999999999865433


Q ss_pred             CCcc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           71 NEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        71 ~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~--~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                      ....   .....+..|++||..... .++.++|+||||+++|++++  +..||.............+...          
T Consensus       183 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~----------  251 (296)
T cd05095         183 GDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR----------  251 (296)
T ss_pred             CcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHh----------
Confidence            2211   112235679999987554 47889999999999999997  7788876554443332211110          


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                .....   ........+++.+.+++.+||+.||++|||+.++++
T Consensus       252 ----------~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         252 ----------DQGRQ---VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ----------hcccc---ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                      00000   000112245688999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=8.1e-29  Score=205.94  Aligned_cols=165  Identities=25%  Similarity=0.403  Sum_probs=129.7

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEecCCCEEEecccccccCCCCC-c---
Q 027927            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-F---   73 (217)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~---   73 (217)
                      |+.|-|++.+  +.+|++.++++|+.++++|+++||..+  |+|||||-+|||+..+|..||||||.+.-..... .   
T Consensus       126 gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e  205 (738)
T KOG1989|consen  126 GGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQE  205 (738)
T ss_pred             CCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHH
Confidence            4799999975  467999999999999999999999988  9999999999999999999999999885322221 1   


Q ss_pred             ------cccccccccccCccccc--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           74 ------MTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        74 ------~~~~~~~~~~~~Pe~~~--~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                            ......|+.|++||.+-  .....+.++|||||||+||.|.....||.+.....++.--   ..-         
T Consensus       206 ~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~---Y~~---------  273 (738)
T KOG1989|consen  206 VNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN---YSF---------  273 (738)
T ss_pred             HHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc---ccC---------
Confidence                  11245689999999973  3345789999999999999999999999765311110000   000         


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                           ..++.++..+.+||+.||+.||.+||++-+++.
T Consensus       274 ---------------------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  274 ---------------------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             ---------------------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                                 011357789999999999999999999998864

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=9e-28  Score=185.99  Aligned_cols=182  Identities=24%  Similarity=0.398  Sum_probs=130.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~   76 (217)
                      |++|.+++..+ ..++...+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........    ...
T Consensus        92 g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  171 (284)
T cd05079          92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD  171 (284)
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCC
Confidence            67899999765 4689999999999999999999999999999999999999999999999999876543321    122


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..++..|+|||.+.+. .++.++|+||+|+++|+++++..|......     ...+..+......    .   .......
T Consensus       172 ~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~----~---~~~~~~~  238 (284)
T cd05079         172 LDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQM----T---VTRLVRV  238 (284)
T ss_pred             CCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccc----c---HHHHHHH
Confidence            3445679999988654 478899999999999999997766533211     0111111111100    0   0011111


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      .....   .......++..+.+++.+||+.+|.+|||++++++
T Consensus       239 ~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         239 LEEGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             HHcCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            11110   01123457899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.95  E-value=1.3e-27  Score=183.97  Aligned_cols=167  Identities=23%  Similarity=0.362  Sum_probs=127.5

Q ss_pred             CccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--
Q 027927            2 DTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--   73 (217)
Q Consensus         2 ~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--   73 (217)
                      +++|.+++...      ..++...+..++.||+.||+|||+.|++|+||+|+||+++.++.++++|||.+........  
T Consensus        91 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~  170 (273)
T cd05074          91 HGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR  170 (273)
T ss_pred             CCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCccee
Confidence            46777776432      2589999999999999999999999999999999999999999999999998876543221  


Q ss_pred             -cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           74 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        74 -~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                       .....+++.|++||.+.... .+.++|+||||+++|++++ |..||...........+... ..               
T Consensus       171 ~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~---------------  233 (273)
T cd05074         171 QGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NR---------------  233 (273)
T ss_pred             cCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-Cc---------------
Confidence             11223356789999885443 6889999999999999998 88888765543333222210 00               


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                    .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       234 --------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         234 --------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          0011245688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=2.2e-27  Score=183.73  Aligned_cols=183  Identities=20%  Similarity=0.315  Sum_probs=129.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   76 (217)
                      +++|.+++.+. ..++...+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.........    ..
T Consensus        91 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  170 (284)
T cd05081          91 YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP  170 (284)
T ss_pred             CCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCC
Confidence            67999999765 56899999999999999999999999999999999999999999999999998765432211    11


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ...+..|++||.+.+. .++.++|+||+|+++++++++..++...... .    .+..+....   ..............
T Consensus       171 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~----~~~~~~~~~---~~~~~~~~~~~~~~  241 (284)
T cd05081         171 GESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-F----MRMMGNDKQ---GQMIVYHLIELLKN  241 (284)
T ss_pred             CCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-h----hhhcccccc---cccchHHHHHHHhc
Confidence            1223458999988654 4788999999999999999987766433211 0    111111000   00000111111111


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ....      .....++.++.+++.+||..+|++|||+.++++
T Consensus       242 ~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         242 NGRL------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             CCcC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1110      122356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.95  E-value=5.9e-29  Score=199.45  Aligned_cols=172  Identities=21%  Similarity=0.353  Sum_probs=134.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC---CCCccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS---ENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~---~~~~~~~~   77 (217)
                      |.+|+.+++-. ..+.......|+.||+.|+.|||.++|+|+|+|..||++..+++|+|+|||++..-.   ........
T Consensus       471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp  550 (678)
T KOG0193|consen  471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQP  550 (678)
T ss_pred             CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCC
Confidence            67899998775 668999999999999999999999999999999999999999999999999985422   22233455


Q ss_pred             cccccccCcccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           78 VVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~--~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      .+...|+|||++...  -+++..+||||||+++|||++|..||......+++...-+  |                    
T Consensus       551 ~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr--G--------------------  608 (678)
T KOG0193|consen  551 HGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR--G--------------------  608 (678)
T ss_pred             ccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc--c--------------------
Confidence            677889999998632  3478899999999999999999999985443222211110  0                    


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                          ...+.......+.+.++++|+..|+.+++++||++.+||.
T Consensus       609 ----~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  609 ----YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ----ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                0011223334456679999999999999999999999876

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=1.5e-27  Score=189.52  Aligned_cols=157  Identities=26%  Similarity=0.385  Sum_probs=118.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccccccccccCccccc
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELLL   90 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~Pe~~~   90 (217)
                      .++...+..++.||+.||+|||++|++|+||||.||+++.++.++++|||++........   .....++..|++||.+.
T Consensus       175 ~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  254 (343)
T cd05103         175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF  254 (343)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhc
Confidence            467888899999999999999999999999999999999999999999998865432211   11123345699999886


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhC
Q 027927           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (217)
Q Consensus        91 ~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (217)
                      +. .++.++|+||||+++|++++ |..||................                       ...      ..+
T Consensus       255 ~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------~~~------~~~  304 (343)
T cd05103         255 DR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-----------------------TRM------RAP  304 (343)
T ss_pred             CC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc-----------------------CCC------CCC
Confidence            54 47889999999999999996 899986643222111111100                       000      011


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          170 PHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       170 ~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                      ...++++.+++.+||+.||.+|||+.++++|
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1256789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=2.4e-27  Score=182.18  Aligned_cols=172  Identities=22%  Similarity=0.280  Sum_probs=125.8

Q ss_pred             CccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---
Q 027927            2 DTDLYQIIRSNQ-----SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---   73 (217)
Q Consensus         2 ~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---   73 (217)
                      +++|.+++....     ..+...+..++.|++.|++|||+.+++|+||||+||+++.++.++|+|||.+........   
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            578999997642     456778889999999999999999999999999999999999999999998864433221   


Q ss_pred             cccccccccccCcccccCCC------CCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccC
Q 027927           74 MTEYVVTRWYRAPELLLNSS------DYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR  146 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~~------~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (217)
                      .....++..|+|||.+.+..      .++.++|+||+|+++|++++ |..||..................          
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------  228 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----------  228 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC----------
Confidence            11234567799999885321      24678999999999999996 99999765543332221110000          


Q ss_pred             chHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  .   ..........++.+.+++++|+ .+|++|||++++++
T Consensus       229 ------------~---~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 ------------K---LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ------------C---CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                        0   0001111235678999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=4.1e-27  Score=180.91  Aligned_cols=172  Identities=19%  Similarity=0.236  Sum_probs=127.0

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---cc
Q 027927            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FM   74 (217)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~   74 (217)
                      +++|.+++++.    ...+...+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||.+.......   ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            57899999864    346777889999999999999999999999999999999999999999999875322111   11


Q ss_pred             ccccccccccCcccccCC------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           75 TEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~------~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      ....++..|+|||.+...      ...+.++|+||+|+++|++++ +..||....+...+..+........         
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---------  229 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL---------  229 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc---------
Confidence            234567789999987431      124678999999999999986 5778876665544444332111000         


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                      ........+++.+.++++.|+ .+|.+|||++++++
T Consensus       230 ----------------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         230 ----------------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ----------------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                            001112246688999999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=195.82  Aligned_cols=173  Identities=26%  Similarity=0.382  Sum_probs=143.6

Q ss_pred             ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            3 TDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |+-.|++.=+ +++.+.++..|..+.+.||+|||+.+.+|+|||..||+++..|.|||+|||.+.....   .+...|||
T Consensus       110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsFvGTP  186 (948)
T KOG0577|consen  110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSFVGTP  186 (948)
T ss_pred             ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhcccCCc
Confidence            4666776544 7899999999999999999999999999999999999999999999999998754332   45678999


Q ss_pred             cccCccccc--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           82 WYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        82 ~~~~Pe~~~--~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      .|+|||++.  ..+.++-++||||||++..++.-+.+|+...+.+.-+..|...-.+.-.                    
T Consensus       187 ywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--------------------  246 (948)
T KOG0577|consen  187 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--------------------  246 (948)
T ss_pred             cccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--------------------
Confidence            999999985  4456788999999999999999999998887766666666553211100                    


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                               .++.|..|..|+.+||+.-|.+|||.+++|.|+|....+
T Consensus       247 ---------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  247 ---------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             ---------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                     123568899999999999999999999999999987544

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.95  E-value=2.1e-27  Score=191.72  Aligned_cols=167  Identities=26%  Similarity=0.392  Sum_probs=126.8

Q ss_pred             ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccc
Q 027927            3 TDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (217)
Q Consensus         3 ~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~   77 (217)
                      +++.+++...  ..++...+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++........   ....
T Consensus       220 ~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~  299 (400)
T cd05105         220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST  299 (400)
T ss_pred             hhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCc
Confidence            4566666653  5699999999999999999999999999999999999999999999999999865433221   1223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+.+.. ++.++|+||||+++|++++ |..||..................                    
T Consensus       300 ~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~--------------------  358 (400)
T cd05105         300 FLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR--------------------  358 (400)
T ss_pred             CCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC--------------------
Confidence            4567799999886544 7889999999999999996 88998764322222111110000                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......++.++.+++.+||+.||++|||+.++.+
T Consensus       359 ---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         359 ---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence                     0012246788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.95  E-value=3.2e-27  Score=202.70  Aligned_cols=169  Identities=22%  Similarity=0.331  Sum_probs=126.2

Q ss_pred             CccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC
Q 027927            2 DTDLYQIIRSN-----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE   70 (217)
Q Consensus         2 ~~~L~~~l~~~-----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~   70 (217)
                      |++|.+++.+.           ..++...+..++.||+.||+|||++|++||||||+||+++.++.++++|||.+.....
T Consensus        86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~  165 (932)
T PRK13184         86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL  165 (932)
T ss_pred             CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccc
Confidence            67899988642           3356678899999999999999999999999999999999999999999999865411


Q ss_pred             C-------------------CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 027927           71 N-------------------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI  131 (217)
Q Consensus        71 ~-------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~  131 (217)
                      .                   .......|++.|+|||.+.+.. .+.++|+||+||++|++++|..||...........  
T Consensus       166 ~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--  242 (932)
T PRK13184        166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--  242 (932)
T ss_pred             ccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--
Confidence            1                   0111245789999999886554 78999999999999999999999976442211111  


Q ss_pred             HHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      .....+.                          .......+++.+.+++.+||+.||++|++..+.+.
T Consensus       243 ~~i~~P~--------------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        243 DVILSPI--------------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhccChh--------------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            0000000                          00011246788999999999999999988765543

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=9.5e-27  Score=187.94  Aligned_cols=157  Identities=26%  Similarity=0.336  Sum_probs=120.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccccccccccCccccc
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELLL   90 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~Pe~~~   90 (217)
                      .++...+..++.||+.||+|||+.+++|+||+|.||+++.++.++|+|||++........   .....++..|++||.+.
T Consensus       235 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  314 (401)
T cd05107         235 ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF  314 (401)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence            467778899999999999999999999999999999999999999999999865432211   12234567899999886


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhC
Q 027927           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (217)
Q Consensus        91 ~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (217)
                      +.. ++.++|+||+|++++++++ |..||......+...........                             ...+
T Consensus       315 ~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~-----------------------------~~~p  364 (401)
T cd05107         315 NNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR-----------------------------MAKP  364 (401)
T ss_pred             CCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC-----------------------------CCCC
Confidence            544 7889999999999999997 88898664433322222110000                             0112


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          170 PHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       170 ~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                      ..++.++.+++.+|++.+|.+||+++++++.
T Consensus       365 ~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         365 AHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3467899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=5.7e-27  Score=181.17  Aligned_cols=182  Identities=22%  Similarity=0.317  Sum_probs=130.4

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----cc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   76 (217)
                      +++|.+++..+. .++...+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.........    ..
T Consensus        92 ~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  171 (284)
T cd05038          92 SGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP  171 (284)
T ss_pred             CCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCC
Confidence            579999998764 6999999999999999999999999999999999999999999999999998765532111    11


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ...+..|.+||.+.+. .++.++|+||||++++++++|..|+.......     ....+....    .............
T Consensus       172 ~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~  241 (284)
T cd05038         172 GESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQG----QMIVTRLLELLKE  241 (284)
T ss_pred             CCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccc----cccHHHHHHHHHc
Confidence            2334569999988655 47889999999999999999998885432110     000000000    0011111111111


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ....      ......+.++.+++.+||+.+|.+|||+.++++
T Consensus       242 ~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         242 GERL------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             CCcC------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1111      012245688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=8.4e-27  Score=199.05  Aligned_cols=65  Identities=31%  Similarity=0.624  Sum_probs=61.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      |++|.+++...+.+++..++.++.||+.||+|||+++|+|+||||+||+++.++.++|+|||++.
T Consensus        88 g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          88 GGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            68999999988899999999999999999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.95  E-value=2.9e-27  Score=196.24  Aligned_cols=164  Identities=24%  Similarity=0.388  Sum_probs=138.9

Q ss_pred             ccHHHHHHhC----------CC----CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccC
Q 027927            3 TDLYQIIRSN----------QS----LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (217)
Q Consensus         3 ~~L~~~l~~~----------~~----l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   68 (217)
                      |+|.+||+.+          .+    |+..+...++.||+.|+.||-++.+||||+..+|+||..+..||++|||+++..
T Consensus       574 GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdi  653 (774)
T KOG1026|consen  574 GDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDI  653 (774)
T ss_pred             ccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhh
Confidence            6888888764          22    889999999999999999999999999999999999999999999999999766


Q ss_pred             CCCCccc---cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           69 SENEFMT---EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        69 ~~~~~~~---~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      -..+...   ...-+.+|+|||.+...+ ++.++||||+||++||+++ |..|+.+..+.+.+..+..-           
T Consensus       654 YssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g-----------  721 (774)
T KOG1026|consen  654 YSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG-----------  721 (774)
T ss_pred             hhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC-----------
Confidence            5554432   223367899999997665 9999999999999999998 89999999888887777541           


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhh
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF  197 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~l  197 (217)
                                         .+-+.+.+.+.++-+||..||+..|++||+++||
T Consensus       722 -------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  722 -------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             -------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence                               1122345688999999999999999999999998

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-27  Score=201.45  Aligned_cols=167  Identities=25%  Similarity=0.386  Sum_probs=138.8

Q ss_pred             CccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc
Q 027927            2 DTDLYQIIRSN-------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM   74 (217)
Q Consensus         2 ~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (217)
                      ||+|..||++.       ..++......++.+|+.|+.||++++++||||..+|+|++....+|++|||+++-.......
T Consensus       779 gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yy  858 (1025)
T KOG1095|consen  779 GGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYY  858 (1025)
T ss_pred             cCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchhe
Confidence            78999999996       34899999999999999999999999999999999999999999999999999744333322


Q ss_pred             cc---ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHH
Q 027927           75 TE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        75 ~~---~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                      ..   ..-...|+|||.+.. ..++.++|||||||++||+++ |..||...++.+.+....+-...+             
T Consensus       859 r~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~-------------  924 (1025)
T KOG1095|consen  859 RKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD-------------  924 (1025)
T ss_pred             eccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC-------------
Confidence            11   122467999999975 459999999999999999998 799999988877766555422111             


Q ss_pred             HHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                       .+..++..+-++|.+||+.+|++||++..++.
T Consensus       925 -----------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 -----------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -----------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                             12347788899999999999999999999987

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.7e-27  Score=182.93  Aligned_cols=129  Identities=27%  Similarity=0.376  Sum_probs=91.5

Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC------ChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN------DHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                      ..|..|++||++.+.+ |++.+||||++|+++||+||..+|...      .+...++.|++++|..+......  ...-+
T Consensus       412 IQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~--Gk~SR  488 (590)
T KOG1290|consen  412 IQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALG--GKYSR  488 (590)
T ss_pred             hhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhc--CcchH
Confidence            4466799999999887 899999999999999999999888532      36889999999999876543211  11112


Q ss_pred             HHHHhCC---------CCCccc----hhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          152 RYIRQLP---------QHPRQS----LAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       152 ~~~~~~~---------~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                      .++...-         ..+-..    ...+...-..++.+|+.-||+++|++||||.++|+|||+....+.
T Consensus       489 dFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  489 DFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             hhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            2222111         000000    001111223678999999999999999999999999999977654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-28  Score=200.46  Aligned_cols=181  Identities=28%  Similarity=0.408  Sum_probs=134.3

Q ss_pred             CccHHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---C--CCEEEecccccccCCCCC
Q 027927            2 DTDLYQIIRSN-QS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---N--CDLKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~~-~~---l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~--~~~~l~d~~~~~~~~~~~   72 (217)
                      ..+|.|++... ..   ...-....++.|++.||++||+.+|+|||+||.|||+..   +  .+++|+|||+++++....
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            46788888884 11   111456788999999999999999999999999999976   3  467899999998876543


Q ss_pred             c----cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           73 F----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        73 ~----~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      .    .....|+-.|+|||.+...+ ...++||+|+||++|+.++| .+||.....  ..+.|..  +            
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~--~------------  728 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILT--G------------  728 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhc--C------------
Confidence            2    34567889999999997766 46799999999999999885 999965431  1111111  0            


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCceeec
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFI  213 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~~~  213 (217)
                                    ...+..+.+....++.+||.+|++++|..||+|.++|.||+|...+....|+
T Consensus       729 --------------~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl  780 (903)
T KOG1027|consen  729 --------------NYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFL  780 (903)
T ss_pred             --------------ccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHH
Confidence                          0000111111112789999999999999999999999999999876655543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1e-26  Score=175.87  Aligned_cols=174  Identities=24%  Similarity=0.414  Sum_probs=139.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc-CCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~-~~~~~~~~~~~~~   80 (217)
                      ||+|-=.++.++.+|++.++.+...|..||+|||++||+++|+|.+|++++.+|.+||+|+|+++. .......++.+|+
T Consensus       335 ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgt  414 (593)
T KOG0695|consen  335 GGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGT  414 (593)
T ss_pred             CcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCC
Confidence            455555566778899999999999999999999999999999999999999999999999999865 4556677889999


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC--CC------hHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG--ND------HVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~--~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      |.|.|||++.+.. ++.+.|.|+|||++++++.|..||.-  .+      +...++-|.+.                   
T Consensus       415 pnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-------------------  474 (593)
T KOG0695|consen  415 PNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-------------------  474 (593)
T ss_pred             Ccccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-------------------
Confidence            9999999997665 89999999999999999999999952  11      11112222221                   


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC------HhhhccCCCCcccc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT------GEFFVPYKPFQCCC  207 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t------~~~ll~~~~f~~~~  207 (217)
                          ..+        ++-.+|..+..+++..|+.||++|.-      ++++-.|+||++..
T Consensus       475 ----qir--------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  475 ----QIR--------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             ----ccc--------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence                111        12235677889999999999999864      67889999999653

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.8e-27  Score=189.03  Aligned_cols=168  Identities=26%  Similarity=0.354  Sum_probs=136.5

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc-cccc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT-EYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~   79 (217)
                      ||+|.++|++++ .++..+...++.+++.||+|||+++++||||.++|+|+..++.+|++|||++.....-.... ..--
T Consensus       245 gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~kl  324 (474)
T KOG0194|consen  245 GGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKL  324 (474)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccC
Confidence            789999999987 59999999999999999999999999999999999999999999999999976543111111 1123


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|+|||.+... .++.++||||+||++||++. |..||.+....+..+++........                    
T Consensus       325 PirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~--------------------  383 (474)
T KOG0194|consen  325 PIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP--------------------  383 (474)
T ss_pred             cceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC--------------------
Confidence            5679999999644 68999999999999999998 7889999887777777644221111                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               .+...+..+..++.+|+..+|++|||+.++.+
T Consensus       384 ---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  384 ---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             ---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                     11134577899999999999999999998854

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.1e-25  Score=184.72  Aligned_cols=173  Identities=19%  Similarity=0.282  Sum_probs=118.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccc--ccccccccCcccccCC
Q 027927           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE--YVVTRWYRAPELLLNS   92 (217)
Q Consensus        15 l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~Pe~~~~~   92 (217)
                      ++...++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...........  ...++.|++||.+...
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            45678899999999999999999999999999999999999999999999865433222222  2336889999987532


Q ss_pred             CC---------------------CCchhhHHHHHHHHHHHHcCCC-CCCCCChHHHHHHHHHHhCCCCCccccccCchHH
Q 027927           93 SD---------------------YTAAIDVWSVGCIFMELMNRRP-LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        93 ~~---------------------~~~~~Diwslg~~l~~l~~~~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                      ..                     .....|+||+||++++++++.. ||........   ..+.            .....
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~------------~~~~~  450 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQ------------YDNDL  450 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhh------------ccchH
Confidence            11                     1124699999999999999865 6643211100   0000            00000


Q ss_pred             HHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCC---CCCCCHhhhccCCCCcc
Q 027927          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP---MKRITGEFFVPYKPFQC  205 (217)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~R~t~~~ll~~~~f~~  205 (217)
                      ..+.. ... ..... ..+...++...+++.+||..+|   .+|+|++|+|+||||.+
T Consensus       451 ~~~r~-~~~-~~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        451 NRWRM-YKG-QKYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             HHHHh-hcc-cCCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            00100 000 00011 1344578999999999999866   68999999999999974

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=173.90  Aligned_cols=171  Identities=24%  Similarity=0.362  Sum_probs=137.1

Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCcccc
Q 027927           11 SNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELL   89 (217)
Q Consensus        11 ~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~   89 (217)
                      .+..+++..+-.+....+.||.||.+ .+|+|||+||+|||++..|.+||||||.+..+..+-......|...|+|||.+
T Consensus       160 q~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi  239 (361)
T KOG1006|consen  160 QKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERI  239 (361)
T ss_pred             HhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhcc
Confidence            34789999999999999999999995 67999999999999999999999999999877776666667888999999999


Q ss_pred             cCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH-hCCCCCccccccCchHHHHHHHhCCCCCccchhh
Q 027927           90 LNSSD-YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ  167 (217)
Q Consensus        90 ~~~~~-~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (217)
                      -.... +..++|+||||++++|+.+|..|+..=+.  ++.++... .|.++--.                       ...
T Consensus       240 ~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~-----------------------~~~  294 (361)
T KOG1006|consen  240 DPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILL-----------------------FDK  294 (361)
T ss_pred             CCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeec-----------------------Ccc
Confidence            65544 78899999999999999999999965322  33333222 22221111                       111


Q ss_pred             hCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          168 VFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       168 ~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      -.-+++..+..+|.-||..|-+.||.-++++.+||++-.
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            112478999999999999999999999999999999844

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-26  Score=182.90  Aligned_cols=182  Identities=26%  Similarity=0.318  Sum_probs=129.8

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC---cEecCcCCCCEEEecCCCEEEecccccccCCC-CCccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMT   75 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~---i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~   75 (217)
                      .|+|.+.|....  ++++....+|+.+++.||+|||+..   |+|||||+.||++|.+...|++|||++..... .....
T Consensus       156 nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~  235 (361)
T KOG1187|consen  156 NGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVS  235 (361)
T ss_pred             CCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccccee
Confidence            379999998875  8999999999999999999999854   99999999999999999999999999965554 33333


Q ss_pred             cc-cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHH-HHhCCCCCccccccCchHHH
Q 027927           76 EY-VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND--HVHQMRLLI-ELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        76 ~~-~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  151 (217)
                      .. .|+..|++||.... +..+.++||||+||++.|+++|+.+.....  ....+..+. ......           ...
T Consensus       236 ~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-----------~~~  303 (361)
T KOG1187|consen  236 TTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-----------KLR  303 (361)
T ss_pred             eecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-----------chh
Confidence            33 78999999998854 557899999999999999999998776432  111111111 100000           111


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ..++...........    ..-..+..+..+|++.+|.+||++.++++
T Consensus       304 eiiD~~l~~~~~~~~----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  304 EIVDPRLKEGEYPDE----KEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             heeCCCccCCCCChH----HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111111110000000    01134788999999999999999999754

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-26  Score=186.54  Aligned_cols=166  Identities=23%  Similarity=0.383  Sum_probs=134.9

Q ss_pred             ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc--
Q 027927            3 TDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--   79 (217)
Q Consensus         3 ~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~--   79 (217)
                      |+|..||+.+ ..|+......+..||..||+|||+.++|||||..+||++.....+||+|||+++............+  
T Consensus       475 GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kL  554 (974)
T KOG4257|consen  475 GELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKL  554 (974)
T ss_pred             hhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcccccc
Confidence            5899999887 6799999999999999999999999999999999999999999999999999988776655444333  


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +.-|+|||.+. -+.++.++|+|.|||.+||++. |..||.+-.+.+.+..+.+                          
T Consensus       555 PIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--------------------------  607 (974)
T KOG4257|consen  555 PIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--------------------------  607 (974)
T ss_pred             ceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC--------------------------
Confidence            34599999884 4558999999999999999876 8999987543333222211                          


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                       .   .....++++++.+-.++.+||.+||.+||++.++..
T Consensus       608 -G---eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  608 -G---ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             -C---CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence             0   111234578899999999999999999999988743

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=8e-26  Score=182.80  Aligned_cols=177  Identities=24%  Similarity=0.398  Sum_probs=136.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC---------CC-
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS---------EN-   71 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~---------~~-   71 (217)
                      ||++-.+|-+.+.+.++.++.++..+..|+++.|++|++||||||+|||+|.+|.+||+|||+++-+.         ++ 
T Consensus       713 GGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gd  792 (1034)
T KOG0608|consen  713 GGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGD  792 (1034)
T ss_pred             CccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCC
Confidence            78899999999999999999999999999999999999999999999999999999999999975211         00 


Q ss_pred             ---------------------------------CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 027927           72 ---------------------------------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF  118 (217)
Q Consensus        72 ---------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf  118 (217)
                                                       .......|++.|++||++...+ ++..+|.|+.||+||+|+.|++||
T Consensus       793 H~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g~~pf  871 (1034)
T KOG0608|consen  793 HHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVGQPPF  871 (1034)
T ss_pred             ccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhCCCCc
Confidence                                             0112357789999999997665 788999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCC---CHh
Q 027927          119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TGE  195 (217)
Q Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---t~~  195 (217)
                      ....+.+...++..         |.         ..   ..      -..-.++|+++.++|.++.+ ++..|.   -++
T Consensus       872 ~~~tp~~tq~kv~n---------w~---------~~---l~------~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d  923 (1034)
T KOG0608|consen  872 LADTPGETQYKVIN---------WR---------NF---LH------IPYQGNLSKEALDLIQKLCC-SADSRLGKNGAD  923 (1034)
T ss_pred             cCCCCCcceeeeee---------hh---------hc---cc------cccccccCHHHHHHHHHHhc-Chhhhhcccchh
Confidence            76654322222211         00         00   00      01123688999999998765 455554   456


Q ss_pred             hhccCCCCcccc
Q 027927          196 FFVPYKPFQCCC  207 (217)
Q Consensus       196 ~ll~~~~f~~~~  207 (217)
                      ++-.||||+.+.
T Consensus       924 ~vKaHpfFkgID  935 (1034)
T KOG0608|consen  924 QVKAHPFFKGID  935 (1034)
T ss_pred             hhhcCccccccc
Confidence            799999999653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-25  Score=187.00  Aligned_cols=176  Identities=24%  Similarity=0.412  Sum_probs=144.1

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccc
Q 027927            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~   78 (217)
                      |||..|++++  +.++.+..+..+++.++.|+.+||.+.++|+|||-.||+++.++.+||.|||.+...... ....+..
T Consensus       105 gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~i  184 (953)
T KOG0587|consen  105 GGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFI  184 (953)
T ss_pred             CccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcC
Confidence            6889999887  478999999999999999999999999999999999999999999999999987655443 3346778


Q ss_pred             ccccccCcccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           79 VTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~----~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      |++.|+|||++.+..    .+...+|+||||++..++.-|.+|+.+..++-.+..|                        
T Consensus       185 GtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I------------------------  240 (953)
T KOG0587|consen  185 GTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------------------------  240 (953)
T ss_pred             CCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC------------------------
Confidence            999999999997553    3466899999999999999999999776543332222                        


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                         ++.|++ ....+...+.+|.+||..||..|-.+||+..++|+|||+..
T Consensus       241 ---pRNPPP-kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  241 ---PRNPPP-KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             ---CCCCCc-cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence               111111 11223346688999999999999999999999999999983

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=4e-25  Score=180.32  Aligned_cols=168  Identities=24%  Similarity=0.309  Sum_probs=139.7

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      .|+|.|.|++  ...|.......++.||+.|+.||.+++++|||+...|+++.....+|++|||+.+.++..+.......
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p  273 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAP  273 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecC
Confidence            4789999988  36789999999999999999999999999999999999999999999999999988877654433222


Q ss_pred             ----cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           80 ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        80 ----~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                          ...|.+||.+.. +.++.++|+|++||++|||++ |+.||.+....+++.++-+....                  
T Consensus       274 ~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL------------------  334 (1039)
T KOG0199|consen  274 QRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL------------------  334 (1039)
T ss_pred             CCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC------------------
Confidence                346999999954 459999999999999999998 79999998877777666431111                  


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                  ..+..++.++-++++.||.++|.+|||+..|...
T Consensus       335 ------------pRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  335 ------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                        1223477899999999999999999999998643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.2e-25  Score=186.39  Aligned_cols=188  Identities=30%  Similarity=0.353  Sum_probs=145.8

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-----Cccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-----EFMTEY   77 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~   77 (217)
                      .+|+.++.....+....+..+++|++.|+.|+|+.|+.|+|+|++|+++..+|.++++|||.+......     ......
T Consensus       405 ~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~  484 (601)
T KOG0590|consen  405 YDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGI  484 (601)
T ss_pred             HHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCc
Confidence            378899999889999999999999999999999999999999999999999999999999987653322     223457


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .|+..|.|||++.+........||||.|+++..|.+|+.||..............                      ...
T Consensus       485 ~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~----------------------~~~  542 (601)
T KOG0590|consen  485 VGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN----------------------YSD  542 (601)
T ss_pred             ccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------------------ccc
Confidence            7889999999997776556789999999999999999999965432111100000                      000


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCceee
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEF  212 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~~  212 (217)
                      ..........+...++..-+.+|.+||++||.+|.|+++|++++||+....|+-.
T Consensus       543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v~  597 (601)
T KOG0590|consen  543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHVD  597 (601)
T ss_pred             ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEec
Confidence            0000111222333466778899999999999999999999999999999888643

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2e-24  Score=174.74  Aligned_cols=164  Identities=23%  Similarity=0.367  Sum_probs=135.6

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      -|+|.|||+.-  .-++.-...+++.||..|+.||..++++|||+...|+|+..+..+|++|||+++.+........ .|
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH-AG  425 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH-AG  425 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc-cC
Confidence            47999999885  4488889999999999999999999999999999999999999999999999987765543322 22


Q ss_pred             ---cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           80 ---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        80 ---~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                         ..-|.|||-+.-+. ++.++|+|+|||+||++.+ |..||.+-+-.+.+..+.+-..                    
T Consensus       426 AKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR--------------------  484 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR--------------------  484 (1157)
T ss_pred             ccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc--------------------
Confidence               44599999886554 8999999999999999988 7899998876666665543110                    


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhh
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF  197 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~l  197 (217)
                                -..+..+++.+-+|++.||++.|+.||++.|+
T Consensus       485 ----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  485 ----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             ----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                      01233578999999999999999999999987

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.91  E-value=2.1e-24  Score=153.03  Aligned_cols=126  Identities=29%  Similarity=0.523  Sum_probs=106.9

Q ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccC
Q 027927            7 QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRA   85 (217)
Q Consensus         7 ~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   85 (217)
                      ..+.+++.+++..+-+++-.++.||.|||++ .++|||+||.|||++..|++|+||||.+..+.++-...-..|...|+|
T Consensus       137 ~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYma  216 (282)
T KOG0984|consen  137 KVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMA  216 (282)
T ss_pred             HHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCC
Confidence            4566779999999999999999999999975 799999999999999999999999999877766655555678889999


Q ss_pred             cccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHH
Q 027927           86 PELLLN---SSDYTAAIDVWSVGCIFMELMNRRPLFPG-NDHVHQMRLLIE  132 (217)
Q Consensus        86 Pe~~~~---~~~~~~~~Diwslg~~l~~l~~~~~pf~~-~~~~~~~~~~~~  132 (217)
                      ||.+..   +..++.++|+||||+++.|+.++..|+.. ..+.+++.++++
T Consensus       217 PEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  217 PERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            998852   33578899999999999999999999964 556666665554

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-25  Score=183.09  Aligned_cols=174  Identities=24%  Similarity=0.315  Sum_probs=148.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      .|+|..||+++ +.++.-+...+++.|+.|+.||-++|.||||+.+.|||++.+..+|++|||+++...+.. ...+..|
T Consensus       714 NGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~G  793 (996)
T KOG0196|consen  714 NGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLG  793 (996)
T ss_pred             CCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccC
Confidence            47899999987 679999999999999999999999999999999999999999999999999998765443 2222222


Q ss_pred             ---cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           80 ---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        80 ---~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                         +.+|.|||.+... +++.++|+||+|+++||.++ |..|+.+..+.+.+..+.+-...|++.+              
T Consensus       794 GKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD--------------  858 (996)
T KOG0196|consen  794 GKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD--------------  858 (996)
T ss_pred             CccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC--------------
Confidence               4679999999644 59999999999999999877 8999999999999988888766665554              


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc--CCCCccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP--YKPFQCC  206 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~--~~~f~~~  206 (217)
                                      .+..+-+|+..|++.|=++||++.+|+.  +..+++.
T Consensus       859 ----------------CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  859 ----------------CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             ----------------CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence                            7788999999999999999999999976  4555443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=9.4e-24  Score=178.23  Aligned_cols=167  Identities=28%  Similarity=0.451  Sum_probs=131.4

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .|+|.+++++.+                .++......++.||+.|++||++.+++|||+..+||++..+..+|++|||++
T Consensus       386 ~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGla  465 (609)
T KOG0200|consen  386 HGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLA  465 (609)
T ss_pred             CCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccce
Confidence            468888888866                4899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCcccc--cc--ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC-hHHHHHHHHHHhCCCCC
Q 027927           66 RPTSENEFMTE--YV--VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGND-HVHQMRLLIELLGTPTD  139 (217)
Q Consensus        66 ~~~~~~~~~~~--~~--~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~-~~~~~~~~~~~~~~~~~  139 (217)
                      +..........  ..  -+..|+|||.+.. ..++.++|+||+|+++||+++ |..|+.+-. ....+. ..+.+...  
T Consensus       466 r~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-~l~~G~r~--  541 (609)
T KOG0200|consen  466 RDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-FLKEGNRM--  541 (609)
T ss_pred             eccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-HHhcCCCC--
Confidence            76554433321  12  2345999999976 558999999999999999988 788887643 333322 22211111  


Q ss_pred             ccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                                 ..+...++++-++++.|++.+|++||++.++..
T Consensus       542 ---------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  542 ---------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence                                       123356789999999999999999999998854

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-24  Score=168.85  Aligned_cols=178  Identities=28%  Similarity=0.462  Sum_probs=136.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEec---CCCEEEecccccccCCCC-----
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNA---NCDLKICDFGLARPTSEN-----   71 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~-----   71 (217)
                      |.+|.=||+.++.+++++++.|+.||+.||.||.+..  |+|-|+||.|||+..   -|.+|++|||+++.+...     
T Consensus       552 GNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~v  631 (775)
T KOG1151|consen  552 GNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSV  631 (775)
T ss_pred             CCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcc
Confidence            4567778899999999999999999999999999865  999999999999843   477999999998764432     


Q ss_pred             ---CccccccccccccCcccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           72 ---EFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        72 ---~~~~~~~~~~~~~~Pe~~~~~---~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                         ...+...|+-+|++||++.-.   +..+.+.||||+||++|..+.|..||..+...   +.|.+.-......+    
T Consensus       632 dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdILqeNTIlkAtE----  704 (775)
T KOG1151|consen  632 DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDILQENTILKATE----  704 (775)
T ss_pred             cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHHHhhhchhccee----
Confidence               233557789999999998643   44688999999999999999999999654321   11111000000000    


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                               .+.+         .-+-+++++++||++||++.-+.|...-++-.||+|.
T Consensus       705 ---------VqFP---------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  705 ---------VQFP---------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             ---------ccCC---------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence                     0000         0124789999999999999999999999999999997

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.91  E-value=7.2e-24  Score=170.00  Aligned_cols=172  Identities=23%  Similarity=0.317  Sum_probs=138.3

Q ss_pred             ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc---cc
Q 027927            3 TDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT---EY   77 (217)
Q Consensus         3 ~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~   77 (217)
                      |+|.+++.++  +.+..+...+++.||+.|++||.+.++||||+.+.|+|++.++.+|++|||+++.+-..+...   ..
T Consensus       620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~  699 (807)
T KOG1094|consen  620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRA  699 (807)
T ss_pred             CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecce
Confidence            6899999988  445777888899999999999999999999999999999999999999999997655544332   23


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHH--HcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l--~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      .-+..|+|+|.+...+ ++.++|+|++|+++||+  ++.+.||....+.+.....-++......                
T Consensus       700 vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~----------------  762 (807)
T KOG1094|consen  700 VLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR----------------  762 (807)
T ss_pred             eeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc----------------
Confidence            3467899999997665 99999999999999997  5689999887776666555444333222                


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV  198 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll  198 (217)
                             +.....++-++..+.++|-+|++.|.++|||++++.
T Consensus       763 -------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  763 -------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             -------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence                   222233445778899999999999999999999884

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.91  E-value=1.3e-24  Score=177.34  Aligned_cols=119  Identities=32%  Similarity=0.521  Sum_probs=108.1

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC--CC--EEEecccccccCCCCCcc
Q 027927            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN--CD--LKICDFGLARPTSENEFM   74 (217)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~--~~--~~l~d~~~~~~~~~~~~~   74 (217)
                      ||+|+.++++-   .-|++.++..++..+..|+.|||++||+||||||.||++...  |+  .||+|||.|+....+..+
T Consensus       101 gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~  180 (732)
T KOG4250|consen  101 GGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLF  180 (732)
T ss_pred             CCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCee
Confidence            78999999764   569999999999999999999999999999999999998543  33  589999999999999899


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG  120 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~  120 (217)
                      ....||+.|.+||.+..++.++...|.||+||++|+++||..||..
T Consensus       181 ~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  181 TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9999999999999997667789999999999999999999999954

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=4.1e-24  Score=165.19  Aligned_cols=193  Identities=30%  Similarity=0.438  Sum_probs=133.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccC-----------------CC--C--
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPT-----------------SE--N--   71 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~-----------------~~--~--   71 (217)
                      .++..++..+++.++.||.++|.+||+||||||.|++.+. .++-.|.|||++...                 ..  .  
T Consensus       128 ~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~  207 (418)
T KOG1167|consen  128 SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKD  207 (418)
T ss_pred             cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCc
Confidence            3678899999999999999999999999999999999975 466789999998610                 00  0  


Q ss_pred             ------------------------CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHH
Q 027927           72 ------------------------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG-NDHVHQ  126 (217)
Q Consensus        72 ------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~-~~~~~~  126 (217)
                                              .......||+.|+|||++...+..+++.|+||.||++..++++..||.. .++...
T Consensus       208 ~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~a  287 (418)
T KOG1167|consen  208 VHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADA  287 (418)
T ss_pred             ccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccch
Confidence                                    0001246788999999998888789999999999999999999999853 444444


Q ss_pred             HHHHHHHhCCCC--------Cc--ccccc---CchHHHHHHHhC----CCCCcc--chhhhCC-CCChhHHHHHHHhccc
Q 027927          127 MRLLIELLGTPT--------DA--DLGFV---RNEDAKRYIRQL----PQHPRQ--SLAQVFP-HVHPLAIDLVDRMLTF  186 (217)
Q Consensus       127 ~~~~~~~~~~~~--------~~--~~~~~---~~~~~~~~~~~~----~~~~~~--~~~~~~~-~~~~~~~~li~~~l~~  186 (217)
                      +..++-..|...        ..  .|...   ...+...-.+..    ......  ...+... ..+..+.+++++||..
T Consensus       288 l~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~  367 (418)
T KOG1167|consen  288 LAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLEL  367 (418)
T ss_pred             HHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccC
Confidence            444443333211        11  01100   111111111111    111111  1222222 3456899999999999


Q ss_pred             CCCCCCCHhhhccCCCCccc
Q 027927          187 DPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       187 dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ||.+|+|++++|.||||...
T Consensus       368 np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  368 NPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             ChhhcccHHHHhcCcCCcch
Confidence            99999999999999999844

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-23  Score=163.96  Aligned_cols=184  Identities=25%  Similarity=0.315  Sum_probs=132.3

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEecCcCCCCEEEecCCCEEEecccccccCCCCCc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA---------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~---------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (217)
                      |+|.++|+.+ .++.....+++..+++||+|||+.         .|+|||||+.|||+..++++.|+|||++..+.....
T Consensus       293 GsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~  371 (534)
T KOG3653|consen  293 GSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKP  371 (534)
T ss_pred             CcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCC
Confidence            7999999994 588999999999999999999973         499999999999999999999999999976554322


Q ss_pred             ---cccccccccccCcccccCCCCCC-----chhhHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHHhCCCCCccccc
Q 027927           74 ---MTEYVVTRWYRAPELLLNSSDYT-----AAIDVWSVGCIFMELMNRRPLFP-GNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        74 ---~~~~~~~~~~~~Pe~~~~~~~~~-----~~~Diwslg~~l~~l~~~~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                         .....||.+|+|||++.+.-...     .+.||||+|.++||++++...+. +..+.-+..--.+.+..|.      
T Consensus       372 ~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt------  445 (534)
T KOG3653|consen  372 QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT------  445 (534)
T ss_pred             CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC------
Confidence               23368899999999996554333     26899999999999999765553 3322222222223333332      


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHh
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE  195 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  195 (217)
                        ...++..+.+...+|..+-.-.-..--..+.+.++.|+..||+.|.|+.
T Consensus       446 --~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  446 --LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             --HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence              2233444444444433322222222336689999999999999999986

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.90  E-value=2e-23  Score=160.66  Aligned_cols=166  Identities=20%  Similarity=0.253  Sum_probs=133.6

Q ss_pred             ccHHHHHH-----h---CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-
Q 027927            3 TDLYQIIR-----S---NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-   73 (217)
Q Consensus         3 ~~L~~~l~-----~---~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-   73 (217)
                      |+|+.+++     +   .+.++..+...++.|++.|+++||++|++|.||..+|++++...++||+|=.+++..-..+. 
T Consensus       373 gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYh  452 (563)
T KOG1024|consen  373 GNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYH  452 (563)
T ss_pred             chHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCccccc
Confidence            57888887     2   25588889999999999999999999999999999999999999999999877765433322 


Q ss_pred             --cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHH
Q 027927           74 --MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        74 --~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                        ......+..|++||.+.+. .++.++|+|||||++||+.+ |+.|+..-++.+....+..-..               
T Consensus       453 cLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR---------------  516 (563)
T KOG1024|consen  453 CLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR---------------  516 (563)
T ss_pred             ccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce---------------
Confidence              1233446679999999755 48999999999999999987 8999988777666554443110               


Q ss_pred             HHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                     -..+.+++.++..++--||..+|++||+.+++..
T Consensus       517 ---------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 ---------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ---------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                           1123468899999999999999999999999864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-23  Score=162.02  Aligned_cols=174  Identities=21%  Similarity=0.331  Sum_probs=121.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEecCcCCCCEEEecCCCEEEecccccccCCCC--
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--   71 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~--------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~--   71 (217)
                      .|||+|||.. ..++.+...+++..++.||++||..        .|+|||||+.||+|..++.+.++|+|++......  
T Consensus       293 ~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~  371 (513)
T KOG2052|consen  293 HGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTD  371 (513)
T ss_pred             CCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCC
Confidence            3799999999 7899999999999999999999963        3999999999999999999999999999654433  


Q ss_pred             ---CccccccccccccCcccccCCCCC-----CchhhHHHHHHHHHHHHcC----------CCCCCCCChHHHHHHHHHH
Q 027927           72 ---EFMTEYVVTRWYRAPELLLNSSDY-----TAAIDVWSVGCIFMELMNR----------RPLFPGNDHVHQMRLLIEL  133 (217)
Q Consensus        72 ---~~~~~~~~~~~~~~Pe~~~~~~~~-----~~~~Diwslg~~l~~l~~~----------~~pf~~~~~~~~~~~~~~~  133 (217)
                         ...+...||.+|+|||++-+.-..     -..+||||||+++||+..+          +.||.+-.+          
T Consensus       372 ~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp----------  441 (513)
T KOG2052|consen  372 TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP----------  441 (513)
T ss_pred             cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC----------
Confidence               223567899999999998544321     1269999999999999763          456644221          


Q ss_pred             hCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCC--ChhHHHHHHHhcccCCCCCCCHhhh
Q 027927          134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV--HPLAIDLVDRMLTFDPMKRITGEFF  197 (217)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~l~~dp~~R~t~~~l  197 (217)
                          +++..     +.+++.+-....+|  .....+...  =..+..+|+.|+..+|..|.|+--+
T Consensus       442 ----~DPs~-----eeMrkVVCv~~~RP--~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  442 ----SDPSF-----EEMRKVVCVQKLRP--NIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             ----CCCCH-----HHHhcceeecccCC--CCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence                11110     01111110001111  111111111  1446889999999999999998654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.89  E-value=1.8e-23  Score=186.12  Aligned_cols=177  Identities=17%  Similarity=0.216  Sum_probs=118.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH---SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh---~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.++++.   +++..+.+++.||+.|++|||   +.+++||||||+||+++.++..++. ++.......   .....
T Consensus       767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~  839 (968)
T PLN00113        767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCF  839 (968)
T ss_pred             CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCcc
Confidence            6889999964   889999999999999999999   6689999999999999998887765 443322111   11235


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ++..|+|||.+.+. .++.++||||+||++||+++|+.||..... ..............          .....+.+..
T Consensus       840 ~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~  908 (968)
T PLN00113        840 ISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD----------CHLDMWIDPS  908 (968)
T ss_pred             ccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc----------cchhheeCcc
Confidence            67889999988654 488999999999999999999999853211 00111111100000          0000011100


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                      .....    ........++.+++.+|++.||++|||++|+++.
T Consensus       909 ~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        909 IRGDV----SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccCCC----CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00000    0000112457899999999999999999999873

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.89  E-value=3.3e-22  Score=147.21  Aligned_cols=138  Identities=39%  Similarity=0.671  Sum_probs=118.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccCCCCC-cccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      |++|.+++... ..++...+..++.+++.++++||+.|++|+||+|.||+++. ++.++++||+.+....... ......
T Consensus        75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence            47899999876 57999999999999999999999999999999999999999 8999999999886554432 123345


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +...|.+||.+......+.++|+|++|++++++                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            677899999886543577899999999999998                                               


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYK  201 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~  201 (217)
                                     ..+.+++.+|++.+|++||++.++++++
T Consensus       188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                           3477899999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=5.3e-22  Score=164.69  Aligned_cols=167  Identities=25%  Similarity=0.304  Sum_probs=132.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc-
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV-   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~-   79 (217)
                      +|+|.|+++.+ ..+..+....|..||+.|+.|||+++++||||-.+|+||.....+|+.|||+++............+ 
T Consensus       781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~g  860 (1177)
T KOG1025|consen  781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGG  860 (1177)
T ss_pred             cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccccccc
Confidence            47899999987 6799999999999999999999999999999999999999999999999999976655443322222 


Q ss_pred             --cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           80 --TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        80 --~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                        .+-|++-|.+... .++.++||||+||++||++| |..|+.+....++-..+ +                       .
T Consensus       861 K~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-e-----------------------~  915 (1177)
T KOG1025|consen  861 KVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-E-----------------------K  915 (1177)
T ss_pred             ccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-h-----------------------c
Confidence              3458888887544 48999999999999999988 89999876533322211 1                       1


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      -.+      -..++..+-++--++.+||..|+..||+++++..
T Consensus       916 geR------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  916 GER------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ccc------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            111      1223457788999999999999999999999843

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-22  Score=162.20  Aligned_cols=117  Identities=26%  Similarity=0.479  Sum_probs=106.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |-+|+|+|.-++++++.+++.+++|++.|+++||+.||+|||||-+|+.++.+|.+||+|||.+-... ++......||.
T Consensus       654 gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k-sgpfd~f~gtv  732 (772)
T KOG1152|consen  654 GIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK-SGPFDVFVGTV  732 (772)
T ss_pred             CcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc-CCCcceeeeec
Confidence            45899999999999999999999999999999999999999999999999999999999999875433 44456778999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP  119 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~  119 (217)
                      .|.|||++-+.+.-+...|||++|+++|.++....||.
T Consensus       733 ~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  733 DYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999888877889999999999999998888874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-21  Score=144.25  Aligned_cols=173  Identities=24%  Similarity=0.343  Sum_probs=119.0

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec--CCCEEEecccccccCCCCCccccccccc
Q 027927            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      +|..-+.. .-+.+...++++.|+++|+.|+|+.++||||||.+|||+-.  ..++||||||...+.+..  ........
T Consensus       108 dL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V~~~~~~~  184 (378)
T KOG1345|consen  108 DLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--VKYLEYVN  184 (378)
T ss_pred             hhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--ehhhhhhc
Confidence            34333333 34778899999999999999999999999999999999843  347999999998665533  22334456


Q ss_pred             cccCcccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           82 WYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        82 ~~~~Pe~~~~~----~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .|.+||.+...    -...+.+|+|+||+++|.+++|..||....- ...+.+...                    +   
T Consensus       185 ~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~--------------------w---  241 (378)
T KOG1345|consen  185 NYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ--------------------W---  241 (378)
T ss_pred             ccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH--------------------H---
Confidence            68888876422    1246789999999999999999999974321 111111111                    1   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCC---CCHhhhccCCCC
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR---ITGEFFVPYKPF  203 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---~t~~~ll~~~~f  203 (217)
                       ..+.....+..+..+++.++.+.++-|..+|++|   .++..-...-|.
T Consensus       242 -~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  242 -LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             -hcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence             1111113344556688999999999999999999   444443333343

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.84  E-value=3.2e-21  Score=156.81  Aligned_cols=179  Identities=26%  Similarity=0.374  Sum_probs=142.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      ||+|.|.-.-.+++++.++..+.+..+.|++|||++|-+|||||-.||+++..|.+++.|||.+-.++-... .....|+
T Consensus        96 ggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGt  175 (829)
T KOG0576|consen   96 GGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGT  175 (829)
T ss_pred             CCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCC
Confidence            567777777778999999999999999999999999999999999999999999999999998765544322 2457899


Q ss_pred             ccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        81 ~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +.|++||+..-  .+.+...+|+|++|+...++-.-++|..+..++.....+.+-.-.++--                  
T Consensus       176 pywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l------------------  237 (829)
T KOG0576|consen  176 PYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL------------------  237 (829)
T ss_pred             ccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc------------------
Confidence            99999998742  3346778999999999999988888877766655555544422222110                  


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                              .-....++-|-+|++.+|-.+|++|||++.+|+|||..+.
T Consensus       238 --------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  238 --------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             --------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                    0112345778999999999999999999999999998754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.83  E-value=1.3e-19  Score=135.06  Aligned_cols=119  Identities=40%  Similarity=0.737  Sum_probs=102.6

Q ss_pred             CccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--cccccc
Q 027927            2 DTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~-l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~   78 (217)
                      +++|.+++..... ++...+..++.+++.++++||+.+++|+|+++.||+++.++.++++|||.+.......  ......
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK  160 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence            3489999988776 8999999999999999999999999999999999999999999999999887665442  334456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG  120 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~  120 (217)
                      +...|++||.+.....++.++|+|++|++++++++|..||..
T Consensus       161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            677899999874334467799999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=2e-20  Score=159.55  Aligned_cols=168  Identities=28%  Similarity=0.421  Sum_probs=123.9

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC--------Ccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--------EFM   74 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~--------~~~   74 (217)
                      .+|+|.+...+-+..-+.+-++.|++.||..+|+.||+|||||.+|||++.=+.+.|+||..-++.-..        -..
T Consensus       105 hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFF  184 (1431)
T KOG1240|consen  105 HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFF  184 (1431)
T ss_pred             hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEE
Confidence            478999999888999999999999999999999999999999999999999999999999865432111        112


Q ss_pred             ccccccccccCcccccCCC----------CCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcccc
Q 027927           75 TEYVVTRWYRAPELLLNSS----------DYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~----------~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  143 (217)
                      .+.....+|.|||.+....          ..+++.||+|+||+++|+++ |.++|.-..    +-....  +        
T Consensus       185 DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~--~--------  250 (1431)
T KOG1240|consen  185 DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRS--G--------  250 (1431)
T ss_pred             ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhc--c--------
Confidence            3344466799999986522          14678999999999999987 688885321    111110  0        


Q ss_pred             ccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                   -...+...+..+   -+..++.+|..|++.||++|.++++.|+-
T Consensus       251 -------------~~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  251 -------------NADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             -------------CccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                         000001111111   12578999999999999999999999874

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=1.9e-20  Score=142.50  Aligned_cols=140  Identities=21%  Similarity=0.275  Sum_probs=95.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCcccccCC--
Q 027927           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNS--   92 (217)
Q Consensus        15 l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--   92 (217)
                      +.......+..|++..+++||+.|++|+||+|+|++++.+|.+.|+||+.....+.....  ...+..|.+||.....  
T Consensus       142 l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~  219 (288)
T PF14531_consen  142 LAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQ  219 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTS
T ss_pred             hHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcc
Confidence            334455666799999999999999999999999999999999999999887665543332  3334678899876432  


Q ss_pred             -----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhh
Q 027927           93 -----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ  167 (217)
Q Consensus        93 -----~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (217)
                           -.++.+.|.|+||+++|.++|+..||........           .+.                       .+..
T Consensus       220 ~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~-----------~~~-----------------------~f~~  265 (288)
T PF14531_consen  220 FGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD-----------PEW-----------------------DFSR  265 (288)
T ss_dssp             CHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST-----------SGG-----------------------GGTT
T ss_pred             cCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc-----------ccc-----------------------cchh
Confidence                 1357799999999999999999999976532100           000                       1222


Q ss_pred             hCCCCChhHHHHHHHhcccCCCCC
Q 027927          168 VFPHVHPLAIDLVDRMLTFDPMKR  191 (217)
Q Consensus       168 ~~~~~~~~~~~li~~~l~~dp~~R  191 (217)
                      .. +++..+++||+++|+.+|.+|
T Consensus       266 C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  266 CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS----HHHHHHHHHHT-SSGGGS
T ss_pred             cC-CcCHHHHHHHHHHccCCcccC
Confidence            23 678999999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=3.1e-19  Score=151.91  Aligned_cols=153  Identities=27%  Similarity=0.386  Sum_probs=126.0

Q ss_pred             HHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC----------------CccccccccccccCcccccC
Q 027927           28 LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----------------EFMTEYVVTRWYRAPELLLN   91 (217)
Q Consensus        28 ~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~----------------~~~~~~~~~~~~~~Pe~~~~   91 (217)
                      +.+++|||+.||+|+|+||+|.+++.-|.+|++|||+.+.....                -.....++++.|+|||++..
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence            67899999999999999999999999999999999987643211                01134588999999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCC
Q 027927           92 SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH  171 (217)
Q Consensus        92 ~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (217)
                      .+ |+..+|.|++|+++|+-+.|..||.+..+.+++...+......++.+                            ..
T Consensus       233 qg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d----------------------------ea  283 (1205)
T KOG0606|consen  233 QG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED----------------------------EA  283 (1205)
T ss_pred             hc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC----------------------------cC
Confidence            65 88899999999999999999999999999888888776544444433                            23


Q ss_pred             CChhHHHHHHHhcccCCCCCCC---HhhhccCCCCccccCc
Q 027927          172 VHPLAIDLVDRMLTFDPMKRIT---GEFFVPYKPFQCCCGC  209 (217)
Q Consensus       172 ~~~~~~~li~~~l~~dp~~R~t---~~~ll~~~~f~~~~~~  209 (217)
                      ++++++++|.++|+.+|..|.-   +-++-+|+||+...+-
T Consensus       284 ~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  284 LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             CCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            6799999999999999999854   4477889999966443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=3.6e-18  Score=132.35  Aligned_cols=165  Identities=25%  Similarity=0.338  Sum_probs=117.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe--cCC--CEEEecccccccCCCC------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANC--DLKICDFGLARPTSEN------   71 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~--~~~--~~~l~d~~~~~~~~~~------   71 (217)
                      +.+|..++-.+ ..+.....-++.|+++|+.+||.+|+.|+|+|++||++.  .++  .+.++|||.+--....      
T Consensus       326 ~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy  404 (598)
T KOG4158|consen  326 RQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPY  404 (598)
T ss_pred             hhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecccccccccc
Confidence            45788888774 466788888999999999999999999999999999983  333  3678999976322221      


Q ss_pred             -CccccccccccccCcccccCCCCC-----CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           72 -EFMTEYVVTRWYRAPELLLNSSDY-----TAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        72 -~~~~~~~~~~~~~~Pe~~~~~~~~-----~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                       .......|.-..++||+....+..     -.++|.|+.|.+.||+++...||.....+..-.+                
T Consensus       405 ~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r----------------  468 (598)
T KOG4158|consen  405 ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR----------------  468 (598)
T ss_pred             ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh----------------
Confidence             111223445567999987533321     2389999999999999999999976432111000                


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhh
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEF  196 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~  196 (217)
                            .+.       ...+...+..+++.+.+++..+|+.||++|++++=
T Consensus       469 ------~Yq-------e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  469 ------TYQ-------ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             ------hhh-------hhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence                  000       11223344568899999999999999999999863

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.75  E-value=5.1e-17  Score=127.10  Aligned_cols=183  Identities=31%  Similarity=0.484  Sum_probs=137.7

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-CEEEecccccccCCCCC-----
Q 027927            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE-----   72 (217)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~-----   72 (217)
                      ++++.+++....   .++...+..++.|++.++.++|+.+++|+|+||+||+++..+ .++++|||.+.......     
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI  161 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccc
Confidence            567777777765   799999999999999999999999999999999999999988 69999999986544332     


Q ss_pred             --ccccccccccccCcccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCC-CCccccc
Q 027927           73 --FMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTP-TDADLGF  144 (217)
Q Consensus        73 --~~~~~~~~~~~~~Pe~~~~~--~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---~~~~~~~~~~~~~~-~~~~~~~  144 (217)
                        ......++..|.+||.+...  .......|+|++|+++++++.+..||.....   .............+ ...... 
T Consensus       162 ~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  240 (384)
T COG0515         162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS-  240 (384)
T ss_pred             cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC-
Confidence              24567889999999998763  4578899999999999999999999876553   22222222222211 000000 


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                        ....   ......+.+++.+++..+|..|.+..+...+++....
T Consensus       241 ------------------~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         241 ------------------PSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             ------------------cccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence                              0000   1123578999999999999999999999888666543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=9.1e-19  Score=139.58  Aligned_cols=163  Identities=26%  Similarity=0.402  Sum_probs=121.2

Q ss_pred             ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-------
Q 027927            3 TDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-------   72 (217)
Q Consensus         3 ~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-------   72 (217)
                      .+|.|+|+..   ...+......+++|++.|+.|   +|.+|+|++|.||++..+..++++|||+........       
T Consensus       341 ~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a  417 (516)
T KOG1033|consen  341 ETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAA  417 (516)
T ss_pred             hhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhh
Confidence            4788999764   346778999999999999999   999999999999999999999999999987765554       


Q ss_pred             ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHh-CCCCCccccccCchHH
Q 027927           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELL-GTPTDADLGFVRNEDA  150 (217)
Q Consensus        73 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  150 (217)
                      ......++..|++||.+.+.. ++.++|||+||+++++++. -.-.+.      ..+....+- +..++.          
T Consensus       418 ~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t~~d~r~g~ip~~----------  480 (516)
T KOG1033|consen  418 SHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFE------RIATLTDIRDGIIPPE----------  480 (516)
T ss_pred             hhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHH------HHHhhhhhhcCCCChH----------
Confidence            345567899999999997654 8999999999999999986 122221      111111100 000000          


Q ss_pred             HHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                                        +..--|.-..|+.+||+..|.+||++.+.-.|+|.
T Consensus       481 ------------------~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  481 ------------------FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ------------------HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                              00011455689999999999999988887777764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=8.9e-19  Score=142.16  Aligned_cols=166  Identities=24%  Similarity=0.372  Sum_probs=135.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |+.|+..+.+...+.+.....+...++.+++++|+.+++|+|+|++||+++.+|.+++.|||..+.....+..   +|+.
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~  157 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY  157 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence            4567777777778889999999999999999999999999999999999999999999999998765544332   7899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|++||++.  + ...++|.|++|++.+++++|..||..    +....|....                           
T Consensus       158 eymApEI~~--g-h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~---------------------------  203 (612)
T KOG0603|consen  158 EYRAPEIIN--G-HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE---------------------------  203 (612)
T ss_pred             hhhhhHhhh--c-cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc---------------------------
Confidence            999999885  2 46789999999999999999999977    3343333311                           


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCH-----hhhccCCCCccccC
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG-----EFFVPYKPFQCCCG  208 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~~ll~~~~f~~~~~  208 (217)
                          ...+..++..+.+++..++..+|.+|.-.     .|+.+|++|+..++
T Consensus       204 ----~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~  251 (612)
T KOG0603|consen  204 ----LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW  251 (612)
T ss_pred             ----cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence                01122356889999999999999999866     69999999996644

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.73  E-value=2.7e-17  Score=121.86  Aligned_cols=161  Identities=18%  Similarity=0.273  Sum_probs=124.1

Q ss_pred             ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEecCCCEEEe--cccccccCCCCCcccc
Q 027927            3 TDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKIC--DFGLARPTSENEFMTE   76 (217)
Q Consensus         3 ~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~--d~~~~~~~~~~~~~~~   76 (217)
                      ++|+.+++.+..  ++..++.+++.+|++|++|||+..  |.--.+++..++++.+.+.++.  |--++  +.    ...
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--fq----e~g  345 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--FQ----EVG  345 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--ee----ccc
Confidence            689999999865  578899999999999999999865  5555688899999998776653  43222  11    123


Q ss_pred             ccccccccCcccccCCCCC--CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDY--TAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~--~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+.|++||.+...+..  -.++|+|||++++||+.++..||.+-.+++...++.-.+                    
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg--------------------  405 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG--------------------  405 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc--------------------
Confidence            3567899999999654432  348999999999999999999999887776655553211                    


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV  198 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll  198 (217)
                               ....+++.++.....++.-|++.||.+||.++.++
T Consensus       406 ---------lrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  406 ---------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ---------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                     11235567889999999999999999999998875

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.71  E-value=8.2e-17  Score=130.15  Aligned_cols=173  Identities=27%  Similarity=0.317  Sum_probs=125.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCc-EecCcCCCCEEEecCCCEEEecccccccCCCC---Ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANV-IHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i-~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~   76 (217)
                      .|+|.|.+.+. ..++.-....++++|+.|++|||+..| +||.+++.|++++....+|++|||+.......   .....
T Consensus        31 rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~  110 (484)
T KOG1023|consen   31 RGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHP  110 (484)
T ss_pred             CccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccch
Confidence            47999999984 678899999999999999999998876 99999999999999999999999987554321   11112


Q ss_pred             ccccccccCcccccCCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCCCccccccC
Q 027927           77 YVVTRWYRAPELLLNSS------DYTAAIDVWSVGCIFMELMNRRPLFPGNDH----VHQMRLLIELLGTPTDADLGFVR  146 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~------~~~~~~Diwslg~~l~~l~~~~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  146 (217)
                      ......|.+||.+....      ..+.+.|+||+|+++++++++..||.....    .+...++.. .+.          
T Consensus       111 ~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~----------  179 (484)
T KOG1023|consen  111 IRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-GGS----------  179 (484)
T ss_pred             hHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-cCC----------
Confidence            22345699999986531      135679999999999999999999976321    112222111 010          


Q ss_pred             chHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhc
Q 027927          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV  198 (217)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll  198 (217)
                                  ...++..... ....+++..+++.|+..+|.+||+++++-
T Consensus       180 ------------~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  180 ------------NPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             ------------CCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHH
Confidence                        0011111111 14556899999999999999999999873

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.68  E-value=1.3e-15  Score=120.16  Aligned_cols=121  Identities=24%  Similarity=0.308  Sum_probs=99.7

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-----CCEEEecccccc--cCCCC
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-----CDLKICDFGLAR--PTSEN   71 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-----~~~~l~d~~~~~--~~~~~   71 (217)
                      +|.+|.++.+..  +.++...+.+++.|++.+|.+||+.|++||||||.|+++...     ..+.+.|||+++  .....
T Consensus       103 ~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~  182 (322)
T KOG1164|consen  103 LGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGD  182 (322)
T ss_pred             cCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCC
Confidence            588999988665  589999999999999999999999999999999999999765     358999999998  32211


Q ss_pred             Cc---------cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 027927           72 EF---------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND  122 (217)
Q Consensus        72 ~~---------~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~  122 (217)
                      ..         .....||..|.++.+..+. ..+.+.|+||++.++.++..|..||....
T Consensus       183 ~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  183 SGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             CCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            10         1223488899999866544 47899999999999999999999996654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.52  E-value=2.1e-13  Score=103.79  Aligned_cols=136  Identities=19%  Similarity=0.313  Sum_probs=107.1

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-----CEEEecccccccCCCCCcc
Q 027927            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-----DLKICDFGLARPTSENEFM   74 (217)
Q Consensus         1 l~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-----~~~l~d~~~~~~~~~~~~~   74 (217)
                      ||.||.|+..= ++.++.+.+.-+++|++.-++++|++.+++|||||+|+|+...+     .+.++|||+++..-.....
T Consensus       106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk  185 (449)
T KOG1165|consen  106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK  185 (449)
T ss_pred             hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence            67888888754 57899999999999999999999999999999999999996543     4789999999765444322


Q ss_pred             --------ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHHHHHhCCC
Q 027927           75 --------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN---DHVHQMRLLIELLGTP  137 (217)
Q Consensus        75 --------~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~---~~~~~~~~~~~~~~~~  137 (217)
                              ....||-.|++--.-.+.. -+...|+=|||=++..-+.|..||.+.   ...+.+.+|-+.....
T Consensus       186 qHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  186 QHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             ccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence                    3456788898876655544 577899999999999999999999874   3455566655444333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=2.5e-15  Score=126.38  Aligned_cols=178  Identities=26%  Similarity=0.387  Sum_probs=138.3

Q ss_pred             CccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HcCcEecCcCCCCEEEecCC-CEEEecccccccCCC-C---Cc
Q 027927            2 DTDLYQII-RSNQ-SLSEEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSE-N---EF   73 (217)
Q Consensus         2 ~~~L~~~l-~~~~-~l~~~~~~~~~~~i~~~l~~Lh-~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~-~---~~   73 (217)
                      |+++++-+ .... ..+...+..++.|+..++.|+| ..++.|+|++|+|.+++.++ ..+..|||++..... .   ..
T Consensus       105 g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~  184 (601)
T KOG0590|consen  105 GGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERS  184 (601)
T ss_pred             ccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCccee
Confidence            45666666 5554 6788899999999999999999 99999999999999999999 999999999976555 2   22


Q ss_pred             cccccc-cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           74 MTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        74 ~~~~~~-~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      .....+ ++.|.+||...+.....+..|+||.|+++.-+++|..|+........              .           
T Consensus       185 ~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------~-----------  239 (601)
T KOG0590|consen  185 LKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------R-----------  239 (601)
T ss_pred             eecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--------------c-----------
Confidence            345667 89999999987655567889999999999999999999966442110              0           


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      +.. ............+..++....+++.+++..+|.+|.+.+++-.++|+..
T Consensus       240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 YSS-WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cee-ecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            000 0000011112334567888999999999999999999999999999987

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=9.6e-14  Score=120.11  Aligned_cols=112  Identities=23%  Similarity=0.377  Sum_probs=97.1

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe-------cCCCEEEeccccccc---CCCCC
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-------ANCDLKICDFGLARP---TSENE   72 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~-------~~~~~~l~d~~~~~~---~~~~~   72 (217)
                      |||.|++..++.+++..++.++.|++..+..||..+|+||||||+|+++.       ....++|+|||.+.-   +....
T Consensus       779 Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~  858 (974)
T KOG1166|consen  779 GTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGT  858 (974)
T ss_pred             ccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCc
Confidence            68999999999999999999999999999999999999999999999984       234589999998743   44445


Q ss_pred             ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCC
Q 027927           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR  115 (217)
Q Consensus        73 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~  115 (217)
                      ......++..+-++|...+. .|++.+|.|.++.+++-|+.|+
T Consensus       859 ~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  859 KFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHH
Confidence            56677888889999988655 5999999999999999999873

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.47  E-value=4.6e-13  Score=97.90  Aligned_cols=132  Identities=23%  Similarity=0.327  Sum_probs=101.7

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC---CCEEEecccccccCCCCCcc--
Q 027927            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFM--   74 (217)
Q Consensus         1 l~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~--   74 (217)
                      ||.||.++..= .++++...+.-++-|++.-++|+|.++++|+||||+|++..-+   .++.++|||++++.-.....  
T Consensus        93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H  172 (341)
T KOG1163|consen   93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH  172 (341)
T ss_pred             cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence            57788887753 4789999999999999999999999999999999999998643   46789999999875443221  


Q ss_pred             ------ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHH
Q 027927           75 ------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIEL  133 (217)
Q Consensus        75 ------~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---~~~~~~~~~~  133 (217)
                            ....||..|.+--+..+-. .+...|+=|+|.++.....|..||.+...   .+.+.+|.+.
T Consensus       173 Ipyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek  239 (341)
T KOG1163|consen  173 IPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK  239 (341)
T ss_pred             CccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence                  2356677788766554333 46678999999999999999999987644   3334444443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.41  E-value=9.6e-13  Score=95.95  Aligned_cols=100  Identities=19%  Similarity=0.141  Sum_probs=73.1

Q ss_pred             HHHHHHHHHHHHHHHHcCcEecCc-CCCCEEEecCCCEEEecccccccCCCCCcc--------------ccccccccccC
Q 027927           21 QYFLYQLLRGLKYIHSANVIHRDL-KPSNLLLNANCDLKICDFGLARPTSENEFM--------------TEYVVTRWYRA   85 (217)
Q Consensus        21 ~~~~~~i~~~l~~Lh~~~i~H~di-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------------~~~~~~~~~~~   85 (217)
                      ..++.|++.+|.++|++|++|+|| +|.||+++.++.++|+|||.+.........              .....++.+++
T Consensus        94 ~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~  173 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALT  173 (218)
T ss_pred             HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence            457889999999999999999999 799999999999999999999754433210              01123455566


Q ss_pred             cccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCC
Q 027927           86 PELLLNSSDYT-AAIDVWSVGCIFMELMNRRPLFPG  120 (217)
Q Consensus        86 Pe~~~~~~~~~-~~~Diwslg~~l~~l~~~~~pf~~  120 (217)
                      |+.-.-....+ ...+..+.|.-+|..+|+..++..
T Consensus       174 ~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        174 PVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            65432222223 456677789999999999888754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.36  E-value=1.5e-12  Score=94.97  Aligned_cols=64  Identities=20%  Similarity=0.292  Sum_probs=54.7

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCcEecCcCCCCEEEecCCCEEEecccccccC
Q 027927            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYI-HSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (217)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~L-h~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   68 (217)
                      ++.....+...++...+..++.|++.+|.++ |+.|++|+||||+||+++ ++.++|+|||.+...
T Consensus       103 ~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         103 GWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            4444434457899999999999999999999 799999999999999998 578999999988544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.31  E-value=6.5e-12  Score=91.71  Aligned_cols=58  Identities=22%  Similarity=0.316  Sum_probs=52.7

Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCC
Q 027927           11 SNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (217)
Q Consensus        11 ~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   69 (217)
                      ...+++...+..++.|++.++.++|+ .|++|+||||+||+++ ++.++|+|||.+....
T Consensus       110 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         110 KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            34678899999999999999999999 9999999999999999 8899999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.28  E-value=2.2e-12  Score=95.75  Aligned_cols=76  Identities=16%  Similarity=0.276  Sum_probs=57.5

Q ss_pred             HHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCcccccCCCCCCchhhHH
Q 027927           23 FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  102 (217)
Q Consensus        23 ~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diw  102 (217)
                      ...+++.++..+|+.|++|||++|.||+++.+| ++++|||.............           .+. .+.+..++|+|
T Consensus       140 ~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d~-----------~vl-er~y~~~~di~  206 (232)
T PRK10359        140 VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKDR-----------IDL-ERHYGIKNEIK  206 (232)
T ss_pred             HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHHH-----------HHH-HhHhccccccc
Confidence            466999999999999999999999999999988 99999997654432211110           122 22355789999


Q ss_pred             HHHHHHHHH
Q 027927          103 SVGCIFMEL  111 (217)
Q Consensus       103 slg~~l~~l  111 (217)
                      +||+++...
T Consensus       207 ~lg~~~~~~  215 (232)
T PRK10359        207 DLGYYLLIY  215 (232)
T ss_pred             ceeEeehHH
Confidence            999987654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=1.7e-12  Score=107.36  Aligned_cols=156  Identities=21%  Similarity=0.305  Sum_probs=111.0

Q ss_pred             HHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCC----------ccccccccccccCcccccC
Q 027927           23 FLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----------FMTEYVVTRWYRAPELLLN   91 (217)
Q Consensus        23 ~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----------~~~~~~~~~~~~~Pe~~~~   91 (217)
                      =+.+++.|+.++|. .++||++|.|++|.++..+..|++.|+++.......          ..........|.+||.+..
T Consensus       104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34455689999995 579999999999999999999999998875433211          0111223456999999866


Q ss_pred             CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCC
Q 027927           92 SSDYTAAIDVWSVGCIFMELM-NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP  170 (217)
Q Consensus        92 ~~~~~~~~Diwslg~~l~~l~-~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (217)
                      . ..+.++|++|+|+++|.+. .|+..+........+..-....+..                           ......
T Consensus       184 ~-~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~---------------------------~~~~s~  235 (700)
T KOG2137|consen  184 T-TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG---------------------------AFGYSN  235 (700)
T ss_pred             c-cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc---------------------------cccccc
Confidence            4 4788999999999999998 5666665443221111111100000                           011124


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          171 HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       171 ~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ++++++.+=+.+++..++..||++.+++..+||...
T Consensus       236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  236 NLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            688999999999999999999999999999999854

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.27  E-value=6.7e-12  Score=108.02  Aligned_cols=176  Identities=26%  Similarity=0.306  Sum_probs=139.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC----------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----------   71 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~----------   71 (217)
                      |++|+.-+++-+..+++.++..+..+..++++||+..+.|+|++|.|.+...++..++.+|+...+.+..          
T Consensus       888 ~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~  967 (1205)
T KOG0606|consen  888 GGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPS  967 (1205)
T ss_pred             cCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCccccc
Confidence            4677788888888899999999999999999999999999999999999999999999988732211100          


Q ss_pred             ----------------------CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 027927           72 ----------------------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL  129 (217)
Q Consensus        72 ----------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~  129 (217)
                                            .......+++.|.+||...+.. ....+|.|+.|+.+++.++|.+||........+..
T Consensus       968 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n 1046 (1205)
T KOG0606|consen  968 SSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFEN 1046 (1205)
T ss_pred             ccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhc
Confidence                                  0112345678899999997766 57789999999999999999999988776555544


Q ss_pred             HHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHh---hhccCCCCccc
Q 027927          130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE---FFVPYKPFQCC  206 (217)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~---~ll~~~~f~~~  206 (217)
                      +...                            ..+|.......++...+++.+.+..+|.+|..+.   ++-.|++|+..
T Consensus      1047 i~~~----------------------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1047 ILNR----------------------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             cccC----------------------------CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            4321                            2233344445778999999999999999999999   88889999944

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.26  E-value=9.9e-12  Score=98.73  Aligned_cols=70  Identities=26%  Similarity=0.411  Sum_probs=57.1

Q ss_pred             HHHHHHHHHHHHHHHHcCcEecCc-CCCCEEEecCCCEEEecccccccCCCCCcc---------ccccccccccCccccc
Q 027927           21 QYFLYQLLRGLKYIHSANVIHRDL-KPSNLLLNANCDLKICDFGLARPTSENEFM---------TEYVVTRWYRAPELLL   90 (217)
Q Consensus        21 ~~~~~~i~~~l~~Lh~~~i~H~di-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~~Pe~~~   90 (217)
                      ..++.+++.||.+||++||+|||| ||+||+++.++.++|+|||++.........         ....++..|.+||.+.
T Consensus       114 ~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            568899999999999999999999 999999999999999999999765443211         1234566688999874

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=2.9e-11  Score=92.34  Aligned_cols=170  Identities=17%  Similarity=0.220  Sum_probs=110.4

Q ss_pred             ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEecCCCEEEeccc--ccccCCCCCc-
Q 027927            3 TDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFG--LARPTSENEF-   73 (217)
Q Consensus         3 ~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~d~~--~~~~~~~~~~-   73 (217)
                      ++|..+|++    +..+....-++|..||+.||.|||+..  |+|+++.-+.|++..+|-++++--.  ..+....... 
T Consensus       157 gs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~  236 (458)
T KOG1266|consen  157 GSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE  236 (458)
T ss_pred             hhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH
Confidence            567777765    467899999999999999999999876  9999999999999999888876422  1111111111 


Q ss_pred             --cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHHhCCCCCccccccCchHH
Q 027927           74 --MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP-GNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        74 --~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                        ..-..+-+.|.+||.=. ......++|||++|+...++..+..--. .......-..+..                  
T Consensus       237 ~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~------------------  297 (458)
T KOG1266|consen  237 AEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN------------------  297 (458)
T ss_pred             hhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh------------------
Confidence              11123345677776321 1224568999999999998876543221 1110000000000                  


Q ss_pred             HHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                        .              +...-.+.-.+++.+||+..|+.||++++++.||-.-+..
T Consensus       298 --~--------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  298 --V--------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             --h--------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence              0              0000113345789999999999999999999999876553

>smart00090 RIO RIO-like kinase

Probab=99.15  E-value=6.4e-11  Score=89.27  Aligned_cols=64  Identities=17%  Similarity=0.196  Sum_probs=53.5

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC-cEecCcCCCCEEEecCCCEEEecccccccC
Q 027927            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (217)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~-i~H~di~~~nil~~~~~~~~l~d~~~~~~~   68 (217)
                      +|......+..+....+..++.||+.++.+||++| ++|+||+|+||+++ ++.++++|||.+...
T Consensus       134 ~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      134 GLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             cccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            44444434455667778899999999999999999 99999999999999 889999999987543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.15  E-value=3.5e-11  Score=98.06  Aligned_cols=171  Identities=24%  Similarity=0.284  Sum_probs=129.8

Q ss_pred             CccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHcCcEecCcCCCCEEEecC-CCEEEecccccccCCCCCccc
Q 027927            2 DTDLYQIIRSNQS-LSEEHCQYFLYQLLR----GLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMT   75 (217)
Q Consensus         2 ~~~L~~~l~~~~~-l~~~~~~~~~~~i~~----~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~   75 (217)
                      |.+|.++...-.. ++...++..+.+...    |+..+|+.+++|.|++|.||+...+ ..++++||++...+.......
T Consensus       201 ~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~  280 (524)
T KOG0601|consen  201 GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSS  280 (524)
T ss_pred             cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCcccc
Confidence            4566666666544 899999999999999    9999999999999999999999999 788999999988776654221


Q ss_pred             ------cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHHHHHhCCCCCccccccCc
Q 027927           76 ------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN--DHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        76 ------~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                            ...+...|.+||...+  .++...|++++|.+..+..++..++..+  ..+.+...+.                
T Consensus       281 ~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~----------------  342 (524)
T KOG0601|consen  281 VFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY----------------  342 (524)
T ss_pred             ceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----------------
Confidence                  1245667999998743  3678999999999999999887776544  2222211110                


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                      .-.+...+.+.++...+..|+..+|..|+++..+.+++++...
T Consensus       343 ----------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 ----------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ----------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                            0011222345566679999999999999999999999988743

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.14  E-value=1.1e-09  Score=86.78  Aligned_cols=171  Identities=14%  Similarity=0.143  Sum_probs=116.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCcccccCCC
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSS   93 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~   93 (217)
                      ........++.+.++.+.+.||+.|.+-||++++|++++.++.+.|.|-..-....+.....+..+...|++||... .+
T Consensus       113 ~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~-~~  191 (637)
T COG4248         113 HCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQT-LP  191 (637)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhc-cc
Confidence            36788999999999999999999999999999999999999999999876655556666667788899999999653 11


Q ss_pred             -----CCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCCc--cccccCchHHHHHHHhCCCCCccch
Q 027927           94 -----DYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDA--DLGFVRNEDAKRYIRQLPQHPRQSL  165 (217)
Q Consensus        94 -----~~~~~~Diwslg~~l~~l~~~-~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  165 (217)
                           ..+...|.+.||+++++++.| .+||.+-..         ..-.+++.  .+..-......+.  . ......+.
T Consensus       192 sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~ap~p~E~~Ia~g~f~ya~~~--~-~g~~p~P~  259 (637)
T COG4248         192 SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDAPNPLETDIAHGRFAYASDQ--R-RGLKPPPR  259 (637)
T ss_pred             cccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCCCCcchhhhhcceeeechhc--c-CCCCCCCC
Confidence                 235689999999999999876 999976420         00001100  0000000011110  0 00111112


Q ss_pred             hhhCCCCChhHHHHHHHhccc--CCCCCCCHhhh
Q 027927          166 AQVFPHVHPLAIDLVDRMLTF--DPMKRITGEFF  197 (217)
Q Consensus       166 ~~~~~~~~~~~~~li~~~l~~--dp~~R~t~~~l  197 (217)
                      +..+.-+++++..+..+|+..  ++.-|||++-.
T Consensus       260 ~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW  293 (637)
T COG4248         260 SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW  293 (637)
T ss_pred             CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence            222334678899999999964  46689998754

>PRK10345 hypothetical protein; Provisional

Probab=99.07  E-value=3.3e-10  Score=83.61  Aligned_cols=60  Identities=25%  Similarity=0.360  Sum_probs=49.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHcCcEecCcCCCCEEEec----CCCEEEecccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGL-KYIHSANVIHRDLKPSNLLLNA----NCDLKICDFGL   64 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l-~~Lh~~~i~H~di~~~nil~~~----~~~~~l~d~~~   64 (217)
                      ++||.+++++. .+++.  ..++.+++.++ +|||+++|+|+||||+||+++.    ++.++|+|++.
T Consensus        91 ~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         91 SITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             chhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            47999999774 56666  36788888887 9999999999999999999974    34799999543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.04  E-value=6.6e-10  Score=83.91  Aligned_cols=60  Identities=28%  Similarity=0.429  Sum_probs=51.0

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   67 (217)
                      .+|.+++.+ .++++..    +.+|+.++++||+.||+|+||+|.||+++.++.++|+|||.+..
T Consensus       132 ~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        132 RDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             CCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            478888765 4566543    57899999999999999999999999999999999999997743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.95  E-value=2.4e-09  Score=79.31  Aligned_cols=61  Identities=33%  Similarity=0.421  Sum_probs=53.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   67 (217)
                      |++|.+++.....    ....++.+++.+|.++|+.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        83 G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         83 GEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            5688888866433    7889999999999999999999999999999999 78999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.92  E-value=2.8e-09  Score=78.30  Aligned_cols=58  Identities=28%  Similarity=0.478  Sum_probs=49.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   67 (217)
                      |++|.+++.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            4567766655322       7899999999999999999999999999999 88999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.92  E-value=2.2e-09  Score=78.91  Aligned_cols=53  Identities=23%  Similarity=0.293  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC
Q 027927           18 EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE   70 (217)
Q Consensus        18 ~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~   70 (217)
                      .....++.+++.++.++|+.|++|+||+|.||+++.++.++|+|||.+.....
T Consensus       125 ~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         125 EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            45667889999999999999999999999999999999999999998855443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.82  E-value=7.5e-09  Score=87.18  Aligned_cols=57  Identities=25%  Similarity=0.425  Sum_probs=49.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   67 (217)
                      |++|.+++.        ....++.+++.+|.+||+.|++|||+||+||++ .++.++++|||.+..
T Consensus       420 g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        420 GKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            456666664        357789999999999999999999999999999 678899999998754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.78  E-value=1.2e-08  Score=74.18  Aligned_cols=51  Identities=24%  Similarity=0.307  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCC
Q 027927           18 EHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (217)
Q Consensus        18 ~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   69 (217)
                      ..+..++.+++.++.++|. .+++|+||+|+||+++ ++.++++|||.+....
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         114 EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            6788999999999999999 9999999999999999 8999999999885443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.71  E-value=2.4e-07  Score=77.22  Aligned_cols=95  Identities=23%  Similarity=0.442  Sum_probs=71.7

Q ss_pred             HHHHHHHHHHHHHHHHHHH-HcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-cccccccccccCcccccCCCC
Q 027927           17 EEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVTRWYRAPELLLNSSD   94 (217)
Q Consensus        17 ~~~~~~~~~~i~~~l~~Lh-~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~Pe~~~~~~~   94 (217)
                      ...+..-++||+.||.||| +.+++|+++.-..|+++..|..+|++|.++........ ......--.|..|+.....  
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s--  180 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS--  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc--
Confidence            6677888999999999998 57799999999999999999999999988754332221 1111222335666644222  


Q ss_pred             CCchhhHHHHHHHHHHHHcC
Q 027927           95 YTAAIDVWSVGCIFMELMNR  114 (217)
Q Consensus        95 ~~~~~Diwslg~~l~~l~~~  114 (217)
                       ....|.|.||+++++++.|
T Consensus       181 -~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 -EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -ccchhhhhHHHHHHHHhCc
Confidence             2467999999999999998

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.65  E-value=1.9e-08  Score=82.41  Aligned_cols=158  Identities=23%  Similarity=0.230  Sum_probs=112.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-CCEEEecccccccCCCCCcccccccccccc-Cccccc
Q 027927           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTEYVVTRWYR-APELLL   90 (217)
Q Consensus        13 ~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~-~Pe~~~   90 (217)
                      ..+.+...+++..|++.++.++|+..++|.|++|+||++..+ +..+++||+....+.-...  ...+...+. ..|++.
T Consensus       361 ~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~--~~~~~~r~~p~~~~~~  438 (524)
T KOG0601|consen  361 QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG--VFHHIDRLYPIAEILL  438 (524)
T ss_pred             HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceecc--cccccccccccchhhc
Confidence            457788899999999999999999999999999999999886 6778999987754222111  112223333 356665


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCC
Q 027927           91 NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP  170 (217)
Q Consensus        91 ~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (217)
                      .......++|+++||+.+.+.+++...-.....+..++                                  .......+
T Consensus       439 e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~----------------------------------~~~~p~~~  484 (524)
T KOG0601|consen  439 EDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR----------------------------------SGDTPNLP  484 (524)
T ss_pred             cccccccccccccccccccccccCcccCcccccceeee----------------------------------cccccCCC
Confidence            66667889999999999999998866543322110000                                  00001112


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          171 HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       171 ~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ..+.++..+.+.++..++..|+++.++..|.-|...
T Consensus       485 ~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  485 GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             chHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            233678889999999999999999999998877644

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.64  E-value=1e-07  Score=70.48  Aligned_cols=64  Identities=27%  Similarity=0.426  Sum_probs=57.5

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC---CEEEeccccccc
Q 027927            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARP   67 (217)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~   67 (217)
                      +|.+++.+....+......++.+++..++-||+.|++|+|+++.||+++.++   .+.++||+.+..
T Consensus       104 ~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  104 DLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             cHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            6888888866688889999999999999999999999999999999999887   789999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.59  E-value=1.4e-07  Score=68.75  Aligned_cols=55  Identities=24%  Similarity=0.388  Sum_probs=46.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHH-HHcCcEecCcCCCCEEEecCCCEEEecccccccCC
Q 027927           14 SLSEEHCQYFLYQLLRGLKYI-HSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~L-h~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   69 (217)
                      .++...+..+..+++.++..| |+.|++|||+++.||++. ++.+.++||+.+....
T Consensus       120 ~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         120 KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            455667788899999999998 899999999999999997 4689999999775443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.57  E-value=2.3e-07  Score=71.11  Aligned_cols=63  Identities=17%  Similarity=0.252  Sum_probs=54.0

Q ss_pred             cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-------CCCEEEecccccc
Q 027927            4 DLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------NCDLKICDFGLAR   66 (217)
Q Consensus         4 ~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-------~~~~~l~d~~~~~   66 (217)
                      +|.+++.+  ..+.+......++.+++..++-||..|++|+|+++.||+++.       ++.+.++||+.+.
T Consensus       122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            67888764  345667788899999999999999999999999999999975       4678999999764

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.42  E-value=8.8e-07  Score=63.14  Aligned_cols=57  Identities=26%  Similarity=0.416  Sum_probs=44.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      |..|+|++...   .    ..++..+-.-+.-||..||+|||+.++||.+..++ +.++|||++.
T Consensus        83 G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          83 GELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             ChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            34556666664   1    44566666677789999999999999999998875 9999999874

>PRK09902 hypothetical protein; Provisional

Probab=98.41  E-value=1.1e-06  Score=64.38  Aligned_cols=64  Identities=17%  Similarity=0.162  Sum_probs=56.2

Q ss_pred             ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC--EEEecccccc
Q 027927            3 TDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICDFGLAR   66 (217)
Q Consensus         3 ~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~   66 (217)
                      .+|.+++.+.  .+.+......++.+|+..++-||+.|+.|+|+.+.||+++.++.  +.++||..+.
T Consensus       111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            5788888774  45688888999999999999999999999999999999986677  8999998664

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.36  E-value=1e-06  Score=61.16  Aligned_cols=51  Identities=33%  Similarity=0.376  Sum_probs=45.5

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHc---CcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           16 SEEHCQYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        16 ~~~~~~~~~~~i~~~l~~Lh~~---~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      +......++.+++.+++.+|..   +++|+|++|.||+++..+.+++.||+.+.
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            4467788899999999999985   69999999999999998999999999763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.32  E-value=2.5e-06  Score=60.85  Aligned_cols=64  Identities=25%  Similarity=0.375  Sum_probs=51.5

Q ss_pred             cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC---EEEeccccccc
Q 027927            4 DLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARP   67 (217)
Q Consensus         4 ~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~   67 (217)
                      ++.+++...  ..........+++.|-+.+.-||.++++|||+..+||++.+++.   +.++|||++..
T Consensus        97 ~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   97 TVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            778888775  33444455789999999999999999999999999999876543   47999998743

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.26  E-value=2e-06  Score=61.30  Aligned_cols=45  Identities=33%  Similarity=0.457  Sum_probs=39.6

Q ss_pred             HHHHHHHHHHHHHHHHcCc-----EecCcCCCCEEEecCCCEEEecccccc
Q 027927           21 QYFLYQLLRGLKYIHSANV-----IHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        21 ~~~~~~i~~~l~~Lh~~~i-----~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      ...+.+++++|+.||+.++     +|||+++.||+++ ++.++++||+.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            4567899999999999885     9999999999999 6789999999763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.25  E-value=8.1e-06  Score=72.45  Aligned_cols=161  Identities=19%  Similarity=0.284  Sum_probs=113.1

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCC---CEEEecCCCEEEe--cccccccCCCCCcccccc
Q 027927            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPS---NLLLNANCDLKIC--DFGLARPTSENEFMTEYV   78 (217)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~---nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~   78 (217)
                      ++.+.+.+-..++.+..+.+..++++|++++|+....|.-+...   +-.++..+.+..+  ||+...............
T Consensus       272 ~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~  351 (1351)
T KOG1035|consen  272 ELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDL  351 (1351)
T ss_pred             chHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhc
Confidence            55667777788999999999999999999999987666655555   3344555666655  888877766655544445


Q ss_pred             ccccccCcccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~-~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ....+.+++...... ..+...|+|.+|.+...+..+..+-....-                                  
T Consensus       352 ~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~----------------------------------  397 (1351)
T KOG1035|consen  352 LAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV----------------------------------  397 (1351)
T ss_pred             CccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc----------------------------------
Confidence            556677777664332 123357999999999998877554321110                                  


Q ss_pred             CCCCccchhhhCCC-CChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          158 PQHPRQSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       158 ~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                             ...+... ......++..+|+.-++++|+++.+++.|++.+-
T Consensus       398 -------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  398 -------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             -------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence                   0001111 1126788999999999999999999999999883

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.16  E-value=4.4e-06  Score=68.70  Aligned_cols=49  Identities=24%  Similarity=0.373  Sum_probs=41.2

Q ss_pred             HHHHHHHHH-HHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC
Q 027927           21 QYFLYQLLR-GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (217)
Q Consensus        21 ~~~~~~i~~-~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   69 (217)
                      ..++..++. .+..+|..|++|+|++|.||+++.+++++++|||.+....
T Consensus       259 ~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       259 KALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            345555555 4778999999999999999999999999999999986654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.07  E-value=1.3e-05  Score=58.14  Aligned_cols=52  Identities=31%  Similarity=0.491  Sum_probs=39.6

Q ss_pred             HHHHHHHHHHHHHHHHH-HHHcCcEecCcCCCCEEEecCCCEEEecccccccCC
Q 027927           17 EEHCQYFLYQLLRGLKY-IHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (217)
Q Consensus        17 ~~~~~~~~~~i~~~l~~-Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   69 (217)
                      .+....++.+++..+.. +|+.|++|||+++.||+++.+ .+.++||+.+....
T Consensus       105 ~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  105 PEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             GSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             chhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            34567788888885555 679999999999999999988 99999999875443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.01  E-value=7.6e-05  Score=61.24  Aligned_cols=89  Identities=21%  Similarity=0.287  Sum_probs=69.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCcccccC
Q 027927           12 NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLN   91 (217)
Q Consensus        12 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~   91 (217)
                      +...+++.++.++.|+..||.++|+.|+.-.-+.+.+|+++++.++++..-|........+           .  +.+. 
T Consensus       387 ~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-----------~--~~le-  452 (655)
T KOG3741|consen  387 NLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-----------T--EPLE-  452 (655)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-----------C--cchh-
Confidence            3557899999999999999999999999999999999999999899888766654433332           1  1121 


Q ss_pred             CCCCCchhhHHHHHHHHHHHHcCCCC
Q 027927           92 SSDYTAAIDVWSVGCIFMELMNRRPL  117 (217)
Q Consensus        92 ~~~~~~~~Diwslg~~l~~l~~~~~p  117 (217)
                         ...+-|.-.||.+++.+.+|..-
T Consensus       453 ---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  453 ---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             ---HHhhhhHHHHHHHHHHHhhcccc
Confidence               12357889999999999998554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.81  E-value=2.4e-05  Score=65.64  Aligned_cols=49  Identities=22%  Similarity=0.472  Sum_probs=38.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC----CEEEecccccccCCC
Q 027927           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSE   70 (217)
Q Consensus        15 l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~   70 (217)
                      +.+..+..++.|++       ..|++|+|++|.||+++.++    +++++|||.+.....
T Consensus       264 la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        264 LAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            44455555555554       58999999999999999988    999999999876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.68  E-value=8.6e-05  Score=54.87  Aligned_cols=42  Identities=24%  Similarity=0.434  Sum_probs=35.8

Q ss_pred             HHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           23 FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        23 ~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +...+.+++..||+.|++|||++|.|++++.+ .++++|++..
T Consensus       140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k  181 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGK  181 (229)
T ss_pred             HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECccc
Confidence            44567788999999999999999999999865 5999999754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.50  E-value=0.00029  Score=53.56  Aligned_cols=52  Identities=23%  Similarity=0.375  Sum_probs=44.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc
Q 027927           16 SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (217)
Q Consensus        16 ~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   67 (217)
                      +.+....++..|++-+...-..|++|||++.-||+++.+|.+.++||--+..
T Consensus       200 ~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         200 DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence            4666777778888877777799999999999999999999999999976543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.16  E-value=0.00066  Score=50.34  Aligned_cols=29  Identities=24%  Similarity=0.462  Sum_probs=25.1

Q ss_pred             cCcEecCcCCCCEEEec--CCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNA--NCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~--~~~~~l~d~~~~   65 (217)
                      ..++|||+++.||+++.  ++.+.++||+.+
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~  204 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELA  204 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence            45899999999999998  566889999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=96.98  E-value=0.0025  Score=47.99  Aligned_cols=52  Identities=19%  Similarity=0.271  Sum_probs=44.1

Q ss_pred             HHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCC
Q 027927           17 EEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (217)
Q Consensus        17 ~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~   69 (217)
                      .+++..+..++++.+.-|-. .++||||++.-|||+. ++.+.++|++-+....
T Consensus       165 ~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         165 LEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             chhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            34678888889998888876 8999999999999999 8899999999775443

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.51  E-value=0.0071  Score=44.02  Aligned_cols=53  Identities=23%  Similarity=0.185  Sum_probs=47.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHH---cCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~---~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      .-+...+.+++.++++.+.+|+.   ..+.-.|++++|+.++.+++++++|...+.
T Consensus        55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            35788999999999999999997   458889999999999999999999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.84  E-value=0.012  Score=44.38  Aligned_cols=29  Identities=34%  Similarity=0.473  Sum_probs=24.7

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .+++|||+.+.|++++.++...++||+.+
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            45899999999999987665679999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.81  E-value=0.015  Score=43.63  Aligned_cols=29  Identities=28%  Similarity=0.446  Sum_probs=25.8

Q ss_pred             cCcEecCcCCCCEEEec-CCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNA-NCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~-~~~~~l~d~~~~   65 (217)
                      ..++|+|+.+.||+++. ++.+.++||.++
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a  199 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYA  199 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence            35999999999999998 578999999876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.59  E-value=0.037  Score=43.46  Aligned_cols=28  Identities=25%  Similarity=0.445  Sum_probs=24.6

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .+++|||+.+.|++++. +.+.++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            46899999999999988 67899999865

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.57  E-value=0.028  Score=44.22  Aligned_cols=29  Identities=38%  Similarity=0.583  Sum_probs=26.2

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .+++|||+++.|++++.++.+.++||+.+
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccc
Confidence            57999999999999999877789999876

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.44  E-value=0.029  Score=43.28  Aligned_cols=51  Identities=29%  Similarity=0.356  Sum_probs=40.0

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHc--CcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           16 SEEHCQYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        16 ~~~~~~~~~~~i~~~l~~Lh~~--~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      +.....+.+..+-.++...+..  -++|+|+.+.|++.++.+.+.|+||..+.
T Consensus       130 ~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         130 DNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             hhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            3445555666666666666655  48999999999999999999999999873

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.39  E-value=0.034  Score=43.56  Aligned_cols=28  Identities=36%  Similarity=0.460  Sum_probs=25.3

Q ss_pred             CcEecCcCCCCEEEecC----CCEEEeccccc
Q 027927           38 NVIHRDLKPSNLLLNAN----CDLKICDFGLA   65 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~----~~~~l~d~~~~   65 (217)
                      .++|+|+.+.||+++.+    +.+.++||.++
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya  211 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA  211 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence            48999999999999885    88999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=95.33  E-value=0.043  Score=43.30  Aligned_cols=29  Identities=34%  Similarity=0.408  Sum_probs=25.3

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .+++|||+.+.||+++.+....++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~  215 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFA  215 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccc
Confidence            47999999999999997665689999876

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.21  E-value=0.038  Score=43.10  Aligned_cols=29  Identities=34%  Similarity=0.438  Sum_probs=25.9

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .+++|||+++.|++++.++.+.++||+.+
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhh
Confidence            46999999999999999877789999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.20  E-value=0.013  Score=48.85  Aligned_cols=92  Identities=16%  Similarity=0.192  Sum_probs=63.4

Q ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChh
Q 027927           96 TAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL  175 (217)
Q Consensus        96 ~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (217)
                      ++++|||++|.++.++..|...+......++...+.+....+-.-. .    .....              .+.-..+..
T Consensus       109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~-~----~a~e~--------------~~~~~~d~~  169 (725)
T KOG1093|consen  109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELL-S----TAMEH--------------LIQLLADKK  169 (725)
T ss_pred             CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHH-H----HHHHH--------------HHHHhhhHh
Confidence            4699999999999999999888877666666555555332221110 0    00000              011124466


Q ss_pred             HHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          176 AIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       176 ~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      +.++..+|+-..|..||...++..++.|.+.
T Consensus       170 ~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  170 RLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHhccCCccccccccchhHHhcCccHHHH
Confidence            8899999999999999999999999988754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=95.14  E-value=0.055  Score=45.60  Aligned_cols=40  Identities=20%  Similarity=0.453  Sum_probs=33.7

Q ss_pred             HHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC
Q 027927           32 KYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (217)
Q Consensus        32 ~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~   71 (217)
                      ..+-..|+.|+|.+|.||+++.+|++.+.|||........
T Consensus       279 ~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         279 RQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            3444589999999999999999999999999998665543

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.03  E-value=0.024  Score=41.09  Aligned_cols=27  Identities=30%  Similarity=0.498  Sum_probs=24.2

Q ss_pred             cEecCcCCCCEEEecCCCEEEecccccc
Q 027927           39 VIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        39 i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      .+|+|+.|.|++++.++ ++++||+++.
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCccc
Confidence            69999999999998777 8899999873

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.90  E-value=0.053  Score=40.27  Aligned_cols=29  Identities=38%  Similarity=0.641  Sum_probs=20.3

Q ss_pred             cCcEecCcCCCCEEEe-cCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLN-ANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~-~~~~~~l~d~~~~   65 (217)
                      ..++|||+.+.||+++ .++++.++||+.+
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             cEEEEeccccccceeeeccceeEEEecccc
Confidence            4599999999999999 6666789999865

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.86  E-value=0.053  Score=42.69  Aligned_cols=28  Identities=21%  Similarity=0.265  Sum_probs=26.1

Q ss_pred             CcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +++|||+.+.|+++++++.+.++||..+
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~  224 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKA  224 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence            6999999999999999999999999876

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=94.74  E-value=0.029  Score=52.83  Aligned_cols=116  Identities=16%  Similarity=0.128  Sum_probs=81.5

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHc-C----cEecCcCCCCEEEecCCCEEEecccccc-cCCCC
Q 027927            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSA-N----VIHRDLKPSNLLLNANCDLKICDFGLAR-PTSEN   71 (217)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~-~----i~H~di~~~nil~~~~~~~~l~d~~~~~-~~~~~   71 (217)
                      +|.+++.|.++    .++....+.....+.+....-.|+. +    -+|.++++-|.++..+..++++++|+.+ .....
T Consensus      1315 ~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~ 1394 (2724)
T KOG1826|consen 1315 FGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL 1394 (2724)
T ss_pred             HhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH
Confidence            57788888775    3455555555555546666665543 2    6889999999999999999999999987 33323


Q ss_pred             CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 027927           72 EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF  118 (217)
Q Consensus        72 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf  118 (217)
                      .......+++.|+.++... .-.++.++|+|..|+.+|..-.|..+|
T Consensus      1395 sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1395 SFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            3334456667778877653 333666799999999999887666665

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=94.54  E-value=0.031  Score=41.98  Aligned_cols=27  Identities=22%  Similarity=0.304  Sum_probs=24.4

Q ss_pred             CcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .++|||+.|.|++++.++ +.++||+.+
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a  180 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDF  180 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhc
Confidence            478999999999999888 999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.50  E-value=0.095  Score=41.54  Aligned_cols=45  Identities=16%  Similarity=0.285  Sum_probs=37.4

Q ss_pred             HHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           21 QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        21 ~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ..+...++.-+--|.++|++|||+.--||+++.++.+.++||--.
T Consensus       205 ~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  205 PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             HHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHh
Confidence            344555556667788999999999999999999999999999754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.40  E-value=0.026  Score=41.75  Aligned_cols=29  Identities=38%  Similarity=0.682  Sum_probs=20.7

Q ss_pred             CcEecCcCCCCEEE-ecCCCEEEecccccc
Q 027927           38 NVIHRDLKPSNLLL-NANCDLKICDFGLAR   66 (217)
Q Consensus        38 ~i~H~di~~~nil~-~~~~~~~l~d~~~~~   66 (217)
                      -++|+|+.+.||++ +.++.++++||.++.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 888999999999873

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=94.39  E-value=0.0095  Score=50.70  Aligned_cols=152  Identities=18%  Similarity=0.147  Sum_probs=96.0

Q ss_pred             HHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCcccccCCCCCCch
Q 027927           19 HCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAA   98 (217)
Q Consensus        19 ~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   98 (217)
                      +.....+.-.++++++|+..-+|+|    ||+... +..++.+|+....+..........+++.+++||+..+.. +...
T Consensus       337 ~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~-~~~~  410 (829)
T KOG0576|consen  337 QFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENT-IDGC  410 (829)
T ss_pred             hhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcccc-cccC
Confidence            3444555566789999988778887    665443 678999999876666555566778899999999886655 6778


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHH
Q 027927           99 IDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID  178 (217)
Q Consensus        99 ~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (217)
                      .|.|++|+-..++.-|-+|-....  ...   ......++...   ....                  +.+.....  .+
T Consensus       411 p~~~~~~~~~~~~ap~~pPr~~P~--~~~---~~~g~~p~s~~---L~~~------------------~aw~~~~~--~~  462 (829)
T KOG0576|consen  411 PDSGSLAVSAIQMAPGLPPRSSPP--AVL---PMIGNGPNSPM---LTDK------------------SAWSPVFH--RD  462 (829)
T ss_pred             CCccCCCcchhhcCCCCCCCCCCc--ccc---CCCCCCCCccc---cchh------------------hhcCcccc--cC
Confidence            899999976666666665553311  000   00000000000   0000                  00110111  14


Q ss_pred             HHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          179 LVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       179 li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                      +...|+.-.|..|++.-+++-|.+|+
T Consensus       463 ~~~~~~~g~P~~pkv~mgacfsKvfn  488 (829)
T KOG0576|consen  463 FPAPCLNGLPPTPKVHMGACFSKVFN  488 (829)
T ss_pred             CcccccCCCCCCCcchhhHHHHHHhc
Confidence            77889999999999999999999998

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=94.36  E-value=0.038  Score=41.81  Aligned_cols=28  Identities=21%  Similarity=0.214  Sum_probs=25.0

Q ss_pred             CcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .++|||+.+.||+++.++.+.|+||+.+
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a  191 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRL  191 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEcccc
Confidence            4899999999999999777789999865

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.35  E-value=0.1  Score=41.94  Aligned_cols=50  Identities=24%  Similarity=0.444  Sum_probs=44.9

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           16 SEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        16 ~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      ..+++..++.+++..++-+.+. ..-|+|+.-.||+++ +|.+.|+||.+++
T Consensus       319 ~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         319 RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence            4678999999999988888864 689999999999999 9999999999886

>TIGR02721 ycfN_thiK thiamine kinase

Probab=94.32  E-value=0.036  Score=42.30  Aligned_cols=28  Identities=29%  Similarity=0.477  Sum_probs=24.7

Q ss_pred             CcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      .++|+|+.+.||+++.++ +.++||+.+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            489999999999999877 7899998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.54  E-value=0.14  Score=40.82  Aligned_cols=27  Identities=41%  Similarity=0.695  Sum_probs=24.6

Q ss_pred             cEecCcCCCCEEEecCCC-EEEeccccc
Q 027927           39 VIHRDLKPSNLLLNANCD-LKICDFGLA   65 (217)
Q Consensus        39 i~H~di~~~nil~~~~~~-~~l~d~~~~   65 (217)
                      ++|+|+.+.||+++.+.. +.++||+.+
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccc
Confidence            999999999999999885 889999865

>PLN02236 choline kinase

Probab=93.17  E-value=0.15  Score=40.85  Aligned_cols=29  Identities=24%  Similarity=0.491  Sum_probs=25.3

Q ss_pred             CcEecCcCCCCEEEec-CCCEEEecccccc
Q 027927           38 NVIHRDLKPSNLLLNA-NCDLKICDFGLAR   66 (217)
Q Consensus        38 ~i~H~di~~~nil~~~-~~~~~l~d~~~~~   66 (217)
                      .++|+|+++.||+++. ++.+.++||.++.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5899999999999986 4679999998773

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=93.17  E-value=0.55  Score=34.52  Aligned_cols=55  Identities=22%  Similarity=0.370  Sum_probs=38.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC----CEEEec
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICD   61 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~d   61 (217)
                      ..||.++++++ .+++ .....   +-+-..+|-+++|+.+|++|.||++....    .+.++|
T Consensus       107 s~TL~~~l~~~-~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  107 SPTLEDYLKEG-GLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CccHHHHHHcC-CccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            45788888664 4655 33333   33445678899999999999999996432    466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=92.73  E-value=0.1  Score=40.48  Aligned_cols=28  Identities=25%  Similarity=0.554  Sum_probs=23.8

Q ss_pred             CcEecCcCCCCEEEecCCC-EEEeccccc
Q 027927           38 NVIHRDLKPSNLLLNANCD-LKICDFGLA   65 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~-~~l~d~~~~   65 (217)
                      .++|||+++.||+++.+++ ..++||+.+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a  214 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEA  214 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhc
Confidence            4899999999999997555 469999876

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK11768 serine/threonine protein kinase; Provisional

Probab=92.65  E-value=0.43  Score=37.95  Aligned_cols=27  Identities=26%  Similarity=0.377  Sum_probs=22.8

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .+++|||+.+.||+++ + .+.++||+.+
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~  222 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDA  222 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCC
Confidence            4689999999999995 4 5789999865

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.56  E-value=0.13  Score=38.55  Aligned_cols=37  Identities=27%  Similarity=0.392  Sum_probs=31.3

Q ss_pred             HHHHHHHHH--cCcEecCcCCCCEEEecCCCEEEecccc
Q 027927           28 LRGLKYIHS--ANVIHRDLKPSNLLLNANCDLKICDFGL   64 (217)
Q Consensus        28 ~~~l~~Lh~--~~i~H~di~~~nil~~~~~~~~l~d~~~   64 (217)
                      +.+|...|+  .+..|||..|+||+-+..|-+||.|-+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            456777884  4599999999999999999999999653

The function of this family is unknown.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=92.56  E-value=0.11  Score=41.14  Aligned_cols=31  Identities=26%  Similarity=0.495  Sum_probs=27.7

Q ss_pred             CcEecCcCCCCEEEecCCCEEEecccccccC
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   68 (217)
                      .++|||+++.|+++++.+.+-+.||+.+...
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            4899999999999999999999999987543

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=92.41  E-value=0.2  Score=39.94  Aligned_cols=37  Identities=27%  Similarity=0.407  Sum_probs=25.5

Q ss_pred             HHHHHHHHHHHHHHHH---HHH-HcCcEecCcCCCCEEEec
Q 027927           17 EEHCQYFLYQLLRGLK---YIH-SANVIHRDLKPSNLLLNA   53 (217)
Q Consensus        17 ~~~~~~~~~~i~~~l~---~Lh-~~~i~H~di~~~nil~~~   53 (217)
                      .+-++.++.||+.-.-   .|- -.+.+|-||||+|||+-+
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  314 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFD  314 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEec
Confidence            4456667777776432   222 246999999999999854

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=92.22  E-value=0.46  Score=34.77  Aligned_cols=28  Identities=29%  Similarity=0.487  Sum_probs=23.4

Q ss_pred             CcEecCcCCCCEEEecCC-----CEEEeccccc
Q 027927           38 NVIHRDLKPSNLLLNANC-----DLKICDFGLA   65 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~-----~~~l~d~~~~   65 (217)
                      .++|||+.+.|+++..++     .+.++||..+
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~  153 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLS  153 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccC
Confidence            489999999999997543     5789999865

subfamily of choline kinases

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=91.95  E-value=0.42  Score=38.08  Aligned_cols=28  Identities=36%  Similarity=0.522  Sum_probs=24.8

Q ss_pred             cEecCcCCCCEEEec-CCCEEEecccccc
Q 027927           39 VIHRDLKPSNLLLNA-NCDLKICDFGLAR   66 (217)
Q Consensus        39 i~H~di~~~nil~~~-~~~~~l~d~~~~~   66 (217)
                      ++|+|+.+.||+++. ++.++++||+++.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999975 4789999999873

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=91.88  E-value=0.69  Score=39.28  Aligned_cols=38  Identities=26%  Similarity=0.446  Sum_probs=31.0

Q ss_pred             HHHHcCcEecCcCCCCEEEec----CCCEEEecccccccCCC
Q 027927           33 YIHSANVIHRDLKPSNLLLNA----NCDLKICDFGLARPTSE   70 (217)
Q Consensus        33 ~Lh~~~i~H~di~~~nil~~~----~~~~~l~d~~~~~~~~~   70 (217)
                      .+-..|++|+|-+|.||++.+    ++.+.+.|+|+......
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            444688999999999999984    67789999998765544

>PRK06148 hypothetical protein; Provisional

Probab=90.86  E-value=0.4  Score=44.18  Aligned_cols=30  Identities=40%  Similarity=0.582  Sum_probs=25.2

Q ss_pred             cCcEecCcCCCCEEEecCC--CE-EEecccccc
Q 027927           37 ANVIHRDLKPSNLLLNANC--DL-KICDFGLAR   66 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~--~~-~l~d~~~~~   66 (217)
                      .+++|+|+++.||+++.++  ++ -++|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            5699999999999999875  45 499999763

>PRK06149 hypothetical protein; Provisional

Probab=90.78  E-value=0.33  Score=44.53  Aligned_cols=30  Identities=20%  Similarity=0.335  Sum_probs=24.6

Q ss_pred             HcCcEecCcCCCCEEEecCC--C---EEEeccccc
Q 027927           36 SANVIHRDLKPSNLLLNANC--D---LKICDFGLA   65 (217)
Q Consensus        36 ~~~i~H~di~~~nil~~~~~--~---~~l~d~~~~   65 (217)
                      ..+++|+|++..||+++.+.  .   ..++|||.+
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~  241 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDL  241 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccc
Confidence            46799999999999998652  3   369999976

>PHA03111 Ser/Thr kinase; Provisional

Probab=88.26  E-value=1.8  Score=34.71  Aligned_cols=38  Identities=29%  Similarity=0.416  Sum_probs=27.6

Q ss_pred             HHHHHHHHHHHHHHHHHH-H---HcCcEecCcCCCCEEEecC
Q 027927           17 EEHCQYFLYQLLRGLKYI-H---SANVIHRDLKPSNLLLNAN   54 (217)
Q Consensus        17 ~~~~~~~~~~i~~~l~~L-h---~~~i~H~di~~~nil~~~~   54 (217)
                      .+-++.++.||+.-.-.. .   -.+++|-||||+|||+-++
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            456777888887755344 2   2459999999999999544

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=88.06  E-value=0.87  Score=33.57  Aligned_cols=41  Identities=34%  Similarity=0.483  Sum_probs=35.1

Q ss_pred             HHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           20 CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        20 ~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ..+-+.+|++-+..+|..||+-+|+++.|..     .-+|+|||.+
T Consensus       166 ~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  166 QIRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             chhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            5667889999999999999999999999986     4488998854

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=86.56  E-value=0.61  Score=38.19  Aligned_cols=29  Identities=21%  Similarity=0.414  Sum_probs=24.6

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      ..++|||+++.||++..+ .++++|+.++.
T Consensus       223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~  251 (401)
T PRK09550        223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF  251 (401)
T ss_pred             CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence            359999999999999776 58999998664

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=86.49  E-value=1.3  Score=34.38  Aligned_cols=27  Identities=33%  Similarity=0.555  Sum_probs=22.1

Q ss_pred             cEecCcCCCCEEEecC--C---CEEEeccccc
Q 027927           39 VIHRDLKPSNLLLNAN--C---DLKICDFGLA   65 (217)
Q Consensus        39 i~H~di~~~nil~~~~--~---~~~l~d~~~~   65 (217)
                      ++|||++..||++..+  |   .+.+.||-.+
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~  248 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLA  248 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccc
Confidence            8999999999999654  3   5788898654

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=85.97  E-value=0.55  Score=37.85  Aligned_cols=29  Identities=21%  Similarity=0.369  Sum_probs=24.0

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      ..++|||+.+.||+++.++ ++++|+.++.
T Consensus       192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~  220 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAF  220 (370)
T ss_pred             ceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence            4589999999999997764 7799987653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=85.42  E-value=0.73  Score=37.67  Aligned_cols=28  Identities=25%  Similarity=0.456  Sum_probs=23.9

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ..++|||++|.||+++.+ ..+++|..++
T Consensus       227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFA  254 (409)
T PRK12396        227 QALIHGDLHTGSVFVKND-STKVIDPEFA  254 (409)
T ss_pred             hhhccCcCCCCCEEecCC-ceEEEccccc
Confidence            349999999999999986 5899997766

>PTZ00296 choline kinase; Provisional

Probab=81.82  E-value=3.5  Score=34.37  Aligned_cols=28  Identities=25%  Similarity=0.445  Sum_probs=23.5

Q ss_pred             CcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      .++|+|+.+.||+.+.+ .+.++||.++.
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeecccc
Confidence            48999999999987654 49999998873

>PLN02876 acyl-CoA dehydrogenase

Probab=81.03  E-value=1.4  Score=39.72  Aligned_cols=30  Identities=23%  Similarity=0.482  Sum_probs=23.9

Q ss_pred             CcEecCcCCCCEEEecC-CC-EEEeccccccc
Q 027927           38 NVIHRDLKPSNLLLNAN-CD-LKICDFGLARP   67 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~-~~-~~l~d~~~~~~   67 (217)
                      .++|||+++.|++++.+ ++ .-+.||+.+..
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            49999999999999853 34 46899987643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	217
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-63
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-62
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-62
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-62
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-61
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-60
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-60
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-60
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-60
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-60
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-60
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-60
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-60
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-60
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-60
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-60
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-60
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-60
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-60
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-60
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-59
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-59
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-59
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-59
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-59
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-59
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-59
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-58
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-58
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-58
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-57
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-57
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-57
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-57
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-57
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-57
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-57
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-57
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-57
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-57
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-57
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-57
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-57
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-57
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-57
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-57
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-57
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-57
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-57
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-57
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-57
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-57
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-57
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-57
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-57
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-57
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-57
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-57
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-57
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-57
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-57
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-57
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-57
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-57
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-57
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-57
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-57
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-57
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-56
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-56
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-56
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-56
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-56
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-56
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-56
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-56
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-56
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-56
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-56
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-56
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-56
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-56
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-56
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-56
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-56
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-56
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-56
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-56
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-56
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-55
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-55
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-51
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-51
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-48
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-46
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-44
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-44
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-42
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-42
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-41
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-41
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-41
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-40
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-40
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-40
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-39
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-39
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-39
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-39
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-39
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-39
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-39
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-39
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-39
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-39
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-39
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-39
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-39
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-39
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-39
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-38
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-38
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-38
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-38
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-38
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-38
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-38
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-38
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-38
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-38
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-38
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-38
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-38
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-37
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-37
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-36
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-36
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-36
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-36
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-36
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-36
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-36
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-36
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-36
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-36
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-36
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-35
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-35
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-35
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-35
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-35
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-35
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-35
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-35
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-35
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-35
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-35
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-35
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-35
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-35
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-35
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-35
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-35
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-35
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-35
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-35
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-35
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-35
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-35
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-35
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-35
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-35
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-34
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-34
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-34
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-34
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-34
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-34
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-34
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-34
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-34
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-34
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-34
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-34
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-34
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-34
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-34
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-34
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-34
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-34
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-34
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-34
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-34
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-34
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-34
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-34
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-34
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-33
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-33
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-33
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-33
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-33
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-33
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-33
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-32
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-32
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-31
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-31
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-30
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-28
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-28
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-28
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-28
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-28
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-28
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-27
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-25
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-22
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-22
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-22
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-22
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-22
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-22
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-22
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-22
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-22
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-22
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-22
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-22
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		9e-22
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		9e-22
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		9e-22
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-22
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-22
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		9e-22
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-22
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		9e-22
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-21
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-21
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-21
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-21
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-21
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-21
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-21
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-21
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-21
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-20
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-20
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-20
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-20
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-20
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-20
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-20
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-19
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-19
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-18
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-17
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-17
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-17
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-17
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-17
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-17
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-17
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-16
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-16
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-16
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-16
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		7e-16
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-16
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		7e-16
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-16
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-16
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-15
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-14
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-14
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-14
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-14
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-14
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-14
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-13
3soa_A	444	Full-Length Human Camkii Length = 444		2e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		8e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-12
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-12
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-09
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		6e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-07
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-07
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-07
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		7e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-06
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-06
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-06
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  236 bits (602), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 113/207 (54%), Positives = 148/207 (71%), Gaps = 13/207 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL+++I S Q LS++H QYF+YQ LR +K +H +NVIHRDLKPSNLL+N+NCDLK+C
Sbjct: 96  MQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVC 154
Query: 61  DFGLAR-----------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           DFGLAR           PT +   MTEYV TRWYRAPE++L S+ Y+ A+DVWS GCI  
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTP-TDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           EL  RRP+FPG D+ HQ+ L+  ++GTP +D DL  + +  A+ YI+ LP +P   L ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITGE 195
           FP V+P  IDL+ RML FDP KRIT +
Sbjct: 275 FPRVNPKGIDLLQRMLVFDPAKRITAK 301

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  233 bits (595), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 111/199 (55%), Positives = 150/199 (75%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY++++S Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLL+N  CDLKIC
Sbjct: 128 METDLYKLLKSQQ-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKIC 186
Query: 61  DFGLAR---PTSENE-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR   P  ++  F+TE V TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 187 DFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y++ LP   + + A++FP     A
Sbjct: 247 IFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKA 306
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+DRMLTF+P KRIT E
Sbjct: 307 LDLLDRMLTFNPNKRITVE 325

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  233 bits (594), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 112/207 (54%), Positives = 147/207 (71%), Gaps = 13/207 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL+++I S Q LS++H QYF+YQ LR +K +H +NVIHRDLKPSNLL+N+NCDLK+C
Sbjct: 96  MQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVC 154
Query: 61  DFGLAR-----------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           DFGLAR           PT +   MTE V TRWYRAPE++L S+ Y+ A+DVWS GCI  
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTP-TDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           EL  RRP+FPG D+ HQ+ L+  ++GTP +D DL  + +  A+ YI+ LP +P   L ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITGE 195
           FP V+P  IDL+ RML FDP KRIT +
Sbjct: 275 FPRVNPKGIDLLQRMLVFDPAKRITAK 301

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  233 bits (593), Expect = 8e-62,   Method: Compositional matrix adjust.
 Identities = 111/207 (53%), Positives = 147/207 (71%), Gaps = 13/207 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL+++I S Q LS++H QYF+YQ LR +K +H +NVIHRDLKPSNLL+N+NCDLK+C
Sbjct: 96  MQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVC 154
Query: 61  DFGLAR-----------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           DFGLAR           PT +   M E+V TRWYRAPE++L S+ Y+ A+DVWS GCI  
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTP-TDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           EL  RRP+FPG D+ HQ+ L+  ++GTP +D DL  + +  A+ YI+ LP +P   L ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITGE 195
           FP V+P  IDL+ RML FDP KRIT +
Sbjct: 275 FPRVNPKGIDLLQRMLVFDPAKRITAK 301

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  229 bits (584), Expect = 9e-61,   Method: Compositional matrix adjust.
 Identities = 114/201 (56%), Positives = 147/201 (73%), Gaps = 9/201 (4%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M++DL+QII S+Q L+ EH +YFLYQLLRGLKY+HSA VIHRDLKPSNLL+N NC+LKI 
Sbjct: 141 MESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIG 200
Query: 61  DFGLAR-----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           DFG+AR     P     FMTEYV TRWYRAPEL+L+  +YT AID+WSVGCIF E++ RR
Sbjct: 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL--AQVFPHVH 173
            LFPG ++VHQ++L++ +LGTP+ A +  V  E  + YI+ LP  PRQ +    V+P   
Sbjct: 261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLP--PRQPVPWETVYPGAD 318
Query: 174 PLAIDLVDRMLTFDPMKRITG 194
             A+ L+ RML F+P  RI+ 
Sbjct: 319 RQALSLLGRMLRFEPSARISA 339

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  228 bits (582), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 114/201 (56%), Positives = 147/201 (73%), Gaps = 9/201 (4%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M++DL+QII S+Q L+ EH +YFLYQLLRGLKY+HSA VIHRDLKPSNLL+N NC+LKI 
Sbjct: 142 MESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIG 201
Query: 61  DFGLAR-----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           DFG+AR     P     FMTEYV TRWYRAPEL+L+  +YT AID+WSVGCIF E++ RR
Sbjct: 202 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL--AQVFPHVH 173
            LFPG ++VHQ++L++ +LGTP+ A +  V  E  + YI+ LP  PRQ +    V+P   
Sbjct: 262 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLP--PRQPVPWETVYPGAD 319
Query: 174 PLAIDLVDRMLTFDPMKRITG 194
             A+ L+ RML F+P  RI+ 
Sbjct: 320 RQALSLLGRMLRFEPSARISA 340

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  228 bits (581), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 110 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 168
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 229 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 288
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 289 LDLLDKMLTFNPHKRIEVE 307

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  228 bits (581), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 110 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 168
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 229 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 288
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 289 LDLLDKMLTFNPHKRIEVE 307

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 113 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 171
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 172 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 232 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 291
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 292 LDLLDKMLTFNPHKRIEVE 310

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 114 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 172
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 173 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 232
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 233 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 292
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 293 LDLLDKMLTFNPHKRIEVE 311

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 105 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 163
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 164 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 223
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 224 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 283
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 284 LDLLDKMLTFNPHKRIEVE 302

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 291 LDLLDKMLTFNPHKRIEVE 309

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 116 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 174
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 175 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 234
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 235 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 294
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 295 LDLLDKMLTFNPHKRIEVE 313

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 287 LDLLDKMLTFNPHKRIEVE 305

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 291 LDLLDKMLTFNPHKRIEVE 309

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 106 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 164
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 165 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 225 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 284
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 285 LDLLDKMLTFNPHKRIEVE 303

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 128 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 186
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 187 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 247 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 306
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 307 LDLLDKMLTFNPHKRIEVE 325

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  228 bits (580), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 287 LDLLDKMLTFNPHKRIEVE 305

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  227 bits (578), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 145/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 106 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 164
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 165 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P   DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 225 IFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 284
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 285 LDLLDKMLTFNPHKRIEVE 303

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  226 bits (577), Expect = 6e-60,   Method: Compositional matrix adjust.
 Identities = 108/199 (54%), Positives = 145/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY++++  Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKC-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 291 LDLLDKMLTFNPHKRIEVE 309

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  225 bits (573), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 107/199 (53%), Positives = 145/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 287 LDLLDKMLTFNPHKRIEVE 305

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  224 bits (571), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 107/199 (53%), Positives = 145/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 291 LDLLDKMLTFNPHKRIEVE 309

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  224 bits (570), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 107/199 (53%), Positives = 145/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 287 LDLLDKMLTFNPHKRIEVE 305

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  224 bits (570), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 107/199 (53%), Positives = 145/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 291 LDLLDKMLTFNPHKRIEVE 309

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  223 bits (568), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 107/199 (53%), Positives = 144/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 110 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKIC 168
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL    N  A+ Y+  LP   +    ++FP+    A
Sbjct: 229 IFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKA 288
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 289 LDLLDKMLTFNPHKRIEVE 307

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  223 bits (567), Expect = 7e-59,   Method: Compositional matrix adjust.
 Identities = 106/199 (53%), Positives = 144/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+ E V TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 291 LDLLDKMLTFNPHKRIEVE 309

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  223 bits (567), Expect = 7e-59,   Method: Compositional matrix adjust.
 Identities = 106/199 (53%), Positives = 144/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 113 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 171
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+ E V TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 172 DFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 232 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 291
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 292 LDLLDKMLTFNPHKRIEVE 310

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  221 bits (564), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 106/199 (53%), Positives = 144/199 (72%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKI 
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIX 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 287 LDLLDKMLTFNPHKRIEVE 305

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  221 bits (564), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 106/199 (53%), Positives = 143/199 (71%), Gaps = 5/199 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 128 MGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 186
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 187 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 247 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 306
Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 307 LDLLDKMLTFNPHKRIEVE 325

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  219 bits (558), Expect = 9e-58,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 139/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN+  Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  218 bits (556), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 139/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T++   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 293 EKMLVLDSDKRITA 306

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  218 bits (556), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 139/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T++   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 293 EKMLVLDSDKRITA 306

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  218 bits (556), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 139/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T++   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 293 EKMLVLDSDKRITA 306

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  218 bits (555), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  218 bits (555), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 121 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 179
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 180 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 238 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 297
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 298 EKMLVLDSDKRITA 311

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 119 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 177
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 178 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 235
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 236 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 295
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 296 EKMLVLDSDKRITA 309

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 293 EKMLVLDSDKRITA 306

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 120 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 178
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 179 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 237 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 296
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 297 EKMLVLDSDKRITA 310

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 174 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 232 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 291
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 292 EKMLVLDSDKRITA 305

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 173 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 231 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 290
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 291 EKMLVLDSDKRITA 304

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  218 bits (554), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 108 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 167 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 225 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 284
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 285 EKMLVLDSDKRITA 298

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 170 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 228 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 287
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 288 EKMLVLDSDKRITA 301

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 128 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 186
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 187 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 245 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 304
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 305 EKMLVLDSDKRITA 318

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 129 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 187
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 188 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 246 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 305
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 306 EKMLVLDSDKRITA 319

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 121 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 179
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 180 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 238 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 297
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 298 EKMLVLDSDKRITA 311

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 121 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 179
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 180 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 238 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 297
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 298 EKMLVLDSDKRITA 311

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 132 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 190
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 191 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 249 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 308
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 309 EKMLVLDSDKRITA 322

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 170 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 228 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 287
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 288 EKMLVLDSDKRITA 301

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  217 bits (553), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 107 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 165
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 166 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 223
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 224 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 283
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 284 EKMLVLDSDKRITA 297

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  217 bits (553), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 164 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 282 EKMLVLDSDKRITA 295

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  217 bits (553), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 173 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 231 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 290
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 291 EKMLVLDSDKRITA 304

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  217 bits (553), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 174 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 232 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 291
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 292 EKMLVLDSDKRITA 305

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  217 bits (553), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 128 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 186
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 187 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 245 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 304
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 305 EKMLVLDSDKRITA 318

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  217 bits (553), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 106 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 164
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 165 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 223 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 282
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 283 EKMLVLDSDKRITA 296

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  217 bits (553), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 129 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 187
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 188 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 246 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 305
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 306 EKMLVLDSDKRITA 319

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  217 bits (553), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 164 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 281
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 282 EKMLVLDSDKRITA 295

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  217 bits (553), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 170 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 228 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 287
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 288 EKMLVLDSDKRITA 301

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  217 bits (553), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 174 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 232 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 291
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 292 EKMLVLDSDKRITA 305

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  217 bits (552), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 102/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 106 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 164
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 165 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 223 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 282
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 283 EKMLVLDSDKRITA 296

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  216 bits (550), Expect = 7e-57,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D+GLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DYGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  216 bits (549), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 132 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 190
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M  YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 191 DFGLARHTDDE--MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 249 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 308
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 309 EKMLVLDSDKRITA 322

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  215 bits (548), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  + L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 105 MGADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 164 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 281
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 282 EKMLVLDSDKRITA 295

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
            FGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 GFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  214 bits (546), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 170 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 228 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 287
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 288 EKMLVLDSDKRITA 301

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  214 bits (546), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 109 MGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  214 bits (546), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 174 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 232 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 291
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 292 EKMLVLDSDKRITA 305

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  214 bits (546), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++S Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 109 MGADLNNIVKS-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL R T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLCRHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  214 bits (546), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D GLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DAGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  214 bits (545), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D GLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DGGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  214 bits (545), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT  V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  214 bits (545), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 100/194 (51%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M  +V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  214 bits (545), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 100/194 (51%), Positives = 139/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 138 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 196
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 197 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPG 254
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH++Q++ ++ L GTP  + +  + + +A+ YI  LPQ P+++ A VF   +PLA+DL+
Sbjct: 255 TDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLL 314
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 315 EKMLVLDTDKRITA 328

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  214 bits (544), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D GLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DRGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  214 bits (544), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 100/194 (51%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M  +V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  214 bits (544), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 100/194 (51%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M  +V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 164 DFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 281
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 282 EKMLVLDSDKRITA 295

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  214 bits (544), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 120 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKIL 178
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 179 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 237 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 296
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 297 EKMLVLDSDKRITA 310

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  214 bits (544), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKIL 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 173 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 231 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 290
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 291 EKMLVLDSDKRITA 304

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  214 bits (544), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKIL 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 173 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 231 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 290
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 291 EKMLVLDSDKRITA 304

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  213 bits (543), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DF LAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFYLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 286 EKMLVLDSDKRITA 299

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  213 bits (543), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 98/194 (50%), Positives = 139/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q+LS+EH Q+ +YQLLRGLKYIHSA +IHRDLKPSN+ +N +C+L+I 
Sbjct: 107 MGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 165
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   E   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 166 DFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 223
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +D++ Q++ ++E++GTP+   L  + +E A+ YI+ LP  P++ L+ +F   +PLAIDL+
Sbjct: 224 SDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLL 283
Query: 181 DRMLTFDPMKRITG 194
            RML  D  +R++ 
Sbjct: 284 GRMLVLDSDQRVSA 297

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  213 bits (543), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 98/194 (50%), Positives = 139/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++S Q+LS+EH Q+ +YQLLRGLKYIHSA +IHRDLKPSN+ +N + +L+I 
Sbjct: 115 MGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   E   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 174 DFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +D++ Q++ ++E++GTP+   L  + +E A+ YI+ LP  P++ L+ +F   +PLAIDL+
Sbjct: 232 SDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLL 291
Query: 181 DRMLTFDPMKRITG 194
            RML  D  +R++ 
Sbjct: 292 GRMLVLDSDQRVSA 305

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  212 bits (539), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 100/194 (51%), Positives = 136/194 (70%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 129 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 187
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M   V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 188 DFGLARHTDDE--MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 246 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 305
Query: 181 DRMLTFDPMKRITG 194
           ++ML  D  KRIT 
Sbjct: 306 EKMLVLDSDKRITA 319

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  211 bits (536), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 97/194 (50%), Positives = 138/194 (71%), Gaps = 3/194 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q+LS+EH Q+ +YQLLRGLKYIHSA +IHRDLKPSN+ +N + +L+I 
Sbjct: 115 MGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   E   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 174 DFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +D++ Q++ ++E++GTP+   L  + +E A+ YI+ LP  P++ L+ +F   +PLAIDL+
Sbjct: 232 SDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLL 291
Query: 181 DRMLTFDPMKRITG 194
            RML  D  +R++ 
Sbjct: 292 GRMLVLDSDQRVSA 305

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 96/207 (46%), Positives = 133/207 (64%), Gaps = 10/207 (4%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL +I+      SEE  QY +YQ+L+GLKYIHSA V+HRDLKP NL +N +C+LKI 
Sbjct: 129 MQTDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 186
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       MT YVVTRWYRAPE++L+   Y   +D+WSVGCI  E++  + LF G
Sbjct: 187 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D++ Q+  ++++ G P    +  + ++ AK YI+ LPQ PR+   Q+FP   P A DL+
Sbjct: 245 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 304
Query: 181 DRMLTFDPMKRITGE------FFVPYK 201
           ++ML  D  KR+T        FF P++
Sbjct: 305 EKMLELDVDKRLTAAQALTHPFFEPFR 331

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  197 bits (502), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 96/207 (46%), Positives = 133/207 (64%), Gaps = 10/207 (4%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL +I+      SEE  QY +YQ+L+GLKYIHSA V+HRDLKP NL +N +C+LKI 
Sbjct: 111 MQTDLQKIM--GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       MT YVVTRWYRAPE++L+   Y   +D+WSVGCI  E++  + LF G
Sbjct: 169 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D++ Q+  ++++ G P    +  + ++ AK YI+ LPQ PR+   Q+FP   P A DL+
Sbjct: 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286
Query: 181 DRMLTFDPMKRITGE------FFVPYK 201
           ++ML  D  KR+T        FF P++
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFEPFR 313

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  188 bits (478), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 87/202 (43%), Positives = 139/202 (68%), Gaps = 5/202 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL ++++ ++ L E+  Q+ +YQ+L+GL+YIH+A +IHRDLKP NL +N +C+LKI 
Sbjct: 112 MGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 170
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       M   VVTRWYRAPE++LN   YT  +D+WSVGCI  E++  + LF G
Sbjct: 171 DFGLARQADSE--MXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q++ ++++ GTP    +  +++++AK Y++ LP+  ++  A +  +  PLA++L+
Sbjct: 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288
Query: 181 DRMLTFDPMKRIT-GEFFV-PY 200
           ++ML  D  +R+T GE    PY
Sbjct: 289 EKMLVLDAEQRVTAGEALAHPY 310

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  179 bits (455), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 103/251 (41%), Positives = 139/251 (55%), Gaps = 59/251 (23%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           D+D  ++ R+   L+E H +  LY LL G+KY+HSA ++HRDLKP+N L+N +C +K+CD
Sbjct: 140 DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD 199
Query: 62  FGLAR--------------------------PTSEN--EFMTEYVVTRWYRAPELLLNSS 93
           FGLAR                          P ++N    +T +VVTRWYRAPEL+L   
Sbjct: 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259
Query: 94  DYTAAIDVWSVGCIFMELMN-----------RRPLFP-------------GND------- 122
           +YT AIDVWS+GCIF EL+N           R PLFP             GND       
Sbjct: 260 NYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRG 319
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
           +  Q+ ++  +LGTP++ D+  +  EDAKRYIR  P+     LA+ FP     AI L+ R
Sbjct: 320 NRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKR 379
Query: 183 MLTFDPMKRIT 193
           ML F+P KRIT
Sbjct: 380 MLVFNPNKRIT 390

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  173 bits (438), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 82/197 (41%), Positives = 122/197 (61%), Gaps = 2/197 (1%)
Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M TDL Q+I   +  +S +H QYF+Y +L GL  +H A V+HRDL P N+LL  N D+ I
Sbjct: 116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           CDF LAR  + +   T YV  RWYRAPEL++    +T  +D+WS GC+  E+ NR+ LF 
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR-QLPQHPRQSLAQVFPHVHPLAID 178
           G+   +Q+  ++E++GTP   D+    +  A+ Y+R  L   P ++   V P   P+A+D
Sbjct: 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 179 LVDRMLTFDPMKRITGE 195
           L+ +ML F+P +RI+ E
Sbjct: 296 LIAKMLEFNPQRRISTE 312

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  173 bits (438), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 82/197 (41%), Positives = 122/197 (61%), Gaps = 2/197 (1%)
Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M TDL Q+I   +  +S +H QYF+Y +L GL  +H A V+HRDL P N+LL  N D+ I
Sbjct: 116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           CDF LAR  + +   T YV  RWYRAPEL++    +T  +D+WS GC+  E+ NR+ LF 
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR-QLPQHPRQSLAQVFPHVHPLAID 178
           G+   +Q+  ++E++GTP   D+    +  A+ Y+R  L   P ++   V P   P+A+D
Sbjct: 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 179 LVDRMLTFDPMKRITGE 195
           L+ +ML F+P +RI+ E
Sbjct: 296 LIAKMLEFNPQRRISTE 312

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  168 bits (426), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/207 (43%), Positives = 128/207 (61%), Gaps = 21/207 (10%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKI 59
           M+TDL  ++     L EEH + F+YQLLRGLKYIHSANV+HRDLKP+NL +N  +  LKI
Sbjct: 104 METDLANVLEQG-PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162
Query: 60  CDFGLARPT----SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR      S    ++E +VT+WYR+P LLL+ ++YT AID+W+ GCIF E++  +
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR-------YIRQLPQHPRQSLAQV 168
            LF G   + QM+L++E         +  V  ED +        YIR     P + L Q+
Sbjct: 223 TLFAGAHELEQMQLILE--------SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL 274
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITGE 195
            P +   A+D ++++LTF PM R+T E
Sbjct: 275 LPGISREAVDFLEQILTFSPMDRLTAE 301

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  167 bits (424), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 134/243 (55%), Gaps = 51/243 (20%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           D+DL ++ ++   L+EEH +  LY LL G  +IH + +IHRDLKP+N LLN +C +K+CD
Sbjct: 113 DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172
Query: 62  FGLARPTS------------ENEF-----------MTEYVVTRWYRAPELLLNSSDYTAA 98
           FGLAR  +            ENE            +T +VVTRWYRAPEL+L   +YT +
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 99  IDVWSVGCIFMELM-----------NRRPLFPGND-----------HVH------QMRLL 130
           ID+WS GCIF EL+           NR PLFPG+             VH      Q+ ++
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNII 292
Query: 131 IELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
             ++GTPT+ DL  +   +  +YI+  P     +L Q +P +    I+L++ ML F+P K
Sbjct: 293 FNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNK 352
Query: 191 RIT 193
           RIT
Sbjct: 353 RIT 355

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  165 bits (418), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 91/232 (39%), Positives = 140/232 (60%), Gaps = 39/232 (16%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDL+ +IR+N  L   H QY +YQL++ +KY+HS  ++HRD+KPSN+LLNA C +K+ 
Sbjct: 93  METDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVA 151
Query: 61  DFGLAR------------PTSENE----------FMTEYVVTRWYRAPELLLNSSDYTAA 98
           DFGL+R            P S NE           +T+YV TRWYRAPE+LL S+ YT  
Sbjct: 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG 211
Query: 99  IDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP 158
           ID+WS+GCI  E++  +P+FPG+  ++Q+  +I ++  P++ D+  +++  AK  I  L 
Sbjct: 212 IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLK 271
Query: 159 QHP--RQS------------LAQVFPHV--HPLAIDLVDRMLTFDPMKRITG 194
           +    RQS            L ++ P    +  A+DL+D++L F+P KRI+ 
Sbjct: 272 EKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  164 bits (414), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 89/205 (43%), Positives = 123/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I  +  L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 109 MDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR  S N  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  EL+    +F G
Sbjct: 167 DFGLARTASTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHP----- 174
            DH+ Q   +IE LGTP+ A+         + Y+   P +P  +  ++FP  + P     
Sbjct: 226 TDHIDQWNKVIEQLGTPS-AEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESER 284
Query: 175 ------LAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 285 DKIKTSQARDLLSKMLVIDPDKRIS 309

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  162 bits (411), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 89/205 (43%), Positives = 123/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I  +  L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    N  MT YVVTR+YRAPE++L    Y A +D+WSVGCI  EL+    +F G
Sbjct: 169 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHP----- 174
            DH+ Q   +IE LGTP+ A+         + Y+   P++P     ++FP  + P     
Sbjct: 228 TDHIDQWNKVIEQLGTPS-AEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESER 286
Query: 175 ------LAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 287 DKIKTSQARDLLSKMLVIDPDKRIS 311

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  162 bits (410), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/246 (37%), Positives = 136/246 (55%), Gaps = 54/246 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           D+DL ++ ++   L+E+H +  LY LL G K+IH + +IHRDLKP+N LLN +C +KICD
Sbjct: 115 DSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICD 174
Query: 62  FGLAR------------------------PTSEN--EFMTEYVVTRWYRAPELLLNSSDY 95
           FGLAR                        P ++N  + +T +VVTRWYRAPEL+L   +Y
Sbjct: 175 FGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 234
Query: 96  TAAIDVWSVGCIFMELM-----------NRRPLFPGN-------DH----VH------QM 127
           T +ID+WS GCIF EL+           NR PLFPG+       DH    VH      Q+
Sbjct: 235 TNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQL 294
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
            ++  ++GTP + DL  +  ++  +YI+  P      L++ +  +    IDL++ ML F+
Sbjct: 295 NIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFN 354
Query: 188 PMKRIT 193
             KRIT
Sbjct: 355 AQKRIT 360

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  160 bits (406), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 86/205 (41%), Positives = 122/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  160 bits (404), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 86/205 (41%), Positives = 122/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  159 bits (401), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 121/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 86/205 (41%), Positives = 121/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 86/205 (41%), Positives = 121/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 112 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 228
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 229 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRIS 312

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 121/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 121/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  157 bits (398), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 149 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRIS 349

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  157 bits (397), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 149 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRIS 349

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 110 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 168 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 226
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 227 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 285
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 286 NKLKASQARDLLSKMLVIDPAKRIS 310

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  157 bits (397), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  157 bits (397), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 112 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 228
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 229 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 287
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 288 NKLKASQARDLLSKMLVIDPAKRIS 312

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 112 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 228
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 229 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 287
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 288 NKLKASQARDLLSKMLVIDPAKRIS 312

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  157 bits (396), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 104 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRIS 304

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  157 bits (396), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 105 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 162
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 163 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 222 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 280
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 281 NKLKASQARDLLSKMLVIDPAKRIS 305

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  157 bits (396), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 124/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 105 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 162
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 163 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 222 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 280
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 281 NKLKASQARDLLSKMLVIDPAKRIS 305

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 84/205 (40%), Positives = 120/205 (58%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVG I  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  155 bits (393), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 84/205 (40%), Positives = 120/205 (58%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVG I  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  155 bits (393), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 84/205 (40%), Positives = 123/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  155 bits (392), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 84/205 (40%), Positives = 120/205 (58%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 113 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 170
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  M  +VVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 171 DFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 229
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 230 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 288
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 289 NKLKASQARDLLSKMLVIDASKRIS 313

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/205 (40%), Positives = 123/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 84/205 (40%), Positives = 123/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 104 MDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRIS 304

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 120/205 (58%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT  VVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NALKASQARDLLSKMLVIDASKRIS 311

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 122/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 105 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 162
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 163 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            D++ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 222 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 280
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 281 NKLKASQARDLLSKMLVIDASKRIS 305

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  155 bits (391), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 122/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 116 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 174 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            D++ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 233 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 291
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 292 NKLKASQARDLLSKMLVIDASKRIS 316

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  154 bits (390), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/211 (40%), Positives = 122/211 (57%), Gaps = 6/211 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEH-CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL Q +    ++   H  + FL+QLLRGL Y H   V+HRDLKP NLL+N   +LK+
Sbjct: 82  LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKL 141
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S   +     VVT WYR P++LL S+DY+  ID+W VGCIF E+   RPLF
Sbjct: 142 ADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201
Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    Q+  +  +LGTPT+    G + NE+ K Y    P++  ++L    P +     
Sbjct: 202 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY--NYPKYRAEALLSHAPRLDSDGA 259
Query: 178 DLVDRMLTFDPMKRITGEFFVPYKPFQCCCG 208
           DL+ ++L F+   RI+ E  + + PF    G
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMKH-PFFLSLG 289

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  154 bits (389), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 84/205 (40%), Positives = 123/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLXQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  153 bits (387), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 84/205 (40%), Positives = 123/205 (60%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  153 bits (386), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 84/205 (40%), Positives = 121/205 (59%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  M   VVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVCHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            D++ Q   +IE LGTP  A +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 RDYIDQWNKVIEQLGTPCPAFMKKLQ-PTVRNYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  150 bits (378), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 88/199 (44%), Positives = 118/199 (59%), Gaps = 9/199 (4%)
Query: 2   DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           D DL +   S N  L  E  + FL+QLL+GL + HS NV+HRDLKP NLL+N N +LK+ 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143
Query: 61  DFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLF 118
           DFGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPLF
Sbjct: 144 DFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLF 203
Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHP-RQSLAQVFPHVHPLA 176
           PGND   Q++ +  LLGTPT+       +  D K Y    P +P   SL  V P ++   
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY----PMYPATTSLVNVVPKLNATG 259
Query: 177 IDLVDRMLTFDPMKRITGE 195
            DL+  +L  +P++RI+ E
Sbjct: 260 RDLLQNLLKCNPVQRISAE 278

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  150 bits (378), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 83/205 (40%), Positives = 120/205 (58%), Gaps = 16/205 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  M   VVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            D++ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  D  KRI+
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRIS 311

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  149 bits (375), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFAFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 291 PTARLT 296

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  149 bits (375), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 193 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 369
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 370 PTARLT 375

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  149 bits (375), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 152 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 328
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 329 PTARLT 334

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 324
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 325 PTARLT 330

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 150 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 326
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 327 PTARLT 332

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 142 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 318
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 319 PTARLT 324

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 291 PTARLT 296

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 119 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 179 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 238
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 239 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 295
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 296 PTARLT 301

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 127 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 303
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 304 PTARLT 309

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 113/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 291 PTARLT 296

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/199 (43%), Positives = 118/199 (59%), Gaps = 9/199 (4%)
Query: 2   DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           D DL +   S N  L  E  + FL+QLL+GL + HS NV+HRDLKP NLL+N N +LK+ 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143
Query: 61  DFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLF 118
           +FGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPLF
Sbjct: 144 NFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHP-RQSLAQVFPHVHPLA 176
           PGND   Q++ +  LLGTPT+       +  D K Y    P +P   SL  V P ++   
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY----PMYPATTSLVNVVPKLNATG 259
Query: 177 IDLVDRMLTFDPMKRITGE 195
            DL+  +L  +P++RI+ E
Sbjct: 260 RDLLQNLLKCNPVQRISAE 278

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFAFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 291 PTARLT 296

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 291 PTARLT 296

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 324
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 325 PTARLT 330

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 133 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 309
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 310 PTARLT 315

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 122 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 298
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 299 PTARLT 304

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 302
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 303 PTARLT 308

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 291 PTARLT 296

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 302
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 303 PTARLT 308

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  145 bits (366), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 118 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 178 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 238 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 294
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 295 PTARLT 300

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  145 bits (366), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 115 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 175 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 234
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 235 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 291
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 292 PTARLT 297

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 75/186 (40%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRIT 193
           P  R+T
Sbjct: 291 PTARLT 296

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 75/196 (38%), Positives = 115/196 (58%), Gaps = 3/196 (1%)
Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+ DL +++  N++ L +   + +LYQLLRG+ + H   ++HRDLKP NLL+N++  LK+
Sbjct: 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++  +PLF
Sbjct: 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG     Q+  +  +LGTP   +   V+     +  R      ++  + + P      ID
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGID 279
Query: 179 LVDRMLTFDPMKRITG 194
           L+  ML FDP KRI+ 
Sbjct: 280 LLSNMLCFDPNKRISA 295

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  144 bits (363), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 75/196 (38%), Positives = 115/196 (58%), Gaps = 3/196 (1%)
Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+ DL +++  N++ L +   + +LYQLLRG+ + H   ++HRDLKP NLL+N++  LK+
Sbjct: 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++  +PLF
Sbjct: 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG     Q+  +  +LGTP   +   V+     +  R      ++  + + P      ID
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGID 279
Query: 179 LVDRMLTFDPMKRITG 194
           L+  ML FDP KRI+ 
Sbjct: 280 LLSNMLCFDPNKRISA 295

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  144 bits (362), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 225 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 283 AHPFFQ 288

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  143 bits (361), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 112 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 171
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 172 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 231
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 232 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 289
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 290 AHPFFQ 295

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 105 IKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 225 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 283 AHPFFQ 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  143 bits (360), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 77/187 (41%), Positives = 109/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 106 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 165
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 225
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 226 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 283 LAHPFFQ 289

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  143 bits (360), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 224 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 282 AHPFFQ 287

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 224 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 282 AHPFFQ 287

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 225 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 283 AHPFFQ 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 225 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 283 AHPFFQ 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 224 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 282 AHPFFQ 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 112 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 171
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 172 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 231
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 232 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 289
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 290 AHPFFQ 295

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 225 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 283 AHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  143 bits (360), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 224 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 282 AHPFFQ 287

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  143 bits (360), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 3/186 (1%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 109 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 168
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 169 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 228
Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV 198
           +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  +
Sbjct: 229 EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 286
Query: 199 PYKPFQ 204
            +  FQ
Sbjct: 287 AHPFFQ 292

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 106 IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE- 164
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 224
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 225 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 283 LAHPFFQ 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 106 IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE- 164
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 224
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 225 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 283 LAHPFFQ 289

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/187 (41%), Positives = 110/187 (58%), Gaps = 7/187 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 225 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 282 LAHPFFQ 288

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 107 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 165
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 225
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 226 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 284 LAHPFFQ 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 108 IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE- 166
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 226
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 227 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 285 LAHPFFQ 291

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE- 163
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 223
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 224 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 282 LAHPFFQ 288

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 107 IKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE- 165
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 225
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 226 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 284 LAHPFFQ 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 163
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 223
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 224 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 282 LAHPFFQ 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 163
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 223
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 224 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 282 LAHPFFQ 288

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 107 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 165
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 225
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 226 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 284 LAHPFFQ 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 162
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 223 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 281 LAHPFFQ 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 162
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 223 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 281 LAHPFFQ 287

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 106 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 164
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 224
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 225 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 283 LAHPFFQ 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 108 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 166
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 226
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 227 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 285 LAHPFFQ 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 109 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 167
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 227
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 228 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 286 LAHPFFQ 292

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 108 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 166
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 226
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 227 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 285 LAHPFFQ 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 108 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 166
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 226
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 227 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 285 LAHPFFQ 291

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 108 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 166
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 226
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 227 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 285 LAHPFFQ 291

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 108 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 166
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 226
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 227 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 285 LAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 107 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 165
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 225
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 226 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 284 LAHPFFQ 290

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 163
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 223
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 224 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 282 LAHPFFQ 288

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEY 77
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E 
Sbjct: 106 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE- 164
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 224
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            +     V +     Y    P+  RQ  ++V P +      L+ +ML +DP KRI+ +  
Sbjct: 225 DEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 283 LAHPFFQ 289

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/194 (39%), Positives = 112/194 (57%), Gaps = 5/194 (2%)
Query: 18  EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY 77
           E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G+  V Q+  +++++G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            + D       D     +       Q + +    +  L  DL+ + LTF+P KRI+    
Sbjct: 239 GEEDW----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 198 VPYKPFQCCCGCIE 211
           + +  FQ    C E
Sbjct: 295 LSHPYFQDLERCKE 308

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/194 (39%), Positives = 112/194 (57%), Gaps = 5/194 (2%)
Query: 18  EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY 77
           E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G+  V Q+  +++++G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            + D       D     +       Q + +    +  L  DL+ + LTF+P KRI+    
Sbjct: 239 GEEDW----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 198 VPYKPFQCCCGCIE 211
           + +  FQ    C E
Sbjct: 295 LSHPYFQDLERCKE 308

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  140 bits (352), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 74/187 (39%), Positives = 110/187 (58%), Gaps = 5/187 (2%)
Query: 18  EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY 77
           E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G+  V Q+  +++++G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF 197
            + D       D     +       Q + +    +  L  DL+ + LTF+P KRI+    
Sbjct: 239 GEEDW----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 198 VPYKPFQ 204
           + +  FQ
Sbjct: 295 LSHPYFQ 301

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 71/176 (40%), Positives = 105/176 (59%), Gaps = 5/176 (2%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEFMTEYVV 79
           + ++YQLLR L YIHS  + HRD+KP NLLL+     LK+ DFG A+     E     + 
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD 139
           +R+YRAPEL+  +++YT  ID+WS GC+  ELM  +PLFPG   + Q+  +I++LGTP+ 
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFDPMKRITG 194
             +  +     +    Q+  HP    ++VF P   P AIDL+ R+L + P  R+T 
Sbjct: 264 EQIKTMNPNYMEHKFPQIRPHP---FSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/210 (38%), Positives = 114/210 (54%), Gaps = 5/210 (2%)
Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+TDL  II+ N   L+  H + ++   L+GL+Y+H   ++HRDLKP+NLLL+ N  LK+
Sbjct: 94  METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL 153
Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA+   S N      VVTRWYRAPELL  +  Y   +D+W+VGCI  EL+ R P  
Sbjct: 154 ADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG+  + Q+  + E LGTPT+     + +       +  P  P   L  +F       +D
Sbjct: 214 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP---LHHIFSAAGDDLLD 270
Query: 179 LVDRMLTFDPMKRITGEFFVPYKPFQCCCG 208
           L+  +  F+P  RIT    +  K F    G
Sbjct: 271 LIQGLFLFNPCARITATQALKMKYFSNRPG 300

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/216 (37%), Positives = 117/216 (54%), Gaps = 24/216 (11%)
Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL +++      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 60  CDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR    P  +    T  VVT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  
Sbjct: 142 ADFGLARAFGIPVRK---YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH-PRQSLAQVFP---- 170
           PLFPG     Q+  +  +LGTP         N      + +LP++ P  ++ +  P    
Sbjct: 199 PLFPGVSEADQLMRIFRILGTP---------NSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 171 --HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ 204
              +    IDL+ +ML  DP +RIT +  + +  F+
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/216 (37%), Positives = 117/216 (54%), Gaps = 24/216 (11%)
Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL +++      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 60  CDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR    P  +    T  VVT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  
Sbjct: 142 ADFGLARAFGIPVRK---YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGA 198
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH-PRQSLAQVFP---- 170
           PLFPG     Q+  +  +LGTP         N      + +LP++ P  ++ +  P    
Sbjct: 199 PLFPGVSEADQLMRIFRILGTP---------NSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 171 --HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ 204
              +    IDL+ +ML  DP +RIT +  + +  F+
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  138 bits (347), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/216 (37%), Positives = 117/216 (54%), Gaps = 24/216 (11%)
Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL +++      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 60  CDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR    P  +    T  +VT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  
Sbjct: 142 ADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH-PRQSLAQVFP---- 170
           PLFPG     Q+  +  +LGTP         N      + +LP++ P  ++ +  P    
Sbjct: 199 PLFPGVSEADQLMRIFRILGTP---------NSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 171 --HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ 204
              +    IDL+ +ML  DP +RIT +  + +  F+
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  137 bits (346), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 72/191 (37%), Positives = 117/191 (61%), Gaps = 5/191 (2%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFG 63
           L   IRS +S+       ++YQL R + +IHS  + HRD+KP NLL+N+  + LK+CDFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            A+    +E     + +R+YRAPEL+L +++YT +ID+WS+GC+F EL+  +PLF G   
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP-LAIDLVDR 182
           + Q+  +I+++GTPT   +  +R       +R  P    +   ++ P   P LAIDL+++
Sbjct: 248 IDQLVRIIQIMGTPTKEQM--IRMNPHYTEVR-FPTLKAKDWRKILPEGTPSLAIDLLEQ 304
Query: 183 MLTFDPMKRIT 193
           +L ++P  RI 
Sbjct: 305 ILRYEPDLRIN 315

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  137 bits (344), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 80/208 (38%), Positives = 120/208 (57%), Gaps = 16/208 (7%)
Query: 1   MDTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           MD DL + + S       + L     +YF +QLL+GL + H   ++HRDLKP NLL+N  
Sbjct: 85  MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR 144
Query: 55  CDLKICDFGLARPTS--ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
             LK+ DFGLAR      N F +E VVT WYRAP++L+ S  Y+ +ID+WS GCI  E++
Sbjct: 145 GQLKLGDFGLARAFGIPVNTFSSE-VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PH 171
             +PLFPG +   Q++L+ +++GTP ++    V      +Y   + Q P + L QV  PH
Sbjct: 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK--LPKYNPNIQQRPPRDLRQVLQPH 261
Query: 172 V-HPLAIDLVD---RMLTFDPMKRITGE 195
              PL  +L+D    +L  +P  R++ +
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRLSAK 289

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  135 bits (339), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 74/181 (40%), Positives = 106/181 (58%), Gaps = 5/181 (2%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
           +T  VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L
Sbjct: 176 LTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+
Sbjct: 235 IGLPPEDD--WPRDVSLPRGAFP-PRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 194 G 194
Sbjct: 291 A 291

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  133 bits (335), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 73/181 (40%), Positives = 105/181 (58%), Gaps = 5/181 (2%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
           +   VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L
Sbjct: 168 LAPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+
Sbjct: 227 IGLPPEDD--WPRDVSLPRGAFP-PRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRIS 282
Query: 194 G 194
Sbjct: 283 A 283

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 73/181 (40%), Positives = 105/181 (58%), Gaps = 5/181 (2%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
           +   VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L
Sbjct: 168 LDPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+
Sbjct: 227 IGLPPEDD--WPRDVSLPRGAFP-PRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRIS 282
Query: 194 G 194
Sbjct: 283 A 283

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  132 bits (331), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 73/181 (40%), Positives = 105/181 (58%), Gaps = 5/181 (2%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
           +   VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L
Sbjct: 168 LFPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+
Sbjct: 227 IGLPPEDD--WPRDVSLPRGAFP-PRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRIS 282
Query: 194 G 194
Sbjct: 283 A 283

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  127 bits (319), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 67/182 (36%), Positives = 106/182 (58%), Gaps = 7/182 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENE 72
            L  +  Q +L+Q++ G+ + HS N+IHRD+KP N+L++ +  +K+CDFG AR   +  E
Sbjct: 120 GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIE 132
              + V TRWYRAPELL+    Y  A+DVW++GC+  E+    PLFPG+  + Q+  ++ 
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239
Query: 133 LLGT--PTDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLAIDLVDRMLTFDPM 189
            LG   P   +L    N++      +LP+   R+ L + +P +  + IDL  + L  DP 
Sbjct: 240 CLGNLIPRHQEL---FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD 296
Query: 190 KR 191
           KR
Sbjct: 297 KR 298

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 115/205 (56%), Gaps = 17/205 (8%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD----- 56
           + DL + +  N  +S    + FLYQL+ G+ + HS   +HRDLKP NLLL+ +       
Sbjct: 116 ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175
Query: 57  LKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LKI DFGLAR    P  +    T  ++T WYR PE+LL S  Y+ ++D+WS+ CI+ E++
Sbjct: 176 LKIGDFGLARAFGIPIRQ---FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVF-P 170
            + PLFPG+  + Q+  + E+LG P D    G     D K   +  P+   ++L +V   
Sbjct: 233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK---QSFPKFRGKTLKRVLGA 289
Query: 171 HVHPLAIDLVDRMLTFDPMKRITGE 195
            +    +DL+  ML  DP+KRI+ +
Sbjct: 290 LLDDEGLDLLTAMLEMDPVKRISAK 314

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  121 bits (304), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 71/188 (37%), Positives = 103/188 (54%), Gaps = 8/188 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS--EN 71
           +LSE   +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S  +N
Sbjct: 123 TLSE--IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 72  EFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
                Y   VVT WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ+ 
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 240
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAIDLVDRMLTFD 187
           L+ +L G+ T      V N +    +  +    R+   ++  +V  P A+DL+D++L  D
Sbjct: 241 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 300
Query: 188 PMKRITGE 195
           P +RI  +
Sbjct: 301 PAQRIDSD 308

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  121 bits (304), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 71/188 (37%), Positives = 103/188 (54%), Gaps = 8/188 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS--EN 71
           +LSE   +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S  +N
Sbjct: 122 TLSE--IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 72  EFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
                Y   VVT WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ+ 
Sbjct: 180 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAIDLVDRMLTFD 187
           L+ +L G+ T      V N +    +  +    R+   ++  +V  P A+DL+D++L  D
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 299
Query: 188 PMKRITGE 195
           P +RI  +
Sbjct: 300 PAQRIDSD 307

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  121 bits (304), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 71/188 (37%), Positives = 103/188 (54%), Gaps = 8/188 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS--EN 71
           +LSE   +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S  +N
Sbjct: 123 TLSE--IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 72  EFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
                Y   VVT WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ+ 
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 240
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAIDLVDRMLTFD 187
           L+ +L G+ T      V N +    +  +    R+   ++  +V  P A+DL+D++L  D
Sbjct: 241 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 300
Query: 188 PMKRITGE 195
           P +RI  +
Sbjct: 301 PAQRIDSD 308

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 71/188 (37%), Positives = 103/188 (54%), Gaps = 8/188 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS--EN 71
           +LSE   +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S  +N
Sbjct: 123 TLSE--IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 72  EFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
                Y   VVT WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ+ 
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 240
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAIDLVDRMLTFD 187
           L+ +L G+ T      V N +    +  +    R+   ++  +V  P A+DL+D++L  D
Sbjct: 241 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 300
Query: 188 PMKRITGE 195
           P +RI  +
Sbjct: 301 PAQRIDSD 308

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  120 bits (301), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 1/194 (0%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T L+++ R  + + E   +   +Q L+ + + H  N IHRD+KP N+L+  +  +K+CDF
Sbjct: 87  TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDF 146
Query: 63  GLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G AR  T  +++  + V TRWYR+PELL+  + Y   +DVW++GC+F EL++  PL+PG 
Sbjct: 147 GFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
             V Q+ L+ + LG                  ++       + L   FP++   A+ L+ 
Sbjct: 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLK 266
Query: 182 RMLTFDPMKRITGE 195
             L  DP +R+T E
Sbjct: 267 GCLHMDPTERLTCE 280

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 55/121 (45%), Positives = 83/121 (68%), Gaps = 3/121 (2%)
Query: 21  QYFLYQLLRGLKYIH--SANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEY 77
           + FL+QL+R +  +H  S NV HRD+KP N+L+N A+  LK+CDFG A+  S +E    Y
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           + +R+YRAPEL+  +  YT A+D+WSVGCIF E+M   P+F G++   Q+  ++ +LG P
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 138 T 138
           +
Sbjct: 252 S 252

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 117/233 (50%), Gaps = 49/233 (21%)
Query: 4   DLYQIIRSNQS---------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           DL+ II+ +++         L     +  LYQ+L G+ Y+H+  V+HRDLKP+N+L+   
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 164
Query: 55  CD----LKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
                 +KI D G AR    P      +   VVT WYRAPELLL +  YT AID+W++GC
Sbjct: 165 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 224
Query: 107 IFMELMNRRPLF--------PGNDHVH-QMRLLIELLGTPTDADLGFVRN--------ED 149
           IF EL+   P+F          N + H Q+  +  ++G P D D   ++         +D
Sbjct: 225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD 284
Query: 150 AKR-------YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE 195
            +R        I+ + +H  +  ++ F         L+ ++LT DP+KRIT E
Sbjct: 285 FRRNTYTNCSLIKYMEKHKVKPDSKAF--------HLLQKLLTMDPIKRITSE 329

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 110/189 (58%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 142 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 201
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 202 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 261
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +A L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 262 KVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 321
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 322 YDHQERLTA 330

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 109/189 (57%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 301 YDHQERLTA 309

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 109/189 (57%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 301 YDHQERLTA 309

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 109/189 (57%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 243 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 302
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 303 YDHQERLTA 311

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 109/189 (57%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 301 YDHQERLTA 309

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 109/189 (57%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 301 YDHQERLTA 309

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 109/189 (57%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 301 YDHQERLTA 309

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 109/189 (57%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 301
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 302 YDHQERLTA 310

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 109/189 (57%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 301 YDHQERLTA 309

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 109/189 (57%), Gaps = 8/189 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 301
Query: 186 FDPMKRITG 194
           +D  +R+T 
Sbjct: 302 YDHQERLTA 310

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  100 bits (249), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N+L++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 117 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 174 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 292
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 293 SPEALDFLDKLLRYDHQSRLTA 314

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQL---RQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 99.8 bits (247), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 99.8 bits (247), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 117 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 174 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 292
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 293 SPEALDFLDKLLRYDHQSRLTA 314

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 99.8 bits (247), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 116 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 173 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 291
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 292 SPEALDFLDKLLRYDHQSRLTA 313

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 99.8 bits (247), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTA 315

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 115/202 (56%), Gaps = 13/202 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 123 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 179
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 180 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 239
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 240 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 298
Query: 173 HPLAIDLVDRMLTFDPMKRITG 194
            P A+D +D++L +D   R+T 
Sbjct: 299 SPEALDFLDKLLRYDHQSRLTA 320

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 116/205 (56%), Gaps = 17/205 (8%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q L++   ++++Y+LL+ L Y HS  ++HRD+KP N++++     L++ 
Sbjct: 119 NTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLI 175
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ RR P F 
Sbjct: 176 DWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFH 235
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAK---RYIRQLPQHPRQSLAQVFPH----- 171
           G D+  Q+  + ++LG  T+   G+++         +   L QH R+   + F H     
Sbjct: 236 GQDNYDQLVRIAKVLG--TEELYGYLKKYHIDLDPHFNDILGQHSRKRW-ENFIHSENRH 292
Query: 172 -VHPLAIDLVDRMLTFDPMKRITGE 195
            V P A+DL+D++L +D  +R+T +
Sbjct: 293 LVSPEALDLLDKLLRYDHQQRLTAK 317

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 115/205 (56%), Gaps = 17/205 (8%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q L++   ++++Y+LL+ L Y HS  ++HRD+KP N++++     L++ 
Sbjct: 124 NTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLI 180
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ RR P F 
Sbjct: 181 DWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFH 240
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAK---RYIRQLPQHPRQSLAQVFPH----- 171
           G D+  Q+  + ++LG  T+   G+++         +   L QH R+     F H     
Sbjct: 241 GQDNYDQLVRIAKVLG--TEELYGYLKKYHIDLDPHFNDILGQHSRKRWEN-FIHSENRH 297
Query: 172 -VHPLAIDLVDRMLTFDPMKRITGE 195
            V P A+DL+D++L +D  +R+T +
Sbjct: 298 LVSPEALDLLDKLLRYDHQQRLTAK 322

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 31/197 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 99  ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 158
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 159 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 216
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 217 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 252
Query: 179 LVDRMLTFDPMKRITGE 195
           LV ++L  DP  R T E
Sbjct: 253 LVKKLLVVDPKARFTTE 269

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 31/197 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 218 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 253
Query: 179 LVDRMLTFDPMKRITGE 195
           LV ++L  DP  R T E
Sbjct: 254 LVKKLLVVDPKARFTTE 270

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 31/197 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 218 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 253
Query: 179 LVDRMLTFDPMKRITGE 195
           LV ++L  DP  R T E
Sbjct: 254 LVKKLLVVDPKARFTTE 270

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 31/197 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 218 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 253
Query: 179 LVDRMLTFDPMKRITGE 195
           LV ++L  DP  R T E
Sbjct: 254 LVKKLLVVDPKARFTTE 270

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 31/197 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 106 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 165
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 166 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 223
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 224 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 259
Query: 179 LVDRMLTFDPMKRITGE 195
           LV ++L  DP  R T E
Sbjct: 260 LVKKLLVVDPKARFTTE 276

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 31/197 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 239 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 298
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 299 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 356
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 357 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 392
Query: 179 LVDRMLTFDPMKRITGE 195
           LV ++L  DP  R T E
Sbjct: 393 LVKKLLVVDPKARFTTE 409

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 53/142 (37%), Positives = 83/142 (58%), Gaps = 7/142 (4%)
Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCD 56
           +  +LY++I+ N  Q  S    + F + +L+ L  +H   +IH DLKP N+LL       
Sbjct: 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +K+ DFG +    E++ +   + +R+YRAPE++L +  Y   ID+WS+GCI  EL+   P
Sbjct: 241 IKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297
Query: 117 LFPGNDHVHQMRLLIELLGTPT 138
           L PG D   Q+  +IELLG P+
Sbjct: 298 LLPGEDEGDQLACMIELLGMPS 319

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 53/142 (37%), Positives = 83/142 (58%), Gaps = 7/142 (4%)
Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCD 56
           +  +LY++I+ N  Q  S    + F + +L+ L  +H   +IH DLKP N+LL       
Sbjct: 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +K+ DFG +    E++ +   + +R+YRAPE++L +  Y   ID+WS+GCI  EL+   P
Sbjct: 241 IKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297
Query: 117 LFPGNDHVHQMRLLIELLGTPT 138
           L PG D   Q+  +IELLG P+
Sbjct: 298 LLPGEDEGDQLACMIELLGMPS 319

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 31/197 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 225 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 342
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 343 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 378
Query: 179 LVDRMLTFDPMKRITGE 195
           LV ++L  DP  R T E
Sbjct: 379 LVKKLLVVDPKARFTTE 395

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 53/141 (37%), Positives = 82/141 (58%), Gaps = 7/141 (4%)
Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCD 56
           +  +LY++I+ N  Q  S    + F + +L+ L  +H   +IH DLKP N+LL       
Sbjct: 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +K+ DFG +    E++ +   + +R+YRAPE++L +  Y   ID+WS+GCI  EL+   P
Sbjct: 241 IKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297
Query: 117 LFPGNDHVHQMRLLIELLGTP 137
           L PG D   Q+  +IELLG P
Sbjct: 298 LLPGEDEGDQLACMIELLGMP 318

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 32/194 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL +   +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y   LPQ         +  +   A DL+
Sbjct: 225 KN------------------EYDILKRVETGKYAFDLPQ---------WRTISDDAKDLI 257
Query: 181 DRMLTFDPMKRITG 194
            +MLTF P  RIT 
Sbjct: 258 RKMLTFHPSLRITA 271

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 32/194 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL +   +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y   LPQ         +  +   A DL+
Sbjct: 225 KN------------------EYDILKRVETGKYAFDLPQ---------WRTISDDAKDLI 257
Query: 181 DRMLTFDPMKRITG 194
            +MLTF P  RIT 
Sbjct: 258 RKMLTFHPSLRITA 271

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 93.6 bits (231), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 32/194 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL +   +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +    ++ +                  +  +Y   LPQ         +  +   A DL+
Sbjct: 225 KNEYDILKRV------------------ETGKYAFDLPQ---------WRTISDDAKDLI 257
Query: 181 DRMLTFDPMKRITG 194
            +MLTF P  RIT 
Sbjct: 258 RKMLTFHPSLRITA 271

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 40/214 (18%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++++E   +YF+ Q ++G++Y+H+  VIHRDLK  NL LN + D+KI DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 65  ARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A     + E   +   T  Y APE+L     ++  +D+WS+GCI   L+  +P F     
Sbjct: 189 ATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTLLVGKPPF----- 242
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +   L E                    YIR      +++   V  H++P+A  L+ RM
Sbjct: 243 --ETSCLKET-------------------YIRI-----KKNEYSVPRHINPVASALIRRM 276
Query: 184 LTFDPMKR------ITGEFFVP-YKPFQCCCGCI 210
           L  DP  R      +T EFF   Y P +    C+
Sbjct: 277 LHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCL 310

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 40/214 (18%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++++E   +YF+ Q ++G++Y+H+  VIHRDLK  NL LN + D+KI DFGL
Sbjct: 113 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 172
Query: 65  ARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A     + E   +   T  Y APE+L     ++  +D+WS+GCI   L+  +P F     
Sbjct: 173 ATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTLLVGKPPF----- 226
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +   L E                    YIR      +++   V  H++P+A  L+ RM
Sbjct: 227 --ETSCLKET-------------------YIRI-----KKNEYSVPRHINPVASALIRRM 260
Query: 184 LTFDPMKR------ITGEFFVP-YKPFQCCCGCI 210
           L  DP  R      +T EFF   Y P +    C+
Sbjct: 261 LHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCL 294

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 40/214 (18%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++++E   +YF+ Q ++G++Y+H+  VIHRDLK  NL LN + D+KI DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 65  ARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A     + E       T  Y APE+L     ++  +D+WS+GCI   L+  +P F     
Sbjct: 189 ATKIEFDGERKKTLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTLLVGKPPF----- 242
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +   L E                    YIR      +++   V  H++P+A  L+ RM
Sbjct: 243 --ETSCLKET-------------------YIRI-----KKNEYSVPRHINPVASALIRRM 276
Query: 184 LTFDPMKR------ITGEFFVP-YKPFQCCCGCI 210
           L  DP  R      +T EFF   Y P +    C+
Sbjct: 277 LHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCL 310

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 40/214 (18%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++++E   +YF+ Q ++G++Y+H+  VIHRDLK  NL LN + D+KI DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 65  ARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A     + E       T  Y APE+L     ++  +D+WS+GCI   L+  +P F     
Sbjct: 189 ATKIEFDGERKKXLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTLLVGKPPF----- 242
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +   L E                    YIR      +++   V  H++P+A  L+ RM
Sbjct: 243 --ETSCLKET-------------------YIRI-----KKNEYSVPRHINPVASALIRRM 276
Query: 184 LTFDPMKR------ITGEFFVP-YKPFQCCCGCI 210
           L  DP  R      +T EFF   Y P +    C+
Sbjct: 277 LHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCL 310

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 25/193 (12%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I+  +  SE    Y + +L+  + ++H   V+HRDLKP NLL    N N ++KI 
Sbjct: 92  ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKII 151
Query: 61  DFGLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFG AR    +N+ +     T  Y APE LLN + Y  + D+WS+G I   +++ +  F 
Sbjct: 152 DFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            +D        +E++      D  F                      + + +V   A DL
Sbjct: 211 SHDRSLTCTSAVEIMKKIKKGDFSFE--------------------GEAWKNVSQEAKDL 250
Query: 180 VDRMLTFDPMKRI 192
           +  +LT DP KR+
Sbjct: 251 IQGLLTVDPNKRL 263

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 236 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 262
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 263 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 291

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+ +   +++                                  L   FP    P A
Sbjct: 235 RAGNEGLIFAKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 290

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 235 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 290

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 233 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 259
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 288

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 39/206 (18%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I DFG 
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 65  AR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PG 120
           A+   P S+      +V T  Y +PELL   S  + + D+W++GCI  +L+   P F  G
Sbjct: 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSA-SKSSDLWALGCIIYQLVAGLPPFRAG 237
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLAIDL 179
           N+++   +++                                  L   FP    P A DL
Sbjct: 238 NEYLIFQKII---------------------------------KLEYDFPEKFFPKARDL 264
Query: 180 VDRMLTFDPMKRITGEFFVPYKPFQC 205
           V+++L  D  KR+  E    Y P + 
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKA 290

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 235 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 290

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 235 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 290

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 236 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 262
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 263 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 291

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 233 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 259
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 288

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 233 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 259
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 288

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 119 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 178
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 179 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 237
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-HPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 238 RAGNEYLIFQKII---------------------------------KLEYDFPAAFFPKA 264
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 265 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 293

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 121 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 180
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 181 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 239
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 240 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 266
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 267 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 295

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 232 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 258
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 259 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 287

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 233 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 259
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 288

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 92  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 151
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 152 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 210
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 211 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 237
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 91  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 150
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 151 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 209
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 210 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 236
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 237 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 265

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 93  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 152
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 153 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 211
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 212 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 238
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 239 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 267

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 98  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 157
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 158 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 216
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 217 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 243
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 244 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 272

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 232 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 258
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 259 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 287

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 94  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 153
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 154 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 212
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 213 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 239
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 240 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 268

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 39/209 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+ +   +++                                  L   FP    P A
Sbjct: 235 RAGNEGLIFAKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQC 205
            DLV+++L  D  KR+  E    Y P + 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKA 290

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 32/194 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL +   + +++I 
Sbjct: 118 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 177
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 178 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 235
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y  +LPQ         +  V   A DL+
Sbjct: 236 AN------------------EYDILKKVEKGKYTFELPQ---------WKKVSESAKDLI 268
Query: 181 DRMLTFDPMKRITG 194
            +MLT+ P  RI+ 
Sbjct: 269 RKMLTYVPSMRISA 282

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 32/193 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL +   + +++I 
Sbjct: 136 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 195
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 196 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 253
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y  +LPQ         +  V   A DL+
Sbjct: 254 AN------------------EYDILKKVEKGKYTFELPQ---------WKKVSESAKDLI 286
Query: 181 DRMLTFDPMKRIT 193
            +MLT+ P  RI+
Sbjct: 287 RKMLTYVPSMRIS 299

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 32/193 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL +   + +++I 
Sbjct: 135 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 194
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 195 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 252
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y  +LPQ         +  V   A DL+
Sbjct: 253 AN------------------EYDILKKVEKGKYTFELPQ---------WKKVSESAKDLI 285
Query: 181 DRMLTFDPMKRIT 193
            +MLT+ P  RI+
Sbjct: 286 RKMLTYVPSMRIS 298

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 32/194 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL +   + +++I 
Sbjct: 112 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 171
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 172 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 229
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y  +LPQ         +  V   A DL+
Sbjct: 230 AN------------------EYDILKKVEKGKYTFELPQ---------WKKVSESAKDLI 262
Query: 181 DRMLTFDPMKRITG 194
            +MLT+ P  RI+ 
Sbjct: 263 RKMLTYVPSMRISA 276

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 32/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I      +E      + Q+L G+ Y+H  N++HRDLKP NLLL +   +  +KI 
Sbjct: 122 ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+      + M E + T +Y APE+L     Y    DVWS+G I   L+   P F G
Sbjct: 182 DFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLAGYPPFGG 239
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                            TD ++  +R  +  +Y    P+         + +V   A DL+
Sbjct: 240 Q----------------TDQEI--LRKVEKGKYTFDSPE---------WKNVSEGAKDLI 272
Query: 181 DRMLTFDPMKRITGE 195
            +ML FD  +RI+ +
Sbjct: 273 KQMLQFDSQRRISAQ 287

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 33/191 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 103 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 162
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 163 LATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 217
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 218 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 250
Query: 183 MLTFDPMKRIT 193
           ML  DP  R T
Sbjct: 251 MLQTDPTARPT 261

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 33/191 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 103 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 162
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 163 LATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 217
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 218 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 250
Query: 183 MLTFDPMKRIT 193
           ML  DP  R T
Sbjct: 251 MLQTDPTARPT 261

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 33/191 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 107 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 166
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 167 LATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 221
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 222 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 254
Query: 183 MLTFDPMKRIT 193
           ML  DP  R T
Sbjct: 255 MLQTDPTARPT 265

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 33/191 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 127 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 186
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 187 LATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 241
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 242 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 274
Query: 183 MLTFDPMKRIT 193
           ML  DP  R T
Sbjct: 275 MLQTDPTARPT 285

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 33/191 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 125 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 184
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 185 LATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 239
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 240 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 272
Query: 183 MLTFDPMKRIT 193
           ML  DP  R T
Sbjct: 273 MLQTDPTARPT 283

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 33/191 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 101 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 160
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 161 LATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 215
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 216 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 248
Query: 183 MLTFDPMKRIT 193
           ML  DP  R T
Sbjct: 249 MLQTDPTARPT 259

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 6   YQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---------- 53
           Y  I+ N  L    +H +   YQ+ + + ++HS  + H DLKP N+L             
Sbjct: 104 YDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163
Query: 54  ---------NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 104
                    N D+K+ DFG A  T ++E  +  V TR YRAPE++L +  ++   DVWS+
Sbjct: 164 IKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSI 220
Query: 105 GCIFMELMNRRPLFPGNDHVHQMRLLIELLG-TPTDA-------------DLGFVRNEDA 150
           GCI +E      +FP +D    + ++  +LG  P                 L +  +  A
Sbjct: 221 GCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280
Query: 151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
            RY+ +  + P +         H    DL+ +ML +DP KRIT
Sbjct: 281 GRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 86/190 (45%), Gaps = 31/190 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  N  L E+  +    Q+L G+ Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 102 ELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   S+ EF+     +  Y APE++         +D+WS G I   L+     F  +DH
Sbjct: 162 LSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDH 220
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           V  +                F +  D   Y  Q              +++P  I L+  M
Sbjct: 221 VPTL----------------FKKICDGIFYTPQ--------------YLNPSVISLLKHM 250
Query: 184 LTFDPMKRIT 193
           L  DPMKR T
Sbjct: 251 LQVDPMKRAT 260

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 6   YQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---------- 53
           Y  I+ N  L    +H +   YQ+ + + ++HS  + H DLKP N+L             
Sbjct: 104 YDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163
Query: 54  ---------NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 104
                    N D+K+ DFG A  T ++E  +  V  R YRAPE++L +  ++   DVWS+
Sbjct: 164 IKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSI 220
Query: 105 GCIFMELMNRRPLFPGNDHVHQMRLLIELLG-TPTDA-------------DLGFVRNEDA 150
           GCI +E      +FP +D    + ++  +LG  P                 L +  +  A
Sbjct: 221 GCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280
Query: 151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
            RY+ +  + P +         H    DL+ +ML +DP KRIT
Sbjct: 281 GRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 75/136 (55%), Gaps = 3/136 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L  GL ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 116 DLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 175
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++   ++E     +  T  Y APE ++N   ++ + D WS G +  E++     F G D
Sbjct: 176 LSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKD 234
Query: 123 HVHQMRLLIEL-LGTP 137
               M L+++  LG P
Sbjct: 235 RKETMTLILKAKLGMP 250

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 31/195 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 91  ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I             
Sbjct: 151 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVI------------- 196
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   L I L+G P   D      ED  R   Q+        +  +  V P A  L+
Sbjct: 197 --------LYILLVGYPPFWD------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 181 DRMLTFDPMKRITGE 195
           D MLT +P KRIT +
Sbjct: 243 DSMLTVNPKKRITAD 257

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 32/194 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y H   ++HRDLKP NLLL +   + +++I 
Sbjct: 112 ELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRII 171
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++   + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 172 DFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 229
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +    ++ +                  +  +Y  +LPQ         +  V   A DL+
Sbjct: 230 ANEYDILKKV------------------EKGKYTFELPQ---------WKKVSESAKDLI 262
Query: 181 DRMLTFDPMKRITG 194
            + LT+ P  RI+ 
Sbjct: 263 RKXLTYVPSXRISA 276

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 31/195 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 91  ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I             
Sbjct: 151 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVI------------- 196
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   L I L+G P   D      ED  R   Q+        +  +  V P A  L+
Sbjct: 197 --------LYILLVGYPPFWD------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 181 DRMLTFDPMKRITGE 195
           D MLT +P KRIT +
Sbjct: 243 DSMLTVNPKKRITAD 257

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 31/195 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 90  ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 149
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I             
Sbjct: 150 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVI------------- 195
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   L I L+G P   D      ED  R   Q+        +  +  V P A  L+
Sbjct: 196 --------LYILLVGYPPFWD------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 241
Query: 181 DRMLTFDPMKRITGE 195
           D MLT +P KRIT +
Sbjct: 242 DSMLTVNPKKRITAD 256

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 39/209 (18%)
Query: 19  HCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL-LNA------------------NCDLKI 59
           H ++  YQL   L+++H   + H DLKP N+L +N+                  N  +++
Sbjct: 156 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 215
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG A  T ++E  T  V TR YR PE++L    +    DVWS+GCI  E      LF 
Sbjct: 216 ADFGSA--TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQ 272
Query: 120 GNDHVHQMRLLIELLGTPTDADL-------------GFVRNEDAK--RYIRQLPQHPRQS 164
            +++   + ++ ++LG P  + +             G V +E++   RY+++  + P +S
Sbjct: 273 THENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKS 330
Query: 165 LAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                   H    DL+ RML FDP +RIT
Sbjct: 331 YMLQDSLEHVQLFDLMRRMLEFDPAQRIT 359

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 39/209 (18%)
Query: 19  HCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL-LNA------------------NCDLKI 59
           H ++  YQL   L+++H   + H DLKP N+L +N+                  N  +++
Sbjct: 133 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 192
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG A  T ++E  T  V TR YR PE++L    +    DVWS+GCI  E      LF 
Sbjct: 193 ADFGSA--TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQ 249
Query: 120 GNDHVHQMRLLIELLGTPTDADL-------------GFVRNEDAK--RYIRQLPQHPRQS 164
            +++   + ++ ++LG P  + +             G V +E++   RY+++  + P +S
Sbjct: 250 THENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKS 307
Query: 165 LAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                   H    DL+ RML FDP +RIT
Sbjct: 308 YMLQDSLEHVQLFDLMRRMLEFDPAQRIT 336

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 39/209 (18%)
Query: 19  HCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL-LNA------------------NCDLKI 59
           H ++  YQL   L+++H   + H DLKP N+L +N+                  N  +++
Sbjct: 124 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG A  T ++E  T  V TR YR PE++L    +    DVWS+GCI  E      LF 
Sbjct: 184 ADFGSA--TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQ 240
Query: 120 GNDHVHQMRLLIELLGTPTDADL-------------GFVRNEDAK--RYIRQLPQHPRQS 164
            +++   + ++ ++LG P  + +             G V +E++   RY+++  + P +S
Sbjct: 241 THENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKS 298
Query: 165 LAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                   H    DL+ RML FDP +RIT
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 90/161 (55%), Gaps = 11/161 (6%)
Query: 4   DLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLL--NANCDL 57
           +LY ++R+   + +S    + F  Q+   L ++ +   ++IH DLKP N+LL       +
Sbjct: 141 NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAI 200
Query: 58  KICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+GCI +E+    PL
Sbjct: 201 KIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPL 257
Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP 158
           F G + V QM  ++E+LG P    L   +   A+++  +LP
Sbjct: 258 FSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFEKLP 296

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 90/161 (55%), Gaps = 11/161 (6%)
Query: 4   DLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLL--NANCDL 57
           +LY ++R+   + +S    + F  Q+   L ++ +   ++IH DLKP N+LL       +
Sbjct: 122 NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAI 181
Query: 58  KICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+GCI +E+    PL
Sbjct: 182 KIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPL 238
Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP 158
           F G + V QM  ++E+LG P    L   +   A+++  +LP
Sbjct: 239 FSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFEKLP 277

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 31/195 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I             
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVI------------- 219
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   L I L+G P   D      ED  R   Q+        +  +  V P A  L+
Sbjct: 220 --------LYILLVGYPPFWD------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265
Query: 181 DRMLTFDPMKRITGE 195
           D MLT +P KRIT +
Sbjct: 266 DSMLTVNPKKRITAD 280

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 32/197 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  + ++H+ N++HRDLKP N+LL+ N  +++ DFG
Sbjct: 186 ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE+L  S D     Y   +D+W+ G I   L+   P F
Sbjct: 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                +  +R+++E                   +Y    P+   +S             D
Sbjct: 306 WHRRQILMLRMIME------------------GQYQFSSPEWDDRS---------STVKD 338
Query: 179 LVDRMLTFDPMKRITGE 195
           L+ R+L  DP  R+T E
Sbjct: 339 LISRLLQVDPEARLTAE 355

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 90/161 (55%), Gaps = 11/161 (6%)
Query: 4   DLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLL--NANCDL 57
           +LY ++R+   + +S    + F  Q+   L ++ +   ++IH DLKP N+LL       +
Sbjct: 141 NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAI 200
Query: 58  KICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+GCI +E+    PL
Sbjct: 201 KIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPL 257
Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP 158
           F G + V QM  ++E+LG P    L   +   A+++  +LP
Sbjct: 258 FSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFEKLP 296

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 37/207 (17%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLL-LNANCDL------------------KIC 60
            ++  +QL + +K++H   + H DLKP N+L +N++ +L                  ++ 
Sbjct: 139 VRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVV 198
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFG A  T ++E  +  V TR YRAPE++L    ++   DVWS+GCI  E      LF  
Sbjct: 199 DFGSA--TFDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQT 255
Query: 121 NDHVHQMRLLIELLG-TPT-------------DADLGFVRNEDAKRYIRQLPQHPRQSLA 166
           +D+   + ++  +LG  P+                L +  N  A RY+R+  +  R+ L 
Sbjct: 256 HDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLT 315
Query: 167 QVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                 H L  DL++ ML ++P KR+T
Sbjct: 316 SEAEEHHQL-FDLIESMLEYEPAKRLT 341

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 75/136 (55%), Gaps = 3/136 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++ + ++E     +  T  Y APE ++N   +T + D WS G +  E++     F G D
Sbjct: 172 LSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
Query: 123 HVHQMRLLIEL-LGTP 137
               M ++++  LG P
Sbjct: 231 RKETMTMILKAKLGMP 246

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 75/136 (55%), Gaps = 3/136 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 113 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 172
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++ + ++E     +  T  Y APE ++N   +T + D WS G +  E++     F G D
Sbjct: 173 LSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 231
Query: 123 HVHQMRLLIEL-LGTP 137
               M ++++  LG P
Sbjct: 232 RKETMTMILKAKLGMP 247

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 75/136 (55%), Gaps = 3/136 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++ + ++E     +  T  Y APE ++N   +T + D WS G +  E++     F G D
Sbjct: 172 LSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
Query: 123 HVHQMRLLIEL-LGTP 137
               M ++++  LG P
Sbjct: 231 RKETMTMILKAKLGMP 246

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 33/206 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + ++Q+L  + +IH  +++HRDLKP NLLL + C    +K+ 
Sbjct: 116 ELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLA 175
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     E +    +  T  Y +PE +L    Y   +D+W+ G I            
Sbjct: 176 DFGLAIEVQGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDIWACGVI------------ 222
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  +  +Q+        +  +  V P A +L
Sbjct: 223 ---------LYILLVGYPPFWD------EDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 180 VDRMLTFDPMKRITGEFFVPYKPFQC 205
           +++MLT +P KRIT +  + + P+ C
Sbjct: 268 INQMLTINPAKRITADQALKH-PWVC 292

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 31/191 (16%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            +L+  I     +SE+  + F  Q++  ++Y H   ++HRDLKP NLLL+ + ++KI DF
Sbjct: 92  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADF 151
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL+   ++  F+     +  Y APE++         +DVWS G I   ++ RR       
Sbjct: 152 GLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR------- 204
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                         P D +   V  ++    +  LP+            + P A  L+ R
Sbjct: 205 -------------LPFDDESIPVLFKNISNGVYTLPK-----------FLSPGAAGLIKR 240
Query: 183 MLTFDPMKRIT 193
           ML  +P+ RI+
Sbjct: 241 MLIVNPLNRIS 251

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 86/195 (44%), Gaps = 32/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L+  I   Q  SE      + Q+L G  Y+H  N++HRDLKP NLLL +      +KI 
Sbjct: 107 ELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIV 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+        M E + T +Y APE+L     Y    DVWS G I   L+   P F G
Sbjct: 167 DFGLSAHFEVGGKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                            TD ++  ++  +  ++    P          +  V   A  LV
Sbjct: 225 Q----------------TDQEI--LKRVEKGKFSFDPPD---------WTQVSDEAKQLV 257
Query: 181 DRMLTFDPMKRITGE 195
             MLT++P KRI+ E
Sbjct: 258 KLMLTYEPSKRISAE 272

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 31/191 (16%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            +L+  I     +SE+  + F  Q++  ++Y H   ++HRDLKP NLLL+ + ++KI DF
Sbjct: 88  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADF 147
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL+   ++  F+     +  Y APE++         +DVWS G I   ++ RR       
Sbjct: 148 GLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR------- 200
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                         P D +   V  ++    +  LP+            + P A  L+ R
Sbjct: 201 -------------LPFDDESIPVLFKNISNGVYTLPK-----------FLSPGAAGLIKR 236
Query: 183 MLTFDPMKRIT 193
           ML  +P+ RI+
Sbjct: 237 MLIVNPLNRIS 247

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 31/191 (16%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            +L+  I     +SE+  + F  Q++  ++Y H   ++HRDLKP NLLL+ + ++KI DF
Sbjct: 98  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADF 157
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL+   ++  F+     +  Y APE++         +DVWS G I   ++ RR       
Sbjct: 158 GLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR------- 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                         P D +   V  ++    +  LP+            + P A  L+ R
Sbjct: 211 -------------LPFDDESIPVLFKNISNGVYTLPK-----------FLSPGAAGLIKR 246
Query: 183 MLTFDPMKRIT 193
           ML  +P+ RI+
Sbjct: 247 MLIVNPLNRIS 257

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/117 (36%), Positives = 70/117 (59%), Gaps = 5/117 (4%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E +    L ++L+GL Y+HS   IHRD+K +N+LL+   D+K+ DFG+A   ++ +  
Sbjct: 113 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 172
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y    D+WS+G   +EL    P  P +D +H MR+L
Sbjct: 173 RNXFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVL 225

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 31/191 (16%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            +L+  I     +SE+  + F  Q++  ++Y H   ++HRDLKP NLLL+ + ++KI DF
Sbjct: 97  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADF 156
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL+   ++  F+     +  Y APE++         +DVWS G I   ++ RR       
Sbjct: 157 GLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR------- 209
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                         P D +   V  ++    +  LP+            + P A  L+ R
Sbjct: 210 -------------LPFDDESIPVLFKNISNGVYTLPK-----------FLSPGAAGLIKR 245
Query: 183 MLTFDPMKRIT 193
           ML  +P+ RI+
Sbjct: 246 MLIVNPLNRIS 256

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 68/108 (62%), Gaps = 5/108 (4%)
Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-TEYVVTRW 82
           L ++L+GL Y+HS   IHRD+K +N+LL+   D+K+ DFG+A   ++ +     +V T +
Sbjct: 126 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 185
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
           + APE++  S+ Y +  D+WS+G   +EL    P  P +D +H MR+L
Sbjct: 186 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVL 229

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 86/195 (44%), Gaps = 32/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L+  I   Q  SE      + Q+L G  Y+H  N++HRDLKP NLLL +      +KI 
Sbjct: 90  ELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIV 149
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+        M E + T +Y APE+L     Y    DVWS G I   L+   P F G
Sbjct: 150 DFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK--YDEKCDVWSCGVILYILLCGYPPFGG 207
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                            TD ++  ++  +  ++    P          +  V   A  LV
Sbjct: 208 Q----------------TDQEI--LKRVEKGKFSFDPPD---------WTQVSDEAKQLV 240
Query: 181 DRMLTFDPMKRITGE 195
             MLT++P KRI+ E
Sbjct: 241 KLMLTYEPSKRISAE 255

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 96  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 155
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 156 LCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 214
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 215 HERLFELIL 223

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 94  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 153
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 154 LCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 212
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 213 HERLFELIL 221

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 35/192 (18%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I   + ++E+  + F  Q++  ++Y H   ++HRDLKP NLLL+ N ++KI DFG
Sbjct: 94  ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG 153
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFPGND 122
           L+   ++  F+     +  Y APE++         +DVWS G + ++ L+ R P      
Sbjct: 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF----- 208
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLAIDLVD 181
                             D  F+ N   K            S   V P  + P A  L+ 
Sbjct: 209 ------------------DDEFIPNLFKK----------VNSCVYVMPDFLSPGAQSLIR 240
Query: 182 RMLTFDPMKRIT 193
           RM+  DPM+RIT
Sbjct: 241 RMIVADPMQRIT 252

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 63/115 (54%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +TE   T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 167 ETTSHNSLTEPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 89  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 148
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 86/193 (44%), Gaps = 31/193 (16%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSEN 71
           +SE      + Q+L G+ Y+H  N++H DLKP N+LL++     D+KI DFG++R     
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
             + E + T  Y APE +LN    T A D+W++G I   L+     F G D         
Sbjct: 188 CELREIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------- 237
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
                          N++    I Q+     +   + F  V  LA D +  +L  +P KR
Sbjct: 238 ---------------NQETYLNISQVNVDYSE---ETFSSVSQLATDFIQSLLVKNPEKR 279
Query: 192 ITGEFFVPYKPFQ 204
            T E  + +   Q
Sbjct: 280 PTAEICLSHSWLQ 292

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 93/175 (53%), Gaps = 25/175 (14%)
Query: 5   LYQIIRSNQSLSEEHCQYF--LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           LY +I S ++L+++  +Y+    Q+L  L YIHS  +IHRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 63  GLAR----------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
           GLA+                P S +  +T  + T  Y A E+L  +  Y   ID++S+G 
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDN-LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQLPQH 160
           IF E++   P   G + V+ ++ L  + +  P D D   ++ E  K+ IR L  H
Sbjct: 220 IFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE--KKIIRLLIDH 270

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 93/175 (53%), Gaps = 25/175 (14%)
Query: 5   LYQIIRSNQSLSEEHCQYF--LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           LY +I S ++L+++  +Y+    Q+L  L YIHS  +IHRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 63  GLAR----------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
           GLA+                P S +  +T  + T  Y A E+L  +  Y   ID++S+G 
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDN-LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQLPQH 160
           IF E++   P   G + V+ ++ L  + +  P D D   ++ E  K+ IR L  H
Sbjct: 220 IFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE--KKIIRLLIDH 270

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 70/117 (59%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++  + + EE        +LRGL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 101 LDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG 160
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y APE  L  + Y+   D+WS+G   +EL + R P+ P
Sbjct: 161 VSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 180
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 181 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVL 233

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 62/104 (59%), Gaps = 2/104 (1%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFM 74
           SE   ++F++Q++ G+ Y+HS  ++HRDL  SNLLL  N ++KI DFGLA      +E  
Sbjct: 110 SENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169
Query: 75  TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
                T  Y +PE+   S+ +    DVWS+GC+F  L+  RP F
Sbjct: 170 YTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 176 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVL 228

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 161 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVL 213

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 161 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVL 213

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 113 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 172
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 173 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 226

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 123 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 182
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 183 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 236

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 115 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 174
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 175 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 228

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 114 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 173
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 174 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 227

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 222

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 108 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 167
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 168 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 221

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 68/119 (57%), Gaps = 8/119 (6%)
Query: 1   MDTDL----YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANC 55
           MDT L     Q+I   Q++ E+        +++ L+++HS  +VIHRD+KPSN+L+NA  
Sbjct: 132 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG 191
Query: 56  DLKICDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMEL 111
            +K+CDFG++    ++   T     + Y APE +   LN   Y+   D+WS+G   +EL
Sbjct: 192 QVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 222

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 167 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 220

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 159 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 218
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N
Sbjct: 219 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 272

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 33/206 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + + H   V+HRDLKP NLLL + C    +K+ 
Sbjct: 89  ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLA 148
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     + +    +  T  Y +PE+L   + Y   +D+W+ G I            
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA-YGKPVDIWACGVI------------ 195
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  +  +Q+        +  +  V P A +L
Sbjct: 196 ---------LYILLVGYPPFWD------EDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 240
Query: 180 VDRMLTFDPMKRITGEFFVPYKPFQC 205
           +++MLT +P KRIT    + + P+ C
Sbjct: 241 INQMLTINPAKRITAHEALKH-PWVC 265

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 60/106 (56%), Gaps = 3/106 (2%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEFM 74
           +E+   ++  Q+L GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +     
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 75  TE-YVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLF 118
           TE +  T  Y APE++      Y  A D+WS+GC  +E+   +P F
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 60/106 (56%), Gaps = 3/106 (2%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEFM 74
           +E+   ++  Q+L GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +     
Sbjct: 106 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 165
Query: 75  TE-YVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLF 118
           TE +  T  Y APE++      Y  A D+WS+GC  +E+   +P F
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   V+HRDLKP NLLL +      +K+ 
Sbjct: 107 ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLA 166
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     E +    +  T  Y +PE +L    Y   +D+W+ G I            
Sbjct: 167 DFGLAIEVEGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVI------------ 213
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  R  +Q+        +  +  V P A DL
Sbjct: 214 ---------LYILLVGYPPFWD------EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 258
Query: 180 VDRMLTFDPMKRITG 194
           +++MLT +P KRIT 
Sbjct: 259 INKMLTINPSKRITA 273

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 95  ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 154
Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 155 GLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 213
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 214 DHEKLFELIL 223

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/125 (37%), Positives = 67/125 (53%), Gaps = 11/125 (8%)
Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNAN 54
           DL  +I    +  Q L EE     + QL   LK  H  +     V+HRDLKP+N+ L+  
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152
Query: 55  CDLKICDFGLARPTSENE-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLAR  + +E F  E+V T +Y +PE  +N   Y    D+WS+GC+  EL  
Sbjct: 153 QNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCA 211
Query: 114 RRPLF 118
             P F
Sbjct: 212 LMPPF 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 32/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I +     E      + Q+L G+ Y+H  N++HRD+KP N+LL   N+  ++KI 
Sbjct: 132 ELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+   S++  + + + T +Y APE+L     Y    DVWS G I   L+   P F G
Sbjct: 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGG 249
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                             D D+           I+++ +         + ++   A +L+
Sbjct: 250 ----------------QNDQDI-----------IKKVEKGKYYFDFNDWKNISDEAKELI 282
Query: 181 DRMLTFDPMKRITGE 195
             MLT+D  KR T E
Sbjct: 283 KLMLTYDYNKRCTAE 297

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 59/109 (54%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   +    Q+L  + Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 97  ELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           L+   S+ EF+ +   +  Y APE++         +D+WS G I   L+
Sbjct: 157 LSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +K+ DFG
Sbjct: 127 DMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 96  ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 155
Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 156 GLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 214
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 215 DHEKLFELIL 224

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +K+ DFG
Sbjct: 127 DMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 94  ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 153
Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 154 GLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 212
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 213 DHEKLFELIL 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG
Sbjct: 110 ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE++      N   Y   +D+WS G I   L+   P F
Sbjct: 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                 H+ ++L+  +    +   G    +D    ++                      D
Sbjct: 230 -----WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK----------------------D 262
Query: 179 LVDRMLTFDPMKRITGEFFVPYKPFQ 204
           LV R L   P KR T E  + +  FQ
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFFQ 288

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 9/176 (5%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG
Sbjct: 97  ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 156
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE++      N   Y   +D+WS G I   L+   P F
Sbjct: 157 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216
Query: 119 PGNDHVHQMRLLIE---LLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH 171
                +  +R+++      G+P   D      +   R++   PQ  R +  +   H
Sbjct: 217 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK-RYTAEEALAH 271

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 67/122 (54%), Gaps = 3/122 (2%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + I S+  LS +    F  Q+L G+K+ H   ++HRD+KP N+L+++N  LKI DFG+
Sbjct: 98  LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157
Query: 65  ARPTSENEFM-TEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           A+  SE     T +V+ T  Y +PE     +      D++S+G +  E++   P F G  
Sbjct: 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGET 216
Query: 123 HV 124
            V
Sbjct: 217 AV 218

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 237 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 296
Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 297 GLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 355
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 356 DHEKLFELIL 365

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEF 73
           L+E   Q    Q L  L Y+H   +IHRDLK  N+L   + D+K+ DFG+ A+ T   + 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 74  MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL 129
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+     + P +  ++ MR+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 130 LIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           L+++       L  P+     F         +N DA+    QL QHP
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 295

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 234 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293
Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 294 GLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 353 DHEKLFELIL 362

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEF 73
           L+E   Q    Q L  L Y+H   +IHRDLK  N+L   + D+K+ DFG+ A+ T   + 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 191
Query: 74  MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL 129
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+     + P +  ++ MR+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 130 LIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           L+++       L  P+     F         +N DA+    QL QHP
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 295

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 65/115 (56%), Gaps = 2/115 (1%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 58/109 (53%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   +    Q+L  + Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 97  ELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           L+   S+ EF+     +  Y APE++         +D+WS G I   L+
Sbjct: 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 65/115 (56%), Gaps = 2/115 (1%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 65/115 (56%), Gaps = 2/115 (1%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 90/175 (51%), Gaps = 25/175 (14%)
Query: 5   LYQIIRSNQSLSEEHCQYF--LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           LY +I S ++L+++  +Y+    Q+L  L YIHS  +IHR+LKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDF 160
Query: 63  GLAR----------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
           GLA+                P S +  +T  + T  Y A E+L  +  Y   ID +S+G 
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDN-LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGI 219
Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQLPQH 160
           IF E +   P   G + V+ ++ L  + +  P D D    + E  K+ IR L  H
Sbjct: 220 IFFEXI--YPFSTGXERVNILKKLRSVSIEFPPDFDDNKXKVE--KKIIRLLIDH 270

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEF 73
           L+E   Q    Q L  L Y+H   +IHRDLK  N+L   + D+K+ DFG+ A+ T   + 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 74  MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL 129
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+     + P +  ++ MR+
Sbjct: 192 RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 130 LIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           L+++       L  P+     F         +N DA+    QL QHP
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 295

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 31/190 (16%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F     
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAK-RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                                V N++ K R + Q   +P +          P + D  + 
Sbjct: 395 K--------------------VENKELKQRVLEQAVTYPDK--------FSPASKDFCEA 426
Query: 183 MLTFDPMKRI 192
           +L  DP KR+
Sbjct: 427 LLQKDPEKRL 436

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 11/160 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL   L+ +  + I 
Sbjct: 102 ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 162 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 220
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN--EDAKRYIRQL 157
            ND     +L  ++L    + D  +  +  + AK +IR L
Sbjct: 221 END----AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 11/160 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL   L+ +  + I 
Sbjct: 102 ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 162 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 220
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN--EDAKRYIRQL 157
            ND     +L  ++L    + D  +  +  + AK +IR L
Sbjct: 221 END----AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 65/115 (56%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           LA+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 LAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 11/160 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL   L+ +  + I 
Sbjct: 102 ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 162 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 220
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN--EDAKRYIRQL 157
            ND     +L  ++L    + D  +  +  + AK +IR L
Sbjct: 221 END----AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 11/160 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL   L+ +  + I 
Sbjct: 102 ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 162 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 220
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN--EDAKRYIRQL 157
            ND     +L  ++L    + D  +  +  + AK +IR L
Sbjct: 221 END----AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 67/119 (56%), Gaps = 8/119 (6%)
Query: 1   MDTDL----YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANC 55
           MDT L     Q+I   Q++ E+        +++ L+++HS  +VIHRD+KPSN+L+NA  
Sbjct: 88  MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG 147
Query: 56  DLKICDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMEL 111
            +K+CDFG++    ++         + Y APE +   LN   Y+   D+WS+G   +EL
Sbjct: 148 QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 33/182 (18%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENE 72
           SE    +++ Q+L  L+Y H  N+IHRD+KP N+LL +   +  +K+ DFG+A    E+ 
Sbjct: 128 SEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG 187
Query: 73  FMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
            +    V T  + APE ++    Y   +DVW  G I   L++                 +
Sbjct: 188 LVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSG---------------CL 231
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
              GT      G ++         +   +PRQ     + H+   A DLV RML  DP +R
Sbjct: 232 PFYGTKERLFEGIIKG--------KYKMNPRQ-----WSHISESAKDLVRRMLMLDPAER 278
Query: 192 IT 193
           IT
Sbjct: 279 IT 280

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 99  ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 159 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 216
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 217 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 249
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 250 FIRRLLVKDPKKRMT 264

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 60/115 (52%), Gaps = 4/115 (3%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E         +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+ +  +T    T +Y APE +L    Y  + D WS+G I   L+   P F  N
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSN 266

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +K+ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPAFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 99  ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 159 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 216
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 217 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 249
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 250 FIRRLLVKDPKKRMT 264

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 69/132 (52%), Gaps = 6/132 (4%)
Query: 8   IIR-SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR 66
           IIR  N++L+E+     L   L+GL+Y+H    IHRD+K  N+LLN     K+ DFG+A 
Sbjct: 114 IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 67  PTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
             ++       V+ T ++ APE ++    Y    D+WS+G   +E+   +P +     +H
Sbjct: 174 QLTDXMAKRNXVIGTPFWMAPE-VIQEIGYNCVADIWSLGITAIEMAEGKPPYA---DIH 229
Query: 126 QMRLLIELLGTP 137
            MR +  +   P
Sbjct: 230 PMRAIFMIPTNP 241

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 93/192 (48%), Gaps = 30/192 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +E   Q ++ +++  L+++H   +I+RD+K  N+LL++N  + + DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 64  LARP--TSENEFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           L++     E E   ++  T  Y AP+++    S +  A+D WS+G +  EL+     F  
Sbjct: 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +   +                    + E ++R ++  P +P++  A        LA DL+
Sbjct: 265 DGEKNS-------------------QAEISRRILKSEPPYPQEMSA--------LAKDLI 297
Query: 181 DRMLTFDPMKRI 192
            R+L  DP KR+
Sbjct: 298 QRLLMKDPKKRL 309

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   V+HR+LKP NLLL +      +K+ 
Sbjct: 96  ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLA 155
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     E +    +  T  Y +PE +L    Y   +D+W+ G I            
Sbjct: 156 DFGLAIEVEGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVI------------ 202
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  R  +Q+        +  +  V P A DL
Sbjct: 203 ---------LYILLVGYPPFWD------EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 180 VDRMLTFDPMKRITG 194
           +++MLT +P KRIT 
Sbjct: 248 INKMLTINPSKRITA 262

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 31/204 (15%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           I S   L+EE        +L+ L Y+H+  VIHRD+K  ++LL  +  +K+ DFG     
Sbjct: 132 IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191
Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           S++    + +V T ++ APE +++ S Y   +D+WS+G + +E+++  P +  +  V  M
Sbjct: 192 SKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           + L        D+    ++N                        V P+  D ++RML  D
Sbjct: 251 KRL-------RDSPPPKLKNSH---------------------KVSPVLRDFLERMLVRD 282
Query: 188 PMKRITGEFFVPYKPFQCCCGCIE 211
           P +R T +  + + PF    G  E
Sbjct: 283 PQERATAQELLDH-PFLLQTGLPE 305

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 76/135 (56%), Gaps = 4/135 (2%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 110 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 169
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGND 122
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+  G+ 
Sbjct: 170 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSG 227
Query: 123 HVHQMRLLIELLGTP 137
            +    LL  ++  P
Sbjct: 228 SMAIFELLDYIVNEP 242

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRIT 193
            + R+L  DP KR+T
Sbjct: 251 FIRRLLVKDPKKRMT 265

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   ++HRDLKP NLLL   +    +K+ 
Sbjct: 89  ELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     + +    +  T  Y +PE +L    Y   +D+W+ G I            
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDMWACGVI------------ 195
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  R  +Q+        +  +  V P A DL
Sbjct: 196 ---------LYILLVGYPPFWD------EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 180 VDRMLTFDPMKRITGEFFVPYKPFQC 205
           +++MLT +P KRIT    + + P+ C
Sbjct: 241 INKMLTINPAKRITASEALKH-PWIC 265

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   ++HRDLKP NLLL   +    +K+ 
Sbjct: 89  ELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     + +    +  T  Y +PE +L    Y   +D+W+ G I            
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDMWACGVI------------ 195
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  R  +Q+        +  +  V P A DL
Sbjct: 196 ---------LYILLVGYPPFWD------EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 180 VDRMLTFDPMKRITGEFFVPYKPFQC 205
           +++MLT +P KRIT    + + P+ C
Sbjct: 241 INKMLTINPAKRITASEALKH-PWIC 265

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 69/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 94  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 153
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++     +E   E+V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P  P
Sbjct: 154 VSGQLI-DEMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 32/206 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG
Sbjct: 110 ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +      E +     T  Y APE++      N   Y   +D+WS G I   L+   P F
Sbjct: 170 FSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                 H+ ++L+  +    +   G    +D    ++                      D
Sbjct: 230 -----WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK----------------------D 262
Query: 179 LVDRMLTFDPMKRITGEFFVPYKPFQ 204
           LV R L   P KR T E  + +  FQ
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFFQ 288

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--AGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 65/115 (56%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           LA+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 LAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 58/97 (59%), Gaps = 3/97 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSEN 71
           + LSE+  +++   L++G++Y+H   +IHRD+KPSNLL+  +  +KI DFG++      +
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 72  EFMTEYVVTRWYRAPELLLNSSDY--TAAIDVWSVGC 106
             ++  V T  + APE L  +       A+DVW++G 
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 33/183 (18%)
Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPT 68
            ++LSE +    + Q++  L Y HS +V+H+DLKP N+L    + +  +KI DFGLA   
Sbjct: 118 GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
             +E  T    T  Y APE+     D T   D+WS G +   L+     F G        
Sbjct: 178 KSDEHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGT------- 228
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
                                +   ++Q   +   + A     + P A+DL+ +MLT DP
Sbjct: 229 ---------------------SLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDP 267
Query: 189 MKR 191
            +R
Sbjct: 268 ERR 270

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--XGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 113 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 172
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 173 FAKRVKGRTWTL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 148 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 208 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 65/116 (56%), Gaps = 7/116 (6%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +DL ++ +  + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DF
Sbjct: 141 SDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRP 116
           G A   +       +V T ++ APE++L  +   Y   +DVWS+G   +EL  R+P
Sbjct: 199 GSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 114 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFG 173
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 174 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWTL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 6/112 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR   +NE+         
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 81  -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
            +W  APE  +N   +T   DVWS G + ME++   R  +PG  +   +R L
Sbjct: 349 IKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 66/111 (59%), Gaps = 3/111 (2%)
Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYRAP 86
           L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +E V T ++ AP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAP 185
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           E++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP
Sbjct: 186 EVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTP 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 6/112 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR   +NE+         
Sbjct: 116 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 175
Query: 81  -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
            +W  APE  +N   +T   DVWS G + ME++   R  +PG  +   +R L
Sbjct: 176 IKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 148 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 208 FAKRVKGATWTL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 120 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 180 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/110 (37%), Positives = 54/110 (49%), Gaps = 5/110 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL---KICDFGLARPTSE 70
            L E   +  L  +   L+Y+H   +IHRDLKP N++L         KI D G A+   +
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 71  NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME-LMNRRPLFP 119
            E  TE+V T  Y APE LL    YT  +D WS G +  E +   RP  P
Sbjct: 177 GELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +LY+ I +    SE+  ++F  QLL G+ Y HS  + HRDLK  N LL+ +    LKICD
Sbjct: 102 ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 105
           FG ++ +  +      V T  Y APE+LL         DVWS G
Sbjct: 162 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG 205

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/110 (37%), Positives = 54/110 (49%), Gaps = 5/110 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL---KICDFGLARPTSE 70
            L E   +  L  +   L+Y+H   +IHRDLKP N++L         KI D G A+   +
Sbjct: 118 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 71  NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME-LMNRRPLFP 119
            E  TE+V T  Y APE LL    YT  +D WS G +  E +   RP  P
Sbjct: 178 GELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 65/116 (56%), Gaps = 7/116 (6%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +DL ++ +  + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DF
Sbjct: 102 SDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRP 116
           G A   +       +V T ++ APE++L  +   Y   +DVWS+G   +EL  R+P
Sbjct: 160 GSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 31/154 (20%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPT---- 68
           SLS +  + ++  L + LK IH   ++HRD+KPSN L N       + DFGLA+ T    
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172
Query: 69  -------------------------SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 103
                                    S  + +     T  +RAPE+L    + T AID+WS
Sbjct: 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232
Query: 104 VGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGT 136
            G IF+ L++ R P +  +D +  +  ++ + G+
Sbjct: 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGS 266

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 63/116 (54%), Gaps = 3/116 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++ N    EE  + F+ +L+  L Y+ +  +IHRD+KP N+LL+ +  + I DF 
Sbjct: 101 DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN 160
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELM-NRRP 116
           +A        +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  RRP
Sbjct: 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 73/137 (53%), Gaps = 5/137 (3%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKI 59
           +D    Q+I   Q++ E+        +++ L+++HS  +VIHRD+KPSN+L+NA   +K 
Sbjct: 119 LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKX 178
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMEL-MNRR 115
           CDFG++    ++         + Y APE +   LN   Y+   D+WS+G   +EL + R 
Sbjct: 179 CDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRF 238
Query: 116 PLFPGNDHVHQMRLLIE 132
           P         Q++ ++E
Sbjct: 239 PYDSWGTPFQQLKQVVE 255

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+ ++R +Q       +++  ++   L+Y+HS ++I+RDLKP N+LL+ N  +KI DFG
Sbjct: 92  ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-NRRPLFPGND 122
            A+   +  +      T  Y APE ++++  Y  +ID WS G +  E++    P +  N 
Sbjct: 152 FAKYVPDVTYXL--CGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
Query: 123 HVHQMRLLIELLGTPTDADLGF--VRNEDAKRYIRQL 157
                ++L        +A+L F    NED K  + +L
Sbjct: 209 MKTYEKIL--------NAELRFPPFFNEDVKDLLSRL 237

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 68/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 153 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 212
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 213 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH- 125
            T++N   T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237
Query: 126 ----QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
               + R+ +   G P + +   V +EDAK+ IR L
Sbjct: 238 SPGMKRRIRLGQYGFP-NPEWSEV-SEDAKQLIRLL 271

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 69/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 178 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 5   LYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           L  + R  Q LS   E+    ++ +L   L Y HS  VIHRD+KP NLLL +N +LKI D
Sbjct: 96  LGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIAD 155
Query: 62  FGLA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           FG +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +   P F 
Sbjct: 156 FGWSVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
            + +    R +  +  T  D    FV  E A+  I +L +H    R +LA+V  H
Sbjct: 212 AHTYQETYRRISRVEFTFPD----FV-TEGARDLISRLLKHNASQRLTLAEVLEH 261

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/125 (36%), Positives = 64/125 (51%), Gaps = 11/125 (8%)
Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIH-----SANVIHRDLKPSNLLLNAN 54
           DL  +I    +  Q L EE     + QL   LK  H        V+HRDLKP+N+ L+  
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152
Query: 55  CDLKICDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLAR  + +  F   +V T +Y +PE  +N   Y    D+WS+GC+  EL  
Sbjct: 153 QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCA 211
Query: 114 RRPLF 118
             P F
Sbjct: 212 LMPPF 216

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 32/194 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+    +   L  +     D D  F                        F H   LA D 
Sbjct: 220 GDT---KQETLANITSVSYDFDEEF------------------------FSHTSELAKDF 252
Query: 180 VDRMLTFDPMKRIT 193
           + ++L  +  KR+T
Sbjct: 253 IRKLLVKETRKRLT 266

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 84/182 (46%), Gaps = 28/182 (15%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
                 E    ++  ++  GL+ +H   +++RDLKP N+LL+ +  ++I D GLA    E
Sbjct: 279 GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338
Query: 71  NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
            + +   V T  Y APE++ N   YT + D W++GC+  E++       G     Q +  
Sbjct: 339 GQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQSPFQQRKKK 391
Query: 131 IELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
           I              + E+ +R ++++P+   +  +       P A  L  ++L  DP +
Sbjct: 392 I--------------KREEVERLVKEVPEEYSERFS-------PQARSLCSQLLCKDPAE 430
Query: 191 RI 192
           R+
Sbjct: 431 RL 432

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 69/130 (53%), Gaps = 5/130 (3%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 105 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 164
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     +  T E+  T  Y APE+LL    Y  ++D WS G +  E++  +  F G D
Sbjct: 165 MCKENMLGDAKTNEFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD 223
Query: 123 H---VHQMRL 129
                H +R+
Sbjct: 224 EEELFHSIRM 233

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/125 (36%), Positives = 64/125 (51%), Gaps = 11/125 (8%)
Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIH-----SANVIHRDLKPSNLLLNAN 54
           DL  +I    +  Q L EE     + QL   LK  H        V+HRDLKP+N+ L+  
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152
Query: 55  CDLKICDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLAR  + +  F   +V T +Y +PE  +N   Y    D+WS+GC+  EL  
Sbjct: 153 QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCA 211
Query: 114 RRPLF 118
             P F
Sbjct: 212 LMPPF 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 3/117 (2%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR 66
           Q+ R    + +  C ++L ++   L ++H   +I+RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 67  PTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +  +  +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHXFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 32/194 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+    +   L  +     D D  F                        F H   LA D 
Sbjct: 220 GDT---KQETLANITSVSYDFDEEF------------------------FSHTSELAKDF 252
Query: 180 VDRMLTFDPMKRIT 193
           + ++L  +  KR+T
Sbjct: 253 IRKLLVKETRKRLT 266

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 28/176 (15%)
Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE 76
           E    ++  ++  GL+ +H   +++RDLKP N+LL+ +  ++I D GLA    E + +  
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344
Query: 77  YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGT 136
            V T  Y APE++ N   YT + D W++GC+  E++       G     Q +  I     
Sbjct: 345 RVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQSPFQQRKKKI----- 392
Query: 137 PTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI 192
                    + E+ +R ++++P+   +  +       P A  L  ++L  DP +R+
Sbjct: 393 ---------KREEVERLVKEVPEEYSERFS-------PQARSLCSQLLCKDPAERL 432

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH- 125
            T++N   T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 218
Query: 126 ----QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
               + R+ +   G P + +   V +EDAK+ IR L
Sbjct: 219 SPGMKRRIRLGQYGFP-NPEWSEV-SEDAKQLIRLL 252

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 3/117 (2%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR 66
           Q+ R    + +  C ++L ++   L ++H   +I+RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 67  PTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +  +  +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 69/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 69/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 69/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 17/175 (9%)
Query: 5   LYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           L  + R  Q LS   E+    ++ +L   L Y HS  VIHRD+KP NLLL +N +LKI D
Sbjct: 96  LGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIAD 155
Query: 62  FGLA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           FG +   P+S  + +     T  Y  PE ++    +   +D+WS+G +  E +   P F 
Sbjct: 156 FGWSVHAPSSRRDTL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
            + +    R +  +  T  D    FV  E A+  I +L +H    R +LA+V  H
Sbjct: 212 AHTYQETYRRISRVEFTFPD----FV-TEGARDLISRLLKHNASQRLTLAEVLEH 261

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 32/190 (16%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCD-LKICDFGLARP-TS 69
            SE      L+ + + ++Y+H+  V+HRDLKPSN+L    + N + ++ICDFG A+   +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC-IFMELMNRRPLFPGNDHVHQMR 128
           EN  +     T  + APE +L    Y AA D+WS+G  ++  L    P   G D   +  
Sbjct: 173 ENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE-- 229
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
              E+L     A +G  +   +  Y               +  V   A DLV +ML  DP
Sbjct: 230 ---EIL-----ARIGSGKFSLSGGY---------------WNSVSDTAKDLVSKMLHVDP 266
Query: 189 MKRITGEFFV 198
            +R+T    +
Sbjct: 267 HQRLTAALVL 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 32/194 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+    +   L  +     D D  F                        F H   LA D 
Sbjct: 220 GDT---KQETLANITSVSYDFDEEF------------------------FSHTSELAKDF 252
Query: 180 VDRMLTFDPMKRIT 193
           + ++L  +  KR+T
Sbjct: 253 IRKLLVKETRKRLT 266

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 69/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 69/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVR--NEDAKRYIRQL 157
           G+    +   L  +     D D  F    +E AK +IR+L
Sbjct: 220 GDT---KQETLANITAVSYDFDEEFFSQTSELAKDFIRKL 256

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 86/195 (44%), Gaps = 33/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKICD
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 160
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G                
Sbjct: 161 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------- 204
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 205 -----VTLYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 252
Query: 179 LVDRMLTFDPMKRIT 193
           L+ R+   DP KRI+
Sbjct: 253 LISRIFVADPAKRIS 267

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     +E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 86/195 (44%), Gaps = 33/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKICD
Sbjct: 100 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 159
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G                
Sbjct: 160 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------- 203
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 204 -----VTLYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 251
Query: 179 LVDRMLTFDPMKRIT 193
           L+ R+   DP KRI+
Sbjct: 252 LISRIFVADPAKRIS 266

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVR--NEDAKRYIRQL 157
           G+    +   L  +     D D  F    +E AK +IR+L
Sbjct: 220 GDT---KQETLANITAVSYDFDEEFFSQTSELAKDFIRKL 256

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  ++    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 32/187 (17%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-----NANCDLKICDFGLARP-T 68
            SE    + L+ + + ++Y+HS  V+HRDLKPSN+L      N  C L+ICDFG A+   
Sbjct: 118 FSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLR 176
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
           +EN  +     T  + APE +L    Y    D+WS+G +   ++     F          
Sbjct: 177 AENGLLMTPCYTANFVAPE-VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG------- 228
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
                   P+D     +    + ++               +  V   A DLV +ML  DP
Sbjct: 229 --------PSDTPEEILTRIGSGKFTLS---------GGNWNTVSETAKDLVSKMLHVDP 271
Query: 189 MKRITGE 195
            +R+T +
Sbjct: 272 HQRLTAK 278

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 52/88 (59%), Gaps = 1/88 (1%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRA 85
           Q+ +G+ YIHS  +IHRDLKPSN+ L     +KI DFGL      +   T    T  Y +
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMN 113
           PE  ++S DY   +D++++G I  EL++
Sbjct: 204 PE-QISSQDYGKEVDLYALGLILAELLH 230

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 61/118 (51%), Gaps = 5/118 (4%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E+     + Q+L  +KY+H   ++HRDLKP NLL      N  + I 
Sbjct: 92  ELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMIT 151
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFGL++   +N  M+    T  Y APE+L     Y+ A+D WS+G I   L+   P F
Sbjct: 152 DFGLSK-MEQNGIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPF 207

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     TE   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TELCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 211 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 32/198 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-----NANCDLK 58
           +L   I   +  SE    + L+ + + ++Y+HS  V+HRDLKPSN+L      N  C L+
Sbjct: 107 ELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LR 165
Query: 59  ICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           ICDFG A+   +EN  +     T  + APE +L    Y    D+WS+G +   ++     
Sbjct: 166 ICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F                  P+D     +    + ++               +  V   A 
Sbjct: 225 FANG---------------PSDTPEEILTRIGSGKFTLS---------GGNWNTVSETAK 260
Query: 178 DLVDRMLTFDPMKRITGE 195
           DLV +ML  DP +R+T +
Sbjct: 261 DLVSKMLHVDPHQRLTAK 278

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSE 70
           ++ L+E   Q    Q+L  L ++HS  +IHRDLK  N+L+    D+++ DFG+ A+    
Sbjct: 111 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170
Query: 71  NEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            +    ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P +  ++ 
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 227
Query: 127 MRLLIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           MR+L+++       L TP+   + F         +N + +    QL +HP
Sbjct: 228 MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 148 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 208 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSE 70
           ++ L+E   Q    Q+L  L ++HS  +IHRDLK  N+L+    D+++ DFG+ A+    
Sbjct: 103 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 162
Query: 71  NEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            +    ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P +  ++ 
Sbjct: 163 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 219
Query: 127 MRLLIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           MR+L+++       L TP+   + F         +N + +    QL +HP
Sbjct: 220 MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 269

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 92  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 151
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP--- 119
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F    
Sbjct: 152 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 210
Query: 120 --------GNDHVHQMRLLIEL-----LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
                     D++ Q+ L  ++     L     + L    N+D K    +L  HP+   A
Sbjct: 211 SSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPK---ERLGCHPQTGFA 267
Query: 167 --QVFPHVHPLAIDLVDRMLTFDPMK-RITGEF 196
             Q  P    +  D++++     P K  I+GEF
Sbjct: 268 DIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEF 300

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVR--NEDAKRYIRQL 157
           G+    +   L  +     D D  F    +E AK +IR+L
Sbjct: 220 GDT---KQETLANITAVSYDFDEEFFSQTSELAKDFIRKL 256

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE+++ S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 63/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    + E+  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 92/185 (49%), Gaps = 17/185 (9%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+E+    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +K+
Sbjct: 94  ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153
Query: 60  CDFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG+A +  + NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 154 IDFGIAHKIEAGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 211
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRN--EDAKRYIRQL----PQHPRQSLAQVFPHV 172
            G     +   L  +     D D  +  N  E AK +IR+L    P+  R ++AQ   H 
Sbjct: 212 LGET---KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKR-RMTIAQSLEHS 267
Query: 173 HPLAI 177
              AI
Sbjct: 268 WIKAI 272

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 122 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 181
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 182 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 120 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 180 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP--- 119
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F    
Sbjct: 156 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 120 --------GNDHVHQMRLLIEL-----LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
                     D++ Q+ L  ++     L     + L    N+D K    +L  HP+   A
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPK---ERLGCHPQTGFA 271
Query: 167 --QVFPHVHPLAIDLVDRMLTFDPMK-RITGEF 196
             Q  P    +  D++++     P K  I+GEF
Sbjct: 272 DIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEF 304

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP--- 119
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F    
Sbjct: 199 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257
Query: 120 --------GNDHVHQMRLLIEL-----LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
                     D++ Q+ L  ++     L     + L    N+D K    +L  HP+   A
Sbjct: 258 SSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPK---ERLGCHPQTGFA 314
Query: 167 --QVFPHVHPLAIDLVDRMLTFDPMK-RITGEF 196
             Q  P    +  D++++     P K  I+GEF
Sbjct: 315 DIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEF 347

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 25/178 (14%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E+     + Q+L  + Y+H   ++HRDLKP NLL    +    + I 
Sbjct: 106 ELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMIS 165
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++   + + M+    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 166 DFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 224
Query: 120 GNDHVHQMRLLIELLGTP-----------TDADLGFVRN----EDAKRYI-RQLPQHP 161
            ND     +L  ++L              +D+   F+RN    +  KRY   Q  +HP
Sbjct: 225 ENDS----KLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHP 278

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 63/119 (52%), Gaps = 6/119 (5%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDL +  + N +L EE   Y   ++LRGL ++H   VIHRD+K  N+LL  N ++K+ DF
Sbjct: 115 TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 63  GLARPTSEN-EFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRP 116
           G++            ++ T ++ APE++       + Y    D+WS+G   +E+    P
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 67/121 (55%), Gaps = 2/121 (1%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +LR L Y+H+  VIHRD+K  ++LL ++  +K+ DFG  A+ 
Sbjct: 132 IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 191
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE +++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 192 SKEVPKRKXLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 250
Query: 128 R 128
           R
Sbjct: 251 R 251

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 65/111 (58%), Gaps = 3/111 (2%)
Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYRAP 86
           L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ AP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           E++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP
Sbjct: 186 EVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTP 234

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 32/190 (16%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCD-LKICDFGLARP-TS 69
            SE      L+ + + ++Y+H+  V+HRDLKPSN+L    + N + ++ICDFG A+   +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC-IFMELMNRRPLFPGNDHVHQMR 128
           EN  +     T  + APE +L    Y AA D+WS+G  ++  L    P   G D   +  
Sbjct: 173 ENGLLXTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPE-- 229
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
              E+L     A +G  +   +  Y               +  V   A DLV + L  DP
Sbjct: 230 ---EIL-----ARIGSGKFSLSGGY---------------WNSVSDTAKDLVSKXLHVDP 266
Query: 189 MKRITGEFFV 198
            +R+T    +
Sbjct: 267 HQRLTAALVL 276

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 107 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 166
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP--- 119
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F    
Sbjct: 167 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 225
Query: 120 --------GNDHVHQMRLLIEL-----LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
                     D++ Q+ L  ++     +     + L    N+D K  +  LPQ     + 
Sbjct: 226 SSDNPDQNTEDYLFQVILEKQIRIPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADI- 284
Query: 167 QVFPHVHPLAIDLVDRMLTFDPMK-RITGEF 196
           Q  P    +  D++++     P K  I+GEF
Sbjct: 285 QGHPFFRNVDWDMMEQKQVVPPFKPNISGEF 315

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 65/111 (58%), Gaps = 3/111 (2%)
Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYRAP 86
           L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ AP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 185
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           E++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP
Sbjct: 186 EVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTP 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y AP ++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 65/111 (58%), Gaps = 3/111 (2%)
Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYRAP 86
           L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ AP
Sbjct: 127 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 186
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           E++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP
Sbjct: 187 EVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTP 235

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+E+    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 160
Query: 60  CDFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG+A +  + NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 161 IDFGIAHKIEAGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRN--EDAKRYIRQL----PQHPRQSLAQVFPH 171
            G     +   L  +     D D  +  N  E AK +IR+L    P+  R  +AQ   H
Sbjct: 219 LGET---KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKR-RMXIAQSLEH 273

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 5/130 (3%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163
Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     +  T  +  T  Y APE+LL    Y  ++D WS G +  E++  +  F G D
Sbjct: 164 MCKENMLGDAKTNXFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
Query: 123 H---VHQMRL 129
                H +R+
Sbjct: 223 EEELFHSIRM 232

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 62/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 97  EVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 156
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 157 FSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 91/185 (49%), Gaps = 17/185 (9%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+E+    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +K+
Sbjct: 115 ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 174
Query: 60  CDFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG+A +  + NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 175 IDFGIAHKIEAGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 232
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRN--EDAKRYIRQL----PQHPRQSLAQVFPHV 172
            G     +   L  +     D D  +  N  E AK +IR+L    P+  R  +AQ   H 
Sbjct: 233 LGET---KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKR-RMXIAQSLEHS 288
Query: 173 HPLAI 177
              AI
Sbjct: 289 WIKAI 293

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           ++Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG
Sbjct: 99  EVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N
Sbjct: 159 WSVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
            +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 215 TYQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T+   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 211 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T+   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 211 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T+   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 156 SVHAPSSRR---TDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 212 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N+L++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 NDHV 124
           +  V
Sbjct: 222 DSPV 225

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 100 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 159
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T+   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 160 SVHAPSSRR---TDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 216 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 61/119 (51%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 100 EVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 159
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +     Y APEL          +DVWS+G I   L++    F G +
Sbjct: 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 33/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKIC 
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICA 160
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +    + V T  Y APE+LL         DVWS G                
Sbjct: 161 FGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------- 204
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 205 -----VTLYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 252
Query: 179 LVDRMLTFDPMKRIT 193
           L+ R+   DP KRI+
Sbjct: 253 LISRIFVADPAKRIS 267

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T    APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           ++Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG
Sbjct: 99  EVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N
Sbjct: 159 WSVHAPSSRRXXLX---GTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
            +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 215 TYQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKI D
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIAD 160
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G                
Sbjct: 161 FGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVT-------------- 206
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                  L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 207 -------LYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 252
Query: 179 LVDRMLTFDPMKRIT 193
           L+ R+   DP KRI+
Sbjct: 253 LISRIFVADPAKRIS 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 99  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 158
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 159 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 214
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 215 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 261

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 214 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 92  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 151
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 152 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 207
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 208 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 254

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 211 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 67/117 (57%), Gaps = 8/117 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDF 62
            L Q+++    L E+   Y+L Q L GL+Y+HS  ++H D+K  N+LL+++     +CDF
Sbjct: 152 SLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDF 211
Query: 63  GLA---RPT--SENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           G A   +P    ++    +Y+  T  + APE++L  S   A +DVWS  C+ + ++N
Sbjct: 212 GHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHMLN 267

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 277 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 336
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 337 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKIC 
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICA 160
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G                
Sbjct: 161 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------- 204
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 205 -----VTLYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 252
Query: 179 LVDRMLTFDPMKRIT 193
           L+ R+   DP KRI+
Sbjct: 253 LISRIFVADPAKRIS 267

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 94  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 153
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 154 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 209
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 210 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 256

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 100 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 159
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 160 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 216 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 211 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 214 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 156 SCHAPSSRR---TTLSGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 212 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 67/117 (57%), Gaps = 8/117 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDF 62
            L Q+++    L E+   Y+L Q L GL+Y+HS  ++H D+K  N+LL+++     +CDF
Sbjct: 171 SLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDF 230
Query: 63  GLA---RPT--SENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           G A   +P    ++    +Y+  T  + APE++L  S   A +DVWS  C+ + ++N
Sbjct: 231 GHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHMLN 286

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 100 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 159
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE  +    +   +D+WS+G +  E +  +P F  N 
Sbjct: 160 SVHAPSSRR---TTLCGTLDYLPPE-XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 216 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPXLREVLEH 262

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 33/182 (18%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENE 72
           SE    +++ Q+L  L+Y H  N+IHRD+KP  +LL +   +  +K+  FG+A    E+ 
Sbjct: 130 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 189
Query: 73  FMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
            +    V T  + APE ++    Y   +DVW  G I   L++                 +
Sbjct: 190 LVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSG---------------CL 233
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
              GT      G ++         +   +PRQ     + H+   A DLV RML  DP +R
Sbjct: 234 PFYGTKERLFEGIIKG--------KYKMNPRQ-----WSHISESAKDLVRRMLMLDPAER 280
Query: 192 IT 193
           IT
Sbjct: 281 IT 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S  + +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 156 SVHAPSSRRDTL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 212 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 62/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 62/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 62/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 6/121 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 181 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236
Query: 123 H 123
           +
Sbjct: 237 Y 237

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 NDHV 124
           +  V
Sbjct: 222 DSPV 225

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 65/111 (58%), Gaps = 3/111 (2%)
Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYRAP 86
           L+ L+++HS  VIHR++K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ AP
Sbjct: 127 LQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 186
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           E++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP
Sbjct: 187 EVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTP 235

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 33/182 (18%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENE 72
           SE    +++ Q+L  L+Y H  N+IHRD+KP  +LL +   +  +K+  FG+A    E+ 
Sbjct: 128 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 73  FMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
            +    V T  + APE ++    Y   +DVW  G I   L++                 +
Sbjct: 188 LVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSG---------------CL 231
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
              GT      G ++         +   +PRQ     + H+   A DLV RML  DP +R
Sbjct: 232 PFYGTKERLFEGIIKG--------KYKMNPRQ-----WSHISESAKDLVRRMLMLDPAER 278
Query: 192 IT 193
           IT
Sbjct: 279 IT 280

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 61/119 (51%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+ + ++KI DFG
Sbjct: 100 EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFG 159
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 160 FSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 NDHV 124
           +  V
Sbjct: 222 DSPV 225

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S  +   +   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRRD---DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 214 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 NDHV 124
           +  V
Sbjct: 222 DSPV 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 63/116 (54%), Gaps = 2/116 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +   E   +++  ++   L Y+HS N+++RDLKP N+LL++   + + DFG
Sbjct: 125 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184
Query: 64  LARPTSE-NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           L +   E N   + +  T  Y APE +L+   Y   +D W +G +  E++   P F
Sbjct: 185 LCKENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 6/121 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 112 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 171
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 172 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 227
Query: 123 H 123
           +
Sbjct: 228 Y 228

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 120 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 179
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 180 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 238
Query: 121 NDHV 124
           +  V
Sbjct: 239 DSPV 242

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 9/172 (5%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR------PT 68
           L E      L ++L GL+Y+H    IHRD+K  N+LL  +  ++I DFG++         
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
           + N+    +V T  + APE++     Y    D+WS G   +EL       P + +     
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 235
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           L++ L   P   + G    E  K+Y +   +     L Q  P   P A +L+
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCL-QKDPEKRPTAAELL 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 9/172 (5%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR------PT 68
           L E      L ++L GL+Y+H    IHRD+K  N+LL  +  ++I DFG++         
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 172
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
           + N+    +V T  + APE++     Y    D+WS G   +EL       P + +     
Sbjct: 173 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 230
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           L++ L   P   + G    E  K+Y +   +     L Q  P   P A +L+
Sbjct: 231 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCL-QKDPEKRPTAAELL 281

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 64/121 (52%), Gaps = 5/121 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 N 121
           +
Sbjct: 222 D 222

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 61/119 (51%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +     Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+  G+ YI   N IHRDL+ +N+L++ +   KI DFGLAR   +NE+         
Sbjct: 115 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 81  -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGNDHVHQMRLL 130
            +W  APE  +N   +T   DVWS G +  E++    + +PG  +   M  L
Sbjct: 175 IKW-TAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 30/153 (19%)
Query: 5   LYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---------- 52
           LY+II  N       E  + +  ++L+ L Y+   ++ H DLKP N+LL+          
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181
Query: 53  ---------------ANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTA 97
                           +  +K+ DFG A  T ++++    + TR YRAPE++LN   +  
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNLG-WDV 238
Query: 98  AIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
           + D+WS GC+  EL     LF  ++H+  + ++
Sbjct: 239 SSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRRXXL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 214 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRRXXL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 211 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRRAAL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 214 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 62/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 92  EVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 151
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 152 FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 6/121 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRRAAL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 H 123
           +
Sbjct: 211 Y 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 97  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 156
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 157 SVHAPSSRRXXL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 213 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 259

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 4   DLYQIIRSNQSL---SEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNANCD- 56
            LY ++   + L   +  H   +  Q  +G+ Y+HS     +IHRDLKP NLLL A    
Sbjct: 86  SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 145
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           LKICDFG A        MT    +  + APE +   S+Y+   DV+S G I  E++ RR 
Sbjct: 146 LKICDFGTA--CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRK 202
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
            F             + +G P    +  V N      I+ LP+ P +SL
Sbjct: 203 PF-------------DEIGGPAFRIMWAVHNGTRPPLIKNLPK-PIESL 237

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 63/121 (52%), Gaps = 6/121 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S  +   +   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 181 SVHAPSSRRD---DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236
Query: 123 H 123
           +
Sbjct: 237 Y 237

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRRAAL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 211 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 17/167 (10%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  RG+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT- 138
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  + 
Sbjct: 176 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL 231
Query: 139 DADLGFVRNEDAKRYIRQLPQ------HPRQSLAQVFPHVHPLAIDL 179
             DL  VR+   KR  R + +        R S  ++   +  LA +L
Sbjct: 232 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 278

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 17/167 (10%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  RG+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT- 138
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  + 
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL 243
Query: 139 DADLGFVRNEDAKRYIRQLPQ------HPRQSLAQVFPHVHPLAIDL 179
             DL  VR+   KR  R + +        R S  ++   +  LA +L
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 290

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 4   DLYQIIRSNQSL---SEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNANCD- 56
            LY ++   + L   +  H   +  Q  +G+ Y+HS     +IHRDLKP NLLL A    
Sbjct: 85  SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           LKICDFG A        MT    +  + APE +   S+Y+   DV+S G I  E++ RR 
Sbjct: 145 LKICDFGTA--CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
            F             + +G P    +  V N      I+ LP+ P +SL
Sbjct: 202 PF-------------DEIGGPAFRIMWAVHNGTRPPLIKNLPK-PIESL 236

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 4/107 (3%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I      SE      + Q+L  + Y+H   ++HRDLKP NLL      +  LKI 
Sbjct: 134 ELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
           DFGL++       M     T  Y APE+L   + Y   +D+WSVG I
Sbjct: 194 DFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGII 239

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 60/102 (58%), Gaps = 3/102 (2%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-PTSENEFMTEYVV 79
           +YF+ QL   L+++HS  V+HRD+KP+N+ + A   +K+ D GL R  +S+       V 
Sbjct: 140 KYFV-QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           T +Y +PE  ++ + Y    D+WS+GC+  E+   +  F G+
Sbjct: 199 TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI +FG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 214 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 431 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 72/141 (51%), Gaps = 17/141 (12%)
Query: 15  LSEEHCQYFLYQLL-------RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR- 66
           L E+  ++ + QL+        G+KY+ + N +HRDL   N+L+N+N   K+ DFGL+R 
Sbjct: 137 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
Query: 67  ----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLFPG 120
               P +        +  RW  APE  ++   +T+A DVWS G +  E+M    RP +  
Sbjct: 197 LEDDPEATYTTSGGKIPIRW-TAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254
Query: 121 NDHVHQMRLLIELLGTPTDAD 141
           ++H   M+ + +    PT  D
Sbjct: 255 SNH-EVMKAINDGFRLPTPMD 274

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI +FG 
Sbjct: 97  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW 156
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 157 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
           +    + +  +  T  D    FV  E A+  I +L +H    R  L +V  H
Sbjct: 213 YQETYKRISRVEFTFPD----FV-TEGARDLISRLLKHNPSQRPMLREVLEH 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 60/119 (50%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++    E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +     Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 171 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 107 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 167 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 226 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 256
Query: 187 DPMKRITGEFFVPYKPFQCCCG 208
           DP +R T    + + PF    G
Sbjct: 257 DPAQRATAAELLKH-PFLAKAG 277

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 175 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 2/130 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E    ++  ++  GL ++H   +I+RDLK  N++L++   +KI DFG
Sbjct: 106 DLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFG 165
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +    +   T E+  T  Y APE++     Y  ++D W+ G +  E++  +P F G D
Sbjct: 166 MCKEHMMDGVTTREFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGED 224
Query: 123 HVHQMRLLIE 132
                + ++E
Sbjct: 225 EDELFQSIME 234

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 270 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 298

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 118 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 177
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 178 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 236
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 237 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 267
Query: 187 DPMKRITGEFFVPYKPFQCCCG 208
           DP +R T    + + PF    G
Sbjct: 268 DPAQRATAAELLKH-PFLAKAG 288

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 156 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 215
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 216 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 244

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 1/87 (1%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRA 85
           Q+ +G+ YIHS  +I+RDLKPSN+ L     +KI DFGL      +        T  Y +
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMS 189
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELM 112
           PE  ++S DY   +D++++G I  EL+
Sbjct: 190 PE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 111 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 170
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 171 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 229
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 230 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 260
Query: 187 DPMKRITGEFFVPYKPFQCCCG 208
           DP +R T    + + PF    G
Sbjct: 261 DPAQRATAAELLKH-PFLAKAG 281

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 116 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 175
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 176 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 234
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 235 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 265
Query: 187 DPMKRITGEFFVPYKPFQCCCG 208
           DP +R T    + + PF    G
Sbjct: 266 DPAQRATAAELLKH-PFLAKAG 286

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 86/196 (43%), Gaps = 21/196 (10%)
Query: 20  CQYFLY--QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR---PTSENEFM 74
           CQ   Y  QL+ GL+Y+HS  ++H+D+KP NLLL     LKI   G+A    P + ++  
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 75  TEYVVTRWYRAPELLLNSSDYTA-AIDVWSVGCIFMELMNRRPLFPGN------DHVHQM 127
                +  ++ PE+      ++   +D+WS G     +      F G+      +++ + 
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG 228
Query: 128 RLLIELLGTPTDADL--GFVRNEDAKRY-IRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
              I     P  +DL  G +  E AKR+ IRQ+ QH        F   HP A   V    
Sbjct: 229 SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH------SWFRKKHPPAEAPVPIPP 282
Query: 185 TFDPMKRITGEFFVPY 200
           + D   R      VPY
Sbjct: 283 SPDTKDRWRSMTVVPY 298

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           + +Q+ RG++++ S   IHRDL   N+LL+ N  +KICDFGLAR   +N        TR 
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 83  ---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
              + APE + +   Y+   DVWS G +  E+ +
Sbjct: 264 PLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFS 296

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 153 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 212
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 213 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 241

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 151 YQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 210
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 211 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 239

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 161 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 221 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 279
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 280 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 310
Query: 187 DPMKRITGEFFVPYKPFQCCCG 208
           DP +R T    + + PF    G
Sbjct: 311 DPAQRATAAELLKH-PFLAKAG 331

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+  G+ YI   N IHRDL+ +N+L++ +   KI DFGLAR   +NE+         
Sbjct: 114 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 81  -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGNDHVHQMRLL 130
            +W  APE  +N   +T   +VWS G +  E++    + +PG  +   M  L
Sbjct: 174 IKW-TAPE-AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN--CDLKICDFGL 64
           +I   +  +SE     ++ Q   GLK++H  +++H D+KP N++        +KI DFGL
Sbjct: 138 RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           A   + +E +     T  + APE++ +        D+W++G +   L++    F G D  
Sbjct: 198 ATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD- 255
Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
                 +E L      D  F  +EDA                  F  V P A D +  +L
Sbjct: 256 ------LETLQNVKRCDWEF--DEDA------------------FSSVSPEAKDFIKNLL 289
Query: 185 TFDPMKRIT 193
             +P KR+T
Sbjct: 290 QKEPRKRLT 298

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 10/109 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR  ++          +W
Sbjct: 283 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAK-------FPIKW 335
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
             APE  +N   +T   DVWS G + ME++   R  +PG  +   +R L
Sbjct: 336 -TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 382

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 17/164 (10%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  RG+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT- 138
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  + 
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL 243
Query: 139 DADLGFVRNEDAKRYIRQLPQ------HPRQSLAQVFPHVHPLA 176
             DL  VR+   KR  R + +        R S  ++   +  LA
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 187 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 222
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 223 ARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELFS 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 229
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 172 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 224
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 225 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 260

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 238 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 298 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 356
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 357 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 387
Query: 187 DPMKRITGEFFVPYKPFQCCCG 208
           DP +R T    + + PF    G
Sbjct: 388 DPAQRATAAELLKH-PFLAKAG 408

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++       R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 57/220 (25%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------NCDLKICDFGLARP-- 67
            L Q+  G+ ++HS  +IHRDLKP N+L++              N  + I DFGL +   
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 68  TSENEFMTEY---VVTRWYRAPELLLNSSD------YTAAIDVWSVGCIFMELMNRRPLF 118
           + ++ F T       T  +RAPELL  S++       T +ID++S+GC+F  ++++    
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-H 238
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ----HPRQSLAQVFPHVHP 174
           P  D                     + R  +  R I  L +    H R  +A+       
Sbjct: 239 PFGDK--------------------YSRESNIIRGIFSLDEMKCLHDRSLIAE------- 271
Query: 175 LAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFIL 214
            A DL+ +M+  DP+KR T    + +  F      +EF+L
Sbjct: 272 -ATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLL 310

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 206
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 207 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 242

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 182 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL  +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 61/132 (46%), Gaps = 6/132 (4%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +LY+ ++ +    E+    F+ +L   L Y H   VIHRD+KP NLL+    +LKI DFG
Sbjct: 100 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+     M     T  Y  PE ++    +   +D+W  G +  E +   P F   
Sbjct: 160 WSVHAPSLRRRXMCG---TLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215
Query: 122 DHVHQMRLLIEL 133
            H    R ++ +
Sbjct: 216 SHTETHRRIVNV 227

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKND---SNYVVKGN 229
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 61/132 (46%), Gaps = 6/132 (4%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +LY+ ++ +    E+    F+ +L   L Y H   VIHRD+KP NLL+    +LKI DFG
Sbjct: 101 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 160
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+     M     T  Y  PE ++    +   +D+W  G +  E +   P F   
Sbjct: 161 WSVHAPSLRRRXM---CGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 216
Query: 122 DHVHQMRLLIEL 133
            H    R ++ +
Sbjct: 217 SHTETHRRIVNV 228

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 183 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGL R   +NE+          +W
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 349 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 195 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  ++I DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  +   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  +   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 208 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 159 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 195
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 196
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 193 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE           +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 194
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 195 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 53/216 (24%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------NCDLKICDFGLARPTS 69
            L Q+  G+ ++HS  +IHRDLKP N+L++              N  + I DFGL +   
Sbjct: 138 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 70  ENEF-----MTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGND 122
             +      +     T  +RAPELL  S+    T +ID++S+GC+F  ++++    P  D
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK-HPFGD 256
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ----HPRQSLAQVFPHVHPLAID 178
                                + R  +  R I  L +    H R  +A+        A D
Sbjct: 257 K--------------------YSRESNIIRGIFSLDEMKCLHDRSLIAE--------ATD 288
Query: 179 LVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFIL 214
           L+ +M+  DP+KR T    + +  F      +EF+L
Sbjct: 289 LISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLL 324

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 157 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 216
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 217 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 215
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 216 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 189
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 190 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 53/216 (24%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------NCDLKICDFGLARPTS 69
            L Q+  G+ ++HS  +IHRDLKP N+L++              N  + I DFGL +   
Sbjct: 138 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 70  ENEF-----MTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGND 122
             +      +     T  +RAPELL  S+    T +ID++S+GC+F  ++++    P  D
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK-HPFGD 256
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ----HPRQSLAQVFPHVHPLAID 178
                                + R  +  R I  L +    H R  +A+        A D
Sbjct: 257 K--------------------YSRESNIIRGIFSLDEMKCLHDRSLIAE--------ATD 288
Query: 179 LVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFIL 214
           L+ +M+  DP+KR T    + +  F      +EF+L
Sbjct: 289 LISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLL 324

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE           +W
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 172 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 4/111 (3%)
Query: 4   DLYQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL++ I + + +   E+    +  Q+   LK++H   ++HRD+K  N+ L  +  +++ D
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168
Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           FG+AR   S  E     + T +Y +PE+  N   Y    D+W++GC+  EL
Sbjct: 169 FGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYEL 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 66/130 (50%), Gaps = 2/130 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++ S  +I+RDLK  N++L++   +KI DFG
Sbjct: 107 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166
Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +    +   T+ +  T  Y APE++     Y  ++D W+ G +  E++  +  F G D
Sbjct: 167 MCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGED 225
Query: 123 HVHQMRLLIE 132
                + ++E
Sbjct: 226 EDELFQSIME 235

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 19/127 (14%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE------- 72
           C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     ++E       
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 73  ------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
                   T  V T+ Y +PE +  +S Y+  +D++S+G I  EL     L+P +  + +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMER 233
Query: 127 MRLLIEL 133
           +R L ++
Sbjct: 234 VRTLTDV 240

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 185 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 186 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 178 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHR+L+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 113 QIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 173 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 209

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 198
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 57/220 (25%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------NCDLKICDFGLARPTS 69
            L Q+  G+ ++HS  +IHRDLKP N+L++              N  + I DFGL +   
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 70  ENEF-----MTEYVVTRWYRAPELLLNSSD------YTAAIDVWSVGCIFMELMNRRPLF 118
             +      +     T  +RAPELL  S++       T +ID++S+GC+F  ++++    
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-H 238
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ----HPRQSLAQVFPHVHP 174
           P  D                     + R  +  R I  L +    H R  +A+       
Sbjct: 239 PFGDK--------------------YSRESNIIRGIFSLDEMKCLHDRSLIAE------- 271
Query: 175 LAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEFIL 214
            A DL+ +M+  DP+KR T    + +  F      +EF+L
Sbjct: 272 -ATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLL 310

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 179 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ YI   N IHRDL+ +N+L+      KI DFGLAR   +NE           +W
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW 172
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDH 123
             APE  L    +T   DVWS G +  EL+ + R  +PG ++
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 202
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 203 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 195
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGA 198
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 257 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 66/130 (50%), Gaps = 2/130 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++ S  +I+RDLK  N++L++   +KI DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +    +   T+ +  T  Y APE++     Y  ++D W+ G +  E++  +  F G D
Sbjct: 488 MCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGED 546
Query: 123 HVHQMRLLIE 132
                + ++E
Sbjct: 547 EDELFQSIME 556

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E  + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGA 196
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 8/117 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDF 62
            L Q+I+    L E+   Y+L Q L GL+Y+H+  ++H D+K  N+LL+++     +CDF
Sbjct: 152 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 211
Query: 63  GLA---RPT--SENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           G A   +P    ++    +Y+  T  + APE+++      A +D+WS  C+ + ++N
Sbjct: 212 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLN 267

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 79/193 (40%), Gaps = 32/193 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ +   +   E      +  +L  + Y H  NV HRDLKP N L    + +  LK+ 
Sbjct: 92  ELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLI 151
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA      + M   V T +Y +P++L     Y    D WS G +   L+   P F  
Sbjct: 152 DFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPF-- 207
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                           PTD ++     E    +       P +     + +V P A  L+
Sbjct: 208 --------------SAPTDXEVMLKIREGTFTF-------PEKD----WLNVSPQAESLI 242
Query: 181 DRMLTFDPMKRIT 193
            R+LT  P +RIT
Sbjct: 243 RRLLTKSPKQRIT 255

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 196 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 8/117 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDF 62
            L Q+I+    L E+   Y+L Q L GL+Y+H+  ++H D+K  N+LL+++     +CDF
Sbjct: 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 63  GLA---RPT--SENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           G A   +P    ++    +Y+  T  + APE+++      A +D+WS  C+ + ++N
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLN 251

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 196 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 79/193 (40%), Gaps = 32/193 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ +   +   E      +  +L  + Y H  NV HRDLKP N L    + +  LK+ 
Sbjct: 109 ELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLI 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA      + M   V T +Y +P++L     Y    D WS G +   L+   P F  
Sbjct: 169 DFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPF-- 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                           PTD ++     E    +       P +     + +V P A  L+
Sbjct: 225 --------------SAPTDXEVMLKIREGTFTF-------PEKD----WLNVSPQAESLI 259
Query: 181 DRMLTFDPMKRIT 193
            R+LT  P +RIT
Sbjct: 260 RRLLTKSPKQRIT 272

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 8/117 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDF 62
            L Q+I+    L E+   Y+L Q L GL+Y+H+  ++H D+K  N+LL+++     +CDF
Sbjct: 150 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 209
Query: 63  GLA---RPT--SENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           G A   +P    ++    +Y+  T  + APE+++      A +D+WS  C+ + ++N
Sbjct: 210 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLN 265

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 63/126 (50%), Gaps = 22/126 (17%)
Query: 26  QLLRGLKYIHSA-NVIHRDLKPSNLLLNAN------CDLKICDFGLARPTSENEFMTEYV 78
           QLL GL Y+H    +IH D+KP N+L+           +KI D G A     +E  T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---------PGNDHVHQMRL 129
            TR YR+PE+LL +  +    D+WS  C+  EL+    LF           +DH+ Q   
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ--- 252
Query: 130 LIELLG 135
           +IELLG
Sbjct: 253 IIELLG 258

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 63/126 (50%), Gaps = 22/126 (17%)
Query: 26  QLLRGLKYIHSA-NVIHRDLKPSNLLLNAN------CDLKICDFGLARPTSENEFMTEYV 78
           QLL GL Y+H    +IH D+KP N+L+           +KI D G A     +E  T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---------PGNDHVHQMRL 129
            TR YR+PE+LL +  +    D+WS  C+  EL+    LF           +DH+ Q   
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ--- 252
Query: 130 LIELLG 135
           +IELLG
Sbjct: 253 IIELLG 258

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 257 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 297

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 14/100 (14%)
Query: 26  QLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV----- 79
            +L    YIH+  N+ HRD+KPSN+L++ N  +K+ DFG      E+E+M +  +     
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG------ESEYMVDKKIKGSRG 212
Query: 80  TRWYRAPELLLNSSDYTAA-IDVWSVG-CIFMELMNRRPL 117
           T  +  PE   N S Y  A +D+WS+G C+++   N  P 
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 255 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 250 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 290

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 201 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 234

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS  +IHRD+KP N+LL+ +  LK+ DFG      E
Sbjct: 167 SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 226
Query: 71  NEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
              +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 227 TGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 230

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 241
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 242 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 282

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 248 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 288

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 237

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 286

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 207 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 247

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 196 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 9/118 (7%)
Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL Q IRS Q + + +    F  Q+ RG++Y+     +HRDL   N +L+ +  +K+ DF
Sbjct: 109 DLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168
Query: 63  GLARPTSENEFMT------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           GLAR   + E+ +        +  +W       L +  +T   DVWS G +  EL+ R
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWTALES--LQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 196 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 11/105 (10%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR----PTSENEFMTEY- 77
            L  +  G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R     TS+  + +   
Sbjct: 140 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199
Query: 78  --VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
             +  RW  APE  +    +T+A DVWS G +  E+M+   RP +
Sbjct: 200 GKIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 242

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 13/111 (11%)
Query: 23  FLYQLLRGLKYIHSANV---IHRDLKPSNLLLN--------ANCDLKICDFGLARPTSEN 71
           +  Q+ RG+ Y+H   +   IHRDLK SN+L+         +N  LKI DFGLAR     
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
             M+      W  APE++  +S ++   DVWS G +  EL+     F G D
Sbjct: 170 TKMSAAGAYAWM-APEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 16/116 (13%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR    +   + YVV   
Sbjct: 177 FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD---SNYVVRGN 233
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL----MNRRPLFPGNDHVHQM 127
                +W  APE L     YT   DVWS G +  E+    +N  P  P + + +++
Sbjct: 234 ARLPVKW-MAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 287

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 38  NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD--- 94
            +IHRD+KPSN+LL+ + ++K+CDFG++    ++   T     R Y APE +  S+    
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 95  YTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           Y    DVWS+G    EL   R  +P  + V
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSV 235

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGLAR     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
              +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 7/170 (4%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL-LNANCD-LKICDFGL 64
           +II  + +L+E     F+ Q+  G++++H   ++H DLKP N+L +N +   +KI DFGL
Sbjct: 176 RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           AR     E +     T  + APE ++N    +   D+WSVG I   L++    F G++  
Sbjct: 236 ARRYKPREKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294
Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL---PQHPRQSLAQVFPH 171
             +  ++       D +   + +E+AK +I +L    +  R S ++   H
Sbjct: 295 ETLNNILACRWDLEDEEFQDI-SEEAKEFISKLLIKEKSWRISASEALKH 343

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 14/106 (13%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF------ 73
           C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     ++E       
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 74  -MTEY------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            M  Y      V T+ Y +PE  ++ ++Y+  +D++S+G I  EL+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/99 (39%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+HS + IHR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                  WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   + E           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           + + L E       Y + +G+ Y+H+ N  ++HRDLK  NLL++    +K+CDFGL+R  
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +     ++    T  + APE+L +      + DV+S G I  EL
Sbjct: 190 ASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRWT-SPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 8/106 (7%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC--DLKICDFGLARP-----TSENEFMT 75
            + Q+   L Y+H+  + HRD+KP N L + N   ++K+ DFGL++        E   MT
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 76  EYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNRRPLFPG 120
               T ++ APE+L  +++ Y    D WS G +   L+     FPG
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG 278

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+   + +HRDL   N+L+N+N   K+ DFG++R     P +        
Sbjct: 136 MLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 195
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  APE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 196 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYW 236

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 13/144 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +    ++        R 
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 190
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
               WY APE L+ S  Y A+ DVWS G    EL+        +     M L ++++G P
Sbjct: 191 SPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELLTY-----CDSDSSPMALFLKMIG-P 242
Query: 138 TDADLGFVRNEDAKRYIRQLPQHP 161
           T   +   R  +  +  ++LP  P
Sbjct: 243 THGQMTVTRLVNTLKEGKRLPCPP 266

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 13/144 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +    ++        R 
Sbjct: 119 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 178
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
               WY APE L+ S  Y A+ DVWS G    EL+        +     M L ++++G P
Sbjct: 179 SPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELLTY-----CDSDSSPMALFLKMIG-P 230
Query: 138 TDADLGFVRNEDAKRYIRQLPQHP 161
           T   +   R  +  +  ++LP  P
Sbjct: 231 THGQMTVTRLVNTLKEGKRLPCPP 254

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 39/219 (17%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLA 65
           I   +  +E      +  +   L ++H+  + HRDLKP N+L    N    +KICDFGL 
Sbjct: 102 IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLG 161
Query: 66  ---------RPTSENEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELM 112
                     P S  E +T    +  Y APE++      +S Y    D+WS+G I   L+
Sbjct: 162 SGIKLNGDCSPISTPELLTP-CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-- 170
           +  P F G                   +D G+ R E        L +  ++   + FP  
Sbjct: 221 SGYPPFVGR----------------CGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDK 263
Query: 171 ---HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC 206
              H+   A DL+ ++L  D  +R++    + +   Q C
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 16/107 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE------ 76
           F   +  G+ Y+HS N+IHRDL   N L+  N ++ + DFGLAR   + +   E      
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 77  ---------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
                     V   ++ APE ++N   Y   +DV+S G +  E++ R
Sbjct: 173 KPDRKKRYTVVGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 210 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
            L  +  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R   EN     Y  +  
Sbjct: 121 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 81  -----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                RW  APE +     +T+A D WS G +  E+M+
Sbjct: 181 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVMS 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 183 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 223

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT---SENEFMTEYVVTRWYRAP 86
           G+ ++H  + IHRD+K +N+LL+     KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 200 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 240

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 183 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 223

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 39/192 (20%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLK--ICDFGLAR--PTSENEFMT 75
            L Q   GL ++HS N++HRDLKP N+L+   NA+  +K  I DFGL +      + F  
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 76  EYVV--TRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
              V  T  + APE+L      + T  +D++S GC+F  +++      G     Q  +  
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-- 240
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
            LLG  +   L   ++ED                         +A +L+++M+  DP KR
Sbjct: 241 -LLGACSLDCLHPEKHEDV------------------------IARELIEKMIAMDPQKR 275
Query: 192 ITGEFFVPYKPF 203
            + +  + + PF
Sbjct: 276 PSAKHVLKH-PF 286

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G++Y+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 150 MLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  APE  +    +T+A DVWS G +  E+M+   RP +
Sbjct: 210 IPVRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 250

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+H+ + IHR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                  WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+   + +HRDL   N+L+N+N   K+ DFG++R     P +        
Sbjct: 115 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  APE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 175 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYW 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KI DFGLAR   ++   
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 201 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+   + +HRDL   N+L+N+N   K+ DFG++R     P +        
Sbjct: 121 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  APE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 181 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYW 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+H+ + IHRDL   N+LL+ +  +KI DFGLA+   E      Y V   
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EXYRVRED 196
Query: 82  ------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 197 GDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 232

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 12/110 (10%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           +N +LS     +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 71  NEFMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +   + Y+V        +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 217 D---SNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG     ++
Sbjct: 166 SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 225
Query: 71  NEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
              +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 226 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT---SENEFMTEYVVTRWYRAP 86
           G+ ++H  + IHRD+K +N+LL+     KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           E L    + T   D++S G + +E++   P
Sbjct: 196 EAL--RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+H+ + IHR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 173
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                  WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 174 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT---SENEFMTEYVVTRWYRAP 86
           G+ ++H  + IHRD+K +N+LL+     KI DFGLAR +   ++       V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+H+ + IHR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 172
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                  WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 173 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 54/109 (49%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  I  +  L E    Y   QL+  + Y+   ++IHRD+K  N+++  +  +K+ DFG
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            A      +    +  T  Y APE+L+ +      +++WS+G     L+
Sbjct: 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG     ++
Sbjct: 166 SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 225
Query: 71  NEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
              +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 226 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGL 64
           ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP N++     + +LK+ DFGL
Sbjct: 244 KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
                  + +     T  + APE +          D+WSVG +   L++    F G +  
Sbjct: 304 TAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362
Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
             +R +        D+    + +ED K +IR+L
Sbjct: 363 ETLRNVKSCDWNMDDSAFSGI-SEDGKDFIRKL 394

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG     ++
Sbjct: 161 SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 71  NEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
              +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT---SENEFMTEYVVTRWYRAP 86
           G+ ++H  + IHRD+K +N+LL+     KI DFGLAR +   ++       V T  Y AP
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           E L    + T   D++S G + +E++   P
Sbjct: 199 EAL--RGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGL 64
           ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP N++     + +LK+ DFGL
Sbjct: 138 KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 197
Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
                  + +     T  + APE +          D+WSVG +   L++    F G +  
Sbjct: 198 TAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 256
Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
             +R +        D+    + +ED K +IR+L
Sbjct: 257 ETLRNVKSCDWNMDDSAFSGI-SEDGKDFIRKL 288

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           + + L E       Y + +G+ Y+H+ N  ++HR+LK  NLL++    +K+CDFGL+R  
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +     ++    T  + APE+L +      + DV+S G I  EL
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 25/115 (21%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            T+                         Y  + D+WS+G I   L+   P F  N
Sbjct: 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR----PTSENEFMTEY- 77
            L  +  G+KY+   N +HR L   N+L+N+N   K+ DFGL+R     TS+  + +   
Sbjct: 114 MLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 78  --VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
             +  RW  APE  +    +T+A DVWS G +  E+M+   RP +
Sbjct: 174 GKIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 216

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 58/110 (52%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+ ++   E   +++  +++  L ++H   +I+RDLK  N+LL+     K+ DFG
Sbjct: 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169
Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           + +    N   T  +  T  Y APE +L    Y  A+D W++G +  E++
Sbjct: 170 MCKEGICNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 565

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 564

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 27  LLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRA 85
           +++ L Y+     VIHRD+KPSN+LL+    +K+CDFG++    +++          Y A
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 86  PELL----LNSSDYTAAIDVWSVGCIFMEL 111
           PE +        DY    DVWS+G   +EL
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-------EFMT 75
            L  +  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R   EN         + 
Sbjct: 123 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182
Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             +  RW  APE +     +T+A D WS G +  E+M+
Sbjct: 183 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVMS 218

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 16/118 (13%)
Query: 15  LSEEHCQYFLYQLL-------RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR- 66
           L +   Q+ + QL+        G+KY+     +HRDL   N+L+N+N   K+ DFGL+R 
Sbjct: 114 LKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 173
Query: 67  ----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
               P +        +  RW  APE +     +T+A DVWS G +  E+++   RP +
Sbjct: 174 LEDDPEAAYTTRGGKIPIRW-TAPEAIAFRK-FTSASDVWSYGIVMWEVVSYGERPYW 229

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 1   MDTD-LYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           ++TD  + I  S  S LS +   +F   + RG+ Y+     IHRDL   N+L+  N   K
Sbjct: 113 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 172
Query: 59  ICDFGLARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           I DFGL+R        T   +  RW       LN S YT   DVWS G +  E+++
Sbjct: 173 IADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 1   MDTD-LYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           ++TD  + I  S  S LS +   +F   + RG+ Y+     IHRDL   N+L+  N   K
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182
Query: 59  ICDFGLARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           I DFGL+R        T   +  RW       LN S YT   DVWS G +  E+++
Sbjct: 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE---NEFMTEYVVTRW 82
           Q  +G+ Y+H+ N+IHRD+K +N+ L+    +KI DFGLA   S    ++ + +   +  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 83  YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 112
           + APE+  + +++ ++   DV+S G +  ELM
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 192 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 224

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 220

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 174 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 206

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 199 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 231

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 177 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 202

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 177 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 65  ARP--TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 200

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVTR 81
            L+Q+  G+KY+   N +HRDL   N+LL      KI DFGL++   +++ + T     +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W   + APE  +N   +++  DVWS G    E ++
Sbjct: 175 WPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTEYVVT 80
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +  P  +  F  +    
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 81  R---WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 237 IVFHLIELL 245

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 12/110 (10%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           +N + S     +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 71  NEFMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +   + Y+V        +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 217 D---SNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLA 65
           I   +  +E      +  +   L ++H+  + HRDLKP N+L    N    +KICDF L 
Sbjct: 102 IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
Query: 66  ---------RPTSENEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELM 112
                     P S  E +T    +  Y APE++      +S Y    D+WS+G I   L+
Sbjct: 162 SGIKLNGDCSPISTPELLTP-CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-- 170
           +  P F G                   +D G+ R E        L +  ++   + FP  
Sbjct: 221 SGYPPFVGR----------------CGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDK 263
Query: 171 ---HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC 206
              H+   A DL+ ++L  D  +R++    + +   Q C
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 52/117 (44%), Gaps = 2/117 (1%)
Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
             SL E     +L   L  L ++HS  ++H D+KP+N+ L      K+ DFGL       
Sbjct: 151 GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210
Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
                      Y APELL  S  Y  A DV+S+G   +E+     L  G +   Q+R
Sbjct: 211 GAGEVQEGDPRYMAPELLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQLR 265

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 17/103 (16%)
Query: 23  FLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTS---------EN 71
             YQ  R ++++H     +IHRDLK  NLLL+    +K+CDFG A   S         + 
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 72  EFMTEYVVTR----WYRAPELLLNSSDY--TAAIDVWSVGCIF 108
             + E  +TR     YR PE++   S++      D+W++GCI 
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 210 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 268 IVFHLIELL 276

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 1   MDTD-LYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           ++TD  + I  S  S LS +   +F   + RG+ Y+     IHR+L   N+L+  N   K
Sbjct: 120 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAK 179
Query: 59  ICDFGLARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           I DFGL+R        T   +  RW       LN S YT   DVWS G +  E+++
Sbjct: 180 IADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 25/132 (18%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHR+L   N+L+     +KI DFGL +   +++   EY   + 
Sbjct: 120 YTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK---EYYKVKE 176
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHV 124
                  WY APE  L  S ++ A DVWS G +  EL     +   P        GND  
Sbjct: 177 PGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 234
Query: 125 HQMRL--LIELL 134
            QM +  LIELL
Sbjct: 235 GQMIVFHLIELL 246

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 12/108 (11%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS     +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    + 
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND- 219
Query: 73  FMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             + Y+V        +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 220 --SNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 126 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 186 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 243
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 244 IVFHLIELL 252

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +LY+ ++ + +  E+     + +L   L Y H   VIHRD+KP NLLL    +LKI DFG
Sbjct: 109 ELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFG 168
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+   + M     T  Y  PE ++    +   +D+W +G +  EL+   P F   
Sbjct: 169 WSVHAPSLRRKTMCG---TLDYLPPE-MIEGRMHNEKVDLWCIGVLCYELLVGNPPFESA 224
Query: 122 DHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQLPQH---PRQSLAQVFPH 171
            H    R ++++ L  P     G      A+  I +L +H    R  LAQV  H
Sbjct: 225 SHNETYRRIVKVDLKFPASVPTG------AQDLISKLLRHNPSERLPLAQVSAH 272

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 117 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 176
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 177 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 234
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 235 IVFHLIELL 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 124 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 184 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 241
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 242 IVFHLIELL 250

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 125 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 185 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 242
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 243 IVFHLIELL 251

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YV 78
           F +Q+ +G++Y+   +++HRDL   N+L+     +KI DFGL+R   E +   +     +
Sbjct: 155 FAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             +W  A E L +   YT   DVWS G +  E++ 
Sbjct: 215 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 123 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 183 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 240
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 241 IVFHLIELL 249

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 237 IVFHLIELL 245

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 239
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 240 IVFHLIELL 248

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 118 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 178 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 235
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 236 IVFHLIELL 244

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 239
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 240 IVFHLIELL 248

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 83/205 (40%), Gaps = 35/205 (17%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLA 65
           I+  +  +E      +  +   L ++H+  + HRDLKP N+L  +      +KICDF L 
Sbjct: 102 IQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLG 161
Query: 66  RPTSENEFMTEYVV--------TRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMN 113
                N   T            +  Y APE++   +D    Y    D+WS+G +   +++
Sbjct: 162 SGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLS 221
Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK----RYIRQLPQHPRQSLAQVF 169
             P F G+                  AD G+ R E  +    +    + +   +   + +
Sbjct: 222 GYPPFVGH----------------CGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW 265
Query: 170 PHVHPLAIDLVDRMLTFDPMKRITG 194
            H+   A DL+ ++L  D  +R++ 
Sbjct: 266 AHISSEAKDLISKLLVRDAKQRLSA 290

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 239
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 240 IVFHLIELL 248

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 237 IVFHLIELL 245

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 254
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 255 IVFHLIELL 263

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---YRA 85
            G+ Y+  A+VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   + +
Sbjct: 114 EGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 172
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           PE + + S Y++  DVWS G +  E+ +   +
Sbjct: 173 PE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YV 78
           F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E +   +     +
Sbjct: 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             +W  A E L +   YT   DVWS G +  E++ 
Sbjct: 215 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP--------GNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL     +   P        GND   QM
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 254
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 255 IVFHLIELL 263

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 5/110 (4%)
Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP 67
           ++   + +   +    L+Q+  G+KY+   N +HR+L   N+LL      KI DFGL++ 
Sbjct: 426 LVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485
Query: 68  -TSENEFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             +++ + T     +W   + APE  +N   +++  DVWS G    E ++
Sbjct: 486 LGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E +    YV    
Sbjct: 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED---SYVKRSQ 211
Query: 83  YRAPELLLNSSD-----YTAAIDVWSVGCIFMELMN 113
            R P   +         YT   DVWS G +  E++ 
Sbjct: 212 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 13/96 (13%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR---- 81
           Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+    ++   +Y V R    
Sbjct: 122 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQ 178
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               WY APE  L+ + ++   DVWS G +  EL  
Sbjct: 179 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 13/96 (13%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR---- 81
           Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+    ++   +Y V R    
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQ 191
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               WY APE  L+ + ++   DVWS G +  EL  
Sbjct: 192 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 13/96 (13%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR---- 81
           Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+    ++   +Y V R    
Sbjct: 123 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQ 179
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               WY APE  L+ + ++   DVWS G +  EL  
Sbjct: 180 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 76/192 (39%), Gaps = 46/192 (23%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-------ARP 67
           L+E+   + L  + RGL+ IH+    HRDLKP+N+LL       + D G           
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 68  TSENEFMTEYVVTR---WYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +   + ++   R    YRAPEL    S        DVWS+GC+   +M     +    
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY---- 246
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR---QLPQHPRQSLAQVFPHVHPLAIDL 179
                             D+ F + +     ++    +PQ PR S A            L
Sbjct: 247 ------------------DMVFQKGDSVALAVQNQLSIPQSPRHSSA---------LWQL 279
Query: 180 VDRMLTFDPMKR 191
           ++ M+T DP +R
Sbjct: 280 LNSMMTVDPHQR 291

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 11/112 (9%)
Query: 9   IRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP 67
           +R N+  L  +    +  Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR 
Sbjct: 109 VRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARL 168
Query: 68  TSENEFMTEY------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
              +E  TEY      V  +W     +L     +T   DVWS G    ELM 
Sbjct: 169 LDIDE--TEYHADGGKVPIKWMALESILRRR--FTHQSDVWSYGVTVWELMT 216

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEYVVTRWYR 84
           G++Y+     +HRDL   N+L+++N   K+ DFGL+R     P +        +  RW  
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT- 221
Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLF 118
           APE +   + +++A DVWS G +  E++    RP +
Sbjct: 222 APEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYW 256

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 20  CQYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFM 74
            QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+ 
Sbjct: 150 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 209
Query: 75  TE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 210 AEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 248

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 20  CQYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFM 74
            QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+ 
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 75  TE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 176 AEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 58/112 (51%), Gaps = 7/112 (6%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L E+  ++++ +++  +  IH  + +HRD+KP N+LL+ N  +++ DFG     +++  
Sbjct: 171 KLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT 230
Query: 74  MTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLF 118
           +   V   T  Y +PE+L    D    Y    D WS+G C++  L    P +
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 123 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 183 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 127 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 187 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 224

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 20  CQYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFM 74
            QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+ 
Sbjct: 117 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 75  TE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 AEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV-- 79
           +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    +   + Y+V  
Sbjct: 164 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND---SNYIVKG 220
Query: 80  -----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 221 NARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 56/111 (50%), Gaps = 7/111 (6%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L EE  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG      E+  +
Sbjct: 172 LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 75  TEYVV--TRWYRAPELLL----NSSDYTAAIDVWSVG-CIFMELMNRRPLF 118
              V   T  Y +PE+L         Y    D WS+G C++  L    P +
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 7/111 (6%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E+  ++++ +++  +  IH  + +HRD+KP N+LL+ N  +++ DFG     +++  +
Sbjct: 188 LPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV 247
Query: 75  TEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLF 118
              V   T  Y +PE+L    D    Y    D WS+G C++  L    P +
Sbjct: 248 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 298

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 178 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 215

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 4/111 (3%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL--LNANCDLKICD 61
           DL+  I     L E   + F  Q++  +++ HS  V+HRD+K  N+L  L   C  K+ D
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-AKLID 183
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           FG +     +E  T++  TR Y  PE +     +     VWS+G +  +++
Sbjct: 184 FG-SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 121 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 180
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 181 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 20  CQYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFM 74
            QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+ 
Sbjct: 141 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 200
Query: 75  TE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 201 AEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV-- 79
           +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    +   + Y+V  
Sbjct: 156 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND---SNYIVKG 212
Query: 80  -----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 213 NARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV-- 79
           +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    +   + Y+V  
Sbjct: 162 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND---SNYIVKG 218
Query: 80  -----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 219 NARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 255

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEYVVTRWYR 84
           G++Y+     +HRDL   N+L+++N   K+ DFGL+R     P +        +  RW  
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT- 221
Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLF 118
           APE +   + +++A DVWS G +  E++    RP +
Sbjct: 222 APEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYW 256

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 171 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 208

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 6/85 (7%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTRWYRA 85
           G++Y+ S   IHRDL   N L+     LKI DFG++R  ++  +        V  +W  A
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-A 283
Query: 86  PELLLNSSDYTAAIDVWSVGCIFME 110
           PE  LN   Y++  DVWS G +  E
Sbjct: 284 PE-ALNYGRYSSESDVWSFGILLWE 307

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 556 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 173 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 25  YQLLRGLKYIHSA---------NVIHRDLKPSNLLLNANCDLKICDFGLA---------R 66
           + + RGL Y+H+           + HRDL   N+L+  +    I DFGL+         R
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 67  PTSENEFMTEYVVTRWYRAPELL---LNSSDYTAA---IDVWSVGCIFMELMNR-RPLFP 119
           P  E+      V T  Y APE+L   +N  D  +A   +D++++G I+ E+  R   LFP
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 120 GND-HVHQMRLLIELLGTPTDADLGFVRNEDAKR 152
           G     +QM    E+   PT  D+  + + + +R
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---YRA 85
            G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   + +
Sbjct: 114 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 172
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           PE + + S Y++  DVWS G +  E+ +   +
Sbjct: 173 PE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 118 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 177
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 178 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 178
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 179 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---YRA 85
            G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   + +
Sbjct: 134 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 192
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           PE + + S Y++  DVWS G +  E+ +   +
Sbjct: 193 PE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 223

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---YRA 85
            G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   + +
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 170
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           PE + + S Y++  DVWS G +  E+ +   +
Sbjct: 171 PE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 181 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 144 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 203
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 204 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 243

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---YRA 85
            G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   + +
Sbjct: 117 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 175
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           PE + + S Y++  DVWS G +  E+ +   +
Sbjct: 176 PE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 206

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 8/99 (8%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----EYVVTR 81
           Q+  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R     ++        +  R
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLF 118
           W   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 201 WM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---YRAP 86
           G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   + +P
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 174
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           E + + S Y++  DVWS G +  E+ +   +
Sbjct: 175 E-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTEYVVTR-- 81
           Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+  P  ++  +         
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 82  -WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            WY APE  L+ + ++   DVWS G +  EL  
Sbjct: 179 FWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+  G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 114 QYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 174 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 211

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVV--TRWYRA 85
           RGL Y+H+  +IHRD+K  N+LL+ N   KI DFG+++  +E ++     VV  T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           PE  +     T   DV+S G +  E++  R
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVV--TRWYRA 85
           RGL Y+H+  +IHRD+K  N+LL+ N   KI DFG+++  +E  +     VV  T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           PE  +     T   DV+S G +  E++  R
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVLCAR 238

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       + 
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 556 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR---PTSENEFMTEYVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R    ++  +     + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP 175
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 6/85 (7%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTRWYRA 85
           G++Y+ S   IHRDL   N L+     LKI DFG++R  ++           V  +W  A
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT-A 283
Query: 86  PELLLNSSDYTAAIDVWSVGCIFME 110
           PE  LN   Y++  DVWS G +  E
Sbjct: 284 PE-ALNYGRYSSESDVWSFGILLWE 307

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F+  +  G++Y+ S N IHRDL   N +L  +  + + DFGL+R     ++  +   +  
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 81  --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 202 PVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTR 235

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 96/258 (37%), Gaps = 71/258 (27%)
Query: 5   LYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNAN-------- 54
           L  II+SN Q L     +  + Q+L+GL Y+H+   +IH D+KP N+LL+ N        
Sbjct: 116 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 175
Query: 55  -----------------------------------------CDLKICDFGLARPTSENEF 73
                                                      +KI D G A     ++ 
Sbjct: 176 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKH 233
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---PGNDHVH---QM 127
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF    G ++      +
Sbjct: 234 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 292
Query: 128 RLLIELLG-TPTDADLG-------FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            L+IELLG  P    +        F +  D K   +  P    + L + +      A   
Sbjct: 293 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF 352
Query: 180 VD---RMLTFDPMKRITG 194
            D    ML   P KR T 
Sbjct: 353 TDFLLPMLELIPEKRATA 370

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 3/120 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   +R    L+       + Q+   L   H+A   HRD+KP N+L++A+    + DFG
Sbjct: 120 DLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG 179
Query: 64  LARPTSENEF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           +A  T++ +   +   V T +Y APE   + S  T   D++++ C+  E +   P + G+
Sbjct: 180 IASATTDEKLTQLGNTVGTLYYXAPE-RFSESHATYRADIYALTCVLYECLTGSPPYQGD 238

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 96/258 (37%), Gaps = 71/258 (27%)
Query: 5   LYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNAN-------- 54
           L  II+SN Q L     +  + Q+L+GL Y+H+   +IH D+KP N+LL+ N        
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 55  -----------------------------------------CDLKICDFGLARPTSENEF 73
                                                      +KI D G A     ++ 
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKH 249
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---PGNDHVH---QM 127
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF    G ++      +
Sbjct: 250 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
Query: 128 RLLIELLG-TPTDADLG-------FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            L+IELLG  P    +        F +  D K   +  P    + L + +      A   
Sbjct: 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF 368
Query: 180 VD---RMLTFDPMKRITG 194
            D    ML   P KR T 
Sbjct: 369 TDFLLPMLELIPEKRATA 386

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           +L++ + GLK  H   + HRD+K  N+LL  N    I DFGLA      +   +    V 
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 80  TRWYRAPELLLNSSDYTA----AIDVWSVGCIFMELMNR 114
           TR Y APE+L  + ++       ID++++G +  EL +R
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 183
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 121 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 180
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 181 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 218

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + F T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF-TAHAGAK 171
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           S +E+ C     Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     ++
Sbjct: 172 SCAEQLC--IARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 74  M----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 + +  RW     +  N   YT   DVW+ G +  E+ +
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFS 271

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAP 86
            ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +P
Sbjct: 112 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 169
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
             +L  S +++  D+W+ G +  E+
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEI 194

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAP 86
            ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +P
Sbjct: 116 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 173
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
             +L  S +++  D+W+ G +  E+
Sbjct: 174 PEVLMYSKFSSKSDIWAFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAP 86
            ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +P
Sbjct: 117 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 174
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
             +L  S +++  D+W+ G +  E+
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 47/86 (54%), Gaps = 5/86 (5%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRA 85
             ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW   
Sbjct: 122 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SP 180
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMEL 111
           PE+L+ S  +++  D+W+ G +  E+
Sbjct: 181 PEVLMYSK-FSSKSDIWAFGVLMWEI 205

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRA 85
             ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +
Sbjct: 131 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--S 188
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMEL 111
           P  +L  S +++  D+W+ G +  E+
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 134 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTY-TAHAGAK 192
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGND 122
           +   + APE L  ++ ++   DVW+ G +  E+       +PG D
Sbjct: 193 FPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGID 236

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAP 86
            ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +P
Sbjct: 117 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRW--SP 174
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
             +L  S +++  D+W+ G +  E+
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 14/120 (11%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 95  NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 153
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 154 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 213

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 58/187 (31%)
Query: 5   LYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLL----------- 51
           L  II+SN Q L     +  + Q+L+GL Y+HS   +IH D+KP N+L+           
Sbjct: 126 LKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMA 185
Query: 52  -----------------------------------NAN-CDLKICDFGLARPTSENEFMT 75
                                              NA+   +KI D G A     ++  T
Sbjct: 186 AEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNA--CWVHKHFT 243
Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---PGNDHVH---QMRL 129
           E + TR YR+ E+L+ +  Y+   D+WS  C+  EL     LF    G D+      +  
Sbjct: 244 EDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAH 302
Query: 130 LIELLGT 136
           +IELLG+
Sbjct: 303 IIELLGS 309

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 14/120 (11%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 91  NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 149
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 150 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 209

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 55/118 (46%), Gaps = 14/118 (11%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ DFG
Sbjct: 141 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFG 199
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           +A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 200 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           Y +  G+ ++ S   IHRDL   N L++ +  +K+ DFG+ R   ++++++  V T++  
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPV 169
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            + APE + +   Y++  DVW+ G +  E+ +
Sbjct: 170 KWSAPE-VFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 14/120 (11%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 169
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 6/102 (5%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L++    +   Q+  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R     ++
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 183
Query: 74  MT----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
                   +  RW   PE ++    +T   DVWS+G +  E+
Sbjct: 184 YRVGGHTMLPIRWM-PPESIM-YRKFTTESDVWSLGVVLWEI 223

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 14/120 (11%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 197
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 14/120 (11%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 92  NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 150
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 178
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           V   + APE  L +  ++ A D W  G    E+
Sbjct: 186 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 185
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           V   + APE  L +  ++ A D W  G    E+
Sbjct: 186 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 3/89 (3%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S  +   +  V   
Sbjct: 113 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 170
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           + APE L  ++ ++   DVWS G +  E+
Sbjct: 171 WTAPEALREAA-FSTKSDVWSFGILLWEI 198

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 178
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           V   + APE  L +  ++ A D W  G    E+
Sbjct: 176 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEM 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 175
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 175
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           V   + APE  L +  ++ A D W  G    E+
Sbjct: 180 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEM 211

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           V   + APE  L +  ++ A D W  G    E+
Sbjct: 176 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEM 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 128 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 186
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 187 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 238

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           V   + APE  L +  ++ A D W  G    E+
Sbjct: 176 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEM 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 177
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 178 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 178
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 178
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           V   + APE  L +  ++ A D W  G    E+
Sbjct: 180 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEM 211

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTR 81
           ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE L +   +T + D+WS G +  E+ +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTR 81
           ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++  +     +  R
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE L +   +T + D+WS G +  E+ +
Sbjct: 197 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 226

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 86/195 (44%), Gaps = 33/195 (16%)
Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKIC 60
           D+++ I ++   L+E     +++Q+   L+++HS N+ H D++P N++     +  +KI 
Sbjct: 87  DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKII 146
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC-IFMELMNRRPLFP 119
           +FG AR     +          Y APE+  +    TA  D+WS+G  +++ L    P   
Sbjct: 147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT-DMWSLGTLVYVLLSGINPFLA 205
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             +         +++    +A+  F  +E+A                  F  +   A+D 
Sbjct: 206 ETNQ--------QIIENIMNAEYTF--DEEA------------------FKEISIEAMDF 237
Query: 180 VDRMLTFDPMKRITG 194
           VDR+L  +   R+T 
Sbjct: 238 VDRLLVKERKSRMTA 252

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S  +   +  V +W
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW 352
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             APE  L    ++   DVWS G +  E+
Sbjct: 353 -TAPE-ALREKKFSTKSDVWSFGILLWEI 379

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + +        
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF 175
Query: 81  --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
             +W  APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 176 PIKW-TAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 226

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  +  +  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 171
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S  +  T  +  +W
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW 180
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             APE  L    ++   DVWS G +  E+
Sbjct: 181 -TAPE-ALREKKFSTKSDVWSFGILLWEI 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 3/89 (3%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S  +   +  V   
Sbjct: 107 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           + APE  L    ++   DVWS G +  E+
Sbjct: 165 WTAPE-ALREKKFSTKSDVWSFGILLWEI 192

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + +        
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF 176
Query: 81  --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
             +W  APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 177 PIKW-TAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/150 (22%), Positives = 62/150 (41%), Gaps = 13/150 (8%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD----LKICDFGLARPTS 69
            L E      L  ++ G+ ++    ++HR++KP N++     D     K+ DFG AR   
Sbjct: 108 GLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 70  ENEFMTEYVVTRWYRAPELLLNS-------SDYTAAIDVWSVGCIFMELMNRR-PLFPGN 121
           ++E       T  Y  P++   +         Y A +D+WS+G  F        P  P  
Sbjct: 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 122 DHVHQMRLLIELL-GTPTDADLGFVRNEDA 150
                  ++ +++ G P+ A  G  + E+ 
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENG 257

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  +  +  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 171
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	217
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-133
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-133
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-132
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-128
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-128
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-128
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-126
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-125
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-124
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-124
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-117
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-117
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-117
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-117
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-114
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-111
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-108
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-90
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-85
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-85
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-85
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-84
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-84
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-82
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-82
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-81
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-81
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-80
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-79
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-71
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-49
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-48
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-48
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-47
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-46
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-46
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-42
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-42
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-42
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-40
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-40
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-38
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-38
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-38
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-37
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-37
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-37
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-37
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-36
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-35
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-35
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-35
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-35
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-35
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-34
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-34
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-34
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-34
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-34
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-34
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-33
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-33
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-33
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-33
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-33
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-33
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-33
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-32
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-32
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-32
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-32
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-32
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-31
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-31
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-31
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-30
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-29
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-29
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-28
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-28
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-28
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-28
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-27
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-27
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-25
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-25
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-24
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-24
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-24
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-24
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-24
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-24
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-23
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-22
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-22
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-21
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-17
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-17
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-17
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-17
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-16
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-14
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-13
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-13
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-12
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-12
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-12
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-10
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-07

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  378 bits (973), Expect = e-133
 Identities = 82/197 (41%), Positives = 122/197 (61%), Gaps = 2/197 (1%)

Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M TDL Q+I   +  +S +H QYF+Y +L GL  +H A V+HRDL P N+LL  N D+ I
Sbjct: 116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           CDF LAR  + +   T YV  RWYRAPEL++    +T  +D+WS GC+  E+ NR+ LF 
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ-LPQHPRQSLAQVFPHVHPLAID 178
           G+   +Q+  ++E++GTP   D+    +  A+ Y+R  L   P ++   V P   P+A+D
Sbjct: 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295

Query: 179 LVDRMLTFDPMKRITGE 195
           L+ +ML F+P +RI+ E
Sbjct: 296 LIAKMLEFNPQRRISTE 312

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  377 bits (969), Expect = e-133
 Identities = 108/199 (54%), Positives = 146/199 (73%), Gaps = 5/199 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170

Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290

Query: 177 IDLVDRMLTFDPMKRITGE 195
           +DL+D+MLTF+P KRI  E
Sbjct: 291 LDLLDKMLTFNPHKRIEVE 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  375 bits (966), Expect = e-132
 Identities = 110/207 (53%), Positives = 146/207 (70%), Gaps = 13/207 (6%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL+++I + Q LS++H QYF+YQ LR +K +H +NVIHRDLKPSNLL+N+NCDLK+C
Sbjct: 96  MQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVC 154

Query: 61  DFGLAR-----------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           DFGLAR           PT +   M E+V TRWYRAPE++L S+ Y+ A+DVWS GCI  
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214

Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           EL  RRP+FPG D+ HQ+ L+  ++GTP  D DL  + +  A+ YI+ LP +P   L ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274

Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITGE 195
           FP V+P  IDL+ RML FDP KRIT +
Sbjct: 275 FPRVNPKGIDLLQRMLVFDPAKRITAK 301

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  365 bits (940), Expect = e-128
 Identities = 85/195 (43%), Positives = 137/195 (70%), Gaps = 3/195 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL ++++  + L E+  Q+ +YQ+L+GL+YIH+A +IHRDLKP NL +N +C+LKI 
Sbjct: 112 MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 170

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTRWYRAPE++LN   YT  +D+WSVGCI  E++  + LF G
Sbjct: 171 DFGLAR--QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q++ ++++ GTP    +  +++++AK Y++ LP+  ++  A +  +  PLA++L+
Sbjct: 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288

Query: 181 DRMLTFDPMKRITGE 195
           ++ML  D  +R+T  
Sbjct: 289 EKMLVLDAEQRVTAG 303

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  364 bits (936), Expect = e-128
 Identities = 89/200 (44%), Positives = 128/200 (64%), Gaps = 7/200 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKI 59
           M+TDL  ++     L EEH + F+YQLLRGLKYIHSANV+HRDLKP+NL +N  +  LKI
Sbjct: 104 METDLANVLEQGP-LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162

Query: 60  CDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR      S    ++E +VT+WYR+P LLL+ ++YT AID+W+ GCIF E++  +
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
            LF G   + QM+L++E +    + D   + +     YIR     P + L Q+ P +   
Sbjct: 223 TLFAGAHELEQMQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISRE 281

Query: 176 AIDLVDRMLTFDPMKRITGE 195
           A+D ++++LTF PM R+T E
Sbjct: 282 AVDFLEQILTFSPMDRLTAE 301

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  365 bits (938), Expect = e-128
 Identities = 102/195 (52%), Positives = 139/195 (71%), Gaps = 3/195 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T++   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292

Query: 181 DRMLTFDPMKRITGE 195
           ++ML  D  KRIT  
Sbjct: 293 EKMLVLDSDKRITAA 307

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  360 bits (927), Expect = e-126
 Identities = 93/195 (47%), Positives = 128/195 (65%), Gaps = 4/195 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL +I+      SEE  QY +YQ+L+GLKYIHSA V+HRDLKP NL +N +C+LKI 
Sbjct: 111 MQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       MT YVVTRWYRAPE++L+   Y   +D+WSVGCI  E++  + LF G
Sbjct: 169 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D++ Q+  ++++ G P    +  + ++ AK YI+ LPQ PR+   Q+FP   P A DL+
Sbjct: 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286

Query: 181 DRMLTFDPMKRITGE 195
           ++ML  D  KR+T  
Sbjct: 287 EKMLELDVDKRLTAA 301

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  359 bits (924), Expect = e-125
 Identities = 89/246 (36%), Positives = 132/246 (53%), Gaps = 51/246 (20%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D+DL ++ ++   L+EEH +  LY LL G  +IH + +IHRDLKP+N LLN +C +K+C
Sbjct: 112 ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVC 171

Query: 61  DFGLARPTS-----------------------ENEFMTEYVVTRWYRAPELLLNSSDYTA 97
           DFGLAR  +                         + +T +VVTRWYRAPEL+L   +YT 
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231

Query: 98  AIDVWSVGCIFMELMN-----------RRPLFPGN-----------------DHVHQMRL 129
           +ID+WS GCIF EL+N           R PLFPG+                  +  Q+ +
Sbjct: 232 SIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNI 291

Query: 130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPM 189
           +  ++GTPT+ DL  +   +  +YI+  P     +L Q +P +    I+L++ ML F+P 
Sbjct: 292 IFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN 351

Query: 190 KRITGE 195
           KRIT +
Sbjct: 352 KRITID 357

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  356 bits (915), Expect = e-124
 Identities = 81/233 (34%), Positives = 130/233 (55%), Gaps = 39/233 (16%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDL+ +IR+   L   H QY +YQL++ +KY+HS  ++HRD+KPSN+LLNA C +K+ 
Sbjct: 93  METDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVA 151

Query: 61  DFGLAR----------------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAA 98
           DFGL+R                         +   +T+YV TRWYRAPE+LL S+ YT  
Sbjct: 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG 211

Query: 99  IDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP 158
           ID+WS+GCI  E++  +P+FPG+  ++Q+  +I ++  P++ D+  +++  AK  I  L 
Sbjct: 212 IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLK 271

Query: 159 QHPRQSLAQVF----------------PHVHPLAIDLVDRMLTFDPMKRITGE 195
           +      +                      +  A+DL+D++L F+P KRI+  
Sbjct: 272 EKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  357 bits (917), Expect = e-124
 Identities = 99/254 (38%), Positives = 135/254 (53%), Gaps = 59/254 (23%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D+D  ++ R+   L+E H +  LY LL G+KY+HSA ++HRDLKP+N L+N +C +K+C
Sbjct: 139 ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVC 198

Query: 61  DFGLAR----------------------------PTSENEFMTEYVVTRWYRAPELLLNS 92
           DFGLAR                              +    +T +VVTRWYRAPEL+L  
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258

Query: 93  SDYTAAIDVWSVGCIFMELMN-----------RRPLFPGND------------------- 122
            +YT AIDVWS+GCIF EL+N           R PLFPG+                    
Sbjct: 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTR 318

Query: 123 -HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
            +  Q+ ++  +LGTP++ D+  +  EDAKRYIR  P+     LA+ FP     AI L+ 
Sbjct: 319 GNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLK 378

Query: 182 RMLTFDPMKRITGE 195
           RML F+P KRIT  
Sbjct: 379 RMLVFNPNKRITIN 392

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  337 bits (866), Expect = e-117
 Identities = 86/207 (41%), Positives = 121/207 (58%), Gaps = 16/207 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 112 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 228

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH------- 173
            DH+ Q   +IE LGTP    +  +     + Y+   P++   S  ++FP V        
Sbjct: 229 TDHIDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287

Query: 174 -----PLAIDLVDRMLTFDPMKRITGE 195
                  A DL+ +ML  D  KRI+ +
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRISVD 314

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  337 bits (867), Expect = e-117
 Identities = 69/201 (34%), Positives = 120/201 (59%), Gaps = 9/201 (4%)

Query: 1   MDTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD 56
           +   L+++++    S +S+       ++YQL R + +IHS  + HRD+KP NLL+N+  +
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 57  -LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            LK+CDFG A+    +E    Y+ +R+YRAPEL+L +++YT +ID+WS+GC+F EL+  +
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP- 174
           PLF G   + Q+  +I+++GTPT   +  +     +      P    +   ++ P   P 
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR---FPTLKAKDWRKILPEGTPS 296

Query: 175 LAIDLVDRMLTFDPMKRITGE 195
           LAIDL++++L ++P  RI   
Sbjct: 297 LAIDLLEQILRYEPDLRINPY 317

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  339 bits (872), Expect = e-117
 Identities = 84/207 (40%), Positives = 122/207 (58%), Gaps = 16/207 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 149 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 265

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH------- 173
            D++ Q   +IE LGTP    +  +     + Y+   P++   +  ++FP          
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324

Query: 174 -----PLAIDLVDRMLTFDPMKRITGE 195
                  A DL+ +ML  DP KRI+ +
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVD 351

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  335 bits (862), Expect = e-117
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 8/203 (3%)

Query: 1   MDTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIH--SANVIHRDLKPSNLLLN-A 53
           +   L++  R+      +      + FL+QL+R +  +H  S NV HRD+KP N+L+N A
Sbjct: 108 VPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167

Query: 54  NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +  LK+CDFG A+  S +E    Y+ +R+YRAPEL+  +  YT A+D+WSVGCIF E+M 
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP-RQSLAQVFPHV 172
             P+F G++   Q+  ++ +LG P+   L  +        +      P     +      
Sbjct: 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKD 287

Query: 173 HPLAIDLVDRMLTFDPMKRITGE 195
              A DL+  +L + P +R+   
Sbjct: 288 AKEAYDLLSALLQYLPEERMKPY 310

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  332 bits (852), Expect = e-114
 Identities = 76/199 (38%), Positives = 116/199 (58%), Gaps = 9/199 (4%)

Query: 1   MDTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD 56
           +   +Y++ R    + Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +  
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194

Query: 57  -LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            LK+CDFG A+     E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHP 174
           P+FPG+  V Q+  +I++LGTPT   +  +          + PQ       +VF P   P
Sbjct: 255 PIFPGDSGVDQLVEIIKVLGTPTREQIREMN---PNYTEFKFPQIKAHPWTKVFRPRTPP 311

Query: 175 LAIDLVDRMLTFDPMKRIT 193
            AI L  R+L + P  R+T
Sbjct: 312 EAIALCSRLLEYTPTARLT 330

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  323 bits (830), Expect = e-111
 Identities = 74/201 (36%), Positives = 112/201 (55%), Gaps = 9/201 (4%)

Query: 1   MDTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD 56
           +   +Y+  R      Q++     + ++YQLLR L YIHS  + HRD+KP NLLL+    
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG 179

Query: 57  -LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            LK+ DFG A+     E    Y+ +R+YRAPEL+  +++YT  ID+WS GC+  ELM  +
Sbjct: 180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHP 174
           PLFPG   + Q+  +I++LGTP+   +  +          + PQ      ++VF P   P
Sbjct: 240 PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN---YMEHKFPQIRPHPFSKVFRPRTPP 296

Query: 175 LAIDLVDRMLTFDPMKRITGE 195
            AIDL+ R+L + P  R+T  
Sbjct: 297 DAIDLISRLLEYTPSARLTAI 317

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  313 bits (804), Expect = e-108
 Identities = 58/201 (28%), Positives = 113/201 (56%), Gaps = 11/201 (5%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKI 59
            +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++
Sbjct: 116 NNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 172

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLF 118
            D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F
Sbjct: 173 IDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232

Query: 119 PGNDHVHQMRLLIELLGTPTDAD-LGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----V 172
            G+D+  Q+  + ++LGT    D +     E   R+   L +H R+   +         V
Sbjct: 233 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 292

Query: 173 HPLAIDLVDRMLTFDPMKRIT 193
            P A+D +D++L +D   R+T
Sbjct: 293 SPEALDFLDKLLRYDHQSRLT 313

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  284 bits (728), Expect = 4e-97
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 2/197 (1%)

Query: 1   MDTDLYQII-RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            D  +   + R  + + E   +   +Q L+ + + H  N IHRD+KP N+L+  +  +K+
Sbjct: 84  CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKL 143

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           CDFG AR  T  +++  + V TRWYR+PELL+  + Y   +DVW++GC+F EL++  PL+
Sbjct: 144 CDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG   V Q+ L+ + LG                  ++       + L   FP++   A+ 
Sbjct: 204 PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALG 263

Query: 179 LVDRMLTFDPMKRITGE 195
           L+   L  DP +R+T E
Sbjct: 264 LLKGCLHMDPTERLTCE 280

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  266 bits (683), Expect = 5e-90
 Identities = 67/199 (33%), Positives = 107/199 (53%), Gaps = 6/199 (3%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D  +   +      L  +  Q +L+Q++ G+ + HS N+IHRD+KP N+L++ +  +K+
Sbjct: 106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKL 165

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           CDFG AR   +  E   + V TRWYRAPELL+    Y  A+DVW++GC+  E+    PLF
Sbjct: 166 CDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLA 176
           PG+  + Q+  ++  LG         F +N        +LP+   R+ L + +P +  + 
Sbjct: 226 PGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV--RLPEIKEREPLERRYPKLSEVV 283

Query: 177 IDLVDRMLTFDPMKRITGE 195
           IDL  + L  DP KR    
Sbjct: 284 IDLAKKCLHIDPDKRPFCA 302

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  253 bits (649), Expect = 2e-85
 Identities = 74/196 (37%), Positives = 100/196 (51%), Gaps = 6/196 (3%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL +++      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  +VT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  PLF
Sbjct: 142 ADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG     Q+  +  +LGTP   +                   +           +    I
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD---PNFTVYEPLPWESFLKGLDESGI 258

Query: 178 DLVDRMLTFDPMKRIT 193
           DL+ +ML  DP +RIT
Sbjct: 259 DLLSKMLKLDPNQRIT 274

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  255 bits (654), Expect = 2e-85
 Identities = 77/196 (39%), Positives = 108/196 (55%), Gaps = 7/196 (3%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+TDL  II+  +  L+  H + ++   L+GL+Y+H   ++HRDLKP+NLLL+ N  LK+
Sbjct: 94  METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL 153

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA+   S N   T  VVTRWYRAPELL  +  Y   +D+W+VGCI  EL+ R P  
Sbjct: 154 ADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+  + Q+  + E LGTPT+          D           P   L  +F       +
Sbjct: 214 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV----TFKSFPGIPLHHIFSAAGDDLL 269

Query: 178 DLVDRMLTFDPMKRIT 193
           DL+  +  F+P  RIT
Sbjct: 270 DLIQGLFLFNPCARIT 285

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  252 bits (647), Expect = 7e-85
 Identities = 73/196 (37%), Positives = 110/196 (56%), Gaps = 5/196 (2%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+ DL +++      L +   + +LYQLLRG+ + H   ++HRDLKP NLL+N++  LK+
Sbjct: 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++  +PLF
Sbjct: 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG     Q+  +  +LGTP   +          K+         ++  + + P      I
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR--TFQVFEKKPWSSIIPGFCQEGI 278

Query: 178 DLVDRMLTFDPMKRIT 193
           DL+  ML FDP KRI+
Sbjct: 279 DLLSNMLCFDPNKRIS 294

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  251 bits (643), Expect = 5e-84
 Identities = 80/196 (40%), Positives = 116/196 (59%), Gaps = 5/196 (2%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL Q +      ++  + + FL+QLLRGL Y H   V+HRDLKP NLL+N   +LK+
Sbjct: 82  LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKL 141

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  +   +     VVT WYR P++LL S+DY+  ID+W VGCIF E+   RPLF
Sbjct: 142 ADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    Q+  +  +LGTPT+    G + NE+ K Y    P++  ++L    P +     
Sbjct: 202 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY--NYPKYRAEALLSHAPRLDSDGA 259

Query: 178 DLVDRMLTFDPMKRIT 193
           DL+ ++L F+   RI+
Sbjct: 260 DLLTKLLQFEGRNRIS 275

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  245 bits (628), Expect = 5e-82
 Identities = 74/196 (37%), Positives = 106/196 (54%), Gaps = 9/196 (4%)

Query: 1   MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           +D DL   +       L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K
Sbjct: 101 VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + DFGLAR  S    +T  VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF
Sbjct: 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLF 219

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
            GN    Q+  + +L+G P + D    V            P    + +  V P +     
Sbjct: 220 CGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA-----FPPRGPRPVQSVVPEMEESGA 274

Query: 178 DLVDRMLTFDPMKRIT 193
            L+  MLTF+P KRI+
Sbjct: 275 QLLLEMLTFNPHKRIS 290

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  246 bits (630), Expect = 6e-82
 Identities = 75/218 (34%), Positives = 117/218 (53%), Gaps = 19/218 (8%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---- 56
            + DL + +  N  +S    + FLYQL+ G+ + HS   +HRDLKP NLLL+ +      
Sbjct: 115 AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP 174

Query: 57  -LKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
            LKI DFGLAR         T  ++T WYR PE+LL S  Y+ ++D+WS+ CI+ E++ +
Sbjct: 175 VLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFP-HV 172
            PLFPG+  + Q+  + E+LG P D    G     D   + +  P+   ++L +V    +
Sbjct: 235 TPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD---WKQSFPKFRGKTLKRVLGALL 291

Query: 173 HPLAIDLVDRMLTFDPMKRITGE------FF--VPYKP 202
               +DL+  ML  DP+KRI+ +      +F    + P
Sbjct: 292 DDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  243 bits (623), Expect = 6e-81
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 9/198 (4%)

Query: 1   MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           +D DL   +       +  E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K
Sbjct: 101 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + DFGLAR  S    +T  VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF
Sbjct: 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLF 219

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
            G+  V Q+  +++++G P + D    V                 Q + +    +  L  
Sbjct: 220 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-----FHSKSAQPIEKFVTDIDELGK 274

Query: 178 DLVDRMLTFDPMKRITGE 195
           DL+ + LTF+P KRI+  
Sbjct: 275 DLLLKCLTFNPAKRISAY 292

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  242 bits (619), Expect = 9e-81
 Identities = 87/200 (43%), Positives = 118/200 (59%), Gaps = 9/200 (4%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            D DL +   S N  L  E  + FL+QLL+GL + HS NV+HRDLKP NLL+N N +LK+
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPL 117
            +FGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPL
Sbjct: 143 ANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query: 118 FPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPL 175
           FPGND   Q++ +  LLGTPT+       +  D K Y    P +P   SL  V P ++  
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY----PMYPATTSLVNVVPKLNAT 258

Query: 176 AIDLVDRMLTFDPMKRITGE 195
             DL+  +L  +P++RI+ E
Sbjct: 259 GRDLLQNLLKCNPVQRISAE 278

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  243 bits (623), Expect = 1e-80
 Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            + DL  ++ +     +    +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+
Sbjct: 106 CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 165

Query: 60  CDFGLARP-----TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
            DFGLAR       S+    T  VVT WYR PELLL   DY   ID+W  GCI  E+  R
Sbjct: 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
            P+  GN   HQ+ L+ +L G+ T          E  ++   +L +  ++ +        
Sbjct: 226 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL--ELVKGQKRKVKDRLKAYV 283

Query: 174 --PLAIDLVDRMLTFDPMKRIT 193
             P A+DL+D++L  DP +RI 
Sbjct: 284 RDPYALDLIDKLLVLDPAQRID 305

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  239 bits (613), Expect = 1e-79
 Identities = 70/208 (33%), Positives = 111/208 (53%), Gaps = 16/208 (7%)

Query: 1   MDTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           MD DL + + S       + L     +YF +QLL+GL + H   ++HRDLKP NLL+N  
Sbjct: 85  MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR 144

Query: 55  CDLKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             LK+ DFGLAR         +  VVT WYRAP++L+ S  Y+ +ID+WS GCI  E++ 
Sbjct: 145 GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVF--- 169
            +PLFPG +   Q++L+ +++GTP ++      +          + Q P + L QV    
Sbjct: 205 GKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN---PNIQQRPPRDLRQVLQPH 261

Query: 170 --PHVHPLAIDLVDRMLTFDPMKRITGE 195
               +    +D +  +L  +P  R++ +
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRLSAK 289

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  220 bits (562), Expect = 7e-71
 Identities = 70/226 (30%), Positives = 107/226 (47%), Gaps = 33/226 (14%)

Query: 1   MDTDLYQIIRS---------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL 51
            + DL+ II+             L     +  LYQ+L G+ Y+H+  V+HRDLKP+N+L+
Sbjct: 102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 161

Query: 52  NANCD----LKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 103
                    +KI D G AR    P      +   VVT WYRAPELLL +  YT AID+W+
Sbjct: 162 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 221

Query: 104 VGCIFMELMNRRPLFPGND---------HVHQMRLLIELLGTPTDADL-GFVRNEDAKRY 153
           +GCIF EL+   P+F             H  Q+  +  ++G P D D     +  +    
Sbjct: 222 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL 281

Query: 154 IRQLPQHP------RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           ++   ++        + + +        A  L+ ++LT DP+KRIT
Sbjct: 282 MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  164 bits (416), Expect = 6e-49
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 35/225 (15%)

Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCD 56
           +  +LY++I+ N  Q  S    + F + +L+ L  +H   +IH DLKP N+LL       
Sbjct: 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +K+ DFG +    E++ +  Y+ +R+YRAPE++L +  Y   ID+WS+GCI  EL+   P
Sbjct: 241 IKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297

Query: 117 LFPGNDHVHQMRLLIELLGTP--------TDADLGFVRNED------------------- 149
           L PG D   Q+  +IELLG P          A                            
Sbjct: 298 LLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGG 357

Query: 150 -AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
            ++R   + P   R+    +     PL +D + + L +DP  R+T
Sbjct: 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  161 bits (409), Expect = 1e-48
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 39/224 (17%)

Query: 5   LYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---------- 52
            Y  I+ N       +H +   YQ+ + + ++HS  + H DLKP N+L            
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162

Query: 53  ---------ANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 103
                     N D+K+ DFG A  T ++E  +  V TR YRAPE++L    ++   DVWS
Sbjct: 163 KIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWS 219

Query: 104 VGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP--------------TDADLGFVRNED 149
           +GCI +E      +FP +D    + ++  +LG                    L +  +  
Sbjct: 220 IGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSS 279

Query: 150 AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           A RY+ +    P +         H    DL+ +ML +DP KRIT
Sbjct: 280 AGRYVSR-ACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  160 bits (407), Expect = 3e-48
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 39/224 (17%)

Query: 5   LYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---------- 52
            ++ ++ N  Q     H ++  YQL   L+++H   + H DLKP N+L            
Sbjct: 108 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167

Query: 53  ---------ANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 103
                     N  +++ DFG A  T ++E  T  V TR YR PE++L    +    DVWS
Sbjct: 168 HKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWS 224

Query: 104 VGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP--------------TDADLGFVRNED 149
           +GCI  E      LF  +++   + ++ ++LG                    L +  N  
Sbjct: 225 IGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSS 284

Query: 150 AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
             RY+++  +  +  + Q     H    DL+ RML FDP +RIT
Sbjct: 285 DGRYVKENCKPLKSYMLQDSLE-HVQLFDLMRRMLEFDPAQRIT 327

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  157 bits (400), Expect = 5e-47
 Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 29/219 (13%)

Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCD- 56
           +  +L  +I+    + +   + +    QLL GL Y+H    +IH D+KP N+L+      
Sbjct: 112 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171

Query: 57  -----LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
                +KI D G A     +E  T  + TR YR+PE+LL +  +    D+WS  C+  EL
Sbjct: 172 ENLIQIKIADLGNA--CWYDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFEL 228

Query: 112 MNRRPLFPGND------HVHQMRLLIELLGTPTDADL-------GFVRNEDAKRYIRQLP 158
           +    LF  ++          +  +IELLG      L        F  +    R I +L 
Sbjct: 229 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 288

Query: 159 QHPRQ----SLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
             P +       +          D +  ML  DP KR  
Sbjct: 289 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  156 bits (396), Expect = 2e-46
 Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 42/232 (18%)

Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLL--NAN 54
           +  +LY ++R+   + +S    + F  Q+   L ++ +   ++IH DLKP N+LL     
Sbjct: 138 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197

Query: 55  CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
             +KI DFG +      + + +Y+ +R+YR+PE+LL    Y  AID+WS+GCI +E+   
Sbjct: 198 SAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTG 254

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTD--------ADLGFVRNEDA---------------- 150
            PLF G + V QM  ++E+LG P          A   F +  D                 
Sbjct: 255 EPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKP 314

Query: 151 ---------KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                           P   R   +      +    DL+ RML +DP  RI 
Sbjct: 315 PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  155 bits (393), Expect = 5e-46
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 45/231 (19%)

Query: 5   LYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---------- 52
           LY+II  N       E  + +  ++L+ L Y+   ++ H DLKP N+LL+          
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181

Query: 53  ---------------ANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTA 97
                           +  +K+ DFG A  T ++++    + TR YRAPE++LN   +  
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNLG-WDV 238

Query: 98  AIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP--------TDADLGFVRNED 149
           + D+WS GC+  EL     LF  ++H+  + ++  ++           T  +     N+D
Sbjct: 239 SSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKD 298

Query: 150 AKRYIRQLPQHPRQSLAQVFPHV-------HPLAIDLVDRMLTFDPMKRIT 193
             +           S+  V   +       H L  D +  +L  DP  R +
Sbjct: 299 ELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  146 bits (369), Expect = 2e-42
 Identities = 30/190 (15%), Positives = 51/190 (26%), Gaps = 25/190 (13%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  +                 QL+R    + S  ++H    P NL +  +  L + D   
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 65  ARPTSENEFMTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
                         V   Y   E L  +++ +T A++ W +G     +      F     
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +       L  P    L F                           +      L+ R 
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAF----------------------GSCTPLPDFVKTLIGRF 336

Query: 184 LTFDPMKRIT 193
           L FD  +R+ 
Sbjct: 337 LNFDRRRRLL 346

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  144 bits (365), Expect = 2e-42
 Identities = 42/206 (20%), Positives = 78/206 (37%), Gaps = 44/206 (21%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 169

Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A    P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

Query: 109 MELMNRRPLFPG-NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             +   +  F    + + ++  +I+                    +  + P         
Sbjct: 230 YYMTYGKTPFQQIINQISKLHAIID------------------PNHEIEFP--------- 262

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRIT 193
                     D++   L  DP +RI+
Sbjct: 263 --DIPEKDLQDVLKCCLKRDPKQRIS 286

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  143 bits (363), Expect = 3e-42
 Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 45/206 (21%)

Query: 4   DLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            LY +I S N +   +       Q+L  L YIHS  +IHRDLKP N+ ++ + ++KI DF
Sbjct: 101 TLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160

Query: 63  GLAR---------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
           GLA+                   ++ +T  + T  Y A E+L  +  Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
           F E++   P   G + V+ ++ L                       I   P         
Sbjct: 221 FFEMIY--PFSTGMERVNILKKLR-------------------SVSIEFPPDFD------ 253

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRIT 193
              +   +   ++  ++  DP KR  
Sbjct: 254 --DNKMKVEKKIIRLLIDHDPNKRPG 277

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  139 bits (351), Expect = 2e-40
 Identities = 43/212 (20%), Positives = 82/212 (38%), Gaps = 23/212 (10%)

Query: 4   DLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---- 56
            LY ++    +   L E      L  ++ G+ ++    ++HR++KP N++     D    
Sbjct: 95  SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD-------YTAAIDVWSVGCIFM 109
            K+ DFG AR   ++E       T  Y  P++   +         Y A +D+WS+G  F 
Sbjct: 155 YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214

Query: 110 ELMNRRPLFPGNDHVHQMRLLIE--LLGTPTDADLGFVRNEDAK-RYIRQLPQHPRQSLA 166
                   F   +   + + ++   + G P+ A  G  + E+    +   +P     S  
Sbjct: 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-- 272

Query: 167 QVFPHVHPLAIDLVDRMLTFDPMKRIT-GEFF 197
                +  L   ++  +L  D  K     +FF
Sbjct: 273 ---RGLQVLLTPVLANILEADQEKCWGFDQFF 301

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  139 bits (351), Expect = 5e-40
 Identities = 42/206 (20%), Positives = 78/206 (37%), Gaps = 44/206 (21%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 92  NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 150

Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A    P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210

Query: 109 MELMNRRPLFPG-NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             +   +  F    + + ++  +I+                    +  + P         
Sbjct: 211 YYMTYGKTPFQQIINQISKLHAIID------------------PNHEIEFP--------- 243

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRIT 193
                     D++   L  DP +RI+
Sbjct: 244 --DIPEKDLQDVLKCCLKRDPKQRIS 267

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (352), Expect = 8e-40
 Identities = 41/206 (19%), Positives = 77/206 (37%), Gaps = 44/206 (21%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 197

Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A    P + +      V    Y  PE + + S            +   DVWS+GCI 
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

Query: 109 MELMNRRPLFPG-NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             +   +  F    + + ++  +I+                    +  + P         
Sbjct: 258 YYMTYGKTPFQQIINQISKLHAIID------------------PNHEIEFP--------- 290

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRIT 193
                     D++   L  DP +RI+
Sbjct: 291 --DIPEKDLQDVLKCCLKRDPKQRIS 314

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  136 bits (344), Expect = 1e-38
 Identities = 41/207 (19%), Positives = 78/207 (37%), Gaps = 22/207 (10%)

Query: 4   DLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---- 56
            LY ++    +   L E      L  ++ G+ ++    ++HR++KP N++     D    
Sbjct: 95  SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD-------YTAAIDVWSVGCIFM 109
            K+ DFG AR   ++E       T  Y  P++   +         Y A +D+WS+G  F 
Sbjct: 155 YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214

Query: 110 ELMNRRPLFPGNDHVHQMRLLIE--LLGTPTDADLGFVRNE-DAKRYIRQLPQHPRQSLA 166
                   F   +   + + ++   + G P+ A  G  + E     +   +P     S  
Sbjct: 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-- 272

Query: 167 QVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                +  L   ++  +L  D  K   
Sbjct: 273 ---RGLQVLLTPVLANILEADQEKCWG 296

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  133 bits (336), Expect = 3e-38
 Identities = 43/192 (22%), Positives = 68/192 (35%), Gaps = 38/192 (19%)

Query: 4   DLYQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
            L Q I  R  + L +        Q+ +G+ YIHS  +I+RDLKPSN+ L     +KI D
Sbjct: 106 TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FGL      +   T    T  Y +PE + +   Y   +D++++G I  EL+         
Sbjct: 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELL--HVCDTA- 221

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
               +       L                 R    +                     L+ 
Sbjct: 222 ---FETSKFFTDL-----------------RDGI-IS-----------DIFDKKEKTLLQ 249

Query: 182 RMLTFDPMKRIT 193
           ++L+  P  R  
Sbjct: 250 KLLSKKPEDRPN 261

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  133 bits (337), Expect = 4e-38
 Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 31/195 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++     Y  A+D WS+G I    ++  P F
Sbjct: 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
             ++H  Q+ L  ++          F+                       +  V   A+D
Sbjct: 220 --SEHRTQVSLKDQITS----GKYNFIPEV--------------------WAEVSEKALD 253

Query: 179 LVDRMLTFDPMKRIT 193
           LV ++L  DP  R T
Sbjct: 254 LVKKLLVVDPKARFT 268

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (334), Expect = 8e-38
 Identities = 45/191 (23%), Positives = 63/191 (32%), Gaps = 35/191 (18%)

Query: 4   DLYQII-RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L Q       SL E     +L   L  L ++HS  ++H D+KP+N+ L      K+ DF
Sbjct: 142 SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDF 201

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL                  Y APELL     Y  A DV+S+G   +E+     L  G +
Sbjct: 202 GLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGE 259

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              Q+R                                P          +      ++  
Sbjct: 260 GWQQLRQGY---------------------------LPPE-----FTAGLSSELRSVLVM 287

Query: 183 MLTFDPMKRIT 193
           ML  DP  R T
Sbjct: 288 MLEPDPKLRAT 298

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  134 bits (340), Expect = 8e-38
 Identities = 42/197 (21%), Positives = 73/197 (37%), Gaps = 38/197 (19%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-----NANCDLKICDF 62
           + + + +         L Q   GL ++HS N++HRDLKP N+L+     +      I DF
Sbjct: 108 VEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167

Query: 63  GLAR----PTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRP 116
           GL +            +    T  + APE+L        T  +D++S GC+F  +++   
Sbjct: 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
              G     Q  +L+                                       H   +A
Sbjct: 228 HPFGKSLQRQANILL-------------------GACSLDCLHPE--------KHEDVIA 260

Query: 177 IDLVDRMLTFDPMKRIT 193
            +L+++M+  DP KR +
Sbjct: 261 RELIEKMIAMDPQKRPS 277

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  134 bits (339), Expect = 1e-37
 Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 31/195 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 225 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++     Y  A+D WS+G I    ++  P F
Sbjct: 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
             +     ++  I      T     F+                       +  V   A+D
Sbjct: 345 SEHRTQVSLKDQI------TSGKYNFIPEV--------------------WAEVSEKALD 378

Query: 179 LVDRMLTFDPMKRIT 193
           LV ++L  DP  R T
Sbjct: 379 LVKKLLVVDPKARFT 393

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  131 bits (331), Expect = 1e-37
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 32/190 (16%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG +   
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
              E + E   T  Y APE++  S +     Y   +D+WS G I   L+   P F     
Sbjct: 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK- 233

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             QM +L  ++      +  F   E                    +        DLV R 
Sbjct: 234 --QMLMLRMIM----SGNYQFGSPE--------------------WDDYSDTVKDLVSRF 267

Query: 184 LTFDPMKRIT 193
           L   P KR T
Sbjct: 268 LVVQPQKRYT 277

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  137 bits (345), Expect = 2e-37
 Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 16/208 (7%)

Query: 4   DLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---L 57
           DL + +   ++   L E   +  L  +   L+Y+H   +IHRDLKP N++L         
Sbjct: 104 DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIH 163

Query: 58  KICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           KI D G A+   + E  TE+V T  Y APELL     YT  +D WS G +  E +     
Sbjct: 164 KIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFR- 221

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLA 176
            P   +   ++   ++     +  + +     A ++   LP  +    +           
Sbjct: 222 -PFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG------KL 274

Query: 177 IDLVDRMLTFDPMKRITGEFFVPYKPFQ 204
              +  ML +   +R T         FQ
Sbjct: 275 ERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  128 bits (325), Expect = 9e-37
 Identities = 45/194 (23%), Positives = 77/194 (39%), Gaps = 43/194 (22%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155

Query: 65  ARPTSENEFMT-----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           +     +         +Y+       PE ++    +   +D+WS+G +  E +  +P F 
Sbjct: 156 SVHAPSSRRTDLCGTLDYL------PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            N +    + +          +  F             P             V   A DL
Sbjct: 209 ANTYQETYKRISR-------VEFTF-------------P-----------DFVTEGARDL 237

Query: 180 VDRMLTFDPMKRIT 193
           + R+L  +P +R  
Sbjct: 238 ISRLLKHNPSQRPM 251

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  130 bits (328), Expect = 2e-36
 Identities = 51/195 (26%), Positives = 84/195 (43%), Gaps = 32/195 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  + ++H+ N++HRDLKP N+LL+ N  +++ DFG
Sbjct: 186 ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE+L  S D     Y   +D+W+ G I   L+   P F
Sbjct: 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                  Q+ +L  ++         F   E                    +        D
Sbjct: 306 WHRR---QILMLRMIME----GQYQFSSPE--------------------WDDRSSTVKD 338

Query: 179 LVDRMLTFDPMKRIT 193
           L+ R+L  DP  R+T
Sbjct: 339 LISRLLQVDPEARLT 353

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  131 bits (331), Expect = 4e-36
 Identities = 57/193 (29%), Positives = 84/193 (43%), Gaps = 32/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E      + Q+L G+ Y+H  N++HRDLKP NLLL     +  +KI 
Sbjct: 122 ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+      + M E + T +Y APE+L     Y    DVWS+G I   L+   P F G
Sbjct: 182 DFGLSAVFENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGG 239

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   +L ++          F   E                    + +V   A DL+
Sbjct: 240 Q---TDQEILRKVE----KGKYTFDSPE--------------------WKNVSEGAKDLI 272

Query: 181 DRMLTFDPMKRIT 193
            +ML FD  +RI+
Sbjct: 273 KQMLQFDSQRRIS 285

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  128 bits (323), Expect = 8e-36
 Identities = 39/193 (20%), Positives = 75/193 (38%), Gaps = 34/193 (17%)

Query: 4   DLYQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL++ I  +      E+    +  Q+   LK++H   ++HRD+K  N+ L  +  +++ D
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168

Query: 62  FGLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           FG+AR  +    +    + T +Y +PE+  N   Y    D+W++GC+  EL   +  F  
Sbjct: 169 FGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEA 227

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
               + +  +I                         +  H    L             LV
Sbjct: 228 GSMKNLVLKII-------------------SGSFPPVSLHYSYDLR-----------SLV 257

Query: 181 DRMLTFDPMKRIT 193
            ++   +P  R +
Sbjct: 258 SQLFKRNPRDRPS 270

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  126 bits (318), Expect = 1e-35
 Identities = 43/206 (20%), Positives = 77/206 (37%), Gaps = 49/206 (23%)

Query: 4   DLYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +L   +    ++       C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+ 
Sbjct: 101 NLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160

Query: 61  DFGLAR-------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
           DFGL               P       T  V T+ Y +PE +  +S Y+  +D++S+G I
Sbjct: 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLI 219

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             EL+   P     + V  +  +                                     
Sbjct: 220 LFELL--YPFSTQMERVRTLTDVRN------------------------------LKFPP 247

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +F   +P    +V  ML+  PM+R  
Sbjct: 248 LFTQKYPCEYVMVQDMLSPSPMERPE 273

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (315), Expect = 4e-35
 Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 33/190 (17%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFGL
Sbjct: 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161

Query: 65  A-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A +   + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F     
Sbjct: 162 ATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SC 219

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + +  L I                   K+    +P            H++P+A  L+ +M
Sbjct: 220 LKETYLRI-------------------KKNEYSIP-----------KHINPVAASLIQKM 249

Query: 184 LTFDPMKRIT 193
           L  DP  R T
Sbjct: 250 LQTDPTARPT 259

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  124 bits (314), Expect = 4e-35
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 31/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 91  ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I   L+   P F  
Sbjct: 151 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D   Q RL  ++          +   E                    +  V P A  L+
Sbjct: 210 ED---QHRLYAQIKA----GAYDYPSPE--------------------WDTVTPEAKSLI 242

Query: 181 DRMLTFDPMKRIT 193
           D MLT +P KRIT
Sbjct: 243 DSMLTVNPKKRIT 255

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  128 bits (323), Expect = 4e-35
 Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 32/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL   + + +++I 
Sbjct: 112 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 171

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L     Y    DVWS G I   L++  P F G
Sbjct: 172 DFGLSTHFEASKKMKDKIGTAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNG 229

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +   +  +L ++          F   +                    +  V   A DL+
Sbjct: 230 AN---EYDILKKVE----KGKYTFELPQ--------------------WKKVSESAKDLI 262

Query: 181 DRMLTFDPMKRIT 193
            +MLT+ P  RI+
Sbjct: 263 RKMLTYVPSMRIS 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  125 bits (315), Expect = 6e-35
 Identities = 43/206 (20%), Positives = 78/206 (37%), Gaps = 49/206 (23%)

Query: 4   DLYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +L   +    SL       C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+ 
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 206

Query: 61  DFGLAR-------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
           DFGL               P       T  V T+ Y +PE  ++ ++Y+  +D++S+G I
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLI 265

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             EL+         + V  +  +                            + P      
Sbjct: 266 LFELLY--SFSTQMERVRIITDVRN-------------------------LKFP-----L 293

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +F   +P    +V  ML+  P +R  
Sbjct: 294 LFTQKYPQEHMMVQDMLSPSPTERPE 319

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (316), Expect = 6e-35
 Identities = 39/191 (20%), Positives = 75/191 (39%), Gaps = 24/191 (12%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
                +  +  +  +  +L    YIH+  N+ HRD+KPSN+L++ N  +K+ DFG +   
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202

Query: 69  SENEFMT-----EYVVTRWYRAPELLLNSSDY-TAAIDVWSVGCIFMELMNRRPLFPGND 122
            + +        E++       PE   N S Y  A +D+WS+G     +      F    
Sbjct: 203 VDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
            + ++   I         ++ +  + +   Y     +    +       +    ID +  
Sbjct: 257 SLVELFNNIR------TKNIEYPLDRNHFLYPLTNKKSTCSN-----NFLSNEDIDFLKL 305

Query: 183 MLTFDPMKRIT 193
            L  +P +RIT
Sbjct: 306 FLRKNPAERIT 316

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  125 bits (316), Expect = 6e-35
 Identities = 60/190 (31%), Positives = 94/190 (49%), Gaps = 33/190 (17%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFGL
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187

Query: 65  A-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A +   + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F     
Sbjct: 188 ATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SC 245

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + +  L I              +NE    Y   +P            H++P+A  L+ +M
Sbjct: 246 LKETYLRI-------------KKNE----Y--SIP-----------KHINPVAASLIQKM 275

Query: 184 LTFDPMKRIT 193
           L  DP  R T
Sbjct: 276 LQTDPTARPT 285

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  125 bits (315), Expect = 8e-35
 Identities = 44/192 (22%), Positives = 76/192 (39%), Gaps = 35/192 (18%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLAR- 66
             +    E+     + Q+   L Y+H+  + HRD+KP N L   N + ++K+ DFGL++ 
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219

Query: 67  ----PTSENEFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNRRPLFPGN 121
                  E   MT    T ++ APE+L  +++ Y    D WS G +   L+     FPG 
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV 279

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
           +         + +    +  L F                        +  + PLA DL+ 
Sbjct: 280 ND-------ADTISQVLNKKLCFENPN--------------------YNVLSPLARDLLS 312

Query: 182 RMLTFDPMKRIT 193
            +L  +  +R  
Sbjct: 313 NLLNRNVDERFD 324

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  127 bits (322), Expect = 1e-34
 Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 32/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I +     E      + Q+L G+ Y+H  N++HRD+KP N+LL   N+  ++KI 
Sbjct: 132 ELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+   S++  + + + T +Y APE+L     Y    DVWS G I   L+   P F G
Sbjct: 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGG 249

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +      ++ ++          F  N+                    + ++   A +L+
Sbjct: 250 QN---DQDIIKKVE----KGKYYFDFND--------------------WKNISDEAKELI 282

Query: 181 DRMLTFDPMKRIT 193
             MLT+D  KR T
Sbjct: 283 KLMLTYDYNKRCT 295

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  127 bits (321), Expect = 1e-34
 Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 32/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL     +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +   +  +L  +          F   +                    +  +   A DL+
Sbjct: 225 KN---EYDILKRVE----TGKYAFDLPQ--------------------WRTISDDAKDLI 257

Query: 181 DRMLTFDPMKRIT 193
            +MLTF P  RIT
Sbjct: 258 RKMLTFHPSLRIT 270

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  122 bits (309), Expect = 2e-34
 Identities = 46/194 (23%), Positives = 76/194 (39%), Gaps = 43/194 (22%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           LY+ ++ +    E+    F+ +L   L Y H   VIHRD+KP NLL+    +LKI DFG 
Sbjct: 101 LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW 160

Query: 65  ARPTSENEFMT-----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           +         T     +Y+       PE ++    +   +D+W  G +  E +   P F 
Sbjct: 161 SVHAPSLRRRTMCGTLDYL------PPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
              H    R ++         DL F             P           P +   + DL
Sbjct: 214 SPSHTETHRRIVN-------VDLKF-------------P-----------PFLSDGSKDL 242

Query: 180 VDRMLTFDPMKRIT 193
           + ++L + P +R+ 
Sbjct: 243 ISKLLRYHPPQRLP 256

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  122 bits (309), Expect = 2e-34
 Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 32/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL     +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +   +  +L  +          F   +                    +  +   A DL+
Sbjct: 225 KN---EYDILKRVE----TGKYAFDLPQ--------------------WRTISDDAKDLI 257

Query: 181 DRMLTFDPMKRIT 193
            +MLTF P  RIT
Sbjct: 258 RKMLTFHPSLRIT 270

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  122 bits (308), Expect = 2e-34
 Identities = 48/193 (24%), Positives = 78/193 (40%), Gaps = 32/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ +   +   E      +  +L  + Y H  NV HRDLKP N L    + +  LK+ 
Sbjct: 92  ELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLI 151

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA      + M   V T +Y +P++L     Y    D WS G +   L+   P F  
Sbjct: 152 DFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSA 209

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   +++++     +    F   +                    + +V P A  L+
Sbjct: 210 PT---DSEVMLKIR----EGTFTFPEKD--------------------WLNVSPQAESLI 242

Query: 181 DRMLTFDPMKRIT 193
            R+LT  P +RIT
Sbjct: 243 RRLLTKSPKQRIT 255

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  121 bits (307), Expect = 4e-34
 Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 41/200 (20%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNAN 54
           DL  +I    +  Q L EE     + QL   LK  H  +     V+HRDLKP+N+ L+  
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152

Query: 55  CDLKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLAR    +  F   +V T +Y +PE +   S Y    D+WS+GC+  EL  
Sbjct: 153 QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCA 211

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
             P F       ++   I                   +   R++P      L        
Sbjct: 212 LMPPFTAFSQ-KELAGKIR------------------EGKFRRIPYRYSDEL-------- 244

Query: 174 PLAIDLVDRMLTFDPMKRIT 193
               +++ RML      R +
Sbjct: 245 ---NEIITRMLNLKDYHRPS 261

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (306), Expect = 5e-34
 Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 34/191 (17%)

Query: 5   LYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           + + +++     SE   ++F++Q++ G+ Y+HS  ++HRDL  SNLLL  N ++KI DFG
Sbjct: 98  MNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157

Query: 64  LA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA +    +E       T  Y +PE +   S +    DVWS+GC+F  L+  RP F   D
Sbjct: 158 LATQLKMPHEKHYTLCGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGRPPFDT-D 215

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
            V      +        AD                P             +   A DL+ +
Sbjct: 216 TVKNTLNKV------VLADYEM-------------P-----------SFLSIEAKDLIHQ 245

Query: 183 MLTFDPMKRIT 193
           +L  +P  R++
Sbjct: 246 LLRRNPADRLS 256

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  122 bits (309), Expect = 5e-34
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 33/190 (17%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGL 64
           +    + +SE      + Q+L G+ Y+H  N++H DLKP N+LL       D+KI DFG+
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFPGNDH 123
           +R       + E + T  Y APE +LN    T A D+W++G I +M L +  P F G D+
Sbjct: 181 SRKIGHACELREIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSP-FVGEDN 238

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                   E     +  ++ +                        F  V  LA D +  +
Sbjct: 239 Q-------ETYLNISQVNVDYSEET--------------------FSSVSQLATDFIQSL 271

Query: 184 LTFDPMKRIT 193
           L  +P KR T
Sbjct: 272 LVKNPEKRPT 281

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  122 bits (309), Expect = 8e-34
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 31/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I   L+   P F  
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D   Q RL  ++          +   E                    +  V P A  L+
Sbjct: 233 ED---QHRLYAQIK----AGAYDYPSPE--------------------WDTVTPEAKSLI 265

Query: 181 DRMLTFDPMKRIT 193
           D MLT +P KRIT
Sbjct: 266 DSMLTVNPKKRIT 278

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  119 bits (302), Expect = 2e-33
 Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 32/194 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKI 59
           +L+  +   +SL+E+    FL Q+L G+ Y+HS  + H DLKP N++L      N  +K+
Sbjct: 94  ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG+A              T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 212

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G           E L   +  +  F                        F +   LA D 
Sbjct: 213 GETKQ-------ETLTNISAVNYDFDEEY--------------------FSNTSELAKDF 245

Query: 180 VDRMLTFDPMKRIT 193
           + R+L  DP +R+T
Sbjct: 246 IRRLLVKDPKRRMT 259

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  120 bits (303), Expect = 4e-33
 Identities = 51/194 (26%), Positives = 79/194 (40%), Gaps = 32/194 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N++L         +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+          E L   T     F                        F H   LA D 
Sbjct: 220 GDTKQ-------ETLANITSVSYDFDEEF--------------------FSHTSELAKDF 252

Query: 180 VDRMLTFDPMKRIT 193
           + ++L  +  KR+T
Sbjct: 253 IRKLLVKETRKRLT 266

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  121 bits (306), Expect = 4e-33
 Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 30/188 (15%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLA 65
           I   +  +SE     ++ Q   GLK++H  +++H D+KP N++        +KI DFGLA
Sbjct: 139 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198

Query: 66  RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
              + +E +     T  + APE +++        D+W++G +   L++    F G D + 
Sbjct: 199 TKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL- 256

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                 E L      D  F  +                     F  V P A D +  +L 
Sbjct: 257 ------ETLQNVKRCDWEFDEDA--------------------FSSVSPEAKDFIKNLLQ 290

Query: 186 FDPMKRIT 193
            +P KR+T
Sbjct: 291 KEPRKRLT 298

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  120 bits (302), Expect = 4e-33
 Identities = 37/124 (29%), Positives = 65/124 (52%), Gaps = 6/124 (4%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL ++I    +  + + E     +  QL   L+++HS  V+HRD+KP+N+ + A   +K+
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL 177

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            D GL R  +S+       V T +Y +PE +  +  Y    D+WS+GC+  E+   +  F
Sbjct: 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPF 236

Query: 119 PGND 122
            G+ 
Sbjct: 237 YGDK 240

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  120 bits (302), Expect = 5e-33
 Identities = 42/189 (22%), Positives = 77/189 (40%), Gaps = 32/189 (16%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLA 65
           I  S   L+E     +++Q+   L+++HS N+ H D++P N++     +  +KI +FG A
Sbjct: 92  INTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151

Query: 66  RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFPGNDHV 124
           R     +          Y APE +      + A D+WS+G + ++ L    P F    + 
Sbjct: 152 RQLKPGDNFRLLFTAPEYYAPE-VHQHDVVSTATDMWSLGTLVYVLLSGINP-FLAETNQ 209

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
                  +++    +A+  F                        F  +   A+D VDR+L
Sbjct: 210 -------QIIENIMNAEYTFDEEA--------------------FKEISIEAMDFVDRLL 242

Query: 185 TFDPMKRIT 193
             +   R+T
Sbjct: 243 VKERKSRMT 251

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (302), Expect = 5e-33
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 32/194 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N++L         +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA              T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 218

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+          E L   +  +  F                        F +   LA D 
Sbjct: 219 GDTKQ-------ETLANVSAVNYEFEDEY--------------------FSNTSALAKDF 251

Query: 180 VDRMLTFDPMKRIT 193
           + R+L  DP KR+T
Sbjct: 252 IRRLLVKDPKKRMT 265

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  120 bits (303), Expect = 6e-33
 Identities = 49/189 (25%), Positives = 75/189 (39%), Gaps = 32/189 (16%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGL 64
           +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N++L         +K+ DFGL
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           A    +         T  + APE ++N        D+WS+G I   L++    F G+   
Sbjct: 166 AHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
                  E L   T     F                        F     LA D + ++L
Sbjct: 225 -------ETLANITAVSYDFDEEF--------------------FSQTSELAKDFIRKLL 257

Query: 185 TFDPMKRIT 193
             +  KR+T
Sbjct: 258 VKETRKRLT 266

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  119 bits (301), Expect = 8e-33
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 25/194 (12%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I+  +  SE    Y + +L+  + ++H   V+HRDLKP NLL    N N ++KI 
Sbjct: 92  ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKII 151

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFG AR    +N+ +     T  Y APE LLN + Y  + D+WS+G I   +++ +  F 
Sbjct: 152 DFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            +D        +E++      D  F                        + +V   A DL
Sbjct: 211 SHDRSLTCTSAVEIMKKIKKGDFSFEGEA--------------------WKNVSQEAKDL 250

Query: 180 VDRMLTFDPMKRIT 193
           +  +LT DP KR+ 
Sbjct: 251 IQGLLTVDPNKRLK 264

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  119 bits (301), Expect = 1e-32
 Identities = 53/193 (27%), Positives = 79/193 (40%), Gaps = 30/193 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      SE      + Q+L  + Y+H   ++HRDLKP NLL      +  LKI 
Sbjct: 134 ELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL++       M     T  Y APE+L   + Y   +D+WSVG I   L+     F  
Sbjct: 194 DFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPF-- 250

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D      +   +L    + +  F+                       +  V   A DLV
Sbjct: 251 YDERGDQFMFRRIL----NCEYYFISPW--------------------WDEVSLNAKDLV 286

Query: 181 DRMLTFDPMKRIT 193
            +++  DP KR+T
Sbjct: 287 RKLIVLDPKKRLT 299

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  118 bits (299), Expect = 2e-32
 Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 28/187 (14%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++++HS N+ HRD+KP NLL      +  LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T++N   T    T +Y APE+L     Y  + D+WS+G I   L+   P F  N     
Sbjct: 180 ETTQNALQTP-CYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSN---TG 234

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF 186
             +   +         GF   E                    +  V   A  L+  +L  
Sbjct: 235 QAISPGMKRRIRLGQYGFPNPE--------------------WSEVSEDAKQLIRLLLKT 274

Query: 187 DPMKRIT 193
           DP +R+T
Sbjct: 275 DPTERLT 281

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  117 bits (296), Expect = 2e-32
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 33/187 (17%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
              ++LSE +    + Q++  L Y HS +V+H+DLKP N+L    + +  +KI DFGLA 
Sbjct: 116 ARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
               +E  T    T  Y APE+     D T   D+WS G +   L+     F G      
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-- 231

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF 186
                E+    T  +  +                 R         + P A+DL+ +MLT 
Sbjct: 232 -----EVQQKATYKEPNY-------------AVECR--------PLTPQAVDLLKQMLTK 265

Query: 187 DPMKRIT 193
           DP +R +
Sbjct: 266 DPERRPS 272

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  118 bits (299), Expect = 2e-32
 Identities = 50/195 (25%), Positives = 79/195 (40%), Gaps = 30/195 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD----LKI 59
           +L   I   +  SE      L+ + + ++Y+H+  V+HRDLKPSN+L          ++I
Sbjct: 102 ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI 161

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           CDFG A+   +EN  +     T  + APE+L     Y AA D+WS+G +   ++     F
Sbjct: 162 CDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPF 220

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                     +L  +                                   +  V   A D
Sbjct: 221 ANGPDDTPEEILARIG----SGKFSLSGGY--------------------WNSVSDTAKD 256

Query: 179 LVDRMLTFDPMKRIT 193
           LV +ML  DP +R+T
Sbjct: 257 LVSKMLHVDPHQRLT 271

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  118 bits (297), Expect = 2e-32
 Identities = 50/206 (24%), Positives = 72/206 (34%), Gaps = 44/206 (21%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            L+  I         L+E+   + L  + RGL+ IH+    HRDLKP+N+LL       +
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175

Query: 60  CDFGLARPTS----------ENEFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCI 107
            D G                  +       T  YRAPEL    S        DVWS+GC+
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
              +M     +           L              V+N+        +PQ PR S   
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVALA-------------VQNQ------LSIPQSPRHS--- 273

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRIT 193
                      L++ M+T DP +R  
Sbjct: 274 ------SALWQLLNSMMTVDPHQRPH 293

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  118 bits (298), Expect = 4e-32
 Identities = 46/188 (24%), Positives = 76/188 (40%), Gaps = 30/188 (15%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLA 65
           II  + +L+E     F+ Q+  G++++H   ++H DLKP N+L        +KI DFGLA
Sbjct: 177 IIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236

Query: 66  RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
           R     E +     T  + APE ++N    +   D+WSVG I   L++    F G++   
Sbjct: 237 RRYKPREKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA- 294

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                 E L             E                    F  +   A + + ++L 
Sbjct: 295 ------ETLNNILACRWDLEDEE--------------------FQDISEEAKEFISKLLI 328

Query: 186 FDPMKRIT 193
            +   RI+
Sbjct: 329 KEKSWRIS 336

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  121 bits (304), Expect = 4e-32
 Identities = 41/188 (21%), Positives = 72/188 (38%), Gaps = 30/188 (15%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLA 65
           +   +  +SE+    ++ Q+ +GL ++H  N +H DLKP N++     + +LK+ DFGL 
Sbjct: 245 VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304

Query: 66  RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
                 + +     T  + APE +          D+WSVG +   L++    F G +   
Sbjct: 305 AHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD- 362

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                 E L      D     +                     F  +     D + ++L 
Sbjct: 363 ------ETLRNVKSCDWNMDDSA--------------------FSGISEDGKDFIRKLLL 396

Query: 186 FDPMKRIT 193
            DP  R+T
Sbjct: 397 ADPNTRMT 404

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (291), Expect = 1e-31
 Identities = 42/213 (19%), Positives = 73/213 (34%), Gaps = 59/213 (27%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN----- 54
            L   I    R      E   +  L Q+ RGL+YIHS +++H D+KPSN+ ++       
Sbjct: 97  SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 156

Query: 55  --------------CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAID 100
                            KI D G    T  +    E      + A E+L  +  +    D
Sbjct: 157 ASEEGDEDDWASNKVMFKIGDLGHV--TRISSPQVE-EGDSRFLANEVLQENYTHLPKAD 213

Query: 101 VWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH 160
           ++++    +      PL    D  H++R                      +  + ++PQ 
Sbjct: 214 IFALALTVVCAAGAEPLPRNGDQWHEIR----------------------QGRLPRIPQV 251

Query: 161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
             Q              +L+  M+  DP +R +
Sbjct: 252 LSQEF-----------TELLKVMIHPDPERRPS 273

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  115 bits (290), Expect = 2e-31
 Identities = 46/188 (24%), Positives = 83/188 (44%), Gaps = 32/188 (17%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           + + + LSE+  +++   L++G++Y+H   +IHRD+KPSNLL+  +  +KI DFG+    
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 68  TSENEFMTEYVVTRWYRAPELLLNSS-DYT-AAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
              +  ++  V T  + APE L  +   ++  A+DVW++G      +  +  F   + + 
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIM 246

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
            +   I                   K    + P  P  +             DL+ RML 
Sbjct: 247 CLHSKI-------------------KSQALEFPDQPDIA---------EDLKDLITRMLD 278

Query: 186 FDPMKRIT 193
            +P  RI 
Sbjct: 279 KNPESRIV 286

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  116 bits (292), Expect = 2e-31
 Identities = 43/196 (21%), Positives = 81/196 (41%), Gaps = 36/196 (18%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFG 63
           L Q+I+    L E+   Y+L Q L GL+Y+H+  ++H D+K  N+LL+++     +CDFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196

Query: 64  LARPTSENEFMTEYVV------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            A     +      +       T  + APE+++      A +D+WS  C+ + ++N    
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP 255

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +       +  L +++   P                   + + P        P   PL  
Sbjct: 256 WT---QYFRGPLCLKIASEPPP-----------------IREIP--------PSCAPLTA 287

Query: 178 DLVDRMLTFDPMKRIT 193
             +   L  +P+ R +
Sbjct: 288 QAIQEGLRKEPVHRAS 303

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  117 bits (293), Expect = 2e-31
 Identities = 26/200 (13%), Positives = 58/200 (29%), Gaps = 48/200 (24%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L     +++SL          Q++R L  +H   ++H  L+P +++L+    + +  F 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 64  LARPTSENEFMTEYVVTRWYRAPELL----------LNSSDYTAAIDVWSVGCIFMELMN 113
                          V+R +  PEL              +  T + D W++G +   +  
Sbjct: 252 HLVRDGA---RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
                  +  +     +                     R  + +P               
Sbjct: 309 ADLPITKDAALGGSEWIF--------------------RSCKNIP--------------- 333

Query: 174 PLAIDLVDRMLTFDPMKRIT 193
                L++  L +    R+ 
Sbjct: 334 QPVRALLEGFLRYPKEDRLL 353

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  114 bits (287), Expect = 6e-31
 Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 32/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E+     + Q+L  +KY+H   ++HRDLKP NLL      N  + I 
Sbjct: 92  ELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMIT 151

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL++   +N  M+    T  Y APE+L     Y+ A+D WS+G I   L+   P F  
Sbjct: 152 DFGLSK-MEQNGIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYE 209

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                + +L  ++     +    F                        +  +   A D +
Sbjct: 210 ET---ESKLFEKIK----EGYYEFESPF--------------------WDDISESAKDFI 242

Query: 181 DRMLTFDPMKRIT 193
             +L  DP +R T
Sbjct: 243 CHLLEKDPNERYT 255

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  115 bits (291), Expect = 7e-31
 Identities = 51/191 (26%), Positives = 79/191 (41%), Gaps = 35/191 (18%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL      N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE+L     Y  + D+WS+G I   L+   P F  N     
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNH---- 267

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQ----LPQHPRQSLAQVFPHVHPLAIDLVDR 182
                   G      +        K  IR      P          +  V      L+  
Sbjct: 268 --------GLAISPGM--------KTRIRMGQYEFPNPE-------WSEVSEEVKMLIRN 304

Query: 183 MLTFDPMKRIT 193
           +L  +P +R+T
Sbjct: 305 LLKTEPTQRMT 315

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  114 bits (288), Expect = 9e-31
 Identities = 49/188 (26%), Positives = 73/188 (38%), Gaps = 33/188 (17%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
            +    SE    +++ Q+L  L+Y H  N+IHRD+KP  +LL     +  +K+  FG+A 
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181

Query: 67  PTSEN-EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
              E+       V T  + APE ++    Y   +DVW  G I   L++    F G     
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-- 238

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                  L              +                    + H+   A DLV RML 
Sbjct: 239 ------RLFEGIIKGKYKMNPRQ--------------------WSHISESAKDLVRRMLM 272

Query: 186 FDPMKRIT 193
            DP +RIT
Sbjct: 273 LDPAERIT 280

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  114 bits (287), Expect = 3e-30
 Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 51/208 (24%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-------------NANCDL 57
           + +   E +    L Q+  G+ ++HS  +IHRDLKP N+L+               N  +
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167

Query: 58  KICDFGLARPTSENEF-----MTEYVVTRWYRAPELLLNSSD------YTAAIDVWSVGC 106
            I DFGL +     +      +     T  +RAPELL  S++       T +ID++S+GC
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227

Query: 107 IFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
           +F  ++++ +  F                           R  +  R I  L +      
Sbjct: 228 VFYYILSKGKHPFGDKYS----------------------RESNIIRGIFSLDEMKCLHD 265

Query: 166 AQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                 +   A DL+ +M+  DP+KR T
Sbjct: 266 ----RSLIAEATDLISQMIDHDPLKRPT 289

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (285), Expect = 7e-30
 Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 32/194 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   V+HR+LKP NLLL        +K+ 
Sbjct: 96  ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLA 155

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     E +    +  T  Y +PE+L     Y   +D+W+ G I   L+   P F 
Sbjct: 156 DFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFW 214

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             D   Q RL  ++          F   E                    +  V P A DL
Sbjct: 215 DED---QHRLYQQIK----AGAYDFPSPE--------------------WDTVTPEAKDL 247

Query: 180 VDRMLTFDPMKRIT 193
           +++MLT +P KRIT
Sbjct: 248 INKMLTINPSKRIT 261

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  111 bits (279), Expect = 1e-29
 Identities = 43/190 (22%), Positives = 83/190 (43%), Gaps = 31/190 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 100 EVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 159

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            +   +    +  +     Y APEL          +DVWS+G I   L++    F G  +
Sbjct: 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QN 218

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + ++R  +                    R   ++P            ++     +L+ R 
Sbjct: 219 LKELRERV-------------------LRGKYRIP-----------FYMSTDCENLLKRF 248

Query: 184 LTFDPMKRIT 193
           L  +P+KR T
Sbjct: 249 LVLNPIKRGT 258

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  109 bits (276), Expect = 1e-29
 Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 31/192 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFGL
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151

Query: 65  A---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           A   R  +    + +   T  Y APELL     +   +DVWS G +   ++      P +
Sbjct: 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
                 +   +                  ++     P          +  +    + L+ 
Sbjct: 210 QPSDSCQEYSDWK----------------EKKTYLNP----------WKKIDSAPLALLH 243

Query: 182 RMLTFDPMKRIT 193
           ++L  +P  RIT
Sbjct: 244 KILVENPSARIT 255

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  111 bits (279), Expect = 3e-29
 Identities = 23/198 (11%), Positives = 52/198 (26%), Gaps = 47/198 (23%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L     +++SL          Q++R L  +H   ++H  L+P +++L+    + +  F  
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257

Query: 65  ARPTSENEFM--TEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
                 +               A  +L     + +  T A D W++G     +       
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL--- 175
             +                                              +F     +   
Sbjct: 318 TDDA--------------------------------------ALGGSEWIFRSCKNIPQP 339

Query: 176 AIDLVDRMLTFDPMKRIT 193
              L++  L +    R+ 
Sbjct: 340 VRALLEGFLRYPKEDRLL 357

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  109 bits (275), Expect = 4e-29
 Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 31/192 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFGL
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151

Query: 65  A---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           A   R  +    + +   T  Y APELL     +   +DVWS G +   ++      P +
Sbjct: 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
                 +   +                  ++     P          +  +    + L+ 
Sbjct: 210 QPSDSCQEYSDWK----------------EKKTYLNP----------WKKIDSAPLALLH 243

Query: 182 RMLTFDPMKRIT 193
           ++L  +P  RIT
Sbjct: 244 KILVENPSARIT 255

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  109 bits (274), Expect = 8e-29
 Identities = 49/207 (23%), Positives = 85/207 (41%), Gaps = 50/207 (24%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICD 61
           +  + + S   LS +      YQ  R ++++H     +IHRDLK  NLLL+    +K+CD
Sbjct: 122 EFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181

Query: 62  FGLARP---------TSENEFMTEYVVTR----WYRAPEL--LLNSSDYTAAIDVWSVGC 106
           FG A           +++   + E  +TR     YR PE+  L ++       D+W++GC
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241

Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
           I   L  R+  F       ++R++                     +Y   +P H  Q   
Sbjct: 242 ILYLLCFRQHPFEDG---AKLRIV-------------------NGKY--SIPPHDTQY-- 275

Query: 167 QVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                   +   L+  ML  +P +R++
Sbjct: 276 -------TVFHSLIRAMLQVNPEERLS 295

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  107 bits (269), Expect = 2e-28
 Identities = 48/194 (24%), Positives = 77/194 (39%), Gaps = 33/194 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDF 62
            L +        +E+   ++  Q+L GLKY+H   ++HRD+K  N+L+N  +  LKI DF
Sbjct: 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 167

Query: 63  GLARPTSENEFMTEYVV-TRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNRRPLFPG 120
           G ++  +     TE    T  Y APE++      Y  A D+WS+GC  +E+   +P  P 
Sbjct: 168 GTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PF 225

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDL 179
            +       +             F         +     HP        P  +   A   
Sbjct: 226 YELGEPQAAM-------------F--------KVGMFKVHPE------IPESMSAEAKAF 258

Query: 180 VDRMLTFDPMKRIT 193
           + +    DP KR  
Sbjct: 259 ILKCFEPDPDKRAC 272

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  107 bits (269), Expect = 3e-28
 Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 35/183 (19%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA---RPTSEN 71
                   +  QL+ GL+Y+HS  ++H+D+KP NLLL     LKI   G+A    P + +
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYT-AAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
           +       +  ++ PE+      ++   +D+WS G     +      F G D+++++   
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFEN 224

Query: 131 IELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
           I                    +    +P               P   DL+  ML ++P K
Sbjct: 225 I-------------------GKGSYAIP-----------GDCGPPLSDLLKGMLEYEPAK 254

Query: 191 RIT 193
           R +
Sbjct: 255 RFS 257

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  107 bits (268), Expect = 4e-28
 Identities = 42/191 (21%), Positives = 71/191 (37%), Gaps = 39/191 (20%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           G      +  +   +  TR Y  PE +     +  +  VWS+G +  +++     F    
Sbjct: 195 GSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---- 249

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                                    E  +  IR                V      L+  
Sbjct: 250 -------------------------EHDEEIIRGQVFFR--------QRVSSECQHLIRW 276

Query: 183 MLTFDPMKRIT 193
            L   P  R T
Sbjct: 277 CLALRPSDRPT 287

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  107 bits (268), Expect = 4e-28
 Identities = 39/190 (20%), Positives = 69/190 (36%), Gaps = 37/190 (19%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  I  +  L E    Y   QL+  + Y+   ++IHRD+K  N+++  +  +K+ DFG
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            A      +    +  T  Y APE+L+ +      +++WS+G     L+     F     
Sbjct: 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF----- 230

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                                    + +  +      P          V    + LV  +
Sbjct: 231 ------------------------CELEETVEAAIHPP--------YLVSKELMSLVSGL 258

Query: 184 LTFDPMKRIT 193
           L   P +R T
Sbjct: 259 LQPVPERRTT 268

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  107 bits (269), Expect = 5e-28
 Identities = 48/190 (25%), Positives = 85/190 (44%), Gaps = 31/190 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I   + ++E+  + F  Q++  ++Y H   ++HRDLKP NLLL+ N ++KI DFG
Sbjct: 94  ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG 153

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   ++  F+     +  Y APE++         +DVWS G +   ++  R  F   + 
Sbjct: 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EF 212

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           +  +   +                      +  +P             + P A  L+ RM
Sbjct: 213 IPNLFKKV-------------------NSCVYVMP-----------DFLSPGAQSLIRRM 242

Query: 184 LTFDPMKRIT 193
           +  DPM+RIT
Sbjct: 243 IVADPMQRIT 252

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  106 bits (266), Expect = 8e-28
 Identities = 41/191 (21%), Positives = 69/191 (36%), Gaps = 39/191 (20%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDF 62
           DL+  I     L E   + F  Q++  +++ HS  V+HRD+K  N+L++      K+ DF
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           G      +  +   +  TR Y  PE +     +     VWS+G +  +++      P   
Sbjct: 185 GSGALLHDEPYTD-FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD--IP--- 238

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                                F R+++        P            HV P    L+ R
Sbjct: 239 ---------------------FERDQEILEAELHFP-----------AHVSPDCCALIRR 266

Query: 183 MLTFDPMKRIT 193
            L   P  R +
Sbjct: 267 CLAPKPSSRPS 277

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  105 bits (264), Expect = 8e-28
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 31/190 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   +    Q+L  + Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 97  ELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   S+ EF+     +  Y APE++         +D+WS G I   L+     F   +H
Sbjct: 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EH 215

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           V  +   I                   +  +  +P            +++     L+  M
Sbjct: 216 VPTLFKKI-------------------RGGVFYIP-----------EYLNRSVATLLMHM 245

Query: 184 LTFDPMKRIT 193
           L  DP+KR T
Sbjct: 246 LQVDPLKRAT 255

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  105 bits (265), Expect = 1e-27
 Identities = 44/208 (21%), Positives = 72/208 (34%), Gaps = 43/208 (20%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLA 65
           I   +  +E      +  +   L ++H+  + HRDLKP N+L    N    +KICDF L 
Sbjct: 102 IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161

Query: 66  RPTSENEFMTEYVVTRW--------YRAPELLLNSSD----YTAAIDVWSVGCIFMELMN 113
                N   +               Y APE++   S+    Y    D+WS+G I   L++
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTD--------ADLGFVRNEDAKRYIRQLPQHPRQSL 165
             P F G           E      +            F   +                 
Sbjct: 222 GYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD----------------- 264

Query: 166 AQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
              + H+   A DL+ ++L  D  +R++
Sbjct: 265 ---WAHISCAAKDLISKLLVRDAKQRLS 289

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  106 bits (266), Expect = 1e-27
 Identities = 52/192 (27%), Positives = 76/192 (39%), Gaps = 27/192 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICD 61
           +LY+ I +    SE+  ++F  QLL G+ Y HS  + HRDLK  N LL  +    LKICD
Sbjct: 102 ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G     ++     F   
Sbjct: 162 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
           +     R  I+ +                      +P             + P    L+ 
Sbjct: 222 EEPRDYRKTIQRI----------------LSVKYSIPDD---------IRISPECCHLIS 256

Query: 182 RMLTFDPMKRIT 193
           R+   DP  RI+
Sbjct: 257 RIFVADPATRIS 268

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  103 bits (259), Expect = 5e-27
 Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 6/134 (4%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKI 59
           +D    Q+I   Q++ E+        +++ L+++HS  +VIHRD+KPSN+L+NA   +K+
Sbjct: 92  LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKM 151

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPE---LLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           CDFG++    ++         + Y APE     LN   Y+   D+WS+G   +EL   R 
Sbjct: 152 CDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR- 210

Query: 117 LFPGNDHVHQMRLL 130
            FP +      + L
Sbjct: 211 -FPYDSWGTPFQQL 223

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  103 bits (258), Expect = 6e-27
 Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 6/128 (4%)

Query: 5   LYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           LY  + +       +       Q  RG+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFG
Sbjct: 106 LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG 165

Query: 64  LAR---PTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLF 118
           LA      S +    +   +  + APE++       Y+   DV++ G +  ELM  +  +
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

Query: 119 PGNDHVHQ 126
              ++  Q
Sbjct: 226 SNINNRDQ 233

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  102 bits (256), Expect = 2e-26
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 49/202 (24%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I DFG
Sbjct: 116 ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 175

Query: 64  LAR--PTSENEFMT-------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
            A+       +          +YV      +PELL        + D+W++GCI  +L+  
Sbjct: 176 TAKVLSPESKQARANSFVGTAQYV------SPELLTE-KSACKSSDLWALGCIIYQLVAG 228

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVH 173
            P F   +      L+ +                     I +L           FP    
Sbjct: 229 LPPFRAGNE----YLIFQK--------------------IIKLEYD--------FPEKFF 256

Query: 174 PLAIDLVDRMLTFDPMKRITGE 195
           P A DLV+++L  D  KR+  E
Sbjct: 257 PKARDLVEKLLVLDATKRLGCE 278

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  104 bits (261), Expect = 2e-26
 Identities = 58/190 (30%), Positives = 83/190 (43%), Gaps = 31/190 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  N  L E+  +    Q+L G+ Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 102 ELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   S+ EF+     +  Y APE++         +D+WS G I   L+     F   DH
Sbjct: 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DH 220

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           V  +   I                      I   P            +++P  I L+  M
Sbjct: 221 VPTLFKKI-------------------CDGIFYTP-----------QYLNPSVISLLKHM 250

Query: 184 LTFDPMKRIT 193
           L  DPMKR T
Sbjct: 251 LQVDPMKRAT 260

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (257), Expect = 3e-26
 Identities = 45/208 (21%), Positives = 89/208 (42%), Gaps = 17/208 (8%)

Query: 1   MDTD-LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLK 58
           MD   L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K
Sbjct: 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 172

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           +CDFG++    ++   + +V TR Y +PE  L  + Y+   D+WS+G   +E+   R   
Sbjct: 173 LCDFGVSGQLIDSMANS-FVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV------ 172
           P  D      +    +           R          +   P  ++ ++  ++      
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290

Query: 173 -------HPLAIDLVDRMLTFDPMKRIT 193
                       D V++ L  +P +R  
Sbjct: 291 KLPSGVFSLEFQDFVNKCLIKNPAERAD 318

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  101 bits (254), Expect = 9e-26
 Identities = 42/194 (21%), Positives = 76/194 (39%), Gaps = 32/194 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++ N    EE  + F+ +L+  L Y+ +  +IHRD+KP N+LL+ +  + I DF 
Sbjct: 101 DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN 160

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           +A        +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  R  +   
Sbjct: 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLV 180
                  +                                       +P       + L+
Sbjct: 221 SSTSSKEI-----------------------VHTFETTVVT------YPSAWSQEMVSLL 251

Query: 181 DRMLTFDPMKRITG 194
            ++L  +P +R + 
Sbjct: 252 KKLLEPNPDQRFSQ 265

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.4 bits (248), Expect = 3e-25
 Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 11/143 (7%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDL +  +   +L EE   Y   ++LRGL ++H   VIHRD+K  N+LL  N ++K+ DF
Sbjct: 115 TDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173

Query: 63  GLARP-TSENEFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPL 117
           G++            ++ T ++ APE++       + Y    D+WS+G   +E+    P 
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 232

Query: 118 FPGNDHVHQMR--LLIELLGTPT 138
            P    +H MR   LI     P 
Sbjct: 233 -P-LCDMHPMRALFLIPRNPAPR 253

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.0 bits (247), Expect = 4e-25
 Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 8/136 (5%)

Query: 1   MDTDLYQII-RSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLK 58
           M T   ++  R    + E         +++ L Y+     VIHRD+KPSN+LL+    +K
Sbjct: 106 MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIK 165

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPE----LLLNSSDYTAAIDVWSVGCIFMELMNR 114
           +CDFG++    +++          Y APE          DY    DVWS+G   +EL   
Sbjct: 166 LCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

Query: 115 RPLFPGNDHVHQMRLL 130
           +  +          +L
Sbjct: 226 QFPYKNCKTD--FEVL 239

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 99.0 bits (247), Expect = 4e-25
 Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 9/139 (6%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +D+ ++   N++L+E+     L   L+GL+Y+H    IHRD+K  N+LLN     K+ DF
Sbjct: 112 SDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G+  + T         + T ++ APE++     Y    D+WS+G   +E+   +P  P  
Sbjct: 170 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKP--P-Y 225

Query: 122 DHVHQMR--LLIELLGTPT 138
             +H MR   +I     PT
Sbjct: 226 ADIHPMRAIFMIPTNPPPT 244

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =   99 bits (249), Expect = 4e-25
 Identities = 47/233 (20%), Positives = 80/233 (34%), Gaps = 37/233 (15%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            DL         ++E    Y L  +L+ L YIH    +HR +K S++L++ +  + +   
Sbjct: 114 KDLICT-HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172

Query: 63  GLA--------RPTSENEFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMN 113
                      R    ++F    V    + +PE+L  N   Y A  D++SVG    EL N
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232

Query: 114 RRPLFPGNDHVHQMRLLIELL--GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH 171
               F     +   ++L+E L    P   D   +  E+      +   +   S +     
Sbjct: 233 GHVPF---KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST 289

Query: 172 VHPLAI----------------DLVDRMLTFDPMKRITGE------FFVPYKP 202
             P                     V++ L  +P  R +        FF   K 
Sbjct: 290 PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 99.6 bits (248), Expect = 6e-25
 Identities = 61/267 (22%), Positives = 96/267 (35%), Gaps = 82/267 (30%)

Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNAN--- 54
           +   L + I  +  Q L     +  + Q+L+GL Y+H+   +IH D+KP N+LL+ N   
Sbjct: 127 LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186

Query: 55  ----------------------------------------------CDLKICDFGLARPT 68
                                                           +KI D G A   
Sbjct: 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV 246

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN------- 121
            ++   TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF  +       
Sbjct: 247 HKH--FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303

Query: 122 --DHVHQMRLLIELLGTPTDADLGFVRNEDAKRY------IRQLPQHPRQSLAQVFPHVH 173
             DH+  +   IELLG      L  V  + +K +      ++ + +     L +V    +
Sbjct: 304 DEDHIALI---IELLGKV-PRKL-IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358

Query: 174 PL-------AIDLVDRMLTFDPMKRIT 193
                      D +  ML   P KR T
Sbjct: 359 EWSQEEAAGFTDFLLPMLELIPEKRAT 385

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 98.2 bits (245), Expect = 6e-25
 Identities = 37/133 (27%), Positives = 57/133 (42%), Gaps = 17/133 (12%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L  II+S            F   +  G+ Y+HS N+IHRDL   N L+  N ++ + DF
Sbjct: 93  TLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADF 152

Query: 63  GLARPTSENEF---------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
           GLAR   + +                    V   ++ APE++   S Y   +DV+S G +
Sbjct: 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIV 211

Query: 108 FMELMNRRPLFPG 120
             E++ R    P 
Sbjct: 212 LCEIIGRVNADPD 224

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.9 bits (246), Expect = 8e-25
 Identities = 22/135 (16%), Positives = 49/135 (36%), Gaps = 17/135 (12%)

Query: 4   DLYQIIR--SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--------- 52
           +   + +    + + +     F  ++L  ++ +H   +IH D+KP N +L          
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215

Query: 53  --ANCDLKICDFGLARPTS---ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
              +  L + D G +       +    T    T  ++  E+L N   +   ID + V   
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAAT 274

Query: 108 FMELMNRRPLFPGND 122
              ++    +   N+
Sbjct: 275 VYCMLFGTYMKVKNE 289

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 97.4 bits (243), Expect = 1e-24
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 7/123 (5%)

Query: 4   DLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLK 58
            LY+++  + +   L E       Y + +G+ Y+H+ N  ++HR+LK  NLL++    +K
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179

Query: 59  ICDFGLARPTSENEF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           +CDFGL+R  +           T  + APE +L         DV+S G I  EL   +  
Sbjct: 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELATLQQP 238

Query: 118 FPG 120
           +  
Sbjct: 239 WGN 241

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 97.4 bits (243), Expect = 2e-24
 Identities = 30/133 (22%), Positives = 57/133 (42%), Gaps = 16/133 (12%)

Query: 5   LYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           LY ++R     L     +    ++++G+ Y+H+  ++H+DLK  N+  + N  + I DFG
Sbjct: 116 LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174

Query: 64  LAR------PTSENEFMTEYVVTRWYRAPELLLNSSD--------YTAAIDVWSVGCIFM 109
           L             + +        + APE++   S         ++   DV+++G I+ 
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234

Query: 110 ELMNRRPLFPGND 122
           EL  R   F    
Sbjct: 235 ELHAREWPFKTQP 247

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 96.6 bits (241), Expect = 2e-24
 Identities = 40/127 (31%), Positives = 62/127 (48%), Gaps = 14/127 (11%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLN--------A 53
           L +++   + +  +    +  Q+ RG+ Y+H      +IHRDLK SN+L+         +
Sbjct: 93  LNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151

Query: 54  NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           N  LKI DFGLAR       M+      W  APE ++ +S ++   DVWS G +  EL+ 
Sbjct: 152 NKILKITDFGLAREWHRTTKMSAAGAYAW-MAPE-VIRASMFSKGSDVWSYGVLLWELLT 209

Query: 114 RRPLFPG 120
               F G
Sbjct: 210 GEVPFRG 216

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 96.6 bits (241), Expect = 2e-24
 Identities = 41/187 (21%), Positives = 65/187 (34%), Gaps = 48/187 (25%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL      N  LK+ DFG   
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-- 166

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
                             A E       Y  + D+WS+G I   L+   P F  N  +  
Sbjct: 167 ------------------AKETTGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF 186
              +   +         F   E                    +  V      L+  +L  
Sbjct: 207 SPGMKTRIRM---GQYEFPNPE--------------------WSEVSEEVKMLIRNLLKT 243

Query: 187 DPMKRIT 193
           +P +R+T
Sbjct: 244 EPTQRMT 250

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 96.6 bits (241), Expect = 2e-24
 Identities = 44/124 (35%), Positives = 61/124 (49%), Gaps = 10/124 (8%)

Query: 4   DLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNANCD- 56
            LY ++   +     +  H   +  Q  +G+ Y+HS     +IHRDLKP NLLL A    
Sbjct: 85  SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           LKICDFG A        MT    +  + APE +   S+Y+   DV+S G I  E++ RR 
Sbjct: 145 LKICDFGTAC--DIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRK 201

Query: 117 LFPG 120
            F  
Sbjct: 202 PFDE 205

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 95.5 bits (238), Expect = 5e-24
 Identities = 34/155 (21%), Positives = 66/155 (42%), Gaps = 8/155 (5%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNA-NCDLKICD 61
           L   ++  + +  +  + +  Q+L+GL+++H+    +IHRDLK  N+ +      +KI D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            GLA     + F    + T  + APE+      Y  ++DV++ G   +E+      +   
Sbjct: 176 LGLATLKRAS-FAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSEC 232

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ 156
            +  Q+       G    +    V   + K  I  
Sbjct: 233 QNAAQI-YRRVTSGVKPAS-FDKVAIPEVKEIIEG 265

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 96.3 bits (240), Expect = 6e-24
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 14/141 (9%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +DL ++    + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DF
Sbjct: 141 SDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFP 119
           G  +     N F    V T ++ APE++L      Y   +DVWS+G   +EL  R+P  P
Sbjct: 199 GSASIMAPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP--P 252

Query: 120 GNDHVHQMR--LLIELLGTPT 138
              +++ M     I    +P 
Sbjct: 253 -LFNMNAMSALYHIAQNESPA 272

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.0 bits (244), Expect = 6e-24
 Identities = 43/188 (22%), Positives = 83/188 (44%), Gaps = 29/188 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+           
Sbjct: 338 LACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS------- 389

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                        P        ++E  +  +    + P            P    L++ +
Sbjct: 390 -------------PFRQHKTKDKHEIDRMTLTMAVELP--------DSFSPELRSLLEGL 428

Query: 184 LTFDPMKR 191
           L  D  +R
Sbjct: 429 LQRDVNRR 436

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 95.1 bits (237), Expect = 6e-24
 Identities = 28/126 (22%), Positives = 54/126 (42%), Gaps = 11/126 (8%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLL-----NANC 55
           DLY  +      +        +  +  G++Y+ + N  ++HRDL+  N+ L     NA  
Sbjct: 107 DLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166

Query: 56  DLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNR 114
             K+ DFGL++ +  +  ++  +    + APE +    + YT   D +S   I   ++  
Sbjct: 167 CAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

Query: 115 RPLFPG 120
              F  
Sbjct: 225 EGPFDE 230

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 95.5 bits (238), Expect = 6e-24
 Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 12/143 (8%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
             +   +  ++ L+E   Q    Q+L  L ++HS  +IHRDLK  N+L+    D+++ DF
Sbjct: 104 DAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF 161

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPL 117
           G+ A+     +    ++ T ++ APE+++      + Y    D+WS+G   +E+    P 
Sbjct: 162 GVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP- 220

Query: 118 FPGNDHVHQMR--LLIELLGTPT 138
            P +  ++ MR  L I     PT
Sbjct: 221 -P-HHELNPMRVLLKIAKSDPPT 241

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 95.4 bits (238), Expect = 1e-23
 Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 50/197 (25%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 64  LARPTSENEFMT-------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
            A+     +  T       E +      APE++L+   Y  A+D W++G +  E+    P
Sbjct: 187 FAK---RVKGRTWTLCGTPEAL------APEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL 175
            F  +  +     ++           G VR                      FP H    
Sbjct: 237 PFFADQPIQIYEKIVS----------GKVR----------------------FPSHFSSD 264

Query: 176 AIDLVDRMLTFDPMKRI 192
             DL+  +L  D  KR 
Sbjct: 265 LKDLLRNLLQVDLTKRF 281

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 94.7 bits (236), Expect = 1e-23
 Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 19/128 (14%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCD 56
           LY  ++   +L    C   +  +  GL ++H           + HRDLK  N+L+  N  
Sbjct: 93  LYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151

Query: 57  LKICDFGLARPTSENEFMTEYVV-----TRWYRAPELL-----LNSSDYTAAIDVWSVGC 106
             I D GLA   S++    +        T+ Y APE+L     ++  D    +D+W+ G 
Sbjct: 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211

Query: 107 IFMELMNR 114
           +  E+  R
Sbjct: 212 VLWEVARR 219

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 95.2 bits (237), Expect = 2e-23
 Identities = 34/128 (26%), Positives = 51/128 (39%), Gaps = 19/128 (14%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--------VIHRDLKPSNLLLNANCD 56
           LY  ++S  +L  +      Y  + GL ++H+          + HRDLK  N+L+  N  
Sbjct: 122 LYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180

Query: 57  LKICDFGLAR-----PTSENEFMTEYVVTRWYRAPELL-----LNSSDYTAAIDVWSVGC 106
             I D GLA          +      V T+ Y  PE+L      N        D++S G 
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240

Query: 107 IFMELMNR 114
           I  E+  R
Sbjct: 241 ILWEVARR 248

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 94.7 bits (236), Expect = 2e-23
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 9/140 (6%)

Query: 1   MDT---DLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNAN 54
           M T     Y+ + S  +  + EE         ++ L ++     +IHRD+KPSN+LL+ +
Sbjct: 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162

Query: 55  CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMEL 111
            ++K+CDFG++    ++   T     R Y APE +    +   Y    DVWS+G    EL
Sbjct: 163 GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

Query: 112 MNRRPLFPGNDHVHQMRLLI 131
              R  +P  + V      +
Sbjct: 223 ATGRFPYPKWNSVFDQLTQV 242

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 93.9 bits (234), Expect = 2e-23
 Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 38/194 (19%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TD+         + E        + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DF
Sbjct: 105 TDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G  A+ T E    +  V T ++ APE++     Y   +D+WS+G + +E++   P  P  
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEP--P-Y 216

Query: 122 DHVHQMR--LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            + + +R   LI   GTP                   L    + S          +  D 
Sbjct: 217 LNENPLRALYLIATNGTPE------------------LQNPEKLS---------AIFRDF 249

Query: 180 VDRMLTFDPMKRIT 193
           ++R L  D  KR +
Sbjct: 250 LNRCLEMDVEKRGS 263

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.0 bits (239), Expect = 3e-23
 Identities = 48/189 (25%), Positives = 85/189 (44%), Gaps = 31/189 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335

Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F     
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVDR 182
                                V N++ K+ + +            +P    P + D  + 
Sbjct: 395 K--------------------VENKELKQRVLEQAVT--------YPDKFSPASKDFCEA 426

Query: 183 MLTFDPMKR 191
           +L  DP KR
Sbjct: 427 LLQKDPEKR 435

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 94.0 bits (234), Expect = 3e-23
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 38/194 (19%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TD+         L+EE        +L+ L Y+H+  VIHRD+K  ++LL  +  +K+ DF
Sbjct: 130 TDIVS----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDF 185

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G  A+ + +       V T ++ APE++   S Y   +D+WS+G + +E+++  P  P  
Sbjct: 186 GFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEP--P-Y 241

Query: 122 DHVHQMR--LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                ++    +     P                   L    + S         P+  D 
Sbjct: 242 FSDSPVQAMKRLRDSPPPK------------------LKNSHKVS---------PVLRDF 274

Query: 180 VDRMLTFDPMKRIT 193
           ++RML  DP +R T
Sbjct: 275 LERMLVRDPQERAT 288

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.6 bits (238), Expect = 4e-23
 Identities = 47/191 (24%), Positives = 87/191 (45%), Gaps = 32/191 (16%)

Query: 4   DL-YQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL + I    Q+   E    ++  ++  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            GLA    E + +   V T  Y APE++ N   YT + D W++GC+  E++  +  F   
Sbjct: 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLV 180
                                  ++ E+ +R ++++P+         +     P A  L 
Sbjct: 389 KKK--------------------IKREEVERLVKEVPEE--------YSERFSPQARSLC 420

Query: 181 DRMLTFDPMKR 191
            ++L  DP +R
Sbjct: 421 SQLLCKDPAER 431

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 92.8 bits (231), Expect = 7e-23
 Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 31/199 (15%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +   + +    +  L E      L ++L GL+Y+H    IHRD+K  N+LL  +  ++I 
Sbjct: 104 IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 163

Query: 61  DFGLARPTSENEFMTE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           DFG++   +    +T       +V T  + APE++     Y    D+WS G   +EL   
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

Query: 115 RPLFPGNDHVHQMR--LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV 172
               P       M+  +L      P+       +    K               + F   
Sbjct: 224 AA--P-YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKK-------------YGKSF--- 264

Query: 173 HPLAIDLVDRMLTFDPMKR 191
                 ++   L  DP KR
Sbjct: 265 ----RKMISLCLQKDPEKR 279

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 92.4 bits (230), Expect = 9e-23
 Identities = 45/139 (32%), Positives = 73/139 (52%), Gaps = 11/139 (7%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            DL +       L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DF
Sbjct: 108 LDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADF 163

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G+  + T        +V T ++ APE++   S Y +  D+WS+G   +EL    P  P +
Sbjct: 164 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEP--PHS 220

Query: 122 DHVHQMR--LLIELLGTPT 138
           + +H M+   LI     PT
Sbjct: 221 E-LHPMKVLFLIPKNNPPT 238

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 91.8 bits (229), Expect = 2e-22
 Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 48/195 (24%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+ ++R +Q       +++  ++   L+Y+HS ++I+RDLKP N+LL+ N  +KI DFG
Sbjct: 92  ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151

Query: 64  LARPTSENEFMT-------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
            A+       +T       +Y+      APE++     Y  +ID WS G +  E++    
Sbjct: 152 FAK---YVPDVTYTLCGTPDYI------APEVVST-KPYNKSIDWWSFGILIYEMLAGYT 201

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
            F  ++ +     ++        A+L F             P           P  +   
Sbjct: 202 PFYDSNTMKTYEKILN-------AELRF-------------P-----------PFFNEDV 230

Query: 177 IDLVDRMLTFDPMKR 191
            DL+ R++T D  +R
Sbjct: 231 KDLLSRLITRDLSQR 245

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 92.1 bits (229), Expect = 2e-22
 Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 28/207 (13%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA----------NVIHRDLKPSNLLLNAN 54
           L   +++N  +S     +    + RGL Y+H             + HRD+K  N+LL  N
Sbjct: 109 LSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167

Query: 55  CDLKICDFGLAR--PTSENEFMTEYVV-TRWYRAPELL----LNSSDYTAAIDVWSVGCI 107
               I DFGLA      ++   T   V TR Y APE+L        D    ID++++G +
Sbjct: 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             EL +R     G    + +    E+   P+  D+  V     KR     P         
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR-----PVLRD----Y 278

Query: 168 VFPHVHPLAI-DLVDRMLTFDPMKRIT 193
              H     + + ++     D   R++
Sbjct: 279 WQKHAGMAMLCETIEECWDHDAEARLS 305

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 90.4 bits (225), Expect = 3e-22
 Identities = 21/122 (17%), Positives = 44/122 (36%), Gaps = 10/122 (8%)

Query: 5   LYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKIC 60
           LY ++    +  + +     F   + RG+ ++H+    +    L   +++++ +   +I 
Sbjct: 96  LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
              +         M       W  APE L          + D+WS   +  EL+ R   F
Sbjct: 156 MADVKFSFQSPGRMYAP---AWV-APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

Query: 119 PG 120
             
Sbjct: 212 AD 213

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 91.1 bits (227), Expect = 5e-22
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 43/194 (22%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E M     T        Y APE+LL    Y  ++D WS G +  E++  +  
Sbjct: 164 MCK-----ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP 217

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F G D   ++   I         +  +                PR         +   A 
Sbjct: 218 FHGQDE-EELFHSI------RMDNPFY----------------PR--------WLEKEAK 246

Query: 178 DLVDRMLTFDPMKR 191
           DL+ ++   +P KR
Sbjct: 247 DLLVKLFVREPEKR 260

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 91.3 bits (227), Expect = 7e-22
 Identities = 36/172 (20%), Positives = 73/172 (42%), Gaps = 14/172 (8%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  + +  + +  E  +++L +++  +  +H    +HRD+KP N+LL+    +++ DFG 
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 65  ARPTSENEFMTEYVV--TRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMNRRP 116
                 +  +   V   T  Y +PE+L        +  Y    D W++G    E+   + 
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

Query: 117 LFPGNDHVHQMRLLI---ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
            F  +        ++   E L  P   +      E+A+ +I++L   P   L
Sbjct: 269 PFYADSTAETYGKIVHYKEHLSLPLVDE---GVPEEARDFIQRLLCPPETRL 317

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 90.4 bits (225), Expect = 8e-22
 Identities = 38/126 (30%), Positives = 71/126 (56%), Gaps = 12/126 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           L +     E +++    +       Y APE+L + +DY  A+D W +G +  E+M  R  
Sbjct: 151 LCK-----EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP 204

Query: 118 FPGNDH 123
           F   DH
Sbjct: 205 FYNQDH 210

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 90.6 bits (225), Expect = 8e-22
 Identities = 30/128 (23%), Positives = 51/128 (39%), Gaps = 19/128 (14%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCD 56
           L+  +    +++ E           GL ++H           + HRDLK  N+L+  N  
Sbjct: 127 LFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185

Query: 57  LKICDFGLARPTSENEFMTEYVV-----TRWYRAPELLLNSS-----DYTAAIDVWSVGC 106
             I D GLA          +        T+ Y APE+L +S      +     D++++G 
Sbjct: 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245

Query: 107 IFMELMNR 114
           +F E+  R
Sbjct: 246 VFWEIARR 253

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 90.0 bits (224), Expect = 1e-21
 Identities = 43/196 (21%), Positives = 87/196 (44%), Gaps = 40/196 (20%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +E   Q ++ +++  L+++H   +I+RD+K  N+LL++N  + + DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204

Query: 64  LARPTSENEFMTEYVVTRW-------YRAPELLL-NSSDYTAAIDVWSVGCIFMELMNRR 115
           L++     EF+ +     +       Y AP+++    S +  A+D WS+G +  EL+   
Sbjct: 205 LSK-----EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
             F  +   +    +   +                   ++  P +P          +  L
Sbjct: 260 SPFTVDGEKNSQAEISRRI-------------------LKSEPPYP--------QEMSAL 292

Query: 176 AIDLVDRMLTFDPMKR 191
           A DL+ R+L  DP KR
Sbjct: 293 AKDLIQRLLMKDPKKR 308

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 89.6 bits (223), Expect = 2e-21
 Identities = 33/126 (26%), Positives = 60/126 (47%), Gaps = 12/126 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+ ++   E   +++  +++  L ++H   +I+RDLK  N+LL+     K+ DFG
Sbjct: 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +   V T        Y APE+L     Y  A+D W++G +  E++     
Sbjct: 170 MCK-----EGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP 223

Query: 118 FPGNDH 123
           F   + 
Sbjct: 224 FEAENE 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.4 bits (220), Expect = 3e-21
 Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 43/194 (22%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           L++     E +              Y APE++     +T + D WS G +  E++     
Sbjct: 172 LSK-----ESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP 225

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F G D    M ++++       A LG              P             + P A 
Sbjct: 226 FQGKDRKETMTMILK-------AKLGM-------------P-----------QFLSPEAQ 254

Query: 178 DLVDRMLTFDPMKR 191
            L+  +   +P  R
Sbjct: 255 SLLRMLFKRNPANR 268

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.4 bits (220), Expect = 4e-21
 Identities = 44/194 (22%), Positives = 83/194 (42%), Gaps = 43/194 (22%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +       E+   ++L ++   L ++H   +I+RDLKP N++LN    +K+ DFG
Sbjct: 107 ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           L +     E + +  VT        Y APE+L+  S +  A+D WS+G +  +++   P 
Sbjct: 167 LCK-----ESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP 220

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F G +    +  +++         L               P           P++   A 
Sbjct: 221 FTGENRKKTIDKILK-------CKLNL-------------P-----------PYLTQEAR 249

Query: 178 DLVDRMLTFDPMKR 191
           DL+ ++L  +   R
Sbjct: 250 DLLKKLLKRNAASR 263

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 89.4 bits (222), Expect = 4e-21
 Identities = 32/126 (25%), Positives = 58/126 (46%), Gaps = 6/126 (4%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  + +    L EE  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG 
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221

Query: 65  ARPTSENEFMTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMNRRPLF 118
                E+  +   V   T  Y +PE+L         Y    D WS+G    E++     F
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

Query: 119 PGNDHV 124
                V
Sbjct: 282 YAESLV 287

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.1 bits (219), Expect = 8e-21
 Identities = 33/126 (26%), Positives = 61/126 (48%), Gaps = 12/126 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +   E   +++  ++   L Y+HS N+++RDLKP N+LL++   + + DFG
Sbjct: 125 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           L +     E +     T        Y APE+L     Y   +D W +G +  E++   P 
Sbjct: 185 LCK-----ENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPP 238

Query: 118 FPGNDH 123
           F   + 
Sbjct: 239 FYSRNT 244

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 86.9 bits (216), Expect = 9e-21
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 9/132 (6%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            DL  ++R    L+       + Q+   L   H+A   HRD+KP N+L++A+    + DF
Sbjct: 119 VDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178

Query: 63  GLARPTSENEF-MTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           G+A  T++ +       V T +Y APE     S  T   D++++ C+  E +   P + G
Sbjct: 179 GIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQG 237

Query: 121 ND------HVHQ 126
           +       H++Q
Sbjct: 238 DQLSVMGAHINQ 249

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 87.3 bits (217), Expect = 1e-20
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 12/126 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++ S  +I+RDLK  N++L++   +KI DFG
Sbjct: 107 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E + + V T+       Y APE++     Y  ++D W+ G +  E++  +  
Sbjct: 167 MCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP 220

Query: 118 FPGNDH 123
           F G D 
Sbjct: 221 FEGEDE 226

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.8 bits (218), Expect = 1e-20
 Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 23/167 (13%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL  ++  N  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG
Sbjct: 155 DLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213

Query: 64  LARPTSENEFMTEYVV--TRWYRAPELLLN---SSDYTAAIDVWSVGCIFMELMNRRPLF 118
                ++   +       T  Y +PE+L +      Y    D WSVG    E++     F
Sbjct: 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

Query: 119 PGNDHV--------HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
             +  V        H+  L       P D D+     ++AK  I   
Sbjct: 274 YADSLVGTYSKIMNHKNSLTF-----PDDNDIS----KEAKNLICAF 311

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 86.9 bits (216), Expect = 2e-20
 Identities = 42/195 (21%), Positives = 77/195 (39%), Gaps = 36/195 (18%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +     T        Y APE+L    DY  ++D W++G +  E+M  R  
Sbjct: 156 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 209

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLA 176
           F                                    + + +   +      P  +   A
Sbjct: 210 FDIVGSSDNP------------------DQNTEDYLFQVILEKQIR-----IPRSLSVKA 246

Query: 177 IDLVDRMLTFDPMKR 191
             ++   L  DP +R
Sbjct: 247 ASVLKSFLNKDPKER 261

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 86.6 bits (215), Expect = 3e-20
 Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 36/195 (18%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +     T        Y APE+L    DY  ++D W++G +  E+M  R  
Sbjct: 199 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 252

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLA 176
           F                                    + + +          P  +   A
Sbjct: 253 FDIVGSSDNP------------------DQNTEDYLFQVILEKQ-----IRIPRSLSVKA 289

Query: 177 IDLVDRMLTFDPMKR 191
             ++   L  DP +R
Sbjct: 290 ASVLKSFLNKDPKER 304

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 85.0 bits (211), Expect = 4e-20
 Identities = 41/120 (34%), Positives = 65/120 (54%), Gaps = 3/120 (2%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
             L + I S+  LS +    F  Q+L G+K+ H   ++HRD+KP N+L+++N  LKI DF
Sbjct: 96  PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDF 155

Query: 63  GLARPTSENEF-MTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           G+A+  SE     T +V+ T  Y +PE            D++S+G +  E++   P F G
Sbjct: 156 GIAKALSETSLTQTNHVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 86.7 bits (215), Expect = 4e-20
 Identities = 41/122 (33%), Positives = 69/122 (56%), Gaps = 3/122 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 234 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293

Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE+L + +DY  A+D W +G +  E+M  R  F   
Sbjct: 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352

Query: 122 DH 123
           DH
Sbjct: 353 DH 354

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 86.6 bits (214), Expect = 5e-20
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 12/126 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++ S  +I+RDLK  N++L++   +KI DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E + + V T+       Y APE++     Y  ++D W+ G +  E++  +  
Sbjct: 488 MCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP 541

Query: 118 FPGNDH 123
           F G D 
Sbjct: 542 FEGEDE 547

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 84.6 bits (210), Expect = 7e-20
 Identities = 34/122 (27%), Positives = 62/122 (50%), Gaps = 5/122 (4%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
             L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DF
Sbjct: 101 VTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 160

Query: 63  GLARPTSENEF---MTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           G+AR  +++      T  V+ T  Y +PE         A  DV+S+GC+  E++   P F
Sbjct: 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPF 219

Query: 119 PG 120
            G
Sbjct: 220 TG 221

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 85.7 bits (212), Expect = 1e-19
 Identities = 35/135 (25%), Positives = 58/135 (42%), Gaps = 11/135 (8%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L +     Q L       +L ++L  L Y+HS  +++ DLKP N++L     LK+ D G
Sbjct: 170 SLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG 226

Query: 64  LARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
                +       Y+  T  ++APE++      T A D+++VG     L    P   G  
Sbjct: 227 AVSRINS----FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNG-R 279

Query: 123 HVHQMRLLIELLGTP 137
           +V  +     +L T 
Sbjct: 280 YVDGLPEDDPVLKTY 294

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 81.8 bits (202), Expect = 1e-18
 Identities = 32/143 (22%), Positives = 56/143 (39%), Gaps = 24/143 (16%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSA---------NVIHRDLKPSNLLLNANCDLKICD 61
           S  +          + + RGL Y+H+           + HRDL   N+L+  +    I D
Sbjct: 104 SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 62  FGLAR---------PTSENEFMTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGC 106
           FGL+          P  E+      V T  Y APE+L  +            +D++++G 
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 107 IFMELMNRRPLFPGNDHVHQMRL 129
           I+ E+  R       + V + ++
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQM 246

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 78.7 bits (195), Expect = 9e-18
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTEYVV-TRWYRA 85
            G+ ++H  + IHRD+K +N+LL+     KI DFGLAR         MT  +V T  Y A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203

Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELM-NRRPL 117
           PE L    + T   D++S G + +E++     +
Sbjct: 204 PEAL--RGEITPKSDIYSFGVVLLEIITGLPAV 234

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 78.5 bits (194), Expect = 1e-17
 Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 12/117 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   ++ ++  +       +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DF
Sbjct: 99  SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GL +   +++    + V         WY APE L  S  ++ A DVWS G +  EL 
Sbjct: 159 GLTKVLPQDK--EFFKVKEPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 78.6 bits (194), Expect = 2e-17
 Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 12/117 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   ++ ++  +       +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DF
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GL +   +++    Y V         WY APE L  S  ++ A DVWS G +  EL 
Sbjct: 190 GLTKVLPQDK--EYYKVKEPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 242

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 76.9 bits (190), Expect = 4e-17
 Identities = 36/126 (28%), Positives = 65/126 (51%), Gaps = 14/126 (11%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFG
Sbjct: 103 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162

Query: 64  LARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--R 114
           L++    +E    Y          +WY APE  +N   +++  DVWS G +  E  +  +
Sbjct: 163 LSKALRADE--NYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWEAFSYGQ 218

Query: 115 RPLFPG 120
           +P + G
Sbjct: 219 KP-YRG 223

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 77.3 bits (191), Expect = 4e-17
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 14/126 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R ++ ++  ++   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI DF
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--R 114
           GLA+     E   EY         +W  A E  +    YT   DVWS G    ELM    
Sbjct: 162 GLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYGVTVWELMTFGS 217

Query: 115 RPLFPG 120
           +P + G
Sbjct: 218 KP-YDG 222

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 76.6 bits (189), Expect = 5e-17
 Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 12/117 (10%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L + +  N   ++ +    +  Q+ +G+ Y+ S   +HRDL   N+L+ +   +KI DF
Sbjct: 111 SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GL +    ++    Y V         WY APE L+ S  +  A DVWS G    EL+
Sbjct: 171 GLTKAIETDK--EYYTVKDDRDSPVFWY-APECLMQSK-FYIASDVWSFGVTLHELL 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 76.6 bits (189), Expect = 8e-17
 Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 12/117 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   ++ ++  L       +  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DF
Sbjct: 112 CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GLA+    ++    YVV         WY APE L ++  ++   DVWS G +  EL 
Sbjct: 172 GLAKLLPLDK--DYYVVREPGQSPIFWY-APESLSDNI-FSRQSDVWSFGVVLYELF 224

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 75.4 bits (186), Expect = 1e-16
 Identities = 38/127 (29%), Positives = 54/127 (42%), Gaps = 15/127 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R +Q          +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DF
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 165

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL R   +N+    YV+         W  APE  L +  ++ A D W  G    E+    
Sbjct: 166 GLMRALPQND--DHYVMQEHRKVPFAWC-APE-SLKTRTFSHASDTWMFGVTLWEMFTYG 221

Query: 114 RRPLFPG 120
           + P + G
Sbjct: 222 QEP-WIG 227

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 76.3 bits (188), Expect = 2e-16
 Identities = 32/116 (27%), Positives = 54/116 (46%), Gaps = 8/116 (6%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            + Q +S     Y   Q+   ++Y+   N IHR+L   N L+  N  +K+ DFGL+R  +
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369

Query: 70  ENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
            + +          +W  APE  L  + ++   DVW+ G +  E+      P +PG
Sbjct: 370 GDTYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 422

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 76.5 bits (188), Expect = 2e-16
 Identities = 37/116 (31%), Positives = 54/116 (46%), Gaps = 8/116 (6%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            + + L          Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414

Query: 70  ENEFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
           +NE+          +W  APE       +T   DVWS G +  EL    R P +PG
Sbjct: 415 DNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 467

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 74.5 bits (184), Expect = 2e-16
 Identities = 32/127 (25%), Positives = 59/127 (46%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +RS+ + L         Y +  G+ ++ S   IHRDL   N L++ +  +K+ DF
Sbjct: 89  CLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDF 148

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           G+ R   ++    +YV +       +W  APE+      Y++  DVW+ G +  E+ +  
Sbjct: 149 GMTRYVLDD----QYVSSVGTKFPVKWS-APEVFHYFK-YSSKSDVWAFGILMWEVFSLG 202

Query: 114 RRPLFPG 120
           + P +  
Sbjct: 203 KMP-YDL 208

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 75.8 bits (187), Expect = 2e-16
 Identities = 35/133 (26%), Positives = 56/133 (42%), Gaps = 12/133 (9%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           D    +R+    L  +     +     G++Y+ S   IHRDL   N L+     LKI DF
Sbjct: 198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257

Query: 63  GLARPTSENEFMTEYVVT----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           G++R  ++  +     +     +W  APE L     Y++  DVWS G +  E  +    P
Sbjct: 258 GMSREEADGVYAASGGLRQVPVKWT-APEALNYGR-YSSESDVWSFGILLWETFSLGASP 315

Query: 117 LFPG--NDHVHQM 127
            +P   N    + 
Sbjct: 316 -YPNLSNQQTREF 327

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 8/104 (7%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
               Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+        
Sbjct: 284 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343

Query: 81  --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             +W  APE       +T   DVWS G +  EL    R P +PG
Sbjct: 344 PIKWT-APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 384

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 74.6 bits (184), Expect = 3e-16
 Identities = 34/127 (26%), Positives = 61/127 (48%), Gaps = 15/127 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L++ +   +  +   +    L+Q+  G+KY+   N +HRDL   N+LL      KI DF
Sbjct: 95  PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL++    ++  + Y          +WY APE  +N   +++  DVWS G    E ++  
Sbjct: 155 GLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGVTMWEALSYG 210

Query: 114 RRPLFPG 120
           ++P +  
Sbjct: 211 QKP-YKK 216

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 73.8 bits (182), Expect = 4e-16
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 6/113 (5%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R    L  +    F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S
Sbjct: 109 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168

Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             +   +  V +W  APE L     ++   DVWS G +  E+ +  R P +P 
Sbjct: 169 STQDTGKLPV-KWT-APEALREKK-FSTKSDVWSFGILLWEIYSFGRVP-YPR 217

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 75.1 bits (185), Expect = 5e-16
 Identities = 41/120 (34%), Positives = 58/120 (48%), Gaps = 16/120 (13%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
                        F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR   
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335

Query: 70  ENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
           +N    EY          +W  APE +   S +T   DVWS G + ME++   R P +PG
Sbjct: 336 DN----EYTAREGAKFPIKWT-APEAINFGS-FTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 74.3 bits (183), Expect = 5e-16
 Identities = 38/108 (35%), Positives = 51/108 (47%), Gaps = 11/108 (10%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
             S+       F  Q+  G+ Y+H+ + IHRDL   N+LL+ +  +KI DFGLA+   E 
Sbjct: 128 RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187

Query: 72  EFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                Y V         WY APE L     +  A DVWS G    EL+
Sbjct: 188 H--EYYRVREDGDSPVFWY-APECLKEYK-FYYASDVWSFGVTLYELL 231

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 73.9 bits (182), Expect = 6e-16
 Identities = 31/127 (24%), Positives = 58/127 (45%), Gaps = 16/127 (12%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R ++ +L  +    +  Q+ +G+ Y+    ++HR+L   N+LL +   +++ DF
Sbjct: 100 SLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           G+A     ++   + ++        +W  A E +     YT   DVWS G    ELM   
Sbjct: 160 GVADLLPPDD---KQLLYSEAKTPIKWM-ALESIHFGK-YTHQSDVWSYGVTVWELMTFG 214

Query: 114 RRPLFPG 120
             P + G
Sbjct: 215 AEP-YAG 220

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 73.4 bits (181), Expect = 7e-16
 Identities = 36/128 (28%), Positives = 57/128 (44%), Gaps = 18/128 (14%)

Query: 4   DLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           +L   +R    Q +S     Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ D
Sbjct: 95  NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 154

Query: 62  FGLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN- 113
           FGL+R  + +     Y          +W  APE L  +  ++   DVW+ G +  E+   
Sbjct: 155 FGLSRLMTGD----TYTAHAGAKFPIKWT-APESLAYNK-FSIKSDVWAFGVLLWEIATY 208

Query: 114 -RRPLFPG 120
              P +PG
Sbjct: 209 GMSP-YPG 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 73.9 bits (182), Expect = 7e-16
 Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 11/116 (9%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R ++ ++  ++   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI DF
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GLA+     E   EY         +W  A E  +    YT   DVWS G    ELM
Sbjct: 162 GLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYGVTVWELM 213

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 73.0 bits (180), Expect = 8e-16
 Identities = 33/127 (25%), Positives = 58/127 (45%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R+ +   + E        +  G+ Y+  A VIHRDL   N L+  N  +K+ DF
Sbjct: 89  CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 148

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           G+ R   ++    +Y  +       +W  +PE+   S  Y++  DVWS G +  E+ +  
Sbjct: 149 GMTRFVLDD----QYTSSTGTKFPVKWA-SPEVFSFSR-YSSKSDVWSFGVLMWEVFSEG 202

Query: 114 RRPLFPG 120
           + P +  
Sbjct: 203 KIP-YEN 208

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 74.2 bits (182), Expect = 9e-16
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 15/127 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L++ +   +  +   +    L+Q+  G+KY+   N +HR+L   N+LL      KI DF
Sbjct: 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL++    ++  + Y          +WY APE  +N   +++  DVWS G    E ++  
Sbjct: 481 GLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGVTMWEALSYG 536

Query: 114 RRPLFPG 120
           ++P +  
Sbjct: 537 QKP-YKK 542

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 72.7 bits (179), Expect = 1e-15
 Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +L   ++  + SL       + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DF
Sbjct: 101 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   ++     Y          +W  APE  +N   +T+A DVW  G    E++   
Sbjct: 161 GLSRYMEDS----TYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHG 214

Query: 114 RRPLFPG 120
            +P F G
Sbjct: 215 VKP-FQG 220

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 72.6 bits (179), Expect = 1e-15
 Identities = 39/116 (33%), Positives = 57/116 (49%), Gaps = 8/116 (6%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            S   L+         Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

Query: 70  ENEFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
           +NE+          +W  APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 161 DNEYTAREGAKFPIKWT-APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 73.5 bits (181), Expect = 1e-15
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 6/113 (5%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R    L  +    F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340

Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             +   +  V +W  APE L     ++   DVWS G +  E+ +  R P +P 
Sbjct: 341 STQDTGKLPV-KWT-APEALREKK-FSTKSDVWSFGILLWEIYSFGRVP-YPR 389

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.0 bits (179), Expect = 2e-15
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 12/119 (10%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           ++ +          L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235

Query: 61  DFGLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           DFGLAR   ++    +YV         +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 236 DFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIF 289

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 72.4 bits (178), Expect = 2e-15
 Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 13/126 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L + +R      S       L  +  G+KY+ + N +HRDL   N+L+N+N   K+ DF
Sbjct: 132 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 191

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--R 114
           GL+R   ++     Y  +      RW  APE +     +T+A DVWS G +  E+M    
Sbjct: 192 GLSRVLEDDP-EATYTTSGGKIPIRWT-APEAISYRK-FTSASDVWSFGIVMWEVMTYGE 248

Query: 115 RPLFPG 120
           RP +  
Sbjct: 249 RP-YWE 253

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 71.5 bits (176), Expect = 3e-15
 Identities = 30/127 (23%), Positives = 57/127 (44%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R  +     +        +   ++Y+ S   +HRDL   N L+N    +K+ DF
Sbjct: 105 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 164

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   ++    EY  +       RW   PE+L+ S  +++  D+W+ G +  E+ +  
Sbjct: 165 GLSRYVLDD----EYTSSVGSKFPVRWS-PPEVLMYSK-FSSKSDIWAFGVLMWEIYSLG 218

Query: 114 RRPLFPG 120
           + P +  
Sbjct: 219 KMP-YER 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 71.9 bits (177), Expect = 4e-15
 Identities = 33/127 (25%), Positives = 58/127 (45%), Gaps = 15/127 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R++    +       L  +  G++Y+     +HRDL   N+L+++N   K+ DF
Sbjct: 136 SLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   ++        T       RW  APE  +    +++A DVWS G +  E++   
Sbjct: 196 GLSRVLEDDPD--AAYTTTGGKIPIRWT-APE-AIAFRTFSSASDVWSFGVVMWEVLAYG 251

Query: 114 RRPLFPG 120
            RP +  
Sbjct: 252 ERP-YWN 257

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 71.1 bits (175), Expect = 5e-15
 Identities = 32/127 (25%), Positives = 59/127 (46%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +L   +  N+ SL       +  Q+ + + Y+ S N +HRD+   N+L+ +   +K+ DF
Sbjct: 98  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   +     +Y          +W  +PE  +N   +T A DVW       E+++  
Sbjct: 158 GLSRYIEDE----DYYKASVTRLPIKWM-SPE-SINFRRFTTASDVWMFAVCMWEILSFG 211

Query: 114 RRPLFPG 120
           ++P F  
Sbjct: 212 KQP-FFW 217

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 71.1 bits (175), Expect = 6e-15
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           +N + S     +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +     Y+V        +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 217 DS---NYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIF 260

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 71.6 bits (176), Expect = 6e-15
 Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 16/109 (14%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
             L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL R   ++    E   T 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP---EAAYTT 207

Query: 81  -------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
                  RW  +PE  +    +T+A DVWS G +  E+M+   RP +  
Sbjct: 208 RGGKIPIRWT-SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERP-YWE 253

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 71.8 bits (176), Expect = 7e-15
 Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +L   ++  + SL       + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DF
Sbjct: 476 ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 535

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   ++     Y          +W  APE  +N   +T+A DVW  G    E++   
Sbjct: 536 GLSRYMEDS----TYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHG 589

Query: 114 RRPLFPG 120
            +P F G
Sbjct: 590 VKP-FQG 595

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.0 bits (172), Expect = 1e-14
 Identities = 42/109 (38%), Positives = 52/109 (47%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
              +L  E    F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +     YVV        +W  APE + N   YT   DVWS G    EL 
Sbjct: 198 DS---NYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELF 241

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 69.6 bits (171), Expect = 2e-14
 Identities = 24/118 (20%), Positives = 43/118 (36%), Gaps = 16/118 (13%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL--------KICDFGLARPTSENEF 73
               QL   + ++    +IH ++   N+LL    D         K+ D G++      + 
Sbjct: 117 EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176

Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG--NDHVHQM 127
           + E +   W   PE + N  +   A D WS G    E+ +   +P      +    Q 
Sbjct: 177 LQERI--PWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQF 230

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 69.5 bits (171), Expect = 2e-14
 Identities = 31/113 (27%), Positives = 53/113 (46%), Gaps = 13/113 (11%)

Query: 29  RGLKYIH---SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW--- 82
           RGL Y+H      +IHRD+K +N+LL+   +  + DFGLA+     +    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 83  --YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIE 132
             + APE L  +   +   DV+  G + +EL+  +R             +L++
Sbjct: 199 IGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 69.2 bits (170), Expect = 3e-14
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 15/98 (15%)

Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTEYVV-TRWYRA 85
           RGL Y+H+  +IHRD+K  N+LL+ N   KI DFG+++     +   ++  V  T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYID 209

Query: 86  PE-----LLLNSSDYTAAIDVWSVGCIFMELM-NRRPL 117
           PE      L   S      DV+S G +  E++  R  +
Sbjct: 210 PEYFIKGRLTEKS------DVYSFGVVLFEVLCARSAI 241

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 68.4 bits (168), Expect = 4e-14
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 12/138 (8%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL Q IRS  ++ + +    F  Q+ RG++Y+     +HRDL   N +L+ +  +K+ DF
Sbjct: 109 DLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--R 114
           GLAR   + E+ +           +W  A E L     +T   DVWS G +  EL+    
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWT-ALESLQTYR-FTTKSDVWSFGVLLWELLTRGA 226

Query: 115 RPLFPGNDHVHQMRLLIE 132
            P +   D       L +
Sbjct: 227 PP-YRHIDPFDLTHFLAQ 243

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.5 bits (168), Expect = 5e-14
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
               L+ E    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +     YVV        +W  APE L     YT   DVWS G +  E+ 
Sbjct: 225 DS---NYVVRGNARLPVKWM-APESLFEGI-YTIKSDVWSYGILLWEIF 268

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 68.1 bits (167), Expect = 6e-14
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
               L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +    +YV         +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 201 DP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIF 244

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 67.8 bits (166), Expect = 1e-13
 Identities = 38/109 (34%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
             + ++ +      YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  + 
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            +    Y  T       +W  APE L +   YT   DVWS G +  E+ 
Sbjct: 256 ID---YYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIF 299

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 67.4 bits (165), Expect = 1e-13
 Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 12/107 (11%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 73  FMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
               Y  T       +W  APE L +   YT   DVWS G +  E+ 
Sbjct: 246 ---YYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIF 287

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 66.7 bits (163), Expect = 2e-13
 Identities = 19/166 (11%), Positives = 34/166 (20%), Gaps = 51/166 (30%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRA 85
            L       H A V      PS + ++ + D+ +                          
Sbjct: 137 SLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------- 179

Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV 145
                         D+  +G     L+  R   P       +                  
Sbjct: 180 ----------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---------------- 213

Query: 146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
               A+R     P  P      +   +      +  R +  D   R
Sbjct: 214 ----AERDTAGQPIEPA----DIDRDIPFQISAVAARSVQGDGGIR 251

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 38/109 (34%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
             + ++ +      YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  + 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            +    Y  T       +W  APE L +   YT   DVWS G +  E+ 
Sbjct: 210 ID---YYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIF 253

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 66.1 bits (162), Expect = 3e-13
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
             ++L+      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            +    YV         +W  A E L +   YT   DVWS G +  E++
Sbjct: 203 ED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 65.9 bits (161), Expect = 5e-13
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 12/138 (8%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   IR+   + + +    F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DF
Sbjct: 177 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 236

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-- 114
           GLAR   + EF + +  T      +W  A E L     +T   DVWS G +  ELM R  
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFGVLLWELMTRGA 294

Query: 115 RPLFPGNDHVHQMRLLIE 132
            P +P  +       L++
Sbjct: 295 PP-YPDVNTFDITVYLLQ 311

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 65.4 bits (160), Expect = 6e-13
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 12/138 (8%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   IR+   + + +    F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DF
Sbjct: 113 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADF 172

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-- 114
           GLAR   + E+ + +  T      +W  A E L     +T   DVWS G +  ELM R  
Sbjct: 173 GLARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFGVLLWELMTRGA 230

Query: 115 RPLFPGNDHVHQMRLLIE 132
            P +P  +       L++
Sbjct: 231 PP-YPDVNTFDITVYLLQ 247

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 65.0 bits (159), Expect = 1e-12
 Identities = 35/98 (35%), Positives = 45/98 (45%), Gaps = 15/98 (15%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
           +F   + RG+ Y+     IHRDL   N+L+  N   KI DFGL+R          YV   
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKKT 199

Query: 81  ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                 RW  A E L  S  YT   DVWS G +  E++
Sbjct: 200 MGRLPVRWM-AIESLNYSV-YTTNSDVWSYGVLLWEIV 235

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 64.7 bits (158), Expect = 1e-12
 Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 12/110 (10%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            +  +L  +    F+  +  G++Y+ S N IHRDL   N +L  +  + + DFGL+R   
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188

Query: 70  ENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
             +    Y          +W  A E L ++  YT   DVW+ G    E+M
Sbjct: 189 SGD---YYRQGCASKLPVKWL-ALESLADNL-YTVHSDVWAFGVTMWEIM 233

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 12/98 (12%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
               ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++   Y    
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGG 198

Query: 81  ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                 RW  +PE L +   +T   DVWS G +  E+ 
Sbjct: 199 KGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIA 234

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 63.8 bits (156), Expect = 2e-12
 Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 12/107 (11%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
             L      +   Q+  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R     +
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 73  FMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +   Y V        RW   PE ++    +T   DVWS G I  E+ 
Sbjct: 188 Y---YRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIF 229

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 63.8 bits (156), Expect = 2e-12
 Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 12/98 (12%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
            F+  +  G++Y+ + N +HRDL   N +L  +  + + DFGL++     +    Y    
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQGR 207

Query: 81  ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                 +W  A E L +   YT+  DVW+ G    E+ 
Sbjct: 208 IAKMPVKWI-AIESLADRV-YTSKSDVWAFGVTMWEIA 243

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 63.1 bits (154), Expect = 4e-12
 Identities = 30/110 (27%), Positives = 46/110 (41%), Gaps = 12/110 (10%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            +   L          Q+  G+ Y+   + +HRDL   N L+     +KI DFG++R   
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209

Query: 70  ENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
             ++   Y V        RW   PE +L    +T   DVWS G +  E+ 
Sbjct: 210 STDY---YRVGGRTMLPIRWM-PPESILYRK-FTTESDVWSFGVVLWEIF 254

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 62.2 bits (152), Expect = 6e-12
 Identities = 27/98 (27%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
           + + Q+  G++Y+ S +V+H+DL   N+L+    ++KI D GL R     +    Y +  
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLG 188

Query: 81  ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                 RW  APE ++    ++   D+WS G +  E+ 
Sbjct: 189 NSLLPIRWM-APEAIMYGK-FSIDSDIWSYGVVLWEVF 224

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 61.9 bits (151), Expect = 1e-11
 Identities = 30/100 (30%), Positives = 41/100 (41%), Gaps = 12/100 (12%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
             LS         Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     +
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 73  FMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 105
               Y          RW   PE +  +  YT   DVW+ G
Sbjct: 229 ---YYKADGNDAIPIRWM-PPESIFYNR-YTTESDVWAYG 263

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 58.5 bits (142), Expect = 1e-10
 Identities = 28/111 (25%), Positives = 43/111 (38%), Gaps = 15/111 (13%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPT 68
             SL+     +    +  G +Y+   + IHRD+   N LL         KI DFG+AR  
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193

Query: 69  SENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
               +   Y          +W   PE  +    +T+  D WS G +  E+ 
Sbjct: 194 YRASY---YRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIF 239

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 28/111 (25%), Positives = 43/111 (38%), Gaps = 15/111 (13%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPT 68
             SL+     +    +  G +Y+   + IHRD+   N LL         KI DFG+AR  
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234

Query: 69  SENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
               +   Y          +W   PE  +    +T+  D WS G +  E+ 
Sbjct: 235 YRAGY---YRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIF 280

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.8 bits (136), Expect = 6e-10
 Identities = 21/117 (17%), Positives = 36/117 (30%), Gaps = 22/117 (18%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLAR---- 66
            +  S    +  L+QL   L    ++    HRDL   N+LL      K+      +    
Sbjct: 155 TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           P+   +                     DYT +        +F ++     LF G+  
Sbjct: 215 PSCGLQVSI-----------------IDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.9 bits (135), Expect = 1e-09
 Identities = 21/65 (32%), Positives = 34/65 (52%), Gaps = 2/65 (3%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCD-LKICD 61
           DL +I   N +  +        ++L  L+YIH    +H D+K +NLLL   N D + + D
Sbjct: 137 DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLAD 196

Query: 62  FGLAR 66
           +GL+ 
Sbjct: 197 YGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.8 bits (127), Expect = 1e-08
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 2/43 (4%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLN-ANCD-LKICDFGLAR 66
           ++L  L+YIH    +H D+K SNLLLN  N D + + D+GLA 
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.8 bits (127), Expect = 1e-08
 Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 5/46 (10%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKIC---DFGLAR 66
           QL+  ++Y+HS N+I+RD+KP N L+    N   ++    DF LA+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.0 bits (125), Expect = 2e-08
 Identities = 8/43 (18%), Positives = 21/43 (48%), Gaps = 2/43 (4%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI--CDFGLAR 66
           +LL  L+++H    +H ++   N+ ++     ++    +G A 
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.0 bits (120), Expect = 1e-07
 Identities = 13/46 (28%), Positives = 25/46 (54%), Gaps = 5/46 (10%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK-----ICDFGLAR 66
           Q+L  ++ IH  ++++RD+KP N L+            + DFG+ +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 49.7 bits (119), Expect = 1e-07
 Identities = 20/45 (44%), Positives = 28/45 (62%), Gaps = 3/45 (6%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLAR 66
            Q++  ++YIHS N IHRD+KP N L+        + I DFGLA+
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 48.9 bits (116), Expect = 4e-07
 Identities = 16/45 (35%), Positives = 28/45 (62%), Gaps = 3/45 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARP 67
           Q++  ++++HS + +HRD+KP N L+        + I DFGLA+ 
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	217
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.98
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.98
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.98
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.98
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.98
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.98
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.98
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.98
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.98
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.98
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.98
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.98
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.98
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.98
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.98
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.98
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.98
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.98
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.98
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.88
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.63
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.2
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.13
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.65
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.38
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.66
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.59
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.55
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.5
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.67
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.6
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	95.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.47
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	94.5
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.24
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	93.66
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.29
3ats_A	357	Putative uncharacterized protein; hypothetical pro	93.23
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.21
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	92.99
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	92.32
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	91.23
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	91.04
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	90.93
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	90.88
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.79
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.35
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.25
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	87.96
3mes_A	424	Choline kinase; malaria, structural genomics, stru	85.91
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	80.54

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-48  Score=308.68  Aligned_cols=208  Identities=53%  Similarity=0.895  Sum_probs=184.9

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-----Cccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-----EFMT   75 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-----~~~~   75 (217)
                      |+|+|.+++.+++++++..++.++.||+.||+|||++||+||||||+||+++.++.+|++|||++......     ....
T Consensus       141 ~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~  220 (398)
T 4b99_A          141 MESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT  220 (398)
T ss_dssp             CSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCC
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccc
Confidence            57899999999999999999999999999999999999999999999999999999999999999765332     2334


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      +.+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+...++..|....+.++...+.............
T Consensus       221 ~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~  300 (398)
T 4b99_A          221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQ  300 (398)
T ss_dssp             SSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHH
T ss_pred             cceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhh
Confidence            57899999999998877768999999999999999999999999999999999999999999988888777777788888


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      .........+...++.+++++++||++||..||++|||++|+|+||||++...
T Consensus       301 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          301 SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            88888888888999999999999999999999999999999999999997643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3e-47  Score=290.73  Aligned_cols=174  Identities=28%  Similarity=0.485  Sum_probs=141.9

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +||+|.+++.+++++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.........+..||
T Consensus        95 ~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT  174 (275)
T 3hyh_A           95 AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS  174 (275)
T ss_dssp             CCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeEC
Confidence            57899999999999999999999999999999999999999999999999999999999999999877666666678899


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+...  .+                       
T Consensus       175 ~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~-----------------------  229 (275)
T 3hyh_A          175 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VY-----------------------  229 (275)
T ss_dssp             CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CC-----------------------
T ss_pred             cccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CC-----------------------
Confidence            99999999977765578999999999999999999999887766665555431  10                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                            ..+..+|+++.+||++||+.||++|||++|+++||||+.
T Consensus       230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                  112347899999999999999999999999999999983

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-45  Score=288.47  Aligned_cols=177  Identities=25%  Similarity=0.438  Sum_probs=151.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      ||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ....+.+||
T Consensus       155 gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT  233 (346)
T 4fih_A          155 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  233 (346)
T ss_dssp             TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred             CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccC
Confidence            6899999987 57999999999999999999999999999999999999999999999999999876543 345567899


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+....... .                     
T Consensus       234 p~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~---------------------  290 (346)
T 4fih_A          234 PYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-L---------------------  290 (346)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-C---------------------
T ss_pred             cCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-C---------------------
Confidence            999999998655 48999999999999999999999999888777666654421100 0                     


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                            ..+..+|+++.+||++||..||++|||++|+|+||||++...
T Consensus       291 ------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          291 ------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             ------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence                  112247899999999999999999999999999999997643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.7e-46  Score=288.49  Aligned_cols=174  Identities=31%  Similarity=0.528  Sum_probs=151.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---Ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~   78 (217)
                      ||+|.+++++.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....   ....+.+
T Consensus       116 gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~  195 (311)
T 4aw0_A          116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV  195 (311)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCC
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcc
Confidence            6899999999999999999999999999999999999999999999999999999999999999876432   2345678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+....+.++....  +                     
T Consensus       196 GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~---------------------  251 (311)
T 4aw0_A          196 GTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--Y---------------------  251 (311)
T ss_dssp             SCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C---------------------
T ss_pred             cCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C---------------------
Confidence            999999999997654 7899999999999999999999999888777777665411  0                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhh------ccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF------VPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~l------l~~~~f~~~~  207 (217)
                              .++..+++++++||++||+.||++|||++|+      ++||||++..
T Consensus       252 --------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          252 --------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             --------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             --------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence                    1123578999999999999999999999984      7899998653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-45  Score=282.16  Aligned_cols=173  Identities=21%  Similarity=0.329  Sum_probs=143.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEec-CCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      ||+|.+++++++++++..+..++.||+.||+|||++|  |+||||||+|||++. ++.+||+|||++.... .....+..
T Consensus       113 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~~~~~~~  191 (290)
T 3fpq_A          113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVI  191 (290)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEESC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-CCccCCcc
Confidence            6899999999999999999999999999999999998  999999999999974 7899999999997543 33455678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+...+.....+                     
T Consensus       192 GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------------------  248 (290)
T 3fpq_A          192 GTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------------------  248 (290)
T ss_dssp             SSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------------------
T ss_pred             cCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC---------------------
Confidence            9999999998853  38999999999999999999999998765544333222211000                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                             .......++++.+||.+||+.||++|||++|+|+||||++
T Consensus       249 -------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                   1122346789999999999999999999999999999984

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-45  Score=284.56  Aligned_cols=173  Identities=26%  Similarity=0.449  Sum_probs=149.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      ||+|.+++++++++++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++..... ....+..||
T Consensus       110 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT  189 (304)
T 3ubd_A          110 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT  189 (304)
T ss_dssp             TCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccC
Confidence            6899999999999999999999999999999999999999999999999999999999999999764433 334567899


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+..+.+..+.+.  .+                       
T Consensus       190 ~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-----------------------  243 (304)
T 3ubd_A          190 VEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KL-----------------------  243 (304)
T ss_dssp             GGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-----------------------
T ss_pred             cccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CC-----------------------
Confidence            9999999997654 889999999999999999999999988877777666541  11                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                            ..+..+|+++.+||++||+.||++|||     ++|+++||||++.
T Consensus       244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence                  112357899999999999999999999     4799999999965

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=289.26  Aligned_cols=177  Identities=25%  Similarity=0.443  Sum_probs=151.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      ||+|.++++. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ......+||
T Consensus       232 gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT  310 (423)
T 4fie_A          232 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  310 (423)
T ss_dssp             TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEEC
T ss_pred             CCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccC
Confidence            6899999976 56999999999999999999999999999999999999999999999999999876543 345567899


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+. .++.++|||||||++|+|++|..||.+......+..+.......                       
T Consensus       311 p~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------------------  366 (423)
T 4fie_A          311 PYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------------------  366 (423)
T ss_dssp             TTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------------------
T ss_pred             cCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------------------
Confidence            999999998655 48999999999999999999999999888777666654421100                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                           ...+..+++++.+||++||..||++|||++|+|+||||++...
T Consensus       367 -----~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          367 -----LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             -----CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             -----CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence                 0122357899999999999999999999999999999997643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.2e-45  Score=286.91  Aligned_cols=173  Identities=23%  Similarity=0.383  Sum_probs=149.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      ||+|.++|..+  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... .....+
T Consensus       107 gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~  186 (350)
T 4b9d_A          107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI  186 (350)
T ss_dssp             TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHH
T ss_pred             CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccC
Confidence            68999999765  457999999999999999999999999999999999999999999999999997765432 234567


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+.++....  .+                    
T Consensus       187 GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~--------------------  243 (350)
T 4b9d_A          187 GTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--FP--------------------  243 (350)
T ss_dssp             SCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CC--------------------
T ss_pred             CCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--CC--------------------
Confidence            999999999986654 8999999999999999999999999888777776665411  10                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                              .....+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus       244 --------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          244 --------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             --------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                    122357899999999999999999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.2e-44  Score=280.03  Aligned_cols=176  Identities=23%  Similarity=0.364  Sum_probs=146.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-CEEEecccccccCCCCCc------c
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEF------M   74 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~------~   74 (217)
                      ||+|.+++++.+++++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+|||++........      .
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~  213 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG  213 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecC
Confidence            689999999999999999999999999999999999999999999999999987 699999999976543321      1


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ...+||+.|+|||++.+.+ ++.++||||+||++|+|++|..||.+.........+...                     
T Consensus       214 ~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---------------------  271 (336)
T 4g3f_A          214 DYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---------------------  271 (336)
T ss_dssp             CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---------------------
T ss_pred             CccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---------------------
Confidence            2357999999999997654 899999999999999999999999876544444433320                     


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhh-------------ccCCCCccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF-------------VPYKPFQCC  206 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~l-------------l~~~~f~~~  206 (217)
                             ......+++.+++++.++|++||+.||++|||+.|+             ++|||+...
T Consensus       272 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          272 -------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             -------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             -------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence                   112234556789999999999999999999999997             789999865

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.2e-43  Score=279.03  Aligned_cols=202  Identities=29%  Similarity=0.473  Sum_probs=150.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-CCEEEecccccccCCCCC--------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENE--------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~--------   72 (217)
                      |++|.++++   .+++.+++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++......        
T Consensus       104 g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~  180 (361)
T 4f9c_A          104 HESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ  180 (361)
T ss_dssp             CCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-
T ss_pred             cccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccc
Confidence            579999984   59999999999999999999999999999999999999877 799999999996543221        


Q ss_pred             ---------------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCChHHHHHHH
Q 027927           73 ---------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP-GNDHVHQMRLL  130 (217)
Q Consensus        73 ---------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~-~~~~~~~~~~~  130 (217)
                                           .....+||+.|+|||++.+.+.++.++|+||+||++|+|++|..||. +.++..++..+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I  260 (361)
T 4f9c_A          181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQI  260 (361)
T ss_dssp             -------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence                                 12335789999999999877668999999999999999999999985 55677888888


Q ss_pred             HHHhCCCCCcccc-----------ccCchHHHHHHHh---CCCC---------CccchhhhCCCCChhHHHHHHHhcccC
Q 027927          131 IELLGTPTDADLG-----------FVRNEDAKRYIRQ---LPQH---------PRQSLAQVFPHVHPLAIDLVDRMLTFD  187 (217)
Q Consensus       131 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~d  187 (217)
                      ....|.+......           .......+.....   ....         ........+..+|++++|||++||++|
T Consensus       261 ~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~d  340 (361)
T 4f9c_A          261 MTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLN  340 (361)
T ss_dssp             HHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSC
T ss_pred             HHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCC
Confidence            8877643211100           0000111111110   0000         001112334578999999999999999


Q ss_pred             CCCCCCHhhhccCCCCccc
Q 027927          188 PMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       188 p~~R~t~~~ll~~~~f~~~  206 (217)
                      |++|+|++|+|+||||++.
T Consensus       341 P~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          341 PASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             TTTSCCHHHHHTSGGGTTC
T ss_pred             hhHCcCHHHHhcCcccCCC
Confidence            9999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=261.32  Aligned_cols=205  Identities=36%  Similarity=0.624  Sum_probs=170.8

Q ss_pred             CCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccc
Q 027927            1 MDTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      ++++|.+++.....  +++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.............
T Consensus       101 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  180 (308)
T 3g33_A          101 VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV  180 (308)
T ss_dssp             CCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGG
T ss_pred             hhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCcc
Confidence            46799999998754  9999999999999999999999999999999999999999999999999998776665566678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+.. ++.++|+|||||++|++++|..||.+.........+.+..+.+.+..+........    ....
T Consensus       181 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~  255 (308)
T 3g33_A          181 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR----GAFP  255 (308)
T ss_dssp             CCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCG----GGSC
T ss_pred             ccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccc----cccC
Confidence            899999999987655 78999999999999999999999999999999999999988887776653332211    1223


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCce
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCI  210 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~  210 (217)
                      ...........+.+++++.++|.+||+.||++|||+.|+|+||||++..+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~~  307 (308)
T 3g33_A          256 PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP  307 (308)
T ss_dssp             CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-------
T ss_pred             CCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCCC
Confidence            3344456667788999999999999999999999999999999999776544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-41  Score=276.90  Aligned_cols=208  Identities=49%  Similarity=0.851  Sum_probs=179.2

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--------
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--------   72 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--------   72 (217)
                      ++++|.++++....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......        
T Consensus       139 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  218 (458)
T 3rp9_A          139 ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI  218 (458)
T ss_dssp             CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-
T ss_pred             cccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcccccccccc
Confidence            578999999999999999999999999999999999999999999999999999999999999997654221        


Q ss_pred             --------------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-----------CCCCCCCC
Q 027927           73 --------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-----------RRPLFPGN  121 (217)
Q Consensus        73 --------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-----------~~~pf~~~  121 (217)
                                          ......+++.|+|||++.....++.++|||||||++|+|++           |.++|.+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~  298 (458)
T 3rp9_A          219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGS  298 (458)
T ss_dssp             --------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--
T ss_pred             CccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCC
Confidence                                12345678999999987666668999999999999999998           67777664


Q ss_pred             C--------------------hHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHH
Q 027927          122 D--------------------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD  181 (217)
Q Consensus       122 ~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  181 (217)
                      .                    ...++..+.+..|.+....+..........+...........+...++..++++.+||+
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~  378 (458)
T 3rp9_A          299 SCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLK  378 (458)
T ss_dssp             ------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHH
T ss_pred             ccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHH
Confidence            4                    35778889999999999988888888888888888888888888888999999999999


Q ss_pred             HhcccCCCCCCCHhhhccCCCCccccC
Q 027927          182 RMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       182 ~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      +||..||++|||++|+|+||||++...
T Consensus       379 ~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          379 RMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             HHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             HHhccCccccCCHHHHhcCHhhhhcCC
Confidence            999999999999999999999997743

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.8e-41  Score=273.83  Aligned_cols=208  Identities=43%  Similarity=0.804  Sum_probs=180.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--------
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--------   72 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--------   72 (217)
                      ++++|.++++.+..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......        
T Consensus       112 ~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  191 (432)
T 3n9x_A          112 ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL  191 (432)
T ss_dssp             CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC------------
T ss_pred             CCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccc
Confidence            578999999999999999999999999999999999999999999999999999999999999997654322        


Q ss_pred             ---------------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-----------CCCCCCCCC----
Q 027927           73 ---------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-----------RRPLFPGND----  122 (217)
Q Consensus        73 ---------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-----------~~~pf~~~~----  122 (217)
                                     ......+++.|+|||.+.....++.++||||+||++|++++           |.++|.+.+    
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~  271 (432)
T 3n9x_A          192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPL  271 (432)
T ss_dssp             -------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC-
T ss_pred             cccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCcccccc
Confidence                           12456779999999987666668999999999999999997           455554443    


Q ss_pred             -------------hHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCC
Q 027927          123 -------------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPM  189 (217)
Q Consensus       123 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  189 (217)
                                   ...++..+.+..|.++...+..........+...........+...++.+++++.+||++||+.||+
T Consensus       272 ~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  351 (432)
T 3n9x_A          272 SPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN  351 (432)
T ss_dssp             ---------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTT
T ss_pred             CcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcc
Confidence                         3678889999999999998888888888888888888888888888899999999999999999999


Q ss_pred             CCCCHhhhccCCCCccccC
Q 027927          190 KRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       190 ~R~t~~~ll~~~~f~~~~~  208 (217)
                      +|||++|+|+||||++...
T Consensus       352 ~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          352 KRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             TSCCHHHHHTCGGGTTTCC
T ss_pred             cCCCHHHHhcChhhhhccC
Confidence            9999999999999997643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-41  Score=267.52  Aligned_cols=205  Identities=42%  Similarity=0.839  Sum_probs=185.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +|++|.++++. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++......  .....++
T Consensus       112 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t  188 (367)
T 1cm8_A          112 MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVT  188 (367)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSC
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc--cCcCcCC
Confidence            47899999987 67999999999999999999999999999999999999999999999999999765433  3345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+...++.++|+||+||+++++++|..||.+.+...++..+.+..+.++...+..........++......
T Consensus       189 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~  268 (367)
T 1cm8_A          189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL  268 (367)
T ss_dssp             GGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCC
T ss_pred             CCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCC
Confidence            99999999977566899999999999999999999999999999999999999999998888888888888888888888


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ....+...++..++++.+||++||..||++|||++++|+||||++...
T Consensus       269 ~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          269 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             CCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            888888888999999999999999999999999999999999997643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-41  Score=269.10  Aligned_cols=205  Identities=50%  Similarity=0.917  Sum_probs=172.0

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +|++|.++++. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++......  .....++
T Consensus       116 ~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t  192 (367)
T 2fst_X          116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVAT  192 (367)
T ss_dssp             CCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------------CC
T ss_pred             cCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcC
Confidence            46788888876 67999999999999999999999999999999999999999999999999998765432  3345778


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+...++.++|+||+||++|++++|..||.+.+...++..+.+..+.+....+..........+.......
T Consensus       193 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~  272 (367)
T 2fst_X          193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM  272 (367)
T ss_dssp             CTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCC
T ss_pred             cCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCC
Confidence            99999999877566889999999999999999999999999999999999999999998888888888888888888888


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      +...+...++..++.+.+||++||+.||++|||++++|+||||++...
T Consensus       273 ~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          273 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             CCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence            888888888999999999999999999999999999999999997643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-41  Score=284.10  Aligned_cols=174  Identities=25%  Similarity=0.391  Sum_probs=146.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      ||+|.++|++++.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ..+.+||+
T Consensus       276 GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp  354 (689)
T 3v5w_A          276 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  354 (689)
T ss_dssp             SCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-CCSCCSCG
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-CCCccCCc
Confidence            78999999999999999999999999999999999999999999999999999999999999998765433 45678999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      .|+|||++.....++.++|+|||||++|+|++|..||.+...   ......+..                       .. 
T Consensus       355 ~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-----------------------~~-  410 (689)
T 3v5w_A          355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------------MA-  410 (689)
T ss_dssp             GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-----------------------CC-
T ss_pred             CccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-----------------------CC-
Confidence            999999996555589999999999999999999999975432   111111111                       00 


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~~  207 (217)
                             ...+..+|+++.+||++||..||++|++     ++|+++||||++..
T Consensus       411 -------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          411 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             -------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence                   0123458899999999999999999998     79999999999653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-41  Score=258.90  Aligned_cols=172  Identities=22%  Similarity=0.314  Sum_probs=138.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---Cccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~   77 (217)
                      ||+|.++|+.. .++++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......   ......
T Consensus       115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~  194 (307)
T 3omv_A          115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP  194 (307)
T ss_dssp             SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------C
T ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeeccc
Confidence            68999999775 67999999999999999999999999999999999999999999999999999754432   223456


Q ss_pred             cccccccCcccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           78 VVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~--~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      .||+.|+|||++...  ..++.++|||||||++|++++|..||.+.........+.......                  
T Consensus       195 ~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~------------------  256 (307)
T 3omv_A          195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS------------------  256 (307)
T ss_dssp             CCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC------------------
T ss_pred             ccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC------------------
Confidence            789999999998643  347889999999999999999999998876655554444321111                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV  198 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll  198 (217)
                             ......+.++++++.++|.+||+.||++|||+.+++
T Consensus       257 -------p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~  292 (307)
T 3omv_A          257 -------PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL  292 (307)
T ss_dssp             -------CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred             -------CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence                   112234456889999999999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.2e-40  Score=257.04  Aligned_cols=207  Identities=37%  Similarity=0.669  Sum_probs=171.2

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~   78 (217)
                      ++++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+...... .......
T Consensus       101 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  180 (311)
T 3niz_A          101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV  180 (311)
T ss_dssp             CSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCC
T ss_pred             CCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCc
Confidence            457888888776 55999999999999999999999999999999999999999999999999999765533 2234456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+...++.++|+||+|+++|++++|..||.+.........+....+.+.+..+........... ....
T Consensus       181 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~  259 (311)
T 3niz_A          181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ-RTFQ  259 (311)
T ss_dssp             CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS-CCCC
T ss_pred             ccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh-cccc
Confidence            789999999987766689999999999999999999999999988899999999999888777665443322111 1122


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ......+....+.+++++.+||++||+.||++|||++|+++||||++...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            22344566777889999999999999999999999999999999997643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.6e-41  Score=269.39  Aligned_cols=208  Identities=39%  Similarity=0.731  Sum_probs=164.8

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC----------
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE----------   70 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~----------   70 (217)
                      ++++|.++++. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....          
T Consensus        93 ~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  171 (388)
T 3oz6_A           93 METDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL  171 (388)
T ss_dssp             CSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGG
T ss_pred             cCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccc
Confidence            46789999987 5799999999999999999999999999999999999999999999999999875432          


Q ss_pred             ------------CCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Q 027927           71 ------------NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT  138 (217)
Q Consensus        71 ------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~  138 (217)
                                  ........+++.|+|||++.+...++.++||||+||++|++++|..||.+.+...++..+....+.+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~  251 (388)
T 3oz6_A          172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPS  251 (388)
T ss_dssp             CCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence                        11223457899999999997766689999999999999999999999999999999999999999888


Q ss_pred             CccccccCchHHHHHHHhCCCC---Cccchh-------------hhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          139 DADLGFVRNEDAKRYIRQLPQH---PRQSLA-------------QVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                      ...+..................   ......             ......++++.+||++||..||++|||++|+|+|||
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          252 NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF  331 (388)
T ss_dssp             HHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTT
T ss_pred             HHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHH
Confidence            7665444433333322211100   000000             112367899999999999999999999999999999


Q ss_pred             CccccCc
Q 027927          203 FQCCCGC  209 (217)
Q Consensus       203 f~~~~~~  209 (217)
                      |+.....
T Consensus       332 ~~~~~~~  338 (388)
T 3oz6_A          332 VSIFHNP  338 (388)
T ss_dssp             TTTTCCG
T ss_pred             HHHhcCC
Confidence            9866443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.4e-41  Score=280.59  Aligned_cols=177  Identities=23%  Similarity=0.351  Sum_probs=153.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC--CCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN--CDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      ||+|++++.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.+  +.+||+|||++............+
T Consensus       238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~  317 (573)
T 3uto_A          238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT  317 (573)
T ss_dssp             CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEEC
T ss_pred             CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeE
Confidence            68999999754 689999999999999999999999999999999999999854  899999999999887777777788


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ||+.|+|||++.+.+ ++.++||||+||++|+|++|..||.+....+.+..+........+                   
T Consensus       318 GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------  377 (573)
T 3uto_A          318 GTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-------------------  377 (573)
T ss_dssp             SSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS-------------------
T ss_pred             ECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc-------------------
Confidence            999999999997654 799999999999999999999999998877777666542211111                   


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                              ..+..+|+++++||++||+.||.+|||+.|+|+||||+..
T Consensus       378 --------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          378 --------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             --------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             --------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence                    2234688999999999999999999999999999999954

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.3e-40  Score=261.68  Aligned_cols=206  Identities=52%  Similarity=0.965  Sum_probs=183.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----ccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~   76 (217)
                      ++++|.++++. +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus       112 ~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  190 (364)
T 3qyz_A          112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE  190 (364)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred             cCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccc
Confidence            46789999987 5699999999999999999999999999999999999999999999999999876543321    234


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.+...++.++|+||||+++|++++|..||.+.........+....+.+....+..........+...
T Consensus       191 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
T 3qyz_A          191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS  270 (364)
T ss_dssp             CCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred             cccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHh
Confidence            57899999999887666688999999999999999999999999999999999999999998888777777777777777


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ........+....+.+++++.+||++||+.||++|||++++|+||||++..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             SCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             cCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence            777777788888899999999999999999999999999999999999763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-41  Score=261.90  Aligned_cols=174  Identities=25%  Similarity=0.443  Sum_probs=129.6

Q ss_pred             CccHHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-----
Q 027927            2 DTDLYQIIRSNQSL---SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----   73 (217)
Q Consensus         2 ~~~L~~~l~~~~~l---~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----   73 (217)
                      |++|.+++++...+   +...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......     
T Consensus        99 gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~  178 (299)
T 4g31_A           99 KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL  178 (299)
T ss_dssp             SCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-------------
T ss_pred             CCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccc
Confidence            68999999987554   4567899999999999999999999999999999999999999999999976543321     


Q ss_pred             --------cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           74 --------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        74 --------~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                              ....+||+.|+|||++.+. .++.++|||||||++|+|++   ||...  .+....+........+      
T Consensus       179 ~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~~p------  246 (299)
T 4g31_A          179 TPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLKFP------  246 (299)
T ss_dssp             -------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTCCC------
T ss_pred             cccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCCCC------
Confidence                    2235789999999998665 48999999999999999996   67532  2222222222111110      


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                                           ..+...++.+.+||++||+.||++|||+.|+++||||++...
T Consensus       247 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          247 ---------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             ---------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             ---------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence                                 011124577889999999999999999999999999997643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.7e-40  Score=270.03  Aligned_cols=203  Identities=41%  Similarity=0.744  Sum_probs=164.3

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      ++++|.+.+..  .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.............++
T Consensus       149 ~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt  226 (464)
T 3ttj_A          149 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT  226 (464)
T ss_dssp             CSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CC
T ss_pred             CCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCccc
Confidence            35677777755  5999999999999999999999999999999999999999999999999999877665555667889


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++||||+||++|++++|..||.+.+...++..+++..+.+.+..+.... .....+.......
T Consensus       227 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~-~~~~~~~~~~~~~  304 (464)
T 3ttj_A          227 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKY  304 (464)
T ss_dssp             CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC-HHHHHHHTTSCCC
T ss_pred             ccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc-hhhhhHhhccccc
Confidence            999999999765 48899999999999999999999999999999999999999998877665543 3444555554444


Q ss_pred             CccchhhhCCCC------------ChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHV------------HPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~------------~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ....+...++..            ++++.+||++||.+||++|||++|+|+||||+.+.
T Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          305 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             CCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence            444444443322            57799999999999999999999999999999654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-39  Score=256.18  Aligned_cols=176  Identities=23%  Similarity=0.385  Sum_probs=152.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++..++++++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.............+++
T Consensus        98 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~  177 (328)
T 3fe3_A           98 GGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP  177 (328)
T ss_dssp             TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSG
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCc
Confidence            68999999998999999999999999999999999999999999999999999999999999998776666666778999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+....+.++|+||+||++|++++|..||.+.+.......+....  .                        
T Consensus       178 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~------------------------  231 (328)
T 3fe3_A          178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--Y------------------------  231 (328)
T ss_dssp             GGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------------------------
T ss_pred             ceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C------------------------
Confidence            99999999877655689999999999999999999998877665555544310  0                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                           ..+..+++++.++|++||..||.+|||++++++||||+....
T Consensus       232 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          232 -----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             -----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence                 112246799999999999999999999999999999986543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=253.62  Aligned_cols=207  Identities=38%  Similarity=0.675  Sum_probs=167.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~   78 (217)
                      ++++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+...... .......
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  161 (324)
T 3mtl_A           82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV  161 (324)
T ss_dssp             CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred             cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccccc
Confidence            467899998875 56999999999999999999999999999999999999999999999999998755432 2233456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+...++.++|+||+|+++|++++|..||.+.........+....+.+.+..+............ ...
T Consensus       162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~  240 (324)
T 3mtl_A          162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY-NYP  240 (324)
T ss_dssp             -CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT-CCC
T ss_pred             CcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc-ccc
Confidence            7899999999877666899999999999999999999999999999999999999999888777655443322221 122


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ...........+.+++++.+||++||+.||++|||++|+|+||||.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            22333445566788999999999999999999999999999999997643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.6e-39  Score=250.99  Aligned_cols=203  Identities=38%  Similarity=0.660  Sum_probs=162.6

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~   78 (217)
                      ++++|.+++... +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...... .......
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  161 (288)
T 1ob3_A           82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI  161 (288)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred             cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccccc
Confidence            356889998875 77999999999999999999999999999999999999999999999999998765432 2233456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+...++.++|+||||+++|++++|..||.+.........+....+.+....+.......  .+.....
T Consensus       162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  239 (288)
T 1ob3_A          162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP--KYDPNFT  239 (288)
T ss_dssp             CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TCCTTCC
T ss_pred             ccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc--ccccccc
Confidence            78999999999766668899999999999999999999999999888899998888877766554322110  0011111


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      ......+......+++++.++|++||+.||++|||++++++||||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            12223455666778999999999999999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.7e-39  Score=257.39  Aligned_cols=204  Identities=46%  Similarity=0.833  Sum_probs=178.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      ++++|.+++.  ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+......  .....++
T Consensus       129 ~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t  204 (371)
T 4exu_A          129 MQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVT  204 (371)
T ss_dssp             CCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCC
T ss_pred             ccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccC
Confidence            3567777774  35999999999999999999999999999999999999999999999999998755433  3345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+...++.++|+||||+++|++++|..||.+.+.......+....+.+...............+.......
T Consensus       205 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (371)
T 4exu_A          205 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT  284 (371)
T ss_dssp             CTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCC
T ss_pred             ccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCC
Confidence            99999999877566889999999999999999999999999999999999999999988888888888888888888888


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      +...+...++.+++++.+||++||+.||.+|||++++|+||||+....
T Consensus       285 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          285 PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence            888888888999999999999999999999999999999999997643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.5e-39  Score=249.53  Aligned_cols=205  Identities=40%  Similarity=0.653  Sum_probs=162.3

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccc
Q 027927            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~   78 (217)
                      ++++|.+++.. ++.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...... .......
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  162 (292)
T 3o0g_A           83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV  162 (292)
T ss_dssp             CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCC
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCc
Confidence            35667776665 578999999999999999999999999999999999999999999999999999766533 2334457


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+...++.++|+||+|+++|++++|..| |.+.+.......+.+..+.+....+.........  ....
T Consensus       163 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~  240 (292)
T 3o0g_A          163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY--KPYP  240 (292)
T ss_dssp             SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC--CCCC
T ss_pred             cccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc--cccc
Confidence            789999999997766679999999999999999987666 5677778888899998888877766543321100  0000


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ............+.+++++.++|++||+.||++|||++|+++||||++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            01111223344567889999999999999999999999999999999765

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.8e-40  Score=252.89  Aligned_cols=172  Identities=20%  Similarity=0.297  Sum_probs=142.7

Q ss_pred             CccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccC
Q 027927            2 DTDLYQIIRSN-------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (217)
Q Consensus         2 ~~~L~~~l~~~-------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   68 (217)
                      ||+|.++|+++             ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus        99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~  178 (299)
T 4asz_A           99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV  178 (299)
T ss_dssp             TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred             CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceec
Confidence            68999999874             36999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           69 SENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        69 ~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      .....   .....+++.|+|||.+.+.. ++.++|||||||++||+++ |..||.+....+....+..... +       
T Consensus       179 ~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-~-------  249 (299)
T 4asz_A          179 YSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-L-------  249 (299)
T ss_dssp             TGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-C-------
T ss_pred             CCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C-------
Confidence            44322   22346789999999997654 8999999999999999998 8999998887766665543110 0       


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                            ..+..+++++.++|.+||+.||++|||+++++  +|+++.
T Consensus       250 ----------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~  287 (299)
T 4asz_A          250 ----------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL  287 (299)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             ----------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence                                  12235789999999999999999999999994  455543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.6e-39  Score=255.92  Aligned_cols=210  Identities=39%  Similarity=0.760  Sum_probs=169.4

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      ++++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.............+
T Consensus       116 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  195 (362)
T 3pg1_A          116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT  195 (362)
T ss_dssp             CSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecc
Confidence            467888888775 4799999999999999999999999999999999999999999999999999976555555556678


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC-C
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL-P  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  158 (217)
                      ++.|+|||.+.+...++.++|+||||+++|++++|..||.+.........+.+..+.+...............+.... .
T Consensus       196 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (362)
T 3pg1_A          196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLS  275 (362)
T ss_dssp             CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCC
T ss_pred             cceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcc
Confidence            899999999877566899999999999999999999999999999999999999988877665555555555554333 3


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCce
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCI  210 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~  210 (217)
                      ..+...+....+..++.+.++|.+||+.||++|||++++++||||++.....
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          276 NVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             CCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             cCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence            3445567777888999999999999999999999999999999999775443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=253.12  Aligned_cols=211  Identities=30%  Similarity=0.572  Sum_probs=156.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.++++..+.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  165 (311)
T 4agu_A           86 HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT  165 (311)
T ss_dssp             EEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------
T ss_pred             CchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCC
Confidence            4578888888889999999999999999999999999999999999999999999999999998765532 233455778


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+...++.++|+||+|+++|++++|..||.+.........+.+..+...+.....................
T Consensus       166 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 4agu_A          166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPE  245 (311)
T ss_dssp             GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCS
T ss_pred             ccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCcc
Confidence            89999999987666899999999999999999999999999888888888777665543221100000000000000011


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCceee
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIEF  212 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~~  212 (217)
                      .........+++++++.++|++||+.||++|||++++++||||++.....++
T Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  297 (311)
T 4agu_A          246 DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL  297 (311)
T ss_dssp             SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-----
T ss_pred             ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHHH
Confidence            1223344456789999999999999999999999999999999987655443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.9e-38  Score=251.40  Aligned_cols=206  Identities=53%  Similarity=0.950  Sum_probs=173.2

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-------
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-------   73 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------   73 (217)
                      ++++|.+++.. +.+++..+..++.||+.||++||++|++|+||||+||+++.++.++|+|||.+........       
T Consensus        96 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  174 (353)
T 2b9h_A           96 MQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG  174 (353)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----------
T ss_pred             cCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccc
Confidence            35789999887 5799999999999999999999999999999999999999999999999999876543221       


Q ss_pred             ----cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCc-cccccCch
Q 027927           74 ----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA-DLGFVRNE  148 (217)
Q Consensus        74 ----~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  148 (217)
                          .....+++.|+|||.+.+...++.++|+||||+++|++++|..||.+.+.......+....+.+... ........
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (353)
T 2b9h_A          175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESP  254 (353)
T ss_dssp             -----CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCH
T ss_pred             cccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccc
Confidence                1234678899999988766668899999999999999999999999999888888888888876643 33334445


Q ss_pred             HHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ....+.......+...+...++.+++++.++|++||+.||++|||++++++||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            55666666666666677788889999999999999999999999999999999999654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=252.44  Aligned_cols=168  Identities=20%  Similarity=0.293  Sum_probs=134.1

Q ss_pred             CccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927            2 DTDLYQIIRSN---------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus         2 ~~~L~~~l~~~---------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      ||+|.++++++               .++++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus       127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~  206 (329)
T 4aoj_A          127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR  206 (329)
T ss_dssp             TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccce
Confidence            68999999864               359999999999999999999999999999999999999999999999999997


Q ss_pred             cCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccc
Q 027927           67 PTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADL  142 (217)
Q Consensus        67 ~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~  142 (217)
                      ......   ......+++.|+|||.+.+.. ++.++|||||||++||+++ |..||.+....+.+..+.+.. .+     
T Consensus       207 ~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~~-----  279 (329)
T 4aoj_A          207 DIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-EL-----  279 (329)
T ss_dssp             -------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-CC-----
T ss_pred             eccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CC-----
Confidence            654332   223456889999999986554 8999999999999999998 899999887776665554311 00     


Q ss_pred             cccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          143 GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                              ..+..+++++.++|.+||+.||++|||++|++++
T Consensus       280 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          280 ------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             ------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                                    1123578999999999999999999999999753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.9e-39  Score=251.60  Aligned_cols=206  Identities=34%  Similarity=0.659  Sum_probs=163.9

Q ss_pred             CCccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Cc
Q 027927            1 MDTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EF   73 (217)
Q Consensus         1 l~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~   73 (217)
                      ++++|.+++...      ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...... ..
T Consensus        85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  164 (317)
T 2pmi_A           85 MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT  164 (317)
T ss_dssp             CCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred             cCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence            457899988764      45999999999999999999999999999999999999999999999999998765433 22


Q ss_pred             cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHH
Q 027927           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (217)
                      .....+++.|+|||.+.+...++.++|+|||||++|++++|..||.+.........+....+.+.+..+.......  .+
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~  242 (317)
T 2pmi_A          165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP--KY  242 (317)
T ss_dssp             CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT--TC
T ss_pred             CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh--hc
Confidence            3445778999999999766668899999999999999999999999999999999999988887766554332110  00


Q ss_pred             HHhCCCCCccch-----hhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          154 IRQLPQHPRQSL-----AQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       154 ~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ...........+     ......+++++.+||++||+.||++|||++++++||||++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence            000111111111     1123357899999999999999999999999999999997643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-39  Score=256.99  Aligned_cols=169  Identities=26%  Similarity=0.376  Sum_probs=139.0

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +|+|.++|++.                ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus       153 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGla  232 (353)
T 4ase_A          153 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA  232 (353)
T ss_dssp             TEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred             CCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhh
Confidence            68999999864                34899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      +......   ......+++.|+|||.+.+.. ++.++|||||||++||+++ |..||.+......+...+.....+    
T Consensus       233 r~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~----  307 (353)
T 4ase_A          233 RDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----  307 (353)
T ss_dssp             SCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----
T ss_pred             hhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC----
Confidence            7654432   223456789999999997654 8999999999999999998 899998765444333333321111    


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                               ..+..+++++.++|.+||+.||++|||++++++|
T Consensus       308 -------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          308 -------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                                     1123577999999999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.2e-39  Score=255.02  Aligned_cols=177  Identities=25%  Similarity=0.403  Sum_probs=151.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC----CEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      |++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++    .++|+|||++............
T Consensus        99 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  178 (361)
T 2yab_A           99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI  178 (361)
T ss_dssp             SCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccC
Confidence            789999999999999999999999999999999999999999999999998776    7999999999877665555667


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .|++.|+|||++.+. .++.++|+||+|+++|++++|..||.+......+..+.......                    
T Consensus       179 ~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------  237 (361)
T 2yab_A          179 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF--------------------  237 (361)
T ss_dssp             CSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC--------------------
T ss_pred             CCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------------
Confidence            899999999998654 47899999999999999999999998887766665554311111                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ....+..+++++.+||++||..||++|||+.++++||||+..
T Consensus       238 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          238 -------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             -------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             -------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence                   112234678999999999999999999999999999999854

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.9e-39  Score=258.10  Aligned_cols=204  Identities=37%  Similarity=0.673  Sum_probs=164.2

Q ss_pred             CccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe-cCCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      ++++.+.+.    ....+++..++.++.||+.||+|||++|++||||||+||+++ .++.++|+|||.+...........
T Consensus       121 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~  200 (394)
T 4e7w_A          121 PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS  200 (394)
T ss_dssp             SEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCS
T ss_pred             CccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcc
Confidence            345554443    367899999999999999999999999999999999999999 789999999999987665555556


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.+...++.++|+||+||++|++++|..||.+.+....+..+.+..+.+....+.........   ..
T Consensus       201 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~---~~  277 (394)
T 4e7w_A          201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME---HK  277 (394)
T ss_dssp             SCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS---SC
T ss_pred             cccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh---hc
Confidence            678999999999977666899999999999999999999999999999999999999888876543322111000   01


Q ss_pred             CCCCCccchhhhC-CCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          157 LPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       157 ~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ........+...+ ..+++++.+||++||+.||++|||+.|+++||||++...
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             cccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            1122222333333 458899999999999999999999999999999997643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.3e-39  Score=250.61  Aligned_cols=168  Identities=18%  Similarity=0.304  Sum_probs=139.7

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +|+|.++|...                ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus       113 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGla  192 (308)
T 4gt4_A          113 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF  192 (308)
T ss_dssp             SCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCB
T ss_pred             CCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccc
Confidence            68999999763                35899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      +......   ......+++.|+|||.+.+.. ++.++|||||||++||+++ |..||.+....+....+......     
T Consensus       193 r~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~-----  266 (308)
T 4gt4_A          193 REVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL-----  266 (308)
T ss_dssp             CGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCC-----
T ss_pred             eeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            7543322   233457889999999997654 8999999999999999998 89999988776665544321100     


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                               ..+..+++++.+++.+||+.||++|||++|++++
T Consensus       267 -------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          267 -------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                     1233578999999999999999999999999763

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.9e-38  Score=246.47  Aligned_cols=206  Identities=38%  Similarity=0.664  Sum_probs=170.0

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccc
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      ++++|.+++...  ..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.............
T Consensus       101 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (326)
T 1blx_A          101 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV  180 (326)
T ss_dssp             CSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCC
T ss_pred             CCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccc
Confidence            357999999885  349999999999999999999999999999999999999999999999999987665544445567


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+.. ++.++|+||||+++|++++|..||.+.........+....+.+....+........    ....
T Consensus       181 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~  255 (326)
T 1blx_A          181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR----QAFH  255 (326)
T ss_dssp             CCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG----GGSC
T ss_pred             cccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccch----hhhc
Confidence            789999999986554 78999999999999999999999999999999999988888776665543221100    1111


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCcee
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIE  211 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~  211 (217)
                      .............+++.+.++|.+||+.||.+|||+.++++||||++...+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  308 (326)
T 1blx_A          256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  308 (326)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             ccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence            12223445566778999999999999999999999999999999998876654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=252.83  Aligned_cols=203  Identities=46%  Similarity=0.829  Sum_probs=173.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      +++|.+++.  ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+......  .....+++
T Consensus       112 ~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~  187 (353)
T 3coi_A          112 QTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTR  187 (353)
T ss_dssp             SEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSB
T ss_pred             cCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCc
Confidence            456666654  35999999999999999999999999999999999999999999999999998654432  23456788


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+...++.++|+||||+++|++++|..||.+.+....+..+.+..+.+....+..........+.......+
T Consensus       188 ~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (353)
T 3coi_A          188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP  267 (353)
T ss_dssp             CCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCS
T ss_pred             CcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCC
Confidence            99999998765668899999999999999999999999999999999999999988887777777777777777777777


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ...+....+.+++++.++|++||+.||++|||++++++||||+....
T Consensus       268 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          268 RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             SCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             CccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence            77777777889999999999999999999999999999999996643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.9e-39  Score=251.64  Aligned_cols=205  Identities=35%  Similarity=0.630  Sum_probs=158.3

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe-----cCCCEEEecccccccCCCC-Ccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-----ANCDLKICDFGLARPTSEN-EFM   74 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~-----~~~~~~l~d~~~~~~~~~~-~~~   74 (217)
                      ++++|.+++..++.+++..+..++.||+.||+|||++|++|+||||+||+++     ..+.++|+|||.+...... ...
T Consensus       115 ~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  194 (329)
T 3gbz_A          115 AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF  194 (329)
T ss_dssp             CSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------
T ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccccc
Confidence            4679999999999999999999999999999999999999999999999995     4455999999998765432 223


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+++.|+|||.+.+...++.++|||||||++|++++|..||.+.........+.+..+.+.+..+.......  .+.
T Consensus       195 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  272 (329)
T 3gbz_A          195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP--DWK  272 (329)
T ss_dssp             -----CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TCC
T ss_pred             CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh--hhh
Confidence            445678999999999776668999999999999999999999999999999999999988887776554322111  000


Q ss_pred             HhCCCCCccch-hhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          155 RQLPQHPRQSL-AQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       155 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ..........+ ......+++++.+||++||+.||++|||++|+|+||||++..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            11111111111 112223779999999999999999999999999999999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-38  Score=250.39  Aligned_cols=204  Identities=38%  Similarity=0.652  Sum_probs=167.9

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~   78 (217)
                      ++++|.+++..+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...... .......
T Consensus        94 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  173 (346)
T 1ua2_A           94 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  173 (346)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             CCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCccc
Confidence            356888888776 47999999999999999999999999999999999999999999999999998765433 2334457


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+...++.++|+||||+++|++++|..||.+......+..+.+..+.+....|.........   ....
T Consensus       174 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~  250 (346)
T 1ua2_A          174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY---VTFK  250 (346)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC---CCCC
T ss_pred             ccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc---cccc
Confidence            7899999999876666789999999999999999999999999999999999998888877665543321100   0111


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ..+...+...+..+++++.++|++||+.||++|||++|+++||||++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence            2223345556678899999999999999999999999999999998653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-38  Score=254.36  Aligned_cols=202  Identities=34%  Similarity=0.646  Sum_probs=163.1

Q ss_pred             CccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe-cCCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      +++|.+.+.    .+..+++..++.++.||+.||+|||++|++||||||+||+++ .++.++|+|||.+...........
T Consensus       121 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~  200 (383)
T 3eb0_A          121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA  200 (383)
T ss_dssp             SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCC
T ss_pred             CccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcC
Confidence            456665554    468899999999999999999999999999999999999998 588999999999987766665666


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.+...++.++|+||+||++|++++|..||.+......+..+++..+.+....+........   ...
T Consensus       201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~---~~~  277 (383)
T 3eb0_A          201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT---EVR  277 (383)
T ss_dssp             CCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CC
T ss_pred             cccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccc---ccc
Confidence            77899999999987766689999999999999999999999999999999999999988886553321111000   001


Q ss_pred             CCCCCccchhhh-CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQV-FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ........+... ...+++++.+||++||+.||++|||+.|+++||||++.
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          278 FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred             CCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence            111122223333 34588999999999999999999999999999999865

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-38  Score=250.64  Aligned_cols=209  Identities=33%  Similarity=0.535  Sum_probs=162.3

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-----Ccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-----EFM   74 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-----~~~   74 (217)
                      ++++|.+.+... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+......     ...
T Consensus       106 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  185 (351)
T 3mi9_A          106 CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY  185 (351)
T ss_dssp             CSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCC
T ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccccccccc
Confidence            356788888765 67999999999999999999999999999999999999999999999999998765422     222


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+++.|+|||.+.+...++.++||||||+++|++++|..||.+.........+....+.+....+............
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  265 (351)
T 3mi9_A          186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL  265 (351)
T ss_dssp             CSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSS
T ss_pred             CCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhccc
Confidence            34567899999999977666899999999999999999999999999999999999998888877665543322111111


Q ss_pred             HhCCCCCccchhhh-CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          155 RQLPQHPRQSLAQV-FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       155 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                      .............. ....++.+.+||++||+.||++|||++|+|+||||++....
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          266 ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             CCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             ccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            10110000000000 00136889999999999999999999999999999865433

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.6e-39  Score=251.62  Aligned_cols=174  Identities=28%  Similarity=0.459  Sum_probs=146.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      ++++|.+++.+.+++++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.............++
T Consensus        91 ~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt  170 (336)
T 3h4j_B           91 AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS  170 (336)
T ss_dssp             CCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTS
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCC
Confidence            47899999999899999999999999999999999999999999999999999999999999999877666666677899


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+....+.++|+||+|+++|++++|..||.+......               ..                .
T Consensus       171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~----------------~  219 (336)
T 3h4j_B          171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FK----------------K  219 (336)
T ss_dssp             TTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BC----------------C
T ss_pred             cCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HH----------------H
Confidence            9999999997665447899999999999999999999976431100               00                0


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      ........+..+++++.++|++||+.||.+|||++|+++||||+.
T Consensus       220 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          220 VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            000111233457899999999999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.4e-38  Score=254.60  Aligned_cols=201  Identities=31%  Similarity=0.570  Sum_probs=159.3

Q ss_pred             CCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC--EEEecccccccCCCCCcccc
Q 027927            1 MDTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         1 l~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~   76 (217)
                      ++++|.+++....  .+++..+..++.||+.||+|||++||+||||||+||+++.++.  ++|+|||.+......  ...
T Consensus       181 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~--~~~  258 (429)
T 3kvw_A          181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYT  258 (429)
T ss_dssp             CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCS
T ss_pred             cCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc--ccc
Confidence            4678999998864  5999999999999999999999999999999999999999887  999999998654432  334


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.+.. ++.++|||||||++|++++|..||.+.+....+..+.+..+.++...+......  ..++..
T Consensus       259 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~--~~~~~~  335 (429)
T 3kvw_A          259 YIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA--KNFVSS  335 (429)
T ss_dssp             SCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH--HHHBCT
T ss_pred             cCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh--hhccCC
Confidence            57889999999997665 789999999999999999999999999999999999999888776543322211  111110


Q ss_pred             CC-----------------------------CCCccchhh-hCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LP-----------------------------QHPRQSLAQ-VFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~-----------------------------~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ..                             ......+.. .....++++.+||++||++||++|||++|+|+||||++.
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          336 KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             TSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             CCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence            00                             000111111 223457889999999999999999999999999999965

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=253.57  Aligned_cols=177  Identities=28%  Similarity=0.406  Sum_probs=149.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe---cCCCEEEecccccccCCCCC-ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---ANCDLKICDFGLARPTSENE-FMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~-~~~~~   77 (217)
                      |++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++   .++.++|+|||++....... .....
T Consensus        94 gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  173 (444)
T 3soa_A           94 GGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF  173 (444)
T ss_dssp             CCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCS
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecc
Confidence            679999999999999999999999999999999999999999999999998   46789999999997655432 23456


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||.+.+. .++.++||||+||++|++++|..||.+.+.......+.......+..                 
T Consensus       174 ~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-----------------  235 (444)
T 3soa_A          174 AGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP-----------------  235 (444)
T ss_dssp             CSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT-----------------
T ss_pred             cCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc-----------------
Confidence            789999999998654 47899999999999999999999998887776666665422221111                 


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                .+..+++++.++|++||+.||++|||+.|+|+||||++.
T Consensus       236 ----------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          236 ----------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ----------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ----------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                      123578999999999999999999999999999999743

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.8e-38  Score=246.02  Aligned_cols=173  Identities=28%  Similarity=0.497  Sum_probs=148.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~   80 (217)
                      |++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.++|+|||++.... .........++
T Consensus        89 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt  168 (337)
T 1o6l_A           89 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  168 (337)
T ss_dssp             TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEEC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccC
Confidence            67999999998999999999999999999999999999999999999999999999999999987533 23344567889


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||||+++|++++|..||.+.+.......+...  ..                       
T Consensus       169 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~-----------------------  222 (337)
T 1o6l_A          169 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EI-----------------------  222 (337)
T ss_dssp             GGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-----------------------
T ss_pred             hhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC-----------------------
Confidence            999999998655 4789999999999999999999999887766555554431  00                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                            ..+..+++++.++|++||+.||++||     +++++++||||+..
T Consensus       223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence                  11235789999999999999999999     99999999999854

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3e-38  Score=255.96  Aligned_cols=203  Identities=37%  Similarity=0.680  Sum_probs=160.6

Q ss_pred             CccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-CCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      +++|.++++    ....+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++...........
T Consensus       136 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~  215 (420)
T 1j1b_A          136 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS  215 (420)
T ss_dssp             CEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCS
T ss_pred             cccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCcee
Confidence            456666554    35789999999999999999999999999999999999999965 5689999999987665555556


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.+...++.++||||+||++|++++|..||.+......+..+++..+.+....+........   ...
T Consensus       216 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~---~~~  292 (420)
T 1j1b_A          216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT---EFK  292 (420)
T ss_dssp             CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC---CCC
T ss_pred             eeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh---hhc
Confidence            67899999999987665689999999999999999999999999999999999999888776543321100000   000


Q ss_pred             CCCCCccchhhh-CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          157 LPQHPRQSLAQV-FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       157 ~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ........+... ...+++++.+||++||..||.+|||+.|+++||||++..
T Consensus       293 ~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             CCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             cCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            111122223333 346789999999999999999999999999999998653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-38  Score=246.95  Aligned_cols=177  Identities=28%  Similarity=0.405  Sum_probs=150.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC----CEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      |++|.+++.....+++..+..++.||+.||+|||++|++|+||+|+||+++.++    .++|+|||.+............
T Consensus        98 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  177 (326)
T 2y0a_A           98 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI  177 (326)
T ss_dssp             SCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCC
T ss_pred             CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccc
Confidence            689999999989999999999999999999999999999999999999998877    7999999999877655555566


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||.+.+. .++.++|+||||+++|++++|..||.+.........+.......                    
T Consensus       178 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------------  236 (326)
T 2y0a_A          178 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF--------------------  236 (326)
T ss_dssp             CSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC--------------------
T ss_pred             cCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc--------------------
Confidence            789999999988544 47899999999999999999999998877665555544311111                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ....+..+++.+.++|++||+.||++|||+.++++||||+..
T Consensus       237 -------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          237 -------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             -------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             -------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                   112234578999999999999999999999999999999854

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-38  Score=253.16  Aligned_cols=203  Identities=42%  Similarity=0.739  Sum_probs=151.0

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      ++++|.+++..  .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.............++
T Consensus       112 ~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt  189 (371)
T 2xrw_A          112 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT  189 (371)
T ss_dssp             CSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------
T ss_pred             CCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceec
Confidence            45788888864  6999999999999999999999999999999999999999999999999999776655445566789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+|||||++|++++|..||.+.+....+..+.+..+.+.+..+.... .....+.......
T Consensus       190 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  267 (371)
T 2xrw_A          190 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKY  267 (371)
T ss_dssp             CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC-HHHHHHHHSSCCC
T ss_pred             CCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh-hHHHHHHhhCccc
Confidence            999999999765 47899999999999999999999999999888888888877777655443332 2233333333322


Q ss_pred             CccchhhhCCC------------CChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPH------------VHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~------------~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ....+....+.            .++++.+||++||..||++|||++|+++||||+.+.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          268 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             cccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence            22222222211            256799999999999999999999999999998653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=251.25  Aligned_cols=173  Identities=21%  Similarity=0.375  Sum_probs=145.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ........++
T Consensus       108 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt  187 (353)
T 3txo_A          108 GGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGT  187 (353)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCC
Confidence            679999999999999999999999999999999999999999999999999999999999999875332 2334556789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+|||||++|++++|..||.+.+....+..+.....                         
T Consensus       188 ~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------------------  241 (353)
T 3txo_A          188 PDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-------------------------  241 (353)
T ss_dssp             GGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------------
T ss_pred             cCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence            9999999986544 78899999999999999999999998887777666654110                         


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH------hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG------EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~------~~ll~~~~f~~~  206 (217)
                            ..+..+++++.++|++||+.||++||++      +++++||||++.
T Consensus       242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence                  1122467899999999999999999999      899999999965

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=248.94  Aligned_cols=177  Identities=23%  Similarity=0.362  Sum_probs=151.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec--CCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.  ++.++|+|||.+.............
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  164 (321)
T 1tki_A           85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF  164 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEE
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccccc
Confidence            57999999876 47999999999999999999999999999999999999987  7899999999998877666666678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+. .++.++|+||+|+++|++++|..||.+.........+........                    
T Consensus       165 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------  223 (321)
T 1tki_A          165 TAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--------------------  223 (321)
T ss_dssp             SCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------------------
T ss_pred             CChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC--------------------
Confidence            89999999998654 368899999999999999999999988877666665554211111                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ...+..+++++.++|++||..||.+|||+.|+|+||||++.
T Consensus       224 -------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          224 -------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                   12234578999999999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.6e-37  Score=238.96  Aligned_cols=177  Identities=21%  Similarity=0.403  Sum_probs=147.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      |++|.+++.+. .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+....... ......++
T Consensus       101 ~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  179 (297)
T 3fxz_A          101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  179 (297)
T ss_dssp             TCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             CCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCC
Confidence            68999999874 69999999999999999999999999999999999999999999999999987655432 23456789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||+|+++|++++|..||...........+.........                     
T Consensus       180 ~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------  237 (297)
T 3fxz_A          180 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ---------------------  237 (297)
T ss_dssp             GGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS---------------------
T ss_pred             cCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---------------------
Confidence            9999999987654 789999999999999999999999887766555544432211110                     


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                             ....+++.+.++|.+||+.||++|||++++++||||+....
T Consensus       238 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          238 -------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             -------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             -------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence                   11246788999999999999999999999999999996543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=254.94  Aligned_cols=206  Identities=34%  Similarity=0.616  Sum_probs=153.6

Q ss_pred             CCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE----ecCCCEEEeccccccc
Q 027927            1 MDTDLYQIIRSN---------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARP   67 (217)
Q Consensus         1 l~~~L~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~   67 (217)
                      ++++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+||++    +.++.++|+|||++..
T Consensus       102 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  181 (405)
T 3rgf_A          102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  181 (405)
T ss_dssp             CSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred             CCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence            356788887642         259999999999999999999999999999999999999    6778999999999976


Q ss_pred             CCCC----CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---------HHHHHHHHHHh
Q 027927           68 TSEN----EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---------VHQMRLLIELL  134 (217)
Q Consensus        68 ~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---------~~~~~~~~~~~  134 (217)
                      ....    .......+++.|+|||.+.+...++.++|||||||++|++++|..||.+...         ...+..+....
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~  261 (405)
T 3rgf_A          182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  261 (405)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred             cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence            5432    2233457789999999997766689999999999999999999999976543         57888999999


Q ss_pred             CCCCCccccccCchHHHH-HHHhCCCCC---c---cchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          135 GTPTDADLGFVRNEDAKR-YIRQLPQHP---R---QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      +.+....|.......... .........   .   ..........++.+.+||++||+.||++|||++|+|+||||.+.
T Consensus       262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED  340 (405)
T ss_dssp             CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred             CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence            998888776544322211 111111100   0   01111223347889999999999999999999999999999865

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.4e-38  Score=248.75  Aligned_cols=177  Identities=29%  Similarity=0.448  Sum_probs=149.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC---CCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++.....+++..+..++.||+.||+|||++||+|+||||+||+++.+   +.++|+|||++.............
T Consensus       112 gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~  191 (362)
T 2bdw_A          112 GGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA  191 (362)
T ss_dssp             SCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSC
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCC
Confidence            67999999999999999999999999999999999999999999999999765   459999999998776655555678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+. .++.++|+|||||++|++++|..||.+.+.......+.......+..                  
T Consensus       192 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------  252 (362)
T 2bdw_A          192 GTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP------------------  252 (362)
T ss_dssp             SCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------
T ss_pred             CCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------
Confidence            89999999998654 47899999999999999999999998877666665554421111111                  


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                               .+..+++++.++|.+||+.||++|||+.++|+||||.+.
T Consensus       253 ---------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          253 ---------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ---------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ---------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                     122477999999999999999999999999999999753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.1e-38  Score=249.39  Aligned_cols=205  Identities=33%  Similarity=0.595  Sum_probs=155.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      +++|.+++.....+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus       108 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t  187 (331)
T 4aaa_A          108 HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT  187 (331)
T ss_dssp             EEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCC
T ss_pred             cchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCC
Confidence            3567777777888999999999999999999999999999999999999999999999999998665432 223445678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+...++.++|+||||+++|++++|..||...........+....+...+.....................
T Consensus       188 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (331)
T 4aaa_A          188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK  267 (331)
T ss_dssp             CTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCS
T ss_pred             ccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcccc
Confidence            89999999976656889999999999999999999999999988888888877766543321110000000000000111


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .........+.+++.+.++|++||+.||.+|||++|+|+||||+..
T Consensus       268 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            2233445566789999999999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-37  Score=246.32  Aligned_cols=173  Identities=25%  Similarity=0.426  Sum_probs=148.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      |++|.+++++.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus       102 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt  181 (345)
T 1xjd_A          102 GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT  181 (345)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCC
Confidence            689999999988999999999999999999999999999999999999999999999999999875432 2334556789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+|||||++|++++|..||.+.+....+..+...  .+                       
T Consensus       182 ~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~-----------------------  235 (345)
T 1xjd_A          182 PDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-----------------------  235 (345)
T ss_dssp             GGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-----------------------
T ss_pred             cccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CC-----------------------
Confidence            9999999986654 789999999999999999999999888766666555431  00                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHh-hhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE-FFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~-~ll~~~~f~~~  206 (217)
                            ..+..+++++.++|++||..||++||++. ++++||||++.
T Consensus       236 ------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          236 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             ------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence                  11224779999999999999999999998 99999999865

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-37  Score=245.62  Aligned_cols=173  Identities=23%  Similarity=0.400  Sum_probs=148.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~   80 (217)
                      |++|.+++++.+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.++|+|||++.... .........|+
T Consensus       105 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt  184 (353)
T 2i0e_A          105 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT  184 (353)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCC
Confidence            67999999998899999999999999999999999999999999999999999999999999987533 23334566789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+|||||++|++++|..||.+.+....+..+....  .                       
T Consensus       185 ~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~-----------------------  238 (353)
T 2i0e_A          185 PDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--V-----------------------  238 (353)
T ss_dssp             GGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C-----------------------
T ss_pred             ccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--C-----------------------
Confidence            9999999986554 7899999999999999999999999887776666665410  0                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                            ..+..+++++.++|++||..||.+||+     ++++++||||+..
T Consensus       239 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          239 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence                  112357899999999999999999994     6999999999854

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-37  Score=240.88  Aligned_cols=171  Identities=26%  Similarity=0.443  Sum_probs=148.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++++...+++..++.++.||+.||+|||++|++||||||+||+++.+|.++|+|||++......  .....+++
T Consensus        90 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~  167 (318)
T 1fot_A           90 GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTP  167 (318)
T ss_dssp             SCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCT
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--cccccCCc
Confidence            6799999999999999999999999999999999999999999999999999999999999999765433  33567899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+. .++.++|+||||+++|++++|..||.+.+....+..+....  .                        
T Consensus       168 ~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~------------------------  220 (318)
T 1fot_A          168 DYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--L------------------------  220 (318)
T ss_dssp             TTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--C------------------------
T ss_pred             cccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C------------------------
Confidence            99999998654 47899999999999999999999998877666665554410  0                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                           ..+..+++++.++|++||..||++||     +++++++||||++.
T Consensus       221 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          221 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             -----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence                 11234779999999999999999999     99999999999854

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5e-37  Score=246.39  Aligned_cols=181  Identities=22%  Similarity=0.382  Sum_probs=143.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc-CCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~-~~~~~~~~~~~~~   80 (217)
                      |++|.+++.+++.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.. ...........|+
T Consensus       137 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt  216 (396)
T 4dc2_A          137 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  216 (396)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCC
Confidence            679999999999999999999999999999999999999999999999999999999999999875 3333445567889


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHH-HHHHHhCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA-KRYIRQLPQ  159 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  159 (217)
                      +.|+|||++.+.. ++.++|+|||||++|++++|..||.........               ........ ........ 
T Consensus       217 ~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~---------------~~~~~~~~~~~i~~~~~-  279 (396)
T 4dc2_A          217 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---------------DQNTEDYLFQVILEKQI-  279 (396)
T ss_dssp             GGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------------CCHHHHHHHHHHCCC-
T ss_pred             cccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccccccc---------------chhhHHHHHHHHhcccc-
Confidence            9999999996654 789999999999999999999999643211000               00000000 11111111 


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCH------hhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG------EFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~------~~ll~~~~f~~~  206 (217)
                             ..+..+++++.++|++||+.||++||++      +++++||||++.
T Consensus       280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          280 -------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             -------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence                   1223578999999999999999999995      799999999865

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.2e-37  Score=236.28  Aligned_cols=179  Identities=29%  Similarity=0.439  Sum_probs=150.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC---EEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+.+..+..+++..+..++.|++.||++||++|++|+||+|+||+++.++.   ++|+|||.+.............
T Consensus        89 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (284)
T 3kk8_A           89 GGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA  168 (284)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCC
Confidence            5799999999899999999999999999999999999999999999999976655   9999999998776665556677


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+.. ++.++|+||+|+++|++++|..||.+.........+.......+.                   
T Consensus       169 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------  228 (284)
T 3kk8_A          169 GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-------------------  228 (284)
T ss_dssp             SCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------------------
T ss_pred             CCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc-------------------
Confidence            899999999986554 789999999999999999999999887766665555432211111                   


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                              .....+++++.++|++||+.||++|||++++++||||++...
T Consensus       229 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          229 --------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             --------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             --------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence                    112357799999999999999999999999999999997643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-37  Score=246.71  Aligned_cols=203  Identities=33%  Similarity=0.570  Sum_probs=159.5

Q ss_pred             CccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--HcCcEecCcCCCCEEEec-CCCEEEecccccccCCCCCcc
Q 027927            2 DTDLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIH--SANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENEFM   74 (217)
Q Consensus         2 ~~~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~Lh--~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~   74 (217)
                      +++|.+.+    .....+++..+..++.|++.||.+||  ++|++|+||||+||+++. ++.++|+|||.+.........
T Consensus       109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  188 (360)
T 3e3p_A          109 PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN  188 (360)
T ss_dssp             SCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC
T ss_pred             cccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc
Confidence            44555444    45678999999999999999999999  999999999999999997 899999999999877666555


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+++.|+|||.+.+...++.++||||||+++|++++|..||.+......+..+.+..+.+....+.........   
T Consensus       189 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  265 (360)
T 3e3p_A          189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD---  265 (360)
T ss_dssp             CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCC---
T ss_pred             ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhh---
Confidence            56678999999999876666899999999999999999999999999999999999888877754432211100000   


Q ss_pred             HhCCCCCccchhhhCC----CCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          155 RQLPQHPRQSLAQVFP----HVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ..........+...+.    ..++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          266 VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            0000011112222222    3568899999999999999999999999999999764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-37  Score=247.34  Aligned_cols=201  Identities=27%  Similarity=0.502  Sum_probs=152.4

Q ss_pred             CCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-------------------------
Q 027927            1 MDTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------------------   53 (217)
Q Consensus         1 l~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-------------------------   53 (217)
                      +|++|.+++....  .+++..+..++.||+.||+|||++|++||||||+||+++.                         
T Consensus       118 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (360)
T 3llt_A          118 LGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK  197 (360)
T ss_dssp             CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEES
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccC
Confidence            4789999998864  5999999999999999999999999999999999999965                         


Q ss_pred             CCCEEEecccccccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Q 027927           54 NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL  133 (217)
Q Consensus        54 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~  133 (217)
                      ++.++|+|||.+......  .....+++.|+|||.+.+.+ ++.++|||||||++|++++|..||...........+...
T Consensus       198 ~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  274 (360)
T 3llt_A          198 STGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI  274 (360)
T ss_dssp             CCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHh
Confidence            788999999998764432  23457789999999997654 889999999999999999999999999888888888877


Q ss_pred             hCCCCCccccccCchHHHHHHHh------CCCCCc---------cchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhc
Q 027927          134 LGTPTDADLGFVRNEDAKRYIRQ------LPQHPR---------QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV  198 (217)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll  198 (217)
                      .+..+...+..........+...      .+....         ..........++.+.+||++||+.||++|||++|+|
T Consensus       275 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL  354 (360)
T 3llt_A          275 IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL  354 (360)
T ss_dssp             TCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             cCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHh
Confidence            76655432111100000000000      000000         000011112457889999999999999999999999


Q ss_pred             cCCCCc
Q 027927          199 PYKPFQ  204 (217)
Q Consensus       199 ~~~~f~  204 (217)
                      +||||+
T Consensus       355 ~hp~f~  360 (360)
T 3llt_A          355 KHKFLE  360 (360)
T ss_dssp             TSGGGC
T ss_pred             cCcccC
Confidence            999996

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.2e-37  Score=240.95  Aligned_cols=178  Identities=26%  Similarity=0.405  Sum_probs=150.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC----CEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      |++|.+++.++..+++..+..++.||+.||++||++|++|+||+|+||+++.++    .++|+|||.+............
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (321)
T 2a2a_A           99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI  178 (321)
T ss_dssp             SCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccccccc
Confidence            679999999999999999999999999999999999999999999999999887    7999999999877665555566


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||.+.+. .++.++|+||||+++|++++|..||.+.........+.......                    
T Consensus       179 ~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------------------  237 (321)
T 2a2a_A          179 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF--------------------  237 (321)
T ss_dssp             CSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC--------------------
T ss_pred             CCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc--------------------
Confidence            789999999998654 47899999999999999999999998877655555443211100                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                             ....+..+++.+.++|++||+.||++|||++++++||||+...
T Consensus       238 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          238 -------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             -------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             -------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence                   1122345789999999999999999999999999999998654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-37  Score=254.43  Aligned_cols=174  Identities=30%  Similarity=0.465  Sum_probs=150.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.+++.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.............+++
T Consensus       100 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~  179 (476)
T 2y94_A          100 GGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP  179 (476)
T ss_dssp             SEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCS
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCc
Confidence            68999999999999999999999999999999999999999999999999999999999999998776666566678999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+....+.++|+||+||++|++++|..||.+.........+....  .                        
T Consensus       180 ~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~------------------------  233 (476)
T 2y94_A          180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--F------------------------  233 (476)
T ss_dssp             TTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--C------------------------
T ss_pred             CeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--c------------------------
Confidence            99999999766545789999999999999999999998876655554443210  0                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                           ..+..+++++.++|++||+.||++|||++++++||||++.
T Consensus       234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                 1122467899999999999999999999999999999853

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-37  Score=246.35  Aligned_cols=177  Identities=24%  Similarity=0.382  Sum_probs=148.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec--CCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.  .+.++|+|||++.............
T Consensus       132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  211 (387)
T 1kob_A          132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT  211 (387)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEEC
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeec
Confidence            67999999876 47999999999999999999999999999999999999974  4779999999998776665556667


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+. .++.++|+|||||++|++++|..||.+.........+........                    
T Consensus       212 gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------------  270 (387)
T 1kob_A          212 ATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--------------------  270 (387)
T ss_dssp             SSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------------------
T ss_pred             cCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------
Confidence            89999999998654 478999999999999999999999988776666555543111110                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ...+..+++++.++|++||..||++|||++++++||||++.
T Consensus       271 -------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          271 -------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             -------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                   11233578999999999999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.8e-37  Score=245.24  Aligned_cols=177  Identities=28%  Similarity=0.506  Sum_probs=148.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.............+++
T Consensus       184 g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~  263 (365)
T 2y7j_A          184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP  263 (365)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCC
Confidence            57999999988899999999999999999999999999999999999999999999999999998776665556678899


Q ss_pred             cccCcccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           82 WYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        82 ~~~~Pe~~~~-----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .|+|||.+.+     ...++.++|+||||+++|++++|..||...........+........                  
T Consensus       264 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------------------  325 (365)
T 2y7j_A          264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS------------------  325 (365)
T ss_dssp             GGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------------------
T ss_pred             CccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence            9999998853     22467899999999999999999999988766555554433111100                  


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                               ...+..+++.+.++|++||+.||++|||++++++||||+.
T Consensus       326 ---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          326 ---------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             ---------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ---------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                     1112357789999999999999999999999999999973

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.6e-37  Score=242.50  Aligned_cols=171  Identities=25%  Similarity=0.422  Sum_probs=148.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++++.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......  .....+++
T Consensus       125 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~  202 (350)
T 1rdq_E          125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTP  202 (350)
T ss_dssp             TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECG
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--cccccCCc
Confidence            6899999999889999999999999999999999999999999999999999999999999999766543  33567899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.. ++.++|+|||||++|++++|..||.+......+..+...  ..                        
T Consensus       203 ~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~------------------------  255 (350)
T 1rdq_E          203 EALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KV------------------------  255 (350)
T ss_dssp             GGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC------------------------
T ss_pred             cccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CC------------------------
Confidence            999999986554 789999999999999999999999887766666655541  00                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                           ..+..+++++.++|++||+.||++||+     ++++++||||++.
T Consensus       256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence                 112357899999999999999999999     9999999999854

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.9e-37  Score=243.27  Aligned_cols=178  Identities=29%  Similarity=0.402  Sum_probs=136.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---CCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++...+.+++..+..++.||+.||+|||++|++|+||||+||+++.   ++.++|+|||++.............
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC  211 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccccc
Confidence            5799999999999999999999999999999999999999999999999975   8899999999987665554455667


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH-QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+.. ++.++|+|||||++|++++|..||....... ....+.......                    
T Consensus       212 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~--------------------  270 (349)
T 2w4o_A          212 GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF--------------------  270 (349)
T ss_dssp             -CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC--------------------
T ss_pred             CCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc--------------------
Confidence            899999999986554 7899999999999999999999997665443 232222210000                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                             .......+++++.++|++||+.||++|||+.++++||||++..
T Consensus       271 -------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          271 -------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             -------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             -------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                   1112345789999999999999999999999999999999654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.7e-37  Score=237.13  Aligned_cols=176  Identities=29%  Similarity=0.424  Sum_probs=150.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE---ecCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++..++.+++..+..++.|++.||++||++|++|+||+|+||++   +.++.++|+|||.+.............
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  169 (277)
T 3f3z_A           90 GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV  169 (277)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccC
Confidence            57999999998999999999999999999999999999999999999999   788999999999998776666666678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+  .++.++|+||||+++|++++|..||...........+.......+                    
T Consensus       170 ~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------  227 (277)
T 3f3z_A          170 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP--------------------  227 (277)
T ss_dssp             SCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------------
T ss_pred             CCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--------------------
Confidence            8999999998853  378899999999999999999999988776665555543211111                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ......+++.+.++|++||+.||.+|||+.++++||||++.
T Consensus       228 -------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          228 -------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             -------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             -------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence                   11123477999999999999999999999999999999865

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.4e-37  Score=244.29  Aligned_cols=177  Identities=23%  Similarity=0.390  Sum_probs=146.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++..+..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.............|++
T Consensus        99 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~  178 (384)
T 4fr4_A           99 GGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTK  178 (384)
T ss_dssp             TEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCc
Confidence            78999999999999999999999999999999999999999999999999999999999999998776666666778999


Q ss_pred             cccCcccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           82 WYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        82 ~~~~Pe~~~~~--~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      .|+|||.+...  ..++.++|+|||||++|++++|..||...............                    ....  
T Consensus       179 ~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--------------------~~~~--  236 (384)
T 4fr4_A          179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--------------------ETTV--  236 (384)
T ss_dssp             GGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--------------------HHCC--
T ss_pred             cccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--------------------hhcc--
Confidence            99999998643  24688999999999999999999999754321111111110                    0000  


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-HhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-GEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-~~~ll~~~~f~~~  206 (217)
                            ...+..+++++.++|++||+.||.+||+ ++++++||||++.
T Consensus       237 ------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          237 ------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             ------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence                  0122357899999999999999999999 8999999999865

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.3e-37  Score=244.40  Aligned_cols=202  Identities=32%  Similarity=0.604  Sum_probs=155.3

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HcCcEecCcCCCCEEEe--cCCCEEEecccccccCCCCCcc
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIH--SANVIHRDLKPSNLLLN--ANCDLKICDFGLARPTSENEFM   74 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh--~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~   74 (217)
                      ++++|.+++...  +.+++..+..++.||+.||.|||  +.||+||||||+||+++  .++.++|+|||.+......  .
T Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~  215 (382)
T 2vx3_A          138 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--I  215 (382)
T ss_dssp             CCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--C
T ss_pred             CCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc--c
Confidence            467999999886  46999999999999999999999  57899999999999995  4778999999999766433  3


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+++.|+|||.+.+.. ++.++|||||||++|++++|..||.+......+..+.+..+.++...+....  ....++
T Consensus       216 ~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~  292 (382)
T 2vx3_A          216 YQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP--KARKFF  292 (382)
T ss_dssp             CSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT--THHHHE
T ss_pred             ccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH--HHHHHH
Confidence            3457889999999997654 8899999999999999999999999999999999999988877654433211  112222


Q ss_pred             HhCCCCCc-----------------cchhhhCC-----------C-------CChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          155 RQLPQHPR-----------------QSLAQVFP-----------H-------VHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       155 ~~~~~~~~-----------------~~~~~~~~-----------~-------~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ........                 ..+.....           .       .++++.+||++||+.||++|||++|+|+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          293 EKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             EECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhc
Confidence            22111100                 00000000           0       0147899999999999999999999999


Q ss_pred             CCCCcccc
Q 027927          200 YKPFQCCC  207 (217)
Q Consensus       200 ~~~f~~~~  207 (217)
                      ||||++..
T Consensus       373 hp~f~~~~  380 (382)
T 2vx3_A          373 HSFFKKTA  380 (382)
T ss_dssp             SGGGCC--
T ss_pred             CcccccCC
Confidence            99999653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.6e-37  Score=241.67  Aligned_cols=171  Identities=23%  Similarity=0.348  Sum_probs=145.6

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW   82 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~   82 (217)
                      .+|.+++..++.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.............+++.
T Consensus       115 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~  194 (335)
T 3dls_A          115 LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE  194 (335)
T ss_dssp             CBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGG
T ss_pred             ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCcc
Confidence            48999999999999999999999999999999999999999999999999999999999999987776666666778999


Q ss_pred             ccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCc
Q 027927           83 YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR  162 (217)
Q Consensus        83 ~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (217)
                      |+|||.+.+....+.++|+||||+++|++++|..||......                             ...      
T Consensus       195 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------------------~~~------  239 (335)
T 3dls_A          195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------------------VEA------  239 (335)
T ss_dssp             GCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------------------TTT------
T ss_pred             ccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------------------Hhh------
Confidence            999999976664478999999999999999999999652210                             000      


Q ss_pred             cchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCce
Q 027927          163 QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCI  210 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~  210 (217)
                        .......+++++.++|++||+.||++|||++++++||||++.....
T Consensus       240 --~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~  285 (335)
T 3dls_A          240 --AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLA  285 (335)
T ss_dssp             --CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCCGG
T ss_pred             --ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCcccc
Confidence              0011224789999999999999999999999999999998764443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-37  Score=239.05  Aligned_cols=171  Identities=26%  Similarity=0.292  Sum_probs=138.2

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      ++++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.............+
T Consensus       139 ~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~g  218 (311)
T 3p1a_A          139 CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEG  218 (311)
T ss_dssp             CCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCC
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCC
Confidence            467899888764 5699999999999999999999999999999999999999999999999999887766555556678


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+  .++.++||||+|+++|++++|..++........   +..   .                       
T Consensus       219 t~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~---~-----------------------  267 (311)
T 3p1a_A          219 DPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ---G-----------------------  267 (311)
T ss_dssp             CGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT---T-----------------------
T ss_pred             CccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc---c-----------------------
Confidence            999999998864  478999999999999999999777754322111   100   0                       


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      .   ........+++++.++|++||+.||++|||++++++||||++
T Consensus       268 ~---~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          268 Y---LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             C---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             C---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            0   011233467899999999999999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.7e-37  Score=241.34  Aligned_cols=178  Identities=29%  Similarity=0.467  Sum_probs=144.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---CCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      |++|.+++...  ..+++..+..++.||+.||++||++|++||||+|+||+++.   ++.++|+|||.+...........
T Consensus       113 ~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~  192 (327)
T 3lm5_A          113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE  192 (327)
T ss_dssp             TEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--------
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcccccc
Confidence            56888888654  77999999999999999999999999999999999999987   78999999999987766555556


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.+. .++.++|+||||+++|++++|..||...........+.........                 
T Consensus       193 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------------  254 (327)
T 3lm5_A          193 IMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-----------------  254 (327)
T ss_dssp             -CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----------------
T ss_pred             ccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-----------------
Confidence            6789999999998654 4789999999999999999999999888776666555443222211                 


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                ..+..+++.+.++|++||+.||.+|||++++|+||||++..
T Consensus       255 ----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          255 ----------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             ----------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             ----------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence                      12235788999999999999999999999999999999764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.9e-37  Score=241.36  Aligned_cols=182  Identities=23%  Similarity=0.373  Sum_probs=142.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~   80 (217)
                      |++|.+++.+++.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.... .........++
T Consensus        94 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt  173 (345)
T 3a8x_A           94 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  173 (345)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCC
Confidence            67999999998999999999999999999999999999999999999999999999999999987533 23344556889


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+|||||++|++++|..||.........               ................  
T Consensus       174 ~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------------~~~~~~~~~~~i~~~~--  235 (345)
T 3a8x_A          174 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---------------DQNTEDYLFQVILEKQ--  235 (345)
T ss_dssp             GGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------------CHHHHHHHHHHCC--
T ss_pred             ccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCccccccc---------------ccccHHHHHHHHHcCC--
Confidence            9999999986554 789999999999999999999999652210000               0000000001111100  


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH------hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG------EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~------~~ll~~~~f~~~  206 (217)
                           ...+..+++++.++|++||+.||++||++      +++++||||++.
T Consensus       236 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          236 -----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence                 01223578999999999999999999995      799999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.7e-37  Score=249.15  Aligned_cols=173  Identities=28%  Similarity=0.481  Sum_probs=146.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~   79 (217)
                      |++|.+++.+.+.+++..+..++.||+.||+|||+ .||+||||||+||+++.++.++|+|||++..... ........+
T Consensus       232 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~g  311 (446)
T 4ejn_A          232 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  311 (446)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSS
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccC
Confidence            57999999998999999999999999999999998 9999999999999999999999999999875332 233455678


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+.. ++.++|+|||||++|++++|..||.+.+.......+.....                        
T Consensus       312 t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------------  366 (446)
T 4ejn_A          312 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------------  366 (446)
T ss_dssp             CGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------------
T ss_pred             CccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC------------------------
Confidence            99999999986554 79999999999999999999999988776666555543110                        


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                             ..+..+++++.++|.+||+.||.+||     |++++++||||++.
T Consensus       367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence                   11234779999999999999999999     99999999999965

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-36  Score=239.34  Aligned_cols=203  Identities=30%  Similarity=0.517  Sum_probs=155.9

Q ss_pred             CCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-------------------CCCEEE
Q 027927            1 MDTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------------NCDLKI   59 (217)
Q Consensus         1 l~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-------------------~~~~~l   59 (217)
                      ++++|.+++..++  ++++..+..++.||+.||+|||++|++|+||||+||+++.                   ++.++|
T Consensus        99 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl  178 (339)
T 1z57_A           99 LGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV  178 (339)
T ss_dssp             CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEE
T ss_pred             CCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceE
Confidence            4789999998875  6899999999999999999999999999999999999987                   668999


Q ss_pred             ecccccccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCC
Q 027927           60 CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD  139 (217)
Q Consensus        60 ~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~  139 (217)
                      +|||.+......  .....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||...+.......+....+..+.
T Consensus       179 ~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~  255 (339)
T 1z57_A          179 VDFGSATYDDEH--HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPK  255 (339)
T ss_dssp             CCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCH
T ss_pred             eeCcccccCccc--cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            999998765433  23457789999999986554 789999999999999999999999998888888888777776554


Q ss_pred             cccccc--------------CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          140 ADLGFV--------------RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       140 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      ..+...              ................ ..........++++.++|++||+.||.+|||+.|+++||||+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          256 HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL-KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHHhhccchhHHhhccccccccccccchhhhcCcch-hhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence            321111              1111111111111110 0011111223577999999999999999999999999999997


Q ss_pred             cc
Q 027927          206 CC  207 (217)
Q Consensus       206 ~~  207 (217)
                      ..
T Consensus       335 ~~  336 (339)
T 1z57_A          335 LK  336 (339)
T ss_dssp             GG
T ss_pred             Hh
Confidence            54

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.7e-37  Score=241.19  Aligned_cols=184  Identities=28%  Similarity=0.468  Sum_probs=124.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC---CEEEecccccccCCCC-Cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSEN-EFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~-~~~~~~   77 (217)
                      |++|.+++.+++.+++..+..++.||+.||+|||++|++||||||+||+++.++   .++|+|||.+...... ......
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  169 (325)
T 3kn6_A           90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP  169 (325)
T ss_dssp             SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccccc
Confidence            579999999999999999999999999999999999999999999999998766   7999999998755433 223455


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||.+.+.. ++.++|+||||+++|++++|..||..........                    .........
T Consensus       170 ~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------------------~~~~~~~~i  228 (325)
T 3kn6_A          170 CFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT--------------------SAVEIMKKI  228 (325)
T ss_dssp             --------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CC--------------------CHHHHHHHH
T ss_pred             CCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccc--------------------cHHHHHHHH
Confidence            6789999999986554 7899999999999999999999997644210000                    000000011


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ...........+..+++++.++|++||+.||++|||++++++||||++.
T Consensus       229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            1100011111223578999999999999999999999999999999865

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.1e-37  Score=241.31  Aligned_cols=177  Identities=27%  Similarity=0.390  Sum_probs=142.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---Ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~   78 (217)
                      |++|.+++..+..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+......   .......
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  168 (323)
T 3tki_A           89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  168 (323)
T ss_dssp             TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCC
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCc
Confidence            5789999998889999999999999999999999999999999999999999999999999998654322   2233567


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+....+.++|+||||+++|++++|..||...................                     
T Consensus       169 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------------  227 (323)
T 3tki_A          169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------------  227 (323)
T ss_dssp             SCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---------------------
T ss_pred             cCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---------------------
Confidence            89999999999766545778999999999999999999997654321111111100000                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ......+++.+.++|++||+.||++|||++|+++||||++.
T Consensus       228 -------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          228 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             -------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             -------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence                   00112467899999999999999999999999999999854

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4e-37  Score=247.81  Aligned_cols=177  Identities=28%  Similarity=0.444  Sum_probs=136.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---CCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      |++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.   ++.++|+|||++...........
T Consensus       143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~  222 (400)
T 1nxk_A          143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT  222 (400)
T ss_dssp             SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------
T ss_pred             CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCcccc
Confidence            57999999885  36999999999999999999999999999999999999987   78899999999987665555566


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH----HHHHHHHHhCCCCCccccccCchHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH----QMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      ..+++.|+|||++.+. .++.++|||||||++|++++|..||.+.....    ....+.                     
T Consensus       223 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---------------------  280 (400)
T 1nxk_A          223 PCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---------------------  280 (400)
T ss_dssp             ----CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---------------------
T ss_pred             CCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---------------------
Confidence            7789999999988544 48899999999999999999999997654211    111111                     


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                        ......+.    ..+..+++++.+||++||+.||++|||++++++||||.+.
T Consensus       281 --~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          281 --MGQYEFPN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             --HTCCCCCT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             --cCcccCCC----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence              11111110    1124578999999999999999999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-37  Score=246.53  Aligned_cols=180  Identities=29%  Similarity=0.409  Sum_probs=131.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC--EEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |++|.+++.+.+++++..+..++.||+.||+|||++|++||||||+||+++.++.  ++|+|||++.............+
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g  179 (361)
T 3uc3_A          100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  179 (361)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcC
Confidence            6799999999899999999999999999999999999999999999999987765  99999999875554444556678


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+....+.++|+||+|+++|++++|..||.+.........+......                   ....
T Consensus       180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-------------------~~~~  240 (361)
T 3uc3_A          180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-------------------VKYS  240 (361)
T ss_dssp             -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT-------------------TCCC
T ss_pred             CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc-------------------CCCC
Confidence            999999999976654445599999999999999999999765432222222211000                   0000


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .+      ....+++++.+||++||+.||++|||+.++++||||...
T Consensus       241 ~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          241 IP------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             CC------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CC------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            00      012467999999999999999999999999999999643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.2e-37  Score=251.79  Aligned_cols=177  Identities=32%  Similarity=0.521  Sum_probs=147.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe---cCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---ANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++   .++.++|+|||++.............
T Consensus       105 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  184 (486)
T 3mwu_A          105 GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI  184 (486)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCT
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCc
Confidence            679999999989999999999999999999999999999999999999995   45679999999998766655556678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||++.+  .++.++||||+||++|++++|..||.+.........+..........                  
T Consensus       185 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------  244 (486)
T 3mwu_A          185 GTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP------------------  244 (486)
T ss_dssp             TGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG------------------
T ss_pred             CCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc------------------
Confidence            8999999999864  37899999999999999999999999888776666654421111111                  


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                               .+..+++++.++|++||+.||++|||+.++|+||||++..
T Consensus       245 ---------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          245 ---------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             ---------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             ---------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                     1224789999999999999999999999999999999654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-36  Score=234.11  Aligned_cols=175  Identities=31%  Similarity=0.432  Sum_probs=136.4

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE---ecCCCEEEecccccccCCCCCcc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEFM   74 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~   74 (217)
                      |++|.+++..    +..+++..+..++.||+.||++||++|++|+||+|+||++   +.++.++|+|||.+.........
T Consensus       104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~  183 (285)
T 3is5_A          104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS  183 (285)
T ss_dssp             CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred             CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccC
Confidence            5688888854    4789999999999999999999999999999999999999   55688999999999776655555


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+++.|+|||.+.  ..++.++|+||||+++|++++|..||.+.................                 
T Consensus       184 ~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  244 (285)
T 3is5_A          184 TNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY-----------------  244 (285)
T ss_dssp             ---CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------
T ss_pred             cCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc-----------------
Confidence            5667899999999884  347899999999999999999999998876554443332210000                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                 ......+++++.++|++||+.||++|||+.|+++||||+++
T Consensus       245 -----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          245 -----------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             -----------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             -----------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence                       00112367899999999999999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-36  Score=234.59  Aligned_cols=178  Identities=29%  Similarity=0.456  Sum_probs=149.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.++..+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.............+++
T Consensus       108 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  187 (298)
T 1phk_A          108 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP  187 (298)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCc
Confidence            57999999998899999999999999999999999999999999999999999999999999998766655555667899


Q ss_pred             cccCccccc-----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           82 WYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        82 ~~~~Pe~~~-----~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .|+|||.+.     ....++.++|+||||++++++++|..||...........+.........                 
T Consensus       188 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------  250 (298)
T 1phk_A          188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS-----------------  250 (298)
T ss_dssp             GGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----------------
T ss_pred             cccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc-----------------
Confidence            999999875     2344688999999999999999999999887765555444431111110                 


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                .....+++.+.++|.+||+.||.+|||++++++||||++.
T Consensus       251 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          251 ----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             ----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ----------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence                      0112467899999999999999999999999999999965

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.3e-37  Score=254.05  Aligned_cols=177  Identities=31%  Similarity=0.494  Sum_probs=151.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE---ecCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++...+.+++..+..++.||+.||+|||++|++||||||+||++   +.++.++|+|||++.............
T Consensus       110 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  189 (484)
T 3nyv_A          110 GGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI  189 (484)
T ss_dssp             SCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHT
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCC
Confidence            68999999999999999999999999999999999999999999999999   567899999999998777666666678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+  .++.++||||+||++|++++|..||.+.........+.........                   
T Consensus       190 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------  248 (484)
T 3nyv_A          190 GTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL-------------------  248 (484)
T ss_dssp             TGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-------------------
T ss_pred             CCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-------------------
Confidence            8999999999865  3789999999999999999999999988877666665442111111                   


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                              ..+..+++++.++|++||+.||++|||++++|+||||+...
T Consensus       249 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          249 --------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             --------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             --------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence                    11224789999999999999999999999999999998653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-36  Score=243.09  Aligned_cols=173  Identities=24%  Similarity=0.453  Sum_probs=148.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccC-CCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~   80 (217)
                      |++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.++|+|||++... ..........|+
T Consensus       123 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt  202 (373)
T 2r5t_A          123 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGT  202 (373)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCC
Confidence            6799999999899999999999999999999999999999999999999999999999999998753 233344566889


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+.. ++.++|+|||||++|++++|..||.+.+....+..+....                          
T Consensus       203 ~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------------------------  255 (373)
T 2r5t_A          203 PEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------------------------  255 (373)
T ss_dssp             CCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------------------------
T ss_pred             ccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------------------
Confidence            9999999986554 7899999999999999999999998887766666655410                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH----hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG----EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~~ll~~~~f~~~  206 (217)
                           ......+++++.++|++||+.||.+||++    .++++||||+..
T Consensus       256 -----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          256 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             -----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             -----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence                 01223578999999999999999999997    599999999854

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.4e-37  Score=247.68  Aligned_cols=179  Identities=23%  Similarity=0.373  Sum_probs=150.1

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--cccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~   78 (217)
                      |++|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.........  ....
T Consensus       158 gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~  237 (437)
T 4aw2_A          158 GGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV  237 (437)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCC
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccccccc
Confidence            7899999988 578999999999999999999999999999999999999999999999999999765544322  3357


Q ss_pred             ccccccCccccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           79 VTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        79 ~~~~~~~Pe~~~----~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      |++.|+|||.+.    +...++.++|+|||||++|++++|..||.+.+..+.+..+........                
T Consensus       238 GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------------  301 (437)
T 4aw2_A          238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ----------------  301 (437)
T ss_dssp             SCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC----------------
T ss_pred             CCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc----------------
Confidence            899999999986    234478899999999999999999999998887777777654211100                


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCC--CCCHhhhccCCCCccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITGEFFVPYKPFQCC  206 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~~ll~~~~f~~~  206 (217)
                                .......+++++.+||++||..+|++  |++++|+++||||++.
T Consensus       302 ----------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          302 ----------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             ----------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             ----------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence                      01112357899999999999999888  9999999999999854

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.9e-36  Score=236.11  Aligned_cols=200  Identities=27%  Similarity=0.554  Sum_probs=149.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-CEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +++|.++++.   +++..+..++.||+.||+|||++|++||||||+||+++.++ .++|+|||.+.............++
T Consensus       117 ~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  193 (330)
T 3nsz_A          117 NTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS  193 (330)
T ss_dssp             CCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSC
T ss_pred             chhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcccccccc
Confidence            4677777754   89999999999999999999999999999999999999777 8999999999876665555666788


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHHhCCCCCccc----cccCchHHHHHHH
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP-GNDHVHQMRLLIELLGTPTDADL----GFVRNEDAKRYIR  155 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  155 (217)
                      ..|+|||.+.+...++.++|+||||+++|++++|..||. +.........+....+.+.....    .............
T Consensus       194 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (330)
T 3nsz_A          194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG  273 (330)
T ss_dssp             GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHC
T ss_pred             ccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhh
Confidence            999999999775668999999999999999999999985 44555666665554443211000    0000000111111


Q ss_pred             hCCCCCccchhhh-----CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          156 QLPQHPRQSLAQV-----FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       156 ~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      .   .....+...     ...+++++.+||++||+.||++|||++|+|+||||++..
T Consensus       274 ~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          274 R---HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             C---CCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             h---ccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            1   111111111     123789999999999999999999999999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-36  Score=245.33  Aligned_cols=177  Identities=25%  Similarity=0.337  Sum_probs=148.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~   79 (217)
                      |++|.+++++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........  .....|
T Consensus       153 gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~g  231 (410)
T 3v8s_A          153 GGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG  231 (410)
T ss_dssp             TEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCS
T ss_pred             CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcC
Confidence            7899999987 4699999999999999999999999999999999999999999999999999977655432  335678


Q ss_pred             cccccCcccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           80 TRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~---~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ++.|+|||++.+...   ++.++|+|||||++|++++|..||.+.+....+..+..........                
T Consensus       232 t~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p----------------  295 (410)
T 3v8s_A          232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP----------------  295 (410)
T ss_dssp             CGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----------------
T ss_pred             CccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC----------------
Confidence            999999999975432   5689999999999999999999999888777777665421111000                


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCC--CCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~~ll~~~~f~~~  206 (217)
                                 ....+++++.+||++||..+|.+  |++++|+++||||++.
T Consensus       296 -----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          296 -----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             -----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             -----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence                       01247899999999999999988  9999999999999965

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-36  Score=251.18  Aligned_cols=176  Identities=32%  Similarity=0.497  Sum_probs=150.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC---CCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++..   +.++|+|||++.............
T Consensus       120 ~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~  199 (494)
T 3lij_A          120 GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL  199 (494)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccC
Confidence            67999999998999999999999999999999999999999999999999764   459999999998776665556678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.  ..++.++||||+||++|++++|..||.+.........+..........                  
T Consensus       200 gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------  259 (494)
T 3lij_A          200 GTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP------------------  259 (494)
T ss_dssp             SCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG------------------
T ss_pred             CCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch------------------
Confidence            899999999884  347899999999999999999999999888776666655422221111                  


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                               .+..+++.+.++|++||+.||.+|||+.++|+||||++.
T Consensus       260 ---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          260 ---------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             ---------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ---------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                     123578999999999999999999999999999999865

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.8e-37  Score=239.13  Aligned_cols=205  Identities=43%  Similarity=0.762  Sum_probs=158.5

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe-cCCCEEEecccccccCCCC----Cccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSEN----EFMT   75 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~----~~~~   75 (217)
                      ++++|.+++.+ +++++..+..++.||+.||++||++|++|+||+|+||+++ .++.++|+|||.+......    ....
T Consensus       104 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  182 (320)
T 2i6l_A          104 METDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS  182 (320)
T ss_dssp             CSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCC
T ss_pred             cCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccc
Confidence            35789999875 6799999999999999999999999999999999999998 4678999999998765322    1223


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...++..|+|||.+.+...++.++|+||||+++|++++|..||.+.........+.................. ...+..
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  261 (320)
T 2i6l_A          183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSV-IPVYIR  261 (320)
T ss_dssp             GGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTT-SCHHHH
T ss_pred             cccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhc-Cccccc
Confidence            4456888999999876566889999999999999999999999998888888777765544332221110000 001112


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      .....+...+....+.+++++.++|++||+.||++|||++++++||||+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          262 NDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             ccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            2223344456667778999999999999999999999999999999999653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-36  Score=238.16  Aligned_cols=173  Identities=24%  Similarity=0.446  Sum_probs=143.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... .......++
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  184 (327)
T 3a62_A          105 GGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGT  184 (327)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSC
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCC
Confidence            6899999999899999999999999999999999999999999999999999999999999998654322 223445789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||||+++|++++|..||.+.........+.....                         
T Consensus       185 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------------------------  238 (327)
T 3a62_A          185 IEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------------------------  238 (327)
T ss_dssp             CTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------------------------
T ss_pred             cCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-------------------------
Confidence            9999999986554 78999999999999999999999988776666555543110                         


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                            ..+..+++++.++|++||..||++||     ++.++++||||++.
T Consensus       239 ------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          239 ------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             ------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence                  11234679999999999999999999     88999999999854

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.6e-36  Score=258.27  Aligned_cols=173  Identities=23%  Similarity=0.399  Sum_probs=150.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCC-CCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~   80 (217)
                      |++|.+++++.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.... .........|+
T Consensus       426 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT  505 (674)
T 3pfq_A          426 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT  505 (674)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCC
Confidence            68999999998999999999999999999999999999999999999999999999999999987533 23344567889


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+.+..+....                          
T Consensus       506 ~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------------------------  558 (674)
T 3pfq_A          506 PDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------------------------  558 (674)
T ss_dssp             SSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--------------------------
T ss_pred             CcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998655 48999999999999999999999999888777766665311                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCH-----hhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITG-----EFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~~ll~~~~f~~~  206 (217)
                           ...+..+++++.+||++||..||++|+++     +++++||||++.
T Consensus       559 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          559 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             -----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence                 01223578999999999999999999998     999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.2e-37  Score=244.26  Aligned_cols=177  Identities=24%  Similarity=0.341  Sum_probs=149.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE--ecCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~--~~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||++  +.++.++|+|||++.............
T Consensus       170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  249 (373)
T 2x4f_A          170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF  249 (373)
T ss_dssp             TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence            57899988765 579999999999999999999999999999999999999  456789999999998776665555667


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+... .++.++|+|||||++|++++|..||.+......+..+........                    
T Consensus       250 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------------------  308 (373)
T 2x4f_A          250 GTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE--------------------  308 (373)
T ss_dssp             SSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC--------------------
T ss_pred             CCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--------------------
Confidence            89999999988544 478899999999999999999999998887776666654211111                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ...+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       309 -------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          309 -------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             -------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             -------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence                   11234578999999999999999999999999999999854

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.8e-36  Score=238.80  Aligned_cols=203  Identities=30%  Similarity=0.507  Sum_probs=155.0

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE-------------------ecCCCEEE
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-------------------NANCDLKI   59 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~-------------------~~~~~~~l   59 (217)
                      ++++|.+++...  ..+++..+..++.||+.||+|||++|++|+||||+||++                   +.++.++|
T Consensus       104 ~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl  183 (355)
T 2eu9_A          104 LGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV  183 (355)
T ss_dssp             CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEE
T ss_pred             cCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEE
Confidence            467888888776  479999999999999999999999999999999999999                   67889999


Q ss_pred             ecccccccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCC
Q 027927           60 CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD  139 (217)
Q Consensus        60 ~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~  139 (217)
                      +|||.+......  .....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||...........+....+..+.
T Consensus       184 ~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~  260 (355)
T 2eu9_A          184 ADFGSATFDHEH--HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPS  260 (355)
T ss_dssp             CCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eecCcccccccc--ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcH
Confidence            999998764433  23457889999999986554 789999999999999999999999998888888888887776654


Q ss_pred             ccccccC--------------chHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          140 ADLGFVR--------------NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       140 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      ..+....              ............... ..........++++.+||++||+.||++|||++++++||||++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  339 (355)
T 2eu9_A          261 HMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG  339 (355)
T ss_dssp             HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHhhhccchhhhcccccccccccchhccccccCCcc-cccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcC
Confidence            3221111              111111111111100 0000111123467999999999999999999999999999997


Q ss_pred             cc
Q 027927          206 CC  207 (217)
Q Consensus       206 ~~  207 (217)
                      ..
T Consensus       340 ~~  341 (355)
T 2eu9_A          340 LT  341 (355)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.6e-36  Score=243.49  Aligned_cols=206  Identities=18%  Similarity=0.230  Sum_probs=141.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC--------
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--------   71 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~--------   71 (217)
                      |++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+......        
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~  189 (389)
T 3gni_B          110 YGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH  189 (389)
T ss_dssp             TCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBC
T ss_pred             CCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccc
Confidence            57999999886  77999999999999999999999999999999999999999999999999987543211        


Q ss_pred             CccccccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC--------CCCccc
Q 027927           72 EFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGT--------PTDADL  142 (217)
Q Consensus        72 ~~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~  142 (217)
                      .......+++.|+|||.+.+. ..++.++|||||||++|++++|..||.+.........+......        +.....
T Consensus       190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (389)
T 3gni_B          190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT  269 (389)
T ss_dssp             CCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------
T ss_pred             cccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccc
Confidence            122234678889999999763 45789999999999999999999999876654444333221100        000000


Q ss_pred             ccc----CchHHHHHHHh---CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          143 GFV----RNEDAKRYIRQ---LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       143 ~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ...    ...........   ...............+++++.+||++||+.||++|||++|+|+||||++..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             ------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             ccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence            000    00000000000   000011112223456889999999999999999999999999999999763

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.2e-36  Score=234.41  Aligned_cols=176  Identities=28%  Similarity=0.475  Sum_probs=144.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      |++|.+++.+ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++....... ......++
T Consensus       126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  204 (321)
T 2c30_A          126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  204 (321)
T ss_dssp             SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCC
Confidence            6789998875 579999999999999999999999999999999999999999999999999987655432 23455789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||||+++|++++|..||...........+....  ++.                     
T Consensus       205 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~---------------------  260 (321)
T 2c30_A          205 PYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--PPK---------------------  260 (321)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--CCC---------------------
T ss_pred             ccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCC---------------------
Confidence            999999998654 47899999999999999999999998876655544443210  000                     


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                           ......+++.+.++|.+||+.||++|||++++++||||.+..
T Consensus       261 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          261 -----LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -----CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -----cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                 001123678899999999999999999999999999998664

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-36  Score=233.08  Aligned_cols=174  Identities=27%  Similarity=0.393  Sum_probs=138.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++..+..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.............+++
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  174 (276)
T 2h6d_A           95 GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP  174 (276)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----------
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCc
Confidence            57999999998899999999999999999999999999999999999999999999999999997766555555567889


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+....+.++|+||||++++++++|..||...........+...  ..                        
T Consensus       175 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------------------  228 (276)
T 2h6d_A          175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VF------------------------  228 (276)
T ss_dssp             --CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC------------------------
T ss_pred             cccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cc------------------------
Confidence            9999999876554468999999999999999999999876655444433320  00                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                           .....+++.+.++|.+||+.||++|||++++++||||++.
T Consensus       229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                 0122467889999999999999999999999999999854

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.6e-36  Score=251.01  Aligned_cols=177  Identities=29%  Similarity=0.451  Sum_probs=151.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC---CEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++.+...+++..+..++.||+.||+|||++|++||||||+||+++.++   .++|+|||++.............
T Consensus       130 gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  209 (504)
T 3q5i_A          130 GGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL  209 (504)
T ss_dssp             TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCcccccc
Confidence            679999999989999999999999999999999999999999999999998776   69999999998777665566678


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+  .++.++|+||+||++|++++|..||.+.........+........                    
T Consensus       210 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------  267 (504)
T 3q5i_A          210 GTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD--------------------  267 (504)
T ss_dssp             SCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------------
T ss_pred             CCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence            9999999998853  478999999999999999999999998877666665544111000                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                             ...+..+++++.++|++||+.||.+|||++++|+||||++..
T Consensus       268 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          268 -------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             -------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             -------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence                   112245789999999999999999999999999999998653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1e-36  Score=240.73  Aligned_cols=178  Identities=27%  Similarity=0.458  Sum_probs=142.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC----CCEEEecccccccCCCC-Ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN----CDLKICDFGLARPTSEN-EFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~~~~-~~~~~   76 (217)
                      |++|.+++.+++.+++..+..++.||+.||+|||++|++||||||+||++...    +.++|+|||++...... .....
T Consensus       100 gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  179 (342)
T 2qr7_A          100 GGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT  179 (342)
T ss_dssp             SCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceec
Confidence            67999999999999999999999999999999999999999999999998443    35999999998765433 33445


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHhCCCCCccccccCchHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---HVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (217)
                      ..+++.|+|||.+.+.. ++.++|+|||||++|++++|..||....   .......+..  +...               
T Consensus       180 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~--~~~~---------------  241 (342)
T 2qr7_A          180 PCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS--GKFS---------------  241 (342)
T ss_dssp             SSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH--CCCC---------------
T ss_pred             cCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc--CCcc---------------
Confidence            67899999999986543 6789999999999999999999997532   2233333222  0000               


Q ss_pred             HHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                .....+..+++++.++|++||..||++|||+.++++||||.++.
T Consensus       242 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          242 ----------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             ----------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             ----------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence                      00112346889999999999999999999999999999998653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-36  Score=234.13  Aligned_cols=177  Identities=27%  Similarity=0.387  Sum_probs=131.4

Q ss_pred             CCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc
Q 027927            1 MDTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT   75 (217)
Q Consensus         1 l~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (217)
                      ++++|.+++..    +..+++..+..++.||+.||+|||++ |++|+||||+||+++.++.++|+|||.+..........
T Consensus        88 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  167 (290)
T 3fme_A           88 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD  167 (290)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred             hccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence            35677776654    57899999999999999999999998 99999999999999999999999999997766555555


Q ss_pred             cccccccccCcccc---cCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           76 EYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~---~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                      ...+++.|+|||.+   .....++.++|+||+|+++|++++|..||.... ...............              
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  233 (290)
T 3fme_A          168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ--------------  233 (290)
T ss_dssp             --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--------------
T ss_pred             ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC--------------
Confidence            56788999999997   234457889999999999999999999997633 233332222210000              


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                     .....+++++.++|.+||+.||++|||+.++++||||+..
T Consensus       234 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          234 ---------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ---------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ---------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                           0112467899999999999999999999999999999854

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.4e-37  Score=237.20  Aligned_cols=187  Identities=19%  Similarity=0.222  Sum_probs=128.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEecCcCCCCEEEecCCCEEEecccccccCCCCCc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~--------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (217)
                      ||+|.+++++ .+++++.+.+++.|++.||+|||++        +|+||||||+|||++.++.+||+|||++........
T Consensus        85 ~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  163 (303)
T 3hmm_A           85 HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  163 (303)
T ss_dssp             TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC
Confidence            6899999987 4699999999999999999999987        899999999999999999999999999875443221


Q ss_pred             -----cccccccccccCcccccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccc
Q 027927           74 -----MTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        74 -----~~~~~~~~~~~~Pe~~~~~~-----~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  143 (217)
                           .....||+.|+|||.+.+..     .++.++|||||||++||+++|..||......+          .+......
T Consensus       164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~----------~p~~~~~~  233 (303)
T 3hmm_A          164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----------LPYYDLVP  233 (303)
T ss_dssp             EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC----------CTTTTTSC
T ss_pred             ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc----------ccchhccc
Confidence                 22357899999999986432     24568999999999999999988775432100          00000000


Q ss_pred             c-cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          144 F-VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       144 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      . ................+..+........+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            0 0011111111111111111111111123356889999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-36  Score=246.63  Aligned_cols=179  Identities=31%  Similarity=0.534  Sum_probs=137.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC---CEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++..++.+++..+..++.||+.||+|||++|++||||||+||+++.++   .++|+|||.+.............
T Consensus       223 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  302 (419)
T 3i6u_A          223 GGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC  302 (419)
T ss_dssp             TCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC---------
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccC
Confidence            679999999989999999999999999999999999999999999999997544   59999999998777665566678


Q ss_pred             ccccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           79 VTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        79 ~~~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      +++.|+|||.+.+  ...++.++|+||||+++|++++|..||..............                       .
T Consensus       303 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~-----------------------~  359 (419)
T 3i6u_A          303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-----------------------S  359 (419)
T ss_dssp             --CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH-----------------------T
T ss_pred             CCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh-----------------------c
Confidence            8999999999853  34467899999999999999999999976432211111111                       0


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ..   .......+..+++.+.++|++||+.||++|||++++++||||++.
T Consensus       360 ~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          360 GK---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             TC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CC---CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            00   011123344688999999999999999999999999999999865

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.1e-36  Score=231.51  Aligned_cols=173  Identities=26%  Similarity=0.390  Sum_probs=143.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      +++|.+++.+...+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+....... .....+++
T Consensus        93 ~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~  171 (279)
T 3fdn_A           93 LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLCGTL  171 (279)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-ccccCCCC
Confidence            57899999998999999999999999999999999999999999999999999999999999885544322 23456789


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+. .++.++|+||||+++|++++|..||...........+.....                          
T Consensus       172 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------  224 (279)
T 3fdn_A          172 DYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------------------------  224 (279)
T ss_dssp             TTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------------------
T ss_pred             CccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------------------------
Confidence            99999988654 478899999999999999999999988776555554433111                          


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                           ..+..+++.+.++|++||+.||.+|||++++++||||++..
T Consensus       225 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          225 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             -----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             -----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                 11224678899999999999999999999999999999653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4e-37  Score=246.12  Aligned_cols=169  Identities=15%  Similarity=0.187  Sum_probs=136.7

Q ss_pred             CCccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc
Q 027927            1 MDTDLYQIIRSNQSLSE-------EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~-------~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (217)
                      ++|+|.+++.+.+.+++       ..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....  .
T Consensus       182 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~  259 (377)
T 3byv_A          182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--R  259 (377)
T ss_dssp             CSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--E
T ss_pred             cCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--c
Confidence            36899999998665665       88889999999999999999999999999999999999999999999976443  2


Q ss_pred             cccccccccccCcccccCC----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccc
Q 027927           74 MTEYVVTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~----------~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  143 (217)
                      .....+ +.|+|||.+.+.          ..++.++|||||||++|++++|..||.+.......                
T Consensus       260 ~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~----------------  322 (377)
T 3byv_A          260 VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS----------------  322 (377)
T ss_dssp             EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS----------------
T ss_pred             ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch----------------
Confidence            334566 899999998755          24789999999999999999999999654311000                


Q ss_pred             ccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                         .........+++++.++|.+||+.||++|||+.++++||||++..
T Consensus       323 -------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          323 -------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             -------------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             -------------------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence                               001112246789999999999999999999999999999998653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-36  Score=233.96  Aligned_cols=172  Identities=25%  Similarity=0.405  Sum_probs=138.1

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~   81 (217)
                      ++|.+++ ...++++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....... ......+++
T Consensus       123 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  201 (298)
T 2zv2_A          123 GPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTP  201 (298)
T ss_dssp             CBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCG
T ss_pred             CcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCc
Confidence            4555543 33679999999999999999999999999999999999999999999999999987655432 234567899


Q ss_pred             cccCcccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           82 WYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        82 ~~~~Pe~~~~~~~--~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      .|+|||.+.+...  .+.++|+||||+++|++++|..||...........+......                       
T Consensus       202 ~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------------------  258 (298)
T 2zv2_A          202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE-----------------------  258 (298)
T ss_dssp             GGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------------
T ss_pred             cccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCC-----------------------
Confidence            9999999865442  367899999999999999999999876654443333221000                       


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                      .      .....+++++.++|.+||+.||++|||++++++||||+
T Consensus       259 ~------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          259 F------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             C------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             C------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            0      01135789999999999999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=242.81  Aligned_cols=178  Identities=22%  Similarity=0.349  Sum_probs=146.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      |++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........  .....
T Consensus       145 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~  224 (412)
T 2vd5_A          145 GGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV  224 (412)
T ss_dssp             SCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceec
Confidence            78999999875 5899999999999999999999999999999999999999999999999999977654432  23457


Q ss_pred             ccccccCcccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           79 VTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        79 ~~~~~~~Pe~~~~------~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      |++.|+|||++..      ...++.++|+|||||++|++++|..||.+.+....+..+........              
T Consensus       225 Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------  290 (412)
T 2vd5_A          225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS--------------  290 (412)
T ss_dssp             SCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------------
T ss_pred             cccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC--------------
Confidence            8999999999862      23478899999999999999999999998887777766654211000              


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCC---CCHhhhccCCCCccc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR---ITGEFFVPYKPFQCC  206 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---~t~~~ll~~~~f~~~  206 (217)
                                  .......+++++.++|++||. +|.+|   ++++++++||||++.
T Consensus       291 ------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          291 ------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             ------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             ------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence                        011123578999999999999 99998   599999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.9e-36  Score=229.91  Aligned_cols=173  Identities=20%  Similarity=0.311  Sum_probs=141.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEe-cCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++.+.+.+++..+..++.||+.||+|||+++  ++|+||+|+||+++ .++.++|+|||.+...... ......
T Consensus       113 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~  191 (290)
T 1t4h_A          113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVI  191 (290)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESC
T ss_pred             CCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-cccccc
Confidence            5799999999899999999999999999999999999  99999999999997 7899999999998654433 234456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+  .++.++|+||||+++|++++|..||..................                      
T Consensus       192 ~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------------  247 (290)
T 1t4h_A          192 GTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------------------  247 (290)
T ss_dssp             SSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------------------
T ss_pred             CCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC----------------------
Confidence            8899999998853  3789999999999999999999999875543333222211100                      


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                            ........++++.++|.+||+.||.+|||++++++||||++
T Consensus       248 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 ------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                  01122346688999999999999999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.4e-36  Score=228.87  Aligned_cols=176  Identities=27%  Similarity=0.412  Sum_probs=141.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---Ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~   78 (217)
                      |++|.+++..+..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......   .......
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  168 (276)
T 2yex_A           89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  168 (276)
T ss_dssp             TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCC
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCc
Confidence            4689999988889999999999999999999999999999999999999999999999999998654322   2233456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH-QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+....+.++|+||||+++|++++|..||....... ....+..                       ..
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------~~  225 (276)
T 2yex_A          169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----------------------KK  225 (276)
T ss_dssp             SCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT-----------------------TC
T ss_pred             cccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh-----------------------cc
Confidence            78899999998765544678999999999999999999997654321 1111111                       00


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ..      ......+++.+.++|++||+.||++|||++++++||||++.
T Consensus       226 ~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          226 TY------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             TT------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             cc------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            00      00112467899999999999999999999999999999965

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.7e-36  Score=232.13  Aligned_cols=177  Identities=26%  Similarity=0.422  Sum_probs=144.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC----CEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      |++|.+++.++..+++..+..++.||+.||.+||++|++|+||+|+||+++.++    .++|+|||.+............
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~  171 (283)
T 3bhy_A           92 GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI  171 (283)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCccccc
Confidence            689999999888999999999999999999999999999999999999998877    7999999999876655545556


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||.+.+. .++.++|+||||++++++++|..||.+.........+......                     
T Consensus       172 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  229 (283)
T 3bhy_A          172 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD---------------------  229 (283)
T ss_dssp             CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------------------
T ss_pred             CCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC---------------------
Confidence            788999999988554 4789999999999999999999999887655544443321000                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                            ........+++.+.++|++||+.||++|||+.++++||||++.
T Consensus       230 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          230 ------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             ------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             ------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence                  0112234578899999999999999999999999999999965

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.3e-36  Score=237.49  Aligned_cols=176  Identities=30%  Similarity=0.414  Sum_probs=140.9

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC---EEEecccccccCCCCCc-
Q 027927            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEF-   73 (217)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~-   73 (217)
                      |++|.+++.+.    ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.   ++|+|||.+........ 
T Consensus       110 g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~  189 (351)
T 3c0i_A          110 GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV  189 (351)
T ss_dssp             SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred             CCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCee
Confidence            57898887653    46999999999999999999999999999999999999986654   99999999977655433 


Q ss_pred             cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHH
Q 027927           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (217)
                      .....+++.|+|||.+.+.. ++.++|+|||||++|++++|..||.+.. ......+...  ..                
T Consensus       190 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~--~~----------------  249 (351)
T 3c0i_A          190 AGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKG--KY----------------  249 (351)
T ss_dssp             CCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHT--CC----------------
T ss_pred             ecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcC--CC----------------
Confidence            34567899999999986554 7899999999999999999999997643 2222222221  00                


Q ss_pred             HHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                           .    .....+..+++++.++|++||+.||++|||+.++++||||++.
T Consensus       250 -----~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          250 -----K----MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             -----C----CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             -----C----CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                 0    0011224578999999999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.3e-36  Score=250.60  Aligned_cols=174  Identities=26%  Similarity=0.458  Sum_probs=144.9

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |++|.+++...+  .+++..+..++.||+.||+|||++||+||||||+||+++.+|.++|+|||++.............|
T Consensus       268 gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~G  347 (576)
T 2acx_A          268 GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG  347 (576)
T ss_dssp             SCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCS
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCC
Confidence            789999998864  499999999999999999999999999999999999999999999999999987766555566789


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ++.|+|||++.+.. ++.++|+|||||++|++++|..||.....   ...+.....                       .
T Consensus       348 T~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-----------------------~  403 (576)
T 2acx_A          348 TVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-----------------------E  403 (576)
T ss_dssp             CGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-----------------------H
T ss_pred             CccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-----------------------c
Confidence            99999999986544 78999999999999999999999976532   111111111                       1


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                      ..       ...+..+++++.++|++||+.||++||     +++|+++||||++.
T Consensus       404 ~~-------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          404 VP-------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             cc-------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            11       012235789999999999999999999     89999999999964

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.1e-36  Score=235.35  Aligned_cols=188  Identities=23%  Similarity=0.345  Sum_probs=135.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC---EEEecccccccCCCCC------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENE------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~------   72 (217)
                      |++|.+++.+++.+++..+..++.||+.||+|||++|++|+||||+||+++.++.   ++|+|||++.......      
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (316)
T 2ac3_A           95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS  174 (316)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence            5899999999899999999999999999999999999999999999999988766   9999999886543211      


Q ss_pred             --ccccccccccccCcccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccc--
Q 027927           73 --FMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF--  144 (217)
Q Consensus        73 --~~~~~~~~~~~~~Pe~~~~~----~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  144 (217)
                        ......+++.|+|||.+...    ..++.++||||||+++|++++|..||.+.....              ..+..  
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------------~~~~~~~  240 (316)
T 2ac3_A          175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD--------------CGWDRGE  240 (316)
T ss_dssp             -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC--------------SCC----
T ss_pred             ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc--------------ccccccc
Confidence              12234578999999998541    236789999999999999999999997653210              00000  


Q ss_pred             cC---chHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          145 VR---NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       145 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ..   ..............   ........+++++.++|++||+.||++|||++++++||||++.
T Consensus       241 ~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYE---FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             cchhHHHHHHHHHhccCcc---cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            00   00001111111100   0011224578999999999999999999999999999999965

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.8e-36  Score=234.17  Aligned_cols=179  Identities=31%  Similarity=0.541  Sum_probs=144.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC---EEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++..+..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.   ++|+|||.+.............
T Consensus        98 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  177 (322)
T 2ycf_A           98 GGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC  177 (322)
T ss_dssp             TEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHH
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccccccccccc
Confidence            5799999999999999999999999999999999999999999999999987665   9999999998776555445567


Q ss_pred             ccccccCccccc--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           79 VTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        79 ~~~~~~~Pe~~~--~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      +++.|+|||.+.  +...++.++|+||||+++|++++|..||................                      
T Consensus       178 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------------------  235 (322)
T 2ycf_A          178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG----------------------  235 (322)
T ss_dssp             SCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT----------------------
T ss_pred             CCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC----------------------
Confidence            899999999874  34457889999999999999999999997643221111111100                      


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                       ..   ......+..+++.+.++|++||..||++|||++++++||||++.
T Consensus       236 -~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          236 -KY---NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             -CC---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             -cc---ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence             00   01122334678999999999999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-35  Score=231.25  Aligned_cols=177  Identities=28%  Similarity=0.415  Sum_probs=147.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE---ecCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++...+.+++..+..++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||.+...... ......
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~  168 (304)
T 2jam_A           90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTAC  168 (304)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHH
T ss_pred             CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cccccc
Confidence            57999999988899999999999999999999999999999999999999   77889999999998654432 234456


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+. .++.++|+||||+++|++++|..||...........+.+.....                     
T Consensus       169 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---------------------  226 (304)
T 2jam_A          169 GTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF---------------------  226 (304)
T ss_dssp             SCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC---------------------
T ss_pred             CCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence            78999999998654 47899999999999999999999998877665555544311111                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                            .......+++++.++|.+||..||++|||++++++||||+...
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          227 ------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             ------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             ------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                  0112345789999999999999999999999999999998653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.7e-36  Score=239.37  Aligned_cols=200  Identities=29%  Similarity=0.434  Sum_probs=148.0

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCC----------------------
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANC----------------------   55 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~----------------------   55 (217)
                      ++++|.+.+...  ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++                      
T Consensus       127 ~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (397)
T 1wak_A          127 LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS  206 (397)
T ss_dssp             CCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-----------
T ss_pred             cCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCC
Confidence            467888887765  5799999999999999999999998 999999999999998765                      


Q ss_pred             ---------------------------CEEEecccccccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHH
Q 027927           56 ---------------------------DLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  108 (217)
Q Consensus        56 ---------------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l  108 (217)
                                                 .++|+|||.+......  .....+++.|+|||.+.+.. ++.++|||||||++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  283 (397)
T 1wak_A          207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMA  283 (397)
T ss_dssp             ----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHH
T ss_pred             CCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHH
Confidence                                       7999999998765443  33457899999999997665 78999999999999


Q ss_pred             HHHHcCCCCCCCCC------hHHHHHHHHHHhCCCCCccccccCchHHHHHHH------hCCCC-Cccc---hh---hhC
Q 027927          109 MELMNRRPLFPGND------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR------QLPQH-PRQS---LA---QVF  169 (217)
Q Consensus       109 ~~l~~~~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-~~~~---~~---~~~  169 (217)
                      |++++|..||....      .......+.+..+.++...+......  ..+..      ..... +...   +.   ...
T Consensus       284 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
T 1wak_A          284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWS  361 (397)
T ss_dssp             HHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCC
T ss_pred             HHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCccccccccccCCcchhHhhhhhcccc
Confidence            99999999997654      45667777777776554321100000  00000      00000 0000   00   001


Q ss_pred             CCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          170 PHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       170 ~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      ...++.+.+||++||+.||++|||++|+|+||||++
T Consensus       362 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          362 QEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            123467899999999999999999999999999974

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-36  Score=241.37  Aligned_cols=184  Identities=16%  Similarity=0.127  Sum_probs=138.2

Q ss_pred             CCccHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc
Q 027927            1 MDTDLYQIIRSN-QSLSEEHC------QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~------~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (217)
                      ++++|.+++... ..++...+      ..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus       170 ~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-  248 (371)
T 3q60_A          170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-  248 (371)
T ss_dssp             CSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-
T ss_pred             CCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-
Confidence            357999999874 44555555      6777999999999999999999999999999999999999999997665432 


Q ss_pred             cccccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           74 MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                       ....+++.|+|||.+.+. ..++.++|+|||||++|++++|..||.......             ...+....      
T Consensus       249 -~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------------~~~~~~~~------  308 (371)
T 3q60_A          249 -PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-------------KGSWKRPS------  308 (371)
T ss_dssp             -EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC-------------TTCCCBCC------
T ss_pred             -cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc-------------ccchhhhh------
Confidence             244556999999999641 347899999999999999999999997653110             00000000      


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                         ................+++.+.++|.+||+.||++|||+.++++||||++...
T Consensus       309 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          309 ---LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             ---TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             ---hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence               00000001111123468899999999999999999999999999999996543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.6e-36  Score=235.31  Aligned_cols=175  Identities=23%  Similarity=0.350  Sum_probs=135.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~   78 (217)
                      +++|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||+++ ++.++|+|||++........   .....
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~  170 (343)
T 3dbq_A           92 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV  170 (343)
T ss_dssp             SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------C
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCc
Confidence            679999999999999999999999999999999999999999999999997 67899999999876543322   23457


Q ss_pred             ccccccCcccccC----------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCCccccccCc
Q 027927           79 VTRWYRAPELLLN----------SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        79 ~~~~~~~Pe~~~~----------~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      +++.|+|||.+.+          ...++.++||||||+++|++++|..||...... .....+.   .....        
T Consensus       171 gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~--------  239 (343)
T 3dbq_A          171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHE--------  239 (343)
T ss_dssp             CCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTSC--------
T ss_pred             CCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh---cCCcc--------
Confidence            8999999999853          244788999999999999999999999764322 1111111   11000        


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                        ...+...++++.++|.+||+.||.+|||+.++++||||+..
T Consensus       240 ------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          240 ------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             ------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence                              01122356789999999999999999999999999999843

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.5e-36  Score=229.36  Aligned_cols=172  Identities=24%  Similarity=0.428  Sum_probs=145.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      +++|.+++..++.+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+...... ......+++
T Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~  176 (284)
T 2vgo_A           98 RGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTMCGTL  176 (284)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBCCCCSCG
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-ccccccCCC
Confidence            5699999999889999999999999999999999999999999999999999999999999988655432 233456789


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.. ++.++|+||||+++|++++|..||...........+....                           
T Consensus       177 ~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------------------------  228 (284)
T 2vgo_A          177 DYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---------------------------  228 (284)
T ss_dssp             GGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------------------------
T ss_pred             CcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc---------------------------
Confidence            999999986544 7889999999999999999999998776555444333210                           


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                          ...+..+++++.++|.+||+.||.+|||++++++||||+..
T Consensus       229 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          229 ----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             ----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence                01123477899999999999999999999999999999854

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-35  Score=237.66  Aligned_cols=175  Identities=23%  Similarity=0.348  Sum_probs=137.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~   78 (217)
                      +++|.+++.....+++..+..++.||+.||+|||++||+||||||+||+++ ++.++|+|||++.......   ......
T Consensus       139 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~  217 (390)
T 2zmd_A          139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV  217 (390)
T ss_dssp             SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCC
Confidence            678999999999999999999999999999999999999999999999995 5899999999997654332   223457


Q ss_pred             ccccccCcccccCC----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCCccccccCc
Q 027927           79 VTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~----------~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      +++.|+|||.+.+.          ..++.++|||||||++|++++|..||...... ..+..+.   .....        
T Consensus       218 gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~---~~~~~--------  286 (390)
T 2zmd_A          218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHE--------  286 (390)
T ss_dssp             CCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---CTTSC--------
T ss_pred             cCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh---Ccccc--------
Confidence            89999999998642          34788999999999999999999999765322 2222111   11000        


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                        ...+...++++.++|++||..||++|||+.++++||||+..
T Consensus       287 ------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          287 ------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             ------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence                              01112346789999999999999999999999999999854

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.7e-35  Score=234.89  Aligned_cols=203  Identities=27%  Similarity=0.429  Sum_probs=148.4

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecC------CCEEEecccccccCCCC
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNAN------CDLKICDFGLARPTSEN   71 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~------~~~~l~d~~~~~~~~~~   71 (217)
                      +|++|.+++...  ..+++..+..++.||+.||+|||++ |++|+||||+||+++.+      +.++|+|||.+......
T Consensus       112 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~  191 (373)
T 1q8y_A          112 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH  191 (373)
T ss_dssp             CCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC
T ss_pred             CCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC
Confidence            478999999874  5699999999999999999999998 99999999999999543      37999999998765543


Q ss_pred             CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC------hHHHHHHHHHHhCCCCCcccccc
Q 027927           72 EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND------HVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        72 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                        .....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||....      .......+.+..+..+...+...
T Consensus       192 --~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  268 (373)
T 1q8y_A          192 --YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG  268 (373)
T ss_dssp             --CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred             --CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhcc
Confidence              23457789999999997654 7899999999999999999999997654      45667777777776654322111


Q ss_pred             CchHHHHHHHh------CCCCCccch----h---hhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          146 RNEDAKRYIRQ------LPQHPRQSL----A---QVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       146 ~~~~~~~~~~~------~~~~~~~~~----~---~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ...  ..+...      .........    .   ......++++.+||++||+.||++|||++|+++||||++...
T Consensus       269 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          269 KYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             TTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             chh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence            100  000000      000000000    0   011234578899999999999999999999999999997643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-35  Score=235.59  Aligned_cols=178  Identities=25%  Similarity=0.413  Sum_probs=141.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~   79 (217)
                      |++|.+++.....+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......  ......+
T Consensus       143 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g  222 (355)
T 1vzo_A          143 GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG  222 (355)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGS
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCccc
Confidence            57999999998899999999999999999999999999999999999999999999999999987654332  2234578


Q ss_pred             cccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++.|+|||.+.+. ..++.++||||||+++|++++|..||...........+..                   ...... 
T Consensus       223 t~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-------------------~~~~~~-  282 (355)
T 1vzo_A          223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-------------------RILKSE-  282 (355)
T ss_dssp             CCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH-------------------HHHHCC-
T ss_pred             CcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH-------------------HHhccC-
Confidence            9999999998653 3467899999999999999999999975432111111111                   000000 


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                             ...+..+++.+.++|++||..||++||     |++++++||||+..
T Consensus       283 -------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          283 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             -------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence                   112235778999999999999999999     99999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.2e-35  Score=226.35  Aligned_cols=169  Identities=23%  Similarity=0.318  Sum_probs=134.7

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-------------------CCEE
Q 027927            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-------------------CDLK   58 (217)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-------------------~~~~   58 (217)
                      |++|.+++.+.    ..+++..+..++.||+.||+|||++|++|+||||+||+++.+                   ..++
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~k  174 (289)
T 1x8b_A           95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK  174 (289)
T ss_dssp             TCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEE
T ss_pred             CCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEE
Confidence            56999999875    779999999999999999999999999999999999999844                   4799


Q ss_pred             EecccccccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Q 027927           59 ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT  138 (217)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~  138 (217)
                      |+|||.+.......   ...+++.|+|||.+.+...++.++||||||++++++++|..++......   ..+..  +   
T Consensus       175 l~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~--~---  243 (289)
T 1x8b_A          175 IGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQ--G---  243 (289)
T ss_dssp             ECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHHHT--T---
T ss_pred             EcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHHHc--C---
Confidence            99999987665433   2357889999999976655678999999999999999998877543211   11110  0   


Q ss_pred             CccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                               .....+..+++++.++|++||+.||++|||++++++||||++.
T Consensus       244 -------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          244 -------------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -------------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -------------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence                                     0112234578999999999999999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-35  Score=229.98  Aligned_cols=186  Identities=24%  Similarity=0.378  Sum_probs=138.8

Q ss_pred             CccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-
Q 027927            2 DTDLYQIIRS--------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-   72 (217)
Q Consensus         2 ~~~L~~~l~~--------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-   72 (217)
                      |++|.+++..        ...+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  176 (303)
T 2vwi_A           97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD  176 (303)
T ss_dssp             TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred             CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence            6799999974        4679999999999999999999999999999999999999999999999999886544321 


Q ss_pred             -----ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           73 -----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        73 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                           ......+++.|+|||.+.+...++.++|+||||+++|++++|..||..............  +.+....      
T Consensus       177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~------  248 (303)
T 2vwi_A          177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPSLE------  248 (303)
T ss_dssp             -----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCCTT------
T ss_pred             ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCccc------
Confidence                 123446788999999886534478899999999999999999999987665443332221  1110000      


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                                   ...........+++++.++|.+||+.||.+|||++++++||||++...
T Consensus       249 -------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          249 -------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             -------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             -------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence                         000112233467899999999999999999999999999999997643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3e-35  Score=231.76  Aligned_cols=174  Identities=32%  Similarity=0.502  Sum_probs=146.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.+++..+..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus       125 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  204 (335)
T 2owb_A          125 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT  204 (335)
T ss_dssp             TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             CCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCC
Confidence            5799999998899999999999999999999999999999999999999999999999999998765432 223445678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+.. ++.++|+||||+++|++++|..||...........+....                          
T Consensus       205 ~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------------------------  257 (335)
T 2owb_A          205 PNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------------------------  257 (335)
T ss_dssp             CSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--------------------------
T ss_pred             ccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--------------------------
Confidence            8999999986554 7889999999999999999999998776554444333210                          


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                           ......+++.+.++|++||+.||++|||++++++|+||.+..
T Consensus       258 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          258 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence                 011224678899999999999999999999999999998653

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.8e-35  Score=228.16  Aligned_cols=177  Identities=32%  Similarity=0.526  Sum_probs=146.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC---CCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++.+...+++..+..++.||+.||.+||++|++|+||+|+||+++.+   +.++|+|||.+.............
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  184 (287)
T 2wei_A          105 GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI  184 (287)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHH
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcccccc
Confidence            57999999888899999999999999999999999999999999999999764   469999999987766555555567


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||.+.+  .++.++|+||||++++++++|..||.+.........+........                    
T Consensus       185 ~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------  242 (287)
T 2wei_A          185 GTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD--------------------  242 (287)
T ss_dssp             HHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------------
T ss_pred             CcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence            8899999998854  378999999999999999999999988776655544433110000                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                             ......+++++.++|++||+.||++|||++++++||||++..
T Consensus       243 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             -------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             -------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence                   011235789999999999999999999999999999998653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.7e-35  Score=227.10  Aligned_cols=174  Identities=32%  Similarity=0.506  Sum_probs=145.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.+++..++.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus        99 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  178 (294)
T 2rku_A           99 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT  178 (294)
T ss_dssp             TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCC
Confidence            5799999998899999999999999999999999999999999999999999999999999998765432 223445678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||||+++|++++|..||...........+...  .                        
T Consensus       179 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~------------------------  231 (294)
T 2rku_A          179 PNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--E------------------------  231 (294)
T ss_dssp             CSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--C------------------------
T ss_pred             CCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--c------------------------
Confidence            899999998654 4788999999999999999999999877654443333210  0                        


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                           ......+++.+.++|++||+.||++|||++++++||||.+..
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence                 011234678999999999999999999999999999998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.7e-35  Score=231.78  Aligned_cols=175  Identities=26%  Similarity=0.373  Sum_probs=143.8

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         1 l~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      ++++|.+++.. ..++++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+......   ....+
T Consensus       136 ~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~g  212 (348)
T 1u5q_A          136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVG  212 (348)
T ss_dssp             CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCS
T ss_pred             CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---CcccC
Confidence            35688888854 578999999999999999999999999999999999999999999999999998765432   34568


Q ss_pred             cccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           80 TRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        80 ~~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ++.|+|||.+..  ...++.++||||||+++|++++|..||...........+.......                    
T Consensus       213 t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------------------  272 (348)
T 1u5q_A          213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------------------  272 (348)
T ss_dssp             CGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------------
T ss_pred             CcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------------
Confidence            899999999853  3457889999999999999999999998877655554443311000                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                               .....+++.+.++|.+||+.||++|||++++++||||.+..
T Consensus       273 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          273 ---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence                     01124678899999999999999999999999999998653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-35  Score=225.41  Aligned_cols=173  Identities=27%  Similarity=0.438  Sum_probs=121.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      +++|.+++.+. .++++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  174 (278)
T 3cok_A           95 NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG  174 (278)
T ss_dssp             TEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccC
Confidence            57899999886 779999999999999999999999999999999999999999999999999987654322 2234567


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+.. ++.++|+||||+++|++++|..||...........+                           ..
T Consensus       175 ~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------------------------~~  226 (278)
T 3cok_A          175 TPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV---------------------------VL  226 (278)
T ss_dssp             ------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------------------------CS
T ss_pred             CCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------------------------hh
Confidence            88999999886544 788999999999999999999999765422111100                           00


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .    ....+..+++++.++|.+||+.||++|||++++++||||.+.
T Consensus       227 ~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          227 A----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             S----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             c----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            0    001223578899999999999999999999999999999865

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-35  Score=234.84  Aligned_cols=166  Identities=25%  Similarity=0.404  Sum_probs=132.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC--CEEEecccccccCCCCC-----ccccccccccccCcc
Q 027927           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC--DLKICDFGLARPTSENE-----FMTEYVVTRWYRAPE   87 (217)
Q Consensus        15 l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~Pe   87 (217)
                      +++..+..++.||+.||+|||++|++|+||+|+||+++.++  .++|+|||.+.......     ......+++.|+|||
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  244 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE  244 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence            46788999999999999999999999999999999998776  89999999987543211     224556889999999


Q ss_pred             cccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchh
Q 027927           88 LLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA  166 (217)
Q Consensus        88 ~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (217)
                      .+.+. ..++.++||||||+++|++++|..||.+.........+.........                           
T Consensus       245 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------  297 (345)
T 3hko_A          245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---------------------------  297 (345)
T ss_dssp             HHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---------------------------
T ss_pred             hhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---------------------------
Confidence            98642 45788999999999999999999999888776666555542111111                           


Q ss_pred             hhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          167 QVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       167 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      .....+++++.++|++||+.||.+|||+.++++||||++..
T Consensus       298 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          298 PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            11123678999999999999999999999999999999764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.6e-35  Score=241.56  Aligned_cols=173  Identities=27%  Similarity=0.426  Sum_probs=142.5

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccc
Q 027927            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~   76 (217)
                      |++|.+++.+.    ..+++..+..++.||+.||+|||++||+||||||+||+++.+|.++|+|||++........ ...
T Consensus       269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~  348 (543)
T 3c4z_A          269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG  348 (543)
T ss_dssp             TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCC
T ss_pred             CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCccccc
Confidence            68999999874    4699999999999999999999999999999999999999999999999999977654433 234


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH----VHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      ..|++.|+|||++.+. .++.++|+|||||++|++++|..||.....    ......+..                    
T Consensus       349 ~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--------------------  407 (543)
T 3c4z_A          349 YAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--------------------  407 (543)
T ss_dssp             CCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--------------------
T ss_pred             ccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--------------------
Confidence            5889999999999664 478999999999999999999999976532    222222221                    


Q ss_pred             HHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                         ...        ..+..+++++.++|++||+.||++||+     ++++++||||++.
T Consensus       408 ---~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          408 ---QAV--------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             ---CCC--------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             ---ccc--------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence               000        122357899999999999999999996     5899999999964

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=225.69  Aligned_cols=179  Identities=25%  Similarity=0.417  Sum_probs=144.7

Q ss_pred             CccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccc
Q 027927            2 DTDLYQIIR-SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~   79 (217)
                      |++|.+++. ....+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  187 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIG  187 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCS
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCC
Confidence            469999997 46789999999999999999999999999999999999999999999999999986654332 2334567


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+.. ++.++|+||||+++|++++|..||...........+...  .....                   
T Consensus       188 ~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~-------------------  245 (314)
T 3com_A          188 TPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN--PPPTF-------------------  245 (314)
T ss_dssp             CGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCC-------------------
T ss_pred             CCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CCccc-------------------
Confidence            88999999986554 788999999999999999999999876654433322211  00000                   


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                             .....+++.+.++|.+||+.||.+|||+.++++||||++..+.
T Consensus       246 -------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          246 -------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             -------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             -------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence                   0112357889999999999999999999999999999977544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.6e-35  Score=235.38  Aligned_cols=198  Identities=23%  Similarity=0.359  Sum_probs=143.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |++|.+++++.+.+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.+...... ......++
T Consensus       115 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt  193 (360)
T 3eqc_A          115 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGT  193 (360)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCC
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCC
Confidence            579999999989999999999999999999999996 9999999999999999999999999988644322 22345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH-hCCCCCccccc---------------
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL-LGTPTDADLGF---------------  144 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~---------------  144 (217)
                      +.|+|||.+.+. .++.++|+||||+++|++++|..||...........+... .+.........               
T Consensus       194 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (360)
T 3eqc_A          194 RSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR  272 (360)
T ss_dssp             CTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------------
T ss_pred             CCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCC
Confidence            999999998655 4789999999999999999999999887655443322111 11111000000               


Q ss_pred             --cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          145 --VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       145 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                        .................     .....+++++.+||++||+.||++|||++++++||||++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          273 PPMAIFELLDYIVNEPPPK-----LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             -CCCHHHHHHHHHHSCCCC-----CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CcccchhhhhHHhccCCCC-----CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence              00000111111111000     1112467899999999999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-35  Score=228.34  Aligned_cols=177  Identities=22%  Similarity=0.354  Sum_probs=137.6

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~   78 (217)
                      +++|.+++...  ..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  190 (326)
T 2x7f_A          111 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI  190 (326)
T ss_dssp             TEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------
T ss_pred             CCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcccccccc
Confidence            46999999875  579999999999999999999999999999999999999999999999999986654322 233456


Q ss_pred             ccccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           79 VTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        79 ~~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      +++.|+|||.+..    ...++.++|+||||+++|++++|..||...........+...  ...                
T Consensus       191 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----------------  252 (326)
T 2x7f_A          191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PAP----------------  252 (326)
T ss_dssp             CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCC----------------
T ss_pred             CCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccc----------------
Confidence            7899999999862    334788999999999999999999999877655444333221  000                


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                 ......+++.+.++|++||..||.+|||++++++||||++..
T Consensus       253 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          253 -----------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             -----------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             -----------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence                       001234678999999999999999999999999999998654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.2e-35  Score=228.67  Aligned_cols=177  Identities=21%  Similarity=0.342  Sum_probs=141.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC----ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~   77 (217)
                      |++|.++++.++++++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......    .....
T Consensus       100 g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  179 (311)
T 3ork_A          100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV  179 (311)
T ss_dssp             EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccccccccccc
Confidence            57999999998999999999999999999999999999999999999999999999999999987654332    12234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||.+.+.. ++.++|+||||+++|++++|..||.+..............                       
T Consensus       180 ~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-----------------------  235 (311)
T 3ork_A          180 IGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED-----------------------  235 (311)
T ss_dssp             --CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-----------------------
T ss_pred             CcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-----------------------
Confidence            6789999999997654 7899999999999999999999998877655444333211                       


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                          ..........+++++.++|.+||+.||.+||++.+++.|+|++..
T Consensus       236 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          236 ----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             ----CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence                011223345688999999999999999999999999999999843

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-34  Score=224.47  Aligned_cols=175  Identities=25%  Similarity=0.421  Sum_probs=144.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~   80 (217)
                      |++|.+++.+ +++++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus       104 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  182 (303)
T 3a7i_A          104 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT  182 (303)
T ss_dssp             TEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSC
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCC
Confidence            5689999876 679999999999999999999999999999999999999999999999999987654432 22345678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+. .++.++|+||||+++|++++|..||...........+...  .+                       
T Consensus       183 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-----------------------  236 (303)
T 3a7i_A          183 PFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP-----------------------  236 (303)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC-----------------------
T ss_pred             cCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC-----------------------
Confidence            899999998654 4788999999999999999999999877655444333220  00                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                           ......++..+.++|.+||+.||.+|||++++++||||.....
T Consensus       237 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          237 -----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             -----CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             -----CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence                 0122357789999999999999999999999999999986543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-34  Score=226.57  Aligned_cols=172  Identities=24%  Similarity=0.419  Sum_probs=133.2

Q ss_pred             CccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC------
Q 027927            2 DTDLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~------   72 (217)
                      |++|.+++.....   .+...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......      
T Consensus       145 ~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~  224 (332)
T 3qd2_B          145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL  224 (332)
T ss_dssp             SSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------
T ss_pred             CCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc
Confidence            5799999988744   5666799999999999999999999999999999999999999999999987655432      


Q ss_pred             -------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           73 -------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        73 -------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                             ......+++.|+|||.+.+.. ++.++|+||||+++|++++|..|+..     ....+........       
T Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~-------  291 (332)
T 3qd2_B          225 TPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKF-------  291 (332)
T ss_dssp             -------CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCC-------
T ss_pred             ccccccccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCC-------
Confidence                   123346889999999987654 78999999999999999997665421     1111111111100       


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                          .......++++.++|++||+.||++|||++++++||||++.
T Consensus       292 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          292 --------------------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             --------------------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             --------------------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence                                01111245788999999999999999999999999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2e-34  Score=223.65  Aligned_cols=180  Identities=21%  Similarity=0.359  Sum_probs=141.5

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Cccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~   79 (217)
                      |++|.+++.. ...+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  179 (302)
T 2j7t_A          100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG  179 (302)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----C
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccC
Confidence            5688888876 577999999999999999999999999999999999999999999999999986432111 11223467


Q ss_pred             cccccCccccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           80 TRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        80 ~~~~~~Pe~~~----~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ++.|+|||.+.    ....++.++|+||||+++|++++|..||...........+....  ....               
T Consensus       180 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---------------  242 (302)
T 2j7t_A          180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPTL---------------  242 (302)
T ss_dssp             CGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCCC---------------
T ss_pred             ChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--Cccc---------------
Confidence            88999999884    34457889999999999999999999998877655544433311  0000               


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                                 .....++..+.++|.+||+.||++|||++++++||||++....
T Consensus       243 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          243 -----------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             -----------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             -----------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence                       0112367889999999999999999999999999999976543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.5e-35  Score=230.04  Aligned_cols=168  Identities=26%  Similarity=0.391  Sum_probs=141.0

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe-cCCCEEEecccccccCCCCCccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      ++|.+++..+..+++..+..++.||+.||+|||++|++|+||+|+||+++ .++.++|+|||.+....... .....+++
T Consensus       134 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~  212 (320)
T 3a99_A          134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTR  212 (320)
T ss_dssp             EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC-BCCCCSCG
T ss_pred             ccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc-ccCCCCCc
Confidence            78999999989999999999999999999999999999999999999999 77899999999987665432 33456889


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+....+.++|+||||+++|++++|..||.....      +..  +.                     .   
T Consensus       213 ~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~---------------------~---  260 (320)
T 3a99_A          213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQ---------------------V---  260 (320)
T ss_dssp             GGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CC---------------------C---
T ss_pred             cCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--cc---------------------c---
Confidence            999999987665457789999999999999999999965321      000  00                     0   


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                           .....+++++.++|++||+.||++|||++++++||||++...
T Consensus       261 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          261 -----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             -----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             -----cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                 112357899999999999999999999999999999997643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-34  Score=223.04  Aligned_cols=175  Identities=22%  Similarity=0.355  Sum_probs=142.7

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC---CCcccc
Q 027927            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE---NEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~~   76 (217)
                      +++|.+++..  ...+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.....   ......
T Consensus        91 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  170 (305)
T 2wtk_C           91 VCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT  170 (305)
T ss_dssp             SEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECC
T ss_pred             cCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcccccccccc
Confidence            4567788776  46799999999999999999999999999999999999999999999999999876542   223345


Q ss_pred             ccccccccCcccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~-~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|+|||.+.+.. ..+.++|+||||+++|++++|..||.+.........+...  .                   
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~-------------------  229 (305)
T 2wtk_C          171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--S-------------------  229 (305)
T ss_dssp             CCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--C-------------------
T ss_pred             CCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--C-------------------
Confidence            56789999999886533 2367999999999999999999999877655544443321  0                   


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                ......+++.+.++|++||..||.+|||++++++||||++..
T Consensus       230 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          230 ----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             ----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             ----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence                      011234678999999999999999999999999999998653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.3e-35  Score=230.99  Aligned_cols=180  Identities=26%  Similarity=0.395  Sum_probs=119.9

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---CCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      |++|.+++....  .+++..+..++.||+.||.|||++|++|+||+|+||+++.   ++.++|+|||.+...... ....
T Consensus       110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~  188 (336)
T 3fhr_A          110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQT  188 (336)
T ss_dssp             TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-cccc
Confidence            569999998863  6999999999999999999999999999999999999976   455999999998765433 2334


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.+. .++.++|+||||+++|++++|..||................                   ...
T Consensus       189 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------------~~~  248 (336)
T 3fhr_A          189 PCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-------------------RLG  248 (336)
T ss_dssp             ---------------C-HHHHHHHHHHHHHHHHHHHHSSCCC--------------------------------------
T ss_pred             CCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh-------------------hcc
Confidence            5678999999988544 47889999999999999999999997654322211111000                   000


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ....    ....+..+++++.++|++||+.||++|||++++++||||++.
T Consensus       249 ~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          249 QYGF----PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             --CC----CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cccc----CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            0000    011223578999999999999999999999999999999865

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-34  Score=229.29  Aligned_cols=192  Identities=20%  Similarity=0.279  Sum_probs=143.5

Q ss_pred             CccHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCC
Q 027927            2 DTDLYQI------IRS--NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~------l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (217)
                      |++|.++      +..  ...+++..+..++.||+.||++||+ +|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus       127 ~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-  205 (348)
T 2pml_X          127 NDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-  205 (348)
T ss_dssp             TCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-
T ss_pred             CCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc-
Confidence            3577777      665  5789999999999999999999999 99999999999999999999999999998765443 


Q ss_pred             ccccccccccccCcccccCCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHH
Q 027927           73 FMTEYVVTRWYRAPELLLNSSDYTA-AIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        73 ~~~~~~~~~~~~~Pe~~~~~~~~~~-~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                      ......+++.|+|||.+.+...++. ++|+||||++++++++|..||..... ......+.......+.......     
T Consensus       206 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~-----  280 (348)
T 2pml_X          206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFL-----  280 (348)
T ss_dssp             EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSST-----
T ss_pred             cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhh-----
Confidence            3445678899999999976644555 99999999999999999999987765 4444333221111111000000     


Q ss_pred             HHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ..............+++++.++|++||+.||.+|||++++++||||++.
T Consensus       281 -------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          281 -------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             -------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             -------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence                   0000011122235688999999999999999999999999999999965

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.3e-34  Score=223.02  Aligned_cols=175  Identities=23%  Similarity=0.343  Sum_probs=135.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~   78 (217)
                      +++|.+++.+...+++..+..++.||+.||++||++|++|+||+|+||+++. +.++|+|||.+........   .....
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~  189 (313)
T 3cek_A          111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQV  189 (313)
T ss_dssp             SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCC
Confidence            6799999999999999999999999999999999999999999999999964 8999999999876543321   23456


Q ss_pred             ccccccCcccccCC----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCCccccccCc
Q 027927           79 VTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~----------~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      +++.|+|||.+.+.          ..++.++|+||||+++|++++|..||...... .....+.   .....        
T Consensus       190 gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~~--------  258 (313)
T 3cek_A          190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHE--------  258 (313)
T ss_dssp             CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTSC--------
T ss_pred             CCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---hcccc--------
Confidence            78999999998641          34678999999999999999999999765322 1111111   10000        


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                        .......++++.++|++||+.||++|||++++++||||+..
T Consensus       259 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          259 ------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             ------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             ------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence                              01122356889999999999999999999999999999965

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.4e-34  Score=222.25  Aligned_cols=177  Identities=23%  Similarity=0.314  Sum_probs=130.3

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |+.+..+... +..+++..+..++.||+.||++||++ |++|+||+|+||+++.++.++|+|||.+.............+
T Consensus       107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  186 (318)
T 2dyl_A          107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG  186 (318)
T ss_dssp             SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCC
Confidence            4445555543 57899999999999999999999995 999999999999999999999999999876655544555678


Q ss_pred             cccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        80 ~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ++.|+|||.+..    ...++.++|+||||+++|++++|..||.... .......+...  ....               
T Consensus       187 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~---------------  249 (318)
T 2dyl_A          187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE--EPPL---------------  249 (318)
T ss_dssp             CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS--CCCC---------------
T ss_pred             CccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc--CCCC---------------
Confidence            899999999852    3346889999999999999999999997643 33333333221  0000               


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                 ......+++++.++|.+||+.||.+|||++++++||||++.
T Consensus       250 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          250 -----------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             -----------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             -----------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence                       00112477999999999999999999999999999999865

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.7e-34  Score=220.84  Aligned_cols=175  Identities=27%  Similarity=0.448  Sum_probs=131.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---------
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---------   71 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---------   71 (217)
                      |++|.+++.+. ..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+......         
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  178 (303)
T 1zy4_A           99 NGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ  178 (303)
T ss_dssp             SCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC----------
T ss_pred             CCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccc
Confidence            57999999865 46889999999999999999999999999999999999999999999999998654321         


Q ss_pred             ------CccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccc
Q 027927           72 ------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        72 ------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  144 (217)
                            .......+++.|+|||.+.+...++.++|+||||+++|++++   ||..... ......+.. ...        
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~-~~~--------  246 (303)
T 1zy4_A          179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS-VSI--------  246 (303)
T ss_dssp             ---------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHS-TTC--------
T ss_pred             cccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccc-ccc--------
Confidence                  122345678899999998766568899999999999999998   5543221 111111111 000        


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                    ..    ........++.+.++|++||+.||.+|||++++++||||+..
T Consensus       247 --------------~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          247 --------------EF----PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             --------------CC----CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             --------------cc----CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence                          00    011223466789999999999999999999999999999865

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-35  Score=237.76  Aligned_cols=167  Identities=14%  Similarity=0.182  Sum_probs=135.6

Q ss_pred             CccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc
Q 027927            2 DTDLYQIIRS-------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM   74 (217)
Q Consensus         2 ~~~L~~~l~~-------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (217)
                      +++|.++++.       +..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......  .
T Consensus       188 ~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~  265 (413)
T 3dzo_A          188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--A  265 (413)
T ss_dssp             SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--E
T ss_pred             cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--c
Confidence            5678888841       345888899999999999999999999999999999999999999999999998765543  3


Q ss_pred             ccccccccccCccccc---------CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           75 TEYVVTRWYRAPELLL---------NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~---------~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                      ....+ +.|+|||.+.         ....++.++|||||||++|++++|..||..........                 
T Consensus       266 ~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~-----------------  327 (413)
T 3dzo_A          266 VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE-----------------  327 (413)
T ss_dssp             CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG-----------------
T ss_pred             ccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH-----------------
Confidence            44566 8999999983         33346789999999999999999999997653211000                 


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                        ........+++++.++|.+||+.||++|||+.++++||||++.
T Consensus       328 ------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          328 ------------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             ------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ------------------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence                              0011123578999999999999999999999999999999865

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.9e-34  Score=219.24  Aligned_cols=178  Identities=25%  Similarity=0.435  Sum_probs=138.2

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-CCCEEEecccccccCCCCC-cccc
Q 027927            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE-FMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~~~   76 (217)
                      |++|.+++...   ..+++..+..++.||+.||++||++|++|+||+|+||+++. ++.++|+|||.+....... ....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  182 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET  182 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence            57999999875   35679999999999999999999999999999999999998 8999999999987654322 2334


Q ss_pred             ccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|+|||.+.+. ..++.++|+||||+++|++++|..||..................                   
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------------  243 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-------------------  243 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------------
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------------
Confidence            5678899999998643 23678999999999999999999999654332211111111000                   


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                               ....+..+++++.++|.+||+.||++|||++++++||||+...
T Consensus       244 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          244 ---------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             ---------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                     0112335789999999999999999999999999999999653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.7e-34  Score=220.55  Aligned_cols=175  Identities=29%  Similarity=0.400  Sum_probs=141.9

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcC-----cEecCcCCCCEEEecCCCEEEecccccccCCCCC
Q 027927            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~-----i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (217)
                      |++|.+++...    ..+++..+..++.|++.||++||+.+     ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~  170 (279)
T 2w5a_A           91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  170 (279)
T ss_dssp             TEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C
T ss_pred             CCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc
Confidence            56999999764    45999999999999999999999999     9999999999999999999999999987655432


Q ss_pred             c-cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           73 F-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        73 ~-~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                      . .....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||...........+....  .              
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~--------------  233 (279)
T 2w5a_A          171 SFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--F--------------  233 (279)
T ss_dssp             HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C--------------
T ss_pred             ccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc--c--------------
Confidence            2 23456788999999986554 7899999999999999999999998876555444443210  0              


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                    ......+++++.++|.+||+.||++|||++++++|+|+....
T Consensus       234 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          234 --------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             --------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                          012235779999999999999999999999999999998654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=225.50  Aligned_cols=167  Identities=25%  Similarity=0.377  Sum_probs=139.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe-cCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |++|.+++.+++.+++..+..++.||+.||++||++|++|+||+|+||+++ .++.++|+|||.+....... .....++
T Consensus       123 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~  201 (312)
T 2iwi_A          123 AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGT  201 (312)
T ss_dssp             EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC-BCCCCSC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc-ccccCCc
Confidence            579999999988999999999999999999999999999999999999999 78999999999987665433 3445678


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      ..|+|||.+.+....+.++|+||||+++|++++|..||.....      +..                       ..   
T Consensus       202 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~-----------------------~~---  249 (312)
T 2iwi_A          202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE-----------------------AE---  249 (312)
T ss_dssp             TTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-----------------------TC---
T ss_pred             ccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh-----------------------hc---
Confidence            8999999886655445689999999999999999999965311      110                       00   


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                           ......+++.+.++|++||+.||++|||++++++||||+..
T Consensus       250 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          250 -----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             -----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence                 01223577999999999999999999999999999999965

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.1e-34  Score=225.11  Aligned_cols=179  Identities=27%  Similarity=0.375  Sum_probs=121.6

Q ss_pred             CccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc
Q 027927            2 DTDLYQIIRS-----NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT   75 (217)
Q Consensus         2 ~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (217)
                      +++|.+++..     ...+++..+..++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||.+..........
T Consensus       104 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  183 (327)
T 3aln_A          104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT  183 (327)
T ss_dssp             SEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred             CCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccc
Confidence            5677777764     57899999999999999999999998 99999999999999999999999999987665554444


Q ss_pred             cccccccccCccccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           76 EYVVTRWYRAPELLL---NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~---~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      ...+++.|+|||.+.   ....++.++|+||||+++|++++|..||........  .+                      
T Consensus       184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----------------------  239 (327)
T 3aln_A          184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QL----------------------  239 (327)
T ss_dssp             ----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------------------
T ss_pred             cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HH----------------------
Confidence            557889999999883   233478899999999999999999999976431100  00                      


Q ss_pred             HHHhCCCC-CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          153 YIRQLPQH-PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       153 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                        ...... ...........+++++.++|++||+.||.+|||++++++||||...
T Consensus       240 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          240 --TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             --CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             --HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence              000000 0000111223578999999999999999999999999999999854

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-33  Score=217.00  Aligned_cols=172  Identities=15%  Similarity=0.187  Sum_probs=137.4

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC-----EEEecccccccCCCCCc-
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-----LKICDFGLARPTSENEF-   73 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~-   73 (217)
                      +|++|.+++... .++++..+..++.||+.||++||++|++|+||||+||+++.++.     ++|+|||.+........ 
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A           88 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             cCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence            378999999875 46999999999999999999999999999999999999987776     99999999876544321 


Q ss_pred             -------cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHhCCCCCcccc
Q 027927           74 -------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---HVHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        74 -------~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~  143 (217)
                             .....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||....   ....+..+.....        
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  238 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--------  238 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH--------
T ss_pred             ccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc--------
Confidence                   23456789999999986544 7899999999999999999999997743   2222222222110        


Q ss_pred             ccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                        ..........+++++.+++.+||+.||++|||++++++
T Consensus       239 ------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          239 ------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             ------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ------------------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence                              01123344568899999999999999999999999865

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=234.81  Aligned_cols=179  Identities=26%  Similarity=0.373  Sum_probs=130.5

Q ss_pred             CCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-----CCCEEEecccccccCCCCC--
Q 027927            1 MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-----NCDLKICDFGLARPTSENE--   72 (217)
Q Consensus         1 l~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-----~~~~~l~d~~~~~~~~~~~--   72 (217)
                      ++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.     ..+++|+|||++.......  
T Consensus       100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            4679999998864 4666677899999999999999999999999999999953     3357899999987655332  


Q ss_pred             --ccccccccccccCcccccC--CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           73 --FMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        73 --~~~~~~~~~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                        ......+++.|+|||.+.+  ...++.++|||||||++|++++ |..||......... .+   .+.......     
T Consensus       180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~---~~~~~~~~~-----  250 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL---LGACSLDCL-----  250 (432)
T ss_dssp             ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH---TTCCCCTTS-----
T ss_pred             eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH---hccCCcccc-----
Confidence              2234568999999999864  2346779999999999999999 89998654322211 11   111100000     


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                                         ......++.+.++|++||+.||++|||++++++||||++..
T Consensus       251 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          251 -------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             -------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             -------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence                               00011235688999999999999999999999999998654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-34  Score=224.23  Aligned_cols=195  Identities=20%  Similarity=0.321  Sum_probs=140.1

Q ss_pred             CccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE----ecCCCEEEecccccccCCCCCcc
Q 027927            2 DTDLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARPTSENEFM   74 (217)
Q Consensus         2 ~~~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~   74 (217)
                      |++|.+++.....   +++..+..++.||+.||+|||++|++|+||||+||++    +.++.++|+|||.+.........
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~  172 (319)
T 4euu_A           93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF  172 (319)
T ss_dssp             TCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCB
T ss_pred             CCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCce
Confidence            5799999987533   9999999999999999999999999999999999998    77778999999999877666655


Q ss_pred             ccccccccccCcccccC-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCCCcccc
Q 027927           75 TEYVVTRWYRAPELLLN-------SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH----VHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~-------~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~  143 (217)
                      ....+++.|+|||.+..       ...++.++|+||||+++|++++|..||.....    ...+..+...  .+ ...+.
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~p-~~~~~  249 (319)
T 4euu_A          173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--KP-SGAIS  249 (319)
T ss_dssp             CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH--CC-TTCCE
T ss_pred             eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC--CC-cccch
Confidence            66778999999998752       34578899999999999999999999965332    2233333221  11 11111


Q ss_pred             ccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                      ......... ..-....  .........+++.+.++|++||+.||++|||++|+|+||-
T Consensus       250 ~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          250 GVQKAENGP-IDWSGDM--PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             EEECSTTCC-EEEESSC--CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hhhcccCCc-cccCccC--CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            100000000 0000000  0000111234567899999999999999999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.8e-33  Score=219.29  Aligned_cols=174  Identities=23%  Similarity=0.385  Sum_probs=133.3

Q ss_pred             CccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccc
Q 027927            2 DTDLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMT   75 (217)
Q Consensus         2 ~~~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~   75 (217)
                      |++|.+++.....   +++..+..++.||+.||+|||++|  ++||||||+||+++.++.++|+|||.+....... ...
T Consensus       118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  197 (309)
T 3p86_A          118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK  197 (309)
T ss_dssp             TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred             CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence            5799999988654   999999999999999999999999  9999999999999999999999999986544332 233


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...+++.|+|||.+.+.. ++.++|+||||+++|++++|..||...........+......                   
T Consensus       198 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------------------  257 (309)
T 3p86_A          198 SAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------------------  257 (309)
T ss_dssp             ----CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-------------------
T ss_pred             cCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------------
Confidence            457889999999986554 789999999999999999999999887765554443221111                   


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc--CCCCcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP--YKPFQC  205 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~--~~~f~~  205 (217)
                                ...+..+++++.++|++||+.||.+|||++++++  .++++.
T Consensus       258 ----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 ----------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                      1123357899999999999999999999999987  444443

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.9e-34  Score=222.11  Aligned_cols=174  Identities=24%  Similarity=0.353  Sum_probs=130.8

Q ss_pred             CccHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-
Q 027927            2 DTDLYQIIRSNQ------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-   74 (217)
Q Consensus         2 ~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-   74 (217)
                      |++|.+++....      .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+......... 
T Consensus       115 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~  194 (323)
T 3qup_A          115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR  194 (323)
T ss_dssp             TCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccccccccccccc
Confidence            569999996642      6999999999999999999999999999999999999999999999999998765443222 


Q ss_pred             --ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           75 --TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        75 --~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                        ....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+.....                
T Consensus       195 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----------------  257 (323)
T 3qup_A          195 QGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR----------------  257 (323)
T ss_dssp             ------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------
T ss_pred             ccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC----------------
Confidence              2334467899999986554 7899999999999999999 8999988766555444432110                


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCC-------HhhhccCCCCccc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-------GEFFVPYKPFQCC  206 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-------~~~ll~~~~f~~~  206 (217)
                                    ......+++++.++|.+||+.||++|||       ++++++|+|+...
T Consensus       258 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          258 --------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             --------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                          0112357789999999999999999999       8888999999854

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.8e-33  Score=223.37  Aligned_cols=156  Identities=26%  Similarity=0.393  Sum_probs=126.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---ccccccccccccCcccccC
Q 027927           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEYVVTRWYRAPELLLN   91 (217)
Q Consensus        15 l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~   91 (217)
                      +++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......   ......+++.|+|||.+.+
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  269 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  269 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence            8999999999999999999999999999999999999999999999999997654332   2234566788999999865


Q ss_pred             CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCC
Q 027927           92 SSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP  170 (217)
Q Consensus        92 ~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (217)
                      .. ++.++||||||+++|++++ |..||.+.................                             ..+.
T Consensus       270 ~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~  319 (359)
T 3vhe_A          270 RV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----------------------------RAPD  319 (359)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------------------CCCT
T ss_pred             CC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------------------CCCC
Confidence            44 7899999999999999998 999998765444333333321111                             1123


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          171 HVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       171 ~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                      .+++++.++|.+||+.||++|||++++++|
T Consensus       320 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          320 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            467899999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.8e-33  Score=222.57  Aligned_cols=167  Identities=28%  Similarity=0.410  Sum_probs=135.4

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      |++|.++++..+                .++...+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  250 (370)
T 2psq_A          171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA  250 (370)
T ss_dssp             TCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSC
T ss_pred             CCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCC
Confidence            579999998754                4899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      ........   .....+++.|+|||.+.+.. ++.++|+|||||++|++++ |..||.+.........+.....      
T Consensus       251 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------  323 (370)
T 2psq_A          251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR------  323 (370)
T ss_dssp             EETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------
T ss_pred             cccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC------
Confidence            76544322   22334567899999987654 8899999999999999998 9999987664444333221000      


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                              ...+..+++++.++|.+||+.||.+|||+.++++
T Consensus       324 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          324 ------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    0122357789999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.5e-33  Score=214.89  Aligned_cols=172  Identities=18%  Similarity=0.214  Sum_probs=136.0

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE---ecCCCEEEecccccccCCCCCc---
Q 027927            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEF---   73 (217)
Q Consensus         1 l~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~---   73 (217)
                      +|++|.+++.. ...+++..+..++.||+.||+|||++|++|+||||+||++   +.++.++|+|||.+........   
T Consensus        87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (296)
T 3uzp_A           87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             cCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence            47899999984 4679999999999999999999999999999999999999   4889999999999876544322   


Q ss_pred             -----cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCCcccccc
Q 027927           74 -----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        74 -----~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                           .....+++.|+|||.+.+.. ++.++||||||+++|++++|..||.....   ...+..+....           
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  234 (296)
T 3uzp_A          167 IPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----------  234 (296)
T ss_dssp             CCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----------
T ss_pred             cccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-----------
Confidence                 23456789999999986554 78999999999999999999999976431   11121111100           


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  .   ..........+++++.++|++||+.||.+|||++++++
T Consensus       235 ------------~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          235 ------------M---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ------------H---HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ------------c---CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                        0   01122334567899999999999999999999999865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-33  Score=217.35  Aligned_cols=172  Identities=18%  Similarity=0.218  Sum_probs=136.4

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE---ecCCCEEEecccccccCCCCCc---
Q 027927            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEF---   73 (217)
Q Consensus         1 l~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~---   73 (217)
                      +|++|.+++.. ...+++..+..++.||+.||+|||++|++|+||||+||++   +.++.++|+|||.+........   
T Consensus        87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~  166 (296)
T 4hgt_A           87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             CCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence            47899999985 4679999999999999999999999999999999999999   7889999999999876544322   


Q ss_pred             -----cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCCCcccccc
Q 027927           74 -----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV---HQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        74 -----~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~  145 (217)
                           .....+++.|+|||.+.+.. ++.++||||+|+++|++++|..||.+....   ..+..+...            
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  233 (296)
T 4hgt_A          167 IPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------------  233 (296)
T ss_dssp             CCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH------------
T ss_pred             CCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc------------
Confidence                 23456789999999986554 789999999999999999999999764321   111111110            


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 .   ...........+++++.++|.+||+.||++|||++++++
T Consensus       234 -----------~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          234 -----------K---MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -----------H---HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -----------c---ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                       0   001122333567899999999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-33  Score=222.67  Aligned_cols=168  Identities=27%  Similarity=0.380  Sum_probs=137.3

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      |++|.+++....                .+++..+..++.||+.||++||++|++||||||+||+++.++.++|+|||.+
T Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a  238 (382)
T 3tt0_A          159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA  238 (382)
T ss_dssp             TCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCC
T ss_pred             CCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcc
Confidence            579999998864                4999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      .......   ......+++.|+|||.+.+.. ++.++||||||++++++++ |..||.+.........+.....      
T Consensus       239 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------  311 (382)
T 3tt0_A          239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR------  311 (382)
T ss_dssp             CCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC------
T ss_pred             cccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            7654332   223345577899999987554 8899999999999999999 9999987765554443332110      


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                              ......+++++.++|++||+.||++|||+++++++
T Consensus       312 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          312 ------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    01123577999999999999999999999999763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.9e-33  Score=215.38  Aligned_cols=174  Identities=26%  Similarity=0.368  Sum_probs=135.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~   79 (217)
                      |++|.+++.+++++++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........  .....+
T Consensus        95 g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  174 (294)
T 4eqm_A           95 GPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG  174 (294)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCcccc
Confidence            679999999999999999999999999999999999999999999999999999999999999876544322  233568


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+.. ++.++|+||||+++|++++|..||.+............                          .
T Consensus       175 t~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--------------------------~  227 (294)
T 4eqm_A          175 TVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ--------------------------D  227 (294)
T ss_dssp             CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--------------------------S
T ss_pred             CccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--------------------------c
Confidence            99999999987654 78899999999999999999999987765443322221                          0


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                      ............+++.+.++|.+||+.||.+||+..+.+.+.|
T Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          228 SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence            1111123344568899999999999999999995555544443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-33  Score=228.41  Aligned_cols=180  Identities=27%  Similarity=0.408  Sum_probs=128.7

Q ss_pred             CCccHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-------------CCEEEe
Q 027927            1 MDTDLYQIIRSNQSLS-------EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-------------CDLKIC   60 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~-------~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-------------~~~~l~   60 (217)
                      ++++|.+++.......       +..+..++.||+.||+|||++||+||||||+||+++.+             +.++|+
T Consensus        91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            4679999998865433       23457899999999999999999999999999999764             479999


Q ss_pred             cccccccCCCCCc-----cccccccccccCcccccC------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 027927           61 DFGLARPTSENEF-----MTEYVVTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMR  128 (217)
Q Consensus        61 d~~~~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~------~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~  128 (217)
                      |||.+........     .....+++.|+|||.+.+      ...++.++|||||||++|++++ |..||.......  .
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~  248 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--S  248 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--H
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--H
Confidence            9999976654321     234578999999999865      2447889999999999999998 899997654322  1


Q ss_pred             HHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .+..  +........                      ......+++++.++|++||+.||++|||+.++++||||...
T Consensus       249 ~i~~--~~~~~~~~~----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          249 NIIR--GIFSLDEMK----------------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             HHHH--TCCCCCCCT----------------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             HHhc--CCCCccccc----------------------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            1111  111000000                      00001244789999999999999999999999999999753

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.4e-33  Score=213.80  Aligned_cols=173  Identities=23%  Similarity=0.352  Sum_probs=130.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC---CCccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE---NEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~~~   77 (217)
                      |++|.+++... ..+++..+..++.||+.||++||++|++|+||||+||+++.++.++|+|||.+.....   .......
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  182 (289)
T 3og7_A          103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL  182 (289)
T ss_dssp             EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccccccc
Confidence            57899999654 6799999999999999999999999999999999999999999999999999865432   2223345


Q ss_pred             cccccccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           78 VVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      .+++.|+|||.+..  ...++.++|+||||+++|++++|..||....................                 
T Consensus       183 ~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------  245 (289)
T 3og7_A          183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-----------------  245 (289)
T ss_dssp             -CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-----------------
T ss_pred             CCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-----------------
Confidence            67899999998852  33467899999999999999999999987666555544444322111                 


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                              ........+++.+.++|.+||+.||.+|||++++++
T Consensus       246 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 --------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             --------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                    112233457899999999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.6e-33  Score=220.03  Aligned_cols=168  Identities=23%  Similarity=0.262  Sum_probs=134.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc---ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~   77 (217)
                      +++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.........   ...
T Consensus       100 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  179 (327)
T 3poz_A          100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG  179 (327)
T ss_dssp             TCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCC
Confidence            67999999874 67999999999999999999999999999999999999999999999999998765443222   223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+.+.. ++.++||||||+++|++++ |..||.+.........+.... ..                   
T Consensus       180 ~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~-------------------  238 (327)
T 3poz_A          180 KVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RL-------------------  238 (327)
T ss_dssp             CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CC-------------------
T ss_pred             CccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-CC-------------------
Confidence            4467899999987554 7899999999999999999 999998765443332222110 00                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                ......+.++.+++.+||+.||.+|||+++++++
T Consensus       239 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                      1123467889999999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.9e-33  Score=219.94  Aligned_cols=173  Identities=17%  Similarity=0.162  Sum_probs=135.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC--CEEEecccccccCCCCC-------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC--DLKICDFGLARPTSENE-------   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~-------   72 (217)
                      |++|.+++...+.+++..+..++.||+.||+|||++|++|+||||+||+++.++  .++|+|||.+.......       
T Consensus       135 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  214 (345)
T 2v62_A          135 GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE  214 (345)
T ss_dssp             EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchh
Confidence            679999999888999999999999999999999999999999999999999887  99999999997653321       


Q ss_pred             -ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHH-HhCCCCCccccccCchH
Q 027927           73 -FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN-DHVHQMRLLIE-LLGTPTDADLGFVRNED  149 (217)
Q Consensus        73 -~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  149 (217)
                       ......+++.|+|||.+.+. .++.++||||||+++|++++|..||... ........... .....            
T Consensus       215 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  281 (345)
T 2v62_A          215 NPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDEL------------  281 (345)
T ss_dssp             CGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTT------------
T ss_pred             ccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccc------------
Confidence             11345678999999998765 4789999999999999999999999642 22222221111 11000            


Q ss_pred             HHHHHHhCCCCCccchhhhCC--CCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          150 AKRYIRQLPQHPRQSLAQVFP--HVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  ........+  .+++++.++|.+||..||++|||++++++
T Consensus       282 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          282 ------------PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             ------------THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ------------cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                        011111122  57899999999999999999999998865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.7e-33  Score=212.71  Aligned_cols=168  Identities=20%  Similarity=0.294  Sum_probs=136.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      |++|.+++... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........  .....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  168 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  168 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence            57999999765 5699999999999999999999999999999999999999999999999999876543321  22334


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+.. ++.++|+||+|+++|++++ |..||...........+......                     
T Consensus       169 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  226 (269)
T 4hcu_A          169 FPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------------------  226 (269)
T ss_dssp             CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------------
T ss_pred             cccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------------------
Confidence            566799999986554 7899999999999999999 99999887766555444321110                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                               ......++.+.+++++||+.||++|||+++++++
T Consensus       227 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          227 ---------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                     0112367889999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.8e-33  Score=219.60  Aligned_cols=168  Identities=21%  Similarity=0.240  Sum_probs=134.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~   77 (217)
                      +++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.......   .....
T Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  177 (325)
T 3kex_A           98 LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA  177 (325)
T ss_dssp             TCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC----
T ss_pred             CCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCC
Confidence            68999999886 689999999999999999999999999999999999999999999999999997654432   22334


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+.... .                    
T Consensus       178 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~--------------------  235 (325)
T 3kex_A          178 KTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-R--------------------  235 (325)
T ss_dssp             -CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-B--------------------
T ss_pred             CCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-C--------------------
Confidence            5667899999986554 7899999999999999999 999998765444333332110 0                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                               ......+++++.++|.+||+.||.+|||+.+++++
T Consensus       236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                     01112356789999999999999999999999764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.8e-33  Score=217.48  Aligned_cols=167  Identities=21%  Similarity=0.277  Sum_probs=134.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~   76 (217)
                      |++|.++++.. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus       134 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  213 (325)
T 3kul_A          134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG  213 (325)
T ss_dssp             TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC-
T ss_pred             CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccC
Confidence            67999999765 6899999999999999999999999999999999999999999999999999976544321    122


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|+|||.+.+.. ++.++||||||+++|++++ |..||...........+......+                  
T Consensus       214 ~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------------  274 (325)
T 3kul_A          214 GKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP------------------  274 (325)
T ss_dssp             --CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC------------------
T ss_pred             CCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC------------------
Confidence            33456799999986544 7889999999999999998 999998877665555443311111                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  ....+++.+.++|.+||..||.+|||++++++
T Consensus       275 ------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          275 ------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                        12357789999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.2e-33  Score=220.49  Aligned_cols=176  Identities=18%  Similarity=0.154  Sum_probs=135.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe--cCCCEEEecccccccCCCCCcc----
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCDLKICDFGLARPTSENEFM----   74 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~----   74 (217)
                      |++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++  .++.++|+|||++.........    
T Consensus       135 g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  214 (364)
T 3op5_A          135 GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA  214 (364)
T ss_dssp             EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSS
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccc
Confidence            78999999886 7899999999999999999999999999999999999999  8899999999999665433211    


Q ss_pred             ----ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchH
Q 027927           75 ----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNED  149 (217)
Q Consensus        75 ----~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (217)
                          ....+++.|+|||.+.+.. ++.++||||||+++|++++|..||.+... ............            ..
T Consensus       215 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~------------~~  281 (364)
T 3op5_A          215 ADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYR------------EN  281 (364)
T ss_dssp             CCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH------------HC
T ss_pred             cCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhh------------hh
Confidence                2344899999999986554 88999999999999999999999985332 222211111000            00


Q ss_pred             HHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          150 AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      .........         ....+++++.+++..||+.||.+|||++++++
T Consensus       282 ~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          282 IASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            001110000         01357899999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.2e-33  Score=213.80  Aligned_cols=167  Identities=23%  Similarity=0.363  Sum_probs=126.5

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--cccc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~   78 (217)
                      +++|.+++...+ .+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.........  ....
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  178 (281)
T 1mp8_A           99 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK  178 (281)
T ss_dssp             TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCC
Confidence            569999998764 7999999999999999999999999999999999999999999999999998765443322  2234


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.... ++.++|+||||+++|++++ |..||.+.........+.....                      
T Consensus       179 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----------------------  235 (281)
T 1mp8_A          179 LPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------------------  235 (281)
T ss_dssp             CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------
T ss_pred             CcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----------------------
Confidence            467899999986544 7889999999999999996 9999987665544443322100                      


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                              ......+++.+.++|.+||+.||++|||+.++++
T Consensus       236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          236 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    0122357899999999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.4e-33  Score=212.68  Aligned_cols=168  Identities=19%  Similarity=0.286  Sum_probs=136.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--cccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~   78 (217)
                      |++|.++++.. ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.........  ....
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  166 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK  166 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCC
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCC
Confidence            57899999876 45999999999999999999999999999999999999999999999999998765544322  2234


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+.. ++.++|+||+|+++|++++ |..||...........+......                     
T Consensus       167 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  224 (268)
T 3sxs_A          167 FPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL---------------------  224 (268)
T ss_dssp             CCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------------------
T ss_pred             cCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------------------
Confidence            456799999986544 7889999999999999998 99999877765554443321100                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                               ......++.+.+++.+||+.||++|||+++++++
T Consensus       225 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 ---------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ---------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                     0112357889999999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.8e-33  Score=219.72  Aligned_cols=168  Identities=25%  Similarity=0.312  Sum_probs=134.3

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      |++|.+++.+.+                .+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~  189 (327)
T 1fvr_A          110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  189 (327)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcC
Confidence            579999998764                7999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      .............+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+....          
T Consensus       190 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~----------  258 (327)
T 1fvr_A          190 RGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----------  258 (327)
T ss_dssp             ESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC----------
T ss_pred             ccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC----------
Confidence            6544333333445577899999886543 7889999999999999998 999998776544433322100          


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                          .......+++++.++|.+||+.||.+|||+++++++
T Consensus       259 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          259 --------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             --------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                001123467899999999999999999999999763

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-33  Score=218.24  Aligned_cols=169  Identities=27%  Similarity=0.367  Sum_probs=135.0

Q ss_pred             CccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEE
Q 027927            2 DTDLYQIIRSNQ-----------------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK   58 (217)
Q Consensus         2 ~~~L~~~l~~~~-----------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~   58 (217)
                      |++|.+++....                       .+++..+..++.||+.||++||++|++|+||||+||+++.++.++
T Consensus       133 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k  212 (344)
T 1rjb_A          133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK  212 (344)
T ss_dssp             TCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEE
T ss_pred             CCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEE
Confidence            579999998753                       389999999999999999999999999999999999999999999


Q ss_pred             EecccccccCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHh
Q 027927           59 ICDFGLARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELL  134 (217)
Q Consensus        59 l~d~~~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~  134 (217)
                      |+|||.+........   .....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+..............
T Consensus       213 L~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  291 (344)
T 1rjb_A          213 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG  291 (344)
T ss_dssp             ECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT
T ss_pred             eCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcC
Confidence            999999865433321   23345577899999886544 7899999999999999998 999998765443333333211


Q ss_pred             CCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          135 GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                      ..+                             .....+++++.++|.+||+.||.+|||+++++++
T Consensus       292 ~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          292 FKM-----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             CCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC-----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            000                             1122467899999999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-32  Score=214.30  Aligned_cols=169  Identities=31%  Similarity=0.427  Sum_probs=136.1

Q ss_pred             CccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccc
Q 027927            2 DTDLYQIIRSNQ------------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG   63 (217)
Q Consensus         2 ~~~L~~~l~~~~------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~   63 (217)
                      |++|.+++....                  ++++..+..++.||+.||++||++|++|+||||+||+++.++.++|+|||
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  190 (313)
T 1t46_A          111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG  190 (313)
T ss_dssp             TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCG
T ss_pred             CCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccc
Confidence            569999998764                  49999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCC
Q 027927           64 LARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTD  139 (217)
Q Consensus        64 ~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~  139 (217)
                      .+........   .....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||...................  
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--  267 (313)
T 1t46_A          191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM--  267 (313)
T ss_dssp             GGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC--
T ss_pred             ccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC--
Confidence            9876554332   22344567899999886554 7899999999999999998 999998765444333333221111  


Q ss_pred             ccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                                 .....+++++.++|.+||+.||.+|||+++++++
T Consensus       268 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          268 ---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence                                       0122467899999999999999999999999863

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.9e-33  Score=213.20  Aligned_cols=168  Identities=17%  Similarity=0.287  Sum_probs=137.4

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      |++|.+++.+ ...+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........  .....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  182 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  182 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTT
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCc
Confidence            6799999987 47799999999999999999999999999999999999999999999999999876543321  12234


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+.. ++.++|+||+|+++|++++ |..||...........+.......                    
T Consensus       183 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------------  241 (283)
T 3gen_A          183 FPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------------  241 (283)
T ss_dssp             SCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------------------
T ss_pred             cCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC--------------------
Confidence            467799999987554 7899999999999999998 999998877655554443311111                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                .....++.+.++|.+||+.||.+|||+++++++
T Consensus       242 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          242 ----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                      112356889999999999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-32  Score=218.00  Aligned_cols=176  Identities=10%  Similarity=0.128  Sum_probs=136.8

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC--CEEEecccccccCCCCC----
Q 027927            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC--DLKICDFGLARPTSENE----   72 (217)
Q Consensus         1 l~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~----   72 (217)
                      +|++|.+++...  ..+++..+..++.||+.||+|||++|++|+||||+||+++.++  .++|+|||.+.......    
T Consensus       140 ~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  219 (352)
T 2jii_A          140 LGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA  219 (352)
T ss_dssp             CCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCC
T ss_pred             CCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccc
Confidence            478999999987  7899999999999999999999999999999999999999998  89999999987654322    


Q ss_pred             ----ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHH-HhCCCCCccccccC
Q 027927           73 ----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIE-LLGTPTDADLGFVR  146 (217)
Q Consensus        73 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~  146 (217)
                          ......+++.|+|||.+.+. .++.++|+||||+++|++++|..||.... .......... ....+....     
T Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----  293 (352)
T 2jii_A          220 YVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFV-----  293 (352)
T ss_dssp             CCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEE-----
T ss_pred             ccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhh-----
Confidence                11334778899999988654 47899999999999999999999997653 2222222221 111111000     


Q ss_pred             chHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                       ........+++++.++|++||+.||++|||++++++
T Consensus       294 -----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          294 -----------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             -----------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -----------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence                             000112246899999999999999999999999965

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.8e-33  Score=212.19  Aligned_cols=168  Identities=21%  Similarity=0.296  Sum_probs=133.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      |++|.+++..+ ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........  .....
T Consensus        96 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  175 (281)
T 3cc6_A           96 YGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR  175 (281)
T ss_dssp             TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCC
T ss_pred             CCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCC
Confidence            57999999775 5699999999999999999999999999999999999999999999999999876544322  22334


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+......                     
T Consensus       176 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---------------------  233 (281)
T 3cc6_A          176 LPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---------------------  233 (281)
T ss_dssp             CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---------------------
T ss_pred             CCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---------------------
Confidence            567899999886444 7899999999999999998 99999766554444333221100                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                               .....+++.+.++|.+||+.||++|||+++++++
T Consensus       234 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 ---------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                     0122467899999999999999999999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-33  Score=216.93  Aligned_cols=167  Identities=23%  Similarity=0.275  Sum_probs=129.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc---ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~   77 (217)
                      +++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.........   ...
T Consensus       100 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~  179 (327)
T 3lzb_A          100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG  179 (327)
T ss_dssp             SCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCC
Confidence            67999999875 67999999999999999999999999999999999999999999999999999765433222   223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+......                    
T Consensus       180 ~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  238 (327)
T 3lzb_A          180 KVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------------------  238 (327)
T ss_dssp             CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------------------
T ss_pred             CccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            4466899999987554 7899999999999999999 99999876654443332221000                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                .....+++++.++|++||+.||.+|||++++++
T Consensus       239 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          239 ----------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                      112346788999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.9e-33  Score=234.75  Aligned_cols=197  Identities=25%  Similarity=0.304  Sum_probs=141.1

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC---EEEecccccccCCCCCccc
Q 027927            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEFMT   75 (217)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~   75 (217)
                      |++|.+++....   .+++..+..++.|++.||+|||+.|++||||+|+||+++.++.   ++|+|||.+..........
T Consensus       102 ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~  181 (676)
T 3qa8_A          102 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT  181 (676)
T ss_dssp             SCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCC
T ss_pred             CCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccc
Confidence            689999998854   6999999999999999999999999999999999999997765   8999999998776665556


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...+++.|+|||.+.+. .++.++|+||+|+++|++++|..||........+.....................     . 
T Consensus       182 ~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~-----~-  254 (676)
T 3qa8_A          182 EFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA-----V-  254 (676)
T ss_dssp             CCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSS-----C-
T ss_pred             cccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccc-----c-
Confidence            67889999999998654 4889999999999999999999999775433221110000000000000000000     0 


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .. .............+++.+.++|++||..||++|||+.++++||||++.
T Consensus       255 ~~-~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          255 KF-SSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CC-CSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             cc-ccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence            00 000000111223356889999999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-32  Score=212.24  Aligned_cols=167  Identities=23%  Similarity=0.292  Sum_probs=136.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----ccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~   77 (217)
                      +++|.+++..++.+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.........    ...
T Consensus       101 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  180 (291)
T 1xbb_A          101 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  180 (291)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccC
Confidence            5799999999999999999999999999999999999999999999999999999999999998765443321    122


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+... ..                    
T Consensus       181 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~--------------------  238 (291)
T 1xbb_A          181 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ER--------------------  238 (291)
T ss_dssp             CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CC--------------------
T ss_pred             CCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CC--------------------
Confidence            3457799999986544 7889999999999999999 99999887655444333220 00                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......+++.+.++|++||+.||.+|||+.++++
T Consensus       239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                     0122357899999999999999999999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.3e-33  Score=215.57  Aligned_cols=168  Identities=24%  Similarity=0.337  Sum_probs=135.5

Q ss_pred             CccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCE
Q 027927            2 DTDLYQIIRSNQS------------------------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL   57 (217)
Q Consensus         2 ~~~L~~~l~~~~~------------------------l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~   57 (217)
                      |++|.+++.....                        +++..+..++.||+.||+|||++|++|+||||+||+++.++.+
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~  189 (314)
T 2ivs_A          110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM  189 (314)
T ss_dssp             TCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEE
T ss_pred             CCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCE
Confidence            5799999987643                        8999999999999999999999999999999999999999999


Q ss_pred             EEecccccccCCCCCcc---ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHH
Q 027927           58 KICDFGLARPTSENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIEL  133 (217)
Q Consensus        58 ~l~d~~~~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~  133 (217)
                      +|+|||.+.........   ....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+...
T Consensus       190 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  268 (314)
T 2ivs_A          190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG  268 (314)
T ss_dssp             EECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             EEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC
Confidence            99999998765443221   2334567899999986543 7899999999999999999 99999876654433322210


Q ss_pred             hCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                      .                              .......+++++.++|.+||+.||++|||+.+++++
T Consensus       269 ~------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          269 H------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             C------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C------------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0                              001223578999999999999999999999999863

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-32  Score=215.81  Aligned_cols=171  Identities=18%  Similarity=0.262  Sum_probs=134.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC-----EEEecccccccCCCCCc-
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-----LKICDFGLARPTSENEF-   73 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~-   73 (217)
                      +|++|.+++... +.+++..+..++.||+.||+|||++|++||||||+||+++.++.     ++|+|||.+........ 
T Consensus        87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~  166 (330)
T 2izr_A           87 LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK  166 (330)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence            478999999874 78999999999999999999999999999999999999998887     99999999976543322 


Q ss_pred             -------cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCCCcccc
Q 027927           74 -------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV---HQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        74 -------~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~  143 (217)
                             .....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||.+....   ..+..+.......      
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~------  239 (330)
T 2izr_A          167 KHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT------  239 (330)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS------
T ss_pred             ccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC------
Confidence                   23567899999999986544 789999999999999999999999874322   2222222110000      


Q ss_pred             ccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                          .........+ ++.+++.+||+.||.+||+++++++
T Consensus       240 --------------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 --------------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             --------------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             --------------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                                0111122233 8999999999999999999998865

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.6e-33  Score=215.70  Aligned_cols=169  Identities=26%  Similarity=0.402  Sum_probs=132.6

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc------
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM------   74 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~------   74 (217)
                      |++|.++++. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.........      
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  170 (310)
T 3s95_A           91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS  170 (310)
T ss_dssp             TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----------
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccc
Confidence            6799999988 578999999999999999999999999999999999999999999999999998765433221      


Q ss_pred             ---------ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           75 ---------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        75 ---------~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                               ....+++.|+|||.+.+. .++.++||||||+++|++++|..|+......              ....   
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~--------------~~~~---  232 (310)
T 3s95_A          171 LKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPR--------------TMDF---  232 (310)
T ss_dssp             ---------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB--------------CTTS---
T ss_pred             ccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhh--------------HHHH---
Confidence                     145688999999998654 4789999999999999999999988653210              0000   


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                       .........          ......+++.+.+++.+||+.||++|||++++++
T Consensus       233 -~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          233 -GLNVRGFLD----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             -SBCHHHHHH----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -hhhhhcccc----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             000111111          1123467899999999999999999999999976

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.4e-33  Score=221.02  Aligned_cols=172  Identities=19%  Similarity=0.267  Sum_probs=138.0

Q ss_pred             CccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC---CEEEecccccccCCC-
Q 027927            2 DTDLYQIIRSN-------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSE-   70 (217)
Q Consensus         2 ~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~-   70 (217)
                      |++|.++++..       ..++...+..++.||+.||+|||++||+||||||+||+++.++   .++|+|||.+..... 
T Consensus       158 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~  237 (367)
T 3l9p_A          158 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA  237 (367)
T ss_dssp             TEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHH
T ss_pred             CCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccc
Confidence            67999999875       3599999999999999999999999999999999999999555   599999999864321 


Q ss_pred             --CCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           71 --NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        71 --~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                        ........+++.|+|||.+.+.. ++.++|||||||++|++++ |..||...........+......           
T Consensus       238 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~-----------  305 (367)
T 3l9p_A          238 GYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-----------  305 (367)
T ss_dssp             SSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-----------
T ss_pred             cccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence              12223445688899999986554 8899999999999999998 99999887766555444331110           


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                                         .....+++.+.++|.+||+.||.+|||+++++++.++-
T Consensus       306 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          306 -------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                               11234678899999999999999999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9e-33  Score=217.95  Aligned_cols=167  Identities=22%  Similarity=0.285  Sum_probs=135.3

Q ss_pred             CccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCE
Q 027927            2 DTDLYQIIRSN------------------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL   57 (217)
Q Consensus         2 ~~~L~~~l~~~------------------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~   57 (217)
                      |++|.++++..                        ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+
T Consensus       134 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~  213 (343)
T 1luf_A          134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV  213 (343)
T ss_dssp             TCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeE
Confidence            56999999874                        579999999999999999999999999999999999999999999


Q ss_pred             EEecccccccCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHH
Q 027927           58 KICDFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIEL  133 (217)
Q Consensus        58 ~l~d~~~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~  133 (217)
                      +|+|||.+.......   ......+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+...
T Consensus       214 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  292 (343)
T 1luf_A          214 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG  292 (343)
T ss_dssp             EECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             EEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC
Confidence            999999986543322   123345678899999886554 7899999999999999998 99999877655544433321


Q ss_pred             hCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                        ..                            ......+++++.++|++||+.||.+|||+.++++
T Consensus       293 --~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          293 --NI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             --CC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --Cc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence              00                            0112357789999999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.4e-32  Score=214.46  Aligned_cols=169  Identities=26%  Similarity=0.382  Sum_probs=135.7

Q ss_pred             CccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQS----------------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~~----------------l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      |++|.+++.....                +++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+
T Consensus       116 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  195 (316)
T 2xir_A          116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA  195 (316)
T ss_dssp             TEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred             CCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccc
Confidence            5799999988654                899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      ........   .....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.................    
T Consensus       196 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----  270 (316)
T 2xir_A          196 RDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----  270 (316)
T ss_dssp             SCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC----
T ss_pred             cccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC----
Confidence            76543322   23345677899999986554 7899999999999999998 999997755333332222211111    


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                               .....+++++.++|.+||+.||.+|||+.++++|
T Consensus       271 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          271 -------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     1122467899999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-32  Score=212.36  Aligned_cols=178  Identities=24%  Similarity=0.330  Sum_probs=129.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH--------SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh--------~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (217)
                      +++|.++++. ..+++..+..++.||+.||+|||        +.+++|+||||+||+++.++.++|+|||.+........
T Consensus        90 ~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  168 (301)
T 3q4u_A           90 MGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN  168 (301)
T ss_dssp             TCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccc
Confidence            5799999965 57999999999999999999999        99999999999999999999999999999865433322


Q ss_pred             -----cccccccccccCcccccCCCC-----CCchhhHHHHHHHHHHHHcC----------CCCCCCCChHHHHHHHHHH
Q 027927           74 -----MTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNR----------RPLFPGNDHVHQMRLLIEL  133 (217)
Q Consensus        74 -----~~~~~~~~~~~~Pe~~~~~~~-----~~~~~Diwslg~~l~~l~~~----------~~pf~~~~~~~~~~~~~~~  133 (217)
                           .....+++.|+|||.+.+...     ++.++||||||+++|++++|          ..||.......        
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~--------  240 (301)
T 3q4u_A          169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND--------  240 (301)
T ss_dssp             EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS--------
T ss_pred             cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC--------
Confidence                 123468899999999865532     33689999999999999999          77775432100        


Q ss_pred             hCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 ................+..+........++++.++|.+||+.||++|||++++++
T Consensus       241 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          241 -----------PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             -----------CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----------cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                       0001111111111111111111122234578999999999999999999999975

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-32  Score=213.94  Aligned_cols=168  Identities=20%  Similarity=0.297  Sum_probs=130.1

Q ss_pred             CccHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--
Q 027927            2 DTDLYQIIR------SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--   73 (217)
Q Consensus         2 ~~~L~~~l~------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--   73 (217)
                      +++|.+++.      ....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+........  
T Consensus       125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  204 (313)
T 3brb_A          125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR  204 (313)
T ss_dssp             TCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------
T ss_pred             CCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccC
Confidence            579999994      346799999999999999999999999999999999999999999999999999876543321  


Q ss_pred             -cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           74 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        74 -~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                       .....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+.....                
T Consensus       205 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------  267 (313)
T 3brb_A          205 QGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR----------------  267 (313)
T ss_dssp             ------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------
T ss_pred             cccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC----------------
Confidence             12334567899999986544 7899999999999999999 8899987665444433322100                


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                    ......+++++.++|.+||..||.+|||+++++++
T Consensus       268 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 --------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             --------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                          01123577899999999999999999999999763

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3e-33  Score=219.19  Aligned_cols=189  Identities=23%  Similarity=0.281  Sum_probs=132.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc----------CcEecCcCCCCEEEecCCCEEEecccccccCCCC
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA----------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~----------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~   71 (217)
                      +++|.+++++ ..+++..+..++.|++.||+|||+.          |++|+||||+||+++.++.++|+|||.+......
T Consensus       106 ~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~  184 (322)
T 3soc_A          106 KGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG  184 (322)
T ss_dssp             TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTT
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccc
Confidence            5799999987 4599999999999999999999999          9999999999999999999999999999765433


Q ss_pred             Cc---cccccccccccCcccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           72 EF---MTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        72 ~~---~~~~~~~~~~~~Pe~~~~~~----~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      ..   .....+++.|+|||.+.+..    .++.++||||||+++|++++|..||.+..+.............+       
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-------  257 (322)
T 3soc_A          185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP-------  257 (322)
T ss_dssp             SCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC-------
T ss_pred             cCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC-------
Confidence            22   23356799999999986532    24557899999999999999999997643211100000000000       


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                       ...............+...........++++.++|++||+.||++|||++++++
T Consensus       258 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          258 -SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             -CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             011111111111111111100011112356999999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.98  E-value=1.4e-32  Score=212.06  Aligned_cols=164  Identities=17%  Similarity=0.222  Sum_probs=130.3

Q ss_pred             CccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCC--------EEEecccccccCCCCC
Q 027927            2 DTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--------LKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~-l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--------~~l~d~~~~~~~~~~~   72 (217)
                      |++|.+++.+.+. +++..+..++.||+.||+|||++|++|+||||+||+++.++.        ++|+|||.+...... 
T Consensus        96 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-  174 (289)
T 4fvq_A           96 FGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-  174 (289)
T ss_dssp             TCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-
Confidence            5799999988754 999999999999999999999999999999999999998887        999999988654332 


Q ss_pred             ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP-LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        73 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                        ....+++.|+|||.+.+...++.++|+||||+++|++++|.. |+......... ......                 
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~-----------------  234 (289)
T 4fvq_A          175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDR-----------------  234 (289)
T ss_dssp             --HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTT-----------------
T ss_pred             --cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhcc-----------------
Confidence              234567889999999764568899999999999999999654 44443322222 221100                 


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                    .......++++.++|++||+.||++|||+++++++
T Consensus       235 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 --------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             --------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                          01122356889999999999999999999999873

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=2.4e-32  Score=210.64  Aligned_cols=168  Identities=20%  Similarity=0.269  Sum_probs=136.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   76 (217)
                      |++|.+++.+. ..+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.........    ..
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  172 (287)
T 1u59_A           93 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  172 (287)
T ss_dssp             TEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred             CCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccc
Confidence            56999999765 66999999999999999999999999999999999999999999999999998766433221    22


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+...  .                   
T Consensus       173 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~--~-------------------  230 (287)
T 1u59_A          173 GKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--K-------------------  230 (287)
T ss_dssp             SCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--C-------------------
T ss_pred             ccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC--C-------------------
Confidence            34467899999986443 7889999999999999998 99999877655544433221  0                   


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                               ....+..+++++.++|.+||+.||++|||+.+++++
T Consensus       231 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          231 ---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                     011233578999999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.98  E-value=2.6e-32  Score=208.67  Aligned_cols=167  Identities=26%  Similarity=0.340  Sum_probs=128.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC---cEecCcCCCCEEEec--------CCCEEEecccccccCCC
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNA--------NCDLKICDFGLARPTSE   70 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~---i~H~di~~~nil~~~--------~~~~~l~d~~~~~~~~~   70 (217)
                      |++|.+++.+ +.+++..+..++.|++.||++||++|   ++|+||+|+||+++.        ++.++|+|||.+.....
T Consensus        90 ~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  168 (271)
T 3dtc_A           90 GGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR  168 (271)
T ss_dssp             TEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------
T ss_pred             CCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccc
Confidence            5788888864 68999999999999999999999999   899999999999986        77899999999876544


Q ss_pred             CCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHH
Q 027927           71 NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (217)
Q Consensus        71 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (217)
                      ... ....+++.|+|||.+.+.. ++.++|+||+|++++++++|..||.+................              
T Consensus       169 ~~~-~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------  232 (271)
T 3dtc_A          169 TTK-MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--------------  232 (271)
T ss_dssp             --------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--------------
T ss_pred             ccc-cCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--------------
Confidence            332 3456789999999986554 789999999999999999999999877654443333221000              


Q ss_pred             HHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                     ......+++.+.++|.+||+.||.+|||+++++++
T Consensus       233 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          233 ---------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                           01223577899999999999999999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.98  E-value=4e-32  Score=213.79  Aligned_cols=168  Identities=28%  Similarity=0.402  Sum_probs=136.5

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      |++|.+++....                .++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  204 (334)
T 2pvf_A          125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA  204 (334)
T ss_dssp             TCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcccccc
Confidence            579999998764                3899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      ........   .....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+.....      
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------  277 (334)
T 2pvf_A          205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR------  277 (334)
T ss_dssp             EECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC------
T ss_pred             ccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC------
Confidence            76554332   12234567899999886544 7889999999999999999 9999987765554443332110      


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                              ......+++++.++|++||+.||.+|||+++++++
T Consensus       278 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          278 ------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    01123577899999999999999999999999763

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.98  E-value=4.1e-32  Score=209.30  Aligned_cols=167  Identities=23%  Similarity=0.350  Sum_probs=135.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~   77 (217)
                      |++|.+++...  ..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+........  ....
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  172 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  172 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCC
Confidence            57999999874  4599999999999999999999999999999999999999999999999999876654332  2234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+.....                     
T Consensus       173 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------------------  230 (288)
T 3kfa_A          173 KFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------------------  230 (288)
T ss_dssp             EECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------------
T ss_pred             ccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---------------------
Confidence            4567899999986554 7899999999999999999 9999987664443333322100                     


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......+++.+.+++++||+.||.+|||++++++
T Consensus       231 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 ---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                     0112357799999999999999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.98  E-value=3.7e-32  Score=207.34  Aligned_cols=167  Identities=20%  Similarity=0.299  Sum_probs=135.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      |++|.+++.+. ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........  .....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  166 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  166 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence            57999999876 5699999999999999999999999999999999999999999999999999876543221  12334


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      ++..|+|||.+.+.. ++.++|+||+|+++|++++ |..||...........+......                     
T Consensus       167 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~---------------------  224 (267)
T 3t9t_A          167 FPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------------------  224 (267)
T ss_dssp             CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------------
T ss_pred             ccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---------------------
Confidence            567899999986544 7899999999999999999 89999887665554443321000                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......++.+.+++++||+.||++|||++++++
T Consensus       225 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          225 ---------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                     011236788999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.98  E-value=3.6e-32  Score=222.08  Aligned_cols=165  Identities=22%  Similarity=0.337  Sum_probs=132.7

Q ss_pred             CccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++++.+.  ++...+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++.......  ....+
T Consensus       271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~  348 (450)
T 1k9a_A          271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKL  348 (450)
T ss_dssp             TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CC
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--cCCCC
Confidence            5799999987643  7999999999999999999999999999999999999999999999999987544322  22355


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|+|||.+.+.. ++.++|+||||+++|++++ |..||......+....+....                        
T Consensus       349 ~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------------------  403 (450)
T 1k9a_A          349 PVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------------------  403 (450)
T ss_dssp             CTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC------------------------
T ss_pred             CcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence            77899999986554 8899999999999999998 999998765444433332100                        


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      .      ...+..+++++.++|++||+.||++|||+.++++
T Consensus       404 ~------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 K------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            0      0122357899999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.98  E-value=1.9e-32  Score=219.02  Aligned_cols=167  Identities=22%  Similarity=0.360  Sum_probs=133.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccc---cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT---EY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~   77 (217)
                      |++|.+++++. ..++...+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++..........   ..
T Consensus       196 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~  275 (377)
T 3cbl_A          196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR  275 (377)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCC
Confidence            57999999875 469999999999999999999999999999999999999999999999999987654332211   12


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+.... ++.++|+||||+++|++++ |..||.+.........+.. ....                   
T Consensus       276 ~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~-------------------  334 (377)
T 3cbl_A          276 QVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGRL-------------------  334 (377)
T ss_dssp             EEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT-TCCC-------------------
T ss_pred             CCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC-------------------
Confidence            3466799999986543 7889999999999999998 9999987765444333221 1000                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ..+..+++++.++|.+||+.||++|||++++++
T Consensus       335 ----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          335 ----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                      012346789999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.98  E-value=2e-32  Score=210.47  Aligned_cols=167  Identities=25%  Similarity=0.325  Sum_probs=136.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +++|.+++...  ..+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus       104 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  183 (284)
T 2a19_B          104 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG  183 (284)
T ss_dssp             SCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCS
T ss_pred             CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCC
Confidence            46999999764  6799999999999999999999999999999999999999999999999999887666555555678


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+.. ++.++|+||||+++|++++|..|+....  .....+.                        .   
T Consensus       184 ~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~------------------------~---  233 (284)
T 2a19_B          184 TLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR------------------------D---  233 (284)
T ss_dssp             CCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH------------------------T---
T ss_pred             cccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh------------------------c---
Confidence            99999999986554 7899999999999999999988773211  0000000                        0   


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                            ......+++.+.++|++||+.||.+|||+.+++++.+.-
T Consensus       234 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          234 ------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             ------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  011234678899999999999999999999999986554

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.98  E-value=1.5e-31  Score=206.17  Aligned_cols=168  Identities=20%  Similarity=0.320  Sum_probs=132.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEecCCC-----EEEecccccccCCCCCc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCD-----LKICDFGLARPTSENEF   73 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~   73 (217)
                      +++|.+++.+. ..+++..+..++.|++.||+|||++|  ++|+||||+||+++.++.     ++|+|||.+.....  .
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~  182 (287)
T 4f0f_A          105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--S  182 (287)
T ss_dssp             TCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--C
T ss_pred             CCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--c
Confidence            57898888765 57999999999999999999999999  999999999999988776     99999999875443  2


Q ss_pred             cccccccccccCcccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHHhCCCCCccccccCchHHH
Q 027927           74 MTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM-RLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~-~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                      .....+++.|+|||.+.. ...++.++|+||||+++|++++|..||......... .......+..              
T Consensus       183 ~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  248 (287)
T 4f0f_A          183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR--------------  248 (287)
T ss_dssp             EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC--------------
T ss_pred             ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC--------------
Confidence            344678899999998843 233578999999999999999999999765432221 1111111100              


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                    ......+++++.++|.+||+.||.+|||++++++
T Consensus       249 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 --------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                          1122357899999999999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=7.7e-32  Score=208.64  Aligned_cols=167  Identities=26%  Similarity=0.355  Sum_probs=131.6

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-----ccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-----FMT   75 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~   75 (217)
                      +++|.++++. ...+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.......     ...
T Consensus       107 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  186 (298)
T 3pls_A          107 HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR  186 (298)
T ss_dssp             TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSS
T ss_pred             CCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCc
Confidence            6899999988 4679999999999999999999999999999999999999999999999999986543322     223


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ...+++.|.|||.+.+. .++.++|+||||+++|++++|..| |...........+......                  
T Consensus       187 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------------  247 (298)
T 3pls_A          187 HARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL------------------  247 (298)
T ss_dssp             CTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC------------------
T ss_pred             CCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC------------------
Confidence            34567889999998654 478999999999999999995554 5444433333222211000                  


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  .....+++.+.+++++||+.||.+|||++++++
T Consensus       248 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 ------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                        112246789999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.98  E-value=3.1e-32  Score=222.70  Aligned_cols=173  Identities=28%  Similarity=0.405  Sum_probs=139.6

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      +++|.++++..  ..++...+..++.||+.||+|||+++++||||||+||+++.++.++|+|||++.........  ...
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~  345 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  345 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCC
Confidence            57999999865  47899999999999999999999999999999999999999999999999999765433211  223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+.... ++.++||||||+++|++++ |..||.+....+....+......+                   
T Consensus       346 ~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------------------  405 (454)
T 1qcf_A          346 KFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------------------  405 (454)
T ss_dssp             SSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------------------
T ss_pred             cccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence            3466799999986544 8899999999999999999 999998877666655544311111                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc--CCCCcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP--YKPFQC  205 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~--~~~f~~  205 (217)
                                 .+..+++++.++|.+||..||++|||++++++  ..++..
T Consensus       406 -----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          406 -----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                       12246789999999999999999999999976  444443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.98  E-value=8.2e-32  Score=205.64  Aligned_cols=165  Identities=18%  Similarity=0.319  Sum_probs=134.2

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEecCCCEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      |++|.+++.+..  .+++..+..++.||+.||+|||++|  ++|+||+|+||+++.++.++++||++......    ...
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----~~~  168 (271)
T 3kmu_A           93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGR  168 (271)
T ss_dssp             TCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----TTC
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc----cCc
Confidence            579999999875  5999999999999999999999999  99999999999999999999998887644322    234


Q ss_pred             cccccccCcccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           78 VVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~--~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      .+++.|+|||.+.+...  .+.++|+||||+++|++++|..||...........+......+                  
T Consensus       169 ~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------  230 (271)
T 3kmu_A          169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP------------------  230 (271)
T ss_dssp             BSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC------------------
T ss_pred             cCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC------------------
Confidence            67889999999875432  2337999999999999999999998877655544443311111                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 ..+..+++++.++|.+||+.||++|||++++++
T Consensus       231 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 -----------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       122357899999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.98  E-value=4.5e-32  Score=222.69  Aligned_cols=172  Identities=17%  Similarity=0.229  Sum_probs=137.1

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE---ecCCCEEEecccccccCCCCCc---
Q 027927            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEF---   73 (217)
Q Consensus         1 l~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~---   73 (217)
                      +|++|.+++.. .+.+++..+..++.||+.||+|||++||+|+||||+||++   +.++.++|+|||++........   
T Consensus        85 ~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (483)
T 3sv0_A           85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH  164 (483)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence            47899999986 5789999999999999999999999999999999999999   6889999999999976544322   


Q ss_pred             -----cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCCcccccc
Q 027927           74 -----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        74 -----~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                           .....+++.|++||.+.+.. ++.++|||||||++|++++|..||.+...   ...+..+.....          
T Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----------  233 (483)
T 3sv0_A          165 IPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----------  233 (483)
T ss_dssp             CCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----------
T ss_pred             cccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----------
Confidence                 12457889999999986554 78999999999999999999999977543   222222221100          


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                      ..........+++++.++|.+||+.||.+||++++|++
T Consensus       234 ----------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          234 ----------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             ----------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ----------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                            01122233467899999999999999999999998854

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.98  E-value=3.2e-32  Score=210.73  Aligned_cols=183  Identities=17%  Similarity=0.250  Sum_probs=131.6

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----ccc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~   76 (217)
                      |++|.+++...+ .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus        97 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  176 (295)
T 3ugc_A           97 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP  176 (295)
T ss_dssp             TCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------C
T ss_pred             CCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccC
Confidence            679999998864 599999999999999999999999999999999999999999999999999876543321    223


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..++..|+|||.+.+.. ++.++||||||+++|++++|..|+......     .....+......   ............
T Consensus       177 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~  247 (295)
T 3ugc_A          177 GESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQ---MIVFHLIELLKN  247 (295)
T ss_dssp             TTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTH---HHHHHHHHHHHT
T ss_pred             CCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccc---hhHHHHHHHHhc
Confidence            34566799999986554 789999999999999999999998653211     111111111100   000011111111


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ....      ..+..+++++.++|++||+.||++|||++++++
T Consensus       248 ~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          248 NGRL------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TCCC------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCcC------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1111      123467899999999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=1.2e-31  Score=211.03  Aligned_cols=167  Identities=23%  Similarity=0.325  Sum_probs=130.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~   76 (217)
                      |++|.+++... ..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+........    ...
T Consensus       130 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  209 (333)
T 1mqb_A          130 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG  209 (333)
T ss_dssp             TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCC
Confidence            56999999875 6799999999999999999999999999999999999999999999999999876543321    112


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..++..|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+......+                  
T Consensus       210 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~------------------  270 (333)
T 1mqb_A          210 GKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------------------  270 (333)
T ss_dssp             -CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------------
T ss_pred             CCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC------------------
Confidence            23466799999986554 7899999999999999998 999998776655444433210000                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  ....+++.+.++|.+||+.||++|||++++++
T Consensus       271 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          271 ------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             ------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        12246788999999999999999999999876

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=8.3e-32  Score=211.86  Aligned_cols=179  Identities=23%  Similarity=0.268  Sum_probs=127.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEecCcCCCCEEEecCCCEEEecccccccCCCCCc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~--------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (217)
                      |++|.+++++. .+++..+..++.|++.||+|||++        |++|+||||+||+++.++.++|+|||.+........
T Consensus       119 ~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  197 (337)
T 3mdy_A          119 NGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN  197 (337)
T ss_dssp             TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccc
Confidence            57999999774 799999999999999999999998        999999999999999999999999999866544322


Q ss_pred             c-----ccccccccccCcccccCCCCCCc-----hhhHHHHHHHHHHHHcC----------CCCCCCCChHHHHHHHHHH
Q 027927           74 M-----TEYVVTRWYRAPELLLNSSDYTA-----AIDVWSVGCIFMELMNR----------RPLFPGNDHVHQMRLLIEL  133 (217)
Q Consensus        74 ~-----~~~~~~~~~~~Pe~~~~~~~~~~-----~~Diwslg~~l~~l~~~----------~~pf~~~~~~~~~~~~~~~  133 (217)
                      .     ....+++.|+|||.+.+......     ++|||||||++|++++|          ..||......         
T Consensus       198 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~---------  268 (337)
T 3mdy_A          198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS---------  268 (337)
T ss_dssp             -----CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS---------
T ss_pred             cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC---------
Confidence            1     23468899999999865542222     49999999999999999          5555432110         


Q ss_pred             hCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                .................+..+.......+++++.++|.+||+.||++|||+++++++
T Consensus       269 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          269 ----------DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             ----------SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----------CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                      000011111111111111111111112355779999999999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.98  E-value=2.1e-32  Score=215.13  Aligned_cols=167  Identities=26%  Similarity=0.392  Sum_probs=116.9

Q ss_pred             CCccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-
Q 027927            1 MDTDLYQIIRS---NQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-   74 (217)
Q Consensus         1 l~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-   74 (217)
                      ++++|.+++..   .+++++..+..++.||+.||+|||++|  ++|+||||+||+++.++.++|+|||.+......... 
T Consensus       116 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  195 (337)
T 3ll6_A          116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS  195 (337)
T ss_dssp             CSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC---
T ss_pred             cCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCccc
Confidence            46789998865   577999999999999999999999999  999999999999999999999999998765443221 


Q ss_pred             ------------ccccccccccCccccc--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCc
Q 027927           75 ------------TEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA  140 (217)
Q Consensus        75 ------------~~~~~~~~~~~Pe~~~--~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~  140 (217)
                                  ....+++.|+|||.+.  ....++.++||||||+++|++++|..||...........           
T Consensus       196 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-----------  264 (337)
T 3ll6_A          196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG-----------  264 (337)
T ss_dssp             ----------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred             ccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC-----------
Confidence                        1345788899999883  233468899999999999999999999965432111100           


Q ss_pred             cccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          141 DLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                      ...      .......++.+.++|++||+.||.+|||+++++++
T Consensus       265 ----------------~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          265 ----------------KYS------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             -----------------CC------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----------------ccc------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            000      00112456789999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.98  E-value=5e-32  Score=212.01  Aligned_cols=168  Identities=21%  Similarity=0.338  Sum_probs=135.6

Q ss_pred             CccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC
Q 027927            2 DTDLYQIIRSN----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (217)
Q Consensus         2 ~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~   71 (217)
                      |++|.++++..          ..++...+..++.||+.||++||++|++|+||||+||+++.++.++|+|||.+......
T Consensus       112 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~  191 (322)
T 1p4o_A          112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  191 (322)
T ss_dssp             TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred             CCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccc
Confidence            57999999763          45799999999999999999999999999999999999999999999999998654433


Q ss_pred             Cc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           72 EF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        72 ~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      ..   .....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+.....            
T Consensus       192 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------  258 (322)
T 1p4o_A          192 DYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL------------  258 (322)
T ss_dssp             GCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred             cccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc------------
Confidence            21   12334577899999986544 7899999999999999999 8999987765554444332100            


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                        ......+++.+.++|.+||+.||.+|||+.+++++
T Consensus       259 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          259 ------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                              01123577899999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.98  E-value=4.7e-32  Score=213.17  Aligned_cols=168  Identities=25%  Similarity=0.333  Sum_probs=133.6

Q ss_pred             CccHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc
Q 027927            2 DTDLYQIIRS--------------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (217)
Q Consensus         2 ~~~L~~~l~~--------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   67 (217)
                      +++|.+++..              +..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus       134 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  213 (333)
T 2i1m_A          134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD  213 (333)
T ss_dssp             TEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCC
T ss_pred             CCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccc
Confidence            5689999875              34689999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcccc
Q 027927           68 TSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        68 ~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  143 (217)
                      ......   .....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.........+.......      
T Consensus       214 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------  286 (333)
T 2i1m_A          214 IMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM------  286 (333)
T ss_dssp             GGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC------
T ss_pred             cccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC------
Confidence            433221   22345567899999886554 7899999999999999998 899998765444433333321111      


Q ss_pred             ccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                             ......++.+.++|.+||+.||.+|||+.++++
T Consensus       287 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          287 -----------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                                   012235788999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=2e-32  Score=212.40  Aligned_cols=161  Identities=25%  Similarity=0.402  Sum_probs=123.4

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---CCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      |++|.+++....  .+++..+..++.||+.||+|||++|++|+||||+||+++.   ++.++|+|||.+.....      
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~------  172 (299)
T 3m2w_A           99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------  172 (299)
T ss_dssp             SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT------
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc------
Confidence            579999998864  6999999999999999999999999999999999999998   78899999998753321      


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                                      ..++.++|+||||+++|++++|..||...........+.       .                .
T Consensus       173 ----------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-------~----------------~  213 (299)
T 3m2w_A          173 ----------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------T----------------R  213 (299)
T ss_dssp             ----------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-------C----------------S
T ss_pred             ----------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-------H----------------H
Confidence                            236779999999999999999999997654221100000       0                0


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ...............+++++.++|++||+.||++|||++++++||||++..
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            000000001112245789999999999999999999999999999998663

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=5.2e-32  Score=216.21  Aligned_cols=167  Identities=23%  Similarity=0.304  Sum_probs=125.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   76 (217)
                      |++|.+++++. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.........    ..
T Consensus       130 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  209 (373)
T 2qol_A          130 NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG  209 (373)
T ss_dssp             TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccC
Confidence            67999999886 47999999999999999999999999999999999999999999999999998765433211    11


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..++..|+|||.+.+.. ++.++||||||+++|++++ |..||...........+......+                  
T Consensus       210 ~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~------------------  270 (373)
T 2qol_A          210 GKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP------------------  270 (373)
T ss_dssp             ----CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC------------------
T ss_pred             CCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence            23356799999986544 7899999999999999997 999998776555444332211000                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  ....++..+.++|.+||+.||++|||++++++
T Consensus       271 ------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 ------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                        11246788999999999999999999999865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=4e-32  Score=208.54  Aligned_cols=167  Identities=25%  Similarity=0.369  Sum_probs=135.9

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      |++|.+++....  .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.........  ...
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  170 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA  170 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCC
Confidence            679999997653  7999999999999999999999999999999999999999999999999998766543322  223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+.+. .++.++|+||||++++++++ |..||.+.........+.....                     
T Consensus       171 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  228 (279)
T 1qpc_A          171 KFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------------------  228 (279)
T ss_dssp             CCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------------
T ss_pred             CCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---------------------
Confidence            456789999988644 37889999999999999999 8999988776555444322100                     


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ......+++++.+++.+||+.||++|||++++++
T Consensus       229 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ---------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                     0112357789999999999999999999999976

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=4.2e-32  Score=209.46  Aligned_cols=168  Identities=22%  Similarity=0.255  Sum_probs=135.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   76 (217)
                      +++|.+++.+. ..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.........    ..
T Consensus       104 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  183 (291)
T 1u46_A          104 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH  183 (291)
T ss_dssp             TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred             CCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhcc
Confidence            57999999875 67999999999999999999999999999999999999999999999999998766543321    22


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..++..|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+.......                  
T Consensus       184 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------  244 (291)
T 1u46_A          184 RKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL------------------  244 (291)
T ss_dssp             --CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC------------------
T ss_pred             CCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC------------------
Confidence            34566799999986543 6889999999999999999 999998877655554443211000                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 .....+++++.++|.+||..||.+|||++++++
T Consensus       245 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          245 -----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       112357799999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=8.9e-32  Score=208.43  Aligned_cols=167  Identities=25%  Similarity=0.346  Sum_probs=131.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~   75 (217)
                      |++|.+++++. ..++...+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........     ..
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  190 (298)
T 3f66_A          111 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT  190 (298)
T ss_dssp             TCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC----
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhcccccc
Confidence            56999999874 6689999999999999999999999999999999999999999999999999876543321     22


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ...+++.|+|||.+.+.. ++.++|+||||+++|++++ +.+||...........+......                  
T Consensus       191 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------------------  251 (298)
T 3f66_A          191 GAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------------------  251 (298)
T ss_dssp             -CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC------------------
T ss_pred             CCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC------------------
Confidence            345567899999986554 7899999999999999999 56677665543333332221000                  


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                  .....+++.+.+++.+||+.||.+|||++++++
T Consensus       252 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          252 ------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        112246788999999999999999999999976

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=9.6e-32  Score=209.51  Aligned_cols=169  Identities=24%  Similarity=0.352  Sum_probs=127.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~   79 (217)
                      |++|.+++.++..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.......  ......+
T Consensus       118 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  197 (309)
T 2h34_A          118 GVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVG  197 (309)
T ss_dssp             CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------C
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCC
Confidence            56999999998899999999999999999999999999999999999999999999999999986554332  2234567


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      ++.|+|||.+.+. .++.++|+||||+++|++++|..||.......... ...  ...                      
T Consensus       198 ~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~--~~~----------------------  251 (309)
T 2h34_A          198 TLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-HIN--QAI----------------------  251 (309)
T ss_dssp             CGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH-HHH--SCC----------------------
T ss_pred             CcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH-Hhc--cCC----------------------
Confidence            8899999988654 47889999999999999999999997754332211 111  000                      


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCC-CHhhhcc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-TGEFFVP  199 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-t~~~ll~  199 (217)
                         .......+.+++++.++|.+||+.||++|| |++++++
T Consensus       252 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 ---PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ---CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence               111233456889999999999999999999 8888765

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=209.40  Aligned_cols=168  Identities=20%  Similarity=0.302  Sum_probs=130.8

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC------CCcc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE------NEFM   74 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~------~~~~   74 (217)
                      |++|.+++...+ .+++..+..++.||+.||++||++|++|+||+|+||+++ ++.++|+|||.+.....      ....
T Consensus       113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~  191 (319)
T 2y4i_B          113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKL  191 (319)
T ss_dssp             SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccccccc
Confidence            579999998864 799999999999999999999999999999999999998 67999999998754321      1222


Q ss_pred             ccccccccccCcccccC--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccC
Q 027927           75 TEYVVTRWYRAPELLLN--------SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR  146 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~--------~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (217)
                      ....+++.|+|||.+..        ...++.++|+||||+++|++++|..||...........+.... .+ .       
T Consensus       192 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-~-------  262 (319)
T 2y4i_B          192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM-KP-N-------  262 (319)
T ss_dssp             BCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC-CC-C-------
T ss_pred             ccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC-CC-C-------
Confidence            33457889999999864        2346889999999999999999999998776554443332210 00 0       


Q ss_pred             chHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                          .....+++++.++|.+||..||.+|||++++++
T Consensus       263 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          263 --------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             --------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             --------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                001246788999999999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=3.6e-32  Score=208.71  Aligned_cols=165  Identities=21%  Similarity=0.315  Sum_probs=127.9

Q ss_pred             CccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      |++|.+++.+.+.  +++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......  ....+
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~  176 (278)
T 1byg_A           99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKL  176 (278)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------C
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--cCCCc
Confidence            4699999987643  8999999999999999999999999999999999999999999999999986544332  23356


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++.|+|||.+.+. .++.++|+||||+++|++++ |..||...........+...                        .
T Consensus       177 ~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~------------------------~  231 (278)
T 1byg_A          177 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------------------Y  231 (278)
T ss_dssp             CTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT------------------------C
T ss_pred             cccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC------------------------C
Confidence            7789999998654 47899999999999999998 99999776543333222110                        0


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                            .......+++.+.++|++||+.||++|||+.++++
T Consensus       232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 ------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                  01122357899999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=6.3e-32  Score=215.66  Aligned_cols=167  Identities=25%  Similarity=0.352  Sum_probs=124.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~   75 (217)
                      |++|.+++++. ..++...+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........     ..
T Consensus       175 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~  254 (373)
T 3c1x_A          175 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT  254 (373)
T ss_dssp             TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred             CCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccC
Confidence            57999999876 5689999999999999999999999999999999999999999999999999875433221     12


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ...+++.|+|||.+.+.. ++.++|+||||+++|++++ |.+||...........+...                     
T Consensus       255 ~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~---------------------  312 (373)
T 3c1x_A          255 GAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---------------------  312 (373)
T ss_dssp             ---CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT---------------------
T ss_pred             CCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC---------------------
Confidence            234567899999986544 7899999999999999999 67788665433332222110                     


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                         ..      ...+..+++.+.++|.+||+.||++|||++++++
T Consensus       313 ---~~------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          313 ---RR------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             ---CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CC------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               00      0112346789999999999999999999999976

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=9.6e-32  Score=227.53  Aligned_cols=167  Identities=23%  Similarity=0.285  Sum_probs=136.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----cccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~   77 (217)
                      +++|.++++.++.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++........    ....
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  532 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  532 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence            679999999999999999999999999999999999999999999999999999999999999876544321    1223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .+++.|+|||.+.... ++.++||||||+++|++++ |..||.+.........+......                    
T Consensus       533 ~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--------------------  591 (635)
T 4fl3_A          533 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------------------  591 (635)
T ss_dssp             --CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------------
T ss_pred             CCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            4467899999996544 8899999999999999998 99999887766555444321100                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ..+..+++++.++|.+||+.||++|||++++++
T Consensus       592 ----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 ----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                      112357799999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=6.6e-32  Score=211.93  Aligned_cols=172  Identities=19%  Similarity=0.273  Sum_probs=136.6

Q ss_pred             CccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---CCCEEEecccccccCCCC
Q 027927            2 DTDLYQIIRSNQ-------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSEN   71 (217)
Q Consensus         2 ~~~L~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~   71 (217)
                      |++|.+++....       .++...+..++.||+.||.+||++|++|+||+|+||+++.   +..++|+|||.+......
T Consensus       117 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~  196 (327)
T 2yfx_A          117 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA  196 (327)
T ss_dssp             TEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-
T ss_pred             CCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccc
Confidence            679999998863       4899999999999999999999999999999999999984   446999999988643222


Q ss_pred             C---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           72 E---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        72 ~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      .   ......+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+......           
T Consensus       197 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  264 (327)
T 2yfx_A          197 SYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-----------  264 (327)
T ss_dssp             -----CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-----------
T ss_pred             cccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC-----------
Confidence            1   123345678899999986554 7899999999999999998 99999877655444433221000           


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                                         .....+++.+.++|.+||+.||.+|||+++++++.|+-
T Consensus       265 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          265 -------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                               11234778999999999999999999999999987654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=9.9e-32  Score=219.58  Aligned_cols=174  Identities=26%  Similarity=0.379  Sum_probs=136.1

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~   77 (217)
                      +++|.++++..  ..++...+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++........  ....
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  341 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  341 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCC
Confidence            57999999753  6799999999999999999999999999999999999999999999999999876543321  1223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+.... ++.++||||||+++|++++ |..||.+....+....+......                    
T Consensus       342 ~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------------------  400 (452)
T 1fmk_A          342 KFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------------  400 (452)
T ss_dssp             -CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------------
T ss_pred             cccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            4467899999986554 8899999999999999999 99999887765554443321000                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc--CCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP--YKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~--~~~f~~~  206 (217)
                                ..+..+++.+.++|.+||+.||++|||++++++  ..++...
T Consensus       401 ----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          401 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                      112357789999999999999999999999987  4666544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=5.2e-31  Score=205.19  Aligned_cols=167  Identities=32%  Similarity=0.448  Sum_probs=126.3

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---cCcEecCcCCCCEEEecCCC-EEEecccccccCCCCCcc
Q 027927            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEFM   74 (217)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~Lh~---~~i~H~di~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~   74 (217)
                      |++|.+++....   .++...+..++.||+.||+|||+   +|++|+||||+||+++.++. ++|+|||.+......  .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~  160 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--M  160 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--c
Confidence            579999998865   47899999999999999999999   89999999999999998887 799999998654432  2


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ....+++.|+|||.+.+. .++.++||||||+++|++++|..||................+..                 
T Consensus       161 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  222 (307)
T 2eva_A          161 TNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-----------------  222 (307)
T ss_dssp             ----CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-----------------
T ss_pred             ccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-----------------
Confidence            334678999999998654 47899999999999999999999997543221110000000000                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 ......+++.+.++|.+||+.||++|||++++++
T Consensus       223 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          223 -----------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             -----------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                       1122357889999999999999999999999976

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=2e-31  Score=206.79  Aligned_cols=182  Identities=20%  Similarity=0.361  Sum_probs=134.7

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----ccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~   76 (217)
                      |++|.+++.. ...+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus       109 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  188 (302)
T 4e5w_A          109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD  188 (302)
T ss_dssp             TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCC
T ss_pred             CCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCC
Confidence            5699999954 47799999999999999999999999999999999999999999999999999876654432    233


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..++..|+|||.+.+.. ++.++|+||||+++|++++|..|+....     .......+.....    ............
T Consensus       189 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~~~  258 (302)
T 4e5w_A          189 RDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQ----MTVTRLVNTLKE  258 (302)
T ss_dssp             TTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGG----GHHHHHHHHHHT
T ss_pred             CCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccc----cCHHHHHHHHhc
Confidence            45677799999886554 7789999999999999999988864321     1112222211111    001111111111


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ....      .....+++++.++|++||+.||.+|||++++++
T Consensus       259 ~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          259 GKRL------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TCCC------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cCCC------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            1111      123467899999999999999999999999975

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=6.5e-32  Score=211.94  Aligned_cols=182  Identities=20%  Similarity=0.298  Sum_probs=134.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~   76 (217)
                      |++|.+++... ..+++..+..++.||+.||++||++|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  189 (327)
T 3lxl_A          110 SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP  189 (327)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSC
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeecc
Confidence            68999999874 6799999999999999999999999999999999999999999999999999976544332    123


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..++..|+|||.+.+.. ++.++|+||||+++|++++|..||.........     ........    ............
T Consensus       190 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~  259 (327)
T 3lxl_A          190 GQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCERDV----PALSRLLELLEE  259 (327)
T ss_dssp             CCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC----C----CHHHHHHHHHHT
T ss_pred             CCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hccccccc----ccHHHHHHHhhc
Confidence            45677799999986544 688999999999999999999998654321110     00000000    000011111111


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ....      .....+++.+.++|++||+.||.+|||++++++
T Consensus       260 ~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          260 GQRL------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             TCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCC------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1111      123467899999999999999999999999954

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=1.3e-32  Score=215.43  Aligned_cols=180  Identities=24%  Similarity=0.287  Sum_probs=131.7

Q ss_pred             CccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---cc
Q 027927            2 DTDLYQIIRSNQ----SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FM   74 (217)
Q Consensus         2 ~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~   74 (217)
                      |++|.+++....    .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......   ..
T Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  198 (321)
T 2qkw_B          119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS  198 (321)
T ss_dssp             TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred             CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            568888887653    59999999999999999999999999999999999999999999999999987543321   22


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCCCccccccCchHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM---RLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                      ....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||.........   ..........              
T Consensus       199 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------  263 (321)
T 2qkw_B          199 TVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG--------------  263 (321)
T ss_dssp             CCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT--------------
T ss_pred             cccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc--------------
Confidence            3345789999999986554 789999999999999999999999754321110   0000000000              


Q ss_pred             HHHHhCCCCCc-cchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          152 RYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       152 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                          ....... .......+..+..+.+++.+||+.||++|||+++++++
T Consensus       264 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          264 ----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             ----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                0000000 00011112245678999999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=1.9e-31  Score=220.10  Aligned_cols=167  Identities=23%  Similarity=0.345  Sum_probs=134.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      +++|.+++++.  ..++...+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.........  ...
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  379 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  379 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTC
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCC
Confidence            57999999874  56999999999999999999999999999999999999999999999999998765433221  223


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+.... ++.++||||||+++|++++ |..||.+.........+...                       
T Consensus       380 ~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----------------------  435 (495)
T 1opk_A          380 KFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-----------------------  435 (495)
T ss_dssp             CCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----------------------
T ss_pred             cCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            3456899999986544 7899999999999999998 99999876654443332210                       


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                       ..      ...+..+++++.++|.+||+.||++|||+.++++
T Consensus       436 -~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          436 -YR------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             -CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CC------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence             00      0122357799999999999999999999999976

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=9.2e-31  Score=203.85  Aligned_cols=169  Identities=28%  Similarity=0.438  Sum_probs=122.4

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-cccc
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~   76 (217)
                      +++|.+++..    ...+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus       116 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  195 (310)
T 2wqm_A          116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  195 (310)
T ss_dssp             SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------------
T ss_pred             CCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccc
Confidence            4689998865    5779999999999999999999999999999999999999999999999999986554332 2234


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|+|||.+.+. .++.++|+||||+++|++++|..||.+... .............+                  
T Consensus       196 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------  256 (310)
T 2wqm_A          196 LVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------------------  256 (310)
T ss_dssp             ---CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC------------------
T ss_pred             cCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC------------------
Confidence            5678899999988654 478999999999999999999999975421 11111111100000                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                            .    .....+++++.++|.+||..||++|||++++++
T Consensus       257 ------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          257 ------P----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             ------C----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------C----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                  0    011347789999999999999999999999975

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=5.3e-31  Score=222.34  Aligned_cols=167  Identities=20%  Similarity=0.268  Sum_probs=133.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   76 (217)
                      |++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.........    ..
T Consensus       419 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             TCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            67999999765 56999999999999999999999999999999999999999999999999999765433211    12


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|+|||.+... .++.++|||||||++|++++ |..||.+....+....+.....                    
T Consensus       499 ~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--------------------  557 (613)
T 2ozo_A          499 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------------------  557 (613)
T ss_dssp             ---CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--------------------
T ss_pred             CCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            2335789999998654 48899999999999999998 9999988776655544432100                    


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                ...+..+++++.++|.+||..||++|||++++++
T Consensus       558 ----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          558 ----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                      0122357899999999999999999999999854

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=1e-31  Score=210.65  Aligned_cols=181  Identities=22%  Similarity=0.263  Sum_probs=132.6

Q ss_pred             CccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHc---CcEecCcCCCCEEEecCCCEEEecccccccCCCCC--
Q 027927            2 DTDLYQIIRSNQ----SLSEEHCQYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--   72 (217)
Q Consensus         2 ~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~Lh~~---~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--   72 (217)
                      |++|.++++...    ++++..+..++.|++.||+|||++   |++|+||||+||+++.++.++|+|||.+.......  
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  190 (326)
T 3uim_A          111 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH  190 (326)
T ss_dssp             TCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccc
Confidence            579999998753    499999999999999999999999   99999999999999999999999999997654332  


Q ss_pred             ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHH
Q 027927           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (217)
Q Consensus        73 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (217)
                      ......+++.|+|||.+.+.. ++.++|+||+|+++|++++|..||.....           ...        .......
T Consensus       191 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~--------~~~~~~~  250 (326)
T 3uim_A          191 VTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARL-----------AND--------DDVMLLD  250 (326)
T ss_dssp             EECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHH-----------TTT--------SCSBHHH
T ss_pred             ccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCccccccc-----------ccc--------cchhHHH
Confidence            233445899999999886554 78999999999999999999999952100           000        0000011


Q ss_pred             HHHhCCCCCc-------cchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCC
Q 027927          153 YIRQLPQHPR-------QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKP  202 (217)
Q Consensus       153 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~  202 (217)
                      +.........       ..........++.+.+++.+||+.||.+|||+++++++-.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            1111000000       0000111123467999999999999999999999988643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=9.5e-32  Score=209.11  Aligned_cols=180  Identities=22%  Similarity=0.295  Sum_probs=132.7

Q ss_pred             CccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC---ccc
Q 027927            2 DTDLYQIIRS---NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMT   75 (217)
Q Consensus         2 ~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~   75 (217)
                      |++|.+++..   ..++++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus       114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  193 (307)
T 2nru_A          114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS  193 (307)
T ss_dssp             TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECS
T ss_pred             CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccccc
Confidence            6799999974   4679999999999999999999999999999999999999999999999999987654322   123


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ...+++.|+|||.+.+  .++.++|+||||+++|++++|..||...........+.+.......         ....+..
T Consensus       194 ~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  262 (307)
T 2nru_A          194 RIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK---------TIEDYID  262 (307)
T ss_dssp             SCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC---------CHHHHSC
T ss_pred             ccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh---------hhhhhcc
Confidence            3567899999998853  3688999999999999999999999765432222222211110000         0001100


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ...       .......+..+.+++.+||+.||++|||++++++
T Consensus       263 ~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          263 KKM-------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             SSC-------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccc-------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            000       0011123467899999999999999999999975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=208.74  Aligned_cols=171  Identities=25%  Similarity=0.365  Sum_probs=129.7

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----   73 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----   73 (217)
                      +++|.+++..    +..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+........    
T Consensus       114 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~  193 (317)
T 2buj_A          114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ  193 (317)
T ss_dssp             TCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHH
T ss_pred             CCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccc
Confidence            4699999876    57899999999999999999999999999999999999999999999999998765432211    


Q ss_pred             ------cccccccccccCcccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcccccc
Q 027927           74 ------MTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (217)
Q Consensus        74 ------~~~~~~~~~~~~Pe~~~~~~--~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (217)
                            .....+++.|+|||.+....  .++.++|+||||+++|++++|..||.......                    
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------------------  253 (317)
T 2buj_A          194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--------------------  253 (317)
T ss_dssp             HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--------------------
T ss_pred             cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--------------------
Confidence                  11234588899999886443  25789999999999999999999994311000                    


Q ss_pred             CchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                        .............      .....+++++.++|.+||+.||.+|||+++++++
T Consensus       254 --~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          254 --DSVALAVQNQLSI------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --SCHHHHHHCC--C------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --chhhHHhhccCCC------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence              0000000000000      0123577899999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=4.9e-32  Score=213.25  Aligned_cols=195  Identities=19%  Similarity=0.239  Sum_probs=131.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEecCcCCCCEEEecCCCEEEecccccccCCCCC
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA---------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~---------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (217)
                      |++|.++++.+. .+...+..++.||+.||+|||+.         |++|+||||+||+++.++.++|+|||.+.......
T Consensus        96 ~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~  174 (336)
T 3g2f_A           96 NGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR  174 (336)
T ss_dssp             TCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSS
T ss_pred             CCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccccc
Confidence            679999998754 48999999999999999999999         99999999999999999999999999997654321


Q ss_pred             ---------ccccccccccccCcccccCC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCC
Q 027927           73 ---------FMTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGT  136 (217)
Q Consensus        73 ---------~~~~~~~~~~~~~Pe~~~~~------~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~  136 (217)
                               ......+++.|+|||.+.+.      ..++.++|||||||++|++++|..||..... ......+....+.
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3g2f_A          175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN  254 (336)
T ss_dssp             CC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCS
T ss_pred             ccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCC
Confidence                     12234688999999998653      2245689999999999999999766643221 0000000000000


Q ss_pred             CCCccccccCchHHHHHHHhCCCCCccchhhhC---CCCChhHHHHHHHhcccCCCCCCCHhhh------ccCCCCccc
Q 027927          137 PTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF---PHVHPLAIDLVDRMLTFDPMKRITGEFF------VPYKPFQCC  206 (217)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~t~~~l------l~~~~f~~~  206 (217)
                      .+       ...............  .......   ...++++.++|.+||+.||++|||++|+      +.++|-++.
T Consensus       255 ~~-------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          255 HP-------TFEDMQVLVSREKQR--PKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             SC-------CHHHHHHHHTTSCCC--CCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             Cc-------hHHHHHhhhcccccC--CCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence            00       000111111111111  1111111   1134579999999999999999999999      557777654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=7.6e-31  Score=206.83  Aligned_cols=175  Identities=21%  Similarity=0.266  Sum_probs=128.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH--------SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh--------~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-   72 (217)
                      +++|.+++.+ ..+++..+..++.|++.||++||        +.|++|+||||+||+++.++.++|+|||.+....... 
T Consensus       124 ~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  202 (342)
T 1b6c_B          124 HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  202 (342)
T ss_dssp             TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccc
Confidence            4699999987 46999999999999999999999        8999999999999999999999999999986654432 


Q ss_pred             ----ccccccccccccCcccccCCCCC-----CchhhHHHHHHHHHHHHcC----------CCCCCCCCh----HHHHHH
Q 027927           73 ----FMTEYVVTRWYRAPELLLNSSDY-----TAAIDVWSVGCIFMELMNR----------RPLFPGNDH----VHQMRL  129 (217)
Q Consensus        73 ----~~~~~~~~~~~~~Pe~~~~~~~~-----~~~~Diwslg~~l~~l~~~----------~~pf~~~~~----~~~~~~  129 (217)
                          ......+++.|+|||.+.+....     +.++|+||||+++|++++|          ..||.....    ......
T Consensus       203 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  282 (342)
T 1b6c_B          203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK  282 (342)
T ss_dssp             EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred             ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHH
Confidence                12345678999999998654322     2689999999999999999          677754321    111111


Q ss_pred             HHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                      .                       .......+...........+..+.++|.+||+.||++|||+.+++++
T Consensus       283 ~-----------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          283 V-----------------------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             H-----------------------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             H-----------------------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            1                       10000000000000111234678999999999999999999999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=1.1e-30  Score=221.83  Aligned_cols=167  Identities=23%  Similarity=0.354  Sum_probs=135.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--cccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~   78 (217)
                      |++|.++++.. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.........  ....
T Consensus       474 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  553 (656)
T 2j0j_A          474 LGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK  553 (656)
T ss_dssp             TCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCC
Confidence            57999999876 47999999999999999999999999999999999999999999999999998765443322  2234


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+. .++.++|+||||+++|++++ |..||.+.........+......                     
T Consensus       554 ~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---------------------  611 (656)
T 2j0j_A          554 LPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---------------------  611 (656)
T ss_dssp             CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---------------------
T ss_pred             CCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---------------------
Confidence            46789999998655 47899999999999999997 99999887766655544331110                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                               ..+..+++.+.++|.+||+.||++|||+.++++
T Consensus       612 ---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                     112357799999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=2.9e-31  Score=207.56  Aligned_cols=181  Identities=24%  Similarity=0.321  Sum_probs=132.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----cccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~   77 (217)
                      +++|.+++.++ .+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+........    ....
T Consensus       119 ~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  197 (318)
T 3lxp_A          119 LGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG  197 (318)
T ss_dssp             TCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---C
T ss_pred             CCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCC
Confidence            56999999875 499999999999999999999999999999999999999999999999999977654432    2234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .++..|+|||.+.+.. ++.++|+||||+++|++++|..||.......     ....+...    ...............
T Consensus       198 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          198 DSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQ----GQMTVLRLTELLERG  267 (318)
T ss_dssp             CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCC----HHHHHHHHHHHHHTT
T ss_pred             CCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccc----cchhHHHHHHHHhcc
Confidence            5677799999986544 7789999999999999999999986532110     00000000    000000111111111


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ..      ......+++++.++|++||+.||++|||++++++
T Consensus       268 ~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          268 ER------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cC------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            11      1123457899999999999999999999999984

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=4.3e-31  Score=219.86  Aligned_cols=174  Identities=26%  Similarity=0.379  Sum_probs=139.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~   77 (217)
                      +++|.++++..  ..+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++........  ....
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  424 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  424 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence            57999999753  6799999999999999999999999999999999999999999999999999876543221  1123


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .++..|+|||.+.... ++.++||||||+++|++++ |..||.+....+....+......                    
T Consensus       425 ~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------------------  483 (535)
T 2h8h_A          425 KFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------------  483 (535)
T ss_dssp             TSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC--------------------
T ss_pred             cCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            3467799999886554 8899999999999999999 89999887765555444321000                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc--CCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP--YKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~--~~~f~~~  206 (217)
                                .....+++.+.++|.+||+.||++|||++++++  ..+|...
T Consensus       484 ----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          484 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                      112357789999999999999999999999987  3666544

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=1.5e-32  Score=220.99  Aligned_cols=190  Identities=21%  Similarity=0.378  Sum_probs=135.8

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEE----ecCCCEEEecccccccCCCCCcc
Q 027927            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARPTSENEFM   74 (217)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~   74 (217)
                      |++|.++++...   .+++..+..++.||+.||+|||++|++||||||+||++    +.++.++|+|||.+.........
T Consensus        93 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~  172 (396)
T 4eut_A           93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF  172 (396)
T ss_dssp             TEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGS
T ss_pred             CCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCcc
Confidence            579999998753   39999999999999999999999999999999999998    67777999999999877666555


Q ss_pred             ccccccccccCcccccCC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCCCCCcccc
Q 027927           75 TEYVVTRWYRAPELLLNS-------SDYTAAIDVWSVGCIFMELMNRRPLFPGND----HVHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~-------~~~~~~~Diwslg~~l~~l~~~~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~  143 (217)
                      ....+++.|+|||.+...       ..++.++|+|||||++|++++|..||....    ....+..+..  +.+... +.
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~p~~~-~~  249 (396)
T 4eut_A          173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPSGA-IS  249 (396)
T ss_dssp             SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--SCCTTC-CE
T ss_pred             ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--CCCccc-ch
Confidence            567789999999987531       235678999999999999999999996432    2333333322  222211 11


Q ss_pred             ccCchHHH--HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          144 FVRNEDAK--RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       144 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ........  .+....     .........+++.+.++|++||..||++|||++++++
T Consensus       250 ~~~~~~~~~~~~~~~~-----~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          250 GVQKAENGPIDWSGDM-----PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             EEECSTTCCEEEESSC-----CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             hheeccCCCcccCccC-----CcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            10000000  000000     0001111234567899999999999999999999854

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=1.7e-30  Score=203.88  Aligned_cols=183  Identities=17%  Similarity=0.251  Sum_probs=134.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~   76 (217)
                      |++|.+++.+. ..+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+........    ...
T Consensus       128 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  207 (326)
T 2w1i_A          128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP  207 (326)
T ss_dssp             TCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSC
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccC
Confidence            57999999886 5699999999999999999999999999999999999999999999999999876654332    122


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..++..|+|||.+.+.. ++.++|+||||++++++++|..|+.....     ...+..+.......   ........+..
T Consensus       208 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~  278 (326)
T 2w1i_A          208 GESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQM---IVFHLIELLKN  278 (326)
T ss_dssp             CSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTHH---HHHHHHHHHHT
T ss_pred             CCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchhh---hHHHHHHHhhc
Confidence            34566799999986544 78899999999999999999988854211     11111111111100   00011111111


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ....      .....+++++.++|++||+.||++|||+.++++
T Consensus       279 ~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          279 NGRL------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TCCC------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCC------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1111      123457899999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=8.7e-31  Score=208.53  Aligned_cols=162  Identities=16%  Similarity=0.228  Sum_probs=127.3

Q ss_pred             CccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-----------CCCEEEeccccc
Q 027927            2 DTDLYQIIRS-----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-----------NCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-----------~~~~~l~d~~~~   65 (217)
                      |++|.+++..     ...+++..+..++.||+.||+|||++||+||||||+||+++.           ++.++|+|||++
T Consensus       151 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a  230 (365)
T 3e7e_A          151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS  230 (365)
T ss_dssp             SCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTC
T ss_pred             CCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchh
Confidence            6899999974     577999999999999999999999999999999999999998           899999999999


Q ss_pred             ccC---CCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccc
Q 027927           66 RPT---SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADL  142 (217)
Q Consensus        66 ~~~---~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~  142 (217)
                      ...   ..........+++.|+|||.+.+.. ++.++|||||||++|++++|..||......                .+
T Consensus       231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~----------------~~  293 (365)
T 3e7e_A          231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG----------------EC  293 (365)
T ss_dssp             EEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT----------------EE
T ss_pred             hhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC----------------ce
Confidence            543   2333445567899999999997654 899999999999999999999999543210                00


Q ss_pred             cccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          143 GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      .             ...    ....  ...++.+.+++.+||+.+|.+|++..+.+.
T Consensus       294 ~-------------~~~----~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          294 K-------------PEG----LFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             E-------------ECS----CCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             e-------------ech----hccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            0             000    0000  013467899999999999999966544443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.96  E-value=2.2e-30  Score=203.97  Aligned_cols=167  Identities=16%  Similarity=0.144  Sum_probs=123.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCcEecCcCCCCEEEecCC--------------------CEEEe
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNANC--------------------DLKIC   60 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh-~~~i~H~di~~~nil~~~~~--------------------~~~l~   60 (217)
                      +|++.+.+.+ +.+++..++.++.||+.||+||| ++||+||||||+||+++.++                    .++|+
T Consensus       146 ~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~  224 (336)
T 2vuw_A          146 GGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII  224 (336)
T ss_dssp             CCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEEC
T ss_pred             CCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEe
Confidence            4445555544 67899999999999999999999 99999999999999999987                    89999


Q ss_pred             cccccccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCC
Q 027927           61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFPGNDH-VHQMRLLIELLGTPT  138 (217)
Q Consensus        61 d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~-l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~  138 (217)
                      |||++......    ...+++.|+|||.+.+..  +.++||||++++ .++++.|..||..... ......+..      
T Consensus       225 DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~------  292 (336)
T 2vuw_A          225 DYTLSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK------  292 (336)
T ss_dssp             CCTTCBEEETT----EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH------
T ss_pred             eccccEecCCC----cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh------
Confidence            99999765432    347899999999996554  789999998766 6778888888843111 001111111      


Q ss_pred             CccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhc-cCCCCc
Q 027927          139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV-PYKPFQ  204 (217)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll-~~~~f~  204 (217)
                                       . ...........+..+++++.+||++||+.|     |++|+| +||||+
T Consensus       293 -----------------~-~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          293 -----------------Q-MTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             -----------------T-CCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             -----------------h-hccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence                             0 000001111122346788999999999977     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.95  E-value=8.8e-29  Score=211.38  Aligned_cols=158  Identities=23%  Similarity=0.297  Sum_probs=124.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++..  .+++..+..++.||+.||.|||++||+|+||||+||+++.+ .++|+|||.+......   ....+++
T Consensus       168 g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~  241 (681)
T 2pzi_A          168 GQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTP  241 (681)
T ss_dssp             CEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCT
T ss_pred             CCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC---CccCCCc
Confidence            5678777665  79999999999999999999999999999999999999885 8999999998766543   3456899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.  .+.++||||||++++++++|..||.+....           ..                    ..  
T Consensus       242 ~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~--------------------~~--  286 (681)
T 2pzi_A          242 GFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GL--------------------PE--  286 (681)
T ss_dssp             TTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SC--------------------CT--
T ss_pred             cccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc-----------cc--------------------cc--
Confidence            99999988643  478999999999999999998888642100           00                    00  


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                      ....    ...++.+.++|.+||+.||.+||+..+.+.++|+.
T Consensus       287 ~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          287 DDPV----LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             TCHH----HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccc----cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            0000    01347899999999999999999999988888775

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.94  E-value=4.1e-26  Score=175.88  Aligned_cols=144  Identities=14%  Similarity=0.066  Sum_probs=111.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.++++++  .....+..++.||+.||+|||++|++|+||||+||+++.++.++|++++..                
T Consensus       115 g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~----------------  176 (286)
T 3uqc_A          115 GGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM----------------  176 (286)
T ss_dssp             EEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC----------------
T ss_pred             CCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc----------------
Confidence            57999999653  356678999999999999999999999999999999999999999855432                


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                         +        .++.++|+||||+++|++++|..||.+......               ...         ........
T Consensus       177 ---~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~---------------~~~---------~~~~~~~~  221 (286)
T 3uqc_A          177 ---P--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG---------------LAP---------AERDTAGQ  221 (286)
T ss_dssp             ---T--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC---------------SEE---------CCBCTTSC
T ss_pred             ---C--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh---------------hHH---------HHHHhccC
Confidence               1        267899999999999999999999976542100               000         00001111


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ..........+++++.++|.+||+.||++| |+.++++
T Consensus       222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            223345566789999999999999999999 9999976

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.88  E-value=1.3e-24  Score=181.67  Aligned_cols=108  Identities=20%  Similarity=0.249  Sum_probs=78.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.++|++++++++.   +++.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++..... ....+..||
T Consensus       326 G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGT  402 (569)
T 4azs_A          326 GRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQS  402 (569)
T ss_dssp             SEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHH
T ss_pred             CCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceec
Confidence            78999999999999875   47899999999999999999999999999999999999999999765443 334567899


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR  114 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~  114 (217)
                      +.|++||.+.+.  ...++|+|++|++++.+..+
T Consensus       403 p~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          403 FFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HHHHHHHHC-------------------CCCCTT
T ss_pred             hhhccHHHhCCC--CCCcccccccccchhhhccc
Confidence            999999998643  56689999999988766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.63  E-value=4.2e-17  Score=135.65  Aligned_cols=107  Identities=24%  Similarity=0.362  Sum_probs=87.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--------
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--------   73 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------   73 (217)
                      |++|.+++.+        +..++.|++.||.|||++||+||||||+||+++.  .++|+|||+++.......        
T Consensus       423 ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~  492 (540)
T 3en9_A          423 GKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVF  492 (540)
T ss_dssp             SEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred             CCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhh
Confidence            5789988877        6689999999999999999999999999999998  999999999987765422        


Q ss_pred             cccccccccccCcccccCC-CCCCchhhHHHHHHHHHHHHcCCCCC
Q 027927           74 MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLF  118 (217)
Q Consensus        74 ~~~~~~~~~~~~Pe~~~~~-~~~~~~~Diwslg~~l~~l~~~~~pf  118 (217)
                      .....+++.|+|||.+... ..++...|+|+..+-..+-+.+..+|
T Consensus       493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2356789999999998641 12566789999888777766655544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.20  E-value=2.5e-11  Score=92.99  Aligned_cols=48  Identities=21%  Similarity=0.267  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccccc
Q 027927           19 HCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (217)
Q Consensus        19 ~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   67 (217)
                      ....++.|++.||.+||++|++|+||||+||+++ ++.++|+|||.+..
T Consensus       194 ~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          194 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            4567999999999999999999999999999999 99999999998853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.13  E-value=4.5e-11  Score=90.37  Aligned_cols=60  Identities=22%  Similarity=0.327  Sum_probs=50.9

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCcEecCcCCCCEEEecCCCEEEecccccccC
Q 027927            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (217)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh-~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~   68 (217)
                      +|.++...   .++..+..++.|++.||.+|| +.|++||||||.||+++.  .++|+|||.+...
T Consensus       159 ~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          159 TLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             BHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             cHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            56665433   235578899999999999999 999999999999999988  8999999998544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.65  E-value=2.8e-08  Score=78.91  Aligned_cols=51  Identities=16%  Similarity=0.162  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC----------CEEEecccccccC
Q 027927           18 EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----------DLKICDFGLARPT   68 (217)
Q Consensus        18 ~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----------~~~l~d~~~~~~~   68 (217)
                      .....++.||+.+|.+||+.|++||||||.|||++.++          .+.++||+-+...
T Consensus       205 ~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          205 PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            34567899999999999999999999999999998876          3789999876443

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.38  E-value=1.1e-05  Score=58.55  Aligned_cols=97  Identities=19%  Similarity=0.144  Sum_probs=64.5

Q ss_pred             cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            4 DLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         4 ~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      ||.++|+. +.++++++++.++.|.+.+|..+-. ..-...=+.+..|++..+|.+.+.+ ..+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            68888876 5899999999999999999877632 1112233456889999999888875 1110           1122


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR  114 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~  114 (217)
                      .+.+||...  ...+.+.-|++||+++|..+--
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhc
Confidence            356777652  2356788999999999999853

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.66  E-value=4.8e-05  Score=57.01  Aligned_cols=29  Identities=24%  Similarity=0.272  Sum_probs=24.3

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ..++|||+++.||+++.++.+.++||+.+
T Consensus       183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             EEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence            44899999999999987655679999865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.59  E-value=3e-05  Score=59.61  Aligned_cols=81  Identities=20%  Similarity=0.223  Sum_probs=46.3

Q ss_pred             CcEecCcCCCCEEEec--CCCEEEecccccccCCCCCccccccccccccCccccc------CCCC-------CCchhhHH
Q 027927           38 NVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLL------NSSD-------YTAAIDVW  102 (217)
Q Consensus        38 ~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~------~~~~-------~~~~~Diw  102 (217)
                      .++|||+++.||+++.  .+.+.++||+.+.......-.........-..|+...      +...       .....+.|
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~  271 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYW  271 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHH
Confidence            3799999999999998  4567899999875432110000000000001111100      0000       01236889


Q ss_pred             HHHHHHHHHHcCCCCC
Q 027927          103 SVGCIFMELMNRRPLF  118 (217)
Q Consensus       103 slg~~l~~l~~~~~pf  118 (217)
                      +++.+++.+.+|..+|
T Consensus       272 ~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          272 SFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHcCCHHH
Confidence            9999999999987766

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.55  E-value=0.00013  Score=57.37  Aligned_cols=53  Identities=19%  Similarity=0.372  Sum_probs=45.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------------------
Q 027927           14 SLSEEHCQYFLYQLLRGLKYIHS---------------------------------------------------------   36 (217)
Q Consensus        14 ~l~~~~~~~~~~~i~~~l~~Lh~---------------------------------------------------------   36 (217)
                      .+++.....++.+++..|+.||+                                                         
T Consensus       135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  214 (359)
T 3dxp_A          135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD  214 (359)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence            36788888999999999999997                                                         


Q ss_pred             -cCcEecCcCCCCEEEecCCC--EEEecccccc
Q 027927           37 -ANVIHRDLKPSNLLLNANCD--LKICDFGLAR   66 (217)
Q Consensus        37 -~~i~H~di~~~nil~~~~~~--~~l~d~~~~~   66 (217)
                       ..++|||+++.||+++.++.  +.++||+.+.
T Consensus       215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             CCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             CceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence             35899999999999997753  5899999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.50  E-value=7.8e-05  Score=55.53  Aligned_cols=27  Identities=22%  Similarity=0.198  Sum_probs=24.0

Q ss_pred             cEecCcCCCCEEEecCCCEEEeccccc
Q 027927           39 VIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        39 i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ++|||+++.||+++.++.+.++||+.+
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhc
Confidence            999999999999987766679999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.60  E-value=0.0039  Score=48.24  Aligned_cols=29  Identities=28%  Similarity=0.414  Sum_probs=26.3

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ..++|||+++.||+++.++.+.++||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            56999999999999988888999999865

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=95.83  E-value=0.019  Score=43.98  Aligned_cols=30  Identities=43%  Similarity=0.615  Sum_probs=24.7

Q ss_pred             CcEecCcCCCCEEEec---CCCE-EEeccccccc
Q 027927           38 NVIHRDLKPSNLLLNA---NCDL-KICDFGLARP   67 (217)
Q Consensus        38 ~i~H~di~~~nil~~~---~~~~-~l~d~~~~~~   67 (217)
                      .++|||+++.||+++.   ++.+ .++||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            4799999999999987   4554 7999987643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.47  E-value=0.013  Score=47.02  Aligned_cols=32  Identities=16%  Similarity=0.322  Sum_probs=27.2

Q ss_pred             HHcCcEecCcCCCCEEEecCCCEEEeccccccc
Q 027927           35 HSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (217)
Q Consensus        35 h~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~   67 (217)
                      +...++|||+++.||+++.++ +.++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            345699999999999998876 99999987753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=94.50  E-value=0.019  Score=42.78  Aligned_cols=27  Identities=26%  Similarity=0.372  Sum_probs=24.1

Q ss_pred             cEecCcCCCCEEEecCCCEEEeccccc
Q 027927           39 VIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        39 i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ++|||+++.||+++.++.+-++||+.+
T Consensus       195 l~HGDl~~~Nil~~~~~~~~viDwe~a  221 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGKLIGCIDVGRV  221 (272)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             EEcCCCCCCeEEEECCeEEEEEECccc
Confidence            899999999999998776779999865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.24  E-value=0.024  Score=43.50  Aligned_cols=29  Identities=34%  Similarity=0.394  Sum_probs=25.0

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .+++|+|+++.||+++.++.+.++||+.+
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a  215 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFA  215 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhc
Confidence            35999999999999998766689999876

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=93.66  E-value=0.034  Score=42.88  Aligned_cols=30  Identities=30%  Similarity=0.476  Sum_probs=25.9

Q ss_pred             cCcEecCcCCCCEEEecC----CCEEEecccccc
Q 027927           37 ANVIHRDLKPSNLLLNAN----CDLKICDFGLAR   66 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~----~~~~l~d~~~~~   66 (217)
                      ..++|||+++.||+++.+    +.+.++||+.+.
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            459999999999999874    678999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.29  E-value=0.074  Score=40.79  Aligned_cols=28  Identities=25%  Similarity=0.324  Sum_probs=23.9

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      ..++|||+++.||+++ + .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            3489999999999998 4 88999998763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=93.23  E-value=0.039  Score=42.98  Aligned_cols=30  Identities=13%  Similarity=0.245  Sum_probs=24.8

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      ..++|||+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            469999999999999964457899998763

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.21  E-value=0.064  Score=41.66  Aligned_cols=30  Identities=20%  Similarity=0.319  Sum_probs=26.4

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      ..++|||+.+.||+++.++.+.++||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            359999999999999988889999998664

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=92.32  E-value=0.16  Score=39.75  Aligned_cols=28  Identities=29%  Similarity=0.619  Sum_probs=23.4

Q ss_pred             CcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      .++|+|+++.||+++.++ +.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            489999999999997654 8999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=91.23  E-value=0.1  Score=39.65  Aligned_cols=28  Identities=21%  Similarity=0.246  Sum_probs=24.2

Q ss_pred             CcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      .++|+|+.+.||+ ..++.+.++||..+.
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            3899999999999 667788999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=91.04  E-value=0.089  Score=42.33  Aligned_cols=17  Identities=35%  Similarity=0.567  Sum_probs=14.9

Q ss_pred             CcEecCcCCCCEEEecC
Q 027927           38 NVIHRDLKPSNLLLNAN   54 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~   54 (217)
                      .++|+|+.+.||+++.+
T Consensus       250 v~~H~Dl~~gNiL~~~~  266 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKA  266 (429)
T ss_dssp             EEECSCCCGGGEEEEC-
T ss_pred             EEEeCCCCCCeEEeeCC
Confidence            48999999999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=90.93  E-value=0.23  Score=39.26  Aligned_cols=29  Identities=24%  Similarity=0.410  Sum_probs=24.6

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      ..++|||+++.||+++.+ .+.++||..+.
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            469999999999999876 48899997653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=90.88  E-value=0.13  Score=40.72  Aligned_cols=29  Identities=28%  Similarity=0.462  Sum_probs=25.8

Q ss_pred             CcEecCcCCCCEEEecC----CCEEEecccccc
Q 027927           38 NVIHRDLKPSNLLLNAN----CDLKICDFGLAR   66 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~----~~~~l~d~~~~~   66 (217)
                      .++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            48999999999999876    789999998774

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.79  E-value=0.12  Score=41.98  Aligned_cols=15  Identities=33%  Similarity=0.410  Sum_probs=14.0

Q ss_pred             CcEecCcCCCCEEEe
Q 027927           38 NVIHRDLKPSNLLLN   52 (217)
Q Consensus        38 ~i~H~di~~~nil~~   52 (217)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            489999999999998

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.25  E-value=0.19  Score=39.99  Aligned_cols=28  Identities=29%  Similarity=0.436  Sum_probs=24.1

Q ss_pred             cEecCcCCCCEEEe------cCCCEEEecccccc
Q 027927           39 VIHRDLKPSNLLLN------ANCDLKICDFGLAR   66 (217)
Q Consensus        39 i~H~di~~~nil~~------~~~~~~l~d~~~~~   66 (217)
                      ++|+|+.+.||++.      .++.+.++||.++.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            68999999999993      45679999999874

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=85.91  E-value=0.38  Score=38.65  Aligned_cols=28  Identities=25%  Similarity=0.532  Sum_probs=25.1

Q ss_pred             CcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      .++|+|+.+.|++ +.++.+.++||.++.
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCC
Confidence            4899999999999 788899999998874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=80.54  E-value=2.6  Score=31.41  Aligned_cols=23  Identities=30%  Similarity=0.373  Sum_probs=19.2

Q ss_pred             CcEecCcCCCCEEEecCCCEEEec
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICD   61 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d   61 (217)
                      .++|||+.+.|++++.++. .+.|
T Consensus       189 ~LvHGDlw~gNvl~~~~g~-~~iD  211 (288)
T 3f7w_A          189 ARIHGDLWNGNVLWQDDGA-VVID  211 (288)
T ss_dssp             EEECSCCSGGGEEEETTEE-EECS
T ss_pred             eeeecCCCCCcEEEcCCCe-EEEe
Confidence            4999999999999998874 4555

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	217
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-50
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-50
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-48
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-47
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-46
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-46
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-46
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-45
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-43
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-40
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-38
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-38
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-38
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-37
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-37
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-31
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-30
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-30
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-29
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-29
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-28
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-27
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-27
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-26
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-26
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-25
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-25
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-25
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-24
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-24
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-24
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-24
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-23
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-23
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-23
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-23
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-22
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-21
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-16

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-50
 Identities = 106/197 (53%), Positives = 142/197 (72%), Gaps = 5/197 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DLY++++  Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 93  MGADLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 151

Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271

Query: 177 IDLVDRMLTFDPMKRIT 193
           +DL+D+MLTF+P KRI 
Sbjct: 272 LDLLDKMLTFNPHKRIE 288

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 2e-50
 Identities = 74/194 (38%), Positives = 112/194 (57%), Gaps = 3/194 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKI 59
           +        R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+
Sbjct: 105 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 164

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           CDFG A+     E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FP
Sbjct: 165 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+  V Q+  +I++LGTPT   +  +     +    Q+  HP   +    P   P AI L
Sbjct: 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV--FRPRTPPEAIAL 282

Query: 180 VDRMLTFDPMKRIT 193
             R+L + P  R+T
Sbjct: 283 CSRLLEYTPTARLT 296

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-48
 Identities = 85/193 (44%), Positives = 137/193 (70%), Gaps = 3/193 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL ++++ ++ L E+  Q+ +YQ+L+GL+YIH+A +IHRDLKP NL +N +C+LKI 
Sbjct: 105 MGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 163

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       MT YVVTRWYRAPE++LN   YT  +D+WSVGCI  E++  + LF G
Sbjct: 164 DFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q++ ++++ GTP    +  +++++AK Y++ LP+  ++  A +  +  PLA++L+
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281

Query: 181 DRMLTFDPMKRIT 193
           ++ML  D  +R+T
Sbjct: 282 EKMLVLDAEQRVT 294

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 8e-48
 Identities = 72/190 (37%), Positives = 105/190 (55%), Gaps = 4/190 (2%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
              I  ++  L+  H + ++   L+GL+Y+H   ++HRDLKP+NLLL+ N  LK+ DFGL
Sbjct: 87  EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 146

Query: 65  ARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A+   S N   T  VVTRWYRAPELL  +  Y   +D+W+VGCI  EL+ R P  PG+  
Sbjct: 147 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + Q+  + E LGTPT+     + +       +  P  P   L  +F       +DL+  +
Sbjct: 207 LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP---LHHIFSAAGDDLLDLIQGL 263

Query: 184 LTFDPMKRIT 193
             F+P  RIT
Sbjct: 264 FLFNPCARIT 273

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 4e-47
 Identities = 74/193 (38%), Positives = 109/193 (56%), Gaps = 5/193 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D   Y        +  E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ 
Sbjct: 99  QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 158

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR  S    +T  VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G
Sbjct: 159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRG 217

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +  V Q+  +++++G P + D       D     +       Q + +    +  L  DL+
Sbjct: 218 SSDVDQLGKILDVIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 273

Query: 181 DRMLTFDPMKRIT 193
            + LTF+P KRI+
Sbjct: 274 LKCLTFNPAKRIS 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  153 bits (386), Expect = 2e-46
 Identities = 73/194 (37%), Positives = 98/194 (50%), Gaps = 3/194 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
                  +      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI 
Sbjct: 83  DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLAR         T  +VT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  PLFP
Sbjct: 143 DFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G     Q+  +  +LGTP   +   V   +  +Y      +           +    IDL
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVT--ELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260

Query: 180 VDRMLTFDPMKRIT 193
           + +ML  DP +RIT
Sbjct: 261 LSKMLKLDPNQRIT 274

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 3e-46
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 6/196 (3%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
               +       +    +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+ DFG
Sbjct: 103 LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162

Query: 64  LAR-----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           LAR       S+    T  VVT WYR PELLL   DY   ID+W  GCI  E+  R P+ 
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-HPLAI 177
            GN   HQ+ L+ +L G+ T      V N +    +  +    R+   ++  +V  P A+
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282

Query: 178 DLVDRMLTFDPMKRIT 193
           DL+D++L  DP +RI 
Sbjct: 283 DLIDKLLVLDPAQRID 298

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 5e-46
 Identities = 99/185 (53%), Positives = 134/185 (72%), Gaps = 2/185 (1%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           I   Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI DFGLAR T
Sbjct: 112 IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
             ++ MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG DH+ Q++
Sbjct: 172 --DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229

Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
           L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+++ML  D 
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289

Query: 189 MKRIT 193
            KRIT
Sbjct: 290 DKRIT 294

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 8e-46
 Identities = 43/204 (21%), Positives = 86/204 (42%), Gaps = 16/204 (7%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDF 62
            L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDF
Sbjct: 90  SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 149

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           G++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+   R   P  D
Sbjct: 150 GVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH----------- 171
                 +    +           R          +   P  ++ ++  +           
Sbjct: 208 AKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267

Query: 172 --VHPLAIDLVDRMLTFDPMKRIT 193
                   D V++ L  +P +R  
Sbjct: 268 GVFSLEFQDFVNKCLIKNPAERAD 291

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 4e-45
 Identities = 74/194 (38%), Positives = 107/194 (55%), Gaps = 3/194 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D   +    +   +     + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ 
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 144

Query: 61  DFGLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLAR         T  VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFP
Sbjct: 145 DFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+  + Q+  +   LGTP +    +        Y    P+  RQ  ++V P +      L
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVV--WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262

Query: 180 VDRMLTFDPMKRIT 193
           + +ML +DP KRI+
Sbjct: 263 LSQMLHYDPNKRIS 276

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  145 bits (366), Expect = 6e-43
 Identities = 59/201 (29%), Positives = 113/201 (56%), Gaps = 11/201 (5%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKI 59
            +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++
Sbjct: 115 NNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 171

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLF 118
            D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F
Sbjct: 172 IDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFP-----HV 172
            G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   +         V
Sbjct: 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 291

Query: 173 HPLAIDLVDRMLTFDPMKRIT 193
            P A+D +D++L +D   R+T
Sbjct: 292 SPEALDFLDKLLRYDHQSRLT 312

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-42
 Identities = 81/210 (38%), Positives = 112/210 (53%), Gaps = 10/210 (4%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
                      N  L  E  + FL+QLL+GL + HS NV+HRDLKP NLL+N N +LK+ 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143

Query: 61  DFGLARPTSE-NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLF 118
           +FGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPLF
Sbjct: 144 NFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PGND   Q++ +  LLGTPT+     +       Y          SL  V P ++    D
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTK--LPDYKPYPMYPATTSLVNVVPKLNATGRD 261

Query: 179 LVDRMLTFDPMKRITGE------FFVPYKP 202
           L+  +L  +P++RI+ E      +F  + P
Sbjct: 262 LLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-42
 Identities = 47/193 (24%), Positives = 77/193 (39%), Gaps = 31/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 89  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 148

Query: 64  LAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           LA      +    + +   T  Y APELL     +   +DVWS G +   ++     +  
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                Q     +   T  +                             +  +    + L+
Sbjct: 209 PSDSCQEYSDWKEKKTYLN----------------------------PWKKIDSAPLALL 240

Query: 181 DRMLTFDPMKRIT 193
            ++L  +P  RIT
Sbjct: 241 HKILVENPSARIT 253

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-42
 Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 33/190 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG
Sbjct: 92  TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 151

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            +     +   T    T  Y  PE++     +   +D+WS+G +  E +  +P F  N +
Sbjct: 152 WSVHAPSSRRTT-LCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTY 209

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
               + +  +  T  D                                V   A DL+ R+
Sbjct: 210 QETYKRISRVEFTFPD-------------------------------FVTEGARDLISRL 238

Query: 184 LTFDPMKRIT 193
           L  +P +R  
Sbjct: 239 LKHNPSQRPM 248

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  141 bits (356), Expect = 4e-42
 Identities = 49/195 (25%), Positives = 80/195 (41%), Gaps = 32/195 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG
Sbjct: 96  ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 155

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE++      N   Y   +D+WS G I   L+   P F
Sbjct: 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                +  +R+++                               Q  +  +        D
Sbjct: 216 WHRKQMLMLRMIM---------------------------SGNYQFGSPEWDDYSDTVKD 248

Query: 179 LVDRMLTFDPMKRIT 193
           LV R L   P KR T
Sbjct: 249 LVSRFLVVQPQKRYT 263

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 8e-40
 Identities = 43/198 (21%), Positives = 74/198 (37%), Gaps = 33/198 (16%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
                  ++   + L+E   Q    Q L  L Y+H   +IHRDLK  N+L   + D+K+ 
Sbjct: 93  GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLA 152

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMNRR 115
           DFG++   T   +    ++ T ++ APE+++  +     Y    DVWS+G   +E+    
Sbjct: 153 DFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
           P     + +  +  +                    K     L Q  R S           
Sbjct: 213 PPHHELNPMRVLLKIA-------------------KSEPPTLAQPSRWS---------SN 244

Query: 176 AIDLVDRMLTFDPMKRIT 193
             D + + L  +   R T
Sbjct: 245 FKDFLKKCLEKNVDARWT 262

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  137 bits (346), Expect = 9e-40
 Identities = 41/193 (21%), Positives = 76/193 (39%), Gaps = 31/193 (16%)

Query: 4   DLYQII-RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKIC 60
           +L++ +   +  +SE+    ++ Q+ +GL ++H  N +H DLKP N++     + +LK+ 
Sbjct: 109 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLI 168

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL       + +     T  + APE+           D+WSVG +   L++    F G
Sbjct: 169 DFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGG 227

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +    +R +        D                             F  +     D +
Sbjct: 228 ENDDETLRNVKSCDWNMDD---------------------------SAFSGISEDGKDFI 260

Query: 181 DRMLTFDPMKRIT 193
            ++L  DP  R+T
Sbjct: 261 RKLLLADPNTRMT 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 9e-39
 Identities = 52/200 (26%), Positives = 77/200 (38%), Gaps = 41/200 (20%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIH-----SANVIHRDLKPSNLLLNAN 54
           DL  +I    +  Q L EE     + QL   LK  H        V+HRDLKP+N+ L+  
Sbjct: 91  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150

Query: 55  CDLKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLAR    +  F   +V T +Y +PE +   S Y    D+WS+GC+  EL  
Sbjct: 151 QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCA 209

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
             P F           + E                      R++P               
Sbjct: 210 LMPPFTAFSQKELAGKIRE-------------------GKFRRIP-----------YRYS 239

Query: 174 PLAIDLVDRMLTFDPMKRIT 193
               +++ RML      R +
Sbjct: 240 DELNEIITRMLNLKDYHRPS 259

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  134 bits (338), Expect = 1e-38
 Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 31/193 (16%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKIC 60
           +L+  I +    +SE     ++ Q   GLK++H  +++H D+KP N++        +KI 
Sbjct: 112 ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 171

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   + +E +     T  + APE +++        D+W++G +   L++    F G
Sbjct: 172 DFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D +  ++ +        +                             F  V P A D +
Sbjct: 231 EDDLETLQNVKRCDWEFDE---------------------------DAFSSVSPEAKDFI 263

Query: 181 DRMLTFDPMKRIT 193
             +L  +P KR+T
Sbjct: 264 KNLLQKEPRKRLT 276

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-38
 Identities = 40/193 (20%), Positives = 81/193 (41%), Gaps = 31/193 (16%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKIC 60
           D+++ I ++   L+E     +++Q+   L+++HS N+ H D++P N++     +  +KI 
Sbjct: 87  DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKII 146

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           +FG AR     +          Y APE+  +    + A D+WS+G +   L++    F  
Sbjct: 147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLA 205

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
             +   +  ++    T  +                           + F  +   A+D V
Sbjct: 206 ETNQQIIENIMNAEYTFDE---------------------------EAFKEISIEAMDFV 238

Query: 181 DRMLTFDPMKRIT 193
           DR+L  +   R+T
Sbjct: 239 DRLLVKERKSRMT 251

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 3e-38
 Identities = 52/207 (25%), Positives = 81/207 (39%), Gaps = 40/207 (19%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
               +    + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DFG
Sbjct: 101 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 160

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGN 121
            A   +       +V T ++ APE++L   +  Y   +DVWS+G   +EL  R+P     
Sbjct: 161 SASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
           + +  +                         +I Q      QS      H      + VD
Sbjct: 218 NAMSAL------------------------YHIAQNESPALQS-----GHWSEYFRNFVD 248

Query: 182 RMLTFDPMKRITGE------FFVPYKP 202
             L   P  R T E      F +  +P
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERP 275

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 7e-38
 Identities = 44/194 (22%), Positives = 80/194 (41%), Gaps = 30/194 (15%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +       + +   + E        + L+ L+++HS  VIHRD+K  N+LL  +  +K+ 
Sbjct: 99  LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFG     T E    +  V T ++ APE++   + Y   +D+WS+G + +E++   P + 
Sbjct: 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL 217

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             + +  + L I   GTP                             Q    +  +  D 
Sbjct: 218 NENPLRALYL-IATNGTPE---------------------------LQNPEKLSAIFRDF 249

Query: 180 VDRMLTFDPMKRIT 193
           ++R L  D  KR +
Sbjct: 250 LNRCLDMDVEKRGS 263

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 7e-38
 Identities = 83/205 (40%), Positives = 120/205 (58%), Gaps = 16/205 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+       E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 104 MDANLCQVIQMELD--HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 220

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH--------- 171
            D++ Q   +IE LGTP    +  +     + Y+   P++   +  ++FP          
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279

Query: 172 ---VHPLAIDLVDRMLTFDPMKRIT 193
                  A DL+ +ML  DP KRI+
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRIS 304

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-37
 Identities = 38/196 (19%), Positives = 77/196 (39%), Gaps = 31/196 (15%)

Query: 4   DLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            LY  +   ++            Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DF
Sbjct: 89  SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDF 148

Query: 63  GLAR---PTSENEFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPL 117
           GLA      S +    +   +  + APE++   + + Y+   DV++ G +  ELM  +  
Sbjct: 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +   ++  Q+  ++                            +    L++V  +      
Sbjct: 209 YSNINNRDQIIFMVGR-------------------------GYLSPDLSKVRSNCPKAMK 243

Query: 178 DLVDRMLTFDPMKRIT 193
            L+   L     +R  
Sbjct: 244 RLMAECLKKKRDERPL 259

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-37
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 35/195 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I DFG
Sbjct: 94  ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 153

Query: 64  LAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
            A+   P S+      +V T  Y +PELL   S    + D+W++GCI  +L+   P F  
Sbjct: 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRA 212

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +     +                       + I+     P            P A DLV
Sbjct: 213 GNEYLIFQ-----------------------KIIKLEYDFP--------EKFFPKARDLV 241

Query: 181 DRMLTFDPMKRITGE 195
           +++L  D  KR+  E
Sbjct: 242 EKLLVLDATKRLGCE 256

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 7e-37
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 29/195 (14%)

Query: 4   DLYQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLK 58
           +L+  I  R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK
Sbjct: 95  ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 154

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + DFG A+ T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F
Sbjct: 155 LTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
             N  +     +                    K  IR             +  V      
Sbjct: 214 YSNHGLAISPGM--------------------KTRIRMGQYEFPN---PEWSEVSEEVKM 250

Query: 179 LVDRMLTFDPMKRIT 193
           L+  +L  +P +R+T
Sbjct: 251 LIRNLLKTEPTQRMT 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-36
 Identities = 34/193 (17%), Positives = 72/193 (37%), Gaps = 34/193 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNA-NCDLKIC 60
            L   ++  + +  +  + +  Q+L+GL+++H+    +IHRDLK  N+ +      +KI 
Sbjct: 98  TLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D GLA       F    + T  + APE+      Y  ++DV++ G   +E+      +  
Sbjct: 158 DLGLAT-LKRASFAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSE 214

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
             +  Q+   +     P   D                                P   +++
Sbjct: 215 CQNAAQIYRRVTSGVKPASFD----------------------------KVAIPEVKEII 246

Query: 181 DRMLTFDPMKRIT 193
           +  +  +  +R +
Sbjct: 247 EGCIRQNKDERYS 259

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (315), Expect = 1e-35
 Identities = 45/193 (23%), Positives = 76/193 (39%), Gaps = 31/193 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL    + +  + I 
Sbjct: 93  ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I   L+   P F  
Sbjct: 153 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 211

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +       +++                                    +  +   A D +
Sbjct: 212 ENDAKLFEQILKAEYEFDS---------------------------PYWDDISDSAKDFI 244

Query: 181 DRMLTFDPMKRIT 193
             ++  DP KR T
Sbjct: 245 RHLMEKDPEKRFT 257

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 6e-34
 Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 33/191 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 89  DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 148

Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     +     +  T  Y APE+LL    Y  ++D WS G +  E++  +  F G D
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD 207

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                                              P +PR         +   A DL+ +
Sbjct: 208 EEELFH-----------------------SIRMDNPFYPR--------WLEKEAKDLLVK 236

Query: 183 MLTFDPMKRIT 193
           +   +P KR+ 
Sbjct: 237 LFVREPEKRLG 247

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  122 bits (306), Expect = 7e-34
 Identities = 42/190 (22%), Positives = 84/190 (44%), Gaps = 29/190 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 93  DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 152

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+     F  +  
Sbjct: 153 LACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +  +                     +  +    + P            P    L++ +
Sbjct: 212 KDKHEID--------------------RMTLTMAVELP--------DSFSPELRSLLEGL 243

Query: 184 LTFDPMKRIT 193
           L  D  +R+ 
Sbjct: 244 LQRDVNRRLG 253

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-33
 Identities = 40/194 (20%), Positives = 75/194 (38%), Gaps = 39/194 (20%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKI 59
              DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+
Sbjct: 93  PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 152

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG      ++   T++  TR Y  PE +     +  +  VWS+G +  +++     F 
Sbjct: 153 IDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            ++ + + ++                                          V      L
Sbjct: 212 HDEEIIRGQVFFR-------------------------------------QRVSSECQHL 234

Query: 180 VDRMLTFDPMKRIT 193
           +   L   P  R T
Sbjct: 235 IRWCLALRPSDRPT 248

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 1e-31
 Identities = 40/196 (20%), Positives = 83/196 (42%), Gaps = 30/196 (15%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
              +L+  +   +  +E   Q ++ +++  L+++H   +I+RD+K  N+LL++N  + + 
Sbjct: 112 NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171

Query: 61  DFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           DFGL++    +E            +     +    S +  A+D WS+G +  EL+     
Sbjct: 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F  +   +    +                   ++R ++  P +P          +  LA 
Sbjct: 232 FTVDGEKNSQAEI-------------------SRRILKSEPPYP--------QEMSALAK 264

Query: 178 DLVDRMLTFDPMKRIT 193
           DL+ R+L  DP KR+ 
Sbjct: 265 DLIQRLLMKDPKKRLG 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 3e-31
 Identities = 52/193 (26%), Positives = 79/193 (40%), Gaps = 32/193 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN----ANCDLKIC 60
           L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N++L         +KI 
Sbjct: 100 LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 159

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA              T  + APE ++N        D+WS+G I   L++    F G
Sbjct: 160 DFGLAHKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +     +  +  +     D                           + F +   LA D +
Sbjct: 219 DTKQETLANVSAVNYEFED---------------------------EYFSNTSALAKDFI 251

Query: 181 DRMLTFDPMKRIT 193
            R+L  DP KR+T
Sbjct: 252 RRLLVKDPKKRMT 264

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 3e-31
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 33/191 (17%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL
Sbjct: 92  LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151

Query: 65  ARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            +   S+   M  +  T  Y APE+L + +DY  A+D W +G +  E+M  R  F   DH
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                                         + +  + P          + P A  L+  +
Sbjct: 211 ERLFE-----------------------LILMEEIRFP--------RTLSPEAKSLLAGL 239

Query: 184 LTFDPMKRITG 194
           L  DP +R+ G
Sbjct: 240 LKKDPKQRLGG 250

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 3e-30
 Identities = 40/208 (19%), Positives = 72/208 (34%), Gaps = 28/208 (13%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANC 55
            L+  +    +++ E           GL ++H           + HRDLK  N+L+  N 
Sbjct: 87  SLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145

Query: 56  DLKICDFGLARPTSENE-----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVG 105
              I D GLA                 V T+ Y APE+L +S      +     D++++G
Sbjct: 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205

Query: 106 CIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
            +F E+  R  +  G    +Q+     +   P+  ++  V  E   R        P    
Sbjct: 206 LVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR--------PNIPN 256

Query: 166 AQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                    +   ++      +   R+T
Sbjct: 257 RWQSCEALRVMAKIMRECWYANGAARLT 284

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 7e-30
 Identities = 36/192 (18%), Positives = 64/192 (33%), Gaps = 34/192 (17%)

Query: 4   DLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
            L   +RS     L  +    F   +   ++Y+   N +HRDL   N+L++ +   K+ D
Sbjct: 87  SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 146

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FGL +  S         +   + APE L     ++   DVWS G +  E+ +   +    
Sbjct: 147 FGLTKEASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPR 203

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
             +  +   +E                  K Y    P               P   +++ 
Sbjct: 204 IPLKDVVPRVE------------------KGYKMDAP-----------DGCPPAVYEVMK 234

Query: 182 RMLTFDPMKRIT 193
                D   R +
Sbjct: 235 NCWHLDAAMRPS 246

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  108 bits (271), Expect = 2e-29
 Identities = 41/194 (21%), Positives = 76/194 (39%), Gaps = 32/194 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG
Sbjct: 97  TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156

Query: 64  LAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           +AR      +        + T  Y +PE     S   A  DV+S+GC+  E++   P F 
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFT 215

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+  V                           +++R+ P  P          +      +
Sbjct: 216 GDSPVSVAY-----------------------QHVREDPIPPS----ARHEGLSADLDAV 248

Query: 180 VDRMLTFDPMKRIT 193
           V + L  +P  R  
Sbjct: 249 VLKALAKNPENRYQ 262

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (275), Expect = 2e-29
 Identities = 42/192 (21%), Positives = 77/192 (40%), Gaps = 34/192 (17%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
              +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFG A+             T    APE++L+   Y  A+D W++G +  E+    P F  
Sbjct: 184 DFGFAKRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFA 240

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +  +                           + +    + P         H      DL+
Sbjct: 241 DQPIQIYE-----------------------KIVSGKVRFP--------SHFSSDLKDLL 269

Query: 181 DRMLTFDPMKRI 192
             +L  D  KR 
Sbjct: 270 RNLLQVDLTKRF 281

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-29
 Identities = 43/195 (22%), Positives = 68/195 (34%), Gaps = 34/195 (17%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
               +    + + L          Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ D
Sbjct: 97  SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 156

Query: 62  FGLARPTSENEF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLF 118
           FGLAR   +NE+           + APE  L    +T   DVWS G +  EL    R  +
Sbjct: 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY 215

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG  +   +  +      P                                P       D
Sbjct: 216 PGMVNREVLDQVERGYRMPCP------------------------------PECPESLHD 245

Query: 179 LVDRMLTFDPMKRIT 193
           L+ +    +P +R T
Sbjct: 246 LMCQCWRKEPEERPT 260

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 4e-29
 Identities = 42/183 (22%), Positives = 67/183 (36%), Gaps = 34/183 (18%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-- 72
           L+ E    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR    +   
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 73  -FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLL 130
                  +   + APE L     YT   DVWS G +  E+ +     +PG         L
Sbjct: 221 VVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279

Query: 131 IELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
           I+                    +    P            +       ++     FD  K
Sbjct: 280 IQ------------------NGFKMDQP-----------FYATEEIYIIMQSCWAFDSRK 310

Query: 191 RIT 193
           R +
Sbjct: 311 RPS 313

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (266), Expect = 2e-28
 Identities = 44/189 (23%), Positives = 83/189 (43%), Gaps = 34/189 (17%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+ ++R +Q       +++  ++   L+Y+HS ++I+RDLKP N+LL+ N  +KI DFG 
Sbjct: 91  LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           A+   +         T  Y APE ++++  Y  +ID WS G +  E++     F  ++ +
Sbjct: 151 AKYVPDV--TYTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
                                      + +    + P        P  +    DL+ R++
Sbjct: 208 KTYE-----------------------KILNAELRFP--------PFFNEDVKDLLSRLI 236

Query: 185 TFDPMKRIT 193
           T D  +R+ 
Sbjct: 237 TRDLSQRLG 245

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (265), Expect = 5e-28
 Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 27/217 (12%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNAN----- 54
            +         ++ +   + +    QLL GL Y+H    +IH D+KP N+L+        
Sbjct: 108 ENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167

Query: 55  -CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
              +KI D G A    E+      + TR YR+PE+LL +  +    D+WS  C+  EL+ 
Sbjct: 168 LIQIKIADLGNACWYDEHYTN--SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELIT 224

Query: 114 RRPLFPGND------HVHQMRLLIELLGTPTDADL-------GFVRNEDAKRYIRQLPQH 160
              LF  ++          +  +IELLG      L        F  +    R I +L   
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284

Query: 161 PRQSL----AQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           P + +     +          D +  ML  DP KR  
Sbjct: 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-27
 Identities = 44/193 (22%), Positives = 68/193 (35%), Gaps = 30/193 (15%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D        +  +LS +   +F   + RG+ Y+     IHRDL   N+L+  N   KI 
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+R        T   +   + A E L N S YT   DVWS G +  E+++       
Sbjct: 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                ++                            +LPQ  R        +      DL+
Sbjct: 229 GMTCAEL--------------------------YEKLPQGYRLEK---PLNCDDEVYDLM 259

Query: 181 DRMLTFDPMKRIT 193
            +     P +R +
Sbjct: 260 RQCWREKPYERPS 272

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (255), Expect = 5e-27
 Identities = 35/196 (17%), Positives = 61/196 (31%), Gaps = 33/196 (16%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           + T           LS         Q+  G+ Y+     +HRDL   N L+  N  +KI 
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182

Query: 61  DFGLAR--PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPL 117
           DFGL+R   +++               P   +  + YT   DVW+ G +  E+ +     
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           + G  H   +  + +                     I   P            +      
Sbjct: 243 YYGMAHEEVIYYVRD-------------------GNILACP-----------ENCPLELY 272

Query: 178 DLVDRMLTFDPMKRIT 193
           +L+    +  P  R +
Sbjct: 273 NLMRLCWSKLPADRPS 288

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-26
 Identities = 40/195 (20%), Positives = 72/195 (36%), Gaps = 36/195 (18%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFG
Sbjct: 93  PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 152

Query: 64  LARPTSENEF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLF 118
           L++    +E      T       + APE +     +++  DVWS G +  E  +  +  +
Sbjct: 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPY 211

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G        +L                    K      P                   D
Sbjct: 212 RGMKGSEVTAMLE-------------------KGERMGCP-----------AGCPREMYD 241

Query: 179 LVDRMLTFDPMKRIT 193
           L++   T+D   R  
Sbjct: 242 LMNLCWTYDVENRPG 256

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 2e-26
 Identities = 45/191 (23%), Positives = 71/191 (37%), Gaps = 34/191 (17%)

Query: 6   YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA 65
           +    S   L+         Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLA
Sbjct: 97  FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156

Query: 66  RPTSENEF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-NRRPLFPGND 122
           R   +NE+           + APE  +N   +T   DVWS G +  E++ + R  +PG  
Sbjct: 157 RLIEDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
           +   ++ L                 E   R +R               +       L+  
Sbjct: 216 NPEVIQNL-----------------ERGYRMVRP-------------DNCPEELYQLMRL 245

Query: 183 MLTFDPMKRIT 193
                P  R T
Sbjct: 246 CWKERPEDRPT 256

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 3e-26
 Identities = 36/197 (18%), Positives = 66/197 (33%), Gaps = 33/197 (16%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           + + L ++ +            +  Q+  G+ Y+ S   IHRDL   NLLL     +KI 
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 153

Query: 61  DFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RP 116
           DFGL R   +N+    M E+    +       L +  ++ A D W  G    E+    + 
Sbjct: 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
            + G +    +                        +  ++  + PR              
Sbjct: 214 PWIGLNGSQIL-----------------------HKIDKEGERLPRP------EDCPQDI 244

Query: 177 IDLVDRMLTFDPMKRIT 193
            +++ +     P  R T
Sbjct: 245 YNVMVQCWAHKPEDRPT 261

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 98.8 bits (245), Expect = 2e-25
 Identities = 31/202 (15%), Positives = 60/202 (29%), Gaps = 35/202 (17%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKI 59
           +        ++  S +       Q++  ++YIHS N IHRD+KP N L         + I
Sbjct: 88  SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 147

Query: 60  CDFGLARPTSENE--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            DFGLA+   +                 T  Y +    L   + +   D+ S+G + M  
Sbjct: 148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYF 206

Query: 112 MNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH 171
                 + G     + +                       +Y R   +     +  +   
Sbjct: 207 NLGSLPWQGLKAATKRQ-----------------------KYERISEKKMSTPIEVLCKG 243

Query: 172 VHPLAIDLVDRMLTFDPMKRIT 193
                   ++   +     +  
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPD 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.1 bits (241), Expect = 5e-25
 Identities = 36/196 (18%), Positives = 67/196 (34%), Gaps = 37/196 (18%)

Query: 4   DLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L++ +    + +   +    L+Q+  G+KY+   N +HRDL   N+LL      KI DF
Sbjct: 94  PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 153

Query: 63  GLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPL 117
           GL++    ++      +       + APE  +N   +++  DVWS G    E ++  +  
Sbjct: 154 GLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALSYGQKP 212

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +        M  +                    +    + P           P   P   
Sbjct: 213 YKKMKGPEVMAFIE-------------------QGKRMECP-----------PECPPELY 242

Query: 178 DLVDRMLTFDPMKRIT 193
            L+     +    R  
Sbjct: 243 ALMSDCWIYKWEDRPD 258

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 96.7 bits (240), Expect = 7e-25
 Identities = 36/193 (18%), Positives = 65/193 (33%), Gaps = 30/193 (15%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           +   Y    + Q +S     Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ D
Sbjct: 99  NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 158

Query: 62  FGLARPTSENEFMTEY-VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           FGL+R  + + +                 L  + ++   DVW+ G +  E+         
Sbjct: 159 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              + Q+  L+E                  K Y  + P                   +L+
Sbjct: 219 GIDLSQVYELLE------------------KDYRMERP-----------EGCPEKVYELM 249

Query: 181 DRMLTFDPMKRIT 193
                ++P  R +
Sbjct: 250 RACWQWNPSDRPS 262

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 2e-24
 Identities = 41/196 (20%), Positives = 71/196 (36%), Gaps = 13/196 (6%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  +     ++  ++   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGL
Sbjct: 98  LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 157

Query: 65  AR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
           A+      +        V   + A E +L+   YT   DVWS G    ELM      + G
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDG 216

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP---RQSLAQVFPHVHPLAI 177
                   +L +    P           D    + +        R    ++      +A 
Sbjct: 217 IPASEISSILEKGERLPQPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

Query: 178 DLVDRMLTFDPMKRIT 193
           D   R L     +R+ 
Sbjct: 273 DP-QRYLVIQGDERMH 287

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.8 bits (235), Expect = 3e-24
 Identities = 37/193 (19%), Positives = 66/193 (34%), Gaps = 33/193 (17%)

Query: 4   DLYQIIRSNQSL-SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R+ + L + E        +  G+ Y+  A VIHRDL   N L+  N  +K+ DF
Sbjct: 86  CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 145

Query: 63  GLARPTSENE--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           G+ R   +++    T       + +PE + + S Y++  DVWS G +  E+ +   +   
Sbjct: 146 GMTRFVLDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           N    ++   I          L                                    ++
Sbjct: 205 NRSNSEVVEDISTGFRLYKPRL-----------------------------ASTHVYQIM 235

Query: 181 DRMLTFDPMKRIT 193
           +      P  R  
Sbjct: 236 NHCWKERPEDRPA 248

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.0 bits (233), Expect = 5e-24
 Identities = 28/196 (14%), Positives = 61/196 (31%), Gaps = 34/196 (17%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
               L  +         +        +   ++Y+ S   +HRDL   N L+N    +K+ 
Sbjct: 83  NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 142

Query: 61  DFGLARPTSENEF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPL 117
           DFGL+R   ++E+           +  PE+L+ S  +++  D+W+ G +  E+ +  +  
Sbjct: 143 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMP 201

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +    +      + + L                                           
Sbjct: 202 YERFTNSETAEHIAQGLRLYRP------------------------------HLASEKVY 231

Query: 178 DLVDRMLTFDPMKRIT 193
            ++         +R T
Sbjct: 232 TIMYSCWHEKADERPT 247

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 94.5 bits (234), Expect = 5e-24
 Identities = 25/202 (12%), Positives = 58/202 (28%), Gaps = 37/202 (18%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-----DL 57
           +    +    +  S +       Q+L  ++ IH  ++++RD+KP N L+          +
Sbjct: 86  SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI 145

Query: 58  KICDFGLARPTSENE--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
            + DFG+ +   +                 T  Y +    L   + +   D+ ++G +FM
Sbjct: 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFM 204

Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF 169
             +     + G       +                       +Y R   +     L ++ 
Sbjct: 205 YFLRGSLPWQGLKAATNKQ-----------------------KYERIGEKKQSTPLRELC 241

Query: 170 PHVHPLAIDLVDRMLTFDPMKR 191
                     +           
Sbjct: 242 AGFPEEFYKYMHYARNLAFDAT 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.0 bits (233), Expect = 7e-24
 Identities = 35/184 (19%), Positives = 59/184 (32%), Gaps = 36/184 (19%)

Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT 75
           +       L  +  G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   ++    
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185

Query: 76  EYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRL 129
            Y      + P             +T+A DVWS G +  E+M+     +    +   +  
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245

Query: 130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPM 189
           + +    P   D                                     L+      D  
Sbjct: 246 IEQDYRLPPPMD------------------------------CPSALHQLMLDCWQKDRN 275

Query: 190 KRIT 193
            R  
Sbjct: 276 HRPK 279

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 2e-23
 Identities = 40/194 (20%), Positives = 72/194 (37%), Gaps = 32/194 (16%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
                 +     SL       + YQL   L Y+ S   +HRD+   N+L+++N  +K+ D
Sbjct: 92  GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 151

Query: 62  FGLARPTSENEFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           FGL+R   ++ +   ++  +   + APE  +N   +T+A DVW  G    E++       
Sbjct: 152 FGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                + +   IE                        +P           P+  P    L
Sbjct: 211 QGVKNNDVIGRIE------------------NGERLPMP-----------PNCPPTLYSL 241

Query: 180 VDRMLTFDPMKRIT 193
           + +   +DP +R  
Sbjct: 242 MTKCWAYDPSRRPR 255

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.4 bits (231), Expect = 2e-23
 Identities = 41/185 (22%), Positives = 72/185 (38%), Gaps = 34/185 (18%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR---PTS 69
             L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR      
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMR 128
           +     +  +   + APE + +   YT   DVWS G +  E+ +     +PG     +  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
             ++                  +    + P            +  P     +      +P
Sbjct: 248 RRLK------------------EGTRMRAP-----------DYTTPEMYQTMLDCWHGEP 278

Query: 189 MKRIT 193
            +R T
Sbjct: 279 SQRPT 283

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 2e-23
 Identities = 36/197 (18%), Positives = 65/197 (32%), Gaps = 34/197 (17%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
                  +   +   S       L  +  G+KY+ + N +HRDL   N+L+N+N   K+ 
Sbjct: 93  NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 152

Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGL+R   ++       +   +   + APE +      +A+ DVWS G +  E+M    
Sbjct: 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGE 211

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
                   H++   I                     +    P                  
Sbjct: 212 RPYWELSNHEVMKAIN------------------DGFRLPTP-----------MDCPSAI 242

Query: 177 IDLVDRMLTFDPMKRIT 193
             L+ +    +  +R  
Sbjct: 243 YQLMMQCWQQERARRPK 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 6e-23
 Identities = 51/195 (26%), Positives = 72/195 (36%), Gaps = 34/195 (17%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T    +     +L  E    F YQ+ +G+ ++ S N IHRDL   N+LL      KICDF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189

Query: 63  GLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLF 118
           GLAR     S         +   + APE + N   YT   DVWS G    EL +     +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPY 248

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG     +   +I+                  + +    P            H      D
Sbjct: 249 PGMPVDSKFYKMIK------------------EGFRMLSP-----------EHAPAEMYD 279

Query: 179 LVDRMLTFDPMKRIT 193
           ++      DP+KR T
Sbjct: 280 IMKTCWDADPLKRPT 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 1e-22
 Identities = 44/197 (22%), Positives = 71/197 (36%), Gaps = 35/197 (17%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           ++          + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI 
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177

Query: 61  DFGLARPTSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RP 116
           DFGLAR     ++  +     +   + APE L +   YT   DVWS G +  E+      
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGS 236

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
            +PG       +LL E                    +    P            +     
Sbjct: 237 PYPGVPVEELFKLLKE-------------------GHRMDKP-----------SNCTNEL 266

Query: 177 IDLVDRMLTFDPMKRIT 193
             ++       P +R T
Sbjct: 267 YMMMRDCWHAVPSQRPT 283

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.5 bits (216), Expect = 3e-21
 Identities = 35/187 (18%), Positives = 65/187 (34%), Gaps = 35/187 (18%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
             + + +    F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + 
Sbjct: 124 THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183

Query: 72  EF-----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
           EF      T   +   + A E L     +T   DVWS G +  ELM R      + +   
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF 186
           + + +         +                             +      +++ +    
Sbjct: 243 ITVYLLQGRRLLQPE-----------------------------YCPDPLYEVMLKCWHP 273

Query: 187 DPMKRIT 193
               R +
Sbjct: 274 KAEMRPS 280

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 4e-21
 Identities = 33/183 (18%), Positives = 68/183 (37%), Gaps = 35/183 (19%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF- 73
            S         ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++ 
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189

Query: 74  --MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
               + ++   + +PE L +   +T   DVWS G +  E+       + G  +   +R +
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

Query: 131 IELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
           +E                        L   P         +   +  +L+     ++P  
Sbjct: 249 ME----------------------GGLLDKP--------DNCPDMLFELMRMCWQYNPKM 278

Query: 191 RIT 193
           R +
Sbjct: 279 RPS 281

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 71.4 bits (174), Expect = 3e-16
 Identities = 15/110 (13%), Positives = 34/110 (30%), Gaps = 14/110 (12%)

Query: 6   YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA 65
               +    +  E+    L  +L  +   +   ++H DL   N+L++    + I DF  +
Sbjct: 91  LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 149

Query: 66  RPTSENE-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
               E             +  ++           Y    D+ S     ++
Sbjct: 150 VEVGEEGWREILERDVRNIITYFS--------RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	217
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.41
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.26
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	94.36
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	93.79
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	93.51
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	92.08
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	86.28

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=277.81  Aligned_cols=195  Identities=38%  Similarity=0.681  Sum_probs=166.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCcccccC
Q 027927           12 NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLN   91 (217)
Q Consensus        12 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~   91 (217)
                      ...+++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+.............||+.|+|||++.+
T Consensus       110 ~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~  189 (305)
T d1blxa_         110 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ  189 (305)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC
Confidence            46799999999999999999999999999999999999999999999999999877666666677889999999999866


Q ss_pred             CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCC
Q 027927           92 SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH  171 (217)
Q Consensus        92 ~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (217)
                      .+ ++.++||||+||++|+|++|..||.+.+....+..+.+..+.+....+........    .................
T Consensus       190 ~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  264 (305)
T d1blxa_         190 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR----QAFHSKSAQPIEKFVTD  264 (305)
T ss_dssp             CC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG----GGSCCCCCCCGGGTCCS
T ss_pred             CC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchh----hhhccccccchhhcccc
Confidence            54 89999999999999999999999999999999999999999887766543322211    11122233345556678


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCcee
Q 027927          172 VHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGCIE  211 (217)
Q Consensus       172 ~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~~~  211 (217)
                      +++.+++||++||+.||++|||++|+|+||||++.+.|.|
T Consensus       265 ~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ke  304 (305)
T d1blxa_         265 IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  304 (305)
T ss_dssp             CCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhCC
Confidence            8999999999999999999999999999999999988865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-45  Score=277.38  Aligned_cols=177  Identities=27%  Similarity=0.390  Sum_probs=144.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---Ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~   78 (217)
                      ||+|.++++++..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......   .......
T Consensus        87 gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~  166 (271)
T d1nvra_          87 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  166 (271)
T ss_dssp             TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCC
T ss_pred             CCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccccee
Confidence            5799999999899999999999999999999999999999999999999999999999999999765332   2334567


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ||+.|+|||++.+....+.++||||+||++|++++|+.||....+..............                     
T Consensus       167 GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------------------  225 (271)
T d1nvra_         167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------------  225 (271)
T ss_dssp             SCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------------
T ss_pred             eCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------------
Confidence            89999999999776645678999999999999999999997654322221111100000                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ...+..+++++.+||++||+.||++|||++|+++||||++.
T Consensus       226 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         226 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             -------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             -------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence                   01123478999999999999999999999999999999853

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-45  Score=274.83  Aligned_cols=171  Identities=26%  Similarity=0.391  Sum_probs=148.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ......||+
T Consensus        90 ~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~  168 (263)
T d2j4za1          90 LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTL  168 (263)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEETTEEG
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccccCCCC
Confidence            6799999999999999999999999999999999999999999999999999999999999999765543 334567899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||++.+.. ++.++|||||||++|++++|+.||.+.+....+..+....  +                        
T Consensus       169 ~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~------------------------  221 (263)
T d2j4za1         169 DYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--F------------------------  221 (263)
T ss_dssp             GGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--C------------------------
T ss_pred             cccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C------------------------
Confidence            999999997654 7899999999999999999999998877666655543210  0                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                           ..+..+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       222 -----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                 112347899999999999999999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=277.57  Aligned_cols=202  Identities=35%  Similarity=0.601  Sum_probs=166.9

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-ccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~   81 (217)
                      +++..+...+..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+....... ......+++
T Consensus        85 ~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~  164 (299)
T d1ua2a_          85 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR  164 (299)
T ss_dssp             EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCC
T ss_pred             hHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecCh
Confidence            3444555556789999999999999999999999999999999999999999999999999997655432 334567899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||++.....++.++||||+||++|++++|..||.+..+.+++..+.+..+.+....+.........   ......+
T Consensus       165 ~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  241 (299)
T d1ua2a_         165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY---VTFKSFP  241 (299)
T ss_dssp             TTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC---CCCCCCC
T ss_pred             hhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh---hhhccCC
Confidence            9999999877666899999999999999999999999999999999999999998877665433221110   1112223


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ...+....+.+++++++||++||+.||++|||++|+|+||||++..
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            3445666778899999999999999999999999999999999754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-44  Score=275.81  Aligned_cols=177  Identities=26%  Similarity=0.435  Sum_probs=138.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe---cCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---ANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||++.   .++.++|+|||++.............
T Consensus        91 gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~  170 (307)
T d1a06a_          91 GGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC  170 (307)
T ss_dssp             SCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------------
T ss_pred             CCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeee
Confidence            689999999999999999999999999999999999999999999999994   57899999999998776666666778


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.........+........                    
T Consensus       171 GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------------  229 (307)
T d1a06a_         171 GTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD--------------------  229 (307)
T ss_dssp             --CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC--------------------
T ss_pred             eCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC--------------------
Confidence            99999999998655 478999999999999999999999988776666655543111111                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             ....+.+|+++.+||.+||+.||++|||++|+++||||++.
T Consensus       230 -------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         230 -------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             -------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             -------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                   12234688999999999999999999999999999999853

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=270.38  Aligned_cols=175  Identities=22%  Similarity=0.413  Sum_probs=148.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      |++|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .......||
T Consensus       101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt  179 (293)
T d1yhwa1         101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  179 (293)
T ss_dssp             TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccC
Confidence            6899998877 57999999999999999999999999999999999999999999999999999876543 334556789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+. .++.++||||+||++|+|++|..||.+.........+........                      
T Consensus       180 ~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~----------------------  236 (293)
T d1yhwa1         180 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL----------------------  236 (293)
T ss_dssp             GGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC----------------------
T ss_pred             CCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----------------------
Confidence            999999999665 478999999999999999999999988776666655544221110                      


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                            ..+..+++++.+||++||+.||++|||++|+|+||||+..
T Consensus       237 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         237 ------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             ------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                  1122478999999999999999999999999999999854

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-43  Score=274.84  Aligned_cols=208  Identities=51%  Similarity=0.959  Sum_probs=181.5

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC----cccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTE   76 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~   76 (217)
                      .|++|.+++..+ .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+.......    ....
T Consensus        93 ~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  171 (345)
T d1pmea_          93 MGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE  171 (345)
T ss_dssp             CCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred             cCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecc
Confidence            478999999874 79999999999999999999999999999999999999999999999999986544332    2344


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|+|||.+.....++.++|+||+||++|++++|..||.+................+...................
T Consensus       172 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (345)
T d1pmea_         172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS  251 (345)
T ss_dssp             CCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred             ccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccccc
Confidence            56889999999987666678999999999999999999999999998889888888888887776666666666677777


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccCc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCGC  209 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~~  209 (217)
                      ........+....+++++++++||.+||+.||.+|||++|+|+||||+.....
T Consensus       252 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             SCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             CCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence            77777777888889999999999999999999999999999999999966443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-43  Score=274.44  Aligned_cols=204  Identities=42%  Similarity=0.843  Sum_probs=182.9

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      +|.+|.+++++ .++++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+......  .....++
T Consensus       105 ~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t  181 (346)
T d1cm8a_         105 MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVT  181 (346)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSC
T ss_pred             ccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc--ccccccc
Confidence            46677777665 67999999999999999999999999999999999999999999999999999776543  3456789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+...++.++||||+||++|++++|..||.+.+....+..+....+.++...+..................
T Consensus       182 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (346)
T d1cm8a_         182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL  261 (346)
T ss_dssp             GGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCC
T ss_pred             ccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcc
Confidence            99999999987766789999999999999999999999999999999999999999988877777777777778888887


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ....+.....++++++++||++||..||++|||++|+|+||||++..
T Consensus       262 ~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         262 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             cccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            78888888889999999999999999999999999999999999754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.9e-43  Score=268.27  Aligned_cols=178  Identities=29%  Similarity=0.457  Sum_probs=153.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.++++.++++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.............|++
T Consensus        94 ~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~  173 (277)
T d1phka_          94 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP  173 (277)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred             CchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccC
Confidence            67999999999999999999999999999999999999999999999999999999999999998877666666678899


Q ss_pred             cccCccccc-----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           82 WYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        82 ~~~~Pe~~~-----~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .|.+||.+.     ....++.++||||+||++|++++|+.||.+.........+......+.                  
T Consensus       174 ~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------  235 (277)
T d1phka_         174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG------------------  235 (277)
T ss_dssp             GGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------------------
T ss_pred             CCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence            999999885     233467899999999999999999999998887766666554211111                  


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                               .....++|+++.+||.+||+.||++|||++|+++||||++.
T Consensus       236 ---------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         236 ---------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             ---------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ---------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                     11223588999999999999999999999999999999853

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=267.95  Aligned_cols=172  Identities=21%  Similarity=0.337  Sum_probs=142.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCcCCCCEEEe-cCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.++++++..+++..++.++.||+.||+|||+++  |+||||||+||+++ .++.+||+|||++..... .......
T Consensus        96 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~~~~~~~  174 (270)
T d1t4ha_          96 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVI  174 (270)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESC
T ss_pred             CCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-CccCCcc
Confidence            6799999999999999999999999999999999998  99999999999996 478999999999975433 3345668


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ||+.|+|||.+.+  .++.++||||+||++|+|++|..||.+........+.+.....+                     
T Consensus       175 GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~---------------------  231 (270)
T d1t4ha_         175 GTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------------------  231 (270)
T ss_dssp             SSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------------------
T ss_pred             cCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC---------------------
Confidence            9999999998854  38899999999999999999999998765443332222110000                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQ  204 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~  204 (217)
                             .......++++.++|++||+.||++|||++|+|+||||+
T Consensus       232 -------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                   112234778999999999999999999999999999996

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.3e-43  Score=268.17  Aligned_cols=201  Identities=37%  Similarity=0.614  Sum_probs=163.3

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-cccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~   81 (217)
                      +.+..+.+.++.+++..+..++.||+.||+|||++||+||||||+||+++.++.++++|||.+........ .....+++
T Consensus        85 ~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  164 (286)
T d1ob3a_          85 DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL  164 (286)
T ss_dssp             EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCC
T ss_pred             hhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccc
Confidence            34555556678899999999999999999999999999999999999999999999999999876554322 34456788


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|.+||.+.+...++.++|+||+||++|++++|..||.+....+...++....+.+....+......  .+.........
T Consensus       165 ~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  242 (286)
T d1ob3a_         165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--PKYDPNFTVYE  242 (286)
T ss_dssp             TTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCCTTCCCCC
T ss_pred             hhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh--hhccccccccc
Confidence            9999999987777899999999999999999999999999999999999998888877665433221  11122223333


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                      ..........+++++.+||++||+.||++|||++|+++||||++
T Consensus       243 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            44566677789999999999999999999999999999999984

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.5e-43  Score=275.27  Aligned_cols=177  Identities=23%  Similarity=0.352  Sum_probs=152.3

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec--CCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      ||+|.+++.+ ++++++..+..++.||+.||+|||++|++||||||+||+++.  ++.+||+|||++.............
T Consensus       107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  186 (350)
T d1koaa2         107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT  186 (350)
T ss_dssp             SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEEC
T ss_pred             CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceec
Confidence            6899999964 468999999999999999999999999999999999999964  5789999999998877776667788


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ||+.|+|||++.+.+ ++.++|||||||++|+|++|..||.+.+..+.+..+.........                   
T Consensus       187 gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------  246 (350)
T d1koaa2         187 GTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-------------------  246 (350)
T ss_dssp             SCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-------------------
T ss_pred             CcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------------------
Confidence            999999999997654 789999999999999999999999988877777766543222111                   


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                              .....+++++.+||++||+.||++|||++|+|+||||++.
T Consensus       247 --------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         247 --------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             --------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             --------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                    1223578999999999999999999999999999999854

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-43  Score=268.55  Aligned_cols=205  Identities=38%  Similarity=0.673  Sum_probs=167.9

Q ss_pred             CCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCccccc
Q 027927            1 MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEY   77 (217)
Q Consensus         1 l~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~   77 (217)
                      +++++.+++..  ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++++|||.+..... .......
T Consensus        83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~  162 (298)
T d1gz8a_          83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE  162 (298)
T ss_dssp             CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCC
T ss_pred             cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceee
Confidence            35666666644  36799999999999999999999999999999999999999999999999999976543 3344556


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||.+......+.++|+||+||++|++++|..||.+.+....+..+....+.+.+..+......  .......
T Consensus       163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~  240 (298)
T d1gz8a_         163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--PDYKPSF  240 (298)
T ss_dssp             BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCCTTS
T ss_pred             cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc--ccccccc
Confidence            78999999999877776789999999999999999999999999989999999888888776655432211  1112222


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ............+.+++++.+||++||+.||++|||++|+++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            23333445566678899999999999999999999999999999999763

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6e-43  Score=274.75  Aligned_cols=177  Identities=24%  Similarity=0.388  Sum_probs=153.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe--cCCCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++.+. .++++..++.++.||+.||+|||++||+||||||+||+++  .++.++|+|||++.............
T Consensus       110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~  189 (352)
T d1koba_         110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT  189 (352)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEEC
T ss_pred             CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeecc
Confidence            68999988765 5799999999999999999999999999999999999997  57899999999998887776677788


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+......++.                   
T Consensus       190 gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------  249 (352)
T d1koba_         190 ATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-------------------  249 (352)
T ss_dssp             SSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-------------------
T ss_pred             CcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------------------
Confidence            999999999986554 899999999999999999999999998877777666552222111                   


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                              ..+..+++++.+||++||+.||.+|||++|+|+||||++.
T Consensus       250 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         250 --------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             --------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             --------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                    1234688999999999999999999999999999999854

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=270.59  Aligned_cols=173  Identities=27%  Similarity=0.482  Sum_probs=150.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCC-CCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~   80 (217)
                      ||+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++..... ........||
T Consensus        89 gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT  168 (337)
T d1o6la_          89 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  168 (337)
T ss_dssp             TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEEC
T ss_pred             CCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeC
Confidence            689999999999999999999999999999999999999999999999999999999999999986543 3445567899


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+.+ ++.++|+||+||++|+|++|..||.+.+.......+...  .+                       
T Consensus       169 ~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~-----------------------  222 (337)
T d1o6la_         169 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EI-----------------------  222 (337)
T ss_dssp             GGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-----------------------
T ss_pred             HHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CC-----------------------
Confidence            9999999987655 799999999999999999999999988876666555431  11                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                            ..+..+|+++++||++||+.||++|++     ++++++||||++.
T Consensus       223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence                  122357899999999999999999994     9999999999854

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=268.86  Aligned_cols=173  Identities=31%  Similarity=0.545  Sum_probs=146.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---Ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~   78 (217)
                      ||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++......   .......
T Consensus        92 gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~  171 (288)
T d1uu3a_          92 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV  171 (288)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CC
T ss_pred             CCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccccccc
Confidence            6799999999999999999999999999999999999999999999999999999999999999766432   2234567


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+.......+...  .+                     
T Consensus       172 GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~---------------------  227 (288)
T d1uu3a_         172 GTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EY---------------------  227 (288)
T ss_dssp             CCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CC---------------------
T ss_pred             CCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CC---------------------
Confidence            899999999997665 789999999999999999999999988777666655431  00                     


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhh------ccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF------VPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~l------l~~~~f~~~  206 (217)
                              .++..+++++.+||++||+.||++|||++|+      ++||||++.
T Consensus       228 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         228 --------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             --------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             --------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence                    1123578999999999999999999999984      789999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-43  Score=267.48  Aligned_cols=177  Identities=21%  Similarity=0.353  Sum_probs=145.8

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Cccccccc
Q 027927            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~   79 (217)
                      ||+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......|
T Consensus        93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~G  172 (288)
T d2jfla1          93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG  172 (288)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCS
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccccccc
Confidence            6899999765 577999999999999999999999999999999999999999999999999998654332 22345678


Q ss_pred             cccccCcccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        80 ~~~~~~Pe~~~~----~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ++.|+|||++..    ...++.++||||+||++|++++|..||.+....+.+..+....  ++.                
T Consensus       173 t~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~~----------------  234 (288)
T d2jfla1         173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PPT----------------  234 (288)
T ss_dssp             CCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CCC----------------
T ss_pred             ccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCC----------------
Confidence            999999999852    3346889999999999999999999998877666655554311  100                


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                                ...+..+++++.+||++||+.||++|||++|+++||||+..
T Consensus       235 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         235 ----------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             ----------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             ----------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                      01123478999999999999999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-42  Score=271.06  Aligned_cols=205  Identities=50%  Similarity=0.908  Sum_probs=180.1

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         1 l~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      .|++|.+++.. +++++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+.....  ......++
T Consensus       105 ~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~  181 (348)
T d2gfsa1         105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVAT  181 (348)
T ss_dssp             CSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--GGSSSCHH
T ss_pred             cCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--cccccccc
Confidence            47899999965 5799999999999999999999999999999999999999999999999999865433  33456788


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||.+.+....+.++|+||+||++|++++|..||.+.+.......+....+.+.......................
T Consensus       182 ~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (348)
T d2gfsa1         182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM  261 (348)
T ss_dssp             HHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCC
T ss_pred             ccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccC
Confidence            99999999877776789999999999999999999999999999999999999888887777777777777777778888


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      +...+......+++++++||++||+.||++|||++|+|+||||++...
T Consensus       262 ~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence            888888888899999999999999999999999999999999997643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=267.60  Aligned_cols=177  Identities=28%  Similarity=0.407  Sum_probs=151.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC----CEEEecccccccCCCCCccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~   77 (217)
                      ||+|.+++++++.+++..++.++.||+.||+|||++||+||||||+||+++.++    .++++|||++............
T Consensus        97 gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~  176 (293)
T d1jksa_          97 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI  176 (293)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCC
T ss_pred             CccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCcccccc
Confidence            689999999999999999999999999999999999999999999999998776    4999999999887766666677


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||++.+. .++.++||||+||++|++++|..||.+.+..+.+..+......                     
T Consensus       177 ~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---------------------  234 (293)
T d1jksa_         177 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE---------------------  234 (293)
T ss_dssp             CCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---------------------
T ss_pred             CCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------------------
Confidence            889999999999654 4789999999999999999999999988776666555431111                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                            .....+.++|+++.+||++||+.||++|||++|+++||||+..
T Consensus       235 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         235 ------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             ------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             ------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                  1122334688999999999999999999999999999999854

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=276.45  Aligned_cols=201  Identities=21%  Similarity=0.357  Sum_probs=142.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (217)
                      |++|.+++.+++.+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++...... ......||
T Consensus        88 gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT  166 (322)
T d1s9ja_          88 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGT  166 (322)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCS
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCC
Confidence            57999999999999999999999999999999997 59999999999999999999999999998755332 23456889


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCCccccccC-------------
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ-MRLLIELLGTPTDADLGFVR-------------  146 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-------------  146 (217)
                      +.|+|||++.+.+ ++.++||||+||++|++++|+.||.+.+.... ........+...........             
T Consensus       167 ~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (322)
T d1s9ja_         167 RSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR  245 (322)
T ss_dssp             SCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------
T ss_pred             ccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccc
Confidence            9999999997655 89999999999999999999999987654322 22222222221111000000             


Q ss_pred             -chHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          147 -NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       147 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                       ..................  .....+|+++.+||++||+.||++|||++|+|+||||++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         246 PPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             CCCCHHHHHHHHHTSCCCC--CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cchhHHHHHhhhhccCCcc--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence             000000000000000000  0012367899999999999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.3e-42  Score=272.63  Aligned_cols=176  Identities=24%  Similarity=0.383  Sum_probs=146.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.++..+++..++.++.||+.||+|||++|++||||||+||+++.+|.+||+|||++....... .....||+
T Consensus        91 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~  169 (364)
T d1omwa3          91 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  169 (364)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCG
T ss_pred             CCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-cccccccc
Confidence            68999999999999999999999999999999999999999999999999999999999999998665443 34567999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||++.....++.++|||||||++|+|++|..||.+................+                        
T Consensus       170 ~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------------------------  225 (364)
T d1omwa3         170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------------------------  225 (364)
T ss_dssp             GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC------------------------
T ss_pred             ccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC------------------------
Confidence            99999999766568899999999999999999999997654322211111100000                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCC-----HhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----GEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~~ll~~~~f~~~  206 (217)
                          ...+..+++++.+||.+||+.||++|||     ++++++||||++.
T Consensus       226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         226 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             ----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence                1123458899999999999999999999     7999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=263.11  Aligned_cols=171  Identities=29%  Similarity=0.443  Sum_probs=135.2

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC-----cEecCcCCCCEEEecCCCEEEecccccccCCCCC
Q 027927            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (217)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~-----i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (217)
                      ||+|.+++.+    +..+++..++.++.||+.||+|||++|     |+||||||+||+++.++.+||+|||++.......
T Consensus        89 ~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  168 (269)
T d2java1          89 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  168 (269)
T ss_dssp             TEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred             CCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence            6799999864    478999999999999999999999976     9999999999999999999999999998765433


Q ss_pred             -ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHH
Q 027927           73 -FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (217)
Q Consensus        73 -~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (217)
                       ......+|+.|+|||++.+. .++.++|||||||++|++++|+.||.+.+..+....+...  ..              
T Consensus       169 ~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--~~--------------  231 (269)
T d2java1         169 SFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KF--------------  231 (269)
T ss_dssp             -------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CC--------------
T ss_pred             CccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CC--------------
Confidence             33456789999999998654 4889999999999999999999999887766665555431  00              


Q ss_pred             HHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCC
Q 027927          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPF  203 (217)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f  203 (217)
                                    ...+..+|+++.+||++||+.||++|||++|+++|||+
T Consensus       232 --------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         232 --------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                          11223578999999999999999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-42  Score=266.90  Aligned_cols=173  Identities=27%  Similarity=0.373  Sum_probs=146.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|..++..++++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......   ....||+
T Consensus        99 ~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~~GT~  175 (309)
T d1u5ra_          99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTP  175 (309)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCG
T ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---CccccCc
Confidence            5677778888899999999999999999999999999999999999999999999999999999765443   3457899


Q ss_pred             cccCcccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           82 WYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        82 ~~~~Pe~~~~--~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      .|+|||++.+  ...++.++|||||||++|++++|..||.+......+..+.......                      
T Consensus       176 ~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------  233 (309)
T d1u5ra_         176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----------------------  233 (309)
T ss_dssp             GGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------------
T ss_pred             cccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----------------------
Confidence            9999999864  2347889999999999999999999998877666655554311110                      


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                             .....+|+++.+||++||+.||++|||++|+|+||||.+.
T Consensus       234 -------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         234 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             -------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence                   0112478999999999999999999999999999999854

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.1e-42  Score=269.35  Aligned_cols=171  Identities=25%  Similarity=0.418  Sum_probs=149.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|.+++.+++.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......  .....|++
T Consensus       125 ~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~  202 (350)
T d1rdqe_         125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTP  202 (350)
T ss_dssp             TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECG
T ss_pred             ccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cccccCcc
Confidence            7899999999999999999999999999999999999999999999999999999999999999876543  34568899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+....  +                        
T Consensus       203 ~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~------------------------  255 (350)
T d1rdqe_         203 EALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--V------------------------  255 (350)
T ss_dssp             GGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------------------------
T ss_pred             ccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--C------------------------
Confidence            999999997654 7899999999999999999999999887766666654411  0                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                           ..+..+++++.++|++||+.||++|+     |++++++||||++.
T Consensus       256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence                 11235789999999999999999995     99999999999854

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-42  Score=270.29  Aligned_cols=204  Identities=37%  Similarity=0.669  Sum_probs=163.3

Q ss_pred             CccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-CEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      ++.+.+.+    .....+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++...........
T Consensus       102 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~  181 (350)
T d1q5ka_         102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS  181 (350)
T ss_dssp             SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCS
T ss_pred             CCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCccccc
Confidence            44444444    4567899999999999999999999999999999999999999875 899999999988776666677


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..+++.|.|||.+.+...++.++||||+||++|++++|..||........+..+.+..+.+....+..........   .
T Consensus       182 ~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~---~  258 (350)
T d1q5ka_         182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---K  258 (350)
T ss_dssp             CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC---C
T ss_pred             ccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc---c
Confidence            7899999999998777678999999999999999999999999999999999999988887655433211110000   0


Q ss_pred             CCCCCccc-hhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          157 LPQHPRQS-LAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       157 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                      ........ .....+..++++.+||++||..||++|||+.|+|+||||++...
T Consensus       259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            11111111 22233567899999999999999999999999999999997644

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-41  Score=262.69  Aligned_cols=171  Identities=26%  Similarity=0.445  Sum_probs=149.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      |++|..++..+..+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||.+......  .....|++
T Consensus        88 gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~  165 (316)
T d1fota_          88 GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTP  165 (316)
T ss_dssp             SCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCT
T ss_pred             CccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cccccCcc
Confidence            6899999999999999999999999999999999999999999999999999999999999999876543  34568999


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||++.+.+ ++.++|||||||++|+|++|..||.+.+..+....+....  .                        
T Consensus       166 ~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~------------------------  218 (316)
T d1fota_         166 DYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--L------------------------  218 (316)
T ss_dssp             TTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--C------------------------
T ss_pred             cccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--C------------------------
Confidence            999999986554 7899999999999999999999999888777766655410  0                        


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                           ..++.+++++.++|++||..||.+|+     |++++++||||++.
T Consensus       219 -----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         219 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             -----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence                 12235789999999999999999996     99999999999865

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-41  Score=261.80  Aligned_cols=203  Identities=34%  Similarity=0.553  Sum_probs=159.0

Q ss_pred             cHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-----ccccc
Q 027927            4 DLYQI-IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-----FMTEY   77 (217)
Q Consensus         4 ~L~~~-l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~   77 (217)
                      .+... ......+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||++.......     .....
T Consensus       102 ~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  181 (318)
T d3blha1         102 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR  181 (318)
T ss_dssp             EHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSC
T ss_pred             CccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccce
Confidence            34433 3445789999999999999999999999999999999999999999999999999986544321     22335


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+|+.|+|||++.+...++.++||||+||++|++++|+.||.+..+......+.+..+.+.+..+...............
T Consensus       182 ~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T d3blha1         182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV  261 (318)
T ss_dssp             CSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CC
T ss_pred             ecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccc
Confidence            68999999999987767899999999999999999999999999999999999999998887766655544444433332


Q ss_pred             CCCCccchhhh-CCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          158 PQHPRQSLAQV-FPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       158 ~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      ........... ....++++++||++||++||++|||++|+|+||||++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             SSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            22222111111 11246889999999999999999999999999999964

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-41  Score=262.93  Aligned_cols=173  Identities=25%  Similarity=0.430  Sum_probs=149.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC-Ccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~   80 (217)
                      ||+|.++++.+..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+...... .......|+
T Consensus        87 ~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt  166 (320)
T d1xjda_          87 GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT  166 (320)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred             CCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCC
Confidence            6799999999999999999999999999999999999999999999999999999999999999765433 334456789


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (217)
                      +.|+|||++.+.. ++.++||||+||++|++++|..||.+.+.......+..  +.+                       
T Consensus       167 ~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~-----------------------  220 (320)
T d1xjda_         167 PDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNP-----------------------  220 (320)
T ss_dssp             GGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC-----------------------
T ss_pred             CCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC-----------------------
Confidence            9999999997654 88999999999999999999999998887776665543  111                       


Q ss_pred             CccchhhhCCCCChhHHHHHHHhcccCCCCCCCHh-hhccCCCCccc
Q 027927          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGE-FFVPYKPFQCC  206 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~-~ll~~~~f~~~  206 (217)
                            ..+..+|+++.+||++||..||++|||+. ++++||||++.
T Consensus       221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence                  11235789999999999999999999996 89999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-42  Score=268.27  Aligned_cols=181  Identities=27%  Similarity=0.430  Sum_probs=143.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec---CCCEEEecccccccCCCCCcccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~   76 (217)
                      ||+|++++++.  ..+++.+++.++.||+.||+|||++||+||||||+||+++.   .+.+||+|||++...........
T Consensus        93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~  172 (335)
T d2ozaa1          93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT  172 (335)
T ss_dssp             SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCC
T ss_pred             CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCcccc
Confidence            68999999874  57999999999999999999999999999999999999975   56799999999987777666677


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      ..|++.|+|||++.+. .++.++|||||||++|++++|..||.+.........+........                  
T Consensus       173 ~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------------------  233 (335)
T d2ozaa1         173 PCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------------------  233 (335)
T ss_dssp             CSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------------------
T ss_pred             ccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------------------
Confidence            8899999999988654 478999999999999999999999977654333322221100000                  


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                       ...+.    .....+|+++.+||++||+.||++|||++|+++||||++.
T Consensus       234 -~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         234 -YEFPN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             -SSCCT----THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             -CCCCC----cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence             00000    1112478999999999999999999999999999999754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=263.40  Aligned_cols=176  Identities=23%  Similarity=0.377  Sum_probs=151.2

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC--CCEEEecccccccCCCCCcccccc
Q 027927            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN--CDLKICDFGLARPTSENEFMTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~   78 (217)
                      |++|.+++..++ ++++..++.++.||+.||+|||++||+||||||+||+++.+  ..++++|||.+.............
T Consensus        85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~  164 (321)
T d1tkia_          85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF  164 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEE
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccc
Confidence            579999998764 79999999999999999999999999999999999999854  579999999998877666667778


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +++.|++||.+.+.. ++.++||||+||++|++++|..||.+......+..+.......+                    
T Consensus       165 ~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------  223 (321)
T d1tkia_         165 TAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--------------------  223 (321)
T ss_dssp             SCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------------------
T ss_pred             cccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------
Confidence            899999999886554 78999999999999999999999998887777776655211111                    


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQC  205 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~  205 (217)
                             ...+..+|+++.+||++||..||++|||++|+++||||++
T Consensus       224 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         224 -------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                   1233457899999999999999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-40  Score=254.56  Aligned_cols=204  Identities=38%  Similarity=0.614  Sum_probs=162.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc-ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~   80 (217)
                      |++|..+++.++.+++..++.++.|++.||+|||++||+||||||+||+++.++.++++|||.+........ .....++
T Consensus        85 ~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~  164 (292)
T d1unla_          85 QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT  164 (292)
T ss_dssp             EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSC
T ss_pred             ccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccc
Confidence            567888888889999999999999999999999999999999999999999999999999999987655432 3344567


Q ss_pred             ccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCC
Q 027927           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (217)
Q Consensus        81 ~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (217)
                      +.|.|||.+.....++.++||||+||++|++++|..|| .+.+..+....+....+.+....+........  .......
T Consensus       165 ~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  242 (292)
T d1unla_         165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD--YKPYPMY  242 (292)
T ss_dssp             GGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT--CCCCCCC
T ss_pred             cchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc--ccccccc
Confidence            78999998877766789999999999999999998885 55666777888888888777665543322110  0000001


Q ss_pred             CCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ............+++.+.+||++||+.||++|||++|+|+||||++.+
T Consensus       243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            112234445567889999999999999999999999999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=258.75  Aligned_cols=168  Identities=26%  Similarity=0.398  Sum_probs=141.4

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecC-CCEEEecccccccCCCCCccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      +++.++++++..+++++++.++.||+.||+|||++||+||||||+||+++.+ +.++|+|||.+...... ......||+
T Consensus        95 ~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~  173 (273)
T d1xwsa_          95 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTR  173 (273)
T ss_dssp             EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCG
T ss_pred             chHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc-cccccccCC
Confidence            5788999999999999999999999999999999999999999999999855 78999999999765443 344567899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+.+..+.++||||+||++|++++|..||....      .+..  +.                         
T Consensus       174 ~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--~~-------------------------  220 (273)
T d1xwsa_         174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--GQ-------------------------  220 (273)
T ss_dssp             GGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--CC-------------------------
T ss_pred             CcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--cc-------------------------
Confidence            99999998766655678999999999999999999996532      1111  00                         


Q ss_pred             ccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                          ......+|+++.+||++||+.||++|||++|+++||||++..-
T Consensus       221 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         221 ----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             ----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             ----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence                0122357899999999999999999999999999999997643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-40  Score=249.26  Aligned_cols=174  Identities=22%  Similarity=0.304  Sum_probs=139.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC---Cccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~   77 (217)
                      ||+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++......   ......
T Consensus        87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  166 (276)
T d1uwha_          87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL  166 (276)
T ss_dssp             EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------C
T ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccccc
Confidence            58999999765 67999999999999999999999999999999999999999999999999998655432   223456


Q ss_pred             cccccccCcccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           78 VVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~--~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      .+++.|+|||.+...  ..++.++|||||||++|++++|..||.+.................                  
T Consensus       167 ~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------------------  228 (276)
T d1uwha_         167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS------------------  228 (276)
T ss_dssp             CCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC------------------
T ss_pred             ccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC------------------
Confidence            789999999998643  346889999999999999999999998877655554444432211                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                             ........++++++.++|.+||+.||++|||+++++++
T Consensus       229 -------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         229 -------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             -------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                   11233445688999999999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.5e-40  Score=257.40  Aligned_cols=201  Identities=28%  Similarity=0.530  Sum_probs=147.9

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCC-CEEEecccccccCCCCCccccccccc
Q 027927            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      ++|.++   .+.+++..++.++.||+.||+|||++||+||||||+||+++.++ .++++|||.+.............+++
T Consensus       117 ~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~  193 (328)
T d3bqca1         117 TDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR  193 (328)
T ss_dssp             CBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCG
T ss_pred             CcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCc
Confidence            455443   35799999999999999999999999999999999999999765 58999999998776666666778899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCCCccccccCchH-HHHHHHhCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN-DHVHQMRLLIELLGTPTDADLGFVRNED-AKRYIRQLPQ  159 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  159 (217)
                      .|+|||.+.+...++.++|+||+||+++++++|..||... +...+...+....+.+....+....... ...+......
T Consensus       194 ~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~  273 (328)
T d3bqca1         194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR  273 (328)
T ss_dssp             GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCC
T ss_pred             cccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhccc
Confidence            9999999887776899999999999999999999999754 4455556665555432211100000000 0000001111


Q ss_pred             CCccchhh-----hCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccc
Q 027927          160 HPRQSLAQ-----VFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCC  206 (217)
Q Consensus       160 ~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~  206 (217)
                      .....+..     ....+++++++||++||++||++|||++|+|+||||+..
T Consensus       274 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         274 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             CCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             ccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            11111111     123478999999999999999999999999999999965

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-39  Score=253.05  Aligned_cols=202  Identities=41%  Similarity=0.720  Sum_probs=152.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~   81 (217)
                      ++++.+.+  +..+++..++.+++||+.||+|||++||+||||||+||+++.++.++++|||.+.............+++
T Consensus       105 ~~~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~  182 (355)
T d2b1pa1         105 DANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR  182 (355)
T ss_dssp             SEEHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------CC
T ss_pred             chHHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccccccccccc
Confidence            45666655  3579999999999999999999999999999999999999999999999999987777666666778899


Q ss_pred             cccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCCCCC
Q 027927           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (217)
Q Consensus        82 ~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (217)
                      .|+|||.+.+. .++.++||||+||+++++++|..||.+.+.......+....+.+....+..... .............
T Consensus       183 ~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  260 (355)
T d2b1pa1         183 YYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYA  260 (355)
T ss_dssp             TTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH-HHHHHHHTSCCCC
T ss_pred             cccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh-hHHHHhhcCcccc
Confidence            99999999765 488999999999999999999999999999888899988887776655444332 2233333333222


Q ss_pred             ccchhhhC------------CCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCcccc
Q 027927          162 RQSLAQVF------------PHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCC  207 (217)
Q Consensus       162 ~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~  207 (217)
                      ........            ...++++.+||++||..||++|||++|+|+||||+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         261 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             ccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            22222211            12467899999999999999999999999999999754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=247.92  Aligned_cols=172  Identities=23%  Similarity=0.307  Sum_probs=140.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----ccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~   77 (217)
                      +|+|.++++++.++++..+..++.||+.||+|||+++++||||||+||+++.++.++++|||+++........    ...
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            6899999999999999999999999999999999999999999999999999999999999999765443221    234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .+++.|+|||.+.+.. ++.++|||||||++|++++ |..||.+....+....+.+  +..                   
T Consensus       171 ~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~--~~~-------------------  228 (277)
T d1xbba_         171 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GER-------------------  228 (277)
T ss_dssp             CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--TCC-------------------
T ss_pred             CCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--CCC-------------------
Confidence            5788999999986554 7899999999999999997 8999988776555444332  100                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhc---cCCCCc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV---PYKPFQ  204 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll---~~~~f~  204 (217)
                               ...+..+++++.++|.+||+.||++|||+++++   +++|++
T Consensus       229 ---------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         229 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                     012235789999999999999999999999984   555543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-39  Score=251.43  Aligned_cols=169  Identities=27%  Similarity=0.373  Sum_probs=138.5

Q ss_pred             CccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEE
Q 027927            2 DTDLYQIIRSNQ-----------------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK   58 (217)
Q Consensus         2 ~~~L~~~l~~~~-----------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~   58 (217)
                      ||+|.++|++++                       .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+|
T Consensus       125 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~K  204 (325)
T d1rjba_         125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK  204 (325)
T ss_dssp             TCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEE
T ss_pred             CCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEE
Confidence            689999997753                       489999999999999999999999999999999999999999999


Q ss_pred             EecccccccCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHh
Q 027927           59 ICDFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELL  134 (217)
Q Consensus        59 l~d~~~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~  134 (217)
                      |+|||+++......   ......+++.|+|||.+.+.. ++.++|||||||++|++++ |..||.+......+..++...
T Consensus       205 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~  283 (325)
T d1rjba_         205 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG  283 (325)
T ss_dssp             ECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT
T ss_pred             EeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence            99999996544332   223456789999999986554 8999999999999999997 899998766555555444321


Q ss_pred             CCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          135 GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                      ..+                             ..+..+++++.+||.+||+.||++|||++||++|
T Consensus       284 ~~~-----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         284 FKM-----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC-----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            111                             1223578999999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-39  Score=249.08  Aligned_cols=178  Identities=24%  Similarity=0.404  Sum_probs=144.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~   79 (217)
                      |++|.+++..++.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+.......  ......+
T Consensus       113 ~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g  192 (322)
T d1vzoa_         113 GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG  192 (322)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGS
T ss_pred             ccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccccccccccccc
Confidence            68999999999999999999999999999999999999999999999999999999999999997654432  2345678


Q ss_pred             cccccCcccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~-~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      ++.|.+||.+.+.. .++.++||||+||++|++++|..||.+.........+.+...                   ....
T Consensus       193 ~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-------------------~~~~  253 (322)
T d1vzoa_         193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-------------------KSEP  253 (322)
T ss_dssp             CCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-------------------HCCC
T ss_pred             ccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-------------------cCCC
Confidence            89999999986543 367899999999999999999999977654333333322110                   0000


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCC-----CHhhhccCCCCccc
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TGEFFVPYKPFQCC  206 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~~ll~~~~f~~~  206 (217)
                              ..+..+++++.+||++||++||.+||     |++|+++||||+..
T Consensus       254 --------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         254 --------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             --------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence                    12235789999999999999999999     58999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-38  Score=244.36  Aligned_cols=169  Identities=26%  Similarity=0.374  Sum_probs=131.6

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ||+|.++++..                ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus       102 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla  181 (299)
T d1ywna1         102 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA  181 (299)
T ss_dssp             TCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC----
T ss_pred             CCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcch
Confidence            68999999764                34899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~-~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      +......   ......||+.|+|||.+.+.. ++.++||||+||++|+++++ ..||.+......+.........+    
T Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~----  256 (299)
T d1ywna1         182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----  256 (299)
T ss_dssp             --CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC----
T ss_pred             hhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----
Confidence            7544332   223457899999999997654 89999999999999999986 56787665444444333322111    


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                               ..+..+++++.++|.+||+.||++|||++|+++|
T Consensus       257 -------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         257 -------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                     1223577999999999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.8e-38  Score=241.92  Aligned_cols=168  Identities=23%  Similarity=0.284  Sum_probs=129.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc------
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM------   74 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~------   74 (217)
                      ||+|.+++..+ +.+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||+++........      
T Consensus       111 ~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  190 (299)
T d1jpaa_         111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA  190 (299)
T ss_dssp             TEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred             CCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeec
Confidence            67999988885 57999999999999999999999999999999999999999999999999999765433221      


Q ss_pred             ccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHH
Q 027927           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (217)
Q Consensus        75 ~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (217)
                      ....+++.|+|||.+.+. .++.++|||||||++|++++ |..||.+....+....+......+                
T Consensus       191 ~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~----------------  253 (299)
T d1jpaa_         191 LGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP----------------  253 (299)
T ss_dssp             -----CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC----------------
T ss_pred             ccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence            123467889999998655 48899999999999999997 899998887666555443211111                


Q ss_pred             HHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                    .+..+++++.++|.+||+.||++|||++++++.
T Consensus       254 --------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 --------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             --------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                          123577899999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-38  Score=237.61  Aligned_cols=168  Identities=20%  Similarity=0.297  Sum_probs=128.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      +|+|.+++.+. ..++++.+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.......  .....
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  163 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  163 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence            68999998776 6689999999999999999999999999999999999999999999999999876554332  22356


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+.. ++.++||||+||++|+++++ .+||......+....+.... .+.                   
T Consensus       164 gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~~-------------------  222 (263)
T d1sm2a_         164 FPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLY-------------------  222 (263)
T ss_dssp             -CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-CCC-------------------
T ss_pred             cCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-CCC-------------------
Confidence            788999999986554 89999999999999999995 66666666555555443311 110                   


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                .+...++++.++|.+||+.||++|||+++++++
T Consensus       223 ----------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         223 ----------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                      112467899999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-38  Score=239.18  Aligned_cols=172  Identities=20%  Similarity=0.269  Sum_probs=141.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   76 (217)
                      ||+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.........    ..
T Consensus        92 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  171 (285)
T d1u59a_          92 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  171 (285)
T ss_dssp             TEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence            57999998764 67999999999999999999999999999999999999999999999999999766543322    23


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|+|||.+... .++.++||||+||++|++++ |..||.+....+....+.+.  ..                  
T Consensus       172 ~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--~~------------------  230 (285)
T d1u59a_         172 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--KR------------------  230 (285)
T ss_dssp             SCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--CC------------------
T ss_pred             cccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CC------------------
Confidence            4567889999998655 47899999999999999998 89999887766555444321  00                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhh---ccCCCCc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFF---VPYKPFQ  204 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~l---l~~~~f~  204 (217)
                                ...++.+++++.++|.+||+.||++|||+.++   |+++|+.
T Consensus       231 ----------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         231 ----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                      01234678999999999999999999999988   5677764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.1e-38  Score=240.82  Aligned_cols=173  Identities=22%  Similarity=0.359  Sum_probs=135.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC----ccccc
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~   77 (217)
                      |++|.+++..++++++.++..++.||+.||+|||++|++||||||+||+++.++..+++|||.+.......    .....
T Consensus        95 g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  174 (277)
T d1o6ya_          95 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV  174 (277)
T ss_dssp             EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC------------
T ss_pred             CCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccc
Confidence            67999999999999999999999999999999999999999999999999999999999999876543322    23456


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .|++.|+|||.+.+. .++.++||||+||++|+|++|..||.+....+....+......                     
T Consensus       175 ~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~---------------------  232 (277)
T d1o6ya_         175 IGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI---------------------  232 (277)
T ss_dssp             ----TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC---------------------
T ss_pred             cCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC---------------------
Confidence            789999999998655 4789999999999999999999999887766665554431111                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCC-CHhhhccCCCC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-TGEFFVPYKPF  203 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-t~~~ll~~~~f  203 (217)
                            ......+.+|+++.++|++||+.||++|| |++++ .++|.
T Consensus       233 ------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~  272 (277)
T d1o6ya_         233 ------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLV  272 (277)
T ss_dssp             ------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred             ------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence                  11233456889999999999999999999 55555 45444

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-38  Score=240.33  Aligned_cols=173  Identities=24%  Similarity=0.338  Sum_probs=138.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--cccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~   77 (217)
                      +|+|.+++...  ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++........  ....
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA  170 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence            57898877654  4699999999999999999999999999999999999999999999999999987654432  2345


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .+++.|+|||.+.... ++.++|||||||++|++++|. +|+......+....+... ..+                   
T Consensus       171 ~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~~~-------------------  229 (272)
T d1qpca_         171 KFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRM-------------------  229 (272)
T ss_dssp             CCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCC-------------------
T ss_pred             CCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCC-------------------
Confidence            6788999999986544 789999999999999999965 455555544444433221 000                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc--CCCCcc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP--YKPFQC  205 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~--~~~f~~  205 (217)
                                ..+..+++++.++|.+||+.||++|||++++++  ++||..
T Consensus       230 ----------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         230 ----------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                      112357889999999999999999999999988  777753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-37  Score=236.63  Aligned_cols=168  Identities=22%  Similarity=0.285  Sum_probs=135.1

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc--ccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~   77 (217)
                      +|+|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........  ...
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~  176 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  176 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccc
Confidence            57999999764  67899999999999999999999999999999999999999999999999999766544322  334


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      .+++.|+|||.+.+.. ++.++||||+||++|+++++..||....+.......+.....                     
T Consensus       177 ~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~---------------------  234 (287)
T d1opja_         177 KFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------------------  234 (287)
T ss_dssp             EECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---------------------
T ss_pred             cccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC---------------------
Confidence            5688899999987654 889999999999999999976666544443333333221100                     


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                              ...+..+++++.+||.+||+.||++|||++++++
T Consensus       235 --------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         235 --------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                    0123357899999999999999999999999976

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-37  Score=231.84  Aligned_cols=168  Identities=17%  Similarity=0.282  Sum_probs=139.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      +|+|.+++... ..+++..+.+++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  .....
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  162 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  162 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence            57888887664 6799999999999999999999999999999999999999999999999999976544332  22356


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+.. ++.++||||+||++|++++ |..||.+....+....+.+....+                    
T Consensus       163 ~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------  221 (258)
T d1k2pa_         163 FPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------------  221 (258)
T ss_dssp             CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------------------
T ss_pred             CCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC--------------------
Confidence            788899999987554 7899999999999999998 799998888766665554311111                    


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                .+...++++.+||++||+.||++|||++++++|
T Consensus       222 ----------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         222 ----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                      122467899999999999999999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-37  Score=239.17  Aligned_cols=168  Identities=23%  Similarity=0.269  Sum_probs=136.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc---cccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~   77 (217)
                      +++|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........   ....
T Consensus        94 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  173 (317)
T d1xkka_          94 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG  173 (317)
T ss_dssp             TCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-------
T ss_pred             CCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccccccccc
Confidence            67888877765 6899999999999999999999999999999999999999999999999999976544332   2234


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .+++.|+|||.+.+.. ++.++|||||||++|++++ |..||.+....+....+.. ...+                   
T Consensus       174 ~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-~~~~-------------------  232 (317)
T d1xkka_         174 KVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERL-------------------  232 (317)
T ss_dssp             -CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-TCCC-------------------
T ss_pred             ccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCC-------------------
Confidence            5788999999987654 8999999999999999998 7889887665554443332 1111                   


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                ..+..+++++.++|.+||+.||++|||+.++++|
T Consensus       233 ----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         233 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                      1123577899999999999999999999999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-37  Score=234.62  Aligned_cols=168  Identities=23%  Similarity=0.350  Sum_probs=129.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc--ccccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~   78 (217)
                      +|+|.+++... ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||++........  .....
T Consensus        91 ~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~  170 (273)
T d1mp8a_          91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK  170 (273)
T ss_dssp             TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------
T ss_pred             CCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceecccee
Confidence            57888887664 6799999999999999999999999999999999999999999999999999976543322  23445


Q ss_pred             ccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhC
Q 027927           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (217)
Q Consensus        79 ~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (217)
                      +++.|+|||.+.+.. ++.++|||||||++|++++ |..||.+....+....+.....                      
T Consensus       171 gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~----------------------  227 (273)
T d1mp8a_         171 LPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------------------  227 (273)
T ss_dssp             CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------
T ss_pred             cCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence            688999999996554 7899999999999999997 8999988776665554432100                      


Q ss_pred             CCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                              ...++++++++.+||.+||+.||++|||+++++++
T Consensus       228 --------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         228 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                    01234678999999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-37  Score=233.87  Aligned_cols=175  Identities=25%  Similarity=0.346  Sum_probs=135.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCC--ccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEY   77 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~   77 (217)
                      +|+|.+++...  +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......  .....
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  174 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  174 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence            57888888653  679999999999999999999999999999999999999999999999999997654332  22335


Q ss_pred             cccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHh
Q 027927           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (217)
Q Consensus        78 ~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (217)
                      .+++.|+|||.+.... ++.++||||+|+++|++++|..|+ ......+.+..+......                    
T Consensus       175 ~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~--------------------  233 (285)
T d1fmka3         175 KFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------------  233 (285)
T ss_dssp             -CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------------
T ss_pred             cccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------------
Confidence            6789999999997554 789999999999999999965554 445444444443321110                    


Q ss_pred             CCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc--CCCCcccc
Q 027927          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP--YKPFQCCC  207 (217)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~--~~~f~~~~  207 (217)
                                ..+..+++++.++|.+||+.||++|||++++++  ++||.+..
T Consensus       234 ----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         234 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                      122357899999999999999999999999998  89998653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-36  Score=230.32  Aligned_cols=167  Identities=23%  Similarity=0.274  Sum_probs=126.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCc----ccc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~   76 (217)
                      ++++.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.......    ...
T Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  172 (283)
T d1mqba_          93 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG  172 (283)
T ss_dssp             TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred             cCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEecc
Confidence            56788877765 6799999999999999999999999999999999999999999999999999976543321    223


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..+++.|+|||.+.+. .++.++|||||||++|+++++..|+ ......+.+..+... ..+                  
T Consensus       173 ~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~------------------  232 (283)
T d1mqba_         173 GKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRL------------------  232 (283)
T ss_dssp             -CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC------------------
T ss_pred             CCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CCC------------------
Confidence            4568899999998655 4889999999999999999965554 444444443333211 000                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                 ..+..+++++.++|.+||+.||++|||++++++
T Consensus       233 -----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         233 -----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             -----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                       112346788999999999999999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-36  Score=232.23  Aligned_cols=167  Identities=28%  Similarity=0.384  Sum_probs=136.9

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      +|+|.++++..                ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||.+
T Consensus       103 ~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~  182 (299)
T d1fgka_         103 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA  182 (299)
T ss_dssp             TCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCC
T ss_pred             CCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhh
Confidence            58999999765                35899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCcc
Q 027927           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (217)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~  141 (217)
                      .......   ......+++.|+|||.+.+. .++.++||||||+++|++++ |..||.+.........+.. ...+    
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~-~~~~----  256 (299)
T d1fgka_         183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-GHRM----  256 (299)
T ss_dssp             CCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TCCC----
T ss_pred             ccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHc-CCCC----
Confidence            7544332   22345678899999999765 48999999999999999997 6888887776554443322 1111    


Q ss_pred             ccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                               ..+..+++++.+||.+||+.||++|||++|+++
T Consensus       257 -------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         257 -------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             -------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                                     112357899999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-36  Score=230.24  Aligned_cols=167  Identities=22%  Similarity=0.258  Sum_probs=135.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc----cc
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   76 (217)
                      +++|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........    ..
T Consensus        94 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~  173 (273)
T d1u46a_          94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH  173 (273)
T ss_dssp             TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred             CcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCc
Confidence            56788776654 67999999999999999999999999999999999999999999999999999876544322    23


Q ss_pred             ccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHH
Q 027927           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (217)
Q Consensus        77 ~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (217)
                      ..++..|+|||.+.+.. ++.++||||||+++|++++ |..||.+.+..+....+.+....+                  
T Consensus       174 ~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~------------------  234 (273)
T d1u46a_         174 RKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL------------------  234 (273)
T ss_dssp             --CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC------------------
T ss_pred             cccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC------------------
Confidence            34577899999997654 7889999999999999997 899999888776666554321111                  


Q ss_pred             hCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhc
Q 027927          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFV  198 (217)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll  198 (217)
                                 ..+..+++++.++|.+||+.||++|||+++++
T Consensus       235 -----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         235 -----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             -----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                       12235789999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-36  Score=232.11  Aligned_cols=167  Identities=22%  Similarity=0.296  Sum_probs=134.6

Q ss_pred             CccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCE
Q 027927            2 DTDLYQIIRSN------------------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL   57 (217)
Q Consensus         2 ~~~L~~~l~~~------------------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~   57 (217)
                      +++|.+++...                        ..++...+..++.||+.||+|||+++++||||||+||+++.++.+
T Consensus       100 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~  179 (301)
T d1lufa_         100 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV  179 (301)
T ss_dssp             TCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcE
Confidence            57888888653                        248999999999999999999999999999999999999999999


Q ss_pred             EEecccccccCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHHH
Q 027927           58 KICDFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIEL  133 (217)
Q Consensus        58 ~l~d~~~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~-~pf~~~~~~~~~~~~~~~  133 (217)
                      ||+|||++.......   ......+++.|+|||.+.+.. ++.++|||||||++|+++++. +||.+.+..+....+.+.
T Consensus       180 Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~  258 (301)
T d1lufa_         180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG  258 (301)
T ss_dssp             EECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             EEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence            999999987543322   223456778899999997554 889999999999999999985 678877766665554321


Q ss_pred             hCCCCCccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                        .                            ....+..+++++.++|.+||+.||++|||+.|+++
T Consensus       259 --~----------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         259 --N----------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             --C----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --C----------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence              0                            01123467899999999999999999999999964

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-36  Score=233.79  Aligned_cols=168  Identities=25%  Similarity=0.311  Sum_probs=137.0

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ||+|.++|+.+                ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a  174 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  174 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccc
Confidence            58999999764                67999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHHHhCCCCCccccc
Q 027927           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (217)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (217)
                      .............++..|+|||.+.+.. ++.++|||||||++|++++|. .||.+.+..+.+..+.+.. .        
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~-~--------  244 (309)
T d1fvra_         175 RGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-R--------  244 (309)
T ss_dssp             ESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-C--------
T ss_pred             ccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-C--------
Confidence            7665554445567889999999997554 789999999999999999965 5677766555544432210 0        


Q ss_pred             cCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                           ...+..+++++.+||++||+.||++|||+++++++
T Consensus       245 ---------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 ---------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             ---------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                 11223577999999999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-36  Score=225.34  Aligned_cols=166  Identities=20%  Similarity=0.307  Sum_probs=130.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccc
Q 027927            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (217)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~   79 (217)
                      +|+|.+++.++  ..+++..+.+++.||+.||+|||+.+++||||+|+||+++.++.++++|||.+......  .....+
T Consensus        85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~  162 (262)
T d1byga_          85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKL  162 (262)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------C
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--Cccccc
Confidence            68999999765  45999999999999999999999999999999999999999999999999998755433  234466


Q ss_pred             cccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCCccccccCchHHHHHHHhCC
Q 027927           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (217)
Q Consensus        80 ~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (217)
                      +..|+|||.+.+.. ++.++||||||+++|++++ |..||......+....+.+.                         
T Consensus       163 ~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-------------------------  216 (262)
T d1byga_         163 PVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-------------------------  216 (262)
T ss_dssp             CTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------------------
T ss_pred             cccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------------------------
Confidence            88899999987654 8999999999999999998 68888776655444433210                         


Q ss_pred             CCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                           .....+..+++++.++|++||+.||++|||+.+++++
T Consensus       217 -----~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         217 -----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 0012234577999999999999999999999999763

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-35  Score=224.75  Aligned_cols=168  Identities=31%  Similarity=0.433  Sum_probs=136.4

Q ss_pred             CccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEeccc
Q 027927            2 DTDLYQIIRSNQ------------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG   63 (217)
Q Consensus         2 ~~~L~~~l~~~~------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~   63 (217)
                      +++|.++++...                  .+++..+..++.||+.||+|||+++++||||||+||+++.++.++++|||
T Consensus       111 ~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG  190 (311)
T d1t46a_         111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG  190 (311)
T ss_dssp             TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCG
T ss_pred             CCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccc
Confidence            578899987653                  58999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCCC
Q 027927           64 LARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTD  139 (217)
Q Consensus        64 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~-~~~pf~~~~~~~~~~~~~~~~~~~~~  139 (217)
                      .+.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||........+.++......+. 
T Consensus       191 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~-  268 (311)
T d1t46a_         191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-  268 (311)
T ss_dssp             GGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-
T ss_pred             hheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence            997655432   22345778999999998654 48999999999999999998 5666766665555555544222111 


Q ss_pred             ccccccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                                  .+...++.+.+||.+||+.||++|||++++++
T Consensus       269 ----------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         269 ----------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             ----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                        11246789999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-35  Score=234.23  Aligned_cols=193  Identities=27%  Similarity=0.421  Sum_probs=139.9

Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCcCCCCEEEecCCC------EEEecccccccCCCCCccccccccccc
Q 027927           11 SNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCD------LKICDFGLARPTSENEFMTEYVVTRWY   83 (217)
Q Consensus        11 ~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~------~~l~d~~~~~~~~~~~~~~~~~~~~~~   83 (217)
                      ....+++..++.++.||+.||+|||+ .||+||||||+||+++.++.      ++++|||.+......  .....+++.|
T Consensus       118 ~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y  195 (362)
T d1q8ya_         118 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREY  195 (362)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGG
T ss_pred             cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccc
Confidence            34789999999999999999999998 88999999999999987653      899999998655433  3456789999


Q ss_pred             cCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC------hHHHHHHHHHHhCCCCCccccccCchHHHHHHH--
Q 027927           84 RAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR--  155 (217)
Q Consensus        84 ~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  155 (217)
                      +|||.+.+.. ++.++|+||+||+++++++|+.||....      ........+...+.++..........  .....  
T Consensus       196 ~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~  272 (362)
T d1q8ya_         196 RSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSR  272 (362)
T ss_dssp             CCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC-
T ss_pred             cChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccccc--ccccccc
Confidence            9999987654 7899999999999999999999996543      34456666677776554432211111  00000  


Q ss_pred             ----hCCCCCccchh-------hhCCCCChhHHHHHHHhcccCCCCCCCHhhhccCCCCccccC
Q 027927          156 ----QLPQHPRQSLA-------QVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPYKPFQCCCG  208 (217)
Q Consensus       156 ----~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~~~f~~~~~  208 (217)
                          ...........       ......++++.+||++||.+||.+|||++|+|+||||++...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG  336 (362)
T ss_dssp             -CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             hhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence                00000000000       111224578999999999999999999999999999996643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-34  Score=223.69  Aligned_cols=168  Identities=24%  Similarity=0.293  Sum_probs=131.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCcc-----c
Q 027927            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-----T   75 (217)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~   75 (217)
                      +++|.+++... ..++...+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++.........     .
T Consensus       113 ~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~  192 (311)
T d1r0pa_         113 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT  192 (311)
T ss_dssp             TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTT
T ss_pred             cCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecc
Confidence            57899988865 56888999999999999999999999999999999999999999999999999765433221     2


Q ss_pred             cccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCCccccccCchHHHHHH
Q 027927           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (217)
Q Consensus        76 ~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (217)
                      ...+++.|+|||.+.... ++.++||||||+++|++++|..||..... .+....+.. ...+                 
T Consensus       193 ~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~-g~~~-----------------  253 (311)
T d1r0pa_         193 GAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRL-----------------  253 (311)
T ss_dssp             CSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-TCCC-----------------
T ss_pred             cccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCC-----------------
Confidence            245688999999986554 79999999999999999998777755332 222221111 0000                 


Q ss_pred             HhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhccC
Q 027927          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVPY  200 (217)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~~  200 (217)
                                  ..+..+++++.++|.+||+.||++|||+.|++++
T Consensus       254 ------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         254 ------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        1123567899999999999999999999999887

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=223.03  Aligned_cols=173  Identities=21%  Similarity=0.330  Sum_probs=140.1

Q ss_pred             CccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCC
Q 027927            2 DTDLYQIIRSN----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (217)
Q Consensus         2 ~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~   71 (217)
                      +|+|.+++...          ..++...+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++......
T Consensus       107 ~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~  186 (308)
T d1p4oa_         107 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  186 (308)
T ss_dssp             TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred             CCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCC
Confidence            57888888653          34789999999999999999999999999999999999999999999999998755433


Q ss_pred             Cc---cccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCCccccccCc
Q 027927           72 EF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (217)
Q Consensus        72 ~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (217)
                      ..   .....+++.|++||.+.+.. ++.++|+||+|+++|++++| ..||.+....+.+..+.....            
T Consensus       187 ~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~------------  253 (308)
T d1p4oa_         187 DYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL------------  253 (308)
T ss_dssp             GCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred             cceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC------------
Confidence            22   23346789999999987654 78899999999999999997 577877776666655543110            


Q ss_pred             hHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc------CCCCcc
Q 027927          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP------YKPFQC  205 (217)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~------~~~f~~  205 (217)
                                        ...+..+++.+.++|.+||+.||++|||++++++      +|+|++
T Consensus       254 ------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         254 ------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             ------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence                              1122357789999999999999999999999987      777764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-34  Score=221.12  Aligned_cols=181  Identities=17%  Similarity=0.180  Sum_probs=136.5

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEe---cCCCEEEecccccccCCCCC----
Q 027927            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---ANCDLKICDFGLARPTSENE----   72 (217)
Q Consensus         1 l~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~----   72 (217)
                      +|++|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+||+++   .+..++++|||.+.......    
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence            46788777765 46899999999999999999999999999999999999975   45579999999997654332    


Q ss_pred             ----ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCccccccCch
Q 027927           73 ----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE  148 (217)
Q Consensus        73 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (217)
                          ......||+.|+|||.+.+.. ++.++|||||||++|++++|..||...........+.....             
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~-------------  230 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-------------  230 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH-------------
T ss_pred             eeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc-------------
Confidence                123457899999999986554 89999999999999999999999977554333222211100             


Q ss_pred             HHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhh---hccCCCCcc
Q 027927          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEF---FVPYKPFQC  205 (217)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~---ll~~~~f~~  205 (217)
                          .      ....+......++++++.++|.+||+.+|++||++++   +|+++|.++
T Consensus       231 ----~------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         231 ----K------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ----H------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----c------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                0      0001223445578899999999999999999999874   467776553

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-34  Score=219.26  Aligned_cols=187  Identities=19%  Similarity=0.220  Sum_probs=129.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------cCcEecCcCCCCEEEecCCCEEEecccccccCCCCC-
Q 027927            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS--------ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-   72 (217)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~Lh~--------~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-   72 (217)
                      +|+|.++++++ .++...+..++.|++.||+|||+        +||+||||||+||+++.++.+||+|||++....... 
T Consensus        85 ~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~  163 (303)
T d1vjya_          85 HGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  163 (303)
T ss_dssp             TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc
Confidence            57999999875 69999999999999999999996        589999999999999999999999999987654322 


Q ss_pred             ----ccccccccccccCcccccCCCC-----CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCCcc-c
Q 027927           73 ----FMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD-L  142 (217)
Q Consensus        73 ----~~~~~~~~~~~~~Pe~~~~~~~-----~~~~~Diwslg~~l~~l~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~-~  142 (217)
                          ......|++.|+|||.+.+...     ++.++|||||||++|++++|..||.......          .+.... .
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~----------~~~~~~~~  233 (303)
T d1vjya_         164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----------LPYYDLVP  233 (303)
T ss_dssp             EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC----------CTTTTTSC
T ss_pred             ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc----------cchhhccc
Confidence                2234578999999999854321     3568999999999999999988875432100          000000 0


Q ss_pred             cccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          143 GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                      ..................+..+...........+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            011111122222111111111111111122356899999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.5e-33  Score=213.58  Aligned_cols=172  Identities=15%  Similarity=0.179  Sum_probs=135.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEec-----CCCEEEecccccccCCCCC--
Q 027927            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-----NCDLKICDFGLARPTSENE--   72 (217)
Q Consensus         1 l~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-----~~~~~l~d~~~~~~~~~~~--   72 (217)
                      +|++|.++++.. ..++...+..++.|++.||++||++||+||||||+||+++.     .+.++++|||+++......  
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (293)
T d1csna_          83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  162 (293)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence            578999999775 57999999999999999999999999999999999999964     5789999999997644321  


Q ss_pred             ------ccccccccccccCcccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCCcccc
Q 027927           73 ------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTPTDADLG  143 (217)
Q Consensus        73 ------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Diwslg~~l~~l~~~~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~  143 (217)
                            ......||+.|+|||.+.+. .++.++|+||||+++|++++|..||.+...   .....++.....        
T Consensus       163 ~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~--------  233 (293)
T d1csna_         163 QHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--------  233 (293)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH--------
T ss_pred             cceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC--------
Confidence                  12345789999999998655 489999999999999999999999976432   222222221100        


Q ss_pred             ccCchHHHHHHHhCCCCCccchhhhCCCCChhHHHHHHHhcccCCCCCCCHhhhcc
Q 027927          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITGEFFVP  199 (217)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~~ll~  199 (217)
                                        .....+...++++++.+++..|+..+|++||+.+.+.+
T Consensus       234 ------------------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         234 ------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             ------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ------------------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                              01123445568899999999999999999998776643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.41  E-value=1.3e-14  Score=103.21  Aligned_cols=87  Identities=18%  Similarity=0.190  Sum_probs=60.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCcEecCcCCCCEEEecCCCEEEecccccccCCCCCccccccccccccCcccccCCCC
Q 027927           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD   94 (217)
Q Consensus        15 l~~~~~~~~~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~   94 (217)
                      ++...+..++.|++.++++||++|++||||||+||+++.+ .++++|||.+................. .-.+.+  .+.
T Consensus       100 l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~-~~~~~f--~r~  175 (191)
T d1zara2         100 VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR-NIITYF--SRT  175 (191)
T ss_dssp             CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHH-HHHHHH--HHH
T ss_pred             hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHH-HHHHHH--cCC
Confidence            5566778899999999999999999999999999999965 589999999866543321110000000 001112  123


Q ss_pred             CCchhhHHHHH
Q 027927           95 YTAAIDVWSVG  105 (217)
Q Consensus        95 ~~~~~Diwslg  105 (217)
                      ++.++|+||+.
T Consensus       176 y~~~~d~~s~~  186 (191)
T d1zara2         176 YRTEKDINSAI  186 (191)
T ss_dssp             HCCCCCHHHHH
T ss_pred             CCCcccHHHHH
Confidence            67788999964

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.26  E-value=0.0026  Score=47.07  Aligned_cols=29  Identities=34%  Similarity=0.394  Sum_probs=26.1

Q ss_pred             cCcEecCcCCCCEEEecCCCEEEeccccc
Q 027927           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        37 ~~i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      .|++|+|+.++|++++.+....++||+.+
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~  211 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFA  211 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             cccccCCcchhhhhcccccceeEeccccc
Confidence            46999999999999999877789999976

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=94.36  E-value=0.01  Score=42.26  Aligned_cols=27  Identities=26%  Similarity=0.334  Sum_probs=23.8

Q ss_pred             cEecCcCCCCEEEecCCCEEEeccccc
Q 027927           39 VIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        39 i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ++|||+.+.||+++.++.+.++||+.+
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a  211 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             EEEeeccCcceeecCCceEEEeechhc
Confidence            899999999999998766679999865

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=93.79  E-value=0.03  Score=41.38  Aligned_cols=58  Identities=14%  Similarity=0.133  Sum_probs=34.1

Q ss_pred             HHHHhCCCCCHHHHH---HHHHHHHHHHHHHHH----cCcEecCcCCCCEEEecCCCEEEecccccc
Q 027927            7 QIIRSNQSLSEEHCQ---YFLYQLLRGLKYIHS----ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus         7 ~~l~~~~~l~~~~~~---~~~~~i~~~l~~Lh~----~~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      +++.....++.+...   ..+..++..+...-.    .+++|||+.+.||+++.+  ..++||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         155 KLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             HHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             HHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            444444444444333   333444433333221    358999999999999743  4589998763

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=93.51  E-value=0.014  Score=41.37  Aligned_cols=27  Identities=22%  Similarity=0.198  Sum_probs=23.9

Q ss_pred             cEecCcCCCCEEEecCCCEEEeccccc
Q 027927           39 VIHRDLKPSNLLLNANCDLKICDFGLA   65 (217)
Q Consensus        39 i~H~di~~~nil~~~~~~~~l~d~~~~   65 (217)
                      ++|||+.+.||+++.+..+.++||+.+
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~  203 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRL  203 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhc
Confidence            899999999999998766779999865

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=92.08  E-value=0.11  Score=39.43  Aligned_cols=28  Identities=25%  Similarity=0.425  Sum_probs=24.4

Q ss_pred             CcEecCcCCCCEEEecCCCEEEecccccc
Q 027927           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (217)
Q Consensus        38 ~i~H~di~~~nil~~~~~~~~l~d~~~~~   66 (217)
                      .++|||+++.||+++.+ .++++||..+.
T Consensus       224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH-ETKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred             ceeccCCcCCceeEcCC-ceEEechhhcc
Confidence            49999999999999876 48999998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=86.28  E-value=0.13  Score=38.92  Aligned_cols=15  Identities=40%  Similarity=0.638  Sum_probs=13.3

Q ss_pred             cEecCcCCCCEEEec
Q 027927           39 VIHRDLKPSNLLLNA   53 (217)
Q Consensus        39 i~H~di~~~nil~~~   53 (217)
                      ++|+|+.+.||++..
T Consensus       220 ~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         220 FCHNDLQEGNILLPK  234 (395)
T ss_dssp             EECSCCCGGGEEEEC
T ss_pred             EEecCCCcccEeecc
Confidence            689999999999854